Cephalon, Inc. (CEPH) and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals, Inc. (MYL) and Barr Pharmaceuticals, Inc. (BRL)

FRAZER, Pa. and PHILADELPHIA — 26-Nov-2008

FRAZER, Pa. and PHILADELPHIA, Nov. 26 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH - News) and Eurand, Inc. (Nasdaq: EURX - News) today announced that they have filed a lawsuit in U.S. District Court in Delaware against Mylan Pharmaceuticals, Inc. and its subsidiary, Mylan, Inc., and Barr Pharmaceuticals, Inc. and its subsidiary, Barr Laboratories, Inc., for infringement of Eurand\'s U.S. Patent Number 7,387,793.

Roche wins European approval for hepatitis drug

By Staff Writer — 5-Dec-2008

Roche has announced that the European Commission has approved Pegasys plus Copegus for the re-treatment of hepatitis C patients who were not successfully treated with an initial course of interferon alpha, either alone or in combination with ribavirin.

Alnylam Pharmaceuticals (ALNY) Strengthens Intellectual Property Estate through Acquisition of Nucleonics Inc. Patent Assets

CAMBRIDGE, Mass — 8-Dec-2008

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company, announced today that it has acquired the intellectual property (IP) assets of Nucleonics, Inc., a privately held biotechnology company. The Nucleonics IP estate includes over 100 active patent filings, including 16 that have granted worldwide and 6 that have been granted in the U.S., Europe, or Japan – the world’s largest pharmaceutical markets.

Gilead accuses Teva of patent infringement

Foster City-based Gilead — 12-Dec-2008

Foster City-based Gilead (NASDAQ:GILD) said the suit, filed in U.S. District Court in New York, centers on patents associated with emtricitabine, a component of Truvada and licensed exclusively to Gilead by Emory University.

Sanofi-Aventis (France) (SASY.PA) And Bristol-Myers Squibb Company (BMY) Prevail Before the U.S. Court of Appeals for the Federal Circuit in the U.S Plavix(R) Patent Infringement Case

PARIS & NEW YORK — 14-Dec-2008

Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) and Bristol-Myers Squibb (New York: NYSE: BMY) announced today that the U.S. Court of Appeals for the Federal Circuit has upheld the June 19, 2007 decision by the U.S. District Court for the Southern District of New York holding the U.S. patent 4,847,265 covering clopidogrel bisulphate, the active ingredient in Plavix®, valid and enforceable. As a result of this ruling, the ‘265 patent protection for this product is maintained in the United States until November 2011.

Gilead Sciences Files Patent Infringement Lawsuit Against Teva Pharmaceuticals

FOSTER CITY, Calif — 15-Dec-2008

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that it has filed a lawsuit in U.S. District Court in New York against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. for infringement of U.S. Patent Numbers 6,642,245 and 6,703,396. Both patents are associated with emtricitabine, a component of Truvada(R) (emtricitabine and tenofovir disoproxil fumarate), and are licensed exclusively to Gilead Sciences by Emory University. Truvada is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.

Transcept: Intermezzo accepted for review by the FDA

By Charlotte Dumezy — 18-Dec-2008

Transcept\'s insomnia drug, Intermezzo, has been accepted for review by the FDA. This sublingual reformulation of zolpidem, designed for the treatment of middle-of-the-night awakenings, provides a fast onset of action and maintains sleep for only four hours. It is not clear that Intermezzo fulfils a significant unmet need and Datamonitor believes the market for such a treatment will be limited.

FDA approves Gleevec (imatinib mesylate) to prevent gastrointestinal stromal tumor

Pharmaceutical News — 21-Dec-2008

The U.S. Food and Drug Administration has approved Gleevec (imatinib mesylate) for a new indication - keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor or GIST.

Pressure BioSciences, Inc. And Battelle Memorial Institute Sign Exclusive Patent License Agreement

Pressure BioSciences, Inc. — 22-Dec-2008

Pressure BioSciences, Inc. (\"PBI\" or the \"Company\") today announced that they have entered into an exclusive patent license agreement with the Battelle Memorial Institute (\"Battelle\"). The licensed technology is described in the patent application filed by Battelle on July 31, 2008 (US serial number 12/183,219). This application includes subject matter related to a method and a system for improving the analysis of protein samples, including through an automated, in-line system utilizing pressure and a pre-selected agent to obtain a digested sample in a significantly shorter period of time than current methods, while maintaining the integrity of the sample throughout the preparatory process.

AstraZeneca and MAP Pharmaceuticals announce collaboration on Unit Dose Budesonide

Pharmaceutical News — 22-Dec-2008

AstraZeneca and MAP Pharmaceuticals, Inc. have announced an exclusive worldwide agreement to develop and commercialize Unit Dose Budesonide (UDB), MAP Pharmaceuticals\' proprietary nebulized formulation of budesonide.

AstraZeneca submits sNDA for NEXIUM (esomeprazole magnesium)

Pharmaceutical News — 22-Dec-2008

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for NEXIUM(R) (esomeprazole magnesium) to seek approval for the short-term (up to 6 weeks) treatment of gastroesophageal reflux disease (GERD) in pediatric patients ages 0 to 1 year old.

Glenmark may beat rivals in novel chemical entity sale

P B Jayakumar / Mumbai — 23-Dec-2008

Glenmark Pharmaceuticals, India’s 11th biggest drug maker by sales, may beat bigger rivals, including Ranbaxy, Dr Reddy’s and Nicholas Piramal, in selling an original drug, or novel chemical entity (NCE), by 2010.

AVI BioPharma Strengthens Its Patent Position in RNA Therapeutics

PORTLAND, OR - AVI BioPharma Inc. — 23-Dec-2008

PORTLAND, OR - AVI BioPharma Inc. (AVII), a developer of RNA–based drugs, announced the issuance of a US patent protecting the composition of matter of its RNA–based therapeutic agent AVI–5126.

Sun Pharmaceutical extends tender offer for Taro

By Staff Writer — 23-Dec-2008

India-based Sun Pharmaceutical Industries has announced that its subsidiary Alkaloida Chemical Company Exclusive Group has extended the expiration date of the tender offer for the purchase of all outstanding ordinary shares of US-based Taro Pharmaceutical Industries.

Bill to amend Apeda Act in LS

New Delhi — 23-Dec-2008

A Bill seeking to amend the Agricultural and Processed Food Products Export Development Authority (Apeda) Act 1985 to empower the Authority to undertake steps for registration and protection of intellectual property rights in respect of specified agricultural and processed food products, including basmati rice, was introduced in the Lok Sabha on Monday.

Aurobindo Pharma gets Canada nod for Terbinafine

Reuters,Mumbai — 24-Dec-2008

Drug maker Aurobindo Pharma said on Wednesday it received the Canadian regulatory approval to sell terbinafine hydrochloride tablets in multiple strengths.

Warner Chilcott Files Lawsuits for Infringement of DORYX Patent

ST. DAVID\'S, BERMUDA — 24-Dec-2008

Warner Chilcott Limited (WCRX) announced in a press release that one of its subsidiaries and Mayne Pharma International Pty. Ltd. (\"Mayne\"), a subsidiary of Hospira, Inc., have filed lawsuits against each of Mutual Pharmaceutical Company Inc. (Mutual), Mylan Pharmaceuticals Inc. (Mylan) and Impax Laboratories Inc. (Impax).

Teva wins approval for generic Seroquel tablets

By Staff Writer — 24-Dec-2008

Teva Pharmaceutical Industries has announced that the FDA has granted tentative approval for the company\'s abbreviated new drug application to market its generic version of AstraZeneca\'s antipsychotic agent Seroquel tablets, equivalent to 25mg base, 50mg base, 100mg base, 150mg base, 200mg base, 300mg base and 400mg base.

Bill to change Apeda Act to protect trade mark interests

G. Srinivasan, New Delhi — 25-Dec-2008

Indias case for safeguarding its specified agricultural and processed food products such as basmati rice, Darjeeling tea or Alfonso mango which have been increasingly challenged by other countries would get a real booster dose once the Agricultural and Processed Food Products Export Development Authority (Amendment) Bill introduced in the just-ended Parliament session gets into the statute

Bristol-Myers to pay $1.1 million as settlement charges in Plavix case

By Staff Writer — 26-Dec-2008

Bristol-Myers Squibb has agreed to pay $1.1 million as part of settlement charges in the Plavix case, which was being investigated by the New York State Attorney General\'s Office, reported Reuters

Dr Reddy\'s resolves patent litigation with Schering and Sepracor

Datamonitor staff writer — 28-Dec-2008

Dr Reddy\'s Laboratories has entered into agreements with Schering and Sepracor which is expected to allow Dr Reddy\'s to manufacture and market generic versions of the Clarinex-D 12 hour and Clarinex-D 24 hour products, with six months marketing exclusivity, and the Clarinex Reditabs product, with six months marketing co-exclusivity, starting in 2012.

US’ Alcon wins case against Ajanta Pharma

Paramita Chatterjee & Khomba Singh, ET Bureau — 29-Dec-2008

US’ Alcon wins case against Ajanta Pharma 29 Dec 2008, 0022 hrs IST, Paramita Chatterjee & Khomba Singh, ET Bureau Print EMail Discuss Share Save Comment Text: NEW DELHI: US-based drugmaker Alcon has won a trademark case against its Indian counterpart Ajanta Pharma preventing the latter from selling its popular eyedrop under the brand ‘Travaxo’ here. The Bombay High Court (HC) granted an injunction in favour of Alcon, restricting Ajanta Pharma from using its product Travaxo on grounds of trademark infringement. The medicine directly competes with Alcon’s Travatan in the highly competitive Rs 33,000-crore drug retail market.

Cree Settles Patent Litigation with Bridgelux

DURHAM, NC — 30-Dec-2008

Cree Inc. announced in a press release that the company and Boston University have agreed with Bridgelux Inc. to settle the parties’ patent infringement litigation and to dismiss all claims and counterclaims in the suits.

Apeda moves Sindh HC against basmati trademark

Chennai — 30-Dec-2008

The Agricultural and Processed Food Products’ Export Development Authority (Apeda) has moved the Sindh High Court in Pakistan against the trademark right given by the Registrar of Trademark, Karachi, to Basmati Growers’ Association, Lahore, for basmati rice. The registrar, in fact, has allowed only the growers to use the trademark. The case is slated to come up for hearing in January.

Aurobindo Pharma gets US nod for Stavudine

Reuters,Mumbai — 31-Dec-2008

Drug firm Aurobindo Pharma said on Wednesday it received the final nod from the US Food and Drug Administration for its stavudine tablets and oral solution.

Bayer sues Abbott, alleging patent infringement

By LINDA A. JOHNSON — 31-Dec-2008

Pharmaceutical and chemical maker Bayer AG has filed a federal lawsuit alleging that drugmaker Abbott Laboratories\' best-selling drug, Humira, infringes on a decade-old Bayer patent.

Novartis Girds for the Day Blockbuster Loses Patent

LONDON — 31-Dec-2008

Sales of Novartis\'s blockbuster drug, Diovan, are expected to tumble when the high-blood-pressure pill\'s patent expires in four years

Akorn-Strides, LLC Announces FDA Approvals for Sterile Vancomycin HCl USP, 500 mg/Vial; 1 g/Vial and Sterile Vancomycin HCl USP, 5 g/Vial Pharmacy Bulk Package

LAKE FOREST, Ill.(BUSINESS WIRE) — 31-Dec-2008

Akorn-Strides, LLC today announced that the U.S. Food and Drug Administration has granted approvals for two Abbreviated New Drug Applications (ANDAs) for Sterile Vancomycin HCl USP, 500 mg/vial, 1 g/vial and Sterile Vancomycin HCl USP, 5 g/vial Pharmacy Bulk Package. Akorn-Strides, LLC is a Joint Venture that was formed in 2004 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab Limited (NSE: STAR) (BSE: 532531). The primary mission for the Joint Venture is to develop liquid, lyophilized and dry powder formulations of generic injectable products targeting several therapeutic markets with a major focus on anti-infectives, analgesics and CNS medicines.

IMPAX Sued Based on ANDA for Generic Doryx®

HAYWARD, Calif.(BUSINESS WIRE) — 01-Jan-2009

IMPAX Laboratories, Inc. today announced that Warner Chilcott Laboratories Ireland Limited, Warner Chilcott Company, Inc., Warner Chilcott (US) LLC, and Mayne Pharma International PTY. LTD have filed suit for patent infringement in the United States District Court for the District of New Jersey based on the Company’s submission of Abbreviated New Drug Application (“ANDA”) for doxycycline hyclate delayed-release tablets (75 and 100 mg), generic of Doryx®, to the Food and Drug Administration. In connection with this ANDA, IMPAX provided notice that its submission includes a Paragraph IV certification stating the Company believes its product does not infringe U.S. Patent No. 6,958,161, or the patent is invalid or unenforceable.

Cipla pips Ranbaxy in domestic market

P B Jayakumar — 2-Jan-2009

Veteran industrialist Y K Hamied-led Cipla has edged out Daiichi-Sankyo-owned Ranbaxy Laboratories as the largest player in the domestic pharmaceutical market in the January-November period, according to data compiled by ORG-IMS..

Ranbaxy misses deadline for migraine drug launch

Khomba Singh, ET Bureau — 2-Jan-2009

NEW DELHI: India\'s largest drugmaker, Ranbaxy Laboratories, has missed its December 2008 deadline to launch an anti-migraine drug as the US regulator has yet to give its approval. Ranbaxy was expecting to earn almost $100 mn from the drug, a low-cost version of GlaxoSmithKine-owned Imitrex.

Labopharm wins FDA approval for pain drug

By Staff Writer — 02-Jan-2009

Labopharm, a Canadian specialty pharmaceutical company, has announced that the FDA has approved Ryzolt, the company\'s once-daily formulation of the analgesic tramadol.

FDA extends review of King Pharmaceuticals\'s Embeda extended release capsules

By Staff Writer — 2-Jan-2009

King Pharmaceuticals has announced that the FDA is continuing its review of the company\'s new drug application for Embeda extended release capsules. It is likely that this review will extend into early 2009.

FDA extends review of King Pharmaceuticals

By Staff Writer — 05-Jan-2009

Imitrex delay: Ranbaxy\'s loss may be Dr Reddy\'s gain

Press Trust Of India / New Delhi — 5-Jan-2009

The delay in Ranbaxy Laboratories getting approval from the USFDA for launching the generic version of GlaxoSmithKline’s (GSK) migraine and headache drug Imitrex could turn out to be a gain for Dr Reddy’s Laboratories, which has already launched the drug in the United States.

Acura and King Pharmaceuticals file NDA for pain drug

By Staff Writer — 05-Jan-2009

Acura Pharmaceuticals and King Pharmaceuticals have submitted a new drug application for Acurox tablets to the FDA including a request for priority review.

Orexigen Therapeutics Issued a Key Fourth US Patent

SAN DIEGO — 05-Jan-2009

Orexigen Therapeutics Inc. announced in a Monday press release that the United States Patent and Trademark Office (USPTO) has issued a patent for what the company refers to as the \"Weber/Cowley methods patent\" (US Patent No. 7,462,626), which provides coverage for Contrave, the company\'s lead obesity product candidate now in Phase 3 clinical trials.

Alexion and PDL BioPharma Resolve Patent Dispute

NCLINE VILLAGE, NEV., and CHESHIRE, CONN — 05-Jan-2009

PDL BioPharma Inc. and Alexion Pharmaceuticals Inc. today jointly announced that the companies have entered into a definitive license agreement and settlement agreement that resolve the legal disputes between them relating to Alexion\'s humanized antibody, Soliris (eculizumab) and PDL\'s patents known as the Queen et al. patents.

Pronova BioPharma ASA Files a Terminal Disclaimer

LYSAKER, NORWAY — 06-Jan-2009

Pronova BioPharma ASA announced in a Tuesday press release that it has filed a Terminal Disclaimer in US Patent No. 5,656,667 (\'667 Patent) with the US Patent and Trademark Office.

Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment

Warner Chilcott Limited — 06-Jan-2009

Warner Chilcott Limited today announced that it has signed an agreement with Dong-A PharmTech Co. Ltd., based in Korea, to develop and market their orally-administered udenafil product, a phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED) in the United States. Dong-A has successfully completed Phase 2 studies of the product in the United States.

Pfizer Wins New Lipitor Patent Expiring in June 2011

Susan Decker — 6-Jan-2009

Pfizer Inc. won new protection on the cholesterol pill Lipitor, the world's best-selling drug, after the U.S. agreed to reissue a patent on the drug's key ingredient that had been invalidated by an appeals court. The U.S. Patent and Trademark Office today said it would reissue a patent that expires in June 2011 after the company altered what an appeals court had called inconsistent language that made the patent invalid.

Sun Pharmaceutical receives FDA approvals for 4 generics

Pharmaceutical News — 7-Jan-2009

Pharmaceutical Industries Ltd. announced that together with its subsidiaries, it has received final approval from U.S. FDA for several Abbreviated New Drug Applications (ANDA).

Marshall Edwards wins IND approval for cancer drug

By Staff Writer — 8-Jan-2009

Marshall Edwards, an oncology company, has received an investigative new drug approval from the FDA to undertake clinical studies with triphendiol as a chemosensitizing agent in combination with gemcitabine.

Adhezion wins FDA clearance for SurgiSeal topical skin adhesive

By Staff Writer — 8-Jan-2009

Adhezion Biomedical, a medical device company, has announced that the FDA has provided marketing clearance for its SurgiSeal topical skin adhesive.

Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication

SOUTH SAN FRANCISCO — 9-Jan-2009

Anesiva, Inc. (Nasdaq: ANSV) today announced that the U.S. Food and Drug Administration (FDA) has approved Anesiva\'s supplemental New Drug Application (sNDA) to expand the indication for Zingo(TM) to treat the pain associated with blood draws to include adults. Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system was previously approved to treat the pain associated with peripheral IV insertions and blood draws in children three to 18 years of age. The notification was received according to PDUFA deadlines.

Silence Therapeutics Granted New Patent

LONDON — 10-Jan-2009

Silence Therapeutics plc, the leading European biopharmaceutical company focused on RNA interference, announced that the European Patent Office (EPO) has granted a patent to Silence that covers the company‘s lead product candidate, Atu027, a press release by the company stated.

Genta Announces Issuance of Two Key US Patents

BERKELEY HEIGHTS, NJ — 10-Jan-2009

Genta Incorporated announced in a press release that two new patents related to the company\'s franchise in gallium-containing products have issued in the United States.

Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin® 24 and Femcon® Fe Patent Litigation

Watson Pharmaceuticals, Inc.; Warner Chilcott Limited — 12-Jan-2009

Watson Pharmaceuticals, Inc. and Warner Chilcott Limited announced today that they have entered into Settlement and License Agreements to resolve pending patent litigation related to Warner Chilcott\'s oral contraceptive products, Loestrin® 24 and Femcon® Fe. Separately, Warner Chilcott and Watson have entered into a Co-Promotion Agreement relating to Warner Chilcott\'s Femring® product and License and Supply Agreements relating to a Warner Chilcott development-stage oral contraceptive product.

VIVUS Announces Issuance of Key European Patent for Qnexa

MOUNTAIN VIEW, CA — 13-Jan-2009

VIVUS Inc.announced in a Tuesday press release that the European Patent Office has granted a patent for Qnexa, an investigational, oral weight loss product for the treatment of obesity and related conditions.

Dey L.P. Granted Three Additional US Patents

PITTSBURGH — 13-Jan-2009

Mylan Inc. announced in a Tuesday press release that its subsidiary Dey L.P. has been issued several additional US patents protecting the company\'s Perforomist Inhalation Solution, a chronic obstructive pulmonary disease (COPD) treatment.

Bavarian Nordic\'s patent infringement suit against Oxford BioMedica

Medical Patent News — 13-Jan-2009

Bavarian Nordic owns several United States patents relating to an attenuated strain of the company\'s core technology, MVA-BN(R), which is the basis for its smallpox vaccine, IMVAMUNE(R).

Oncolytics Biotech issued new U.S. patent \"Reovirus for the Treatment of Neoplasia\"

Medical Patent News — 14-Jan-2009

Oncolytics Biotech Inc. has announced that it has been granted its 31st U.S. Patent, # 7,476,382, entitled \"Reovirus for the Treatment of Neoplasia.\"

Vical Announces Issuance of New US Patent

SAN DIEGO — 14-Jan-2009

Vical Incorporated announced in a Wednesday press release the issuance of US Patent No. 7,470,675 covering the composition, delivery and use of gene-based interferon-omega.

China Pharma wins approval for Tiopronin enteric-coated capsules

By Staff Writer — 14-Jan-2009

China Pharma Holdings, a developer, manufacturer and marketer of specialty pharmaceuticals, has received approval from China\'s State Food and Drug Administration for the production of Tiopronin enteric-coated capsules. Tiopronin is listed in the National Medical Insurance Program, thus allowing patients to obtain reimbursement.

Eli Lilly Said to Be Near $1.4 Billion U.S. Settlement

By GARDINER HARRIS and ALEX BERENSON — 14-Jan-2009

Eli Lilly, the drug company, is expected to agree as soon as Thursday to pay $1.4 billion to settle criminal and civil charges that it illegally marketed its blockbuster antipsychotic drug Zyprexa for unauthorized use in patients particularly vulnerable to its risky side effects.

Not a patent process

New Delhi — 15-Jan-2009

Our patent regime is yet to gain full credibility although the patent law conforms to global norms

Dr Reddy’s consignment of drugs to Brazil seized

Radhieka Pandeya — 15-Jan-2009

This is the first time a shipment of a large Indian company has been held on charges of patent infringement

Oscient files patent lawsuit against another drug firm

Boston Globe Business Team — 15-Jan-2009

Oscient Pharmaceuticals Corp. of Waltham said it has filed a patent infringement lawsuit against Lupin Pharmaceuticals Inc., which is seeking to market a generic version of one of Oscient\'s drugs.

India to drag EU to WTO over the issue of patents

PTI — 16-Jan-2009

NEW DELHI: The tussle between Indian generic drug industry and western innovative pharmaceutical firms is set to get stronger as India is considering dragging the European Union to WTO on the issue.

No antidote to stop copies of patented drugs: Health min

Khomba Singh & Sushmi Dey — 17-Jan-2009

NEW DELHI: The health ministry has said it is not equipped with technical expertise to stop domestic pharmaceutical companies from copying patented drugs.

Drug cos concerned over definition of counterfeits

P.T. Jyothi Datta,Mumbai — 18-Jan-2009

The seizure of a transiting export consignment belonging to Dr Reddy’s Laboratories by customs authorities in Netherlands, barely two months after another local drug-maker Ind-Swift faced a similar situation, has the domestic pharmaceutical industry concerned about what they say are efforts to block the movement of generic drugs.

\'Uniform patent policy needed for cheaper drugs\'

AHMEDABAD — 18-Jan-2009

Chief justice of Gujarat High Court, KS Radhakrishnan has called for a uniform patenting policy in order to curtail price rise of life saving drugs.

Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent

HAMILTON, Bermuda — 19-Jan-2009

Warner Chilcott Limited announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. (\"Mayne\"), a subsidiary of Hospira, Inc., have filed a lawsuit against Sandoz Inc. (\"Sandoz\") in the District Court for the District of New Jersey for infringement of Mayne\'s U.S. Patent No. 6,958,161 (the \"\'161 Patent\") which covers DORYX, a tetracycline-class oral antibiotic.

Oscient and Ethypharm file lawsuit against Lupin

Datamonitor staff writer — 19-Jan-2009

Oscient Pharmaceuticals, a commercial-stage pharmaceutical company, has announced that the company, its wholly owned subsidiary Guardian II Acquisition, and its licensor, Ethypharm, have filed a lawsuit against Lupin Limited and its subsidiary Lupin Pharmaceuticals in the US District Court of Maryland for the infringement of a US patent which covers Antara (fenofibrate) capsules.

CSL Behring\'s bleeding disorder drug RiaSTAP gets US FDA marketing nod

King of Prussia, Pennsylvania — 20-Jan-2009

US Food and Drug Administration (FDA) has granted marketing approval to CSL Behring for RiaSTAP, the first and only treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.

Alexza Pharmaceuticals (ALXA) Initiates AZ-104 Phase 2b Clinical Trial in Patients With Migraine Headaches

Corporate News — 20-Jan-2009

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated a Phase 2b clinical trial with AZ-104 (Staccato loxapine) in patients with migraine headaches.

Corgenix Receives Two Additional Patents on AtherOx® Technology

Corgenix Medical Corporation — 20-Jan-2009

Corgenix Medical Corporation , a worldwide developer and marketer of diagnostic test kits, has received notification of two new patents for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.

Geneart wins new European patent

By Staff Writer — 20-Jan-2009

Geneart, a provider of DNA engineering and processing solutions, has received a new patent for selective evolution of proteins from the European Patent Office.

Dr Reddy\'s Labs back in the black

BS Reporter / Mumbai — 21-Jan-2009

Dr Reddy’s Laboratories, India’s biggest drug maker by sales, said it turned to profit in the third-quarter, helped by higher sales of an authorised generic drug in the US, even as it set aside money for foreign exchange losses.

King Pharma Has A Patent Problem

Lisa LaMotta — 21-Jan-2009

King Pharmaceuticals was looking a little less than regal Wednesday when a court invalidated two patents for its best-selling drug.

GeoPharma Announces Settlement of Clarinex ANDA Patent Litigation

LARGO, FLA — 21-Jan-2009

GeoPharma, Inc. announced in a Wednesday press release that it has reached agreement with the Schering Corporation, and Sepracor Inc. and the University of Massachusetts settling all Hatch-Waxman litigation relating to Desloratadine tablets (5 mg), with the Company receiving a license under all relevant patents.

HC allows CPAA to join Bayer-Cipla case

Khomba Singh & Sushmi Dey — 21-Jan-2009

NEW DELHI: The Delhi High Court (HC) has allowed cancer patient group Cancer Patients Aid Association (CPAA) to join the Bayer AG and Cipla case. The German drugmaker Bayer AG had sued the Indian government, its drug regulator and domestic drug company Cipla for giving marketing approval to Cipla for Bayer\'s patented cancer drug Nexavar.

Silence Therapeutics announces favorable ruling in European patent lawsuit

By Staff Writer — 21-Jan-2009

Silence Therapeutics, a UK-based RNAi-focused biotechnology company, has announced that a second member of the Kreutzer-Limmer patent family has been revoked in its entirety.

Drugs regulator issues warning letters to Wyeth pharma, GVK

Radhieka Pandeya — 22-Jan-2009

Office of the drugs controller general of India issued warning letters asking for explanations, based on the audit findings

GSK wins European approval for weight loss drug

By Staff Writer — 22-Jan-2009

GlaxoSmithKline has received a non-prescription license for alli, a drug indicated for weight loss in adults, with a BMI 28kg/m2 or more, when used along with a reduced calorie, lower-fat diet.

Alnylam Provides Update on Kreutzer-Limmer Patent Family

CAMBRIDGE, MASS — 22-Jan-2009

Alnylam Pharmaceuticals Inc., a leading RNAi therapeutics company, announced in a press release that the European Patent Office (EPO) has ruled in favor of the opposing parties in oral proceedings before the European Opposition Board related to the \'945 (EP 1214945) patent in its Kreutzer-Limmer patent estate.

Ranbaxy losses mount on forex hit

BS Reporter / New Delhi — 23-Jan-2009

Ranbaxy Laboratories, India’s biggest drug maker, posted a loss for the second straight quarter on adverse foreign exchange fluctuations.

Lilly, Bristol withdraw FDA Erbitux lung cancer application

By Wallace Witkowski — 23-Jan-2009

SAN FRANCISCO (MarketWatch) -- ImClone Systems, which was recently acquired by Eli Lilly & Co.and Bristol-Myers Squibb Co. said Friday they decided to withdraw a Food and Drug Administration application to market cancer drug Erbitux for a type of advanced lung cancer.

GSK wins European positive opinion for pneumococcal vaccine

By Staff Writer — 23-Jan-2009

GlaxoSmithKline has announced that the European Medicines Agency\'s Committee for Medicinal Products for Human Use has issued a positive opinion and recommended the approval of GSK\'s pediatric pneumococcal candidate vaccine Synflorix.

GeoPharma settles patent litigation with Schering and Sepracor

Datamonitor staff writer — 23-Jan-2009

GeoPharma has reached an agreement with Schering, Sepracor and the University of Massachusetts settling all Hatch-Waxman litigation relating to desloratadine tablets 5mg, with the company receiving a license under all relevant patents.

A Pfizer-Wyeth Merger Isn\'t the Cure-All

By Catherine Arnst — 24-Jan-2009

Buying Wyeth would boost Pfizer\'s revenues, but it won\'t help with the litany of marketing challenges and other problems plaguing Big Pharma

Pfizer, Wyeth close to deal: reports

AP / PTI / New York — 26-Jan-2009

Drugmakers Pfizer and Wyeth are closing in on a deal worth $68 billion that could be announced before the markets open today, according to published reports.

Stromedix awarded U.S. patent for antibody-based therapeutics

Medical Patent News — 26-Jan-2009

Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, has announced that the U.S. Patent Office has granted patent number US 7,465,449, which broadly covers monoclonal antibodies to integrin ávβ6, including compositions related to its lead product, STX-100.

\'Ranbaxy\'s investments in Indian drug cos yet to pay off\'

Khomba Singh — 27-Jan-2009

NEW DELHI: Ranbaxy Laboratories\' strategic investments in Indian drug companies have so far not delivered desired results, feel industry analysts.

Indian arms of Pfizer, Wyeth to merge soon

BS Reporter / New Delhi — 27-Jan-2009

The decision of Pfizer to acquire rival drugmaker Wyeth in a $68-billion cash-and-stock deal will also see merger of the listed Indian subsidiaries of both US multinationals soon.

WHO won\'t redefine fake drugs

Sushmi Dey & Khomba Singh — 27-Jan-2009

NEW DELHI: In a major victory for India\'s cheap but high quality generic drug industry, the World Health Organisation (WHO) has decided to shelve its plans of redefining counterfeit medicines-a move that could have posed a threat to sale and export of legitimate generic medicines, a government official said.

Pfizer-Wyeth may climb to No 2 spot

P B Jayakumar / Mumbai — 28-Jan-2009

The merger of Pfizer and Wyeth is expected to create the second-biggest drug maker among multinational companies in India. The world\'s largest drug maker Pfizer yesterday announced a $68-billion acquisition of US-based Wyeth.

Jannssen-Cilag\'s Stelara approved in EU for psoriasis

Katie McQue- Reporter — 28-Jan-2009

The European Commission has approved Janssen-Cilag\'s (Johnson & Johnson) novel human monoclonal antibody drug Stelara (ustekinumab) for the treatment of moderate-to-severe plaque psoriasis in adults who have failed to respond to, are intolerant to, or have a contraindication to other systemic therapies including ciclosporin, methotrexate and psoralen plus ultraviolet light (PUVA).

Drug prices increased

Our Bureau ,New Delhi — 28-Jan-2009

Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has revised the price of 174 formulation packs and three bulk drugs. Prices of most of the drugs have been revised upward.

Mylan receives final FDA approvals for generic Lamictal tablets

Pharmaceutical News — 29-Jan-2009

Mylan Inc has announced that its subsidiaries Mylan Pharmaceuticals Inc. and Genpharm ULC received final approvals from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug Applications (ANDAs) for Lamotrigine Tablets.

Medarex announces allowance of IND application for antibody-drug conjugate, MDX-1203

Pharmaceutical News — 29-Jan-2009

Medarex, Inc. has announced the allowance of an investigational new drug (IND) application filed with the U.S. Food & Drug Administration (FDA) for MDX-1203, the Company\'s first Antibody-Drug Conjugate (ADC) candidate generated from its proprietary technology.

Cadila to strengthen US reach with fresh approvals

BS Reporter / Mumbai/ Ahmedabad — 30-Jan-2009

Ahmedabad based pharma major Zydus Cadila has got a shot in the arm as it has received three product approvals from the United States Food and Drug Administration (USFDA) in quick succession.

Merck eyes Indian drug biggie, brands

P B Jayakumar / Mumbai — 30-Jan-2009

Germany-based Merck KGaA, the world’s oldest multinational pharmaceutical company, is eyeing to acquire a prominent Indian pharmaceutical company and established drug brands.

Pfizer\'s acquisition of Wyeth brings scale but will fail to deliver sustainable sales growth

By Datamonitor staff writer — 30-Jan-2009

The Pfizer-Wyeth merger will create a prescription pharmaceutical company of unprecedented scale. The combined entity would have recorded total company sales in excess of $70 billion and prescription pharmaceutical sales of over $60 billion in 2008.

Patents grant for mere change under scanner

C.H. Unnikrishnan — 30-Jan-2009

Mumbai: The Mumbai patent office has initiated an inquiry into alleged violations in granting patents for modified forms of existing drugs, even as newly available documents related to these present evidence of negligence.

Seattle Genetics\'s lymphoma drug wins orphan designation

By Datamonitor staff writer — 30-Jan-2009

Seattle Genetics, a clinical stage biotechnology company, has announced that its antibody-drug conjugate SGN-35 has received the orphan drug designation from the European Medicines Agency for the treatment of Hodgkin lymphoma and anaplastic large cell lymphoma, or ALCL, and from the FDA for the treatment of ALCL.

Pfizer pancreatic cancer drug fails, trial halted

NEW YORK — 30-Jan-2009

Pfizer Inc (PFE.N), in its latest research setback, said on Friday it stopped a late stage study of an experimental drug to treat advanced pancreatic cancer after an independent monitoring board found no evidence that it prolongs survival.

Warner Chilcott files patent suit against Actavis

Hamilton, Bermuda — 30-Jan-2009

Warner Chilcott Limited announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. (\"Mayne\") have filed a lawsuit against Actavis Elizabeth LLC (\"Actavis\") in the District Court for the District of New Jersey for infringement of Mayne\'s U.S. Patent No. 6,958,161 (the \"\'161 Patent\") which covers DORYX, a tetracycline-class oral antibiotic.

Shah Rukh in legal soup over copyright

Vignesh Iyer, Mumbai — 31-Jan-2009

A petition has been filed against Shah Rukh Khans Red Chillies Private Ltd, TV channel NDTV Imagine and Sunanda Oberai by Neha Joshi for making a serial Ghar Ki Baat, based on the script written by her father, Sharad, for a comedy serial called Yeh Jo Hai Zindagi, without obtaining any prior permission and violating the Copyright Act

India to move WTO on Dutch drug seizure

New Delhi — 31-Jan-2009

India and Brazil have decided to mount a joint offensive at the World Trade Organisation against the Netherlands for seizing a consignment in transit, which was on its way from India to Brazil.

FTC challenges Par Solvay patent settlement

Vidya L Nathan, Bangalore — 2-Feb-2009

Par Pharmaceutical Cos Inc said federal and state regulators filed an antitrust lawsuit against it related to its patent settlement over Belgian drugmaker Solvay\'s testosterone gel, AndroGel.

New Trademarks Act in Force in Dominica

ROSEAU — 3-Feb-2009

The final deadline by which granted UK marks can be registered in Dominica will expire on February 1, 2010 - one year from the date of entry into force of the new legislation.

US lawmakers propose bill to stop generic drug patent deals

Diane Bartz, Washington — 3-Feb-2009

Two senior senators have introduced a bill that would make it illegal for pharmaceutical companies to pay generic drugmakers to keep lower priced alternatives off the market.

Intellectual property rights issues stall Bhel-NTPC project

Utpal Bhaskar — 04-Feb-2009

New Delhi: An alleged dispute over intellectual property rights has stalled a joint initiative between Bharat Heavy Electricals Ltd (Bhel) and NTPC Ltd to build less-polluting power generation plants.

India, Brazil slam Dutch govt for seizing drugs

D Ravi Kanth — 04-Feb-2009

India and Brazil today strongly denounced the Netherlands Customs authorities at the World Trade Organization for seizing several consignments of generic medicines from the two countries.

The IAS grabs the patent office too

Latha Jishnu — 04-Feb-2009

India’s patents office, or the Office of the Controller General of Patents, Designs and Trademarks to give its full title, was one of those dreary government departments, badly-equipped and poorly-staffed, its decrepit state of little interest to officialdom — or to the media — till January 1, 2005.

Cipla export consignment too seized at Amsterdam

P.T. Jyothi Datta — 04-Feb-2009

It is not just drug makers Ind-Swift and Dr Reddy’s Laboratories’ export consignments that were confiscated by Customs authorities in Amsterdam in the last three-odd months on the grounds of patent infringement.

EpiCept receives permission to file leukemia drug NDA

By Datamonitor staff writer — 04-Feb-2009

EpiCept a specialty pharmaceutical company has announced that the FDA indicated that the company has the necessary pivotal data to file a new drug application for Ceplene in conjunction with interleukin-2 as a remission maintenance treatment of acute myeloid leukemia.

Antarctic patents strain goals of shared science

Alister Doyle, Environment Correspondent, Rothera Base, Antarctica — 05-Feb-2009

An increasing number of companies developing new products through biological discovery or \"bioprospecting\" are trying to file patents on Antarctic organisms or molecules for items from cosmetics to medicines, putting new strains on the treaty.

Wockhardt launches Sanofis Lantus generic in India

REUTERS — 10-Feb-2009

Drugmaker Wockhardt Ltd said on Tuesday it has launched a new insulin Glaritus in India for the treatment of diabetes.

Geneart wins European patent for new screening system

By Datamonitor staff writer — 10-Feb-2009

Geneart a provider for DNA engineering and processing services has received a patent from European patent office for a new screening system based on synthesized virus like reporter genes with which a new class of antiviral drug candidates may be identified.

Wockhardt launches Sanofis Lantus generic in India

REUTERS — 10-Feb-2009

Drugmaker Wockhardt Ltd said on Tuesday it has launched a new insulin Glaritus in India for the treatment of diabetes.

Ranbaxy gets USFDA approval for migraine drug

Khomba Singh — 10-Feb-2009

The company had earlier missed its December 2008 launch date as it did not get approval from the US drug regulator.

OSI Pharmaceuticals Announces Notification of ANDA Filing for Tarceva

MELVILLE, NY — 11-Feb-2009

OSI Pharmaceuticals Inc announced the receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals USA Inc submitted an Abbreviated New Drug Application to the US Food and Drug Administration requesting permission to manufacture and market a generic version of Tarceva.

Global drug majors slow R&D offshoring to India

P B Jayakumar — 12-Feb-2009

New drug discovery and contract research have taken a back seat as global drug majors have slowed down their research and development offshoring to India.

Dr Reddys Losing the edge

Shobhana Subramanian & Varun Sharma — 12-Feb-2009

The upside from generic Imitrex will be lower with Ranbaxy also selling the 100mg dosage in the US market.

Teijin Pharma and Takeda Announces ULORIC Received FDA Approval for the Chronic Management of Hyperuricemia in Patients with Gout

TOKYO & OSAKA, Japan — 13-Feb-2009

Teijin Pharma Limited and Takeda Pharmaceutical Company Limited announced today that on February 13 2009 Teijin Pharmas US licensee for febuxostat and Takedas wholly owned subsidiary Takeda Pharmaceuticals North America Inc received FDA marketing approval for ULORIC for the chronic management of hyperuricemia in patients with gout.

Cubist plans to file patent infringement lawsuit against Teva

By Datamonitor staff writer — 13-Feb-2009

Cubist Pharmaceuticals a biopharmaceutical company has said that it intends to file a patent infringement lawsuit against Teva Parenteral Medicines in response to the abbreviated new drug application filing that TPM had submitted to the FDA for approval to market a generic version of Cubicin.

Glaxo proposes patent pool for neglected diseases

By Lisa Richwine — 13-Feb-2009

GlaxoSmithKline Plcs chief executive urged creation of a voluntary patent pool to spark development of new treatments for neglected diseases in the worlds poorest countries.

GlaxoSmithKline vows cheap medicine for the poor

AFP,LONDON — 14-Feb-2009

The head of British drugs giant GlaxoSmithKline said in a British newspaper Saturday he would cut prices for medication in developing countries and share knowledge of patented treatments.

FDA nod key to drug cos US growth

P B Jayakumar / Mumbai — 16-Feb-2009

Ranbaxy Dr Reddys and other Indian drug makers which earn a third of their earnings from selling products in the US need higher drug approvals from the Food and Drug Administration of that country in the next financial year to maintain 20 per cent sales growth.

As valuations dip Sun Pharma is in M&A mode

Ruchita Saxena — 16-Feb-2009

With valuations in the Indian pharmaceutical sector correcting in the last few months Sun Pharmaceutical is aggressively looking for an acquisition.

Piramal Glaxo deal may trigger top level exits

Mahima Puri — 16-Feb-2009

Many top executives of Mumbai based generic drug maker Piramal Healthcare and the Indian arm of British pharma company GlaxoSmithKline Formula for successful business are exploring exit options following reports of a possible acquisition of the Indian firm according to head hunters.

New norms for MNC drug prices

Sushmi Dey — 16-Feb-2009

In a move that would prevent MNCs such as GlaxoSmithKline Eli Lilly Roche and Pfizer from selling their drugs at a huge premium in India the government may soon finalise norms for monitoring prices of costly imported patented medicines for diseases such as diabetes arthritis obesity cancer and heart diseases.

Alnylam wins new patent for RNAi therapeutics

By Datamonitor staff writer — 16-Feb-2009

Alnylam Pharmaceuticals an RNAi therapeutics company has announced the first grant for the Kay & McCaffrey patent an early fundamental patent in the RNAi therapeutics field.

Pirate Bay copyright test case begins in Sweden

Simon Johnson, Stockholm — 19-Feb-2009

A copyright test case involving one of the world\'s biggest free file-sharing websites that could help music and film companies recoup millions of dollars in lost revenues started on Monday in Stockholm.

Gilead Receives Response From US FDA on Companys Request for Formal Dispute Resolution for Aztreonam for Inhalation Solution

FOSTER CITY, Calif — 18-Feb-2009

Gilead Sciences Inc today announced that the company has received a response from the US Food and Drug Administrationto its appeal submitted under the formal Dispute Resolution process regarding the Agencys Complete Response Letter for its New Drug Application for aztreonam for inhalation solution.

Teva to seek US approval for Neupogen biosimilar

By Lewis Krauskopf — 18-Feb-2009

Teva Pharmaceutical Industries Ltd hopes to seek US approval for its version of Amgen Incs Neupogen this year company officials said on Wednesday as it seeks to establish leadership in the emerging field of generic biotech medicines.

To GSK with awe and some scepticism

Latha Jishnu / New Delhi — 18-Feb-2009

Pharmaceutical giant GlaxoSmithKline appears to have knocked almost everyone into a cocked hat with its announcement last week of slashing prices of drugs for the poorest countries and sharing part of the profits with these countries to beef up health facilities.

Most trials conducted under strict FDA European rules

C.H. Unnikrishnan — 19-Feb-2009

India has been a preferred destination for clinical trials ever since pharmaceutical outsourcing picked up at the start of the decade.

GSK Pharma scouts for domestic buys

P B Jayakumar / Mumbai — 19-Feb-2009

GlaxoSmithKline Pharmaceuticals the Indian arm of global drug major GlaxoSmithKline is scouting for acquisitions in the domestic market to consolidate its Indian business.

Vion files new drug application for leukemia drug

By Datamonitor staff writer — 19-Feb-2009

Onrigin injection a single agent for remission induction treatment for acute leukemia

Pharma industry may see more consolidation

C.H. Unnikrishnan & Nesil Staney — 19-Feb-2009

3 multinationals said to be looking to expand India businesses GlaxoSmithKline Sanofi Aventis Merck

Schering Takeda Unit Sue Teva Over Snake Drug Patent

By Phil Milford — 19-Feb-2009

Schering Corp and Takeda Pharmaceutical Cos Millennium unit accused Israels Teva Pharmaceutical Industries Ltd of infringing their US patent for Integrilin anti clotting agent made from rattlesnake venom.

Tweaking inputs no ground for raising drug prices NPPA

Sushmi Dey & Khomba Singh — 20-Feb-2009

The drug price regulator has ruled that pharma companies cannot unilaterally increase prices of medicines that are under price control by merely tweaking their composition.

Endo and Penwest Pharmaceuticals Settle Opana ER Litigation with Actavis South Atlantic LLC

Corporate News — 20-Feb-2009

Endo Pharmaceuticals and Penwest Pharmaceuticals have settled litigation with Actavis South Atlantic LLC regarding the production and sale of generic formulations of Opana ER Extended Release Tablets CII.

USV to sell generic version of cancer drug bicalutamide in US

P.T. Jyothi Datta — 20-Feb-2009

USV Ltd will be able to see its generic version of bicalutamide the active pharmaceutical ingredient in Astra Zenecas prostate cancer drug Casodex when the patent on this drug expires in the US in April.

Patent office to dispose of all pending cases by March end

PTI, New Delhi — 20-Feb-2009

Though the all India numbers of the pending cases were not disclosed but an official said that in Delhi alone there are roughly 154 cases

Pharma companies eye new markets to drive sales

Joe C Mathew / New Delhi — 21-Feb-2009

Indian pharmaceutical companies whose global revenues were affected by their exposure to foreign currencies and slump in the US sales have seen significant revenue growth in the newer or emerging markets across continents.

Aurobindo gets nod for HIV drug

Our Bureau — 21-Feb-2009

Aurobindo Pharma Ltd has received tentative approval for Tenofovir Disoproxil Fumarate tablets in 300 mg dosage from the US Food & Drug Administration.

Daiichi Sankyo to launch flu preventive drug

Nikkei,TOKYO — 22-Feb-2009

Japans Daiichi Sankyo Co plans to launch as early as 2011 a new influenza preventive drug that could be effective against a strain unresponsive to widely used Tamiflu of Roche the Nikkei business daily said.

Merck girds to battle Tevas generic Singulair

By Ransdell Pierson — 22-Feb-2009

Although many analysts expect the larger Merck to prevail in the trial at federal court in Trenton New Jersey a victory by Teva could allow the Israeli company to launch its generic well before Singulairs US patent lapses in August 2012.

Gen Next turns its back on small medium pharma companies

P B Jayakumar / Mumbai — 23-Feb-2009

India was import dependent on drugs till 1970 when Indira Gandhi the then prime minister decided to amend the Patent Act to legalise process patenting or copying of drugs innovated by multinationals.

Cordex files amended SPA for tachycardia drug to FDA

By Datamonitor staff writer — 23-Feb-2009

Cordex Pharma a developer of new cardiovascular medicines has submitted to the FDA an amended Phase III protocol for ATPace to be reviewed as a special protocol assessment.

LG Electronics asks for patent suit against Kodak

Diane Bartz, Washington — 23-Feb-2009

LG Electronics has asked a trade panel to investigate possible digital camera patent infringement by Eastman Kodak, the International Trade Commission announced.

Sun Taro chiefs meet for out of court settlement

BS Reporter / Mumbai — 24-Feb-2009

Sun Pharmaceutical Industries and Israel based Taro Pharmaceutical have started fresh rounds of negotiations to settle their differences over a takeover by the Indian company out of court.

Pharma cos may face penalties for overpricing

Sushmi Dey,NEW DELHI — 24-Feb-2009

Drugmakers such as Dr Reddys Laboratories Wyeth GlaxoSmithKline Pharmaceuticals and Alkem Laboratories may now have to face state officials for failing to pay up penalties for overpricing.

US companies get Cuba trademarks wait for change

Esteban Israel, Havana — 24-Feb-2009

As recently as December the Cuban Office of Intellectual Property registered trademarks for new products for Coca-Cola, Google and Ford Motor Co.

Genentech says US patent office upholds key patent

Bill Berkrot, New York — 24-Feb-2009

Genentech Inc said on Tuesday that the US Patent and Trademark Office has confirmed its claims of the validity of a key patent that governs the biotechnology company\'s method of producing some of its drugs.

Endo and Penwest settle litigation with Actavis

By Datamonitor staff writer — 25-Feb-2009

Endo and Penwest have agreed to dismiss their suit with prejudice and Actavis has agreed to dismiss its counterclaims with prejudice.

Cipla opposes GSKs patent on Tykerb in India

Anju Ghangurde — 25-Feb-2009

Cipla has filed a post grant opposition against GlaxoSmithKline s patent on the breast cancer drug Tykerb in India.

Will continue to cooperate with USFDA Ranbaxy

BS Reporter / Mumbai — 26-Feb-2009

Ranbaxy has just received a letter and information indicating that all pending and approved ANDAs from Ranbaxys Paonta Sahib facility have been added to a list maintained under a policy entitled Application Integrity Policy or AIP.

VIA Pharmaceuticals Announces Grant of New Patent

SAN FRANCISCO, CA — 26-Feb-2009

VIA Pharmaceuticals Inc announced the issuance of United States Patent No 7495024 entitled Phenylalkyl N Hydroxyureas for Combating Atherosclerotic Plaque covering the use of VIAs lead compound VIA 2291 for the treatment of atherosclerosis.

Genentech Receives Final Notification Upholding Cabilly Patent in Reexamination Proceeding

SOUTH SAN FRANCISCO, Calif.(BUSINESS WIRE) — 26-Feb-2009

Genentech Inc today announced that the US Patent and Trademark Office has issued a Notice of Intent to Issue a Reexamination Certificate confirming the patentability of all claims of the Cabilly et al patent US Patent No 6331415 of which claims 21 through 32 were amended in a manner that does not affect the commercial importance of the patent.

Ranbaxy to isolate Canada bound drugs from HP unit

Press Trust of India / Toronto — 27-Feb-2009

Indian pharmaceutical firm Ranbaxy has agreed to a Health Canada request to quarantine all drugs coming into the North American country from the Paonta Sahib manufacturing facility in Himachal Pradesh Canadian Press reported on Thursday quoting the company.

Pfizer close to deal with Nigeria in drug lawsuit

By Mike Oboh — 27-Feb-2009

Nigeria is close to a settlement in a multi billion dollar lawsuit against Pfizer Inc over a 1996 drug trial it says caused the death of 11 children and left dozens more disabled lawyers said on Friday.

Daiichi Ranbaxy form joint team to counter FDA charges

BS Reporters / New Delhi/mumbai — 27-Feb-2009

Daiichi Sankyo which owns Indias biggest drug maker said it had formed a team with Ranbaxy Laboratories to address the data falsification charges levied by the US Food and Drug Administrationeven as analysts foresaw more trouble for the drug maker.

Suit against Amgen for drug marketing unsealed

LOS ANGELES,Reuters — 27-Feb-2009

A whistle blower lawsuit accusing Amgen Inc of illegally marketing its blockbuster drugs Enbrel and Aranesp has been unsealed a company spokesman said on Friday.

USFDA action against Ranbaxy based on false drug stability data

Our Bureau — 27-Feb-2009

The action by the US Food and Drug Administration against Ranbaxy on Wednesday was triggered after it was found out that the company had given incorrect data to prove drugs are stable over a certain time period.

Obama calls for generic biotech drugs

By RICARDO ALONSO-ZALDIVAR, — 27-Feb-2009

President Barack Obamas budget aims to foster generic competition for costly biotech drugs used to treat cancer and other intractable ailments.

Kissei and Takeda win Japanese approval for diabetes treatment

By Datamonitor staff writer — 27-Feb-2009

Japan based Kissei Pharmaceutical and Takeda Pharmaceutical Company have announced that an additional indication of combination therapy with insulin sensitizer for Glufast 5mg tablet and 10mg tablet which is being co marketed by both the companies was approved by the regulatory authorities in Japan.

Pfizer generics chief eyes licensing injectables

By Lewis Krauskopf — 27-Feb-2009

Pfizer Inc is seeking licensing deals to help turn its burgeoning business focused on generic drugs into a growth engine for the worlds largest drug maker over the next several years.

Another jolt for Ranbaxy Labs

BS Reporter / Mumbai — 28-Feb-2009

Ranbaxy Laboratories which has been charged by the US Food and Drug Administration with falsifying data has agreed to a Canadian governments request to quarantine all drugs coming into Canada from its drug making facility in Himachal Pradesh.

AstraZeneca FDA approves Symbicort

Edited Press Release — 02-Mar-2009

AstraZeneca Monday announced that the US Food and Drug Administration has approved SYMBICORT 160 45 mcg for the twice daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease including chronic bronchitis and emphysema.

DoJ files suit against KV Pharma

BANGALORE — 02-Mar-2009

The US Department of Justice said it sued KV Pharmaceutical Co to block the drugmaker from making and distributing adulterated and unapproved drugs.

SC asks Roche not to pursue Cipla case until patent examination

Khomba Singh — 02-Mar-2009

The Supreme Court has asked Swiss company Roche not to pursue the patent violation case against the generic version of Ciplas anti infection drug Valcept until the Chennai patent office re examines the patent granted to Roche.

SC asks Chennai patent office to hear Roche

Khomba Singh — 02-Mar-2009

The Supreme Court on Monday asked the Chennai patent office to hear and take a final view for all post grant oppositions for a patent it had granted to Swiss company Roche for its anti infection drug Valcyte .

Jubilant gets Canadian nod for anti heart disease generic

Agencies ,Mumbai — 02-Mar-2009

Drug maker Jubilant Organosys on Monday said its Canadian subsidiary has received approval from Canadian health regulator for its anti heart disease generic Sestamibi in that country.

Pfizer Expands Portfolio of Generic Medicines in the US and Europe

NEW YORK — 03-Mar-2009

Pfizer Inc announced that it has entered into a series of agreements with Aurobindo Pharma Ltd a pharmaceutical company based in India to commercialize medicines that are no longer patent protected and have lost market exclusivity in the United States and Europe further progressing its Established Products Business Unit strategy.

Basilea Pharmaceutica files claims against Johnson & Johnson

By Datamonitor staff writer — 03-Mar-2009

Basilea Pharmaceutica has filed claims in arbitration against Johnson & Johnson and affiliated companies related to delays in approval of ceftobiprole.

Congress takes up patent redo damages fight looms

WASHINGTON — 3-Mar-2009

Senior US lawmakers launched a new patent reform attempt on Tuesday with controversial legislation that would reduce damages paid for infringement.

Pfizer to license 50 generics from Aurobindo

BS Reporter / New York — 4-Mar-2009

Pfizer Inc has agreed to license an array of generic pills and injectable medicines from Indias Aurobindo Pharma Ltd as the worlds largest drugmaker looks to off patent medicines for growth.

Aurobindo gets USFDA nod for anti depressant

ET Bureau,MUMBAI — 04-Mar-2009

Drug major Aurobindo Pharma on Wednesday said it has got tentative USFDA approval to market escitalopram oxalate tablets.

Way to go New patents for old drugs

Latha Jishnu / New Delhi — 04-Mar-2009

It is one of the great ironies of this country that regulations put together after careful thought and debate to prevent their misuse by smart companies are carelessly flouted by the implementing agency.

Cordex Pharma Files ATPace Formulation Patent

LA JOLLA, Calif — 04-Mar-2009

Cordex Pharma Inc announced today that it has filed a formulation patent covering its lead product ATPace.

Aussie regulator puts Ranbaxy under scanner

ET Bureau,NEW DELHI — 5-Mar-2009

The Australian drug regulator Therapeutic Goods Administration said it is reviewing 62 drugs sold in the country which are made by Ranbaxy at its Paonta Sahib plant.

Pharma to get new regulatory regime

Gireesh Chandra Prasad — 05-Mar-2009

Drug makers in the country will get a new regulatory regime that is more friendly for investing heavily into high risk research testing experimental drugs on animals protecting the costly research data shared with the regulators and everything needed to lead them to the global league of drug inventors.

USFDA door wide open for Indian pharma cos

Joe C Mathew / New Delhi — 6-Mar-2009

The trend is likely to continue as Indian companies account for 35 per cent of all ANDA approvals given by the FDA in the first two months of 2009. ANDA is an application for a generic drug approval for an existing licensed medication or an approved drug.

Slowdown pill chokes Reliance Pharma

C.H. Unnikrishnan — 6-Mar-2009

Reliance Pharmaceuticals Pvt Ltd a generics or off patent drug manufacturing and exporting firm that is being set up at a cost of at least Rs1000 crore may start functioning later than originally envisaged.

Indian firms expect US FDAs local office to speed up approvals

Nina Mehta — 6-Mar-2009

The US Food and Drugs Administrations new office in India could likely boost local pharma companies efforts to process their applications and speed up approvals for marketing in the global market.

Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium

CORONA, Calif. — 6-Mar-2009

Watson Pharmaceuticals Inc a leading specialty pharmaceutical company announced today that it has reached a settlement with Elan Corporation Plc on outstanding patent litigation related to Watsons generic version of Naprelan tablets.

Ranbaxy gets approval to market anti fungal drugs in Australia

PTI,NEW DELHI — 6-Mar-2009

Drug major Ranbaxy Laboratories on Friday said it has received approval from the Australian health regulator to market its anti fungaltablets Serbifin Terbinafine in that country.

New drug regulatory norms on cards

Gireesh Chandra Prasad — 7-Mar-2009

The government is putting finishing touches on a new regulatory regime for the countrys pharmaceutical sector that will seek to catapult domestic drug makers into the global league of inventors from being successful copiers of expensive multinational brands.

UN agency protests Dutch seizure of Indian HIV drugs

Radhieka Pandeya — 7-Mar-2009

The purchase by the Clinton Foundation through UNITAID was confiscated at Amsterdams Schiphol airport on 12 November on grounds that it contained counterfeit goods and infringed IPRs

Watson to pay $18 million to Elan to settle patent suit

By Kathy Shwiff — 7-Mar-2009

Watson Pharmaceuticals Inc will pay $18 million to Elan Corp PLC to settle patent litigation related to Watsons generic version of Naprelan or naproxen sodium tablets.

Takeda stock sold off on key drug approval concerns

Nathan Layne — 9-Mar-2009

Shares of Japanese drugmaker Takeda Pharmaceutical Co were untraded due to a glut of sell orders on news that US regulators have asked for more data to complete a review of a key diabetes drug candidate.

Indias Ranbaxy gets US FDA nod for ramipril

Janaki Krishnan — 9-Mar-2009

Indian drug maker Ranbaxy Laboratories Ltd said on Monday it had received approval from the US Food and Drug Administration to manufacture and market ramipril capsules.

For Big Pharma the playfields here

Priyanka Golikeri & C Chitti Pantulu — 9-Mar-2009

Multinational drugmakers are taking Masefield a little too seriously. They are fast moving eastward with India in the periscope.

Merck Schering Plough deal What happens to subsidiaries

P.T. Jyothi Datta — 09-Mar-2009

Early days yet to map how the acquisition will pan out in India.

Drug Mergers Killers for Research

By Catherine Arnst — 09-Mar-2009

Further out however Merck may find itself in the same wobbly boat its in now No big drugs to replace the best sellers that are on the verge of losing patent protection.

Ranbaxy gets USFDA nod for heart drug

Our Bureau ,New Delhi — 09-Mar-2009

Ranbaxy Laboratories Ltd announced on Monday that it has received an approval from the US Food and Drug Administration to market and manufacture cardiovascular drug Ramipril Capsules

Pfizer Aurobindo pact may expand to CIS Asian markets

Joe C Mathew / New Delhi — 10-Mar-2009

Pfizer the worlds largest drug maker which announced a licensing and supply pact on March 3 with Aurobindo Pharma to source over 50 generic medicines for sale in the US and Europe will expand this to about 30 countries in Asia and the CIS region soon.

Tax free bonds to fund drug research venture

Sushmi Dey & Gireesh Chandra Prasad — 10-Mar-2009

Much of Indias strengths in this sector are in making copycat versions of popular drugs discovered abroad and making medicines whose patents have expired.

Cordex files patent application for anti arrhythmic drug

By Datamonitor staff writer — 10-Mar-2009

Cordex Pharma a developer of cardiovascular medicines has filed a formulation patent covering its lead product ATPace.

USPTO Issues Notice of Final Determination for Patent Term Extension for NAMENDA

Forest Laboratories — 10-Mar-2009

Forest Laboratories Inc Forest Laboratories Holdings Ltd Merz Pharma GmbH & Co KGaA and Merz Pharmaceuticals GmbH announced today that the US Patent and Trademark Office has issued a Notice of Final Determination granting the full five years of patent term extension for US Patent No 5061703 which is listed in the US Food and Drug Administration Orange Book for NAMENDA.

Merck deal puts pressure on drugmakers AstraZeneca Sanofi J&J

Bloomberg / New Delhi — 11-Mar-2009

The worlds biggest drugmakers armed with about $100 billion in cash and short term investments are seeking acquisitions to replace $84 billion in sales from products nearing the end of their patent life.

Moodys cuts Pfizer as Lipitor patent nears expiry

Karen Brettell,NEW YORK — 13-Mar-2009

Moodys Investors Service on Wednesday cut its ratings on Pfizer citing declining credit quality at the pharmaceutical company due to the upcoming expiration of its patent for cholesterol drug Lipitor.

India Brazil protest seizure of generic drugs by Dutch

Sheila Mathrani,GENEVA — 11-Mar-2009

India and Brazil have expressed their deep concern over the public health implications of the seizure of generic drugs in transit by European nations and its systemic implications.

Mercks Schering Plough buy is a win win deal

Pillman,Mumbai — 12-Mar-2009

To make the going tough patent expiries burnt a major hole into Mercks revenues.

Sepracor Inc Reaches Xopenex Deal with Teva Pharmaceutical Industries Limited

MARLBOROUGH, Mass,BUSINESS WIRE — 12-Mar-2009

Sepracor Inc today announced that it has entered into a Settlement and License Agreement with Teva Pharmaceuticals USA Inc and Barr Laboratories Inc a wholly owned subsidiary of Teva to resolve the patent litigation against Barr involving Sepracors XOPENEX brand levalbuterol HCl Inhalation Solution products and to grant a license to Barr and Teva.

Pharma MNCs want to take a shot at Indias vaccine market

Nina Mehta,MUMBAI — 12-Mar-2009

MSD Pharmaceuticals GlaxoSmithKline Novartis and Pfizer are some of the companies that want to be a part of this story.

Strides Arcolab to launch over 25 products this year

Dow Jones — 13-Mar-2009

Bangalore Mumbai 12 Pharmaceutical company Strides Arcolab Ltd expects new product launches mainly in the US and Europe to drive its revenue growth this year its Vice Chairman and Chief Executive said.

Pfizer says CEOs 2008 pay over $13 mln

By Ransdell Pierson — 13-Mar-2009

Pfizers biggest challenge comes in 2011 when its $12 billion a year Lipitor cholesterol fighter loses US patent protection and confronts cheaper generic competition.

Govt to spend $2 b annually till 20 on drug discovery

ET Bureau,AHMEDABAD — 14-Mar-2009

We have ability of backward engineering but we lack innovation he added Mr Kumar said about $103 billion worth of patented drugs will go off patent in the years to come.

Dr Reddys wins drug patent case in US

Our Bureau — 14-Mar-2009

Hyderabad March 13 A US District Court has granted a summary judgment that pharma major Dr Reddys Laboratories Ltd does not infringe the patents in its Abbreviated New Drug Application for Omeprazole.

Glaxo proposes patent pool for new treatment of neglected diseases

REUTERS — 15-Mar-2009

GlaxoSmithKline Plcs chief executive urged creation of a voluntary patent pool to spark development of new treatments for neglected diseases in the worlds poorest countries.

Pfizer to give data on smoking cessation drug impact in India

C.H. Unnikrishnan — 16-Mar-2009

Indian drug regulator has askedPfizer Ltd the Indian arm of the worlds largest drug maker Pfizer Inc to submit data of a compulsory post sales study on its smoking cessation drug Champix

Tatas seek patent security for Nano against copycats

Kala Vijayraghavan & Lijee Philip — 16-Mar-2009

Tata Motors has applied for patent protection for over 37 inventions and innovations linked to its high profile affordable car Nano aggressive move to protect the brand against imitation in the ultra competitive car industry.

Natco successfully opposes patent application

BS Reporter / Hyderabad — 16-Mar-2009

Hyderabad based Natco Pharma limited said that it had successfully opposed a patent application in India that covers the composition of Glatiramer Acetate the generic version of Teva Pharmaceutical Industries Copaxone.

Patent offices asked to clear opposition cases by 31 March

C.H. Unnikrishnan — 17-Mar-2009

The new controller general of patents designs and trademarks has ordered the heads of all four regional offices to issue final orders in some 600 patent and trademark opposition cases by 31 March.

IIT B to encash its intellectual bonds

Mumbai — 17-Mar-2009

Converting their ideas into monetary value will now become easier for the IIT Bombay faculty thanks to a partnership between the institute and Intellectual Ventures IV.

USPTO Grants Reissue Patent Relating to Lipitor

NEW YORK — 17-Mar-2009

Pfizer Inc announced in a press release that the US Patent and Trademark Office has granted reissue patent RE40667 relating to Lipitor.

Drug Firms Bet Big on High Risk Deals

By RON WINSLOW and AVERY JOHNSON — 17-Mar-2009

Amid the biggest financial crisis since the Great Depression drug giants Pfizer Inc Merck & Co and Roche Holding AG are pulling off an impressive feat

Shire Files Lawsuit Against Barr for Infringement of FOSRENOL Patents

WASHINGTON, DC — 17-Mar-2009

Shire plc announced in a press release that it has filed a lawsuit in the US District Court of the Southern District of New York against Barr Laboratories Inc for infringement of three of Shires patents US Patent No 5968976 US Patent No 7381428 and US Patent No 7465465.

Warner Chilcott faces new patent dispute

Associated Press — 17-Mar-2009

Warner Chilcott Ltd said Tuesday Impax Laboratories has challenged the drug developers patent on another dose of the antibiotic Doryx.

First to file Para IV suits on steady rise along with patent settlements

Kiran Kabtta Somvanshi — 17-Mar-2009

A latest study conducted in US by Stanford Group Company a member of the Stanford Financial Group shows that patent challenges as well as settlements continue to be on the rise.

Samsung to file fresh petition in dual SIM case

C.H. Unnikrishnan — 18-Mar-2009

The firm is challenging a law that linked a patent enforcement provision in import rules under which Samsung mobile phones that use double SIM were seized in Mumbai and Chennai

Hope is a patent troll for IIT Bombay

Latha Jishnu / New Delhi — 18-Mar-2009

The patent trolls main activity is seen as litigation and thus the reason for its unsavoury reputation.

Genzyme sues Impax in patent fight

Bloomberg News ,WASHINGTON — 18-Mar-2009

Genzyme Corp the worlds largest maker of drugs for rare genetic disorders sued Impax Laboratories Inc for allegedly infringing a patent used for its Renagel kidney medicine.

Medicis Teva end dispute relating to Solodyn

Helen Chernikoff — 18-Mar-2009

Israels Teva the worlds largest generic drugmaker confirmed that Medicis patents relating to Solodyn Extended Release Tablets are valid and enforceable and has agreed to stop all further shipments of its generic version of the drug.

Cadila moves SC against Dabur Baidyanath on trademark

Press Trust of India / New Delhi — 18-Mar-2009

Pharma major Cadila Healthcare has moved the Supreme Court seeking to restrain Dabur India and Shree Baidyanath Ayurved from using its trademark Sugar free used for artificial sweeteners.

Merck gives malaria drug to non profit group

Ben Hirschler — 18-Mar-2009

Last month GlaxoSmithKlines chief executive urged the creation of a voluntary patent pool to spark development of new treatments for neglected diseases including malaria.

EU Patent Court drug rulings must consider public interest

By Lynne Taylor — 18-Mar-2009

The European Union Patent Court proposed by the European Commission must crucially take due care of the public interest in its considerations regarding pharmaceutical patents say generic drugmakers.

Strides Acrolab receives US FDA approval

Kiran Kabtta Somvanshi — 18-Mar-2009

Amidst stringent US Food & Drug Administration compliance Bangalore based Strides Acrolab has reasons to cheer.

US bill may dent Dr Reddys growth plans

Amriteshwar Mathur — 19-Mar-2009

Dr Reddys Laboratories could be affected if a recent US bill that seeks ban on MNC pharma companies from transferring authorised generics to third parties becomes a law.

Chennai tops in filing of trademarks

Our Bureau — 19-Mar-2009

In India the Chennai branch of the Patent and Trademark Office has the highest number of trademarks filed and Bangalore stands first in the e filing of trademarks

Warner Chilcott sues Impax over acne drug Doryx

NEW YORK — 19-Mar-2009

Warner Chilcott Ltd said Thursday it is suing Impax Laboratories Inc accusing Impax of infringing a patent supporting 150 milligram tablets of Warner Chilcotts acne medication Doryx.

OSI Pharma files suit against Teva Mylan

Helen Chernikoff — 19-Mar-2009

OSI Pharmaceuticals Inc on Thursday announced that it filed two lawsuits against rival drug companies regarding patents associated with Tarceva OSIs cancer drug the company said in a statement.

Dr Reddys to exit small generic drug markets abroad

Our Bureau — 20-Mar-2009

Dr Reddys Laboratories Ltd has decided to exit from the small distributor driven markets in its global generics business.

Global pharma consolidates

ET Bureau — 20-Mar-2009

Big pharma is set to lose nearly $100 billion in sales as many blockbuster drugs are set to lose patent protection over the next five years.

Epix Pharmaceuticals wins new US patent

Datamonitor staff writer — 20-Mar-2009

The granted claims of this patent are directed to the highly selective 5HT4 small molecule agonist, PRX03140, and to compositions that include PRX03140 as one of the active ingredients. Epix also has pending patent applications relating to compositions and methods of using PRX03140.

US court rules largely for patent office on Glaxo

By Diane Bartz — 20-Mar-2009

A US appeals court largely overturned on Friday GlaxoSmithKline Plcs summary judgment win in a fight against new patent office rules.

Appeals Court Revives Some Patent Rules Attacked By Glaxo

Dow Jones,WASHINGTON — 20-Mar-2009

GlaxoSmithKline PLC and an independent inventor challenged the rules before they went into effect arguing that Congress had not given the patent office the authority to make substantive changes to the patent process.

Sepracor sues to suppress generic copies of Lunesta

Bloomberg News — 21-Mar-2009

Sepracor Inc said it filed a lawsuit to prevent companies from selling generic versions of its top selling sleep drug Lunesta.

Pharma lobby wants a probe into delayed orders

C.H. Unnikrishnan, — 23-Mar-2009

The Indian Pharmaceutical Alliance or IPA has sought an investigation into several delayed orders in patent opposition cases.

Ricoh and Taisei Join Eco Patent Commons

Press Releases — 23-Mar-2009

Ricoh Company Ltd a global leader in office solutions and Taisei Corporation a leading engineering construction company have joined the Eco Patent Commons a first of a kind business effort coordinated by the World Business Council for Sustainable Development to help the environment by pledging environmentally beneficial patents to the public domain.

Drug makers get ready to work on vaccine for cervical cancer

P.T. Jyothi Datta — 23-Mar-2009

Gennovas patent team had given the research team the go ahead Dr Singh said responding to whether their vaccines could infringe the innovators patents.

Patent filing facility soon

Shastry V. Mallady — 23-Mar-2009

Micro Small and Medium Enterprises in the State will soon have a patent filing facility as the Tamil Nadu State Council for Science and Technology is launching an initiative in this direction.

Cubist Pharma Files Patent Infringement Lawsuit Against Teva Update

by RTT Staff Writer — 23-Mar-2009

Monday drug maker Cubist Pharmaceuticals Inc said it filed a patent infringement lawsuit against Teva Parenteral Medicines Inc or TPM Teva Pharmaceuticals USA Inc alleging violation of its US patents related to daptomycin.

American Bio Medica to receive two new US patents

By Datamonitor staff writer — 23-Mar-2009

American Bio Medica a biotechnology company has received notification from the US Patent & Trademark office that it will be granted two new patents one for its oral fluid drug testing product line and the other for its all inclusive urine point of collection drug test cup product line.

Lillys Zyprexa Prozac combo wins expanded use

Lewis Krauskopf — 23-Mar-2009

US regulators have expanded the approval of Eli Lilly and Cos Symbyax which combines the active ingredients of its Zyprexa antipsychotic and Prozac antidepressant for treatment resistant depression the company said on Monday.

Court Denies Wyeth Bid For Patent Extension On Cydectin

By Brent Kendall — 24-Mar-2009

A US trial judge on Monday denied Wyeths bid for a 10 month extension on its patent rights to Cydectin an animal health drug.

Glaxo pools 800 patents cuts drug prices for poor

Ben Hirschler — 24-Mar-2009

GlaxoSmithKline Plc will share more than 800 of its patents with others seeking to develop new medicines for neglected tropical diseases and slash the cost of many of its drugs in poor countries from next week.

Plexxikon wins key patents for new drug compounds

By Datamonitor staff writer — 24-Mar-2009

Plexxikon a developer of small molecule pharmaceuticals has received key composition of matter patents covering novel compounds discovered through the companys Scaffold based Drug Discovery platform.

Allergan soars on Glaxo takeover speculation

Val Brickates Kennedy — 24-Mar-2009

An Allergan buy would immediately bolster Glaxos lucrative migraine headache franchise as a key patent for Imitrex is set to expire this year.

Patent for Making Combination Chemotherapy Work Better

NexGen Biomedical, Inc — 24-Mar-2009

Patent 7507704 issued on 03 24 09 to NexGen Biomedical Inc founder Mark Zamoyski of San Jose California discloses an improved method of treating lung brain pancreatic breast and colon cancers that are driven by a mutation known as HER1 overexpression.

Foreign drug companies gain sales muscle following mergers

C.H. Unnikrishnan — 25-Mar-2009

The growth of local drug firms had actually begun in the 1970s following the abolition of the product patent regime.Coincidentally foreign drug makers are set to gain market share after the reversal of the patent regime in 2005.

Ranbaxy gets Australia nod for antipsychotic drug

Devidutta Tripathy — 25-Mar-2009

Indian drug maker Ranbaxy Laboratories said on Wednesday it had received the Australian drug regulators approval to market a generic version of Johnson & Johnsons antipsychotic drug Risperdal.

New diabetes drug approved without trial

Radhieka Pandeya — 26-Mar-2009

A new drug to combat diabetes which is administered orally and not injected was given a marketing approval by the Drugs Controller General of India without being put through the mandatory human clinical trials highlighting a possible lapse in Indian laws dealing with the testing and approval of drugs.

India may drag EU to WTO on seizure of drugs in transit

ET Bureau — 26-Mar-2009

EU authorities have been seizing cargoes of drugs from India because they believe these medicines infringe local patent laws while transiting from its customs.

Pantaloon 1 a or 2 the names mine

Rasul Bailay — 26-Mar-2009

Firm seeks cancellation of registrations granted to R Adag for using the Reliance Big Bazar trademark

UK discovers counterfeit Novo Nordisk insulin pens

Ben Hirschler — 27-Mar-2009

Britains medicines watchdog said on Friday it had discovered a batch of counterfeit Novo Nordisk insulin pen needles circulating in the country and urged diabetics not to use them.

Teva gets FDA approval on version of J&Js Topamax

Associated Press — 27-Mar-2009

The drugs key patents expired in March.

BCCI Zee fight over Twenty20 trademarks

Rasul Bailay & — 28-Mar-2009

Over the past 15 months the Essel Group popularly referred to as Zee Group after the television channels it runs has filed at least four dozen applications with the countrys trademark office seeking registration of various combinations of Twenty20.

Local companies blocked from selling cheap lifesaving drug

Janet Silvera — 29-Mar-2009

JAMAICAN pharmaceutical company Indies Pharma is gearing up for a court battle with international drug manufacturing giant Pfizer USA over local distribution of hypertension medication used by thousands of Jamaicans living with the debilitating illness.

US FDA approves Suns new drug to market Topamax topiramate

PTI,MUMBAI — 29-Mar-2009

Sun Pharma today said the US Food and Drug Administration has granted an approval for its abbreviated new drug application to market generic Topamax topiramate tablets.

Cadila Pharma to launch product to curb sudden cardiac death

BS Reporter / Mumbai/ Ahmedabad — 30-Mar-2009

Leading pharma company Cadila Pharmaceuticals in collaboration with McMaster University of Hamilton Canada has announced its plans to launch a product worldwide to bring down cardiovascular morbidity and mortality.

Ranbaxy Aurobindo get US FDA nod for epilepsy drug

PTI — 30-Mar-2009

Pharma firm Ranbaxy on Monday said it has received US regulatory approval for Topiramate tablets used in the treatment of epilepsy.

Unichem Lab gets FDA nod for Topiramate tablets

Agencies ,Mumbai — 30-Mar-2009

Pharma company Unichem Laboratories on Monday said it has received US regulatory approval for Topiramate tablets used for the treatment of epilepsy.

Eli Lilly eyes acquisitions WSJ

Ajay Kamalakaran — 31-Mar-2009

Lillys best selling drug the antipsychotic Zyprexa loses patent protection in 2011.

New Cadila combo pill may cut risk of stroke by half

Sangeeta Singh,New Delhi — 31-Mar-2009

Medical professionals have long theorized on the benefits of a combination pill in cardiac disorders but it wasnt known if such a drug could be formulated and at the same time be effective

Amicus Therapeutics wins new US patent

By Datamonitor staff writer — 31-Mar-2009

Amicus Therapeutics a biopharmaceutical company has received a new US patent isofagomine the active ingredient in the companys investigational drug Plicera and its use for the treatment of Gaucher disease.

Aurobindo Pharma gets tentative US nod for HIV drug

REUTERS — 31-Mar-2009

Drug maker Aurobindo Pharma said on Tuesday it secured a tentative approval from the US Food and Drug Administration to sell its emtricitabine and tenofovir disproxil fumarate combination drug in tablet form.

US FDA warns firms selling unapproved narcotics

Lisa Richwine — 31-Mar-2009

US regulators warned nine companies on Tuesday to stop selling 14 unapproved narcotic pain medicines part of an ongoing effort to rid the market of drugs without proper clearance.

Matrix Labs gets USFDA nod for HIV infection tablets

PTI,MUMBAI — 31-Mar-2009

Drug manufacturer Matrix Laboratories on Tuesday said it has received US regulators approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets used in controlling HIV infection.

Eli Lilly looks to make more deals

INDIANAPOLIS — 31-Mar-2009

Lilly will lose patent protection for its best selling drug the antipsychotic Zyprexa in 2011.

Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta and Declares Patent Invalid

Patty Eisenhaur — 31-Mar-2009

Watson Pharmaceuticals Inc a leading specialty pharmaceutical company announced today that the United States District Court for the District of Delaware has ruled that Watsons generic version of Concerta does not infringe United States Patent No 6919373 and that the 373 Patent is invalid.

Clearance for only one Ranbaxy site

Radhieka Pandeya — 1-Apr-2009

Information provided by Ranbaxy Laboratories Ltd in filings to the stock exchanges and a press release issued on 23 March has led some analysts and at least one international news agency into assuming that the companys Paonta Sahib facility censured by the US Food and Drug Administration had been subsequently given the all clear by the drug regulators of the UK and Australia.

Glenmark to stop sale of its pain killer in US

Radhieka Pandeya — 01-Apr-2009

Glenmark Pharmaceuticals Ltd said it will stop selling its morphine sulfate drug in the US complying with a warning by that countrys drugs regulator

District Court decision received in Concerta patent sase

Medical Patent News — 01-Apr-2009

The US has rendered a decision in the patent litigation between Alza Corporation McNeil PPC Inc and Andrx Pharmaceuticals LLC McNeil Pediatrics Division of Ortho McNeil Janssen Pharmaceuticals Inc which markets Concerta Extended Release Tablets CII said the court held that the patent in suit is not valid or infringed by the filing of Andrxs Abbreviated New Drug Application.

Mylan confirms four first to file ANDA lawsuits

By Datamonitor staff writer — 01-Apr-2009

Believes it to be the first to have filed substantially complete ANDAs containing Paragraph IV certification.

US senators agree on patent changes

By Diane Bartz — 01-Apr-2009

Leaders of the US Senate Judiciary Committee said on Wednesday they had reached agreement on key elements of a bill to revise US patent law.

US Senate panel approves patent reform

By Diane Bartz — 02-Apr-2009

The Senate Judiciary Committee voted on Thursday to approve a patent reform bill that has had drug high tech and other industries at loggerheads for several years.

Watson Does Not Infringe Patent Related to Generic Version of Concerta

CORONA, CA — 2-Apr-2009

Watson Pharmaceuticals Inc announced in a press release that the United States District Court for the District of Delaware has ruled that Watsons generic version of Concerta does not infringe United States Patent No 6919373 and that the 373 Patent is invalid.

Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL Patents

Shire Plc — 2-Apr-2009

Shire plc announces that it has filed a lawsuit in the US District Court for the Southern District of New York against Natco Pharma Limited for infringement of two of Shires patents US Patent No 5968976 and US Patent No 7381428.

MNC drug makers eye generics in India other emerging countries

PB Jayakumar / Mumbai — 3-Apr-2009

Multinational drug makers such as Pfizer and GlaxoSmithkline are planning large scale forays into generic manufacturing or the reverse engineered cheap drugs business threatening the growth prospects and survival of Indian generic companies such as Ranbaxy Laboratories Dr Reddys Laboratories and Sun Pharma and global generic leaders like Teva Sandoz and Mylan.

Better protection of intellectual property to boost indigenous innovation

Ayushman Baruah — 3-Apr-2009

According to a BSA IDC global software piracy study the Indian software industry lost around $2 billion due to software piracy last year.

Patent to Bajaj could mean trouble for TVS

Shally Seth — 3-Apr-2009

Indias patents office has granted exclusive rights to an engine technology Bajaj Auto Ltd uses in all its motorcycles which could land its rival TVS Motor Co Ltd into trouble since it also uses the same technology in some of its bikes.

What is the Satyam Upaid case about

Raghuvir Srinivasan — 3-Apr-2009

Armed with the patent Upaid filed a suit against Qualcomm and Verizon Wireless in 2005 alleging that they were using the patented technology.

Acquisition overdose Worries over future of pharma industry

P.T. Jyothi Datta — 3-Apr-2009

Challenges are in store for local drug companies also in the form of patent related challenges in India and abroad.

Court rules for Lilly in patent fight with Ariad

Diane Bartz — 03-Apr-2009

Eli Lilly did not infringe a patent owned by Ariad Pharmaceuticals when it made its Evista osteoporosis drug and Xigris sepsis treatment a US appeals court said on Friday.

Boston Scientific announces key rulings in stent litigation with J&J

By Datamonitor staff writer — 03-Apr-2009

Boston Scientific a developer manufacturer and marketer of medical devices has reported that the Court of Appeals for the Federal Circuit has issued a positive ruling in the companys stent litigation with Johnson and Johnson or J&J.

AstraZeneca sues Apotex over generic asthma drug

Bill Berkrot — 03-Apr-2009

Pulmicort had US sales of $982 million in 2008 with about 90 percent of that coming from the form of the medicine that is being disputed in the patent case.

Patent to Bajaj will not affect us TVS Motor

Our Bureau — 4-Apr-2009

Mumbai April 3 TVS Motor Company has stated that the grant of the ExhausTEC patent to Bajaj Auto does not in any way impact its products in the market.

Nomadix Wins Patent Enforcement Action Against Second Rule LLC

NEWBURY PARK, CA — 4-Apr-2009

DOCOMO interTouch announced that its subsidiary Nomadix Inc has won a patent enforcement action against Second Rule LLC the maker of the IP3 NetAccess gateway a press release by Nomadix stated.

Five Indian inventions win US patent

NEW DELHI (Xinhua) — 5-Apr-2009

Five inventions by a New Delhi resident named Anadish Pal have won patent from the United States government Navbharat Times reported on Sunday.

Gilead Reviews Tevas Generic Application May File Suit

DOW JONES NEWSWIRES — 06-Apr-2009

Gilead Sciences Inc said it is reviewing a notice letter and has 45 days to file a patent infringement lawsuit against Teva Pharmaceutical Industries Ltd following Tevas submission to manufacture and market a generic version of HIV drug Atripla.

Impax sued by Genzyme in patent challenge

Associated Press — 06-Apr-2009

Drug developer Impax Laboratories Inc said Monday it is being sued by Genzyme Corp over a patent challenge to that companys kidney condition drug Renvela.

Sepracor files NDA for seizure drug

By Datamonitor staff writer — 06-Apr-2009

Sepracor a research based pharmaceutical company has submitted a new drug application to the FDA for the use of eslicarbazepine acetate as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy.

Arrow Coated Products gets patent for specialised films

BS Reporter / Mumbai — 06-Apr-2009

Arrow Coated Products Ltd one of Indias leading and pioneering manufacturers of pressure sensitive adhesive coated films has been granted patent for Embedded Water Soluble Films by Australian Patent office Patent Grant No 2002356417 till October 07 2022 the company said in a BSE filing.

Teva Pharma A Safe Prescription

RTTNews — 6-Apr-2009

Hit by a triple whammy of pipeline woes an onslaught of blockbuster patent expiries and regulatory stringency the once invincible branded drugs giants are engulfed in a fog of uncertainty.

Ex Bristol Myers Executive Pleads Guilty In Plavix Patent Case

DOW JONES NEWSWIRES — 6-Apr-2009

Andrew Bodnar a former executive of Bristol Myers Squibb Co pleaded guilty Monday to a charge related to his role in a patent deal the drug maker struck to keep a generic competitor to its popular blood thinning drug Plavix off the market.

Impax Confirms Patent Challenge Relating to Renvela

HAYWARD, CA — 07-Apr-2009

Impax Laboratories Inc confirmed that it has initiated a challenge of the patents listed by Genzyme Corporation in connection with its Renvela 800 mg tablets a press release by Impax stated.

Rambus Buys Inapac Patents

Corporate News — 07-Apr-2009

Rambus Inc announced it has acquired a number of patents from Inapac Technology Inc to broaden its offerings for the mobile memory market.

Gilead Sciences Announces Notification of ANDA Filing for Atripla

BUSINESS WIRE — 07-Apr-2009

Gilead Sciences Inc today announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application to the US Food and Drug Administration requesting permission to manufacture and market a generic version of Atripla.

AstraZeneca Files Suit Against Apotex

LONDON — 07-Apr-2009

AstraZeneca has filed a lawsuit in the US District Court for the District of New Jersey against Apotex seeking a declaration of patent infringement a press release by AstraZeneca stated.

Indian drug makers welcome to join patent pool prog GSK

PTI — 07-Apr-2009

Global drug major GlaxoSmithKline has said Indian drug makers and research firms can join its patent pool programme aimed at developing low cost drugs for 16 neglected tropical diseases.

Re evaluating pharma

Business Standard / New Delhi — 8-Apr-2009

The last avenue has been opened up with patent protection taking root in India.

Pfizer reorganizes units for Wyeth buy

Shannon Pettypiece — 8-Apr-2009

Pfizer the worlds biggest drug maker needs to ramp up new drug development as it braces to lose $10 billion in annual sales in 2011 when patent protection ends for its cholesterol pill Lipitor analysts said.

Many Drug Prescriptions are Now Going Unfilled

By JONATHAN D. ROCKOFF — 08-Apr-2009

That isnt good news for drug makers already struggling to replace the sales of top selling medicines losing patent protection over the next several years.

Affitech wins new European patent for antibody screening technology

By Datamonitor staff writer — 08-Apr-2009

Affitech an antibody R&D company has reported that the European Patent Office has granted a European patent on the use of phagemid particles having an antibody coliphage pIII fusion protein to identify tumor associated antigens on cells by negative selection.

Are Patent Problems Stifling US Innovation

Damian Joseph. — 08-Apr-2009

The US Patent and Trademark Office is drowning in applications while its budget shrinks.

Microsoft ordered to pay Uniloc $388 million

SEATTLE — 08-Apr-2009

A federal judge on Monday ordered Microsoft Corp to pay $388 million in damages after finding the worlds largest software maker infringed on a patent held by Uniloc Inc.

Mylan Announces Clarinex Settlement Agreement

Mylan Inc. — 8-Apr-2009

Mylan Inc today announced the settlement of all patent litigation relating to Desloratadine Tablets 5 mg the generic version of Schering Ploughs Clarinex allergy medication.

Aurobindo gets nod from Swissmedic

Agencies — 8-Apr-2009

Drug maker Aurobindo Pharma on Wednesday said it has received approval from the Switzerland government for marketing Finasteride APL a drug used for treating enlarged prostate in men.

Wockhardt to hive off biotech division

P B Jayakumar / Mumbai — 9-Apr-2009

Wockhardt has one of the largest off patent biotech drugs under development in India.

Takeda takes back Actos rights from Lilly

Yumiko Nishitani — 9-Apr-2009

Like its peers Takeda Japans largest drugmaker faces pressure from the economic slowdown in the United States the biggest market for Actos and it will lose patent protection on the drug there in 2011.

Cipla can benefit if Medpro acquisition goes through

P.T. Jyothi Datta — 10-Apr-2009

Mumbai based drug maker Cipla Ltd can look to expand its presence in South Africa and indeed other parts of the region if South Africa s Adcock Ingram Healthcare Ltds $233 million proposal to acquire generic drugs player Cipla Medro goes through.

Novartis retailers lock horns over direct sales

Khomba Singh, — 10-Apr-2009

An open battle has erupted between drug retailers in Mumbai and Novartis a Swiss company and its subsidiary Sandoz.

Samsung files appeal with board against dual SIM patent

C.H. Unnikrishnan — 10-Apr-2009

The firm filed a petition with IPAB asking it to revoke the existing patent for issued toan Indian inventor

Natco Lupin tie up for generic drug to treat kidney failure

Our Bureau — 10-Apr-2009

Natco Pharma Ltd has tied up with Lupin Ltd to jointly commercialise generic equivalents of Lanthanum Carbonate tablets used to treat kidney failure.

Wockhardt to foray into biosimilar market

Nina Mehta,MUMBAI — 10-Apr-2009

Wockhardt is planning to tap the $33 billion biosimilar market and focus on products that lose patent protection in 2013 2015.

We will be back to normal soon

P. T. Jyothi Datta — 10-Apr-2009

Wockhardt watchers also observe that the company like many corporates in and outside the pharmaceutical segment went on an acquisition over kill and worse funded it through debt when the going was good.

United Treatment Centers Inc Acquires a Stake in Bel Ea Co and Its Trademarks

ASTORIA, NEW YORK -- (MARKET WIRE) — 10-Apr-2009

United Treatment Centers Inc today announced it has acquired a 50% stake of Bel Ea Co from an existing shareholder.

Daiichi Sankyo Files Patent Infringement Actions Against 11 Generics Companies

ag-IP-news — 11-Apr-2009

Daiichi Sankyo Ltd announced in a press release that it has brought patent infringement litigations against 11 generics companies for the substance patent 2008845 and usage patent 1659502 for Levofloxacin Hydrate brand name Cravit tablets and Cravit fine granules.

HP Files Appeal in Patent Dispute with Cornell University

PALO ALTO, CA — 12-Apr-2009

HP announced in a press release that it has filed an appeal in its patent dispute with Cornell University and the Cornell Research Foundation Cornell.

J&J expected to report lower earnings

Val Brickates Kennedy — 12-Apr-2009

J&Js pharmaceutical division once its core business has been hit in recent quarters by the loss of patent exclusivity on such brand names as Risperdal and Topamax.

Defensive pharma promises solid Q1 results

Ben Hirschler and Lewis Krauskopf — 12-Apr-2009

A looming cliff of patent expiries growing political pressure in the United States and elsewhere and a lack of new drugs coming out of research labs mean drug companies are struggling with over capacity just like other industries.

Sun loses US patent case for lucrative drug

PB Jayakumar / Mumbai — 12-Apr-2009

Sun Pharmaceutical Industries has lost a patent infringement case in the US on Cardene a drug for controlling high blood pressure.

HC to hear dual SIM patent case today

Niranjana Ramesh, — 13-Apr-2009

The Madras High Court will hear a petition filed by a Madurai based engineer Somasundaram Ramkumar seeking the enforcement of patent protection for his invention the dual SIM card technology used in mobile phones.

Cadila looking at global tie ups for Polycap

Press Trust Of India / New Delhi — 13-Apr-2009

Ahmedabad based Cadila Pharmaceuticals is looking for global tie ups to market its new patented product Polycap a combination of five medicines that prevents heart attack.

Indias Sun Pharma gets FDA nod for generic Roxicodone

Prashant Mehra — 13-Apr-2009

The generic oxycodone hydrochloride tablets are used as a painkiller.

CoolTouch Inc Settles Diomed Lawsuit Files Re examination Request for Cynosure 873 Patent

CoolTouch Inc. — 13-Apr-2009

ROSEVILLE Calif PRNewswire On April 7 2009 the Boston District Court dismissed the Diomed lawsuit between Endolaser Associates LLC and CoolTouch Inc after CoolTouch signed a settlement agreement with Dr Luis Navarro.

US rejects Alcatel patent could affect award

Bill Rigby — 13-Apr-2009

The US Patent and Trademark Office has rejected two patents claimed by French telecoms equipment Alcatel Lucent which could end up nullifying a multi million dollar damages award against software maker Microsoft Corp.

Alcatel Patent in $358 Million Suit Rejected by US

By Susan Decker — 14-Apr-2009

An Alcatel Lucent SA patent that resulted in a $358 million jury verdict against Microsoft Corp was rejected by the US Patent and Trademark Office after the agency took a second look at the invention.

These are quality medicines Indias success formula

Daara B Patel, — 14-Apr-2009

Fixed Dose Combinations have been manufactured successfully in India and abroad for many years.

We should properly evaluate these combination drugs

M Venkateswarlu, — 14-Apr-2009

Any drug before being permitted for marketing in the country for the first time undergoes a series of scientific studies pre clinical studies or M Venkateswarlu Former Drugs Controller General of India animal model studies and clinical trials carried out in three phases.

Zydus Pharma sued in US over anti depressant

Reghu Balakrishnan — 14-Apr-2009

Zydus Pharma Inc the US subsidiary of the Ahmedabad based pharma major Zydus Cadila has been sued by US major Wyeth following the latters paragraph IV ANDA submission for the marketing approval of Effexor a leading anti depressant drug with $4 billion sales revenue owned by Wyeth in the US market.

Mylan challenges patent sued by Roche

Associated Press — 14-Apr-2009

Mylan Inc said Tuesday it is being sued by Roche after challenging the Swiss drug developers patent on the cancer treatment Xeloda.

Mylan Confirms First To File Patent Challenge Relating To Xeloda Cancer Treatment

Mylan Inc. — 14-Apr-2009

Mylan Inc today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc have been sued by Hoffmann La Roche Inc in connection with the filing of an Abbreviated New Drug Application with the US Food and Drug Administration for Capecitabine Tablets 150 mg and 500 mg the generic version of Xeloda Tablets a chemotherapy treatment for breast and colorectal cancer.

Samsung files appeal against dual SIM

Bettina Wassener — 15-Apr-2009

Prateek Garg a 26 year old software engineer who lives in Delhi has been unemployed since September and has had only two job interviews since then.

Rib X Granted Key Antibiotic Patent in China

NEW HAVEN, Conn. — 15-Apr-2009

Rib X Pharmaceuticals Inc a development stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic resistant infections today announced the issuance of a key antibiotic patent in China.

Peregrine wins new US patent

By Datamonitor staff writer — 15-Apr-2009

Peregrine Pharmaceuticals a biopharmaceutical company has received a new US patent that is expected to strengthen the companys intellectual property in the field of phospholipid targeting agents for the treatment of life threatening diseases.

CORRECT Sales forecast haunts Abbott shares

By Val Brickates Kennedy — 15-Apr-2009

Abbott Laboratory shares moved notably lower Wednesday as investors reacted negatively to news that sales growth for the companys popular rheumatoid arthritis drug Humira might not be as robust as previously expected.

India rejects patent to Glivecs second variant

Joe C Mathew / Bangalore — 15-Apr-2009

Ruling intended to prevent patenting of inventions known earlier.

New drug research is a high risk game

P B Jayakumar / Mumbai — 16-Apr-2009

Lupin Ltd one of the top five drug companies in India grew over 30 per cent yearly in the past four years and maintained 38 per cent growth in turnover and 49 per cent growth in profits in the first nine months of 2008 09.

Troikaa Pharma launches cancer drug

Our Bureau — 16-Apr-2009

The lozenges and their holders are indigenously designed and patented.

AstraZeneca India announces CRESTOR tablets launch

Sushmi — 16-Apr-2009

AstraZeneca India announced the launch of CRESTOR rosuvastatin 5 10 20 and 40 mg tablets today.

Piramal gets injunction in drug trademark case

C.H. UnnikRishnan — 16-Apr-2009

The injunction temporarily restrains these companies from using brand names similar to Esgipyrin for marketing the same drug combination

Pig patent row upsets top EU producer Germany

By Brian Rohan — 16-Apr-2009

A test to check pigs for a gene that makes them produce more meat has sparked a row in Germany where farmers ecologists and politicians filed objections to its patent before an appeals deadline on Thursday.

Court Grants AstraZeneca Temporary Restraining Order Against Apotex in PULMICORT RESPULES Patent Litigation

AstraZeneca — 16-Apr-2009

On 16 April 2009 the US District Court for the District of New Jersey granted AstraZenecas request for a temporary restraining order barring Apotex from launching a generic version of AstraZenecas PULMICORT RESPULES until further order of the court.

Rib X granted patent for novel oxazolidinone in China

Medical Patent News — 16-Apr-2009

Pharmaceuticals Inc has announced the issuance of a key antibiotic patent in China.

Roches Hepatitis drug patent upheld

Joe C Mathew / Bangalore — 17-Apr-2009

The patent office has upheld the validity of Roches patent rights over Pegasys pegylated interferon alfa2a a Hepatitis C medicine.

Sepracor disputes patent on Wyeths Pristiq

Associated Press — 17-Apr-2009

Sepracor Inc on Friday took a step toward a potential challenge of patents supporting Pristiq an antidepressant marketed by Wyeth.

Patentholder asks Noida excise dept to cancel Samsung licence

C.H. Unnikrishnan — 17-Apr-2009

A Madurai based engineer has asked authorities to cancel Samsungs licence to manufacture dual SIM mobile phones as he holds the local patent for such mobiles

Nobel Biocare wins patent ruling in Germany

Katie Reid — 17-Apr-2009

Swiss dental implant maker Nobel Biocare said on Friday it had won a German court ruling in a patent infringement case brought by Materialise Dental in relation to Nobel Biocares NobelGuide software.

Glaxo Pfizer to merge HIV drug units in challenge to Gilead

Bloomberg / London — 18-Apr-2009

GlaxoSmithKline Plc once the worlds biggest maker of AIDS drugs will form a new company with rival Pfizer Inc to increase its share of the $12.3 billion HIV market now dominated by Gilead Sciences Inc.

Drug patents India to take EU to WTO

Arun S — 18-Apr-2009

The patents battle between India and the European Union in the pharmaceutical space will soon reach the dispute settlement body of the World Trade Organisation.

Adcocks plan to buy Medpro hits Cipla hurdle

ET Bureau — 18-Apr-2009

South African company Adcock Ingrams plans to buy Cipla Medpro with whom Indian pharma major Cipla has a 20 year drugsupply agreement has run into trouble with the Mumbai based company opposing the $228 million takeover.

Sepracor Announces Patent Interference Proceedings Against Wyeth

MARLBOROUGH, MASS — 18-Apr-2009

Sepracor Inc announced that the Board of Patent Appeals and Interferences of the US Patent and Trademark Office has combined three patent interferences into a single interference between Sepracor and Wyeth and set a date for oral arguments.

Indian pharma industry may gain $18.4 bn from global mkt

PTI,NEW DELHI — 19-Apr-2009

With the global pharmaceutical market likely to witness products worth 123 billion dollars loosing patents by 2012 the generics driven Indian drugs industry could get benefit of around 18.4 billion dollars about Rs 91576 crore from those products.

Pharma MNCs ask DCGI to liaison with patent offices

Reghu Balakrishnan — 19-Apr-2009

In the backdrop of Wednesdays Delhi High Court verdict that allowed Cipla to manufacture and sell a patented cancer drug in India multinational pharma companies plan to urge the Drug Controller General of India to improve its co ordination with patent offices across the country.

Pharma companies headed for slower earnings growth analysts

C.H. Unnikrishnan and Radhieka Pandeya — 20-Apr-2009

Average growth in sales for the quarter likely to be less than 11% compared with 14% in the year ago period

Govt protests as generic drugs get bitter pill in Africa

Arun S — 20-Apr-2009

India has called an extraordinary meeting of the ambassadors of all African countries in the Capital this week to register its strong protest against a recently passed Anti Counterfeit Act in Kenya that could severely restrict the market for Indian generic drugs into Africa.

Scope to improve in big markets where the firm is already present

Radhieka Pandeya — 20-Apr-2009

Russia has been a good market for us. It is a branded generics market and we have been in the market for long

Drug firms may exceed growth targets

PB Jayakumar / Mumbai — 20-Apr-2009

Despite forex losses and currency fluctuations impacting profitability leading Indian drug companies such as Cipla Sun Pharma Dr Reddys Laboratories and Wockhardt are likely to exceed revenue growth targets set for financial year 2008 09.

Indian lawyer turns IPR into a board game

Malathi Nayak — 20-Apr-2009

The game is the brainchild of Pravin Anand one of Indias best known IPR lawyers.

IPR course for women

STAFF REPORTER — 20-Apr-2009

The training is aimed at having a pool of resources trained in scientific and technical aspects of intellectual property rights.

Achillion wins new US patent

By Datamonitor staff writer — 20-Apr-2009

Achillion Pharmaceuticals a US based biopharmaceutical company has announced that the US Patent & Trademark Office has granted Achillion a US patent related to the companys NS4A antagonists to treat the hepatitis C virus.

Glaxo to buy skin care firm for at least $2.9 billion

By Steve Goldstein — 20-Apr-2009

Companies in the sector have been looking for deals to boost their stable of new products as the patent protection for older medications expire.

Expert committee suggests patenting microorganisms too

C.H. Unnikrishnan — 21-Apr-2009

An expert group has suggested significant changes to Indias patent regime that will address contentious provisions that barred the issue of patents to anything that isnt a new chemical or medical entity and to drugs built around microorganisms.

Covidien Files Patent Infringement Lawsuit over Davols Mesh Fixation Device and Applier

NORTH HAVEN, Conn — 21-Apr-2009

The lawsuit contends that Davols recently released Sorbafix device infringes multiple claims of Covidiens US Patent Number 6562051.

Par Pharma settles patent dispute with Reliant

Associated Press — 21-Apr-2009

Generic drug developer Par Pharmaceutical Cos said Tuesday it settled a patent dispute with Reliant Pharmaceuticals Inc over the abnormal heart rhythm treatment Rythmol SR.

Glaxo Pfizer HIV research JV may harm generic cos

Nina Mehta — 22-Apr-2009

Ranjit Kapadia a pharma analyst with HDFC Securities said that the formation of the new firm will affect Indian companies if they are violating or challenging patents.

Big Pharma evergreening nixed

Priyanka Golikeri — 22-Apr-2009

Introducing highly expensive patented drugs that show little or no improvement over existing ones or attempts to evergreen patents is getting tougher for multinationals.

Glaxo Pfizers patent claims turned down

ET Bureau — 22-Apr-2009

Indian authorities have rejected the patent applications of GlaxoSmithklines anti diabetic drug Avandia and Pfizers cholesterol lowering drug Caduet allowing other companies to sell generic versions of these drugs.

ACTA to fight copyright infringement

PK Vasudeva — 22-Apr-2009

The US is considering bringing an Anti Counterfeiting Trade Agreement.

The US Is Losing Its Lead in Patents

By Michael Arndt — 22-Apr-2009

Innovation is coming from abroad these days and foreign applications are coming faster and faster.

Dr Reddys launches Redispar in India

Press Trust of India / Mumbai — 22-Apr-2009

Pharmaceutical firm Dr Reddys Laboratories today said it has launched Redispar drugs used in the treatment of chronic kidney diseases in the country.

IMS Health Cuts Pharma Growth Forecast

By Catherine Arnst — 22-Apr-2009

Big Pharma isnt so immune to the recession after all.

Piramal Health eyes acquisitions in US Europe

Reuters — 22-Apr-2009

Piramal Healthcare and a related firm Piramal Life Sciences Ltd would together invest about Rs1 billion during the 12 months to March 2010 mostly on new drug development and research.

Lilly says judge prevents launch of generic Evista

by Deena Beasley — 22-Apr-2009

Eli Lilly and Co said on Wednesday that a federal judge issued a preliminary injunction preventing the launch of a generic version of osteoporosis drug Evista.

NicOx acquires Nitromeds NO donating patents

SOPHIA ANTIPOLIS, FRANCE, MARKET WIRE — 23-Apr-2009

NicOx SA today announced it has agreed to purchase Nitromeds unlicensed patent estate covering nitric oxide donating compounds.

Teva Glenmark call an end to patent dispute

Nina Mehta — 23-Apr-2009

Israeli generic major Teva and Mumbai based Glenmark Pharmaceuticals have settled a patent dispute over various generic versions of Corega drug used for treating congestive heart failure out of court.

Gilead to challenge Tamiflu verdict

Reghu Balakrishnan — 23-Apr-2009

The patent office had recently rejected Gileads patent application owing to lack of inventiveness in the drug.

Teva to appeal against preliminary injunction for Generic Evista update

by RTT Staff Writer — 23-Apr-2009

Teva Pharmaceutical Industries Ltd said Thursday that it plans to appeal the Courts order in the litigation with Eli Lilly & Co.

Intellectual property report favours conditional patenting of micro organisms

P.T. Jyothi Datta — 24-Apr-2009

Mumbai April 23 Without much ado the Technical Expert Group on Patent Law Issues headed by Dr R A Mashelkar has resubmitted its report to the Union Ministry of Commerce.

Delhi High Court dismisses Roche plea on patent

PTI — 24-Apr-2009

The Delhi High Court on Friday allowed Indian pharmaceutical company Cipla to manufacture and sell the generic version of patented lung cancer drug Erlotinid of Swiss pharma firm Hoffman La Roche Ltd.

J&J Wins Approval to Sell Arthritis Drug in US

By Shannon Pettypiece and Alex Nussbaum — 24-Apr-2009

Remicades patent will expire in 2018 said Brian Kenney a spokesman for J&Js Centocor Ortho Biotech unit.

Cipla gets HC relief in Roche case

Radhieka Pandeya — 25-Apr-2009

In a ruling that could encourage more generic or off patent drug makers here to challenge patents held my multinational pharma firms the Delhi high court dismissed a patent infringement suit filed by Swiss pharma company Hoffman La Roche Ltd for its lung cancer drug Tarceva thereby allowing Indian drug maker Cipla Ltd to continue marketing the generic version of the drug.

Govt gives diplomatic push to pharma exports to Africa

Amiti Sen & Sushmi Dey — 25-Apr-2009

India has started a diplomatic exercise to counter a propaganda by multinational pharmaceutical companies against Indian generics or off patent drugs exported to Africa.

Govt to create 1380 patent examiners posts

Our Bureau — 27-Apr-2009

The Centre plans to create 1380 patent examiners posts during the 11th Plan period of which 414 will be filled up this year alone.

Sanofi Rebuffed by US High Court on Lovenox Patent

By Greg Stohr and Susan Decker — 27-Apr-2009

The US Supreme Court rejected an appeal by two Sanofi Aventis SA units refusing to reinstate a patent that prevented generic competition to the companys top selling product the blood thinner Lovenox.

Not too enticing

Ram Prasad Sahu / Mumbai — 27-Apr-2009

Going ahead although there are issues pertaining to patent registration and pricing if the company does manage to sort out these and use the listed arm for new launches sales could witness a jump considering its presence in high growth areas of anti diabetic cardiovascular gynaecology and anti ulcerants.

Qualcomm and Broadcom Settle Patent

Corporate News — 27-Apr-2009

Qualcomm Incorporated and Broadcom Corporation entered into a settlement and multi year patent agreement with Qualcomm paying Broadcom $891 million over a four year period.

FTC focused on drug pay for delay settlements

By Diane Bartz — 27-Apr-2009

The FTC while watching legislative efforts to ban the practice of big drug companies paying off generics as part of patent lawsuits has challenged the deals in court with mixed success.

Sinobiopharma Secures Rights to Seven Key Patents

NANJING, China — 27-Apr-2009

The patents that will significantly enhance Sinobiopharmas ability to execute on its mission of bringing safe low cost high efficacy biopharmaceuticals to market.

L&T unit files for 108 patents in 2008 09

Our Bureau — 28-Apr-2009

Mumbai April 27 Larsen and Toubros Electrical and Electronics Division has filed 108 patents applications in 2008 09 for its electrical and electronic products.

Cipla ready to supply generic drug to West

Corporate Bureau — 28-Apr-2009

Early this month the Delhi patent office had rejected the application of Gilead Sciences the manufacturer of Tamiflu for a patent considering Ciplas arguments that the drug lacked inventiveness.

Local drug cos may chip in to treat swine flu

Khomba Singh & Sushmi Dey — 28-Apr-2009

Cipla and other Indian pharma majors can now legally manufacture generic versions of Tamiflu after the patent office in Delhi last month rejected a patent application by Swiss company Roche which markets the antiviral in India.

US watch list on patents irks India

PTI ,New Delhi — 28-Apr-2009

India has conveyed its big disappointment to the US for retaining New Delhi on the Priority Watch List which binds Washington to exert pressure on Americas trade partners to improve their copyright and patent regimes.

US approval for Glenmark cholesterol drug

BS Reporter / Mumbai — 28-Apr-2009

Sources said Zetia had sales of $1.5 billion in 2008 and the main patent for this drug would expire in 2014.

Watson and Novartis battle over Enablex patent

Associated Press — 28-Apr-2009

Watson Pharmaceuticals Inc is disputing the patent on Novartis AGs extended release overactive bladder treatment Enablex Watson said Tuesday.

AVI BioPharma Receives Key Patents

PORTLAND, OR — 28-Apr-2009

AVI BioPharma Inc a developer of RNA based drugs announced in a Tuesday press release the issuance of the second of two key US patents covering the companys candidate drug for the treatment of Ebola Zaire infection.

NicOx to acquire NO donating patents from Nitromed

By Datamonitor staff writer — 28-Apr-2009

France based NicOx has agreed to purchase US based Nitromeds unlicensed patent estate covering nitric oxide donating compounds.

Dr Reddy launches anti acne drug Nexret in India

Agencies — 28-Apr-2009

Pharmaceutical firm Dr Reddy said it has launched a variety of gel Nexret used in the treatment of skin diseases.

Watson Confirms Filing of Abbreviated New Drug Application for Generic Enablex

CORONA, Calif — 28-Apr-2009

Watson Pharmaceuticals Inc a leading specialty pharmaceutical company today confirmed that it has filed an Abbreviated New Drug Application with the US Food and Drug Administration seeking approval to market its darifenacin hydrobromide extendedrelease 7.5 mg and 15 mg product prior to the expiration of a patent owned by Novartis AG.

i2 Files Intellectual Property Lawsuit

DALLAS--(BUSINESS WIRE) — 29-Apr-2009

i2 Technologies Inc announced today that it has filed a suit for patent infringement against Oracle Corporation.

McCurry beats McDonald in Malaysia lawsuit

David Chance, Kuala Lumpur — 29-May-2009

Fast food chain McDonald\'s lost a lawsuit in Malaysia on Wednesday after an appeals court overruled a decision that its trademark had been infringed by a local restaurant called McCurry.

The Patent Reform Act Means Progress

by Senator Patrick Leahy — 29-Apr-2009

Ingenuity and innovation have been cornerstones of the American economy from the time Thomas Jefferson issued the first patent.

FDAs Tamiflu move to spur generics mkt

Reghu Balakrishnan — 30-Apr-2009

Earlier this month the Delhi patent office had rejected the patent application for Tamiflu filed by Gilead Sciences while considering the pre grant opposition of Cipla.

The Patent Reform Act Means Progress

by Senator Patrick Leahy — 30-Apr-2009

Ingenuity and innovation have been cornerstones of the American economy from the time Thomas Jefferson issued the first patent.

Wockhardt may get rights for two Parkinsons drugs

BS Reporter / Mumbai April 30 — 30-Apr-2009

Settles 3 patent infringement cases out of court.

Ready to supply anti flu drug at short notice says Ranbaxy

ET Bureau — 30-Apr-2009

The timely rejection of Gileads other patent application for Tamiflu in India has come as a shot in the arm for Indian generic players.

Warner Chilcott Files New Lawsuit for Infringement of DORYX Patent

HAMILTON, Bermuda — 01-May-2009

Warner Chilcott Limited announced today that one of its subsidiaries and Mayne Pharma International Pty Ltd have filed a second lawsuit against Mylan Pharmaceuticals Inc and Mylan Inc in the District Court for the District of New Jersey for infringement of Maynes US Patent No 6958161 which covers DORYX a tetracycline class oral antibiotic.

New Delhi rejects American firms plea to patent Hepatitis B drug

Khomba Singh — 01-May-2009

The Delhi Patent Office has rejected American company Gilead Sciences plea to patent its Hepatitis B drug adefovir dipivoxil sold under the brand name Hepsera.

ImmunoCellular Therapeutics wins new patent for monoclonal antibody technology

By Datamonitor staff writer — 01-May-2009

ImmunoCellular Therapeutics a biotechnology company has received a new US patent relating to the companys monoclonal antibody therapeutics.

Gileads Hepatitis patent plea rejected

Khomba Singh, — 2-May-2009

The Delhi Patent Office has rejected American company Gilead Sciences plea to patent its Hepatitis B drug adefovir dipivoxil sold under the brand name Hepsera.

Indian pharma emerges big player in Japan

PB Jayakumar / Mumbai — 2-May-2009

Leading Indian drug makers such as Ranbaxy Lupin Zydus Cadila and Dishman which forayed into Japan in the past three years have emerged as important players in the generic or copycat drug business of patented medicines in that market the second largest in the world.

Ranbaxy recalls Nitrofurantoin capsules from US market

ET Bureau,NEW DELHI — 2-May-2009

Indias largest drug company by sales Ranbaxy Laboratories is voluntarily recalling its entire lots of Nitrofurantoin 100 mg capsules from the US retail market after it was discovered that the drugs did not meet the US drug manufacturing standards.

Patent office lets Roche keep Hepatitis C drug

Priyanka Golikeri — 02-May-2009

According to the World Health Organisation as many as 180 million people worldwide have been infected by the hepatitis C virus with 3 4 million being added to the list every year.

India to move WTO against EU MNCs blocking its generics

Sushmi Dey — 02-May-2009

India along with Brazil will lodge a complaint with the World Trade Organisation against the European Union alleging that Europe based multinational pharmaceutical firms are persuading African nations to enact anti counterfeit laws.

Google and other firms sued over use of Android name

TEL AVIV — 3-May-2009

An Illinois software developer sued some four dozen companies including Google Inc claiming that they infringed his trademark on the word Android weekend media reports said.

20th Century Fox sues B R Films for plagiarism

Press Trust of India / Mumbai — 3-May-2009

Hollywoods famous studio Twentieth Century Fox has moved the Bombay High Court against B R Chopra Films seeking Rs 7 crore damages and an injunction against the release of the Hindi film Banda Yeh Bindaas Hai alleging it was a remake of Oscar winning My Cousin Vinny.

IPL brands work on intellectual property bouquets

Malathi Nayak — 04-May-2009

Rodney D Ryder partner at law firm Kochhar and Co refers to the Indian Premier League the popular Twenty20 cricket tournament as the intellectual property league.

Pharma The 10 Most Promising New Drugs

By Arthur Wong — 04-May-2009

The pharmaceutical industry continues to march toward the patent cliff in 2010 2012 when a record amount of drug sales will lose patent protection in the US.

Hetero Drugs close to receiving orders for its swine flu medicines

Khomba Singh — 04-May-2009

Its patent application was rejected by the India patent office in March 2009 which paved the way for Indian companies to legally manufacture and sell their generic version of the drug.

Acclarent Inc Granted Key Patent Covering Balloon Sinuplasty Technologies

MENLO PARK, Calif — 04-May-2009

Acclarent Inc the pioneer of Balloon Sinuplasty technologies for use in the treatment of chronic sinusitis announced today that the US Patent and Trademark Office awarded US Patent Number 7500971 entitled Devices Systems and Methods for Treating Disorders of the Ear Nose and Throat to the company.

Indian drugmakers facing takeover threat says Govt panel

PTI — 04-May-2009

With a large number of drugs going off patent in developed markets like the US and Europe Indian companies are expected to garner a lions share in the segment.

Hetero bags mega chunk of govts anti flu drug deal

Khomba Singh — 5-May-2009

Roche does not hold a patent for Tamiflu in India.

India may ask Kenya to review drug law

Amiti Sen & Sushmi Dey, — 05-May-2009

India is likely to ask Kenya to make amendments in its recent anti counterfeit law to protect Indian pharmaceutical exports.

Takeda Lilly Lead $28.5 Billion in Biotech Deals Report Says

By Lisa Rapaport — 05-May-2009

Drugs with about $24 billion in annual sales are set to lose patent protection this year according to IMS Health Inc the Norwalk Connecticut based research firm.

3 Monsanto DuPont bicker over herbicide tolerant tech

By Steve James — 05-May-2009

This violates Monsantos contract rights and US patents it said in the suit demanding DuPont honor its agreements and respect patented technologies.

NanoLogix Inc to Exhibit at The American Society for Microbiology General Meeting in Philadelphia Announces Two New Patents

Carol Surrena — 05-May-2009

NanoLogix recently received two patents.

Warner Chilcott files new patent infringement lawsuit against Mylan

By Datamonitor staff writer — 05-May-2009

Warner Chilcott a Bermuda based specialty pharmaceutical company has reported that one of its subsidiaries and Mayne Pharma International have filed a second lawsuit against Mylan Pharmaceuticals Inc and Mylan Inc in the District Court of New Jersey for infringement of Maynes US patent which covers Doryx a tetracycline class oral antibiotic.

Biotech Pharma Docket

By Suresh Pillai — 5-May-2009

In the lawsuit filed in July 2008 Norvartis alleges that Roxane infringed Novartis patents covering Famvir a treatment for genital and oral herpes.

Patent law again

Business Standard / New Delhi — 6-May-2009

The revised report of the technical expert group on patent law issues is not very different from the one that the group had to withdraw in 2007.

Global model to give instant patent relief to drug cos

Khomba Singh — 6-May-2009

In what will pave the way for global pharma firms to obtain patents in India easily the United Nations arm on intellectual property is planning to implement a global patenting model that will mandate all member countries including India to grant patent to drugs approved by any two international patent offices.

Pfizer sues Sun Wockhardt Lupin in US

Joe C Mathew / Bangalore — 6-May-2009

Files patent infringement suits against generic versions of best selling nerve drug.

Pharma cos seek retail opening for swine flu drug

Nina Mehta & Khomba Singh, — 6-May-2009

This time though the timely rejection of Roches patent in March has allowed Indian companies to manufacture the product and sell it in India and the countries where Roche does not have patent protection.

Teva says Parkinsons drug patent extended to 2017

Associated Press — 06-May-2009

Drugmaker Teva Pharmaceutical Industries Ltd said Wednesday that one of the patents on Azilect its Parkinsons disease drug has been extended by five years into 2017.

10 Q PAR PHARMACEUTICAL COMPANIES INC

EDGAR Online via COMTEX — 6-May-2009

Certain statements in this Report constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including those concerning managements expectations with respect to future financial performance trends and future events particularly relating to sales of current products and the development approval and introduction of new products.

Wockhardt seeks to sell animal healthcare biz

BS Reporter / Mumbai — 7-May-2009

Wockhardt has one of the largest number of off patent biotech drugs under development in India.

Wi LAN settles patent litigation with Infineon

by Krishna Chaithanya — 07-May-2009

Technology licensing firm Wi LAN Inc said it settled a patent litigation with German chipmaker Infineon Technologies AG for an undisclosed amount.

IL wins patent infringement lawsuit against Diagnostica Stago

By Datamonitor staff writer — 07-May-2009

Instrumentation Laboratory and its parent company Instrumentation Laboratory SpA or IL have reported that the Paris First Level Civil Court has determined that Diagnostica Stago infringed the French counterparts of two European patents licensed exclusively to IL and committed acts of unfair competition due to denigrating advertisements.

China drug maker Zensun eyes Nasdaq listing in 2011

by David Lin — 7-May-2009

Zhou also the chief executive of the firm said that he is in talks with several US pharmaceutical firms to sell the patent of Neuregulin and hopefully to gain the Food and Drug Administrations approval to sell it in the United States.

India pips US UK in IP laws enforcement practices

PTI — 7-May-2009

Indian has been ranked top globally for enforcing intellectual property laws ahead of some of the most advanced nations like the United States and the United Kingdom a survey says.

Indian pharma cos upbeat on biogenerics

Joe C Mathew / Bangalore — 8-May-2009

Even as the substitutability of biogeneric or biosimilar medicines with their original patented counterparts continues to be a matter of debate world over Indian drug companies which have introduced biogeneric products or copies of biotechnology drugs in the country are bullish over the marketing prospects of biogenerics after patents expire in developed markets.

Wyeth sues Sun and its US subsidiary over Protonix drug

Radhieka Pandeya — 8-May-2009

US based Wyeth Pharmaceuticals has sued Mumbai based Sun Pharmaceutical Industries Ltd and its US subsidiary Caraco Pharmaceutical Laboratories Ltd for claiming that their heartburn drug was a generic version of its Protonix drug.

Gucci sues Guess for trademark infringement

Bloomberg / New York — 8-May-2009

Guess Inc was sued by Gucci Groups US unit for trademark infringement over allegations the Los Angeles based apparel company uses a network of wholesale buyers to sell imitations of Guccis best selling designs.

Gene Network Sciences wins new US patent

By Datamonitor staff writer — 08-May-2009

Gene Network Sciences a biotechnology company has received a US patent that covers the companys core model learning and simulation platform REFS.

The war for intellectual property

Latha Jishnu / New Delhi — 9-May-2009

At the Geneva headquarters of the World Intellectual Property Organisation skirmishes between rich nations and the developing world take place with predictable regularity.

Pfizer counters Dr Reddys claims against its anti smoking drug

ET Bureau — 9-May-2009

Pfizer has responded to the post grant opposition filed by Dr Reddys Laboratories against its anti smoking drug Champix.

Cadila expects Rs 100 cr revenue from Policap

PTI,NEW DELHI — 9-May-2009

Ahmedabad based Cadila Pharmaceuticals on Saturday said it is expecting a revenue of Rs 100 crore from the sale of its patented combination drug Policap which it expects to launch by the middle of next month.

The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica

Bavarian Nordic — 9-May-2009

Oxford Biomedicas second attempt to dismiss Bavarian Nordics patent infringement suit in the United States has failed.

India asks Africa to keep doors open to generic drug imports

Addis Ababa (IANS) — 10-May-2009

India has urged African countries not to put barriers on the production and import of generic drugs to the continent especially in the current economic slowdown which could adversely affect the purchasing power of patients.

Drug to curb Diabetes gets patent rights

KAKINADA,TNN — 11-May-2009

Chintaluru village in East Godavari district which had become a popular place in the state for the manufacture of ayurvedic drugs for several decades has earned a rare distinction of getting patent rights for one of its product meant for curbing diabetes.

Pharma cos seek rise in prices of regulated drugs

Khomba Singh & Sushmi Dey — 11-May-2009

The domestic pharma industry is going to seek an upward revision in drug prices by submitting a report on the increase in conversion and packaging costs to the Indian drug price regulator National Pharmaceutical Pricing Authority.

Takeda Q4 profit more than doubles sees growth ahead

by Yumiko Nishitani — 11-May-2009

Joining other drugmakers using acquisitions to stave off earnings declines on patent expirations Takeda bought US biotech firm Millennium Pharmaceuticals and absorbed its part of former US joint venture TAP Pharmaceuticals.

SISVEL Patent Pool for 3G Long Term Evolution LTE

TURIN, Italy — 11-May-2009

Following talks with the stakeholders in the LTE field worldwide that began last year and culminated in April 2009 in a presentation on the benefits of an LTE patent pool delivered to the IPR Plenary Assembly of the Next Generation Mobile Network Alliance today SISVEL issued a call for patents and patent applications that are essential to the LTE standard.

Nanosys Licenses Nanowire Technology to QuantuMDx Group for Next Generation Diagnostic and Sequencing Technologies

PALO ALTO, Calif. and LONDON,PRNewswire — 11-May-2009

Nanosys Inc and QuantuMDx Group today announced that QMDx has signed a non exclusive license agreement with Nanosys for several patents and patent applications related to the use of nanowires for biosensors.

AstraZeneca shares jump on blood thinner drug study

Val Brickates Kennedy — 11-May-2009

Plavix is due to lose patent protection in late 2011.

WIPO clarifies

IST,NEW DELHI — 11-May-2009

This is with reference to the story Global model to give instant patent relief to drug cos which purports to relate to matters under discussion this week in the Patent Cooperation Treaty Working Group at WIPO.

Concert Pharmaceuticals Granted Patents on Deuterium Modified Compounds

LEXINGTON, Mass — 11-May-2009

Concert Pharmaceuticals Inc announced today that its first patents have been granted by the US Patent and Trademark Office.

Lupin settles antidepressant drug litigation with Wyeth

BS Reporter / Mumbai — 12-May-2009

Lupin a generic drug maker has settled all patent litigation with US drug maker Wyeth for Effexor XR capsules the US firms branded anti depressant.

Japans Daiichi says deep in red due to Ranbaxy deal

REUTERS — 12-May-2009

Ranbaxy which derives 80 percent of its sales from abroad has grown by selling cheap copies of branded drugs that have gone off patent and through successful challenges to patents owned by Western companies.

Cancer Patients Challenge the Patenting of a Gene

By JOHN SCHWARTZ — 12-May-2009

On Tuesday Ms Girard 39 who lives in the Austin Tex area filed a lawsuit against Myriad and the Patent Office challenging the decision to grant a patent on a gene to Myriad and companies like it.

Global HIV AIDS initiative to help Indian pharma

PB Jayakumar / Mumbai — 13-May-2009

Global healthcare aid agencies such as UNITAID and Medicines Sans Frontieres have begun to lobby for a patent pool of HIV AIDS drugs.

Satyam Upaid get chance to try out of court settlement

Andy Mukherjee & Jessica Mehroin Irani — 13-May-2009

Satyam Computer Services and UK based mobile solutions company Upaid have been offered a chance to settle their dispute out of court.

OMAX Announces Settlement in Patent Litigation

KENT, Wash — 13-May-2009

OMAX has announced the settlement of the outstanding patent litigation with Flow Corporation along with the cessation of merger negotiations with the company.

ACLU and PUBPAT Challenge Patents on Breast Cancer Genes

ag-IP-news Agency — 13-May-2009

The American Civil Liberties Union and the Public Patent Foundation at Benjamin N Cardozo School of Law filed a lawsuit charging that patents on two human genes associated with breast and ovarian cancer stifle research that could lead to cures and limit womens options regarding their medical care.

Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel

The Procter & Gamble Company — 13-May-2009

Today the United States Court of Appeals for the Federal Circuit ruled in favor of The Procter & Gamble Company in the patent infringement lawsuit filed by P&G against Teva Pharmaceuticals USA Inc.

Bajaj gets patent for multi spring shock absorbers

PTI — 14-May-2009

Pune based Bajaj Auto today said it has received patent for its invention multi spring vehicle shock absorber used in its motorcycles with which it hopes to counter cheap Chinese copycats.

Indian group to sell copy of Tamiflu

By Andrew Jack in London — 14-May-2009

An Indian pharmaceutical company is gearing up to sell a cheap version of Tamiflu the leading patented antiviral flu drug to emerging economies in a move that will pit intellectual property rights against affordable access to drugs.

Teva wins a round in court in Protonix fight

by Diane Bartz — 14-May-2009

A US appeals court refused on Thursday to give drugmakers Altana AG and Wyeth a preliminary injunction in a patent fight with Teva Pharmaceutical Industries over the ulcer drug Protonix.

Piramal Healthcare launches ActiPatch for pain therapy

PTI — 14-May-2009

Its unique delivery system using patented technology provides a cost effective patient friendly method to reduce soft tissue pain and swelling Piramal said.

Gilead sues Teva in Atripla patent dispute

Associated Press — 14-May-2009

Gilead Sciences Inc said Thursday it is suing Teva Pharmaceuticals Industries Ltd over the drugmakers plans to make a generic version of the blockbuster HIV treatment Atripla.

UCB stock rises as US clears arthritis drug

By Philip Blenkinsop and Antonia van de Velde — 14-May-2009

The news will reduce UCBs reliance on older drugs some of which have lost patent protection and is a vindication of its investment in biotechnology.

Competitive Technologies wins new patent for nanoparticle bone biomaterial

By Staff Reporter — 15-May-2009

Third patent supports first two patents and provides additional claims regarding the preparation of the primary components of bone cement

Indian drug seizure by EU may force firms to change routes

Press Trust Of India / New Delhi — 16-May-2009

Frequent seizure of Indian drug consignments in Europe may force domestic pharmaceutical firms to avoid the European sea routes to destinations in Africa and Latin America Commerce Secretary G K Pillai said.

USPTO Upholds StemCells Patents

PALO ALTO, CA — 16-May-2009

StemCells Inc announced in a press release that the US Patent and Trademark Office has upheld the validity of the remaining two neural stem cell patents which were subjected to reexamination proceedings commenced by Neuralstem Inc.

22 patent department officers transferred

C.H. Unnikrishnan — 18-May-2009

However the transfers have drawn criticism from within the office on the grounds that some of the officials are wrong targets

Calcutta HC Bench admits ITC appeal

Our Bureau — 18-May-2009

ITC had moved the High Court against Godfrey Phillips alleging infringement of copyright and illegal use of a registered trademark of ITC products.

Wealth of microbes

Surinder Sud / New Delhi — 19-May-2009

Many feel that microbes being live forms should not be patented as these are the creations of nature and not of man.

US firm sues Lupin over patent infringement

By fe Bureau — 19-May-2009

Lupin Pharmaceuticals the US subsidiary of Indian pharma major Lupin has been sued by US firm Genzyme.

Madras HC allows TVS to use Bajajs patented tech

T E Narsimhan & Swaraj Baggonkar / Chennai/mumbai — 19-May-2009

The Madras High Court today set aside its earlier order restraining countrys third largest two wheeler manufacturer TVS Motors from manufacturing and marketing vehicles with twin spark technology.

Atherotech receives patent for ApoB measurement for determining heart disease risk

Medicinal Patent News — 19-May-2009

Atherotech Inc developer of the VAP Cholesterol Test has announced it has received a patent on its method to derive and report apolipoprotein B100 using the Vertical Auto Profile technology.

A patent attempt at cultural sensitivity

Leslie D`Monte / New Delhi — 19-May-2009

You may soon get an email with a colour that suits your culture and nerves now that IBM the over $100 billion IT giant which has a current active portfolio of about 26000 patents in the US and over 40000 patents worldwide has applied for a patent to cover a method for customising colour in an email message based on the cultural perspective of each recipient.

Intradigm Announces Issuance of RNA Interference Patent Covering Potent siRNA Sequence

Intradigm Corporation — 19-May-2009

Intradigm Corporation a leading developer of targeted systemic RNA interference therapeutics today announced the issuance of United States patent 7534878 titled Composition and Methods of RNAi Therapeutics for Treatment of Cancer and Other Neovascularization Diseases.

Bulk drug firms want pollution norms relaxed

B Krishna Mohan / Hyderabad — 19-May-2009

Bulk drug manufacturers see a business opportunity arising when many drug patents expire next year.

DVD patent violation Toshiba sues Moser Baer

Corporate,NEW DELHI — 19-May-2009

Japanese electronics major Toshiba Corporation has filed a lawsuit against optical storage device maker Moser Baer India for alleged DVD patents infringement.

SanDisk Samsung talking over patents

By Anupreeta Das — 19-May-2009

SanDisk Corp continues to negotiate with rival Samsung Electronics Co Ltd over renewing their patent licensing agreement that is set to expire this August SanDisk Chief Executive Eli Harari said.

Resverlogix files two patents on compounds for inflammatory diseases

Medical Patent News — 20-May-2009

Two new patent applications have been filed for novel compounds and their use in regulating inflammatory markers.

Avigen Granted AV411 Patent for Neuropathic Pain

ALAMEDA, CA - — 20-May-2009

Avigen Inc announced in a press release that it has been granted United States Patent No 7534806 entitled Method for Treating Neuropathic Pain and Associated Syndromes.

HC lifts stay against TVS on Flame

Agencies, fe Bureau — 20-May-2009

TVS has been a licencee of patent dated May 25 2000 and Bajaj held the patent as of July 1 2002.

Court grants AstraZeneca preliminary injunction against Apotex in PULMICORT RESPULES patent litigation

Wilmington, DE — 20-May-2009

No trial date for the patent litigation has been set.

GenVault Receives Four Critical US and EU Patent Allowances for Key Biosample Management Technologies

Bret Dash — 20-May-2009

GenVault Corporation is pleased to announce notice of allowance for four key patents in its growing portfolio.

Microsoft ordered to pay $200 million in patent case

by Bill Rigby — 20-May-2009

Microsoft Corp said on Wednesday a Texas federal jury ordered the company to pay Canadian software firm i4i Ltd $200 million in damages for infringing a patent.

Indian pharma players to benefit from generic drugs in US

Nina Mehta — 20-May-2009

According to GPhAs analysis high growth rates were driven by factors such as increase in the overall percentage of generic utilisation and loss of patent protection by several brand name blockbusters such as Pravachol Ambien Fosamax Zoloft and Zocor.

Qualcomm others found to infringe Tessera patents

By Diane Bartz — 20-May-2009

Qualcomm and others infringed Tessera Technologies patents for methods to package semiconductor chips so they are protected inside portable devices the US International Trade Commission said on Wednesday.

Pfizer strikes deals in generics emerging markets

By Lewis Krauskopf — 20-May-2009

The deals announced by Pfizer on Wednesday with Aurobindo Pharma Ltd and Claris Lifesciences Ltd substantially increase Pfizers offerings in medicines that have lost patent protection in markets around the world.

Pfizer to market off patent injectables with Claris

BS Reporter / Ahmedabad — 21-May-2009

Leading pharmaceutical company Pfizer Inc has entered into a partnership with Ahmedabad based Claris Lifesciences Ltd to commercialise sterile injectible drugs that are off patent and have lost exclusivity in the United States Canada Australia New Zealand and Europe.

We do not foresee much implication of Toshiba suit Moser Baer

Our Bureau — 22-May-2009

The Moser Baer India Chairman Mr Deepak Puri said Thursday that he does not foresee much implication of the Toshiba lawsuit and that as per his preliminary reading the infringement allegations pertain to optical media disk drives whereas his company is into manufacturing of optical storage media.

Drug regulator to expand survey on fake medicines

Thomas K. Thomas — 22-May-2009

The Drug Controller General of India plans to widen the survey to map the prevalence of counterfeit drugs in the country with larger number of samples.

Conceptus files patent suit against Hologic

by Anand Basu — 22-May-2009

Conceptus Inc a maker of contraception devices filed a lawsuit against Hologic Inc alleging that the medical diagnostics companys sterilization system will infringe several US patents owned by Conceptus.

Viral Genetics issued patent for novel cancer therapies

Medical Patent News — 22-May-2009

Biotechnology firm Viral Genetics Inc has been issued a patent for novel cancer therapies.

Amsterdam authorities release Ind Swift exports

P.T. Jyothi Datta — 23-May-2009

Diplomacy and legal channels have helped the Chandigarh based Ind Swift get its export consignment released from customs authorities in Amsterdam about six months after it was seized.

Epistar Soars to 16 Month High After Winning Patent Appeal

By Weiyi Lim — 25-May-2009

Epistar Corp. jumped to its highest in 16 months after winning its appeal in a patent infringement case in which Royal Philips Electronics NV s Lumileds unit was trying to block the Taiwanese companys chips from US markets.

AAU for patent of mechanised production of basundi

Shubhlakshmi Shukla — 25-May-2009

Anand Agriculture University authorities plan to patent the mechanised production of basundi.

Television brands turn tangible

Shuchi Bansal / New Delhi — 25-May-2009

Piracy that is infringement of IPR is our other challenge in the market place adds Jibi George.

Fake drugs

Sudhir Chowdhary — 25-May-2009

Recently enforcement officials of the European Union seized a consignment of fake drugs which included not just Viagra but also other serious medicines such as anti cholesterols anti osteoporosis and anti hypertensives.

Supplies delay Ranbaxy may take $50 mn hit

Radhieka Pandeya — 26-May-2009

This follows from a manufacturing agreement that was part of a bigger patent infringement settlement between Ranbaxy and AstraZeneca in April 2008.

Advaxis Receives US Patent and Trademark Office Approval on Act A Protein Patent Pending Rights

NORTH BRUNSWICK, N.J — 26-May-2009

The US Patent and Trademark office approved Advaxis Incorporated patent application Compositions and Methods for Enhancing the Immunogenicity of Antigens Application US20050118184 A1.

Ranbaxy shares spurt 20% on BSE

BS Reporter / Mumbai — 26-May-2009

Daiichi Sankyo has strength in developing patented products for lifestyle diseases such as hypertension diabetes mellitus autoimmune disorders hyperlipidemia or atherosclerosis and bacterial infections

Samsung may win dual SIM patent case

C.H. Unnikrishnan — 26-May-2009

The Chennai patent office had in January 2008 granted a patent to Ramkumar for mobile phones with the capability of using two SIM cards.

US District Court Orders Hynix to Post Security for Infringing Rambus Patents

LOS ALTOS, Calif — 26-May-2009

Rambus Inc today announced that the US District Court for the Northern District of California has ordered Hynix Semiconductor to secure the judgment amount of approximately $397 million through a combination of a bond and a lien on a Hynix property in South Korea for infringing Rambus patents.

Medicis Announces New Patents for SOLODYN

SCOTTSDALE, ARIZ — 26-May-2009

Medicis announced in a Tuesday press release that the United States Patent and Trademark Office has advised the company that US Patent No 7541347 directed to the use of SOLODYN in 90mg tablet form will issue on June 2 2009 and that US Patent No 7544373 directed to SOLODYN in 90mg tablet form will issue on June 9 2009.

Bajaj Auto to move SC on TVS issue

T E Narasimhan & Swaraj Baggonkar / Chennai/mumbai — 27-May-2009

The High Courts ruling had come as a big relief for TVS Motor which was restricted by an earlier verdict from the same court that did not allow the company to produce or sell the disputed motorcycle Flame a 125cc bike sporting twin spark plugs as Bajaj Auto held patent rights for the same.

Your genes Not on your life

Latha Jishnu / New Delhi — 27-May-2009

In a first of its kind a motley group of interests from cancer patients and civil liberties activists to clinic pathologists and researchers have challenged the gene patents granted to a US biopharmaceutical company.

New US patent issued for Limbrel in osteoarthritis

Medical Patent News — 27-May-2009

Primus Pharmaceuticals Inc has announced the issuance of a new composition of matter patent for Limbrel the first prescription medical food product to safely meet the distinctive nutritional requirements of patients with osteoarthritis.

US reexamines Mercks Singulair patent

By Ransdell Pierson — 28-May-2009

Merck & Co said on Thursday the US Patent Office is reexamining the patent on its biggest product $4.5 billion a year asthma treatment Singulair.

Osteologix Receives Key US Patent Allowance for Novel Osteoporosis Drug

GLEN ALLEN, Va. BUSINESS WIRE — 28-May-2009

Osteologix Inc today announced that is has received a Notice of Allowance from the US Patent and Trademark Office for its US Patent Application Number 11269289 titled Water Soluble Strontium Salts for Use in Treatment of Cartilage and or Bone Conditions reporting allowance of claims covering the treatment of osteoporosis and related bone conditions using NB S101 the Companys lead osteoporosis drug candidate.

Indian court uses blog reference to solve TVS Bajaj patent issue

Soumya Shanker & Malathi Nayak — 29-May-2009

Ablog post by a student was instrumental in TVS Motor Co Ltds victory over Bajaj Auto Ltd in their recent legal skirmish over patent infringement issues setting a precedent for the use of blog content by the countrys courts.

Citigroup upgrades Sanofi Aventis to buy

By Sarah Turner — 29-May-2009

They noted that data at the upcoming ASCO meeting could be significant and that patent challenges are not insurmountable.

Unigen\'s First Site Directed Bone Growth Patent Issues

BOONTON, NJ — 30-May-2009

Unigene Laboratories Inc reported that its first patent covering its Site Directed Bone Growth technology has been issued a press release by Unigene stated.

Venus Remedies gets patent for anti pneumonia drug

Corporate,NEW DELHI — 01-Jun-2009

Pharmaceutical firm Venus Remedies on Monday said it has received a patent right in South Korea for its drug which is used for the treatment pneumonia.

Supreme Court to Review Business Method Patents

By Michael Orey — 01-Jun-2009

The high court will decide if such things as financial products and Internet commerce systems deserve intellectual property protection

Medtronic announces appeal decision in patent case with DePuy Spine

Medical Patent News — 01-Jun-2009

Medtronic Inc has announced results from a Federal Circuit Court review of a December 2007 patent infringement verdict regarding the Vertex line of multiaxial screws which are no longer on the market.

Top court to hear business method patent case

by Diane Bartz — 1-Jun-2009

The Supreme Court said on Monday it would hear the Bilski patent case which would tell high tech and software companies how far they could go in patenting software financial strategies and other abstract processes.

First Product Patent Granted to Venus Remedies in South Korea

ag-IP-news ,HARYANA — 1-Jun-2009

The Korean Intellectual Property Office has granted a Product Patent to one of the research products of Venus used for the treatment of pneumonia.

Sanofi has winning cancer drug but short patent

By Ben Hirschler — 1-Jun-2009

Sanofi Aventis may have bagged a winning cancer drug when it agreed to buy privately held BiPar Sciences for up to $500 million in April but a short patent could limit the French groups scope to cash in on sales.

BASF Sues DuPont for Patent Infringement

Mark Stephenson, BASF Corporation — 1-Jun-2009

BASF Plant Science GmbH seeks an injunction and damages against DuPont and its subsidiary Pioneer Hi Bred International for this unlawful use of BASFs patented technology.

GraphOn Announces Settlement Resolving Legal Dispute with Google

SANTA CRUZ, Calif — 1-Jun-2009

GraphOn Corporation today announced a settlement that resolves the legal dispute between GraphOn and Google Inc.

Microsoft Lucent battle in huge patent case

by Diane Bartz — 02-Jun-2009

Microsoft Corp argued before an appeals court on Tuesday that its Outlook calendar date picker tool did not infringe an Alcatel Lucent patent and asked for a $358 million jury verdict to be overturned.

Zydus Teva end patent disputes

Nina Mehta — 2-Jun-2009

Ahmedabad based ZydusCadila and Israeli generic major Teva have settled their patent disputes over active pharmaceutical ingredients used to make generic versions of GlaxoSmithKlines heart drug and Johnson & Johnsons anti psychotic drug.

InterDigital Nokia finish patent fight hearing

By Diane Bartz — 02-Jun-2009

Wireless technology firm InterDigital and the worlds top cellphone maker Nokia wrapped up hearings on Tuesday at the International Trade Commission in a battle over four patents said InterDigital spokesman Jack Indekeu.

They opposed Novartis on Glivec but now seek patent

Priyanka Golikeri — 02-Jun-2009

If you thought only multinational drugmakers were monopolistic and fought fiercely to secure patents for new forms of known molecules you are so wrong.

Nvidia US patent office rejects Rambus claims

SANTA CLARA, Calif. — 2-Jun-2009

Nvidia Corp said Tuesday the US Patent and Trademark Office has rejected 41 claims against the chip maker brought by Rambus Inc a company that licenses semiconductor technology.

Top court to hear business method patent case

By Diane Bartz — 2-Jun-2009

The Supreme Court said on Monday that it would hear the Bilski patent case which will tell high tech and software companies how far they can go in patenting software financial strategies and other abstract processes.

Denial of patent to Gilead beneficial for Indian firms

BS Reporter / Mumbai — 3-Jun-2009

The Indian Patent Offices decision to reject a product patent for Gilead Sciences Incs adefovir dipivoxil variant a new form of its Hepatitis B drug Hepsera has come as a boon for Indian copy cat drug makers such as Ranbaxy Cipla and Sun Pharma.

Vical Announces Issuance of US Patent for Universal Influenza Vaccine Approach

SAN DIEGO — 03-Jun-2009

Vical Incorporated announced in a Wednesday press release the issuance of US Patent No 7537768 covering the use of influenza virus gene sequences in a universal vaccine that could provide protection against circulating seasonal strains as well as emerging pandemic strains of influenza viruses.

Echostar To Pay TiVo Another $103 Million In Patent Case

By Rory Maher — 03-Jun-2009

In the latest chaper of a patent infringement case on its DVR technology that dates back to 2004 TiVo was awarded an additional $103 million by the United States District Court in Texas after a failed appeal by Echostar.

ARIAD Announces Updates On NF kB Patent Appeals

CAMBRIDGE, MASS — 03-Jun-2009

ARIAD Pharmaceuticals Inc and its co plaintiffs announced that they are filing a petition for an en banc rehearing of an April decision by the US Court of Appeals for the Federal Circuit in its patent infringement case against Eli Lilly and Company.

Rallis India seeks patent for three new biomolecules

C.H. Unnikrishnan — 3-Jun-2009

In a move that could help extend its presence in the global crop protection market Rallis India Ltd a Tata group agrochemical company has developed at least three new biomolecules for use in fungicides

Novocell Obtains US Patent for Drug Screening Human Embryonic Cell Derived Endoderm Cells

SAN DIEGO — 3-Jun-2009

Novocell Inc a stem cell engineering company today announced that it has received US Patent No 7541185 with method claims covering the use of endoderm cells derived from human embryonic stem cells for drug discovery.

Almirall gets FDA approval for migraine drug

by Tracy Rucinski — 3-Jun-2009

Almiralls patent on Almotriptan in the United States has been extended to November 2015.

Mylan Again Calls for an End to Authorized Generics During 180 Day Exclusivity Period

PITTSBURGH — 3-Jun-2009

The committees hearing Pay to Delay Are Patent Settlements That Delay Generic Drug Market Entry Anticompetitive was called to gather information about the effects of settlements.

Vical Receives US Patent For Universal Influenza Vaccine Approach

By Staff Reporter — 3-Jun-2009

Vical has received US Patent No 7537768 covering the use of influenza virus gene sequences in a universal vaccine that could provide protection against circulating seasonal strains as well as emerging pandemic strains of influenza viruses.

Agilent wins patent fight with Affymetrix

by Maggie Fox and Diane Bartz — 04-Jun-2009

A US patent appeals court ruled on Thursday in favor of Agilent Technologies which had been involved in a patent fight with Affymetrix Inc.

German market for Indian drugs shrinks

C.H. Unnikrishnan — 4-Jun-2009

Orchid is currently focusing on products that enjoy patent protection but once they go off patent the company will be affected.

J&J upbeat on drugs business cites new medicines

By Ransdell Pierson — 04-Jun-2009

J&J whose first quarter earnings fell slightly due to generic competition for its Risperdal schizophrenia drug and waning demand for its anemia medicines is now under even greater pressure due to the expiration in March of the US patent on its $2.5 billion a year Topamax epilepsy drug.

Crash boom bax the rise & fall of Ranbaxy

Radhieka Pandeya — 4-Jun-2009

And the Ranbaxy story is as characteristic of what happens in most family owned and run businesses in India as it is of the Indian pharma industrys evolution from makers of cheap illegal copycat drugs and suppliers of raw material to respected manufacturers of generics legal copies of off patent drugs and ultimately to research driven firms.

Takeda to delay European application for key drug

By Yumiko Nishitani — 04-Jun-2009

Actos accounts for roughly a quarter of Takedas revenues and will lose US patent protection in 2011.

Curbs on Amul Vadilal to use American Dry Fruits trade name for their products

Virendra Pandit — 5-Jun-2009

About Vadilals argument that the plaintiff had not obtained registration of trademark till date Mr Sheikh observed that evidence proved that the company had obtained proprietary rights to use trade name and it cannot be termed as pirator of trade name.

Neuralstem Receives Patent Allowance for Compounds That Promote Neurogenesis

ROCKVILLE, Md.(BUSINESS WIRE) — 05-Jun-2009

Neuralstem Inc announced today it received a notice of allowance from the US Patent and Trademark Office for a patent on four new chemical entities that boost the generation of new neurons.

Playing defense on patents

By Kenneth Klee — 5-Jun-2009

The idea of developing patents as a kind of asset class is still new and controversial.

Vizio files TV patent suit against LG in US

by Rhee So-eui — 07-Jun-2009

US TV brand Vizio Inc has filed a patent infringement suit against South Koreas LG Electronics Inc seeking an injunction to ban LG from importing and selling certain TVs in the United States.

16 out of 17 drug consignment seizures in the Dutch were from India

P.T. Jyothi Datta — 8-Jun-2009

There were 17 incidents of drug seizure last year in the Netherlands on the grounds of patent infringement and 16 of them were Indian medicine exports says Health Action International a Dutch network that works on increasing access to medicines.

Row over generic drugs intensifies after seizure in Germany

Khomba Singh — 8-Jun-2009

German authorities last month seized a large consignment of antibiotic Amoxicillin made by Chennai based Medopharm during transit at Frankfurt over alleged trademark infringement in the latest incident of European Union nations interfering in legitimate trade of generic medicine.

IITs to market patents with help from investment firms

Kalpana Pathak & Shivani Shinde / Mumbai — 8-Jun-2009

Sitting on a pool of close to 900 patents the Indian Institutes of Technology are for the first time planning to monetise these intellectual properties by exploring tie ups with firms that invest in inventions.

Pharma firms continue to face patent violation charges in Europe

Rupali Mukherjee — 8-Jun-2009

Even after India raised concerns with EU troubles of generic companies which export drugs to developing countries through Europe are far from over as seizures by Dutch customs still continue.

Bulk pharma imports to go under DCGI scanner

Radhieka Pandeya — 9-Jun-2009

Regulator acts after evidence of attempts to evade import duty and bring in spurious drugs to Mumbai Chennai

Purdue KV settle OxyContin drug patent dispute

Edwin Chan — 09-Jun-2009

Purdue Pharma LP has settled a patent dispute over OxyContin with KV Pharmaceutical agreeing to let KV sell generic versions of the popular painkiller on a limited basis in the United States.

Impliant granted two new US patents successfully defends European patent

Medical Patent News — 09-Jun-2009

Impliant Inc a developer of novel spine arthroplasty alternatives to fusion surgery today announced that the European Patent Office has confirmed the validity of one of its key patents following an Opposition by Archus Orthopedics Inc that concluded with oral proceedings on May 12 2009 in Munich Germany.

India can become a global pharma innovation hub experts say

PTI,WASHINGTON — 09-Jun-2009

William Chin Vice President Discovery Research & Clinical Investigation Eli Lilly felt the pharma industry is under siege with flood of patent expiries higher safety hurdles and pricing pressure.

New Mashelkar report has well little new

Priyanka Golikeri — 10-Jun-2009

The Mashelkar committee report on pharmaceutical and micro organism patents has reared its controversial head again.

Pfizer exec reinforces companys generic drug plancos

Associated Press — 10-Jun-2009

Dave Simmons Pfizers president of established products told analysts at Goldman Sachs Healthcare Conference in New York that part of the companys strategy includes focusing on the off patent marketplace.

Access Pharmaceuticals Receives Two US Patents For MuGard

By Staff Reporter — 10-Jun-2009

Access Pharmaceuticals has announced that the company has received issue notifications from the US Patent and Trademark Office that two US patents relating to MuGard the companys approved oral rinse product for the management of mucositis will issue in June as US Patent numbers 7544348 and 7547433.

BUY OR SELL Daiichi Sankyo to rebound from rocky Ranbaxy ride

By Yumiko Nishitani — 10-Jun-2009

Analysts reckon Daiichi Sankyo is the top long term pick among Japans drug stocks with Takeda Pharmaceutical and Astellas Pharma more exposed to the impact of patent expirations on key drugs.

Vitro Obtains US Adult Stem Cell Patent

By Staff Reporter — 10-Jun-2009

Vitro declared that it has received US Patent number 7527971 entitled Generation and Differentiation of Adult Stem Cells.

Solvay challenged in US on male hormone therapy

Aaron Gray-Block — 10-Jun-2009

Solvay said Perrigo Israels application with the US Food and Drug Administration challenged a United States patent relating to its treatment Androgel which runs through the next decade.

Collegium Pharmaceutical Inc Announces Submission of a Request for Special Protocol Assessment to FDA for Pivotal Trial for Tamper Resistant Extended Release Opioid COL 003

CUMBERLAND, R.I — 10-Jun-2009

COL 003 is a tamper resistant formulation of extended release oxycodone that incorporates the Companys patented DETERx™ delivery technology.

India to prepare case on drug confiscations at European ports

Amiti Sen & Deepshikha Sikarwar — 11-Jun-2009

India is preparing its case on the repeated seizures at European ports of its consignments containing off patent drugs meant for other developing nations before it moves the European Union and the World Trade Organisation according to a commerce ministry official.

Watson Files ANDA For Generic Mucinex D

By Staff Reporter — 11-Jun-2009

Watson has filed an Abbreviated New Drug Application with the FDA seeking approval to market its guaifenesin pseudoephedrine HCI extended release 600mg 60mg and 1200mg 120mg tablets prior to the expiration of patents owned by Reckitt Benckiser.

EU seeks greater commitment on IPR

Radhieka Pandeya and Asit Ranjan Mishra — 12-Jun-2009

The EU is also demanding that India should extend the monopoly accorded by a patent for up to 5 additional years in order to compensate for the time required for the marketing approval of a medicinal product

Take strong action against fake drugs India to China

BS Reporter — 12-Jun-2009

India has asked China to take strong action against Chinese pharma manufacturers who are exporting fake drugs under Made in India label.

Satoris Receives Patent Allowance for Use of Plasma Biomarkers in Alzheimers Disease Detection

PRWeb — 12-Jun-2009

Patent acknowledges utility of blood biomarkers in diagnosing Alzheimers.

RPT Pfizer eyes deals to raise emerging markets presence

By John Irish — 14-Jun-2009

Pfizer which posted $48 billion in revenue last year faces severe sales declines in the coming years from patent expirations to its own products including its blockbuster Lipitor cholesterol treatment.

Apex Court overrules HC order favouring Gufic Ltd

15-Jun-2009

The Supreme Court today set aside the Delhi high court order which had allowed the Indian company, Gufic Ltd, to use the name ‘Cliniq’ in its skin care product. The bench headed by Justice B Sudershan Reddy vacated the order on the appeal of Clinique Laboratories against the high court order.

Sharp wins US patent fight with Samsung

by Diane Bartz — 15-Jun-2009

Japanese electronics maker Sharp Corp has won a fight with South Koreas Samsung Electronics Co over patented technology for liquid crystal displays according to an administrative law judges ruling from the US International Trade Commission.

US Patent Office Provides Re Examination Office Action for US Patent No 5735844

press release — 15-Jun-2009

Palomar also added 27 new claims to the 844 patent and the PTO confirmed these new claims as patentable.

Report on pharma innovation to be released at USIBC meet

Lalit K Jha — 16-Jun-2009

A report identifying a broad range of potential benefits of incremental pharmaceutical innovation for India would be released later this week by the US India Business Council (USIBC). Commissioned by the USIBC and Coalition for Healthy India (CHI), and funded by the US Chamber of Commerce\'s Innovation, Development and Employment Alliance, the report \'The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business\' was produced by White & Case LLP and Dua Consulting.

Martek European regulator upholds patent with narrower claims

by Jennifer Robin Raj in Bangalore — 16-Jun-2009

Martek Biosciences Corp a health and nutritional supplements maker said the European Patent Office upheld its arachidonic patent granted in 2007 but with narrower claims.

DuPont fires back at Monsantos patent lawsuit

By ERNEST SCHEYDER — 16-Jun-2009

DuPont fired back at Monsantos patent lawsuit Tuesday telling a federal court it did not err in combining its genetically modified soybeans with Monsantos herbicide product.

MicroFluidic Systems Receives Patent for Method to Selectively Process Different Biological Cell Types for Analysis.

M. Allen Northrup,MicroFluidic Systems — 16-Jun-2009

Microfluidic Systems a privately held company announced today that they received patent number 7541166 entitled Sonication to Selectively Lyse Different Cell Types.

India losing 2,000 patents every year: Jairam Ramesh

17-Jun-2009

India is losing about 2,000 patents every year in the US and Europe on traditional formulations as the knowledge on these is not documented, said union minister of state for environment and forests Jairam Ramesh

Drug industry expects final EU probe report July 8

By Ben Hirschler — 17-Jun-2009

There could also be a couple of positive recommendations he added such as backing for a common European patent applicable in all EU countries and the introduction of a specialised patent litigation system.

US firm files patent infringement case against Ranbaxy

18-Jun-2009

Medicis Pharmaceutical Corporation, a US-based skincare drug manufacturer, has filed a lawsuit against Daiichi Sankyo-owned Ranbaxy Pharmaceuticals for alleged infringement of its patent on Solodyn, a minocycline hydrochloride extended-release tablet used to treat acne.

Sanofi says US court ruled against it on Eloxatin

by Deena Beasley — 18-Jun-2009

Sanofi Aventi SA on Thursday said a US court ruled against the French pharmaceutical company by granting summary judgment motions brought by generic drugmakers in patent litigation over the cancer drug Eloxatin.

Novartiss Sandoz Sued by J&J Over Contraceptive Pill Patent

By Susan Decker — 19-Jun-2009

J&Js Ortho McNeil Janssen Pharmaceuticals unit wants a federal judge to prevent Sandoz from getting regulatory approval until a patent expires in 2019.

Big Pharma comes calling to India

P B Jayakumar / Mumbai — 19-Jun-2009

Thanks to the favourable patent regime in India till 2005 his team of scientists and he worked in small research and development laboratories in Hyderabad and successfully reverse engineered patented drugs of multinationals to make low cost generic drugs.

Pfizer Wins Canadian Patent Protection for Viagra

By Joe Schneider — 19-Jun-2009

Pfizer Inc the worlds biggest drugmaker has a valid Canadian patent on the impotence pill Viagra a federal judge ruled dismissing a bid by Novopharm Ltd to introduce a generic version of the drug.

Generic cos board biosimilars wagon

Priyanka Golikeri — 19-Jun-2009

Move over off patent chemical drugs.

Elder signs deal with US co for human trials of anti cancer drug

Sushmi Dey — 19-Jun-2009

The company follows the non infringing business model of either in licensing products of innovator companies or manufacturing off patented drugs.

Madras HC stays customs order on dual SIM phones

C.H. Unnikrishnan — 19-Jun-2009

The leading parties in the legal case were Samsung India Electronics Ltd and Hansum India Ltd which were arguing against Madurai based engineer S. Ramkumar who holds a patent for dual SIM phones in India.

Prices of essential drugs may drop by 30 70%

Gireesh Chandra Prasad & Sushmi Dey — 19-Jun-2009

The government is likely to revise the plan to have a comprehensive new drug policy which would extend a milder form of price control to 354 essential medicines.

Advinus seeks approval for trials of new diabetes molecule

Our Bureau — 19-Jun-2009

Advinus Therapeutics has filed its first investigational new drug application with the Drugs Controller General of India to start clinical trials on humans for a new diabetes type 2 molecule.

Cannabis Science To File Patent For Cannabis Processing and Drug Delivery Systems

By Staff Reporter — 19-Jun-2009

Cannabis Science has announced that patent filings are expected for two of its key innovations.

Chavez may end patents on medicine in Venezuela

by Frank Jack Daniel — 21-Jun-2009

President Hugo Chavez has vowed to shake up the rules governing intellectual property rights on medicines and other products in Venezuela the socialists latest move against the private sector.

Pfizer charges Sun with another patent violation

Nina Mehta — 22-Jun-2009

A legal battle between US pharma giant Pfizer and Indian company Sun Pharmaceutical has escalated with the worlds largest maker of medicines alleging in court filings that in addition to the original patent that it claims Sun violated it infringed another patent when it sought approval for its generic version of Lyrica a blockbuster drug used to treat seizures.

Pharma sector told to focus on improving HR quality

22-Jun-2009

Finishing schools in the information technology industry are creating more awareness towards the Intellectual Property Rights environment and the pharma industry should emulate it said panellists at the Bangalore Bio 2009 here Saturday.

i2india hopes to bridge industry academia gap

L.N. Revathy — 22-Jun-2009

i2india an IPR Intellectual Property Rights commercialisation and investment company is striving to bridge the gap between the industry and academia by providing the nucleus for growing such companies in India.

Intellectual property issues in school franchising

Anuradha Salhotra — 22-Jun-2009

Emergence of school franchises bodes well for the several thousand students all over the country who scramble to study in well known schools.

A Scholar Activist Challenges US Patent Law

By Michael Orey — 22-Jun-2009

John Duffy wants courts to rethink what can be patented and how to calculate damages.

ION sues WesternGeco for patent infringement

by Arup Roychoudhury in Bangalore — 22-Jun-2009

ION Geophysical Corp said it filed a patent infringement lawsuit against privately held WesternGeco LLC over technology related to steering devices and control systems for marine seismic streamers.

Ericsson signs LTE patent deals

by Sven Nordenstam — 22-Jun-2009

Swedish telecom equipment maker Ericsson has signed its first license agreements for LTE technology patents allowing other companies to use the technology an Ericsson official said on Monday.

U.S. Patent Infringement Lawsuit Filed by Aperio Technologies Inc.

David A. Leinwand — 23-Jun-2009

A U.S. patent infringement lawsuit was filed on June 10 2009 against Hamamatsu Photonics K.K. Hamamatsu Corporation and Olympus America Inc.

UNITAID to meet Indian drug manufacturers

Press Trust of India / New Delhi — 23-Jun-2009

The UNITAID patent pool initiative seeks to ensure that patents do not prevent the production of generic ARVs particularly the development and production of fixed dose combinations and AIDS medicines for children.

A global patenting model for India

PK Vasudeva — 24-Jun-2009

The United Nations arm on intellectual property is planning to implement a global patenting model which will pave the way for global firms to obtain patents in India easily.

CEL SCI Files Patent Application For LEAPS Immune Therapy Drugs

By Staff Reporter — 24-Jun-2009

CEL SCI has filed a provisional US patent application covering its LEAPS immune therapy drugs vaccines.

Actavis Launches Finasteride As Patent Expires In France

By Staff Reporter — 24-Jun-2009

Actavis has launched Finasteride in France just one day before the patent expired.

DRDO records jump in patents filing

General — 24-Jun-2009

The Defence Research and Development Organisation DRDO has registered a substantial jump in filing patents and set a 10 per cent growth target for the current year.

Vicious sting in the tail of FTAs

Latha Jishnu / New Delhi — 24-Jun-2009

Because FTAs have more stringent provisions than those mandated by the World Trade Organisation under the TRIPS for protecting the intellectual property rights IPRs of the developed world such agreements can directly impact access to affordable medicines

Drug patent pool proposal gets a push

P. T. Jyothi Datta — 25-Jun-2009

Concerned over the changing intellectual property environment where medicines are getting patented across the world UNITAID had proposed a patent pool to make drugs more accessible.

Sharp may appeal ruling in patent row with Samsung

by Mayumi Negishi in TOKYO and Diane Bartz in WASHINGTON — 25-Jun-2009

Sharp Corp said it may appeal a ruling by a US trade panel that said the Japanese electronics maker had violated an LCD patent held by South Koreas Samsung Electronics.

Japan approves first generic biotech drug

Reuters — 25-Jun-2009

Biosimilars are viewed as a promising new market given the pent up demand for cheaper versions of extremely expensive biotech drugs some of which are coming to the end of their patent life.

Irish court invalidates patent on Glaxos top drug

by Ben Hirschler — 26-Jun-2009

An Irish court has ruled that a key patent protecting GlaxoSmithKlines biggest selling medicine is invalid the British based drugmaker said on Friday.

The Real Reason Big Pharma Mergers Are Wise

Charles Farkas and Tim van Biesen — 26-Jun-2009

Thats important because of the looming patent cliff as blockbuster drugs lose their patent protection faster than new ones can emerge.

Takeda fails to get US approval for diabetes drug

by Leika Kihara — 27-Jun-2009

Takeda Pharmaceutical Japans largest drugmaker said on Saturday a key diabetes drug had failed to get approval from U.S. regulators who had asked for additional safety tests a process the company predicts could take at least two years.

Takeda shares down on diabetes drug setback

by Mayumi Negishi — 28-Jun-2009

Actos patent expires in 2011.

Now Kinnauri shawl to get a patent

Pratibha Chauhan — 28-Jun-2009

After the Kullu shawl Kangra tea and the Chamba rumaal it is now the turn of the Kinnauri shawl to acquire a patent and a GI Geographical Indication stamp a hallmark for quality and authenticity.

Glenmark banks on new drugs to recover losses

C.H. Unnikrishnan — 29-Jun-2009

While the generics or off patent drug business of Glenmark has been growing it had to write off in the March quarter at least Rs130 crore on account of stock withdrawals following delayed US market approvals and Rs117 crore for price erosion of distributor stock after the expiry of US market exclusivity of its anti epilepsy drug oxcarbazapine.

India needs a brilliant wave of entrepreneurs

ET Bureau — 29-Jun-2009

Koshy has been working towards his dream for seven years now and had applied for a patent as well.

US study wants India to allow frivolous patenting

Priyanka Golikeri — 29-Jun-2009

Multinational drug makers seem hell bent upon forcing the government to alter the patent regulations in their favour.

14 years of data exclusivity is crazy

Nina Mehta — 29-Jun-2009

Founder of the generic trade association in the US William Haddad chairman and CEO of Biogenerics initiated and negotiated the Drug Price Competition and Patent Restoration Act Hatch Waxman.

Make it a criminal violation Japan

Priyanka Golikeri — 29-Jun-2009

But a bigger demand from Japan is stringent enforcement of intellectual property laws including criminal procedures against patent infringement.

Indian firm sues South Africa after losing AIDS drug contract

AGENCIES,JOHANNESBURG — 29-Jun-2009

An Indian manufacturer of drugs to treat HIV AIDS is suing the South African government after failing to clinch a $400 million tender South African media reported on Monday.

Jury returns $1.67B drug verdict against Abbott

by Ransdell Pierson and Jonathan Spicer — 29-Jun-2009

A U.S. federal jury returned a $1.67 billion verdict against Abbott Laboratories in a patent suit brought by Johnson & Johnson related to arthritis treatments the drug companies said on Monday.

Aurobindo Pharma sues SA govt over AIDS drug bids

BV Mahalakshmi — 30-Jun-2009

The balance was awarded to the patent holding companies.

Sun Pharma Inclement weather

Shobhana Subramanian / Mumbai — 30-Jun-2009

Sales of Para IV products those abbreviated new drug applications that face a patent challenge fetch a larger amount estimated at $150 million.

Biocon Mylan team up for global biogenerics play

C Chitti Pantulu — 30-Jun-2009

An initial list of products has been identified that includes a basket of biologics that will go off patent by 2016 he said.

Collegium Pharmaceutical Announces the Sale of AllerNaze to Lupin

CUMBERLAND, R.I. — 30-Jun-2009

COL 003 is a tamper resistant formulation of extended release oxycodone that utilizes the Companys patented DETERx™ delivery technology.

Abbott Loses Drug Patent Suit

By THE ASSOCIATED PRESS — 30-Jun-2009

A unit of Johnson & Johnson said Monday that a jury has ordered Abbott Laboratories to pay $1.67 billion in a patent infringement suit over rheumatoid arthritis drugs.

U.S. group questions AstraZenecas Crestor patent

by Diane Bartz — 1-Jul-2009

A U.S. patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plcs patent for its cholesterol fighter Crestor invalid.

LG and Hitachi Settle Patent Fights Over TVs and Servers

By Susan Decker — 2-Jul-2009

Hitachi Ltd Japans largest electronics maker and South Koreas LG Electronics Inc. have settled their U.S. patent disputes over plasma televisions computer servers and car radio and navigation systems.

Pharma not IT is Indias next big thing

Pallavi Aiyar — 2-Jul-2009

Indian companies know they cant survive on the generic model alone forever. So once they have a serious self interest in protecting patents that will be the tipping point.

Dish wins stay in TiVo patent fight

The Associated Press — 02-Jul-2009

Dish Network satellite TV customers can keep using their digital video recorders while a court battle continues with TiVo Inc.

Bayer Files Lawsuit Against Teva

By Staff Reporter — 02-Jul-2009

Bayer Schering and Bayer HealthCare together with Schering have filed a patent infringement lawsuit in the US Federal Court in the District of Delaware against Teva Pharmaceuticals and Teva Pharmaceutical Industries.

Glenmark gets first to file status for 3 drugs in US

Nina Mehta — 3-Jul-2009

First to file status typically recognises a generic company as being the first to file a para IV application challenging a particular patent and seeking to manufacture generic versions of a drug which at present does not have generic competition.

Biotechnology can be the next big driver for the pharma sector

Pillman — 03-Jul-2009

The authors of the study noted The fact that a biotech product will assume Lipitors crown in 2012 after the cholesterol lowering drug phenomenon goes off patent is indicative of the increasing dominance of biotech products and specifically cancer antibodies.

Ayurveda drug for cancer Experts

Minati Singha — 03-Jul-2009

Lavekar said they have the credit of obtaining as many as 22 patents including one international patent right on drugs.

Bitter Pill Novartis patent plea for cancer drug Gilvec rejected

REUTERS — 05-Jul-2009

Novartis Indias application to patent its cancer drug Glivec has been rejected by the Intellectual Property Appellate Board IPAB.

Emami plans to make 50 Ayurvedic drugs from Zandu stable

Aveek Datta — 6-Jul-2009

The company had even tried to secure patent for some of its formulations but couldnt because of unfriendly patent offices Bhatt added.

Novartis may challenge verdict denying patent for cancer drug

C.H. Unnikrishnan — 6-Jul-2009

The Indian tribunal had cited non compatibility with domestic patent laws and unaffordable pricing as reasons

Fake drugs reach Kenya now

Amiti Sen — 6-Jul-2009

Africa is an important market for Indian drug producers as it accounts for over 15% of Indias total generic off patent drugs exports worth Rs 30000 crore annually.

Precision BioSciences Issues Update Regarding Recent U.S. Patent Office Action Concerning Cellectis Patents

RESEARCH TRIANGLE PARK, N.C (BUSINESS WIRE) — 06-Jul-2009

The United States Patent and Trademark Office is reexamining two currently issued U.S. patents owned by the Institut Pasteur and the Universite Pierre et Marie Curie and licensed to Cellectis SA.

Takeda Sues Torrent to Stop Generic Copy of Actos Diabetes Pill

By Susan Decker — 06-Jul-2009

Takeda Pharmaceutical Co. sued Indias Torrent Pharmaceuticals Ltd. to prevent it from selling a copy of the Actos diabetes pill in the U.S. until 2016.

A Prescription for Saving Big Drugmakers

By Mark Schneider — 6-Jul-2009

But concerns over patent expirations of blockbuster drugs generic drug competition regulatory problems and a lack of promising new products are giving investors caution.

Dor BioPharma Receives European Patent For Drug Delivery Technology

By Staff Reporter — 8-Jul-2009

Dor BioPharma has received a European patent for its Lipid Polymer Micelle technology for the improved oral delivery of drugs.

Astellas wins OK for broader use of key drug in Japan

by Yumiko Nishitani — 07-Jul-2009

In the United States where Prograf lost patent protection in April last year Astellas expects competition from a generic rival in the financial year ending in March 2010.

U.S. court to rehear spat over patent office rules

by Diane Bartz — 07-Jul-2009

A U.S. appeals court has said it would rehear a fight between drugmaker GlaxoSmithKline Plc and the patent office over new rules aimed at cutting a backlog of patent applications.

Star Scientific seeks to overturn Reynolds verdict

By Ian Sherr — 07-Jul-2009

Tobacco company Star Scientific Inc is seeking reversal of a jury ruling that cleared a Reynolds American Inc unit of violating a Star patent for reducing cancer causing agents in tobacco.

DOJ Shifts Policy on Generic Drug Patent Settlements

By BRENT KENDALL — 7-Jul-2009

The U.S. Department of Justice on Monday took a skeptical view on the legality of pharmaceutical patent settlements that delay the introduction of generic drugs the latest change in antitrust policy under the Obama administration.

Teva stops shipping generic birth control pill

The Associated Press — 7-Jul-2009

The worlds largest generic drug maker said it agreed to stop shipping the drug pending a preliminary injunction hearing in a patent infringement lawsuit from Johnson & Johnson.

Glivec patent ruling a welcome turn for Novartis

Priyanka Golikeri & KV Ramana — 8-Jul-2009

The rejection of Novartis patent application for the beta crystalline version of cancer drug Glivec by the Intellectual Property Appellate Board on the ground that it is priced beyond the reach of the common man may have given the company new ground to challenge Indian patent rules.

Alnylam Joins GSK In Patent Pool For Neglected Tropical Diseases

By Staff Reporter — 8-Jul-2009

Alnylam shall contribute more than 1500 issued or pending patents on its RNA interference technology patent estate to the patent pool established by GlaxoSmithKline.

Alnylam Joins GSK in Donating IP to Patent Pool

CAMBRIDGE, MASS & LONDON — 08-Jul-2009

GlaxoSmithKline and Alnylam Pharmaceuticals Inc. announced on July 8 2009 that Alnylam will contribute more than 1500 issued or pending patents on its RNA interference technology patent estate to the patent pool established by GSK earlier this year according to Alnylam.

Dilemma on traditional knowledge

Latha Jishnu / New Delhi — 8-Jul-2009

Last Friday the World Intellectual Property Organisation ended a five day meeting of the Inter governmental Committee on Intellectual Property and Genetic Resources Traditional Knowledge and Folklore without Indias participation.

Ranbaxy faces new legal trouble in US

Radhieka Pandeya — 9-Jul-2009

Ranbaxy Laboratories Ltd whose share price has been roiled by its troubles with the US drug regulator suffered a further blow with Canadian generic or off patent drug maker Apotex Inc. questioning in court the companys ability to launch two generic drugs on schedule.

Nestle Takeda sue Lupin Torrent over patents

PB Jayakumar / Mumbai — 9-Jul-2009

Cases aimed at stopping approval of new generics

EU raps Big Pharma Indian copycat kings boosted

Priyanka Golikeri — 9-Jul-2009

Though it does not actually mention the term evergreening it details the primary patents and secondary patents which Big Pharma seek said an intellectual property expert based in New Delhi who is closely monitoring the report.

Lupin Matrix face antitrust probe in EU

BS Reporter / Mumbai — 9-Jul-2009

The Commission said it would continue to probe whether use of patents to delay generics violated antitrust rules as companies used a variety of techniques to delay introduction of generics.

Teva Servier Face EU Antitrust Probe for Drug Delays

By Matthew Newman and Naomi Kresge — 9-Jul-2009

The commission called for a community patent that would be valid in all of the EUs 27 member states.

Knotted patent litigations inflict medical devices mkt

Soma Das — 9-Jul-2009

The lucrative domestic medical devices industry estimated to touch $1.7 billion in 2010 and expected to grow at an annual growth rate of around 23% is getting mired in entangled patent litigation cases with companies dragging each other to courts.

Drug firms come under EU lens over antitrust practices

Foo Yun Chee / Reuters — 09-Jul-2009

The EU executive said it would examine current EU rules on price and reimbursement urged European countries to introduce legislation to facilitate the entry of generics and stress the need for a Europe wide patent.

3 Indian pharma cos face EU anti trust probe

fe Bureau, Agencies — 09-Jul-2009

In April 2007 Lupin had sold certain patent and intellectual property rights of perindopril to French firm Laboratories Servier for Rs 115.31 crore euro 20 million.

Europe Is Studying Delays in Access to Generic Drugs

By JAMES KANTER — 09-Jul-2009

Commission officials said that generic versions of drugs often were unavailable for at least seven months after the patent on the original version expired a factor that drove costs up by at least 3 billion euros from 2000 to 2007 in 17 European Union countries.

Lupin 2 others face Europe anti trust probe

Our Bureau — 10-Jul-2009

The investigation is still at an early stage and the EC has said that the publication of its statement does not imply it has proof of an infringement of the competition rules Lupin told the media.

Matrix drags Israeli co Teva to court over patent issue

Chandra Ranganathan & Sai Deepika Amirapu — 10-Jul-2009

The dust hasnt settled yet on the Novartis case and another patent dispute has emerged in the pharma space.

Cipla gets notices for alleged overcharging

Our Bureau — 10-Jul-2009

The issue has been under litigation for over five years and the total alleged overcharging amount on Cipla at present is over Rs 1000 crore.

Ranbaxy recalls drug in US

Khomba Singh — 10-Jul-2009

Industry experts say consumer litigation are unlikely for such drug recalls.

Forest Lundbeck settle patent row over Lexapro

by Lewis Krauskopf — 10-Jul-2009

Forest Laboratories Inc and H Lundbeck AS have settled patent infringement litigation with two generic drugmakers on their blockbuster Lexapro anti depressant the companies said on Friday.

STOCKS TO WATCH Infosys Matrix Labs Ranbaxy

ET Bureau — 10-Jul-2009

Matrix Laboratories has filed an application against Israeli drugmaker Teva Pharmaceuticals Industries challenging a process patent used to make Tevas blockbuster drug Copaxone.

Pfizer CEO Braces For Changes

Arlene Weintraub — 10-Jul-2009

Thats particularly a challenge in light of drugs going off patent.

Dark clouds loom on Big Pharma horizon

By Sam Cage — 10-Jul-2009

Consolidation was the major theme of early 2009 as some companies tried to escape the patent crunch by splashing the cash aiming for synergies to offset the depressed outlook for growth over the next few years.

Ranbaxy plans to launch growth hormone drug

Mohit Bhalla — 11-Jul-2009

Ranbaxy Laboratories is planning a new growth hormone product to target the emerging global market for new versions of patent expired biotech drugs a person familiar with the development said.

Efficacy point in Glivec ruling impractical

Pillman — 11-Jul-2009

The controversy over patent to Novartis magic bullet Glivec continues to deepen.

Foreign copycats rattle Gujarat brands

Vishal Dutta — 11-Jul-2009

The US trademark office turned down the Patel familys request for registration.

Team heads to Africa on quality mission

Amiti Sen — 13-Jul-2009

Africa accounts for over 15% of Indias total generic off patent drugs exports worth Rs 30000 crore annually.

Delhi HC rejects German pharma cos plea

Legal,NEW DELHI — 13-Jul-2009

The Delhi High Court has rejected the plea of German pharma company B Braun Melsungen AG claiming patent rights to an item sold by healthcare products manufacturer Eastern Medikit.

We have a conservative generic policy

Nina Mehta — 13-Jul-2009

We do make generic versions of our previously patented products.

Sun Pharmaceutical Rises Most in Three Weeks on Suit Settlement

By Rajhkumar K Shaaw — 13-Jul-2009

Sun Pharmaceutical Industries Ltd. rose the most in three weeks after it reached an agreement with Forest Laboratories Inc. to drop a lawsuit challenging patents on the antidepressant Lexapro.

India Inc finds stem cells a healthy business

PB Jayakumar / Mumbai — 14-Jul-2009

The company already owns seven patents.

West uses Africa in war against generic drugs

Priyanka Golikeri — 14-Jul-2009

Now the developed world is using this vulnerability and turning it into a campaign against legitimate generics by branding them counterfeits which has to do more with IPR and patent violations than quality.

Sun Pharma up on patent deal with Forest Labs

BS Reporter / Mumbai — 14-Jul-2009

Sun Pharma rose 2.6 per cent to Rs 1149.75 after the company and its subsidiary Caraco Pharma entered into agreement with Forest Labs and H Lundbeck over Lexapro.

Merck to revise labelling on cervical cancer vaccine

P.T. Jyothi Datta — 14-Jul-2009

Multinational drug major Merck Sharp & Dohme will revise the labelling on its cervical cancer vaccine Gardasil after it informs the Indian drug regulatory authority later this month.

PE & VC firms bullish on Healthcare investments

ET Bureau — 14-Jul-2009

In the Life Sciences segment investors concerns are focused on the high risk of failure especially in new drug R&D stiff competition from inside and outside India as well as patent related issues.

Sun Pharma A dose of good news

Shobhana Subramanian / Mumbai — 14-Jul-2009

The US authorities still need to bless the settlement that Sun Pharma has entered into with Forest Laboratories Holdings over the patent litigation for Lexapro an anti depressant.

Kenya gives clean chit to imported drugs from India

Sushmi Dey — 14-Jul-2009

The legislation recognises intellectual property rights registered in any country of the world and not necessarily in Kenya.

Retailer Knockoffs Abound in India

By HEATHER TIMMONS — 15-Jul-2009

The United States has long tussled over intellectual property rights with China where counterfeiters crank out knockoffs of designer bags and iPhones and manufacturers have even made entire vehicles that look just like foreign cars.

R&D gets a boost

ET Bureau — 15-Jul-2009

In tandem whats required is to promptly update the norms on royalty payment for use of trademark or brand and fees for technology transfer.

Bisleri Coke may smoke peace pipe

Monica Behura — 16-Jul-2009

Last year the Delhi High Court was prima facie of the view that Coca Cola was the owner of the Maaza trademark in India.

Indian pharma firms swallow bitter pill in US Europe

PB Jayakumar / Mumbai — 16-Jul-2009

Regulators tighten net on safety grounds

US amendment may leave Indian biopharma cos shaken & stirred

Nina Mehta — 16-Jul-2009

Once a patent is filed it takes a company almost 10 years to develop the product and reach the market.

IPL teams to now bat for trademark rights

Monica Behura — 16-Jul-2009

All eight franchises of the Indian Premier League including Shahrukh Khans Knight Riders Deccan Chargers and Delhi Daredevils have filed applications before government authorities in 12 13 cricket playing countries seeking exclusive trademark rights for their names.

Madras HC stays appellate board order on dual SIM patent

Niranjana Ramesh — 16-Jul-2009

The Madras High Court on Wednesday set aside an interim order passed by the Intellectual Property Appellate Board suspending the patent held by Madurai based engineer Somasundaram Ramkumar for the technology that enables usage of more than one SIM card in mobile handsets popularly called a dual SIM.

Roche set to move SC against high court ruling on Tarceva

C.H. Unnikrishnan — 16-Jul-2009

Roche had appealed against a ruling that allowed Cipla to continue selling a generic version of the cancer drug Tarceva despite having a patent of it in India.

Patents will only benefit patients claim drug cos

Priyanka Golikeri — 17-Jul-2009

As the issue of patent protection assumes centrestage not only in India but also in the countrys free trade agreements with different countries multinationals are dredging up a number of reasons to support their demand for patent protection.

Pvt equity venture capital cos turning to healthcare Report

Our Bureau — 17-Jul-2009

Another issue is the high risk of failure especially in new drug discovery competition from within and outside India as well as patent related issues.

Govt orders recall as Natco cancer drug fails toxin test

Sushmi Dey — 18-Jul-2009

Natco has filed pre grant opposition on the patents in India which are yet to be granted.

IT firms push for IPR multiple standards for e gov projects

Vivek Seal — 18-Jul-2009

There are a couple of points in the policy that I think needs further debate one is single standard versus multiple standard and the role of intellectual property rights IPR.

Novartis set to appeal move on Glivec

Our Bureau — 18-Jul-2009

Novartis looks set to appeal the recent decision by the Intellectual Property Appellate Board IPAB against its cancer drug Glivec.

Novartis to challenge IPABs patent decision on Glivec

Nina Mehta — 20-Jul-2009

The Indian subsidiary of Swiss drugmaker Novartis will challenge a decision by the Intellectual Property Appellate Board IPAB that said its cancer drug Glivec was not patentable.

Dual SIM dispute highlights flaws in Indias patent process

C.H. Unnikrishnan — 20-Jul-2009

Patent experts expressed surprise that Ipab passed an interim order instead of deciding the patents validity

Earnings Preview: Pfizer preps for Wyeth deal

By LINDA A. JOHNSON — 20-Jul-2009

It also broadened its partnership with an Indian generic drugmaker and started a new one with an Indian maker of injected medicines part of an effort to boost sales of off patent drugs and of products in developing countries.

A Trips plus agenda at WIPO

D Ravi Kanth — 21-Jul-2009

Those who cannot remember the past are condemned to repeat it is a timely reminder for key actors who are bent on pushing failed agendas.

Its an MNC agenda to prevent competition

Anand Grover — 21-Jul-2009

The recent anti counterfeiting measures worldwide seizures of generic drugs in Holland the proposals in the WHO the moves in the East African Anand Grover Director Lawyers Collective HIV AIDS Unit region and in the Andean community to criminalise patent infringements etc.

18230 patents granted in 2008 09

Press Trust of India / New Delhi — 21-Jul-2009

The Indian Patent Office has granted 18230 new patents in 2008 09 Lok Sabha was informed today.

Incidence high in countries where access to medicines is poor

Tapan Ray — 21-Jul-2009

Incidents like recent detention in transit of DRL shipment of the generic version of Losartan in the Netherlands or a consignment of Amoxicillin at the Frankfurt airport on the ground of patent infringement cannot be considered as attempts of MNCs to brand Indian generic drugs as counterfeit medicines.

Cadila loses Mexate trademark case

BS Reporter / Mumbai/ Ahmedabad — 21-Jul-2009

Ahmedabad based Cadila Healthcare Ltd has lost the case in a civil suit which it had filed for its brand Mexate against Wallace Pharmaceuticals Pvt Ltd.

DSM in talks to supply Lipitor ingredient

Khomba Singh — 23-Jul-2009

Pfizers patent for Lipitor in the US expires in 2011.

Barking up the wrong tree

By René B. Azurin — 23-Jul-2009

For the pharmaceutical companies that own patents to various drugs this meant that they are deemed to have no further legal claims insofar as the resale of their products is concerned.

Sun Pharma arm faces class action suit in US

Khomba Singh and Nina Mehta — 23-Jul-2009

Caraco Pharmaceuticals the US arm of Sun Pharma has been slapped with a class action suit in the United States for allegedly Top 10 Drugmakers by sale not disclosing adequate information about US regulatory action that hurt its shares rendering Indias most valuable drugmaker vulnerable to the prospect of hefty payouts as damages.

Costly drugs prompt exclusivity debate

Andrew Pollack — 23-Jul-2009

For starters whatever the exclusivity period biologic drugs would also continue to be protected from copycats by patents.

Moser Baer Philips settle patent dispute

BS Reporter / New Delhi — 23-Jul-2009

Global technology company Moser Baer has settled a patent and licence dispute with global electronics giant Philips.

Give info on counterfeit drugs get rewarded

Kounteya Sinha — 23-Jul-2009

Informing the government about spurious drugs could soon earn you big money.

Non market strategies making a comeback in West

Dibeyendu Ganguly — 24-Jul-2009

A blood cancer drug called Glivec has been a money spinner for Novartis all over the world except in India where the patent authorities have turned down the Swiss companys application for a product patent on the grounds that it does not offer sufficient improved efficacy over its predecessor.

Teva J&J settle oral contraceptive patent case

By Lewis Krauskopf — 24-Jul-2009

Teva Pharmaceutical Industries Ltd said on Friday it settled a patent infringement lawsuit with Johnson & Johnson over Tevas U.S. generic version of J&Js Ortho Tri Cyclen Lo birth control pill.

Ranbaxy net jumps 30 fold to Rs 693 cr

ET Bureau — 25-Jul-2009

FTFs are the main growth drivers for most leading Indian companies that make generic versions of expensive drugs that have gone off patent.

Quality stamp for drugs in works

Sushmi Dey — 27-Jul-2009

A generic drug is not protected by patents and can be manufactured without paying royalty.

How pharma companies can be better long term bets

Kiran Kabtta Somvanshi and Santanu Mishra — 27-Jul-2009

Over dependence on cost competitiveness however comes with its own set of risks increased scrutiny and clamps from drug regulators legal risks in challenging patented drugs and rising pricing pressure as regulated markets overhaul their healthcare systems.

Anna University IPR centre files 53 patents

D Suresh Kumar — 27-Jul-2009

Inventors and innovators including college students who are keen on getting their work patented no longer need to spend time and money undertaking a taxing documentation process or familiarising themselves with legal jargons.

Global drug cos set sights on Indias veterinary market

Nina Mehta — 27-Jul-2009

Animal healthcare in India is no longer an afterthought as global pharmaceutical companies facing loss in revenues due to expiring drug patents are looking for new growth markets.

Sanofi Aventis to acquire Indian vaccine company

PARIS — 27-Jul-2009

It aims to refill a development pipeline that analysts see as woefully light on new drugs to replace those that will soon go off patent and face competition from cheaper copies.

An incubator that takes care of everything

Deepti Chaudhary — 27-Jul-2009

In India i2india has signed patent agreements with institutions such as Indian Institutes of Technology and Indian Institute of Science.

IT firms speed up patent filing

Vishwanath Kulkarni,Shamik Paul — 28-Jul-2009

Stepping up efforts to commercialise their intellectual property IP Indian IT services firms have accelerated their patent filing process.

Lunch with BS Malvinder Mohan Singh

Bhupesh Bhandari / New Delhi — 28-Jul-2009

What made you sell I ask Malavs friends say the patent litigations switched him off pharmaceuticals such litigation can be expensive and nerve wracking.

Drug sector fears bias in Tamiflu sourcing

P.T.Jyothi Datta — 28-Jul-2009

India did not grant a patent to innovator Gilead on Oseltamivir.

GITAM varsity plans IPR cell

Our Bureau — 28-Jul-2009

The GITAM Institute of International Business is setting up an intellectual property rights IPR cell with the assistance of the National Research and Development Corporation according to Prof V.K Kumar the Director.

Right and wrong medicines

Business Standard / New Delhi — 29-Jul-2009

One recent step has been to hire more inspectors another to float the idea of a quality mark for generic medicines which have no patent cover.

Sanofi profits soar prepared for Plavix Taxotere patent losses

By Kevin Grogan — 29-Jul-2009

Sanofi Aventis has posted a strong set of figures for the second quarter this morning and says it has laid the groundwork to cope with patent expiries.

India Patent Rights and Wrongs

By ROGER BATE — 29-Jul-2009

India promised to protect intellectual property when it signed up to the World Trade Organizations rules in 2005.

SemBioSys shares soar after insulin patent granted

by Nina Lex — 30-Jul-2009

Shares of SemBioSys Genetics Inc soared as much as 74 percent on Thursday morning after the company announced it had been granted a U.S. patent for commercial production of insulin by using oil from the seeds of safflower plants.

Takeda swings back to profit keeps forecast

By Yumiko Nishitani — 31-Jul-2009

Takeda launched Kapidex ahead of the patent expiration in November for its predecessor drug Prevacid in the United States but analysts expect competition to keep Kapidex from compensating fully for a likely drop in Prevacid sales.

$70 bn worth drugs to go off patent benefiting India Report

PTI — 02-Aug-2009

The Indian drug industry would make huge gains as over $70 billion worth of drugs are expected to go off patent in the US the worlds largest pharma market in the next three years according to a report.

The French connection

BV Mahalakshmi, Sudhir Chowdhary — 3-Aug-2009

The fact that Shantha Biotech was able to attract Sanofi with its intellectual property and good manufacturing facilities is a sign of the maturity of the Indian vaccine industry.

Copycat Indian drug cos turn MNC partners

Khomba Singh — 3-Aug-2009

This seems to be the strategy of multinational pharmaceutical companies vis a vis the highly Top 10 Drugmakers by sales successful Indian drug industry that makes a living out of copying off patent blockbuster drugs.

Indias Sun Pharma MedImmune settle on ethyol

by Bharghavi Nagaraju — 3-Aug-2009

Indias Sun Pharmaceutical Industries Ltd said on Monday it has settled a patent dispute with AstraZenecas MedImmune unit for generic version of Ethyol resolving all litigation between them.

India set to sign pharma export deal with Nigeria

Sushmi Dey & Gireesh Chandra Prasad — 3-Aug-2009

The government is set to sign an exhaustive deal with Nigeria to boost pharmaceutical exports to its eighth largest global consumer where the reputation of Indian drugs was recently dented by fake drugs from China bearing Made in India labels.

Daiichi wins court battle against Mylan Matrix

Press Trust of India / Tokyo/ New Delhi — 03-Aug-2009

Japanese drug major Daiichi Sankyo said today a US Court has ruled in its favour in a patent litigation related to the anti hypertensive drug Benicar against Mylan Inc and its Indian subsidiary Matrix Laboratories.

A patent case for invention

P. V. INDIRESAN — 3-Aug-2009

India needs improved patent laws that will protect genuine inventors better and minimise disputes on trivial grounds.

India grants 3500 pharma patents in three yrs

Press Trust of India / New Delhi — 03-Aug-2009

The Indian Patent Office has granted 3506 patents relating to pharmaceutical innovations over the last three years the government said today.

Combating spurious drugs

Pharmaceutical — 4-Aug-2009

The whistle blower scheme outlined by the Union Health Minister is a workable idea but only a consistent multi level approach can snuff out spurious drug makers.

Roche prepares to defend local patent for Valcyte

C.H. Unnikrishnan — 04-Aug-2009

Firm facing at least five post grant oppositions at Chennai patent office it has cut price of the drug by 35%

India may move WTO to protest drug seizures

Joe C Mathew / New Delhi — 4-Aug-2009

The government is planning to approach the dispute settlement body of the World Trade Organization against frequent seizure of Indian medicines at various European ports.

Interpol scans fake drugs with Made in India label

PTI,New Delhi — 04-Aug-2009

Recently fake drugs carrying the Made in India label were seized in Nigeria but were allegedly manufactured in China.

MNCs eye Indian pharma

ET Bureau — 5-Aug-2009

Till a few years ago it was believed Indian pharma companies highly profitable generic business model they were able to corner a large share of market for drugs going off patent and occasionally challenged patents through Para IV filings in the US would allow them to build financial muscle.

A singular victory for open innovation

Latha Jishnu / New Delhi — 5-Aug-2009

At the conference sponsored by the World Intellectual Property Organisation on July 13 and 14 he would launch his Initiative for Open Innovation globally to promote transparency in the patent system a disruptive democratising cyber infrastructure to make it possible to turn the patent system into a transparent fixable part of society as he called it in his letter.

Nigerian drug regulator to open Indian offices

ET Bureau — 05-Aug-2009

Reacting to the seizure of fake Chinese drugs carrying a made in India tag the Nigerian drug regulator has decided to set up its offices in India.

US exclusivity law may hit Indian biotech cos

Nina Mehta — 6-Aug-2009

These companies will have to choose their products carefully and focus on those products which are already off patent or scheduled to go off patent soon said Sanjay Singh associate director KPMG.

India may get its first novel drug by 2014

Priyanka Golikeri — 6-Aug-2009

From the last few years almost every Indian company worth its name is talking of having novel molecules new chemicals entities and a few new biological entities in its kitty.

Lupin to launch more branded generics in US

Khomba Singh — 6-Aug-2009

Branded generics are rip off versions of off patent drugs but since they incorporate added advantages such as lower dosages the US drug regulator allows them to be sold under a brand.

Ailing drugmakers may seek foreign cure

By Pratish Narayanan — 6-Aug-2009

Global heavyweight Pfizer is seen as the most likely suitor of Indian rivals as it looks to replace revenue lost from the lapse of key patents while Merck and Sanofi Aventis may also seek to shake hands with Indian producers analysts said.

BR Films pays up Rs1 crore in copycat case

Anshika Misra, Mumbai — 6-Aug-2009

Bollywood will now think twice before getting inspired by Hollywood again. BR Films,which was dragged to court by Twentieth Century Fox for alleged plagiarism, on Wednesday agreed to pay a settlement amount of $200,000 (a little less than Rs1 crore)to the American studio.

Roche will only help itself by making drugs affordable

Pillman — 7-Aug-2009

In a recent judgment by the Intellectual Property Appellate Board on Novartis Glivec the need to make the drug affordable was emphasised.

GSK to up output of inhaler drug

Nina Mehta — 7-Aug-2009

GSK and Biota which invented the drug and holds the patent till the end of 2014 are not the only ones who have been approached to supply the drug.

Pfizer agrees to cut price of TB drug

By Andrew Jack in London — 7-Aug-2009

Mylan will reduce the price of four HIV drugs that are off patent atazanavir ritonavir tenofovir and lamivudine to $475 a year falling to $425 a year from 2010 which is 28 per cent less than current prices.

US court to hear Glenmarks patent dispute on Aug 19

ET Bureau — 7-Aug-2009

Glenmark Pharmaceuticals patent challenge against Schering Ploughs cholesterol lowering drug Zetia will come up for hearing in the US district court of New Jersey on August 19.

Oppn to officials taking up plum posts in WTO WIPO

Joe C Mathew / New Delhi — 8-Aug-2009

Civil society groups have complained against the practice of senior commerce ministry officials taking up plum posts with international agencies such as the World Trade Organization and World Intellectual Property Organisation with whom they have been involved in direct negotiations on issues of national interest.

HC bans MNS Pharma from lipid control drug sale

Khomba Singh — 8-Aug-2009

Rosuva is a registered trademark of Ranbaxy.

Old medicine new patents

Gaurav Choudhury — 08-Aug-2009

Slowly but surely India Inc is waking up to the virtues of traditional wisdom.

Low costs a draw for foreign drug makers

C.H. Unnikrishnan — 09-Aug-2009

Low costs high technical capabilities and a skilled work force are making India an attractive destination for research and contract manufacturing of drugs.

Human clinical trials for stem cell research on cards

Vishal Dutta — 10-Aug-2009

StemCyte has patented the plasma depletion technology that helps in collecting higher volume of stem cells and better cell counts resulting in successful therapeutic applications for over 70 diseases.

GI tags sought for veena lock

Our Correspondent — 10-Aug-2009

The Tamil Nadu State Council has taken steps to get Geographical Indication Tags of Thanjavur Veena and Dindigul Lock establishing their place of origin.

Indian companies may pitch in with generic version of Tamiflu

Khomba Singh & Sushmi Dey — 10-Aug-2009

US Patent and Trademark Office Issues Key Patent For OncoGenexs OGX 011

By Staff Reporter — 10-Aug-2009

US Patent and Trademark Office has issued US Patent Number 7569551 entitled Chemo and Radiation sensitization of Cancer by Antisense TRPM 2 Oligodeoxynucleotides on the method of using OncoGenexs OGX 011 to treat certain cancers.

Azad says wont wait for desi swine flu vaccine will import

Kounteya Sinha — 11-Aug-2009

At present only one US based company Biosystem has the patent of the real time PCR kits for detection of H1N1 being used globally.

India warned on moving WTO over drug seizures

Joe C Mathew / New Delhi — 11-Aug-2009

Even as India considers the European Union directive that allows seizure of goods in transit by its member countries as violative of the World Trade Organizations TRIPS trade related aspects of intellectual property rights agreement legal experts caution against the central governments plans to approach the dispute settlement body of WTO.

HC returns appeal on dual SIM card case

C.H. Unnikrishnan — 11-Aug-2009

The Madras high court on Friday returned an appeal filed by Madurai Tamil Nadu based electronics engineer S. Ramkumar to the Customs Appellate Tribunal in a case related to his patent on dual SIM card mobile phones.

immatics gets European patent for IMA901 product & US patent for MUC 1 peptide

Martinsried, Munich — 11-Aug-2009

immatics biotechnologies GmbH has obtained European patent protection for the composition of matter for its drug candidate IMA901.

Swiss firm moves apex court against Cipla

C.H. Unnikrishnan — 11-Aug-2009

Swiss drug maker F. Hoffmann La Roche Ltd has petitioned the Supreme Court against a Delhi high court order in a patent violation lawsuit regarding its cancer drug Tarceva with Indian pharma firm Cipla Ltd.

Schering settles final Clarinex patent litigation

LOS ANGELES — 11-Aug-2009

Drugmaker Schering Plough Corp SGP.N said on Tuesday it settled patent litigation with Orchid Chemicals & Pharmaceuticals Ltd related to generic versions of its allergy medication Clarinex.

Strides Arcolab ready to supply Swine Flu drug

PTI — 11-Aug-2009

Oseltamivir Capsules are the generic version of Roches patented drug Tamiflu.

Novartis hits Astellas with transplant drug generic

Yumiko Nishitani — 11-Aug-2009

Astellas lost U.S. patent protection for Prograf in April 2008 but until now has not faced any generic competition.

China admits its companies involvement in fake drugs case

PTI — 11-Aug-2009

China has admitted that its pharmaceutical companies were involved in shipping fake drugs labeled Made In India to Nigeria.

Ranbaxy gets USFDA nod for Sumatriptan Succinate Tablets

Agencies — 11-Aug-2009

The office of generic drugs USFDA has determined that the Ranbaxy formulations to be bio equivalence and have same therapeutic effect as that of GlaxoSmithKlines patented drug Imitrex Ranbaxy said.

Sun Pharma gets US nod for two generic drugs

REUTERS — 12-Aug-2009

Sun Pharmaceutical Industries has got the US Food and Drug Administrations approval to launch its generic version of GlaxoSmithKlines Imitrex tablets to treat migraine the Indian drugmaker said.

India emerging global pharma outsourcing hub Study

Our Bureau — 12-Aug-2009

Of the total global outsourcing custom manufacturing phase IIb to the off patent stage including intermediates API and formulations contributes almost 65 per cent of the $51 billion market in 2008.

Swine Flu H1N1- Prevention & Treatment

12-Aug-2009

There is no vaccine available right now to protect against novel H1N1 virus. However, a novel H1N1 vaccine is currently in production and may be ready for the public in the fall. As always, a vaccine will be available to protect against seasonal influenza. There are everyday actions that can help prevent the spread of germs that cause respiratory illnesses like influenza.

Courtesy: Jimmy George

Information on Swine Flu - II

12-Aug-2009

Important Information on Swine Flu H1N1.

Courtesy: Mr. Amit Didwania, Drishya Holidays Pvt. Ltd.

Information on Swine Flu - I

12-Aug-2009

Government Authorized Hospitals For Treatment Of Swine Flu

Courtesy: Mr. Amit Didwania, Drishya Holidays Pvt. Ltd.

Stricter law on fake drugs now in force

Radhieka Pandeya — 13-Aug-2009

India finally has a law to combat the menace of fake and adulterated drugs and not all pharma companies are happy with it.

IDMA urges law makers to initiate measures to save Indian generic drugs

Ramesh Shankar, Mumbai — 13-Aug-2009

The products had no Patent or Trade Mark problem either in India origin country or the destination country.

Orchid settles Schering lawsuit

Our Bureau — 13-Aug-2009

Orchid Chemicals and Pharmaceuticals has reached an out of court settlement with the US based Schering Plough Corporation on a 2006 patent lawsuit regarding allergy medicines Clarinex and Clarinex Reditabs.

Sun Pharmas US arm reliant on generic launches

Manas Chakravarty and Mobis Philipose — 13-Aug-2009

In the previous year two such Para IV filings for abbreviated new drug applications which challenge an existing patent in order to launch a slightly different generic version of the same product with one off revenue potential accounting for 57% of revenues.

Macro gain for ASEAN micro pain for India

G. Srinivasan — 14-Aug-2009

Effectively this implies that India has less than 50 60 items in its negative list for each ASEAN country a patent asymmetric pact from negotiation angle leaving legions of domestic industries vulnerable to dumping and material injury.

Allow retail sale of drug say domestic pharma players

P B Jayakumar & Joe C Mathew / Mumbai & New Delhi — 14-Aug-2009

The central governments decision to continue controlling supply of the swine flu drug oseltamivir will help the drug innovator Swiss multinational Hoffmann La Roche and its Indian licencee Hetero Drugs maintain their effective monopoly in the country even as the drug lacks patent protection in India fear domestic industry circles.

Remedy for a malady

By Andrew Jack — 14-Aug-2009

He cites as symptomatic the large scale takeovers this year of Wyeth by Pfizer and Schering Plough by Merck which he argues were primarily designed to defer patent expiries and cut costs rather than provide a solution to falling research productivity.

Novartis reportedly sues GlaxoSmithKline over patent

By Polya Lesova — 16-Aug-2009

Swiss drugmaker Novartis AG has filed a legal action against rival GlaxoSmithKline over a vaccine patent according to a media report Sunday.

Pharma patents Mashelkar report gets Centre approval

Amitabh Sinha — 16-Aug-2009

Mashelkar as head of a Technical Expert Group that had four other members had been asked by the government in 2005 to examine whether the grant of patents for pharmaceutical substances could be limited only to new chemical entities and new medical entities involving one or more inventive steps or they could be granted to incremental innovations on existing drugs as well.

Big pharma companies join outsourcing queue

PB Jayakumar / Mumbai — 17-Aug-2009

Diminishing numbers of new drugs as against existing drugs going off patent high research and development costs and pressure to reduce healthcare costs are forcing Big Pharma to rope in strategic partners to contain manufacturing and drug development expenses.

Maker of fake drugs has fled to Hong Kong

S Balakrishnan — 17-Aug-2009

Chairman and MD of Phikon Biotech Pvt Ltd D J Vaidya who is allegedly involved in the manufacture of fake drugs for heart ailments and cancer has fled to Hong Kong.

Patently right

The Indian Express ,Mashelkar report — 17-Aug-2009

Should patents be granted to incremental changes on existing drugs not just to completely new medical and chemical entities Yes said the government appointed Mashelkar Committee report and yes says the Centre by accepting the reports findings.

Indian generics profit from Glaxo patent expiry

P B Jayakumar / Mumbai — 18-Aug-2009

GlaxoSmithKline Plcs anti migraine drug brand Imitrex is turning out to be a good revenue earner for Indian generic companies as the US Food and Drug Administration has given almost half of the final approvals for the reverse engineered or generic versions of the drug made by Indian pharmaceutical companies following its patent expiry.

Govt wont tweak drug patent rules

Khomba Singh & Sushmi Dey — 18-Aug-2009

The commerce ministrys decision to accept the Mashelkar committees revised report that recommends not to restrict patenting to new drugs has come in for strong criticism from health activists and some generic drugmakers even as patent experts supported the move thats in line with international norms.

Govt accepts panel report against narrowing of Indian patent law

BS Reporter / New Delhi — 18-Aug-2009

The central government has accepted the recommendations of an expert committee headed by former Council of Scientific and Industrial Research chief R A Mashelkar on patent laws.

We have filed a world patent for a new energy saving technology

Business Standard / New Delhi — 18-Aug-2009

Deepak Pahwa Managing Director of Pahwa Enterprises Indias largest private sector SME in the HVAC&R heating ventilation air conditioning and refrigeration industry tells Business Standard that some of his key customers are pharma units and since dehumidification machines are at the heart of pharma units his company was unaffected by the downturn.

Major win for Indian pharma cos as HC dismisses Bayer petition

ET Bureau — 18-Aug-2009

In a major win for Indian pharmaceutical companies the Delhi High Court on Tuesday dismissed German drug major Bayer Healthcares attempt to stop Drug Controller General of India from giving marketing approval to Indian company Cipla for the generic version of Bayers patented kidney cancer drug Nexavar.

Lilly shares fall after court invalidates patent

by Toni Clarke — 18-Aug-2009

Shares of Eli Lilly & Co fell 1.4 percent in premarket trading on Tuesday after a court invalidated a key patent governing its cancer drug Gemzar.

Daiichi Sankyo Lupin in talks for marketing tie up

Radhieka Pandeya — 19-Aug-2009

Today MNCs are looking at how they can create opportunities after patent expiry and joining hands with generic companies.

Microsofts Patent Dust Ups

Aaron Ricadela — 19-Aug-2009

For the past half dozen years Microsoft has been busily getting its patent house in order.

Courts being used to stifle generic challengers

Joe C Mathew / New Delhi — 19-Aug-2009

Patent fights are becoming more difficult for domestic pharmaceutical companies as multinational drug giants which obtain patent protection for medicines that are vulnerable to post grant oppositions are increasingly approaching Indian courts to stall competition from low cost local manufacturers.

Govt in talks with Roche for cheaper Tamiflu

Soma Das — 19-Aug-2009

Last month Roche the patent holder of Tamiflu not in India started a new initiative to supply the anti viral drug to select developing countries at a reduced cost of $2.80 and $8.50 in consultation with the WHO.

Glenmark faces patent infringement case in US

Press Trust Of India / Mumbai — 19-Aug-2009

Drug maker Glenmark Pharmaceuticals today said it was facing a lawsuit in a US District Court for a patent infringement case of an anti malaria product.

Bayers attempt to stop Cipla drug sale fails

BS Reporter / New Delhi — 19-Aug-2009

Court rejects bid to introduce a linkage between regulatory approval of a medicine and its patent status

Big Pharma must mend its ways to succeed in India

Pillman — 20-Aug-2009

Close on the heels of the Intellectual Property Appellate Board halting Novartis Glivec patent application and linking it to threatening public disorder on account of its high prices, the Delhi High Court has dealt a body blow to German drug maker Bayers ambitions to monopolise the Indian market with its kidney cancer drug Nexavar.

M&M wins disputed internet site case at WIPO

Press Trust Of India / New Delhi — 20-Aug-2009

Mahindra & Mahindra has won a cybersquatting case at the World Intellectual Property Organisation against a US based person who was using the name Mahindra in an internet domain.

Incremental innovations

ET Bureau — 20-Aug-2009

It is hard to quibble with the Mashelkar Committees report on patenting of pharmaceutical substances for its main theme that it is wrong to deny patents to incremental innovations if they have significantly better safety and efficacy standards over the known molecule.

Sun wins US court ruling in Eli Lilly patent challenge

BS Reporter / New Delhi — 20-Aug-2009

Clears way for low cost cancer drug launch in 2010.

Sun Pharma wins Gemzar patent case

NewsWire18 — 20-Aug-2009

The US district court for the eastern district of Michigan delivered a partial summary judgement on Monday invalidating Eli Lillys patent for method of use for Gemzar.

Bayer beaten in Indian court over patent law

By Kevin Grogan — 20-Aug-2009

Bayer has suffered a setback after a court in India dismissed the German firms attempt to prevent the countrys regulator from approving a generic version of its kidney and liver cancer drug Nexavar that is being prepared by Cipla.

Mashelkar report runs into fresh controversy

Joe C Mathew / New Delhi — 21-Aug-2009

Patent expert says his views were misinterpreted to support conclusion that Indias patent laws could not be tightened.

Merck wins Singulair patent infringement suit against Teva

Whitehouse Station, New Jersey — 21-Aug-2009

Merck & Co Inc announced that the US District Court for the District of New Jersey has ruled in Mercks favour in a patent infringement suit against Teva Pharmaceuticals USA Inc.

Drug makers face penalty for overcharging

Sushmi Dey — 21-Aug-2009

Drug manufacturing companies such as Cipla Ranbaxy Johnson & Johnson and Dr Reddys Laboratories may have to pay over Rs 2038 crore to the government for overcharging consumers on price controlled medicines.

Govt plans retail clamp on Ciplas Tamiflu substitute

Joe C Mathew & Pb Jayakumar / New Delhi — 22-Aug-2009

Relenza a pre 1995 molecule lacks patent protection in India and legally Cipla can manufacture and sell the drug.

Hetero bags deal for 10 m Tamiflu

Khomba Singh — 22-Aug-2009

Roches application seeking patent for Tamiflu in India was rejected in March allowing Indian companies to market the generic versions in India and other countries where Roche does not hold the patent.

We must look to avoid grant of frivolous patents at all costs

Priyanka Golikeri — 22-Aug-2009

With the government accepting the Mashelkar Committee Report on pharmaceutical patents the stage is now set for a new battle over patents and public health.

North Indian pharma Focusing on R&D and tie ups to meet challenging conditions

Sanjay Pingle, Mumbai — 24-Aug-2009

It has set up five R&D centers and got 24 product patents valid in more than 60 countries worldwide.

Dump the Mashelkar report

Business Standard / New Delhi — 24-Aug-2009

Even as the government accepts the revised report of the technical expert group on patent law issues headed by RA Mashelkar a key conclusion of the group has run into fresh controversy over the reasoning on which it is based.

India Infoline maintains Reduce rating on Sun Pharma

ET Bureau — 24-Aug-2009

The company received US FDA approval for Eloxatin only to be suspended soon after on account of continuing patent litigation.

The R&D debacle

Ram Prasad Sahu / Mumbai — 24-Aug-2009

One of the four is the anti malarial drug Malarone on which the company is facing a patent infringement suit by Smithkline Beecham.

Stem cell therapy market picking up as 4 new firms look to expand

C.H. Unnikrishnan — 24-Aug-2009

The recent government decision to allow patenting of micro organisms and its processes and increased awareness about cord blood cell banking are giving a boost to the new therapy.

Verva licenses FGFR intellectual property rights to Isis Pharma to treat obesity & other diseases

Geelong, Australia — 24-Aug-2009

Verva Pharmaceuticals Ltd and Isis Pharmaceuticals Inc announced the completion of an agreement providing Isis an exclusive license to Vervas intellectual property rights targeting the Fibroblast Growth Factor Receptor with antisense technology for the treatment of diseases including obesity and other metabolic disorders.

Govt should not succumb to the WIPO pressure

Dr.Y.K.Hamied — 25-Aug-2009

I strongly subscribe to the view that the ongoing reform of the Patent Cooperation Treaty at the behest of WIPO is an attempt to undermine the sovereign rights of the Indian government to make laws to suit its domestic needs.

The treaty is a cornerstone of multilateral cooperation

Claus Matthes — 25-Aug-2009

Recently articles have surfaced in the Indian press about international efforts to reform the Patent Cooperation Treaty an agreement that binds 141 countries in a pact that facilitates the process of seeking protection for an invention in multiple countries.

Concerns of WIPOs members and its customers differ

D G Shah — 25-Aug-2009

WIPO like other UN organisations is a member driven organisation.

Sanofi sues Sun Pharma over Taxotere generic

Bloomberg — 26-Aug-2009

Sun is pursuing approval from the US FDA to market two dosage forms of the drug before the patents expire in 2012 according to the complaint filed by Sanofi Aventis SA.

US pharma association disapproves Customs seizure of generics

Joe C Mathew / New Delhi — 26-Aug-2009

The response comes after 17 consignments of genuine generic medicines from India were recently seized at various European ports alleging intellectual property violations.

Stringent IP enforcement will limit access to generic drugs

fe Bureaus — 26-Aug-2009

Civil society organisations led by Centre for Trade and Development have sent a strong missive to the Confederation of Indian Industry urging it to be careful about associating with multinational corporations and developed countries that are keen to push more stringent intellectual property enforcement laws in India .

Biocon mulls listing of two of its arms by next yr

Press Trust of India / Chennai — 26-Aug-2009

Biocons patent portfolio totals close to 942 applications worldwide with over 182 granted patents.

Indian patent laws not conducive to domestic R&D OPPI

Agencies — 26-Aug-2009

The countrys pharmaceutical industry today said the present patent laws do not value incremental innovations and are not conducive to the research and development activities of domestic firms.

Drug Biotech Research Spending Hangs Tough

By Emily Thornton and Frederick Jespersen — 27-Aug-2009

With billions of dollars worth of branded drugs losing their patent protection the pharmaceutical industry is under pressure to boost its pipeline of innovative new drugs.

Incremental pharma innovation in patent regime to benefit local firms

fe Bureaus — 27-Aug-2009

Expanding the scope of Indias current patent regime to include incremental pharma innovation would benefit the domestic pharma players according to a study commissioned by the US India Business Council which was released on Wednesday.

Even European Union doesnt link regulatory approval for generics to innovator patent

Priyanka Golikeri — 27-Aug-2009

German healthcare giant Bayer is determined to introduce in India a system that can prevent early entry of low cost generics despite the Delhi High Court quashing its plea to link regulatory approval to last week saying the company was trying to tweak public policy.

Patent regime poses new challenges for health Minister

IANS — 27-Aug-2009

Minister of State for Health Dinesh Trivedi Thursday called for taking a serious look at the intellectual property rights regime so that Indian patients are not adversely affected.

GSK to launch promecta in India by 2009 end

Agencies — 27-Aug-2009

Glaxo SmithKline Pharmaceutical said it is looking at launching its patented medicine promecta used in treatment of depleted platelet count in India by this year end or early next year.

Encouraging drug innovation

Shamnad Basheer — 28-Aug-2009

The Mashelkar committee report on drug patent law may have stirred controversy but it sets the right tone

Cipla gets relief as SC rejects Roche plea

ET Bureau — 29-Aug-2009

The Supreme Court on Friday rejected Swiss drugmaker Roches petition to stop Indian firm Cipla from selling the generic version of its cancer drug Tarceva to ensure that Indians have access to the medicine at a lower cost till the Delhi High Court decides on Ciplas patent challenge plea.

Sharma to take up drug seizures issue with EU commissioner

Asit Ranjan Mishra and Radhieka Pandeya — 29-Aug-2009

According to European Commission laws if a consignment of drugs is not patented either in the country of origin or its final destination it could be seized.

Novartis moves SC in Glivec patent case

ET Bureau — 29-Aug-2009

Swiss major Novartis AG has moved the Supreme Court challenging Intellectual Property Appellate Board decision to reject its patent application of blood cancer drug Glivec in India.

Cipla calls off marketing alliance with Avesthagen

Nina Mehta — 29-Aug-2009

Cipla has terminated its marketing agreement with Avesthagen and is looking at selling its 5.8% stake in the Bangalore based company.

Govt curbs sale of flu drug Zanamivir

Khomba Singh — 29-Aug-2009

The government is set to put Zanamivir the only swine flu drug that is freely available in the market currently under restricted sale category.

Tata Sons wins trademark case against MakeMyTrip

Shubhra Tandon — 30-Aug-2009

Tata Sons recently won a trademark case at the World Intellectual Property Organisation against New Delhi based travel portal MakeMyTrip for the use of the word TATA in the latters sister Web site okaytatabyebye.com an online networking forum for the travel community.

Lack of clarity in drugs Act may hit generic companies

Nina Mehta — 31-Aug-2009

Ambiguity in the amended Drugs and Cosmetics Act over the definition of the terms adulterated and spurious drugs could affect Indian generic drug players.

Insurance firm told to pay up

BS Reporter / New Delhi — 31-Aug-2009

The Supreme Court will on Monday hear Swiss drug maker Novartis AGs plea against denial of patent for its blood cancer drug Glivec in its beta crystal form.

DRL seeks USFDA help to make cancer drug clone

Sai Deepika Amirapu — 31-Aug-2009

Dr Reddys Laboratories Indias second largest drug maker by sales has approached the US Food and Drug Administration to overcome impediments in making the generic version of Revlimid an expensive drug used to treat blood cancer.

GSK plans to launch H1N1 drug in India

Press Trust Of India / New Delhi — 31-Aug-2009

UK based drug maker GlaxoSmithKline is in talks with the Indian government for introducing its patented drug Relenza which is used for the treatment of Influenza A H1N1.

Big multinationals dumping excess vendor baggage

Shelley Singh — 31-Aug-2009

Companies doing R&D remotely also try to limit the number of third party vendors to protect intellectual property and any infringements of patents.

Britannia settles Tiger brand tangle with US firm

IANS — 31-Aug-2009

The Nusli Wadia led Britannia was embroiled in a bitter intellectual property right violation litigation with its partner Groupe Danone after the Indian company charged the French dairy major with using its Tiger trademark a key intellectual property in the overseas market without prior consent.

SC to hear Novartis case next week

Press Trust of India / New Delhi — 31-Aug-2009

The Supreme Court will hear Swiss drug maker Novartis AGs plea against denial of patent for its blood cancer drug Glivec next week.

Swiss NGO flays Novartis Glivec appeal

Priyanka Golikeri — 01-Sep-2009

A Switzerland based NGO has come out strongly against Swiss pharma giant Novartis appeal to the Supreme Court last week over the rejection of its patent for cancer drug Glivec.

Britannia to sharpen focus on global biz

BS Reporter / Kolkata — 01-Sep-2009

Biscuits major Britannia Industries plans to focus on strengthening its international business and expand its brand presence in the aftermath of its settlement with Danone on the intellectual property rights issue over the Tiger brand.

Novartis Glivec case to be heard by another Bench

Our Bureau — 01-Sep-2009

Swiss drug maker Novartis challenge in the Supreme Court on being denied a patent for its cancer drug Glivec will now be re assigned to another Bench by the Chief Justice of India.

Bayer CropScience Wins Patent Litigation

By Staff Reporter — 01-Sep-2009

Under the settlement Tian Rong and Hua Dong to cease the infringing acts.

India refuses patent protection for AIDS drug of US company

Joe C Mathew / New Delhi — 2-Sep-2009

More appeals pending domestic manufacturing some way off.

Setting aside Bayers spurious claims

Latha Jishnu / New Delhi — 2-Sep-2009

Two weeks ago Justice S Ravindra Bhat of the Delhi High Court dismissed with costs the writ petition filed by the German pharmaceuticals giant Bayer Corporation against the Union of India the Drug Controller General of India and Cipla.

Govt may move WTO on EU drug seizures

Priyanka Golikeri — 3-Sep-2009

The government plans to file a complaint to the World Trade Organisation against seizures of its legitimate low cost generic drugs by the European Union according to people in the know.

NGO asks govt to further amend Patent Act to avoid frivolous patent filings

Ramesh Shankar, Mumbai — 03-Sep-2009

The National Working Group on Patent Law an NGO working on patent issues in the country has asked the government to further amend the Amended Patent Act 1970 to avoid frivolous and questionable patent claims being filed by the industry and are being granted by the Patent Offices.

HC asks DGCI to grant licence to Ciplas anti cancer drug

Press Trust of India / New Delhi — 04-Sep-2009

The Delhi High Court today directed the drug regulator of the country to go ahead with the process of granting a licence to Cipla for producing a generic version of the anti cancer medication Nexavar against which global drug maker Bayer Corp is fighting a legal battle.

Protecting the Patent System for Entrepreneurs

By Scott A. Shane — 04-Sep-2009

Recently a number of companies from the information technology and financial services sectors have been pushing Congress to change the patent system.

India rejects patent claims on two HIV AIDS drugs

R. Prasad — 04-Sep-2009

The Indian Patent Office has rejected applications from two US pharmaceutical companies on grounds of evergreening raising hopes of a further lowering of prices of two life saving drugs used by HIV AIDS patients in the country.

Revamping legal mechanism alone cant stop spurious drug makers

Pillman — 4-Sep-2009

Excessive pressure from global agencies pushed India to make significant changes in the Drugs and Cosmetics Act that will now subject perpetrators of spurious drugs to harsher punishments.

Ayurvedic remedies gain ground in India

Saikat Chatterjee and Arush Chopra / Bloomberg — 4-Sep-2009

Residents have switched to traditional Ayurvedic healing used for hundreds of years to boost immunity as well as unproven remedies being sold to take advantage of the outbreak

Process Ciplas licence for Soranib HC

Press Trust Of India / New Delhi — 5-Sep-2009

The Delhi High Court today directed the Drug Controller General of India to process the licence application of Cipla for production and sale of the generic version of global pharma major Bayer Corporations liver and kidney cancer drug Nexavar.

Toyota patent trade case

Bloomberg / Washington — 5-Sep-2009

Toyota Motor Corp the world’ biggest seller of autos powered by a combination of gasoline and electricity faces a patent infringement claim that may result in a US import ban on its Prius and other hybrid models.

Bayers bid to stay Cipla cancer drug foiled next hearing on Oct 6

ET Bureau — 5-Sep-2009

Germanys largest drug maker Bayer failed to get a court stay on Cipla from seeking permission to launch the European companys copycat of cancer treating drug Nexavar in India.

Process Ciplas licence for Soranib HC

Press Trust Of India / New Delhi — 5-Sep-2009

EU will take steps to resolve drug seizure cases says Ashton

ET Bureau — 06-Sep-2009

The EU has assured India that it will take steps to resolve the issue related to the recent cases of life saving generic or off patent medicines exported from India to other countries being seized at European ports.

IT dept takes drug companies to court

Khushboo Narayan and C.H. Unnikrishnan — 7-Sep-2009

Barring the top 300 pharma firms most of the 15000 drug units operating in India are engaged in contract manufacturing.

Pfizer India arm to launch 2 3 generic drugs by Dec

MUMBAI (Reuters) — 07-Sep-2009

Drug maker Pfizer Ltd plans to launch two or three generic drugs in India by December as part of its efforts to widen its portfolio and market share its managing director said late on Friday.

Innovation can benefit Indian drug industry

ENS Economic Bureau — 07-Sep-2009

Extending patent protection to incremental pharmaceutical innovation should encourage Indian pharmaceutical companies to expand further their investment in innovation and ultimately become major sources of new products for both the Indian and global markets.

U.S. court backs Synthes in U.S. patent case

by Lisa Jucca — 07-Sep-2009

Switzerland based medical device maker Synthes Inc has won a key ruling in an ongoing U.S. patent case against U.S. competitor Medtronic the Swiss company said on Monday.

Venus Remedies gets Indian patent for Potentox

Our Bureau, Mumbai — 08-Sep-2009

Venus Remedies a mid cap Rs 260 crore plus Chandigarh based pharma company has received first ever injectable FDC product patent for Potentox a research product of the company from the Indian Patent Office Government of India.

3 provisions helped India cull frivolous patents study

C.H. Unnikrishnan — 8-Sep-2009

Three patent provisions that have come under flak from foreign companies and governments for not being compliant with global intellecutual property regimes have actually helped India weed out frivolous patents since 2005 when the country moved to a new patent regime.

McDonalds loses trademark fight against McCurry

The Associated Press — 8-Sep-2009

U.S. fast food giant McDonalds lost an eight year trademark battle to prevent local restaurant McCurry from using the Mc prefix in a precedent setting judgment by Malaysias highest court.

Cipla to produce biotech drugs

BS Reporter / New Delhi — 8-Sep-2009

Cipla the countrys second largest drug company will foray into the production of biotechnology medicines soon.

DCGI asks states to effect fake drug norms

Sushmi Dey — 8-Sep-2009

The recent amendments in the Drugs & Cosmetics Act prescribes stricter punishment for companies guilty of manufacturing adulterated or spurious drugs.

Suven gets milestone payment from Eli Lilly

KV Ramana — 8-Sep-2009

Once it is launched we will keep getting the royalty till the drug is covered by the patent he said.

India patent rejections welcomed by HIV AIDS groups

By Bappa Majumdar — 09-Sep-2009

Indias rejection of patent applications on two life saving HIV AIDS drugs last week has been welcomed by health officials who say it will ensure wider access to the medicines.

Marico Agro Tech in trademark tussle

T Knight Ridder/Tribune — 09-Sep-2009

Marico India the maker of cooking oils Saffola and Sweekar has sued Agro Tech Foods an affiliate of American foods giant ConAgra Foods over what it believes is trademark violation by the latter.

Pfizer plans major push into generics

C.H. Unnikrishnan — 11-Sep-2009

Pfizer Ltd the Indian subsidiary of the worlds largest drug maker Pfizer Inc. is making an aggressive play in the Indian generics or off patent drugs market.

Mid cap pharma firms focus on LatAm market

Nina Mehta — 11-Sep-2009

Indian companies faced with increased competition in developed markets and stiff standards set by the US Food and Drug Administration are looking to markets where rules are less stringent as governments focus on affordability of healthcare rather than defending patents on billions of dollars of drugs.

SC notices to Centre pharma companies on Novartis petition

PTI — 11-Sep-2009

The Supreme Court on Friday issued notices to the Centre pharma major Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others on a pettion filed by Swiss firm Novartis AG challenging the denial of patent for its blood cancer drug Glivec in beta crystal form.

IPA calls for amendment to D&C Act to exclude IPR issues from Sec 17

Joseph Alexander, New Delhi — 12-Sep-2009

In a recent meeting jointly held by different departments including health pharma and commerce on the issue the IPA has suggested that the terms of counterfeit and spurious be defined separately and the IPR related issues e.g misbranded should be removed from Section 17 of the Drugs and Cosmetic Act.

Pfizer Indias new strategy for emerging markets

Manas Chakravarty and Ravi Ananthanarayan — 12-Sep-2009

Profitability improvements would come from a higher share of products that have patent protection.

IPRS issues notices to hotels mall for copyright violation

BS Reporter / Mumbai/ Ahmedabad — 12-Sep-2009

We have sent legal notices to the hotels and the mall for violating copyright under Section 33 of the Copyright Act 1957.

SC issues notices in Novartis patent case

Manish Ranjan — 12-Sep-2009

The apex court sought replies from the commerce ministry the comptroller general of patents the Cancer Patient Aid Association and the four pharma firms that state their objections on why the patent should not be granted to Novartis.

Biocon joins hands with US co Amylin for diabetes drug

ET Now — 12-Sep-2009

Even as Amylin will own the intellectual property rights to the molecule and phybrid technology Biocon will hold the IP for manufacturing.

Fake drugs WHO body rejects MNC argument

Rupali Mukherjee — 12-Sep-2009

The World Health Organisation regional committee has rejected the counterfeit drugs agenda propagated by developed countries and pharma MNCs which is already threatening the entry of legitimate generics exported from India.

Lupin Novartis end patent row for Lotrel

Khomba Singh, — 12-Sep-2009

Mumbai based pharma firm Lupin has reached an out of court settlement with Swiss pharma major Novartis for the latters hypertension drug sold under the brand name Lotrel which will allow the Indian firm to launch the generic version of the drug ahead of its patent expiry in 2017 and get a one time revenue upside said a person familiar with the development.

Suven gets two US patents for neurodegenerative disorder drugs

Our Bureau, Mumbai — 14-Sep-2009

Suven Life Sciences Ltd announced that the US Patent Office has issued two Patents US 7507835 and US 7388024 corresponding to two New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid until 2022 & 2024 respectively.

WHO SEARO rejects counterfeit agenda of pharma MNCs

Ramesh Shankar, Mumbai — 15-Sep-2009

The meeting noted that the term and definition of counterfeit relates to infringement of intellectual property rights and should not be equated with substandard medical products.

Major growth will come from generics business

C.R. Sukumar — 15-Sep-2009

Dr. Reddys Laboratories Ltds vice chairman and chief executive G.V. Prasad shares the drug makers future ambitions.

Patent expiry to open huge opportunity for Indian pharma

PTI — 15-Sep-2009

Patent expiry will be a major avenue of growth for the Indian pharmaceutical industry as products worth $235 billion are going off patent within horizon of five years from 2009 to 2014 a top pharma company official said here today.

Mega deals boost pharma in crisis

Rupali Mukherjee — 15-Sep-2009

With the so called patent cliff and stagnating pipelines of big pharma companies are trying to augment their portfolios and revenues like Pfizer gets the biotech and OTC business of Wyeth to augment revenues.

DRL faces patent suit in US over allergy generic

ET Bureau — 15-Sep-2009

NYSE listed Dr Reddys Laboratories is embroiled in a fresh patent infringement row with US based drug discovery firm Albany Molecular Research.

India Wins European Patent Battle For Jute

FE Reporter — 15-Sep-2009

In a major victory for the ailing jute industry Jute Manufacturers Development Council successfully fought to revoke a UK based firms patent for use of hessian cloth to cover waste and dumping grounds.

The IPR icing on Brazils cotton victory

Latha Jishnu / New Delhi — 16-Sep-2009

The more significant aspect of the arbitration panels ruling is that it allows cross retaliation by Brazil against intellectual property rights which is protected by the WTOs Agreement on Trade Related Aspects of Intellectual Property Rights TRIPS or on services.

Vedi asked not to use Le Passage trademark

Manish Ranjan — 16-Sep-2009

Delhi high court on Tuesday restrained Vedis International Tours and Travels from infringing on the registered trademark and the domain name of another tour operator Le Passage to India Tours and Travels.

Tirupati laddu gets global patent

TNN — 16-Sep-2009

Temple sources said the Tirupati laddu got the patent rights under the Geographical Indications of Goods Registration and Protection Act on Tuesday.

SC reserves judgement on Bajaj TVS patent case

Legal — 16-Sep-2009

The Supreme Court on Tuesday reserved its judgement on the patent case between two wheeler rivals Bajaj Auto and TVS Motor.

Centre plans action against EU customs rules

Amiti Sen — 16-Sep-2009

India is not willing to take the European Commissions verbal assurances on sorting out the issue of seizure of Indian drugs at European ports.

India has immense potential to take on global pharma markets

PTI — 16-Sep-2009

Primary problems faced by the Indian pharma sector today are issues of intangibles namely lack of skilled manpower lack of consistency and quality lack of clarity on IPR and patenting regulatory failures and a highly fragmented sector it said.

Sun Pharma Caraco plan to file 30 patent pleas for generics

BS Reporter / Mumbai — 17-Sep-2009

Sun Pharmaceutical Industries and its troubled US subsidiary Caraco Pharmaceuticals plan to together file 30 Abbreviated New Drug Applications with the US Food and Drug Administration to market generic drugs despite regulatory issues for the US company.

TVS can sell Flame with twin spark plug

Press Trust Of India / New Delhi — 17-Sep-2009

A Supreme Court Bench asks the Madras High Court to decide the matter before November 30.

Counterview A laddu is a laddu is a laddu

Amrith Lal — 17-Sep-2009

But these are not convincing reasons to claim that the Tirupati laddu is an exceptional item like the Darjeeling tea or Goan feni to have geographical indications patent rights.

View Good candidate for GI status

Amrith Lal — 17-Sep-2009

After Darjeeling tea champagne and Florida oranges its the turn of Tirupati laddus to get a geographical indications patent.

Dr Reddys Promoter exit wont come cheap

Pillman — 17-Sep-2009

The one off windfall gains through patent challenges of the last few years are also not so much talked about as more and more companies increasingly shake hands and call truce to save spiralling litigation costs.

The Apex Court of India Sets Guidelines for All IP Litigation in Lower Courts

ag-IP-news Agency — 17-Sep-2009

A landmark Judgment has been passed by the Supreme Court of India which could change the course of Intellectual Property litigation in India.

Appeals court affirms patent infringement rulings against Roches peg EPO product

Thousand Oaks, California — 18-Sep-2009

Amgen announced that the Court of Appeals for the Federal Circuit affirmed the Massachusetts District Courts decision that Roches peg EPO product Mircera infringes four Amgen patents relating to recombinant erythropoietin and processes for making it.

Skype founders file a copyright suit against eBay

New York Times — 18-Sep-2009

The founders of Skype are escalating their legal battle with eBay.

Reliance Life trims pharma plans to keep cash in hand

C.H. Unnikrishnan — 18-Sep-2009

The pharma arm will now focus on selected high value but low volume specialty drugs.

Banarasi silk sarees get copyright cover

Binay Singh — 18-Sep-2009

Banarasi silk products have now joined the league of Pochampalli Tirupati laddu and Darjeeling tea under the registered name of Banaras Brocades and Sarees by securing Geographical Indication rights.

Glaxo seen eyeing 5% stake in Dr Reddys

REUTERS — 18-Sep-2009

Dr Reddys will get a lot of mileage in terms of selling their products in new markets while Glaxo will get access to a basket of generics at a time when a large numbers of drugs are going off patent.

Merck to launch 13 innovator drugs here

Khomba Singh — 19-Sep-2009

Besides the drugs launch we would go to smaller towns and cities where nobody has gone.Our growth will be driven by patented drugs.

Patented drugs market in India to touch $8 bn by 2015 Report

Press Trust Of India — 20-Sep-2009

The increasing population of higher income group in the country will open a potential $ 8 billion market for multi national companies selling costly patented drugs by 2015 a FICCI Ernst & Young study said.

Now an Invention Inventors Will Like

By STEVE LOHR — 20-Sep-2009

The world can be a rough place for independent inventors.

Innovation the key for winning organisations

Our Bureau — 20-Sep-2009

Innovation is all about research and development turned into an application and needs to come from all levels within an organisation.

Sun Pharma to file 30 applications for generic drugs

PTI — 21-Sep-2009

The company would file these applications along with its US based subsidiary Caraco which is facing trouble due to non compliance of current good manufacturing practice of the US drug regulator.

Pharma market in global top 10 by 2015 Report

BS Reporter / New Delhi — 21-Sep-2009

A report by the Federation of Indian Chambers of Commerce and Industry with Ernst and Young states that India could be a potential $8 billion market for multinational companies with patented drugs accounting for 8 10 per cent of the total market.

Indian global pharma firms find it worthwhile to join hands

Ravi Anathanarayanan — 21-Sep-2009

Companies began by selling generic drugs in India and other non regulated markets also invested in the US branded generic drugs market targeting drugs that went off patent and also challenging some patents.

Developing countries express concern over WIPOs hidden agenda of pushing patent harmonization

Ramesh Shankar, Mumbai — 21-Sep-2009

Even as the World Intellectual Property Organisations two day Global Symposium of IP Authorities is underway in Geneva the developing countries are expressing concern on the larger agenda of the organisation controlled by US EU and Japan on pushing a patent harmonization agenda.

Pharma market may touch $20 billion by 2015

PTI — 21-Sep-2009

Patent products may capture 8 10% share of the total market by 2015 the report said.

OSI Pharma receives reissued patent for Tarceva

Melville, New York — 21-Sep-2009

OSI Pharmaceuticals Inc announced that the US Patent & Trademark Office has issued a Notice of Allowance in OSIs reissue application for US Patent No.5747498 composition of matter patent for Tarceva.

Proposed patent Bill is flawed say experts

C.H. Unnikrishnan — 21-Sep-2009

A patent and intellectual property rights Bill modelled on a 1980 Act of the US Congress and due to be tabled in the Parliaments December session is drawing criticism from researchers and academics for not addressing key issues and jeopardizing public interest.

Govt begins efforts to establish Indian pharmacy chains in Africa to counter issue of fake drugs with made in India label by China

Ramesh Shankar, Mumbai — 21-Sep-2009

In an effort to effectively counter the complex issue of spurious drugs with made in India label but were produced by Chinese companies to tarnish the image of Indian generic drugs in the African countries the Indian government has started initiatives to establish a chain of pharmacies in African countries by the reputed Indian pharmacy chains like Apollo Group and Hetero Group.

Brazil India to oppose EU at WTO

D Ravi Kanth / Geneva — 22-Sep-2009

Indian generic drug companies have been charged with violating EUs patent laws.

SC order on IPR violations may have left door open for misuse

Manish Ranjan — 22-Sep-2009

Analysts say in some cases especially those with evidence of literal copying temporary relief may be required.

When patenting is in question

K M Gopakumar — 22-Sep-2009

The report of the Technical Expert Group on Patent Law Issues also known as the Mashelkar Committee Report has once again created controversy.

Growing pharma market makes India a clinical trial destination Report

Our Bureau — 22-Sep-2009

By 2015 MNCs with patented drugs could account for $8 billion in the domestic pharmaceutical market nearly 8 10 per cent of the total market.

Resolvyx gets US patent for first Resolvin therapeutic to enter human trials

Bedford, Maryland — 22-Sep-2009

Resolvyx Pharmaceuticals Inc. the leading Resolvin therapeutics company announced that the US Patent and Trademark Office has granted a patent covering composition of matter for RX 10045 the first Resolvin therapeutic to enter clinical trials.

An idea thats a patent misfit

Views — 23-Sep-2009

Indias intellectual property rights regime can barely be improved by blindly transplanting a three decade old US law.

GSK drug deal talk lifts DRL scrip

ET Bureau — 23-Sep-2009

Shares of Dr Reddys Laboratories touched an intra day high of Rs 878.70 amid speculation that the Indian drug maker is in preliminary talks with UK based GlaxoSmithKline to market Red Heart Pill used to treat those with heart ailments.

Glaxo eyes Piramal Dr Reddys Labs

C.H. Unnikrishnan and Baiju Kalesh — 23-Sep-2009

At least $70 billion worth of patented drugs will go off patent by 2012.

Venus Remedies Korean firm sign out licensing deal

Press Trust of India / Mumbai — 23-Sep-2009

The company has also received patent for Sulbactomax from South African authorities and is scouting for partner to market the drug in the country.

Eli Lilly Wins Ruling on Evista Patent Validity in Teva Case

By Edvard Pettersson — 24-Sep-2009

Eli Lilly & Co. won a ruling on the validity of patents for its Evista osteoporosis treatment blocking an attempt by Teva Pharmaceutical Industries Ltd. to sell a generic version of the bone loss drug.

Wockhardt gets award for patents

Press Trust of India / New Delhi — 24-Sep-2009

Drug maker Wockhardt today said it has been chosen as the pharmaceutical company for the maximum number of patent filings and grants from India.

Pharma M&As sounding death knell for low cost drugs

Priyanka Golikeri — 24-Sep-2009

Indian companies which have been actively pursuing pre grant and post grant oppositions against the patents of MNCs would become less aggressive after being acquired by Big Pharma and their focus would shift more towards the generic markets in the US and the EU from India say healthcare and legal experts working in the area of access to medicines.

Consolidation will happen in the domestic drug industry

P B Jayakumar / Mumbai — 25-Sep-2009

India has moved to product patents has a huge middle class its healthcare and insurance systems are improving and it has a good branded generics market.

TVS set to make twin spark plug Flame

fe Bureau — 25-Sep-2009

The company statement added that in the patent dispute between Bajaj Auto Limited vs TVS Motor Company Limited the Supreme Court in its order dated September 16 has allowed TVS to sell the twin spark plug TVS Flame.

Merck vaccine move signals shift in Big Pharma

Pillman — 25-Sep-2009

We have come a long way since the days when vaccines were considered a business of marginal interest for multinational companies.

Sanofi Aventis scans India for acquisitions

Nina Mehta & George Smith Alexander — 26-Sep-2009

The absence of blockbuster patented drugs is forcing these companies to increase their revenues by buying up generic companies in developing markets which are growing exponentially because of economic prosperity.

Pharmaceutical exports up 17%

BS Reporter / Chennai/ Hyderabad — 26-Sep-2009

The government is working to provide a conducive policy environment through flexible patent legislation to make the sector self reliant he said.

India objects efforts of developed nations to undermine flexibilities in TRIPS at WIPO

Ramesh Shankar, Mumbai — 26-Sep-2009

India has taken strong objection to the efforts being made by the developed nations through the World Intellectual Property Organization to undermine the flexibilities available under TRIPS by stretching the definition of counterfeiting.

Orchid wins US court battle against Wyeth

fe Bureaus — 26-Sep-2009

Wyeths plea for a TRO was in connection with its lawsuit against the USFDA as it challenged the regulators approval of Orchids abbreviated new drug applications for its generic products Piperacillin and Tazobactam for injections.

Ideal Cures bags Pharmexcil awards

Our Bureau, Mumbai — 26-Sep-2009

Bagging the Government of India Patents Ideal Cures was honoured with the prestigious Government of India Patents Award and the Outstanding Export Performance Award in Drugs and Pharmaceuticals for the year 2008 09 by the Pharmexcil apex body under Ministry of Commerce and Industry Government of India on Friday September 25 2009 at the Indo Africa Pharma Business Meet at the Convention Centre Hotel Marriot in Hyderabad.

Not such a patent misfit

Shyam Sunder,S. Subramanyan,Karan Thakur — 27-Sep-2009

Commercialization of patents in India remains weak is because the enforcement mechanism.

Indian drug market to triple to $ 20 bn by 2015 Report

ET Bureau — 27-Sep-2009

The report notes that In 2015 India could be a potential USD 8 billion market for MNCs with patented drugs accounting for nearly 8 10 % of the total market.

Lupin buys cholesterol drug for $39 million

PB Jayakumar & Joe C Mathew / Mumbai/delhi — 29-Sep-2009

The drug has strong brand equity with primary care physicians and has patent protection till 2020.

D Ravi Kanth Doha drifts again

D Ravi Kanth / New Delhi — 29-Sep-2009

We sail within a vast sphere ever drifting in uncertainty driven from end to end is what the G20 leaders conveyed to their trade negotiators at the Pittsburgh summit last Friday.

Indo Jap FTA Data exclusivity threat to generics

Priyanka Golikeri — 29-Sep-2009

According to intellectual property experts keeping close tabs on the FTA Japan is pressing amongst other thing for data exclusivity which could increase costs and delay the process of bringing low cost generic drugs to the market if it is granted.

Lunch with BS Anand Burman

Bhupesh Bhandari / New Delhi — 29-Sep-2009

Burman 57 is a scientist his father and the grand old man of Dabur A C Burman never got to finish college with over 40 patents against his name.

Public interest groups urge India to oppose moves at WIPO to harmonise patent administration

Joseph Alexander, New Delhi — 29-Sep-2009

A number of public interest organizations mainly in the health sector have urged the Centre to oppose any effort at WIPO General Assembly on harmonization of patent administration as it can fundamentally change the way in which substantive decisions about granting patents are taken by the patent offices in developing countries.

Encourage innovation in pharma and healthcare

Our Bureau — 29-Sep-2009

Participating at a panel discussion on pharma and biotech industry the Chairman and Managing Director Bharat Biotech Dr Krishna M. Ella said the absence of laws protecting intellectual property rights was discouraging innovation.

Recession and the global patent effect

Latha Jishnu / New Delhi — 30-Sep-2009

What happens when the apex patents organisation brings an economist sorry a chief economist on board

Reverse innovation isnt optional. It is oxygen

Vivek Kaul — 30-Sep-2009

Multinational companies need to change the very way they conduct business suggests Vijay Govindarajan noted expert on strategy & innovation and author of the international bestseller Ten Rules for Strategic Innovators.

Bharat Biotech gets patent for Lysostaphin

BS Reporter / Hyderabad — 30-Sep-2009

Hyderabad based vaccines and biotherapeutics manufacturer Bharat Biotech International announced on Wednesday that its anti staphylococcal molecule Lysostaphin had secured patent rights in US Europe China Australia and other nations.

Developing IPR is not a zero sum scenario

Joe C Mathew / New Delhi — 30-Sep-2009

The Geneva based World Intellectual Property Organization a specialised agency of the United Nations aims at developing a balanced and accessible international intellectual property system among its 184 member countries.

Taro files new lawsuit against Sun Pharma

BS Reporters / New Delhi/mumbai — 1-Oct-2009

Recent action by the USFDA against Suns majority owned US subsidiary Caraco Laboratories Inc.

The promise of WIPOs development plan

By John Tarpey — 1-Oct-2009

A group of states known as the Friends of Development launched a far reaching proposal in 2004 to put development at the heart of the activities of the World Intellectual Property Organization.

China way ahead of India in patent filings

Our Bureau — 1-Oct-2009

The Indian Patent Office ranks 9th in the number of patents filed and 12th in the number of patents granted according to the World Intellectual Property Organisations latest data.

Actavis launches generic Lipitor in Spain

By Kevin Grogan — 02-Oct-2009

Actavis said that atorvastatin tablets are subject to widely varying patent situations around the world which is why Medis has invested significantly in different forms of the molecule.

Geographical indicators and beyond

RAJESH HALDIPUR — 3-Oct-2009

GIs are just one stop in a long journey to strengthen the intellectual property rights of traditional and artisan products.

Big Pharma urged to pool HIV patents

Priyanka Golikeri — 3-Oct-2009

Médecins Sans Frontières an international humanitarian organisation has called upon nine global pharma giants to pool their HIV patents in order to make available treatment to millions living with HIV AIDS.

Plea filed in apex court against GI tag for Tirupati Laddu

Vinson Kurian — 3-Oct-2009

A public interest petition has been filed in the Supreme Court seeking suo motu action against the grant of intellectual property right protection to Tirupati Laddu which is a temple offering.

Cordis enters pact with Boston to settle selected stent litigation cases

3-Oct-2009

Cordis Corporation has reached an agreement with Boston Scientific resolving its Palmaz infringement suit relating to Bostons NIR stent settling several other cardiology related cases relating to patents in the Ding Kastenhofer Palmaz and Fontirroche patent families and exchanging paid up licenses for certain intellectual properties.

Indian formulation mkt to cross $13.7 billion by 2013

R Ravichandran — 5-Oct-2009

Global investors are under pressure due to growing patent expiries of major blockbuster drugs price restrictions and slowdown in new product approvals and launches.

PCT reforms at WIPO will benefit Indian innovators exporters OPPI

Ramesh Shankar, Mumbai — 5-Oct-2009

The Organisation of Pharmaceutical Producers of India which represents multinational pharma companies in the country has joined issue with the forces who are opposing the efforts of the developed nations at WIPO for the patent harmonization which is feared to undermine the flexibilities available under TRIPS.

India may file case against EU at WTO

Amiti Sen — 5-Oct-2009

Its illegal as it not only violated the international intellectual property agreement but was also against the GATT provisions on transit a commerce department official told ET requesting anonymity.

Glenmark Generics listing unlocks value for parent

Ravi Ananthanarayanan — 6-Oct-2009

GGL has also focused on niche segments where there is lower competition and on drugs where there are patent challenge opportunities.

Astellas US sues Wockhardt for alleged patent infringement of Adenoscan

Gireesh Babu, Mumbai — 6-Oct-2009

Astellas US LLC the US subsidiary of the Japanese drug major Astellas Pharma has sued the Mumbai based Wockhardt Ltd and its US subsidiary for alleged infringement of its patent on pharmacological stress agent Adenoscan adenosine injection as the latter has filed an abbreviated new drug application for generic version of the product.

Lupin outlicences drug delivery tech to Salix

Our Bureau — 6-Oct-2009

According to the agreement Lupin and Salix have also entered into an exclusive agreement in the US for supply of Rifaximin active pharmaceutical ingredient.

Glaxo eyes Dr Reddys as Big Pharma hunts in India

By Ben Hirschler and Quentin Webb — 07-Oct-2009

But attitudes are changing fast as slowing markets at home and a cliff of patent expiries has forced Big Pharma to explore new business models.

Developing nations gain victory at WIPO against patent harmonization agenda

Ramesh Shankar, Mumbai — 8-Oct-2009

The member states of the WIPO have reached an agreement on a renewed and strengthened mandate for the Intergovernmental Committee on IP on Genetic Resources Traditional Knowledge and Folklore which would now undertake text based negotiations on an international legal instrument aimed at protecting these resources.

Patent experts pool being set up to advise courts

C.H. Unnikrishnan — 8-Oct-2009

Move to assist the judiciary which is not yet fully conversant with the technical aspects of patent cases.

EU officials raid Ranbaxy French unit

ET Bureau — 8-Oct-2009

Generic companies make the low cost version of original drugs and they challenge the patent of original drugmakers so that they are able to launch their drugs before patent expiry.

Brazil may team up with India against EC

Asit Ranjan Mishra — 8-Oct-2009

India is appealing against EC at WTO for seizure of in transit consignments citing patent infringement.

Basic Research Loses Some Allure

By DON CLARK and CHRISTOPHER RHOADS — 08-Oct-2009

Last year 70% of its patents were for software and services reflecting its shift away from computers and semiconductors where pure science plays a bigger role.

Pharma cos build immunity against counterfeiters

Nina Mehta & Prashant Mahesh — 9-Oct-2009

The company has filed several patent applications for this technology which it says can be easily integrated into a pharma companys manufacturing process.

Uganda Tanzania Zambia too planning anticounterfeit legislations despite Indias caution

Joseph Alexander, New Delhi — 9-Oct-2009

In the World Trade Organization Agreement on Trade Related Aspects of Intellectual Property Rights TRIPS counterfeit is defined as pertaining to trademark infringement.

Scanner at shops multi coloured pills to detect counterfeit medicines

Nina Mehta & Prashant Mahesh — 09-Oct-2009

The company has filed several patent applications for this technology which it says can be easily integrated into a pharma companys manufacturing process.

Court directive to Texmo on trade mark issue

Our Legal Correspondent — 10-Oct-2009

The Madras High Court has directed the Madhya Pradesh based Texmo Pipes & Products Ltd to print or project in its publication advertisement pertaining to public issue of 50 lakh equity shares of Rs 10 each that its right to use the trade mark Texmo had nothing to do with the plaintiffs firm viz. Aqua Pump Industries or its trade mark Texmo Aqua.

Indian scientists develop sulphur free sugar

Shivani Vig — 10-Oct-2009

Before this we would be filing a patent for the developed sugar within a month and once through it would be the biggest achievement for the sugar industry and for NSI as well concluded Prof Narendra Mohan.

Lupin pills hit legal wall in United States

PB Jayakumar / Mumbai — 11-Oct-2009

Teva Womens Health of Israel and Warner Chilcott of Puerto Rico have sued Indias Lupin in separate patent infringement cases in the US.

Lupin eyes $200 mn opportunity in US contraceptives market

PTI — 11-Oct-2009

Mumbai based pharmaceutical firm Lupin is gearing to tap opportunities to the tune of up to $200 million in the US oral contraceptives market despite patent litigation from rivals on its plans to sell generic drugs there.

Carlos Correa accuses Mashelkar for misinterpreting his quotes in revised report

Ramesh Shankar, Mumbai — 12-Oct-2009

The government had set up a technical expert group with Dr R A Mashelkar as its chairman and four other members on April 5 2005 on the twin issues of evergreening of patents and excluding micro organism from patentability.

Improved product mix margins make Atul a good long term bet

Ujjval Jauharri — 12-Oct-2009

Atul also plans to introduce new products coming off patent.

The end of a drug alliance

Shamnad Basheer — 12-Oct-2009

Recent alliances such as Ranbaxy Daiichi Indian generics firms are now acquiring dual personalities and speaking the language of patents and innovation.

Big Pharma targets emerging mkts

Joe C Mathew /New Delhi — 12-Oct-2009

According to a recent KPMG study drugs worth $65 70 billion are expected to go off patent in five years while there are very few new drugs that can generate similar revenues.

Storm over drug patent linkage after court rejects Bayer petition

AZB and Partners — 12-Oct-2009

Bayer contended DCGI should not approve any application for a generic drug if the original has been patented.

US District Court approves sanofi aventis Sun Pharma patent settlement on Eloxatin

Gireesh Babu, Mumbai — 12-Oct-2009

The District Court has now ruled that since the terms of the agreement were explained in both the letter of intent and the term sheets the agreement is enforceable without considering whether all the required signatures are obtained or not.

Outlook for pharmaceutical companies looks good

Manas chakravarty, Ravi Ananthanarayanan and Vatsala Kama — 12-Oct-2009

IMS Health a global pharmaceutical market research company has released its latest forecast for 2010 in which it projects the global pharmaceutical market to grow by 4 6%.

Panel on pricing of patented drugs undecided on formula with no data on imported drugs

Joseph Alexander, New Delhi — 12-Oct-2009

The panel set up by the chemicals ministry in February 2007 to suggest a framework to fix prices of imported drugs through negotiations still could not muster enough support for its formula.

Mashelkar clarifies on patent report conclusions

Joe C Mathew / New Delhi — 13-Oct-2009

Nearly two months after Argentine patent expert Carlos M Correa complained about the misinterpretation of his observations to conclude an expert group report on Indian patent laws the chairman of the Technical Expert Group R A Mashelkar clarified that the reports conclusions were not based on Correas views but on TEGs own interpretations.

Phytogen develops a range of modified dosage nutraceuticals scouts for marketing par

Nandita Vijay, Bangalore — 14-Oct-2009

All the products have gone in for trademark clearances.

Glenmark Pharma plans to list its generics subsidiary

Nina Mehta — 14-Oct-2009

Glenmark Pharmaceuticals is planning to list its generics subsidiary Glenmark Generics and has filed a draft red herring prospectus with SEBI.

EMPOWERING SMEs

P A Francis — 14-Oct-2009

With the amendment of Indian Patent Act in 2005 allowing product patent Indian pharmaceutical market has become very attractive to MNCs.

We dont have space for more partnerships

Joe C Mathew & Vandana Gombar / New Delhi — 14-Oct-2009

Piramal Healthcare Ltd the countrys fourth largest drug company has been focusing on international partnerships and collaborations instead of following the high risk route of patent challenges to grow revenues.

Indian excipients market expected to grow 15 to 18% in near future say experts

Gireesh Babu, Mumbai — 14-Oct-2009

Owing to the large chunk of drugs going off patent in the coming years the experts expect a growth rate of Indian excipients market at around 15 to 18 per cent annum as against the global growth rate.

Sun acquisitions on hold will resume

C.H. Unnikrishnan — 14-Oct-2009

Dilip Shanghvi Suns chairman and managing director has put the companys new expansion plans on hold as he battles over Taro and tries to sort out US subsidiary Caraco Pharmaceutical Laboratories Ltd. which has had operations halted by the US FDA.

The campaign against that pesky 3 d

Latha Jishnu / New Delhi — 14-Oct-2009

Section 3 d is a singular provision aimed at preventing the evergreening of patents by drug inventors.

Pharma industry seeks new technical committee in place of Mashelkar panel

Joseph Alexander, New Delhi — 14-Oct-2009

Pharma industry has called for further amendment to the Patents Act to strengthen the criteria of patent protection and constitution of a fresh technical expert committee on the scope of patentability of pharma products as the earlier panel headed by Dr R A Mashelkar has run into controversy yet again.

Suven Lifes Alzheimers Drug Gets Patents

By RUMMAN AHMED — 14-Oct-2009

Suven Life Sciences Ltd. said Wednesday it has secured product patents in nine regions for its experimental drug for treating Alzheimers disease and schizophrenia.

Better monitoring of clinical research an imperative

Pillman — 15-Oct-2009

In truth the largest benefit of globalised trials comes from faster time to market reducing development time by half results in nearly two thirds reduction in overall development cost and provides a longer post approval patent term in which to recoup the investment.

EC seeks views on Darjeeling tea patent

PTI — 15-Oct-2009

The European Commission has invited public comments on a proposal from India seeking protection for Darjeeling tea against grant of patent for the beverage leaves grown in the hilly region of West Bengal.

USFDA tells Glenmark to withdraw drug

BS Reporter / Mumbai — 15-Oct-2009

The US Food and Drug Administration has directed Glenmarks US arm Glenmark Generics Inc and three other manufacturers to stop the marketing of unapproved codeine sulphate tablets in the US market.

EUs latest moves on counterfeit drugs cause fresh concerns to Indian pharma

Joseph Alexander, New Delhi — 15-Oct-2009

The recent moves by the developed countries especially the European Union on the counterfeit medicines issue have caused fresh worries among the Indian generic exporters prompting them to take recourse with the authorities for renewed efforts including international intervention along with other developing countries.

Darjeeling tea closes in on Europe

Sachin P Mampatta — 16-Oct-2009

The Indian application for a Geographical Indication mark for Darjeeling tea has entered a crucial six month period after which it would be given the same status as products such as Roquefort cheese and Napa Valley wines.

US Court rules Ranbaxys generic valganciclovir does not infringe Roches Valcyte patent

Gireesh Babu, Mumbai — 16-Oct-2009

The verdict is on a complaint filed by Roche alleging Ranbaxy of patent infringement of the formers US Patent No 6083953 following an Abbreviated New Drug Application filed by Ranbaxy on amorphous form of valganciclovir with the US Food and Drug Administration in 2006.

Made in India dominates US AIDS scheme

P B Jayakumar / Mumbai — 16-Oct-2009

Even patent protected drugs are procured for supply with a tentative approval in the countries covered under the programme.

Teva sues Mylan alleging Copaxone patent infringement

Esha Dey in Bangalore — 17-Oct-2009

Generic drugmaker Teva Pharmaceutical Industries Ltd sued rival Mylan Inc alleging that Mylans application to market a copycat version of Tevas multiple sclerosis drug Copaxone was infringing certain patents.

Generics face uniform patent norms threat

Priyanka Golikeri — 17-Oct-2009

Patients suffering from swine flu in India have a choice of buying the medicine oseltamivir from Natco Pharma Hetero Drugs and Strides Arcolab etc all of whose brands are available in the market.

Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio

Matthew Swetonic — 19-Oct-2009

Health Discovery Corporation is pleased to announce numerous additional issued patents and Notices of Allowance since its last press release describing its intellectual property portfolio.

India to lodge complaint with WTO against seizure of drug exports at EU ports

Ramesh Shankar, Mumbai — 20-Oct-2009

The government so far failed to cut much ice with the EU authorities in relaxing regulations on patent and trade mark issues so that at least the drug shipments on transit cannot be seized at the EU ports on charges of counterfeiting and patents infringement.

Bisleri told to stop using Maaza trademark

Press Trust Of India / New Delhi — 21-Oct-2009

The Delhi High Court today asked Bisleri International not to sell its mango flavoured soft drink under the trade name Maaza in India.

Dont dilute Right To Information Act with amendments

Ashutosh Shukla — 21-Oct-2009

The amendments to the RTI Act proposed by the central government have made activists as well as the public information commissioners increasingly unhappy.

GI protection Gain for some pain for others

Vandana Gombar & Ch Prashanth Reddy / New Delhi/hyderabad — 21-Oct-2009

Early next month the Madras High Court will hear a unique case a petition challenging the geographical indications protection given to the famous Tirupati laddu produced by the Tirumala Tirupati Devasthanam.

FDA seizes spurious drugs worth Rs10 lakh

Ninad Siddhaye — 21-Oct-2009

Drug inspectors of the state Food and Drug Administration have seized a huge stock of spurious drugs from a godown in MIDC Turbhe.

International public interest groups slam EU on double standards on drug laws

Joseph Alexander, New Delhi — 21-Oct-2009

International public interest organizations have charged the European Union with adopting double standards vis à vis poor and developed countries and blocking the access to essential medicines across the world especially in the underdeveloped countries.

Patenting Landscape in India

Stephen Albainy-Jenei — 21-Oct-2009

In recent years India has witnessed rapid changes in its patenting landscape as a result of the growing economic activity and reforms.

ImmunoCellular seeks US patent protection for intellectual property relating to novel glycosylated epitopes

Los Angeles, California — 21-Oct-2009

ImmunoCellular Therapeutics Ltd a clinical stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers has filed a provisional patent application at US Patent Office seeking protection of intellectual property relating to novel glycosylated epitopes present in lung cancer pancreatic cancer and colon cancer that are targeted by the Companys ICT 109 monoclonal antibody product candidate.

Indias patent progress

Science|Business reporting — 22-Oct-2009

The reform of Indias patent system has given foreign companies the confidence that they can protect their intellectual property rights but the economic boom is yet to translate through to a surge in home grown innovation according to the latest research from the market analyst Evalueserve.

RA Mashelkar For me its national interest that comes first

C.H. Unnikrishnan — 22-Oct-2009

Former director general of the Council of Scientific and Industrial Research R. A. Mashelkar who chaired the technical experts group on patent law constituted by the government has been dragged into a fresh controversy.

India need to develop strong legal system against bio piracy Prof. K V Krishnamurthy

Peethaambaran Kunnathoor, Chennai — 22-Oct-2009

The usurping of indigenous knowledge or traditional knowledge including medical knowledge without any benefit to the owner society is called bio piracy or gene robbing.

Nokia sues Apple for patent infringement

REUTERS — 22-Oct-2009

The worlds top cellphone maker Nokia Oyj on Thursday charged Apple with infringing Nokia patents in its iPhone.

India rejects draft WTO services schedule by US

D Ravi Kanth / Geneva — 23-Oct-2009

India along with other countries today shot down a concerted move by the United States Australia and Canada to prepare draft scheduling of commitments in Doha services negotiations based on signals made by trade ministers during the failed ministerial meeting last year a trade envoy told Business Standard.

Biocon banks on biosimilars novel drugs

Priyanka Golikeri — 23-Oct-2009

Estimates suggest that by 2016 about $25 billion worth of biologics would lose patent protection.

It was only growth that eluded us

Business Standard / New Delhi — 23-Oct-2009

We at Nasscom are looking at monitoring of patents as many companies now have to declare their patents in India.

BJP may soon claim patent on poll defeat

Devesh Kumar — 23-Oct-2009

For BJP tasting defeats in electoral battles has by now become routine.

The new pharmaceutical order

Bhupesh Bhandari / New Delhi — 23-Oct-2009

All of them not so long ago shared a common dream quickly capture the market for drugs that have gone off patent in the west.

Pfizer scans India for shopping options

Khomba Singh — 23-Oct-2009

Pfizer has approached several Indian drugmakers for possible alliances as part of moves to try and bolster revenues threatened by the expiry of patents on key blockbuster drugs in the next three years three persons with direct knowledge of the matter said.

Sun to stop making Alzheimers drug after losing patent battle

ET Bureau — 24-Oct-2009

Sun Pharmaceuticals has agreed not to manufacture and market the generic version of Alzheimers drug of Forest Laboratories after it lost patent battle with the US drugmaker on Thursday.

Allergan wins ruling in patent case against 2 drugmakers

By Robert Daniel — 25-Oct-2009

Allergan Inc. won a ruling in federal court that its patents on Alphagan which lowers pressure in the eye in patients with open angle glaucoma and ocular hypertension were infringed.

Biocon starts reaping benefits of Mylan pact

Joe C Mathew / New Delhi — 25-Oct-2009

Under the partnership Biocon is to develop four biosimilar products low cost versions of patented biotechnology products and supply them to Mylan for selling globally.

Govt gives overt & covert support to US stand on climate CPI M

Press Trust Of India — 25-Oct-2009

It also said India should work for freeing of technology transfers from restrictions of Intellectual Property Rights regime.

Nokia may seek up to$1 billion from Apple

Tarmo Virki — 26-Oct-2009

Apple a latecomer to the cellphone industry has won a considerable share of the higher end of the market but it has limited intellectual property assets compared with rivals when all vendors work under cross licensing agreements.

India seeks help from global NGOs to dissuade African nations enacting anti counterfeit laws

Ramesh Shankar, Mumbai — 26-Oct-2009

The Indian government has asked the NGOs about the need to segregate twin issues of Intellectual Property and counterfeit drugs.

Glenmark Generics launches first four products in UK market

Our Bureau, Mumbai — 27-Oct-2009

Of the four products launched Topiramate Tablets 25mg 50mg 100mg 200mg was launched on September 24 2009 which was day 1 of patent expiry in the UK market.

Pfizers Handa is new MD of Wyeth India

fe Bureaus — 27-Oct-2009

Pfizer has launched five patented products in India since 2005 Vfend Viagra Lyrica Caduet and Macugen.

Allergan wins brimonidine patent infringement case against Exela PharmSci & Apotex

Irvine, California — 27-Oct-2009

Innovation in medicine has improved lives reduced suffering and advanced the quality of patient care and our intellectual property embodies our commitment to and investment in medical innovation said Douglas S Ingram Allergans executive vice president chief administrative officer and secretary.

India may ask exporters to boycott KLM to deter EU for holding up drug cargo

Ramesh Shankar, Mumbai — 28-Oct-2009

Even as the Indian government is planning to file a complaint with World Trade Organisation against the European Union on the issue of seizure of Indian drug shipments at EU ports the government is also exploring other options to pressurise the EU nations to change the patent laws amended some time back to make them more stringent.

Proposed PCT II revisions in WIPO against developing countries: IDMA

Our Bureau, Mumbai — 28-Oct-2009

Now WIPO proposes a new treaty for a Global Patenting Order.

Watson and Barr Settle Lawsuit Over Oxytrol

CORONA, Calif — 29-Oct-2009

Watson Pharmaceuticals Inc. a leading specialty pharmaceutical company announced today that its subsidiary Watson Laboratories Inc. has reached a settlement with Barr Laboratories Inc. on outstanding patent litigation related to Watsons Oxytrol® product.

Music industry wins Indias biggest plea bargaining case: IMI

Chitra Unnithan / Mumbai/ Ahmedabad — 29-Oct-2009

In a significant case of copyright infringement under the concept of plea bargaining the Indian Music Industry won a compensation amount of Rs 12 lakhs in a copyright case.

Seeds of trouble

Latha Jishnu / New Delhi — 29-Oct-2009

Last week the debate on intellectual property rights on seeds became more contentious when Olivier de Schutter the UNs Special Rapporteur on the Right to Food warned that the increasing dependency on commercial seed varieties controlled by a handful of very powerful multinational companies could have a severe impact on small farmers in developing countries.

Prof Baker too finds fault with Mashelkars revised report after Correas objections

Ramesh Shankar, Mumbai — 29-Oct-2009

Close on the heels of international patent expert professor Carlos Correas criticism of the revised Mashelkar Committee report another international patent expert professor Brook K Baker has lambasted the Mashelkar Committee report stating that the revised version underestimates Indias right to define patentability.

Sun Pharma net profit dips 11.5%

BS Reporter / Mumbai — 29-Oct-2009

Analysts said despite regulatory issues in the US for its subsidiary Caraco growth in domestic business Caracos better sales than what was clocked in the immediate previous quarter and the patent settlement with Forest Laboratories during the recent quarter helped the company post better than expected profits.

Takeda holds forecast drugs outlook still tough

by Nobuhiro Kubo — 30-Oct-2009

Takedas sales may drop from next year on as patents of some drugs will expire and most investors are wondering how Takeda will deal with the problem.

Bumpy road ahead for India EU FTA

Nirmala Ganapathy — 31-Oct-2009

Though Ms Smadja said the priority in the negotiations remained issues like tariff market access non tariff barriers government procurement and IPR she also maintained that non trade issues were also important.

Sanofi sues Sandoz for infringing cancer drug patent

Tom Hals — 31-Oct-2009

French drugmaker Sanofi Aventis SA asked a U.S. federal court to block a Novartis unit from selling a generic version of its cancer drug in the United States because it infringes a patent according to court documents.

Popular cold pain drugs face ban

Rupali Mukherjee — 31-Oct-2009

Popular and widely used medicines like phenylpropanolamine or PPA found in cough and cold remedies like Vicks Action 500 Solvin Wincold gastrointestinal tegaserod anti bacterial gatifloxacin and painkiller nimesulide are under government scanner on concerns raised about their adverse reactions.

India in talks with US PTO for granting access to TKDL data to curb bio piracy

Joseph Alexander, New Delhi — 2-Nov-2009

After sharing the database of Traditional Knowledge Digital Library with European countries India is now in talks with more countries including the US for similar agreement to grant access to the details in a bid to prevent wrong patents across the world on Indian medicinal plants.

India ready to face WTO over wines spirits duties

Nayanima Basu / New Delhi — 3-Nov-2009

Negotiations to create a trade and investment agreement were initiated on June 2007 covering trade in goods services investment intellectual property rights competition policy and geographical indications among others.

Novartis Venture Funds looking at innovative India opportunities

P. T. Jyothi Datta — 3-Nov-2009

Also working in favour of target companies was strong intellectual property and capital efficiency he added.

Experts suspect Cotonou Declaration another attempt by developed nations to push counterfeit agenda

Ramesh Shankar — 3-Nov-2009

Recently the WHO South East Asia Regional Office passed a resolution stressing the need to separate issues related to intellectual property enforcement from the safety quality and efficacy of medicines.

ICFAI told to pay $1 million for infringing trademark in US

Kalpana Pathak / Mumbai — 3-Nov-2009

The Hyderabad based Institute of Chartered Financial Analysts of India has been asked to pay over $1 million to the US based Chartered Financial Analyst Institute in damages for using the CFA trademark in the US.

EU seizes another generic package

Priyanka Golikeri — 3-Nov-2009

In yet another instance of attacks on Indian generics in the European Union a consignment of 1.74 million tablets of anti platelet drug clopidogrel from Mumbai based Macleods Pharma to Venezuela is learnt to have been seized at the Paris airport in October on grounds of patent violation.

ABLEs fourth biotech investor forum to kick off in Mumbai on Nov 5

Our Bureau, Bangalore — 3-Nov-2009

The deliberation will focus on partnering & alliances opportunities from Intellectual Property sharing risk and explore other avenues to generate revenues which include monetizing assets licensing opportunities & services.

No fair play in pharma industry

MM Sharma Head — 3-Nov-2009

These drugs contain same active ingredients as the original formulations invented by the originator companies mostly from Europe or United States and in most cases the usual life 20 years of the patents have expired or are about to expire.

Not the right medicine

Business Standard / New Delhi — 3-Nov-2009

Big global pharmaceutical firms seeking to buy into prominent Indian generic players is in fact a vindication of the Indian pharmaceutical story which began with the decision by Indira Gandhi to rein in the cost of medicines and allow process and not product patents.

Share tech to manage climate change

Urmi Goswami — 3-Nov-2009

The failure to arrive at a consensus on the issue of sharing IPRs could well be one of the hurdles to an outcome at the Copenhagen summit.

Indian drugs may get safe EU passage

Amiti Sen — 4-Nov-2009

Pharma exports from India are likely to be promised safe passage by the European Union after India took up the issue following seizure of two consignments while in transit through the region.

Quick fix solution

M J Antony / New Delhi — 4-Nov-2009

Two judgments of the Supreme Court delivered in recent weeks are significant as they highlight the problem of long delays in cases involving intellectual property rights and the quick fix solution suggested by the court.

Pharma firms now need to shift focus to marketing: PwCs Friend

C.H. Unnikrishnan — 4-Nov-2009

Big pharmaceutical companies such as Pfizer Inc. Novartis AG and GlaxoSmithKline Plc have followed a strategy to invest in the research and development of new drugs to feed their market needs driven by speciality and patent protected products.

India takes drug seizure issue to WTO council

Joe C Mathew / New Delhi — 4-Nov-2009

The seizure of another consignment of Indian generic drugs in transit has pushed India to drag the issue to the TRIPS Council a high level body of the World Trade Organization dealing with intellectual property issues.

Core group for promoting local mfg of telecom infra

Press Trust of India / New Delhi — 04-Nov-2009

The meeting also discussed issues such as investments manufacturing and Indian intellectual property rights.

EU review mechanism on customs laws not likely to cover drug seizure issue

Joseph Alexander, New Delhi — 5-Nov-2009

Even as the repeated seizure of drugs by the European authorities raised resentment and the EU claimed to be reviewing the contentious regulatory clause relating to the issue India has expressed apprehension about the review and its chances of resolving the matter permanently.

FTA negotiation tops agenda at India EU bilateral summit

fe Bureaus — 5-Nov-2009

It is at a critical phase as it will involve bargaining on duty cuts market access on services sector IPR as well as toning down non tariff barriers.

Salix Pharma gets US patent for Rifaximin

Raleigh, North Carolina — 06-Nov-2009

Salix Pharmaceuticals Ltd announced that the US Patent and Trademark Office has issued US Patent No. 7612199 entitled Polymorphic Forms Alpha Beta and Gamma of Rifaximin.

EU to resolve drugs seizure issue soon

ET Bureau — 6-Nov-2009

Since the beginning of the year the EU have been confiscating Indian generic drugs that are on transit to Africa and Latin America on the ground that it violated the EUs patent regime.

Indian drug cos need to focus on niche segments in US generic market: Pharmexcil Study

Gireesh Babu, Mumbai — 6-Nov-2009

The Indian pharma companies should focus more on complex chemistry biotech based medicines and advance formulations to tap the lucrative US generic market in future suggests a study conducted by Pharmaceuticals Exports Promotion Council the apex body governing pharma exports under the Union Ministry of Commerce.

India EU to resolve generic drugs exports tangle

IANS — 06-Nov-2009

These shipments were for third countries so they did not violate either TRIPS Trade Related Intellectual Property Rights agreement or other existing laws.

Biocon hums with plans pitches for global top 3 slot

P B Jayakumar / Mumbai — 7-Nov-2009

About $25 billion worth of biological drugs are losing patent protection by 2016 and it is predicted that seven of the 10 top selling drugs will be biologics by 2020.

Dr Reddys develops generic version of Pfizers Lipitor

P B Jayakumar / Mumbai — 7-Nov-2009

With this the Indian drug maker has joined the club of only a few generic companies hoping to grab a share of the cholesterol lowering drugs market when its patent expires from next year.

Generic drug cos see a bitter pill in counterfeit label

Soma Das — 7-Nov-2009

The fear of generic drugs coming under the definition of counterfeit drugs is haunting the Indian pharma industry yet again.

Barkha Dutt wins domain dispute against Hyderabad based entity

STAFF WRITER — 08-Nov-2009

Barkha Dutt a noted journalist and Group Editor of NDTV news channel has won an internet domain dispute at the World Intellectual Property Organisation against a Hyderabad based entity.

Centre protests copyright violation by Google Books

Rituparna Bhuyan — 9-Nov-2009

The portal has led to numerous class action suites by authors and publishers in the US France and Germany for offering this facility in alleged violation of copyrights laws.

Brain League set to tap start up

Nandita Vijay, Bangalore — 9-Nov-2009

BrainLeague a knowledge management and Intellectual Property consultancy company has now started a special service for pharma biotech start ups where it will offer IP generation protection management and commercialization advise.

Generics Gateway

BV Mahalakshmi, Sudhir Chowdhary — 9-Nov-2009

The global generics market driven by a series of growth factors such as increasing genericisation favourable government support significant patent expiries and an ageing population is projected to grow at an attractive rate.

IP rights create a secure environment for investment in innovation

Francis Gurry — 9-Nov-2009

The sustained growth of Indias IT sector is a further example of what can be achieved through strategic use of IP.

AstraZeneca sues Lupin to protect patent rights of anti ulcer drug Nexium

Gireesh Babu, Mumbai — 10-Nov-2009

AstraZeneca the Anglo Swedish drug major has filed a patent infringement lawsuit at the US District Court of New Jersey against the Mumbai based Lupin Ltd and its US subsidiary to curb the latters move to manufacture and market the generic version of its blockbuster acid reflux drug Nexium.

Indian generic firms to gain from Obamas healthcare bill

Khomba Singh — 10-Nov-2009

In return for patents which are valid for 20 years innovator companies have to share the research work of their new drugs so that other companies can use the knowledge to develop copies of the drug when the original drugs patent expires.

Access to US biosimilars market set to get tougher

Priyanka Golikeri — 10-Nov-2009

The US is considering a measure that would prevent the US Food and Drug Administration from approving a biosimilar off patent version of a biopharmaceutical drug until 12 years have passed since the innovator biologic was first approved.

Patent disputes give global biggies the jitters

Bloomberg — 10-Nov-2009

The US Supreme Court on Monday considers a patent dispute that will determine how much legal protection is afforded abstract business innovations and has drawn in companies including Microsoft Google and Novartis.

Dr Reddys unit rev to grow 10 15pct in FY10

By Sumeet Chatterjee — 11-Nov-2009

Analysts say growth in the sector will also be boosted by the biggest loss of patent protection in history in the next couple of years depriving global pharma majors of exclusivity on some of the worlds most famous and profitable medicines.

HC stops Zydus drug sale on Sun petition

BS Reporters / Mumbai/chennai — 11-Nov-2009

Unlike patent litigation trademark cases can be filed anywhere in India where the company sells the drug explained Gopakumar Nair an expert on patents and managing director of Patent Gurukul.

Medicis files another patent infringement suit against Glenmark

Gireesh Babu, Mumbai — 11-Nov-2009

The US based Medicis Pharmaceutical Corp the specialty pharmaceutical company focusing on dermatological and aesthetic products has sued the Mumbai based Glenmark Generics Ltd and its US subsidiary in the District Court of New Jersey for alleged infringement of its patent rights on antifungal agent Loprox Gel.

Mahabaleshwar seeks GI tag for its strawberries

ET Bureau — 11-Nov-2009

After the Puneri pagdi Tirupati laddoo basmati rice the Mahabaleshwar strawberry is seeking geographical identification status.

Lupin issues notice to Depomed Inc relating to Glumetza patent

Our Bureau, Mumbai — 11-Nov-2009

Lupin Ltd a Rs 3775 crore fifth largest Indian pharma major has issued a Paragraph IV certification notice to Depomed Inc regarding filing of an ANDA with the US FDA for a generic version of Glumetza 500 mg and 1000 mg strengths.

AstraZeneca sues Lupin for infringing on drug patent

fe Bureau — 11-Nov-2009

Anglo Swedish drug giant AstraZeneca has sued the Mumbai based pharma company Lupin Ltd in the US District Court of New Jersey charging it of infringing the innovators patent coverage by attempting to manufacture and market anti ulcer drug Nexium one of the top five blockbuster drugs globally.

Daiichi to leverage Ranbaxy abroad

Mohit Bhalla & Khomba Singh — 11-Nov-2009

Japans Daiichi Sankyo which controls Ranbaxy Laboratories will use the Indian company as a launch pad to sell its patented drugs in Europe China and the US and will work together in developing new products a senior company official said.

MNCs working against Indian drug firms Anand Sharma tells WIPO chief

PTI — 11-Nov-2009

India on Wednesday complained to the UN intellectual property rights body WIPO that some multinational firms have launched campaign against countrys pharmaceutical industry which has broken their cartel in the generic drugs.

Outsourcing arm of Dr Reddys expects 10 15% revenue growth

Sumeet Chatterjee — 12-Nov-2009

Analysts say growth in the sector will also be boosted by the biggest loss of patent protection in history in the next couple of years depriving global pharma firms of exclusivity on some of the worlds most famous and profitable medicines.

E7 the new El Dorado for pharma

Priyanka Golikeri — 12-Nov-2009

Even for biosimilars off patent versions of biopharmaceutical drugs potential lies in Latin America and Asia says Kiran Mazumdar Shaw CMD of Bangalore based biotechnology player Biocon.

Novartis puts R&D activities in India on hold

Nina Mehta — 12-Nov-2009

Frustrated with patent challenges Swiss pharma giant Novartis has put its research and development activities in India on the back burner its CEO Daniel Vasella said. Mr Vasella who was in town to attend the Pepsico board meet said the intellectual property protection was not up to the mark in India.

Rs 55k cr domestic drug mkt largely spurious free claims health ministry

By Soma Das — 12-Nov-2009

The much awaited official word of the government on the penetration of counterfeit drug in the domestic market is out.

Method mania

Latha Jishnu / New Delhi — 12-Nov-2009

A US Supreme Court case on the patenting of business methods draws pharma and software giants into the battle.

Cipla offers to step up swine flu drug supplies

Our Bureau — 12-Nov-2009

Cipla has offered to sell generic Oseltamivir the generic version of Roches anti viral drug Tamiflu to the US said Cipla Chairman and Managing Director Dr Y.K. Hamied adding however that at present it does not sell to the US and Europe because the drug is patent protected in these markets.

Valuing intangible property

By Anuradha Salhotra — 12-Nov-2009

Over the past few years businesses have given more and more prominence to intellectual property.

WIPO Director General Pledges Support for Indias Visually Impaired Community

ag-IP-news ,GENEVA — 12-Nov-2009

The World Intellectual Property Organization Director General Francis Gurry met representatives of Indias visually impaired community at a conference on the Right to Read of persons with print disabilities and copyright challenges.

Astellas Pharma set to launch Prograf in India works on marketing strategy

Gireesh Babu, Mumbai — 13-Nov-2009

The product has been enjoying the top ranks in the segment in the US market till it lost the patent protection.

Now cosmetics from cow

Ramu Bhagwat — 13-Nov-2009

The research centre situated at Deolapar 65 km from here has already won patents from the United States and China for its cow urine distillate.

Venus bags another product patent for Potentox from South Africa

Our Bureau, Mumbai — 13-Nov-2009

Venus Remedies a research based pharma company has received fifth product patent in the current year.

Top drug firms growth to come from Russia Brazil and India

C.H. Unnikrishnan — 13-Nov-2009

In the past half a decade big pharmaceutical firms havent developed any new blockbuster drugs the lifeblood for them.

No cure in sight for India EU drug seizure controversy

Pallavi Aiyar / Brussels — 14-Nov-2009

Last month the Indian mission to the World Trade Organization in Geneva informed a TRIPS council meeting that widespread and repeated seizures were having an adverse impact on the legitimate trade of generic medicines universal access to medicines in developing countries and national public health budgets.

Endo Pharma to pay US$ 23 mn to LecTec to settle patent litigation

Chadds Ford, Pennsylvania — 14-Nov-2009

Endo Pharmaceuticals has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTecs US Patent Nos. 5536263 and 5741510.

Cash crunch hits intellectual property office reforms

Gunjan Sharma — 14-Nov-2009

The Controller General of Patents Design and Trademarks PH Kurian has said that budget constraints are hindering the reforms in the functioning of the Intellectual Property Office.

Drug Makers Raise Prices in Face of Health Care Reform

By DUFF WILSON — 15-Nov-2009

But drug companies say they are having to raise prices to maintain the profits necessary to invest in research and development of new drugs as the patents on many of their most popular drugs are set to expire over the next few years.

Affordable innovation in healthcare

Kiran Mazumdar-Shaw — 16-Nov-2009

Perhaps the most poignant present day paradox is that even as medical knowledge advances and global wealth grows health inequity between the rich and the poor is widening.

Govt to free tech tie ups trademark use

Anindita Dey / Mumbai — 16-Nov-2009

In a move that would help Indian companies access technology and trademarks more freely the government has decided to free the pricing for import of technology and use of trademark.

Glenmark Generics settles litigation with Medicis

REUTERS — 16-Nov-2009

Glenmark Generics Inc the US unit of Glenmark Generics Ltd on Monday said that it has settled all pending litigation with Medicis Pharmaceutical Corp relating to patent actions regarding Fluocinonide.

Now Zydus moves court against Sun

ET Bureau — 16-Nov-2009

The battle lines have been drawn between Mumbai based Sun Pharmaceutical and its Ahmedabad based rival Zydus Cadila.

Garmin says has not infringed Pioneers patents

by Savio D\'Souza in Bangalore — 16-Nov-2009

U.S. navigation device maker Garmin denied it infringed any patents and said it intended to defend itself against a patent suit filed by Japanese consumer electronics maker Pioneer Corp a Garmin spokesperson told Reuters.

TVS Bajaj case adjourned to Wednesday

ET Bureau — 16-Nov-2009

Barely days after TVS Motor re launched the contentious TVS Flame 125 cc motorcycle fitted with twin spark plug on the back of a Supreme Court order the battle between the company and Bajaj Auto made a comeback to the Madras High Court.

Tangaliya gets GI status

Rupam Singh Gupta — 16-Nov-2009

The Tangaliya shawl which uses a unique weaving technique and was almost on the verge of extinction has been given GI recognition by the Central government.

Purdue Pharma sues Sun Pharma following Para IV patent filing on pain killer drug

Gireesh Babu, Mumbai — 17-Nov-2009

The US based Purdue Pharma products LP and its partner Napp Pharmaceutical Group Ltd have filed a patent infringement petition against Sun Pharmaceuticals and its US arms following a para IV certification filed by the latter to manufacture and market generic version of the formers pain killer Ryzolt tramadol hydrochloride extended release drug.

Plea to protect intellectual property rights

LESLEY STONES — 17-Nov-2009

SA NEEDS to protect the intellectual property rights of companies more vigorously to spark greater innovations that will benefit the economy says the Free Market Foundation.

Medicis deal generic biz to boost financials

Kiran Kabtta Somvanshi — 17-Nov-2009

Glenmark has also settled a patent litigation with the same company over the latters two products.

TRIPS flexibilities sacred no plans to touch them

KG Narendranath — 17-Nov-2009

Francis Gurry the director general of the World Intellectual Property Organisation was in the capital recently amid the controversies over multilateral bodys plans to reform the Patent Cooperation Treaty which some quarters allege would lead to infringing upon the powers of national governments in matters of patent examination and grant.

Intel withdraws suit against govt

PTI — 17-Nov-2009

The worlds largest chip maker Intel Corporation today withdrew its suit before the Delhi High Court against the government trademark registry and the two small firms which have got registered its trademark till 2017.

NGOs warn against proposal to link marketing approval with patent status

Joseph Alexander, New Delhi — 18-Nov-2009

The public interest groups have again warned the Health Ministry against any attempt to link marketing approval with patent status as being pushed by the multinational companies saying that it would turn the drug regulator into Indias patent police.

Suven Life Sciences plans to raise funds for clinical trials

C.R. Sukumar — 18-Nov-2009

Its chairman and CEO Venkat Jasti said SUVN 502 is intended for the symptomatic treatment of Alzheimers disease schizophrenia and other disorders of memory and cognition

Protectionism by another name

Business Standard / New Delhi — 18-Nov-2009

The India European Union Joint Customs Cooperation Committee has met in New Delhi and failed to resolve the issue over Indian generic drugs being seized when they are in transit through European ports.

Mahindra Satyam could service M&M

Shweta Bhanot, Rachana Khanzode — 18-Nov-2009

According to Natarajan the firm currently helps its clients in the intellectual property IP space for designing products working out new regulations industrial products for emission fuel efficiency & fuel cost reduction and safety aspects in aerospace area.

Bayers patent case hearing in HC today

TNN — 18-Nov-2009

Drug multinational Bayers appeal against rejection of its petition in the Delhi high court indirectly seeking patent linkages will come up for hearing on November 18.

Supreme Court: When Do Ideas Deserve Patents

By Adi Narayan — 18-Nov-2009

It all started in 1997 when a little known company wanted to patent a method for letting customers of utility companies pay a fixed predictable sum each month.

90% of local patents applied for and granted come from nonresidents

Max V. de Leon / Reporter — 18-Nov-2009

THE countrys patent landscape continues to be dominated by foreign owners with data both from the World Intellectual Property Organization and the Intellectual Property Office of the Philippines indicating that over 90 percent of the patents applied for and granted here were from nonresidents.

Wockhardt Sun get US okay for generic drug

BS Reporter / Mumbai — 19-Nov-2009

The patents covering this product had expired yesterday.

EU blamed for breaking Doha Declaration denying access to cheaper medicines to poor nations

Joseph Alexander, New Delhi — 19-Nov-2009

Alleging that the European Unions trade agenda has taken a wrong turn and charging the EU with breaking its commitment under the Doha Declaration on TRIPS three leading international organizations have sought corrections in the existing policies and a new approach towards the issue.

Dabur accuses US firm of infringing on its trademark

Press Trust Of India / New Delhi — 19-Nov-2009

FMCG major Dabur has alleged that US based company Aveda which manufactures and sells Ayurvedic cosmetic products is infringing on the trademark of its skincare range.

In healthcare we can at best play catch up with China

Pillman — 20-Nov-2009

Dan Vasella the chief executive of Swiss firm Novartis which has been struggling for the last five years to secure the patent rights in India on Glivec its therapy for a rare form of blood cancer called chronic myeloid leukemia has spoken again on the alleged gaps in the Indian patent system.

Patent Volume Isnt the Best Innovation Gauge

Michael Arndt — 22-Nov-2009

Patent volume based on new analysis isnt necessarily a valid proxy for innovation.

Fake Vicks Vaporabs tablets worth Rs 30L seized from medical stores in Karanj Shahpur

TNN — 22-Nov-2009

The Enforcers of Intellectual Property Rights officials working against copyright and trademark violations had got a tip off about infringement of the P&G products in Ahmedabad.

Experts confirm that RP had not reneged on its IP commitments

Economy — 23-Nov-2009

THE recently enacted Intellectual Property Code of the Philippines and the Quality and Affordable Medicine Act passed into law late last year are compliant with the countrys commitments to the World Trade Organization.

Fake Chinese drugs deluge mkt with Made in India tag

Soma Das — 23-Nov-2009

Barely four months after China made fake drugs with deceptive Made in India labels were seized in Nigeria more cases of spurious drugs are surfacing in the Indian market with alleged links to China.

AYUSH to take home remedies out to market

Aditya Dev — 23-Nov-2009

If those are found effective in subsequent trials the department will try to get the person forwarding it the methods patent and also devise ways to market the idea.

Drug seizure Govt to drag EU to WTO

Amiti Sen — 23-Nov-2009

India is preparing to file a case against the European Union at the World Trade Organisation for wrongful seizure of high quality Indian drugs at its ports while in transit to other destinations a commerce department official has said.

Medicis takes Lupin to US court on patent charge

Joe C Mathew / New Delhi — 23-Nov-2009

Alleges infringement of patent for dermatology medicine.

In the mesh of FTAs whither generics?

Priyanka Golikeri — 23-Nov-2009

All the three blocs are pressing for a measure called data exclusivity a period during which the innovator drug companys clinical trial data cannot be relied upon to register a generic exact off patent version of the innovator drug which is 40 80% cheaper.

Spencer Stuart Perspectives Leadership challenge looms for generics firms

Filomena Leonardi, Sachin Rajan and Claudia Schütz — 23-Nov-2009

With generic medicines already representing a large and growing share of the pharmaceutical market these companies are looking ahead to the patent expirations of tens of billions of dollars of branded drugs over the next several years.

India US ink pacts on Intellectual Property Rights

Betwa Sharma in Washington — 24-Nov-2009

India and United States on Monday signed two inter governmental agreements on Intellectual Property Rights to help prevent misappropriation of traditional knowledge through mistaken issuance of patents.

Pharmexcils 2nd Patent Facilitation Centre to be set up at NIPER Mohali

Gireesh Babu, Mumbai — 25-Nov-2009

The Pharmaceuticals Export Promotion Council will launch its second Patent Facilitation Centre at National Institute of Pharmaceutical Education and Research Mohali by the end of the month to provide patent related information for the exporters in Northern Region.

Novo Nordisk to launch range of insulin products in India

Sohini Das / Mumbai/ Ahmedabad — 25-Nov-2009

Denmark based Novo Nordisk a world leader in diabetes care is bullish on setting up robust clinical research functions and also leveraging the India opportunity in related fields such as data management and studying the patent situation of the medicines under development as well as shared services.

Lupin moves to block rival generics

K V Ramana — 25-Nov-2009

However after expiry of the patent that year the company took the drug off the market following which Lupin started selling its generic version.

Tread cautiously on bilateral investment treaties

PRABHASH RANJAN — 25-Nov-2009

For example most BITs and this includes BITs entered by India bind the host nation not to discriminate between foreign and national investments allow full repatriation of income in foreign exchange to the home country of the investor provide an extremely wide definition of foreign investment which includes portfolio investment and intellectual property rights and provide very high compensation criteria for both direct and indirect expropriations with very limited manoeuvrability to the host state.

EU ends four year probe into Qualcomm

By Nikki Tait in Brussels — 25-Nov-2009

Europes top competition regulator has ended a four year inquiry into patent royalty rates charged by Qualcomm after the remaining companies that had brought a complaint against the US mobile chipmaker withdrew.

Increased trade okay but FTA a difficult task

fe Bureaus — 25-Nov-2009

The US has very high expectations on compliance of intellectual property rights which goes beyond the prevision of the TRIPS agreement said RS Ratna professor Indian Institute of Foreign Trade.

Chennai HC records 17 issues on Bajaj TVS dispute

T E Narasimhan / Chennai — 25-Nov-2009

Some of the issues raised by TVS include whether they infringe Bajajs patent if TVS is entitled to question the patent and if so, whether Bajajs patent is valid if Bajaj is entitled to claim damages whether a lean air fuel mixture combustion constitutes an essential element in the patent and so on.

Glenmark signs licensing deal with US firm

C.H. Unnikrishnan — 25-Nov-2009

A Glenmark official said on condition of anonymity that the company is exploring opportunities to licence out the newly patented acne treating antibiotic to firms in the European market.

Govt may give sops to drug exports avoiding Europe

Press Trust of India / New Delhi — 25-Nov-2009

The European Union has been seizing Indian generic drugs en route Latin America and Africa citing patent violations.

The WIPO knife edge

Latha Jishnu — 26-Nov-2009

For well over a decade the chirpy sounding acronym for the WTOs agreement on intellectual property rights TRIPS has rolled familiarly off tongues albeit with fear and loathing in the developing world.

Broadcasters protest move to amend Copyright Act

TNN — 26-Nov-2009

Indian broadcasters have demanded immediate consultation on proposed amendments in the Copyright Act which they feel will completely skew the field against television and radio industries in fact could even jeopardise their survival while spelling windfall gains for monopolistic music companies and copyright societies.

Pfizer pins hopes on Aurobindo does not rule out Indian buys

C.R. Sukumar — 27-Nov-2009

To counter competition from generic drugs and impact of patent expiry Pfizer is implementing a three pronged strategy.

Ranbaxy set for Rs 1000 cr boost from Valtrex clone

K V Ramana — 27-Nov-2009

Gurgaon based Ranbaxy Laboratories has launched generic Valtrex tablets in the US over two years after it settled a patent dispute with GlaxoSmithKline and secured a 180 day sales exclusivity for it.

Supply of fake drugs grossly overstated

Radhieka Pandeya — 27-Nov-2009

Two intellectual property right issues are not involved.

Patent worries

Business Standard / New Delhi — 27-Nov-2009

Few people in this country understand how seriously Indias development as those of other Third World countries would be impacted by a stifling intellectual property regime.

The fall of the worlds best selling drug

By Andrew Jack — 28-Nov-2009

Once its patents expire in 2011 generic drug manufacturers will be able to sell it far more cheaply.

Many ills in draft Copyright Act

ET Bureau — 28-Nov-2009

The HRD ministrys proposals for amending the Copyright Act which are slated to be discussed by the Cabinet shortly contain provisos that will hurt the interests of artists and reduce the accountability of copyright societies.

Avon to gain from nod to Ranbaxys drug

P B Jayakumar / Mumbai — 29-Nov-2009

The company will supply the main active pharmaceutical ingredient for Valtrex.

The reality of free

Rajan Anandan — 30-Nov-2009

The company is the worlds largest holder of IP rights with 13400 patents worldwide but it also spends billions on its open innovation efforts under which it is working with the open source software community to facilitate faster and easier access to Microsoft technologies and IP.

City techie receives patent for anti virus software

SiddharthKelkar — 30-Nov-2009

A system that can curtail virus attacks on computer networks as well as minimise false alerts of attacks invented by city based computer expert received central government patent recently.

Revised Copyright Act to pinch broadcasters pockets

Ashish Sinha / New Delhi — 30-Nov-2009

These included tinkering with the fair use provisions of Section 52 insertion of Section 33A and changes in Section 31 among others.

Abbott gives Teva TriCor rights as early as 2011

The Associated Press — 30-Nov-2009

Pharmaceutical and medical products maker Abbott Laboratories and Laboratories Fournier SA granted intellectual property rights for the cholesterol medication TriCor to Teva Pharmaceutical Laboratories Ltd. according to a Securities and Exchange Commission filing Monday.

Depomed sues Indias Lupin for patent infringement

Esha Dey in Bangalore — 30-Nov-2009

Drug developer Depomed Inc said it filed a lawsuit in a U.S. federal court against Indias Lupin Ltd alleging that Lupins application to market a generic version of Depomeds diabetes drug Glumetza infringed its patents.

Suven gets patents from EPO for 3 drugs

Press Trust of India / Mumbai — 30-Nov-2009

Pharmaceutical firm Suven Life Sciences today said the European Patent Office has issued three patents to its chemical entities which are used in treating nerve disorders.

Fake medicine sale rampant cops helpless

Express News Service — 1-Dec-2009

Fake drugs are sold rampantly in the state.

Troikaa Pharma gets patent in Australia for Diclofenac painkiller injections

Our Bureau, Mumbai — 01-Dec-2009

Troikaa Pharmaceuticals Ltd a fast growing healthcare company has been granted patent in Australia for its novel drug delivery form of Diclofenac injections Dynapar AQ the worlds first painless painkiller injection.

Cipla in drug supply talks with Pfizer

C.H. Unnikrishnan — 02-Dec-2009

Pfizer after sluggish growth in its speciality and patented pharmaceutical business in the developed markets has been aggressive on the generic or off patented drugs business.

Gilead set to benefit from HIV guidelines

By Andrew Jack in London — 02-Dec-2009

Yusuf Hamied head of Cipla the Indian generics company that is one of the largest providers of stavudine and other HIV treatments dismissed the financial impact pointing out that he could also sell Gileads principal drug in developing countries after overturning the US companys patent on tenofovir in India.

Sunny re rating of pharma companies

B G Shirsat & Ashok Divase / Mumbai — 2-Dec-2009

It is aiming at entering the market with a new biotech product off patent and with a market size of $5 billion.

Japans largest drug maker Takeda plans India foray

Press Trust of India / New Delhi — 02-Dec-2009

Besides Takedas best selling anti diabetic anti diabetic medicine Actos will lose patent protection in 2011.

Copyright draft is tough on covers

Nivedita Mookerji — 2-Dec-2009

Broadcasting organisations will have to give prior notice to the Copyright Board for airing published literary or musical work.

Japans top pharma comes calling

MG Arun — 2-Dec-2009

In March this year Pfizer entered into an agreement with Aurobindo Pharma to market drugs that are no longer patent protected and dont have market exclusivity in the US and Europe.

Doha progress only with new market access: US

D Ravi Kanth / Geneva — 2-Dec-2009

Meanwhile India Brazil and South Africa yesterday decided to pool their energies for adopting common positions on all issues pertaining to WTO and World Intellectual Properties Organization.

Pfizer Cipla in Aurobindo redux plan

K V Ramana — 2-Dec-2009

Drug maker Cipla could soon be supporting the strategies of global pharma giant Pfizer for expanding its footprint and protecting its business interests as many of its drugs go off patent.

Technology Of Hope

Kiran Mazumdar-Shaw — 3-Dec-2009

A large number of blockbuster drugs are also set to go off patent giving the sector here tremendous opportunities.

Commerce ministry plans to add booster dose to border scrutiny to check spurious drug exports

Soma Das — 04-Dec-2009

After the health ministry declared the domestic pharma market largely free of spurious and substandard drugs the commerce ministry now wants to step up the vigil at the checkpoints to scrutinise pharma export consignments and assess the quantum of spurious drugs that could be leaving the country and ascertain whether such channels of spurious drugs exist.

Bridging the gap on clean technology

Padmaparna Ghosh — 04-Dec-2009

Developed nations say it will destroy the incentive for innovation.

Bata drags Relaxo to court over brand infringement

Press Trust of India / New Delhi — 04-Dec-2009

Footwear major Bata today dragged its rival Relaxo Footwear before the Delhi High Court alleging infringement of one of its popular brand Sparx.

Kodak Sells OLED Business To LG, Cos Will Share Patents

DOW JONES NEWSWIRES — 04-Dec-2009

Eastman Kodak Co. agreed to sell its organic light emitting diode business to a group of South Koreas LG companies and also said it has an agreement with LG Electronics Inc. that will allow each company broad access to the others patent portfolio.

Data exclusivity study draws flak from Indian drug industry

Khomba Singh — 5-Dec-2009

The industrys main objection is the fact that the study is being carried out by the Delhi based law firm Anand and Anand who has regularly represented global pharma companies in patent disputes besides being a member of the Satwant Committee an industry excessive said.

Drug trial data issue invites pharma fire

Joe C Mathew / New Delhi — 5-Dec-2009

The controversial issue of exclusivity of drug trial data which saw overseas multinational companies and Indian pharma companies taking opposite positions is back on the table.

Our negotiating position has strengthened: Jairam

Nitin Sethi — 5-Dec-2009

The same IPR issues that dominated the pharmaceutical debate are now coming to dominate the climate change debate.

News broadcasters oppose amendment of copyright laws

Ashish Sinha / New Delhi — 5-Dec-2009

The issue of proposed amendments to the existing Copyright Act 1957 is becoming a flash point between broadcasters and the Ministry of Human Resource Development with news broadcasters asking the government to take them into confidence before undertaking any amendment to the law.

Cephalon files patent lawsuit against Teva for armodafinil tabs

Frazer, Pennsylvania — 5-Dec-2009

Cephalon Inc has filed a lawsuit in US District Court in Delaware against Teva Pharmaceuticals USA Inc for infringement of US Patent Nos. 7132570 the 570 Patent 7297346 the 346 Patent and RE37516 the 516 Patent for the Cephalon product Nuvigil armodafinil Tablets.

Data exclusivity study draws flak from Indian drug industry

Khomba Singh — 06-Dec-2009

A WHO official asking not be named as he is not the authorised spokesman said: Neither the TRIPs or the Doha declaration mention data exclusivity.

Intellectual Property Right is a social crime

DNA,Ahmedabad — 06-Dec-2009

There was a time when knowledge was imparted freely.

Column : Buzz in pharma biz

MG Arun — 7-Dec-2009

Their profitability is under pressure owing to patent expiries challenges in pricing and falling R&D productivity.

India to take on EU over drug seizures

C.H. Unnikrishnan — 7-Dec-2009

The seizures were made for alleged patent law violations as some of these drugs are still under protection in European countries.

Bill seeks to make trademark registrations easier

Our Bureau — 7-Dec-2009

A Bill seeking to amend the Trade Marks Act 1999 with a view to enabling Indian nationals as well as foreign nationals to secure simultaneous protection of trademarks in other countries was tabled in Parliament on Friday.

Our growth does not depend on acquisitions’

BV Mahalakshmi — 7-Dec-2009

Established products are medicines that have lost patent exclusivity or are close to losing exclusivity.

Trademarks sans borders

Editorial — 8-Dec-2009

It is only logical that countries that adhere to a philosophy of open trade must also recognise trademarks registered in one country to be universally applicable across markets.

US Gilead appeals against patent rejection of AIDS drug Viread

Khomba Singh — 8-Dec-2009

US drug company Gilead Sciences has filed an appeal in the Indian Intellectual Property Appellate Board to challenge a recent order by an Indian Patent Office that rejected two patent claims for its best seller drug Viread tenofovir disoproxil fumarate.

Indian IP firm adjudged best in Asia Pacific

Our Bureau — 9-Dec-2009

J Trivedi & Co an Ahmedabad based law firm specialising in intellectual property rights and patent related issues has emerged the Highly Commended Law Firm of the Year in the Asia Pacific region at the 2009 World Leaders International IP Awards.

HIV patent pool hobbles as drug firms want India China excluded

Priyanka Golikeri — 9-Dec-2009

Efforts to bring together nine global drugmakers to pool their HIV patents in order to make available treatment to millions living with HIV AIDS in the developing world seem to have faltered over a crucial issue the inclusion of middle income countries such as India and China in the list of beneficiaries.

Do we need data exclusivity ?

Business Standard / New Delhi — 9-Dec-2009

The term DE is new to India as it does not figure in the Trade Related Intellectual Property Rights Agreement of the WTO.

Ranbaxy admits to infringement of Purdues Oxcontin patent in US

Gireesh Babu, Mumbai — 10-Dec-2009

Ranbaxy Pharmaceuticals Inc the US subsidiary of the Gurgaon based Ranbaxy Laboratories has reportedly admitted infringement of the US based Purdue Pharmas patent for the blockbuster drug Oxycontin in the District Court for the Southern District of New York US.

Satyam Upaid in $70 million settlement Deloitte is auditor

Lison Joseph — 10-Dec-2009

The settlement requires the British firm to give Mahindra Satyam a worldwide royalty free licence to all its patents besides withdrawing all pending legal actions initiated by it.

Who owns the eggplant?

Latha Jishnu / New Delhi — 10-Dec-2009

What would be the nature of intellectual property rights that the developers would enjoy given that the technology is owned by Mahyco a company in which Monsanto has a 26 per cent stake and how soon would the universities be allowed to release their seeds?

FTAs could hurt farmers too

Priyanka Golikeri — 11-Dec-2009

After generic drugmakers its the farmers who are feeling the heat of the intellectual property regime.

IT firms focus on patents to widen revenue window

Surabhi Agarwal — 11-Dec-2009

This is a game changer for the companies showing how far they have traveled from just adapting software off the shelves as they aggressively try to acquire intellectual property rights to fuel future revenue growth.

Pfizer sues Dr Reddys over Lipitor patent

Phil Milford / Bloomberg — 11-Dec-2009

Dr Reddys had notified Pfizer in October that it was seeking US Food and Drug Administration permission to sell copies of Lipitor and that the patent wasnt infringed according to the lawsuit

History of Jeans Modi\'fied Denim Denim ka Bandhan

TNN , TOI Crest — 12-Dec-2009

He teamed up with Strauss and the two received US Patent 139121 for their rivetted and rivetting product.

Apple hits back at Nokia in patent war

By Joseph Menn in San Francisco and Andrew Parker in,London — 12-Dec-2009

Applefiled a countersuit against Nokia yesterday claiming that the Finnish company has pursued anti competitive practices and infringed 13 of its patents.

Recession hits patent filings in US fall 2.3% in 09

Press Trust of India — 13-Dec-2009

The financial crisis has not only rattled the US economy but seems to have also choked innovations among the Americans with patent filings declining for the first time in over a decade in 2009.

Indian pharma industry can improve share in global market

Express News Service — 13-Dec-2009

The Indian pharmaceutical companies are already lining up the US FDA office to get patent on the first to file basis of the drugs which will get off patented in 2012.

NGOs slam move to keep India out of patent pool

BS Reporter / New Delhi — 13-Dec-2009

Indian civil society organisations have opposed a reported move by global drug procurement agency UNITAID to exclude countries such as China Brazil and India from a proposed patent pool for AIDS drugs.

Indian drugs face EU music

Joe C Mathew / New Delhi — 13-Dec-2009

Indian medicine accounted for over 50 per cent of all drug seizures in Europe for intellectual property rights violation last year.

India to maintain edge in generics

BS Reporter / Chennai/ Hyderabad — 14-Dec-2009

Bad reputation on quality of medicines exported from India and weak combat mechanisms from the government to weed out counterfeit medicines in the international society are the bottlenecks for the Indian pharmaceutical companies to grow in Japan according to Kenji Toda chairman Japan Pharmaceutical Manufacturers Association.

Wipo goes green for domain name dispute resolution

PTI — 14-Dec-2009

Amid the ongoing global debate on climate change the World Intellectual Property Organisation has said it will launch paperless procedures in matters relating to domain name dispute from Monday.

Bangalore scores an A in Biotech

Kiran Mazumdar-Shaw — 14-Dec-2009

Offering fiscal incentives to the tune of Rs400 crore and benefits such as investment promotion subsidy interest free loan on VAT and financial support for patent registration the policy goes to show the strong support the sector receives from the government.

Consideration for use of copyright is not royalty

HP Agarwal / New Delhi — 14-Dec-2009

In many cases foreign companies grant access to Indian companies for using their data base and other copyrighted material.

Technology transfer development pact to be feather on Indias cap

Urmi A Goswami — 14-Dec-2009

The poorer countries will also get support for the deployment and diffusion of environmentally safe and sound technologies efforts to leverage public and private investment in technology incremental costs of soft and hard technologies for implementation of adaptation and mitigation purchasing of licences and other intellectual property rights issues.

Suven Life gets patent in Canada for two new chemical entities

Press Trust of India / New Delhi — 14-Dec-2009

Drug maker Suven Life Sciences today said it has recieved patent for two new chemical entities used in the treatment of diseases like Parkinson and schizophrenia from the Canadian Intellectual Property Office.

Court pulls up Microsoft for forum hiring

Our Bureau — 15-Dec-2009

The Delhi High Court has asked software major Microsoft to shell out Rs 8 lakh as cost security for deliberately choosing Delhi to file copyright violation cases despite having offices in cities where the offences were allegedly committed by opposite parties.

FM III may say whats not news

Nivedita Mookerji — 15-Dec-2009

The HRD ministry was late in giving its input over issues related to copyright and intellectual property rights a source pointed out.

Glenmark may settle with Merck on cholesterol drug

C.H. Unnikrishnan — 15-Dec-2009

Glenmark Pharmaceuticals Ltd may settle with US firm Merck Schering Plough Pharmaceuticals Llc resulting in the withdrawal of patent litigations related to the launch of a copy of the latters $1.6 billion in sales drug ezetimibe in the US market next year according to a report released by First Global Securities Ltd last week.

India fourth largest illegal downloader

IANS — 15-Dec-2009

According to their findings India trails only the US Britain and Canada in online copyright infringement.

Trademark case: Interim injunction favours Witco

Our Bureau — 15-Dec-2009

Witco a multi-brand travel accessories retailer with stores in Chennai Bangalore and Kerala has got a breather from the Madras High Court in a trademark infringement case.

Health Ministrys nod to WHO for a study on data exclusivity raises concern

Ramesh Shankar, Mumbai — 16-Dec-2009

The union health ministrys move has raised eyebrows among the patient community and the public interest groups in the country as they view that data exclusivity could prevent the registration of low cost quality generic versions of medicines even when there is no patent on a medicine when a drug does not meet the standards for patentability.

HUL to pay 1% of net sales as trademark royalty

TNN — 16-Dec-2009

Hindustan Unilever Ltd has entered into a fresh trademark licence agreement with its parent company Unilever under which the Indian subsidiary will pay royalty of 1% on net sales of specific brands whose trademark is owned by the Anglo Dutch parent company.

Patent pool for AIDS gets UNITAIDs approval

Radhieka Pandeya — 16-Dec-2009

In a relief for civil society and stakeholders from India Unitaid the international facility for the purchase of drugs against HIV AIDS has included middle income countries such as India in the pool

Cipla in talks to supply drugs to Germanys BI

Khomba Singh — 16-Dec-2009

Global innovator pharma majors are expected to see a drop in sales in the next 2 3 years because the patent on their top selling drugs would expire and they dont have a strong research pipeline to supplement the revenue loss.

The Indian Dream

Vivek Wadhwa — 16-Dec-2009

We calculated that foreign nationals residing in the US were named as inventors or co inventors in one quarter of WIPO patent applications filed from the US in 2006.

U.S. Patents Take a Fall

By Michael Arndt — 17-Dec-2009

Hurt by smaller R&D budgets and offshoring U.S. patent applications fell this year and Yankees are winning fewer grants than non residents

Lok Sabha nod to amended trademark law

Press Trust of India / New Delhi — 18-Dec-2009

A person seeking global trade mark now need not apply for it in several countries incurring a big cost as Lok Sabha today amended the trade mark law to simplify the procedures.

HC permits Madras Fertilizers agent to use trade name Vijay Agro

Our Legal Correspondent — 19-Dec-2009

The Madras High Court in its interim order on an original application of the State owned Madras Fertilizers Ltd has permitted a firm in Erode district of Tamil Nadu to use the trade name Vijay Agro from February 1 2010 in selling its product mixture fertiliser.

Dr Reddys plans to launch Lipitors generic version in US

Press Trust Of India / Hyderabad — 21-Dec-2009

Under the new drug application submitted to the US drug regulators approval Para IV filing are those which seeks nod for launching the drug before expiry of patent.

India to be part of patent pool for HIV drugs clarifies UNITAID

Joseph Alexander, New Delhi — 21-Dec-2009

UNITAID which hast just voted to create a patent pool for HIV AIDS drugs with the aim of bringing down the prices of medicines for this dreaded disease has clarified that India will also be included in the pool.

Outsourcing steroid for Indian pharma firms

B G Shirsat & P B Jayakumar / Mumbai — 21-Dec-2009

Daiichi Sankyo owned Ranbaxy Laboratories struggling with its US business due to manufacturing discrepancies at two of its Indian units is also likely to recover in future with drug supply deals and exclusivities as part of patent case settlements with drug majors said analysts.

Abbott Sues Sandoz Over Patent for Muscle Relaxant Nimbex

By Phil Milford — 22-Dec-2009

Abbott Laboratories a diversified healthcare product maker accused Sandoz Inc. of infringing a patent for the muscle relaxant Nimbex by seeking approval to market a generic copy of the drug in the U.S.

Five years on patent regime implementation still needs work

P.T.Jyothi Datta — 22-Dec-2009

It was on the eve of January 2005 that an Ordinance was issued to amend the Patent Act 1970 and bring in a regime that would honour product patents.

Sanofi to acquire Chattem expand presence in US

Bloomberg — 22-Dec-2009

Hes also looking beyond branded drugs and the search for new blockbusters to businesses that are less subject to patent expirations

Pharma 2009: No medicine to cure adversity

Press Trust of India / New Delhi — 22-Dec-2009

Indian pharma industry found that it had no medicine to cure adversities that came its way in 2009 when it battled shipment seizures by EU authorities tightened US regulations Chinese drug piracy and currency fluctuations.

Microsoft Loses Lawsuit But Word Likely to Stay

David Coursey — 22-Dec-2009

First the good news: No you won have to turn in your copies of Office 2007 even now that Microsoft has lost its appeal of a lawsuit brought by the Canadian company i4i.

Lupin settles litigation with Forest Labs for Alzheimers drug

BS Reporter / Mumbai — 23-Dec-2009

Lupin Ltd has settled all its ongoing patent litigation with US based Forest Laboratories on the Alzheimers disease treatment drug Namenda memantine tablets.

Pharma cos want govt to question European seizure statistics

Soma Das — 23-Dec-2009

Apart from goading the Centre to move the WTO against the recent drug seizures in Europe the domestic pharma industry is also urging the government to officially question the statistical claims of the European Commission that project India as a major source of counterfeit drugs.

WTO rules against China; Victory for US

Press Trust Of India / Washington — 23-Dec-2009

The WTO Appellate Body yesterday held that China was obstructing trade by forcing foreign suppliers to distribute certain copyright intensive products through state owned companies which is inconsistent with the Beijings obligations with the WTO.

Opposition slams government on Copenhagen Accord

Gargi Parsai — 23-Dec-2009

Mr. Yechury described the financial commitments under the accord as woolly and said the Intellectual Property Rights regime on transfer technology was effectively negated in the accord.

Troikaa Pharma to put Sanand plan on hold till December 2010

Sohini Das / Mumbai/ Ahmedabad — 23-Dec-2009

Expects to get patent approvals for Dynapar AQ in 99 countries in six months

Do drug prices need control?

BS Bureau — 23-Dec-2009

This is essential for the proper implementation of Indian patent law safeguards that facilitate the local production of low cost generic versions of patented medicines and vaccines through government use licences.

Indian American works new way to save refineries billions

IANS — 23-Dec-2009

Purdue has filed a patent application for the new crude distillation sequences.

Top drug firms take in licensing route to up sales

P B Jayakumar / Mumbai — 24-Dec-2009

Most of the in licensed products by Indian companies are niche innovative patented drugs that are selling well in the US and Europe and are made by medium scale players in those countries.

Citys top pubs hotels served notices for not paying music licence fee

Express News Service — 24-Dec-2009

Under the statutory sanction of section 35 of the Indian Copyright Act playing commercial music in public without paying the requisite licence fee is liable to contempt of court.

Copyright aggression

Latha Jishnu / New Delhi — 24-Dec-2009

Microsofts methods of protecting copyright have been slammed by the court as abuse of its money power.

AFDIL sues Fizikem Labs for trademark infringement of its Beplex Forte

Our Bureau, Bangalore — 24-Dec-2009

Anglo French Drugs & Industries Limited has resorted to legal proceedings against the Baddi based Fizikem Laboratories for trademark infringement of its flagship brand Beplex Forte.

Eisai bets big on India

BV Mahalakshmi — 24-Dec-2009

Incidentally the companys flagship product Aricept used for treating Alzheimers diseases and contributing close to $3.2 billion of the total revenue of $8.6 billion is going off patent in 2010.

Patent office braces for surge in applications

P.T. Jyothi Datta — 24-Dec-2009

The Indian Patent Office is set to address the shortage in patent examiners and the standardised implementation of the Patents Amendment Act 2005 as it braces for the increasing flood of patent applications.

Indoco eyes US Europe markets; will sign four contract research treaties soon

Reghu Balakrishnan — 24-Dec-2009

The company is in the process of submitting abbreviated new drug applications ANDAs with the USFDA for the products proposed for marketing.

New bill to amend copyright laws music to creators ears

Indo Asian News Service — 24-Dec-2009

Musicians writers and film directors who were earlier exploited by producers and music companies can now hope to reclaim commercial rights to their works and earn royalty from them.

Govt in pre Xmas reforms drive

BS Reporter / New Delhi — 25-Dec-2009

The amendments to the domestic Copyright Act would bring it in conformity with the World Intellectual Property Organisation Internet Treaties WIPO Copyright Treaty and WIPO Performances and Phonograms Treaty which have set the international standards in these spheres.

Two GM varieties of wheat developed by Indian co registered

Prabha Jagannathan — 26-Dec-2009

The new wheat varieties are being registered under the Protection of Plant Varieties and Farmers Rights Act which meets all the requirements under the TRIPS agreement for intellectual property rights for plants.

Amgen wins recombinant erythropoietin patent dispute against Roche

Thousand Oaks, California — 26-Dec-2009

Amgen announced that the United States District Court in Boston has entered final judgment and a permanent injunction against Roche prohibiting Roche from infringing Amgens patents on recombinant erythropoietin thus bringing the five year patent infringement dispute to an end.

Generics cos in the cold as big pharma has its way in US

REUTERS — 26-Dec-2009

The massive US Senate healthcare reform measure passed on Thursday with support from the multibillion drug industry but makers of cheaper generic rivals are feeling left out in the cold.

India gives EU another chance to settle drug seizure case

Amiti Sen — 26-Dec-2009

These seizures violate the international patent agreement Trips as the drugs being confiscated are off patent both in India and the countries it was being exported to the official said.

Roche eyes acquisitions in India

P B Jayakumar / Mumbai — 27-Dec-2009

What holds us back is the patent protection system in the country which needs improvement Agarwal points out.

Pharma PSUs: Caught between public interest and commercial goals

Gireesh Chandra Prasad — 28-Dec-2009

Secondly if the government has to break a patent held by a private company that refuses to sell a drug at an affordable price it should have a state entity to rely on for making a copy of the costly private sector brand.

Emerging Middle Class Nations

Sanjaya Baru / New Delhi — 28-Dec-2009

Goldman Sachs may want to patent its term BRIC for Brazil Russia India and China that lie at the core of the new middle.

Fairchild Infineon settle patent lawsuits

by Divya Sharma in Bangalore — 29-Dec-2009

Fairchild Semiconductor International Inc said it reached a patent settlement deal with Infineon Technologies and that it entered into a cross license deal with the company.

Spreadsheet

fe Bureau — 29-Dec-2009

This is because the patent law has limited the number of patented medicines which has reduced the scope of import of formulations.

CSIR set to recruit patent examiners

C.H. Unnikrishnan — 29-Dec-2009

The patent office had been so far relying on govt agencies for recruitment

Global mobile market turns into a legal battleground

New York Times — 29-Dec-2009

When Nokia the worlds largest maker of mobile phones sued Apple Samsung LG and eight other competitors within six weeks beginning in October it said it was conducting a routine defense of its intellectual property.

Lupin eyes acquisitions to gain market share

Radhieka Pandeya — 29-Dec-2009

We will get there through the organic and inorganic growth route and in licensing products especially patented products that have no presence in India said Chakraborty.

Music industry cheers royalty bonanza

Indo Asian News Service — 29-Dec-2009

The Rs.740 crore Rs.7.4 billion Indian music industry is cheering the cabinets decision to amend the Copyright Act of 1957 that will fetch royalty to composers singers lyricists et al.

Indian sweets drinks and clothes get copyrights

Siddharth Kumar/PTI / New Delhi — 29-Dec-2009

Places famous for their food drink or clothes like Tirupati Ladu Goa Feni and Banarsi Saree from much before the days of copyrights and trademarks won the exclusive right to use these names in 2009.

Depomed files second Para IV infringement suit against Lupin on Glumetza patent

Gireesh Babu, Mumbai — 30-Dec-2009

The US based Depomed Inc has filed one more Para IV patent infringement suit against the Mumbai based Lupin Pharmaceuticals and its US subsidiary alleging infringement of four patents on its anti diabetic pill Glumetza in the District Court of Maryland.

US Bill a challenge for Indian generic firms

Manas Chakravarty, Ravi Ananthanarayanan and Vatsala Kamat — 30-Dec-2009

Initially companies were fighting the patent challenge battles in court.

Nokia steps up smartphone patent battle

By Joseph Menn in San Francisco and Maija Palmer in,London — 30-Dec-2009

Nokia escalated its patent dispute with rival Apple over smartphone technology yesterday filing a complaint with the US International Trade Commission.

Industry flays IPR pact with WIPO

Gireesh Chandra Prasad, KG Narendranath — 30-Dec-2009

The governments plan to take the help of the World Intellectual Property Organisation a UN arm to put into action an intellectual property rights strategy has met with strong disapproval from a section of the local pharma industry which suspects the arrangement would benefit only multinational patent holders.

Drugmaker has unique model to compete with rivals

By John O\'Doherty — 30-Dec-2009

But Jordan based Hikma has managed to create a business from selling both generic medicines and drugs that are still under patent to other pharma groups.

South Korean trade pact with India going into effect

IANS — 30-Dec-2009

The agreement which is similar to a free trade agreement and covers trade in goods and services and investments along with chapters on competition and intellectual property rights also includes phased eliminations of other tariffs most notably in the car industry.

Nokias latest patent strike on Apple a risk but may pay off

Brett Young — 30-Dec-2009

Nokias latest patent strike against Apple underscores the changing dynamics of the cell phone market with the sector leader no longer holding the whip hand over rivals in terms of product development.

Geographical Indication move to boost Ceylon Tea

By Nizla Naizer — 30-Dec-2009

The tea industry in Sri Lanka is moving one step closer to protecting the value of Ceylon Tea by deciding to obtain a Geographical Indication for the commodity from the World Trade Organisation.

No copyright music without licence this year

Amit Sharma — 30-Dec-2009

Pubs and discotheques will have to dance to the tune of the music industry to go ahead with their high voltage New Year parties thanks to a Bombay High Court order on Wednesday that barred hotels and other commercial establishments in the city from playing copyright music without licence.

Reliance Life ups stake in GeneMedix to 79%

Sreejiraj Eluvangal — 31-Dec-2009

GeneMedix is primarily into making biosimilars biopharmaceutical drugs that have emerged out of their patent period and was acquired by Mukesh Ambani in 2007 with an eye to on two of its products EPO and GCSF.

Top grosser 3 Idiots to fund real life inventors

Samar Halarnkar — 31-Dec-2009

Its generated 220 patent applications in India and one in the US.

Google plays games after patent application

Martin Waller: City Diary — 31-Dec-2009

Is YouTube the worlds biggest online video portal also planning on setting up some sort of gaming service?

India EU free trade talks enter key phase

Asit Ranjan Mishra — 31-Dec-2009

Small groups have already met on sanitary and phyto sanitary measures investment and intellectual property rights he said.

U.S. panel to probe Richtek patent charges

by Diane Bartz — 31-Dec-2009

A U.S. trade court has agreed to investigate Richtek Technology Corps charges that Advanced Micro Devices and other companies violated its patents for power supply regulating devices.

Innovation culture still absent

P.T. JYOTHI DATTA — 31-Dec-2009

Protecting intellectual property can be an incentive to spur innovative work which helps drive research in areas where few others tread.

Paris Hilton sued by shoe company

ANI — 31-Dec-2009

According to documents filed last week New York based firm Gwyneth Shoes are suing Hilton for trademark and patent infringement.

A new prescription

Radhieka Pandeya — 01-Jan-2010

In what is referred to as the patent cliff starting in 2010 and running up to 2012 innovator pharmaceutical companies are set to lose billions of dollars from patent expiries of some of their hottest drugs.

News on Royalty payment brings cheer in new year

Kumkum Sen / New Delhi — 2-Jan-2010

The Patent Act 1970 was conducive to methods such as reverse engineering and incremental adaptation leading to inefficient and unrealistic self reliance.

Pharma cos see opportunity in India

P.T. Jyothi Datta — 2-Jan-2010

This year marks five years since the Patent Law was amended to respect product patents.

Patent regime set for fresh changes

Joe C Mathew / New Delhi — 03-Jan-2010

Quality of applications to improve as most old applications have been cleared.

A prescription for soul

Jumana Shah & Himansh Dhomse — 03-Jan-2010

Now I have a vision that India and particularly Cadila should work on new molecules and patent them.

Puneri Pagdi obtains geographical indication status

By Shivaji (ANI) — 03-Jan-2010

Shree Puneri Pagdi Sangha recently managed to obtain geographical indication status for the famed Puneri Pagadi the traditional headgear of Maharashtrians and thus ensure its conservation.

Copyrights mired in grey

Alisha Coelho — 03-Jan-2010

3 Idiots controversy has opened the intellectual property rights can of worms. Lifting plots or tunes is punishable... but its still only on paper say lawyers

Indian drug makers maintain pace of US marketing approvals

P B Jayakumar / Mumbai — 4-Jan-2010

Twenty five Indian generic drug makers got a little over 200 approvals from the US Food and Drug Administration in 2009 half a dozen more than the number approved in 2008.

Web portal owner held for uploading Jaggubai

Express News Service — 4-Jan-2010

The CCC deleted the film from all from the websites and arrested the owner of www.cine-entertainment.com Shankerganesh in Coimbatore on Saturday and booked him under the Indian Information Technology Act and the Indian Copyright Act.

Ranbaxy launches dermatological product Lulifin

BS Reporter / Mumbai — 04-Jan-2010

It is well recognised that in the post patent era licensing would be the key strategy to bring new chemical entities to India.

Indias Cipla in drug supply talks with GSK Teva

By Farah Master — 04-Jan-2010

But Hamied said that WTO regulations which since 2005 have prevented Indian generic drug firms from copying patented drugs mean Indian generic companies have to change their business model or risk being swallowed up by multinational firms.

Rich & poor countries now dont agree on biodiversity

ET Bureau — 5-Jan-2010

Some 2000 patents related to the Indian system of medicine are granted every year by the US Trade and Patents Office European Patents Office and other overseas patent offices.

Marico acquires Malaysian hair care brand Code 10 from Colgate

ET Bureau — 5-Jan-2010

The acquisition by Maricos Malaysian unit estimated to be about Rs 25 crore by analysts also gets intellectual property rights related to the brand from Colgate Palmolive.

CA rules in PALs favor in infringement case

Joel R. San Juan / Reporter — 05-Jan-2010

THE Court of Appeals has ordered the dismissal of the 18 year old infringement case filed against flag carrier Philippine Airlines by a textile manufacturer for the alleged illegal use of her patented shell designs on table linens and placemats in its commercial flights.

India documents traditional formulations yoga postures

STAFF WRITER — 5-Jan-2010

TKDL is an effort to protect our traditional knowledge mainly traditional medicine and yoga postures from misappropriation through patents granted abroad as had happened with the use of neem and haldi Environment Minister Jairam Ramesh told reporters.

Novartis to get leg up in India with Alcon buy

P B Jayakumar & Praveen Bose / Mumbai/ Bangalore — 5-Jan-2010

Will get access to large distribution network in eyecare segment.

Why piling eye drops high can make a lot of sense to Novartis

Dominic Walsh: Tempus — 5-Jan-2010

However a quick glance at the likely patent expiries among the leading pharmaceutical companies in 2010 explains why Novartis may pay top dollar for eye drops.

Free copyright control to help blind students: Xaviers Resource Centre

Mayura Janwalkar — 6-Jan-2010

An amendment in copyright laws is needed to bring about this awareness.

SC rejects Pernod Ricards plea in trademark violation case

Indu Bhan — 6-Jan-2010

In a set back to global alcoholic giant Pernod Ricard SA France the Supreme Court has rejected its claim of exclusivity over usage of the word Imperial thus allowing other liquor manufacturers to use it in their respective brands.

Dr Reddys poised to gain from new drug

Ravi Ananthanarayanan and Manas Chakravarty — 6-Jan-2010

The drug will lose patent protection in the US in 2011.

India for one binding deal on use of bio resources

Our Bureau — 6-Jan-2010

Bio piracy is going to be the new battle ground for the rich and poor countries.

Pfizer to source 40 off patent cancer care drugs from Strides

BS Reporter / Bangalore — 7-Jan-2010

Global pharma major Pfizer is to source source 40 off patent cancer care products from Bangalore based Strides Arcolab and sell the products in the United States.

We dont want MNCs to patent Indian traditional knowledge

Rediff — 07-Jan-2010

Multinational companies will now find it very difficult to patent products made by using Indian traditional knowledge of science.

Copyrights and wrongs

Latha Jishnu / New Delhi — 7-Jan-2010

The 3 Idiots spat is not really about violation of authors rights by filmmakers moral or otherwise.

Pharma industry urges govt to withdraw WHO study on data exclusivity

Ramesh Shankar, Mumbai — 7-Jan-2010

This the industry feels is an attempt on the part of the multinational companies to get monopoly by creating a new IP Right.

Wockhardt gets tentative nod from US FDA

Press Trust of India / New Delhi — 7-Jan-2010

The patent covering this product is under litigation in the US courts.

Stay awake drugs second act focus on battling jet lag

Andrew Pollack — 8-Jan-2010

For Cephalon a drug company in Frazer Pennsylvania with a reputation for aggressive business tactics the approval for jet lag is part of a plan to extend the patent protection for its core franchise in stay awake drugs.

Government creates patent watchdog

By Jonathan Moules — 08-Jan-2010

The government has created an intellectual property regulator to ensure that those using lawyers to set up patent and trade mark protection get a fair service and appropriate redress when things go wrong.

Robust growth in auto sales may fuel fake components market

Aveek Datta and Tarun Shukla — 8-Jan-2010

Pankaj Chadha director of automotive practice at Ernst and Young India says the spread of fake parts is the biggest disincentive for a multinational to step into India because it loses control over its intellectual property rights.

Challenges to domestic drug patents grow

Joe C Mathew / New Delhi — 8-Jan-2010

Domestic drug companies who have been challenging drug patents in the US and Europe are now taking the first steps to challenge patents granted in India to companies based there.

Pfizer Strides Arcolab enter pact to sell generic drugs in US

C.H. Unnikrishnan — 8-Jan-2010

The move would further bolster Pfizers stake in the generics market 40 off patent products expected to be delivered.

Microsoft appeals Word patent case once more

by Bill Rigby — 08-Jan-2010

Microsoft asks full panel of judges to review case.

AstraZeneca heads off Nexium threat with Teva deal

Ben Hirschler — 8-Jan-2010

Anglo Swedish drug maker AstraZeneca Plc settled a US patent row over Nexium with Israels Teva Pharmaceutical Industries Ltd on Thursday protecting its top selling heartburn drug from immediate generic competition.

Counterfeiting piracy leave deep holes in firms pockets

BS Reporter / Chennai/ Bangalore — 9-Jan-2010

The industry estimates that 20 per cent of the drugs available in the market today are spurious.

Creative rights v/s copyright

Subhash K Jha — 9-Jan-2010

Its about creative rights copyright the relationship between cinema and literature and between the world of words and visuals.

Roches cancer drug loses protection

Joe C Mathew / New Delhi — 9-Jan-2010

Likely test case with courts yet to rule on patent challenge from generic manufacturers.

Delhi HC rejects B Brauns plea

Khomba Singh — 9-Jan-2010

The German company was granted patent for manufacturing and marketing safety IV cannula in India in September 2007.

NRIs invited to invest in pharmaceutical sector

Our Bureau — 10-Jan-2010

Azad points to drugs worth $80 going off patent.

Rush begins to become patent agents

Joe C Mathew / New Delhi — 10-Jan-2010

There has been a sharp increase in the number of graduates who want to qualify as patent agents the intermediates between patent applicants and the patent office.

India: A nation develops

By Joe Leahy — 10-Jan-2010

During the same decade the number of patent applications soared to 500 a year by 2007 the study found.

NSE seeks trademark for currency derivatives label

Press Trust of India / New Delhi — 10-Jan-2010

The National Stock Exchange has applied before authorities for registration of trademark for its Currency Derivatives label.

Japan may open up to Indian generics

Amiti Sen & Khomba Singh — 11-Jan-2010

Japan has veered round to considering Indias demand to open up its over $100 billion pharmaceutical market to Indian generic or off patent drug producers after four years of dogged resistance a government official involved in the talks said.

Mahableshwar strawberry awaits its special status

Anuradha Mane, Gitesh Shelke — 11-Jan-2010

Nearly 1500 strawberry farmers from Mahabaleshwar and surrounding areas have applied for a geographical indication status for their strawberries.

Natco to launch cancer drug as min stays DCGI order

Khomba Singh — 11-Jan-2010

Natco has filed a pre grant opposition on Abraxis patent for its drug in India.

Trademarks and their licensing to preserve the distinctiveness of the brand

AZB and Partners — 11-Jan-2010

A major criterion for choosing a specific brand is the goodwill that the brand has

Novartis gets patent for cancer drug

PB Jayakumar / Mumbai — 11-Jan-2010

Swiss drug manufacturer Novartis AG has been granted patent protection in India for Nilotinib a superior version of blood cancer drug Gleevec.

Dr. Reddys AstraZeneca may settle patent case out of court

PTI — 11-Jan-2010

Dr Reddys Laboratories long standing patent dispute with Europes AstraZeneca over a drug to treat heartburn may be resolved out of court following a similar settlement between the European drug maker and Israels Teva feel market watchers.

Novartis gains on getting patent right

BS Reporter / Mumbai — 11-Jan-2010

Novartis finally ended with a Rs 21 or 3.6% gain at Rs 590.

Biodiversity Forum expresses concern over biopiracy

Roy Mathew — 11-Jan-2010

According to an official release of the Union Ministry for Environment and Forests about 2000 patents related to the Indian Systems of Medicine are granted every year in the U.S. Patent and Trademark Office the European Patent Office and other overseas patent offices.

Patent expiries set to knock drug group profits

By Andrew Jack in London — 11-Jan-2010

Patent expiries in the coming years on some of the worlds top selling medicines will have an unexpectedly large impact on profits because of margins which can reach nearly 90 per cent a US investment analyst has warned.

Spurious drugmakers harm countrys image says Azad

Staff Reporter — 11-Jan-2010

In the event of drugs worth $80 billion going off patent Mr. Azad urged industry heads to seize the day and harness the fullest benefit from this opportunity to the advantage of the Indian economy.

Pharma looks up to fresh opportunities in generics market

Venkata Ramana — 12-Jan-2010

Several drugs going off patent some markets such as Japan trying to encourage generics penetration and the agreements the global pharma companies are forging with the Indian pharmaceutical companies are expected to add strength to the Indian generic pharma story a chief operating officer of a pharma company said on condition of anonymity.

Infosys awaits nod for 219 patent applications in India US

Press Trust of India / New Delhi — 12-Jan-2010

IT behemoth Infosys Technologies which today came out with its third quarter earnings is awaiting approval for 219 patent applications in India and the US.

Ministers in retreat over copyright law

By Jean Eaglesham, Chief Political Correspondent — 13-Jan-2010

Ministers last night retreated from a proposed sweeping power to change copyright law amid increased political wrangling over digital piracy and internet regulation.

Patent office begins data compilation on working patents in India

Ramesh Shankar, Mumbai — 13-Jan-2010

For the first time in the history of patents in the country the government has started the gargantuan process of compilation of data regarding the status of the valid patents granted during the last over 20 years in the country.

Pharmas Govt join for $80 bn off patent market

Sanchita Sharma — 13-Jan-2010

Pfizers Viagra will be among 61 drugs worth over US $ 80 billion that will go off patent at the US Patent and Trademark Office between 2011 and 2013 and the Indian pharmaceutical industry is gearing to make the most of it.

Suven Life gets two patents

Our bureau — 13-Jan-2010

Suven Life Sciences Ltd has been granted two product patents for its New Chemical Entities in China and Russia.

Drug patent settlements to come under EU scanner

Pallavi Aiyar / Brussels — 13-Jan-2010

Patent settlements between pharmaceutical companies that make original drugs and their generic manufacturing rivals are to come under renewed scrutiny from the European Unions competition regulation authority as part of an ongoing probe into the sector.

IBM May Not Be the Patent King After All

By Steve LeVine — 13-Jan-2010

No one beats IBM on patents.

A generic giant juggernaut called Teva Pharma

Pillman — 14-Jan-2010

Within the biosimilars sphere Teva has said $115 billion worth of products will go off patent by 2015.

Copenhagen to Nagoya

Business Standard / New Delhi — 13-Jan-2010

India being one of the worlds most biodiversity rich countries has been a victim of bio piracy despite the existence of the CBD and agreement on trade related intellectual property rights.

Wockhardt gets US FDA tentative nod for Levofloxacin tablets

PTI — 13-Jan-2010

The Mumbai based pharmaceutical firm will launch the product immediately upon expiration of the patent on June 20 2011 it said.

Dr Reddys Nexium plan faces hurdle

KV Ramana — 14-Jan-2010

Dr Reddys Laboratories plans to get a pie of the $4 billion market of generic Nexium are likely to be cut short by the patent holder of the drug AstraZeneca.

Bharti Walmart flagship brand faces opposition

Rasul Bailay — 14-Jan-2010

The management will fight to protect intellectual property of its Great Value label applications filed in 08.

Drug cos patent settlements to cost Americans $3.5 bn annually

PTI — 14-Jan-2010

Under such deals innovator companies have entered into agreements with the generic firms to delay the launch of generic version of patented drugs.

Pharma tops in patent suits

Joe C Mathew / New Delhi — 16-Jan-2010

Pharmaceutical patents are just over a fourth of all patents granted in the country but domestic drug makers account for almost all post grant patent opposition filed official data reveals.

Intellectual bottlenecks

AMIT SHOVON RAY, SABYASACHI SAHA — 16-Jan-2010

Indias strive towards self reliance shaped its post independence policy agenda in all spheres.

McSuppiahs Uttapam

Saritha Rai — 17-Jan-2010

McDonalds sued him for trademark violation.

For a new approach to China

Nick Schulz — 18-Jan-2010

Life for innovation intensive businesses is difficult in countries where there is scant respect for liberty

Indian cos grab 32% of total ANDAs approved by US FDA in 2009

Sanjay Pingle, Mumbai — 18-Jan-2010

Research based Indian pharmaceutical companies and their subsidiaries are increasingly cornering a large percentage of approvals for ANDAs from the US FDA during the last three years as per a compilation did by Pharmabiz.

Torrent has reach product mix edge

Nitin Shrivastava — 18-Jan-2010

Torrentd revenues would be driven by steady growth in its domestic formulation segment increasing presence in developing markets and huge opportunities on account of newer product introduction and expiry of patents on large number of products in developed markets.

Could copyright be wrong?

V. Raghunathan — 18-Jan-2010

Much media attention has gone into how much Vidhu Vinod Chopras movie 3 Idiots has borrowed from Chetan Bhagats novel Five Point Someone.

Pharma sector looks at inventory correction gradual restocking

Reghu Balakrishnan — 19-Jan-2010

Aventis Pharma Ltd will be one of the key beneficiaries of the patent regime as the parent company has a strong R&D pipeline.

Fake mineral water plant unearthed in Lodhika

Express News Service — 19-Jan-2010

In a joint operation officers of the local police and Enforcers of Intellectual Property Rights unearthed a duplicate manufacturing plant of a standard mineral water company at Lodhika in Rajkot district on Monday.

Nokia victory in IPCom patent suit

By Andrew Ward in Stockholm and Jane Croft in London — 19-Jan-2010

Nokia the worlds largest maker of mobile phones yesterday won an important court victory in a longrunning patent dispute with German based IPCom as it braced itself for fresh legal conflict with Apple of the US.

Pharma tops in patent suits

Joe C Mathew in New Delhi — 19-Jan-2010

Pharmaceutical patents are just over a fourth of all patents granted in the country but domestic drug makers account for almost all post grant patent opposition filed official data reveals.

Lupin cant sell pill in US Teva files patent suit

Khomba Singh & Vishal Dutta — 20-Jan-2010

Israeli drugmaker Teva Pharma has filed a patent infringement suit in the US against Lupin that prevents the Indian pharma company from selling the generic or copycat version of Tevas birth control drug LoSeasonique for 30 months in a key market.

Ranbaxy to buy biotech firm Biovel Lifesciences

Press Trust of India — 20-Jan-2010

Ranbaxy Laboratories on Tuesday said it would acquire Bangalore based Biovel Lifesciences for an undisclosed amount.

4 brokerages predict strong growth for top drug makers

C.H. Unnikrishnan and Radhieka Pandeya — 20-Jan-2010

The Rs90000 crore drug industry sells more than one third of its production in the international market

With 219 patents pending Infosys awaits a non linear push

Amit Tripathi — 20-Jan-2010

Infosys Technologies which surprised analysts with a 6.1% volume growth for the quarter ended December is betting on its 219 pending patent applications in India and the US for a sustained non linear growth.

US to curb delay in entry of generic drugs

Joe C Mathew & P B Jayakumar / New Delhi/mumbai — 20-Jan-2010

Indian pharmaceutical companies which are increasingly choosing to settle patent litigation with global drug majors in the US would have to be more cautious now.

Flexible pricing pays off for drugs groups

By Andrew Jack in London — 22-Jan-2010

GSK which also has a significant presence in China remained in India when many of its foreign peers cut back during the nationalisations and weakening of patent rules in the 1970s.

Perils of the US model

Latha Jishnu / New Delhi — 21-Jan-2010

Copying the Bayh Dole legislation to promote the culture of innovation in India can be counterproductive

India issues demarche to China on trade barriers

Dhiraj Nayyar — 21-Jan-2010

The demarche also demands the removal of local content requirement and recognition of the international IPR registration regime in order to create a favourable investment environment in wind non conventional energy.

The curious case of patent agents

FEROZ ALI — 21-Jan-2010

Patent Agents are hybrid professionals whose area of practice is at the intersection of law and science.

Scientists fume over new patent bill

Rema Nagarajan — 22-Jan-2010

Thousands of scientists working in government supported research institutes and labs in India are seething over a proposed law which makes it mandatory to patent all new innovations generated by public funded research.

Domestic pharma cos fare well in patent litigation tests

Soma Das — 22-Jan-2010

In the legal mesh of pharma patent litigations in the largest drug market the US Lupin Pharma Sun Pharma Ranbaxy Labs Ltd and Dr Reddys Ltd top the list of domestic pharma companies which have best battled the court cases in the last decade.

Immigrants in US see better prospects back home

Vivek Wadhwa — 23-Jan-2010

My research teams at Duke University calculated that foreign nationals were named as inventors or co inventors in one quarter of WIPO patent applications filed from the US in 2006.

Anand Sharma pins hopes on concluding Doha Round

ET Bureau — 23-Jan-2010

CIIs two day 16th partnership summit began in Chennai on Saturday under the theme global partnerships:

Lawsuit against Salman in HC seeks stay on screening of Veer

PTI — 23-Jan-2010

Choudary has sought damages of Rs20 lakh from the producer and the director of the film for alleged violation of his copyright for making illegal gains by lifting a portion from his book Trilogy of Wisdom.

Google wins domain name dispute against Indian cybersquatter

PTI — 24-Jan-2010

Internet search engine Google has won a domain name dispute against an Indian cybersquatter at the World Intellectual Property Organisation.

Student innovations have no takers in India

TNN — 25-Jan-2010

Around six lakh students graduate from technical institutes every year in our country and none of their innovative project works is considered worthy of a patent.

Still in the trial phase

Ram Prasad Sahu / Mumbai — 25-Jan-2010

The company wants to set up an unit at the SEZ get the clearances from European and US federal authorities and market off patent drugs in those geographies.

We need to step up research in IPR regime

VR Kaundinya — 25-Jan-2010

The use of technology is helping breeders around the world to maximise the potential for crops to become a source of renewable energy food and feed while minimising the environmental impact.

DIPP in mysterious pact on patents with Wipo

Latha Jishnu / New Delhi — 25-Jan-2010

Agreement mentions Indias IP strategy and action plan but govt declines to reveal what these contain.

Traditional knowledge: Concern on access pact

Vinson Kurian — 25-Jan-2010

The access agreement that India has signed with foreign patent offices to share Traditional Knowledge Digital Library in the form of a prior art could undermine its confidentiality.

Bajaj Auto gets European patent for ExhausTEC

Corporate — 25-Jan-2010

Leading auto maker Bajaj Auto on Monday said its technology ExhausTEC which help improve performance of a two wheeler has been granted a patent by the Munich headquartered European Patent Office.

New vaccine may help cure multiple diseases

Sohini Das & Maulik Pathak / Ahmedabad — 27-Jan-2010

A brainchild of Pawan Saharan chairman of Mumbai based Biomix Network the active pharmaceutical ingredient is patented in India as Radha 108.

Virgin Atlantic files case in UK against Jet

P.R. Sanjai — 27-Jan-2010

Virgin founded by Richard Branson holds the patent and design rights for the flatbed seating system in several countries including in the UK

Claris talking to 3 more pharma majors for Pfizer type deal

P B Jayakumar / Mumbai — 27-Jan-2010

Claris and Pfizer had entered into a deal in May last year for supply of sterile injectable drugs that are off patent and have lost exclusivity in the US Canada Australia New Zealand and Europe.

The problem with patents

Shamnad Basheer — 27-Jan-2010

The 2008 Protection and Utilization of Public Funded Intellectual Property Bill popularly called the Indian Bayh Dole Bill since it draws inspiration from the US Bayh Dole Act of 1980 is currently undergoing scrutiny by a parliamentary select committee.

Cipla asks UNITAID to address all related issues to make patent pool workable & realistic

Ramesh Shankar, Mumbai — 27-Jan-2010

Indian pharma major Cipla has expressed apprehensions on achieving the goal of the UNITAIDs patent pool initiative which was recently created for HIV AIDS drugs unless and until the terms and reference objectives and all issues of patent pool are spelt out clearly.

Drug patent regime has led to high prices: US Study

Joe C Mathew / New Delhi — 27-Jan-2010

Other reasons include transfer of marketing rights to larger companies and mergers and acquisitions among drug companies.

Microsoft joins network designed to counter patent trolls

By John Letzing — 27-Jan-2010

Microsoft Corp. a technology giant that wins thousands of patents every year has joined RPX Corp. a start up network aimed at aggregating intellectual property to shield its members from what are known as patent trolls.

Merck loses temozolomide patent infringement suit against Teva in US court

Whitehouse Station, New Jersey — 28-Jan-2010

Merck & Co Inc announced that the US District Court for the District of Delaware ruled against the company in a patent infringement suit against Teva Pharmaceuticals USA Inc.

India asks Kenya to change law making generics illegal

Amiti Sen & Khomba Singh — 28-Jan-2010

The Kenyan legislation lays down that all generics will be treated as counterfeits and rejected in case a patent holder in a third country files a dispute.

Pharma research: Pool of skills and low costs fosters growth

By Amy Kazmin in Bangalore — 28-Jan-2010

Indias pharmaceutical industry cut its teeth in the 1970s fostered by local patent laws that only protected the unique processes of synthesising a drug molecule rather than the molecules themselves.

HC to hear pharma patent issue on Monday

Indu Bhan — 29-Jan-2010

The Delhi High Court will hear on Monday a batch of petitions filed by global pharma majors seeking quashing of the patent offices decision that rejected their applications for grant of patents for their respective drugs.

Farmers chip in against Bt Brinjal

Swati Mathur — 30-Jan-2010

Even as scientists and farmers cry foul over the ill effects of genetically modified crops an equally large community of scientists and patent holders are making a strong case in favour of Bt brinjal.

A journey without maps

Pratik Kanjilal — 30-Jan-2010

Any cultural nationalist can tell you that like all good things multiculturalism originated in India and we have a patent on it.

Strong patent law may lead to rise in costs

Express News Service — 30-Jan-2010

A strong patent law may lead to increase in the costs of essential supplies including the inputs for improved agricultural and industrial production thereby raising the cost of living of the poor and the marganilised said N R Madhava Menon member of the Commission on Centre State Relations.

Indian authors publishers take Google to court on book deal

Our Bureau — 30-Jan-2010

Claim violation of copyright laws.

Frivolous patents make drugs costly

TNN — 30-Jan-2010

Many pharma companies are making huge money just by making minor changes over existing technologies or drugs a patent expert said

Eco labelling norms for ornamental fish formulated

fe Bureaus — 1-Feb-2010

The task force also looked in to the geographical indications of each species and requirements needed for import of exotic species.

Drugs companies face deeper cuts in research

Carl Mortished, World Business Editor — 1-Feb-2010

The extent to which the recession has cut into high value research and development jobs in the pharmaceutical industry will be laid bare this week as job losses in the industry climb to 12000.

Apeda initiates registration process of basmati under GI

Sandip Das — 1-Feb-2010

After much delay the process of registration of basmati rice famaous across the globe for aroma and long grain under the geographical indications certification has started in the country.

Secretly India talked free trade agreement with EU again

Priyanka Golikeri — 1-Feb-2010

There is absolutely no word on how Indias concerns on intellectual property tariffs on agriculture second hand goods etc would get addressed said a source closely associated with the government.

Boston Scientific reaches $1.73 bn patent settlement with J&J

Press Trust of India / New York — 01-Feb-2010

US medical devices maker Boston Scientific Corp today said it will pay $1.73 billion to settle three patent disputes with healthcare firm Johnson & Johnson.

FE Editorial: Google booked

The Financial Express — 1-Feb-2010

After all intellectual property issues didnt really gain global traction till the last part of the twentieth century at which point they exploded all across a host of commerce verticals ranging from pharmaceutical to artistic works.

Sun gets a boost as FDA rejects rival Osmoticas plea

ET Bureau — 1-Feb-2010

As Sun and Osmoticas drugs are in the form of tablets and therefore not replicas of Wyeths drug capsulesthese companies do not have to wait for the Pfizer group companys patent to expire later this year.

Court relief for city firm in copyright case

Kartikeya — 01-Feb-2010

In a significant judicial order aimed at protecting intellectual property rights of internet driven and telephonic services the Delhi high court has restrained a website from using a directory of telephone numbers originally compiled by a Mumbai based dial up firm.

Informatica reports record quarterly revenues of $151 mn and 25 pct license revenue growth

Businesswire India — 2-Feb-2010

This compares to $39.5 million in income from operations in the fourth quarter of 2008 which included the one time benefit of $11.5 million from patent related litigation proceeds net of patent contingency accruals.

Delhi HC stays patent revocation of Abbotts drug

Joe C Mathew / New Delhi — 3-Feb-2010

The Delhi High Court has stayed a decision to revoke the patent granted to Abbott Laboratories blockbuster rheumatoid arthritis drug Humira adalimumab.

Governments move to relax Copyright Act lacks vision

Manish Ranjan — 3-Feb-2010

People with visual handicaps can read printed material only when it is converted into older formats such as Braille or newer and more flexible audio and electronic formats

Cautionary tale of trolls

Latha Jishnu / New Delhi — 4-Feb-2010

Patent trolls and not patent holders are raking in money from lawsuits and firms are desperately seeking a way out

Wed restrict filings to those of high quality

Jacob P. Koshy — 4-Feb-2010

The chief patent counsel for Microsoft Corp. Bart Eppenauer spoke in an interview about his companys growing engagement with Indian patent offices and law firms to strengthen its intellectual property portfolio in the country

BlackBerry wins patent battle with Motorola in Britain

IANS — 04-Feb-2010

BlackBerry maker Research In Motion Wednesday won its patent battle in Britain with Motorola when a court in London ruled in favour of the Canadian wireless giant based at Waterloo near here.

Kiris market pie gets bigger but debt weighs

Ramkrishna Kashelkar — 5-Feb-2010

The buyout entailed purchase of 17 manufacturing facilities out of Dystars 19 along with all brands patents and intellectual property rights.

India reluctant to relent on greater market access to EU

Asit Ranjan Mishra — 5-Feb-2010

Leena Menghaney campaign coordinator for access to essential medicines Medecins Sans Frontieres raised concerns about the EUs insistence on stringent TRIPS plus trade related aspects of intellectual property rights measures.

IPL: SET Max & organisers to check ambush marketing

Monica Behura — 5-Feb-2010

Six IPL franchisee teams have also protected their Intellectual Property Rights and Trademark rights in India and eight other cricket playing nations for their merchandise and logos.

Swedens generic drive to help Indian pharma cos

Soma Das — 5-Feb-2010

If buyers choose to pay the difference between the cheapest available option and the brand prescribed in case of an off patent drug they could buy the latter.

Foreign drug makers may lose monopoly

C.H. Unnikrishnan — 5-Feb-2010

Patent office can revoke monopoly rights if firms cannot prove obligations were met within their 3 year window

China tops India comes in third in IPR violations

T.E. Raja Simhan — 5-Feb-2010

For the US China remains the top trading partner for IPR violations followed by Hong Kong in the second place and India third during 2009 according to the US Customs and Border Protection and the Immigration and Customs Enforcement.

Zari industry set to regain lost lustre

Melvyn Thomas — 05-Feb-2010

The industry is likely to be registered under the Geographical Indication Act of Government of India which stipulates protection of the market of the producers and safeguards the interests of the consumers of the unique product by mid 2010.

Fears regarding amendments to Copyright Act will diminish

ET Bureau — 6-Feb-2010

HRD Minister Kapil Sibal in an interview with ET says talks at length about the proposed amendments to Copyright Act.

Jaggi Vasudev hits out at Bt brinjal

Express News Service — 8-Feb-2010

Pointing out that the Western multinational companies hold patent for these GM foods he said, when the farmers in the country tend to use these genetically engineered seeds the royalties for it would go to the European countries.

Scientists want changes in innovation Bill

Anika Gupta — 8-Feb-2010

The scientists presented complaints regarding the proposed Protection and Utilization of Public Funded Intellectual Property Bill 2008.

Indian SMEs keep pharma prices under check: Study

Joe C Mathew / New Delhi — 8-Feb-2010

A global study by Health Action International a non government body on the price variations of Ciproflaxin a commonly used medicine in 93 countries found the price charged by Bayer the originator of the drug to be the lowest in India.

Google book project US stance firm but not enough for Indian writers

Lison Joseph — 8-Feb-2010

In its Friday submission the department told the court the US government believes that the court lacks authority to approve a proposed settlement agreement as it involved the rights of many foreign copyright owners too.

Troikaa drug to get US patent

Press Trust of India — 8-Feb-2010

Troikaa Pharmaceuticals a Gujarat based fast growing healthcare company is likely to get US patent for its novel drug delivery form of Diclofenac injections Dyanapar AQ.

Lupin goes all out to make up for lost chances

Satish John & — 8-Feb-2010

An ANDA filing is an application with the US Food and Drug Administration for permission to introduce a generic version of an already patented drug in the market.

CRISIL assigns IPO grade 4/5 to Glenmark Generics

ET Bureau — 09-Feb-2010

According to estimates by CRISIL Research drugs worth an estimated $137 billion is scheduled to go off patent in the US and Europe over the next five years which implies significant generics opportunity for India.

Purdue Pharma sues Lupin following Para IV filing on controlled release painkiller drug

Our Bureau, Mumbai — 9-Feb-2010

The US based Purdue Pharma Products LP and its UK based partner Napp Pharmaceutical Group Ltd has filed a para IV patent infringement suit against the Mumbai based Lupin Ltd and its US subsidiary for the latters move to manufacture and market the generic version of the narcotic painkiller drug Ultram ER.

Dispute on patent adds to Toyotas problems

By Bernard Simon in Toronto — 09-Feb-2010

As if Toyota did not have enough on its plate with a series of damaging recalls the Japanese carmaker is embroiled in a long running patent infringement dispute in the US involving a key part of the technology that drives its hybrid petrol electric vehicles.

China fifth in UN patent filings India way behind

D Ravi Kanth / Geneva — 9-Feb-2010

China is on its way to become a global leader in scientific research while India has a long way to go according to data issued by a Geneva based organisation on international patent filings.

Sambalpuri Bastralaya moves for patenting

Express News Service — 9-Feb-2010

Sambalpuri Bastralaya Handloom Co operative Society Limited has filed a patent application on textile weaving technology and design application on wall hanging made by it using the new technology.

Court throws out pharma cos patent claim

Manish Ranjan — 9-Feb-2010

The patents authority had rejected the claim saying The claimed invention covered by the subject application lacks inventive steps

Approach patents body first: HC to pharma firms

BS Reporter / New Delhi — 9-Feb-2010

Delhi High Court dismisses six petitions of drug majors.

UK court overturns GSK patent for lupus drug

By Andrew Jack in London — 09-Feb-2010

The UK courts on Tuesday overturned a patent on belimumab a treatment for the auto immune disease lupus under joint development by GlaxoSmithKline and Human Genome Sciences.

Everyones connected

Manju Menon and Kanchi Kohli Manju Menon and Kanchi Kohli — 09-Feb-2010

In one of the meetings in 2007 126 approvals for Intellectual Property Rights from the Council for Scientific and Industrial Research were approved.

HC rejects petition of UCB Franchim

STAFF WRITER — 10-Feb-2010

The Delhi High Court has rejected the petition of global biopharma major UCB Farchim against the Indian drugmaker Cipla and the countrys patent authority over rejection of its patent of a new anti allergic drug and directed it to approach sectoral tribunal IPAB.

Danone begins marketing flavoured milk

Ratna Bhushan — 10-Feb-2010

The Wadia Group had sued Groupe Danone in a Singapore court claiming violation of its intellectual property rights of the Tiger brand.

Parliament panel wants govt review on Innovation Bill

C.H. Unnikrishnan — 10-Feb-2010

Critics say there is a disconnect between its objectives and the efficacy of a Bayh Dole structure

US pharma cos sue Lupin for patent infringement

fe Bureau — 10-Feb-2010

US based Purdue Pharma Products LP and UK based Napp Pharmaceutical Group have sued Lupin Ltd and its US subsidiary Lupin Pharma Inc claiming that their attempt to manufacture and market the generic version of the analgesic tramadol ER infringes patent coverage of the innovator.

HC rejects Bayers patent plea on cancer drug

BS Reporter / New Delhi — 10-Feb-2010

A bench of the High Court here today dismissed an appeal by Bayer the German pharmaceutical company on an earlier decision to allow marketing of generic versions of its patented drug.

Book famine

Atty. Adrian S. Cristobal Jr. — 11-Feb-2010

In one of the committee hearings concerning amendments to the copyright laws at the House of Representatives there was a contingent of blind people led by an advocate who participated in the discussions on House Bill 4217 sponsored by Rep. Irwin Tieng.

Every generic drug is not spurious says court

P.T. Jyothi Datta — 11-Feb-2010

Observations made in Bayer patent link case.

Glaxo Voltas in brand war

Joe C Mathew / New Delhi — 11-Feb-2010

Volmax vs Voltas dispute back with Intellectual Property Board

Indian pharma cos to grow 12% will witness more deals

fe Bureaus — 12-Feb-2010

The pharmaceutical industry globally is facing a period of significant drug patent expiries which expands the addressable market for generics companies.

Renault likely to take charge of Logan revival

Murali Gopalan — 12-Feb-2010

Sources say that the most likely solution will result in M&M divesting its 51 per cent stake in favour of Renault which by the end of the day holds the intellectual property rights for the Logan.

Drug Makers Decry Indian Patent Law

GEETA ANAND — 12-Feb-2010

Multinational drug companies have pushed big time into India in recent years after the country agreed to respect intellectual property rights for pharmaceutical products.

Market flooded with Smartphone look-alikes

Writankar Mukherjee & Debjoy Sengupta — 13-Feb-2010

While it is a conscious business decision to launch models which are look alike of bigger brands we do make certain design modifications to ensure that there are no IPR or legal issues.

US patent for Avanir Pharmas low dose quinidine formulations of Zeniva

Aliso Viejo, California — 13-Feb-2010

Avanir Pharmaceuticals Inc announced that the United States Patent and Trademark Office has issued the company a new patent for its lead drug candidate Zenvia extending the period of patent protection in the United States into late 2025.

IPR policy resolves issues in knowledge sharing

Vinson Kurian — 13-Feb-2010

Proposes commons licence for traditional knowledge.

Indian pharma in midst of corporate transformation

P B Jayakumar / Mumbai — 13-Feb-2010

Industry sources also said Ahmedabad based Cadila Pharmaceuticals is also planning to appoint a CEO with strong background in biological drug development as the company is planning to develop a large portfolio of copycat off patent biologic drugs.

Indian cotton products may soon carry US trademark seal

Amit Mitra — 13-Feb-2010

Indian consumers of cotton apparel and home furnishings may soon have an additional point of interest to pick up their favourite products from retail stores.

Drug trials begin for cancer Alzheimers

IANS — 14-Feb-2010

We re into research that can give us patents.

India EU FTA gets flak in Europe

Priyanka Golikeri — 15-Feb-2010

Intellectual property in trade agreements could endanger the poor mans access to affordable medicines according to a veteran member of the European Parliament.

Indian drug makers worried by East Africas legal proposals

C.H. Unnikrishnan — 16-Feb-2010

Countries such as Uganda and Tanzania are taking their cue from a Kenyan law against fakes

Biotech industry pushes for fiscal sops, duty exemption

K Ramnath Shenoy/PTI / Bangalore — 16-Feb-2010

This is short sighted in view of the fact that international patent filings are key to the biotech sector she said.

While Bayer pushes patent EU parliamentary group opposes

Priyanka Golikeri — 16-Feb-2010

While German firm Bayer has adopted a try till you succeed stance on pursuing patent linkage in India on the other hand a European parliamentary group is planning to call on the EU and European Commission the executive arm of the EU to not push for provisions such as patent linkage in developing countries.

GSK to increase headcount introduce more products

P.T. Jyothi Datta — 16-Feb-2010

Two of the drugs are patented and the medicines will be priced differently in the local market he said adding that the price had not yet been decided.

Northern SMEs gear up to file for patents

Komal Amit Gera / Chandigarh — 16-Feb-2010

Taking inspiration from their bigger brothers small and medium units in the northern region are gearing up to seek patents for their products in the international market.

Delhi HC dismisses B Brauns appeal for interim injunction against Poly Medicure

Gireesh Babu, Mumbai — 17-Feb-2010

A division bench of the High Court of Delhi has dismissed an appeal filed by the Germany based B Braun Melsungen AG and its Indian subsidiary against the New Delhi based Poly Medicure Ltd seeking an interim injunction restraining the latter from manufacturing and selling a needle guard product for which the company claims to have an Indian patent.

Drug induced speculation in India

By HARSH JOSHI — 17-Feb-2010

For blockbuster drugs like Lipitor and Plavix the patent expiration schedule is even more front loaded.

70000 patent applications lying due to shortage of examiners

PTI — 17-Feb-2010

Over 70000 patent applications are in the pipeline for examination and may need at least 3 4 years for approval under the Intellectual Property Rights Act due to shortage of examiners a senior government official said.

Industry can handle todays problem but need us for tomorrows science

Joe C Mathew & Vandana Gombar — 18-Feb-2010

CSIR gets patents but doesnt sell these exclusively exclusivity reaches only the rich.

Patents weapon of biopirates of the West

Gokul Chandrasekar — 18-Feb-2010

Biodiversity is in the air: 2010 is being observed as its international year and an international biodiversity summit will be held in Nagoya in October.

Experts NGOs oppose CII GWU summit on IP for strong patent regime in India

Ramesh Shankar, Mumbai — 18-Feb-2010

Even as the Confederation of Indian Industry two day Summit on IP in association with the George Washington University has got underway in Mumbai several public interest groups and experts have raised eyebrows expressing apprehensions that the one sided focus of IP Summit is detrimental to Indian interests.

Berry enterprising

By Siddharth Gadkari — 18-Feb-2010

Not wanting to let farmers from other regions fool consumers into buying their strawberries by saying they are from Mahabaleshwar producers of the original fruit have applied for a patent

Patent offices need more staff

Special Correspondent — 18-Feb-2010

70000 patent applications in the pipeline for process: Controller General of Patents

Book building worries

Latha Jishnu / New Delhi — 18-Feb-2010

Googles project to digitise the worlds books raises complex issues of copyright fair use and fears of monopoly power.

Does India Want Drug Innovation or Not?

By RONALD A. CASS — 18-Feb-2010

A string of recent court decisions degrading patent rights suggests the answer is no.

Sun Pharmas cancer drug application gets EMA backing

PTI — 19-Feb-2010

The development comes at a time when Sun is up against a suit by Sanofi Aventis in the US alleging patent infringement and asking the US Food and Drug Administration not to grant approval to market it in America.

Biogen to bring its global drug portfolio to India

Khomba Singh — 19-Feb-2010

We have sought patents for these drugs in India and the country will be part of future global launches of all our drugs Ms Seth added.

Does Cong have a patent in visiting Dalit homes asks BJP

PTI — 20-Feb-2010

Taking strong exception to Congress remark that its chief Nitin Gadkari was aping Rahul Gandhi by visiting Dalit households BJP today asked if any particular party has a patent to do so.

GI marker of Tirupati laddus gets nod

Express News Service — 20-Feb-2010

The Geographical Indication Registry has not committed any illegality by registering Tirupati laddus as a geographical indication the Registry has submitted in its counter affidavit filed in the Madras High Court on Friday.

We should do R&D in India

Joe C Mathew / New Delhi — 21-Feb-2010

Medical technology is not like pharmaceuticals where a single chemical has been patented and no one can come out with that product.

Poly Medicure gets Germany nod for safety IV Cannula

fe Bureaus — 22-Feb-2010

In these preliminary injunctions the German court had found that the attacked products infringed the German part of the European Patent 1 911 486.

Protecting pharma patents

Ronald A. Cass / WSJ — 22-Feb-2010

Degrading patents has serious side effects.

Copyright ya wrong

M Suganth — 22-Feb-2010

Now that Aamir Khan is back on the HRD ministrys copyright panel which is debating the amendment to copyright laws it is time to step away from the brouhaha and focus on the matter at hand amending our archaic copyright laws governed by the Copyright Act 1957.

Indian exporters breathe easy as East African nations reject draft

C.H. Unnikrishnan — 23-Feb-2010

The new legislation in East Africa was mainly aimed at stopping affordable generic drugs from India

Indian FTAs may hit SE Asian ryots

Priyanka Golikeri — 23-Feb-2010

While India mulls another free trade agreement with Australia and New Zealand its FTAs with European Union and Japan remains shrouded in uncertainty with its decisions regarding intellectual property rights likely to impact not just India but other developing South East Asian countries as well.

Govt considers liberalizing merger and acquisition norms

Sangeeta Singh — 23-Feb-2010

Industry has also suggested that acquisition of dead or dormant companies of intangibles such as intellectual property rights and companies primarily into exports be exempt from CCI ratification.

Pharma sector wants govt to cut excise duty on bulk drugs to 4%

Rediff Business — 23-Feb-2010

At the same time they are also entering into generic business segment by tie up with low manufacturing countries as block buster drugs worth of USD 100 billion are expected to come out of patent in the next five years.

Host Analytics expands presence in India to support rapid product innovation

Businesswire India — 24-Feb-2010

Host Analytics Indian engineering team has made important contributions to the companys intellectual property and patent portfolio as well as its industry leading analyst recommended financial performance solutions.

Polymed gets to sell IV device in Germany

Khomba Singh — 24-Feb-2010

Indian law allow patent holders to have exclusive marketing rights for 20 years.

Infosys expects increase in patent filings

Kirtika Suneja / New Delhi — 24-Feb-2010

Infosys Technologies expects an increase in its patent filings on the back of new technologies like cloud computing analytics and emerging information and communication technologies.

Ambanis now fighting over trademarks

rasul.b — 24-Feb-2010

Rival Reliance groups that had turned a blind eye to conflicting names in the past spar over Finance and Financial

Patent office to recruit 257 new examiners to clear huge backlog of applications

Suja Nair-Shirodkar, Mumbai — 25-Feb-2010

Faced with a huge backlog of more than 70000 patent applications that are in the pipeline for process and examination in the country the government has decided to recruit another 257 patent examiners to expedite the process of patent scrutiny and its disposal.

More delay in supplies to AstraZeneca may hit Ranbaxy revenue

Radhieka Pandeya — 25-Feb-2010

The accord between the two companies follows from a manufacturing agreement that was part of a bigger patent infringement settlement between Ranbaxy and AstraZeneca in April 2008.

Bayer drags Cipla to SC over anti cancer drug patent

Indu Bhan — 25-Feb-2010

German drug major Bayer AG on Wednesday approached the Supreme Court seeking protection for its drug Nexavar even as Ciplas plea for marketing approval for Sorafenib the generic version of its kidney cancer drug is pending with the regulatory authorities.

Big Pharma starts believing in outside innovation

Pillman — 25-Feb-2010

One business development executive felt that the approvals from the FDA are coming at a faster speed now and so there could be big drugs in the offing but another remained skeptical saying that newer approaches to research like patent pools and collaborative work may fetch better dividends.

Customs duty move to help media gaming firms in India

by Shilpa Jamkhandikar and Bharghavi Nagaraju — 26-Feb-2010

The governments move to simplify the customs duty on imported films will help the entertainment industry cut costs but imposing service tax on intellectual property rights could be a dampener officials said.

Desi Viagra likely to roll out of Kerala institute

IANS — 26-Feb-2010

TBGRI director A. Subramonian principal investigator of the project undertaken for the past three years said they were in the process of applying for a patent.

Pharma sector gets booster dose for innovation

fe Bureau — 27-Feb-2010

For instance a biotech company must file international patents in order to protect its IP and to conduct clinical trials which are all legitimate R&D expenses that would need to be covered under the weighted deduction scheme.

No interim relief for Bayer: Supreme Court

Manish Ranjan — 27-Feb-2010

The apex court refused to stay a Delhi HC order of 10 Feb which rejected Bayers attempt to block the DCGI from allowing Cipla to market its generic version of Nexavar

Copyright panel cancels meet

Bharati Dubey — 28-Feb-2010

The joint committee of producers and writers formed by the HRD ministry has cancelled its meeting scheduled for Sunday after Bollywood producers abstained from attending it.

Bayh Dole in India: Not a great idea

Dwijen Rangnekar — 28-Feb-2010

In recent times the making of intellectual property law in India has been ironically tarnished by claims of plagiarism.

No interim stay on Ciplas Nexavar clone

Khomba Singh — 01-Mar-2010

The Supreme Court on Friday turned down a request by German drugmaker Bayer AG to stop Mumbai based Cipla from launching the low cost version of Bayers patented cancer medicine Nexavar while admitting the case.

Budget could push R&D spend by 25 50%: pharma players

Sohini Das / Mumbai/ Ahmedabad — 01-Mar-2010

Troikaa Pharma is in the process of getting patent approvals for its novel drug delivery system for Diclofenac injections Dynapar AQ from several countries.

FM injects new life into pharma

TNN — 01-Mar-2010

From this year on companies will also be allowed to claim the weighted deduction benefit on expenses incurred on clinical trials and product patent registrations.

A few extramural research projects under ICMR get patents set for commercialisation

Joseph Alexander, New Delhi — 2-Mar-2010

A number of extramural research projects going on in different institutes under the Indian Council for Medical Research and in Universities with the support of ICMR have reached laboratory scale stage and in the process of being commercialized after having granted patents.

A Passage to India

Bhupesh Bhandari / New Delhi — 2-Mar-2010

The absence of product patents had made them experts in reverse engineering.

Supreme Court admits Bayer patent linkage plea

Priyanka Golikeri — 2-Mar-2010

The Supreme Court has admitted a special leave petition filed by Bayer seeking introduction of patent linkage system in India.

Apple sues rival HTC as phone competition rises

Corporate News — 3-Mar-2010

Apple said HTC has infringed on 20 of its patents covering aspects of the iPhones user interface and hardware

Ranbaxy loses out on FDA delay

Khomba Singh — 3-Mar-2010

Ranbaxy the Indian unit of Japanese drugmaker Daiichi Sankyo was to launch the generic version of the Japan based Astellas Flomax on March 2 in the US eight weeks before the drugs patent expires in the US following an out of court settlement in 2007.

Copyright content to pinch pockets of FM TV channels

Pradipta Mukherjee & Swarup Chakraborty / Kolkata/mumbai — 4-Mar-2010

According to the Bill service tax will be levied on any temporary transfer of copyright or permitting the use or enjoyment of any copyright defined in the Copyright Act 1957 except the following: original literary dramatic musical and artistic works Section 13 a of the Copyright Act 1957].

EU trade chief sees progress in India FTA talks

by Bate Felix — 04-Mar-2010

Disagreements over market access intellectual property rights a dispute over generic drugs and the EUs desire to include issues such as climate change and child labour have stalled the talks.

Insidious India project

Latha Jishnu / New Delhi — 4-Mar-2010

MNC backed IP summits try to influence sitting judges on patent law enforcement issues pending in Indian courts

IIT drug to treat kidney diseases gets patent

TNN — 4-Mar-2010

An indigenous drug, developed by scientists at the Indian Institute of Technology Madras which can remove toxic phosphorous from the body of a patient with chronic kidney failure has been awarded a process patent.

Ranbaxy faces more trouble in US

Joe C Mathew / New Delhi — 4-Mar-2010

Local arm faces lawsuit for alleged marketing of products with false patent claims.

Kolhapuri chappals scale new heights

Sujata Reddy — 04-Mar-2010

In an effort to protect intellectual property rights of the popular Kolhapuri Chappals Shivaji University Kolhapur had decided to apply for Intellectual Property Rights close to five years back.

Strides buys Aspen unit for $75 m

Priyanka Golikeri — 5-Mar-2010

The acquisition is believed to facilitate the contract that Strides signed with US behemoth Pfizer in January 2010 whereby the two companies struck a deal to deliver 40 off patent products mainly injectable cancer medicines and oral medicines to patients in the US.

How pharma can use deduction as addition

Gireesh Chandra Prasad — 5-Mar-2010

The US allows a six month exclusive marketing right to the first generic copy that enters the market without infringing the patent protecting the original drug or by proving that the patent was invalid.

Pharma cos filing multiple patents for same drug

Priyanka Golikeri — 5-Mar-2010

In September 2009 a patent application for AIDS drug darunavir was rejected as it did not meet patentability criteria laid down in the Indian Patent Act.

Natco moves SC against Novartis drug

Indu Bhan — 5-Mar-2010

Natco Pharma has approached the Supreme Court challenging a part of the Intellectual Property Appellate Boards decision that said Swiss drug maker Novartis blood cancer drug Glivec was novel and inventive.

Ranbaxy may still gain from Flomax

Radhieka Pandeya — 5-Mar-2010

The company may get a one time payment for enabling the launchof its generic versionin the US market

AstraZeneca sues Sun Pharma in us court

BS Reporter / Mumbai — 5-Mar-2010

Sun had challenged the patent on Nexium IV in the US market.

UP slack in claiming its intellectual rights

TNN — 6-Mar-2010

Despite being a repository of rich biodiversity Uttar Pradesh is one of the poorest performers when it comes to protecting their traditional knowledge.

India tops exporting generic medicines

Nageshwar Patnaik — 07-Mar-2010

The word generic is used to describe a product particularly a drug which does not have a trademark.

India-US to sign key trade pact on Mar 17

STAFF WRITER — 07-Mar-2010

The US has been seeking greater market access in India and raising concern over protection of the intellectual property rights.

India to submit IPR report to US trade representative

Joe C Mathew / New Delhi — 07-Mar-2010

India will submit a status report on the progress it has made on intellectual property rights protection and enforcement during the last year to the United States Trade Representative.

Public interest groups object to disguised lobbying with judges policymakers by GWU and CII

Ramesh Shankar, Mumbai — 8-Mar-2010

Several public interest groups in the country have asked the central government to take immediate steps to put a stop to the industry sponsored lobbying with judges and policymakers in the country as part of the of Summits on Intellectual Property being organised in different cities in India jointly by the US based George Washington University and the Confederation of Indian Industry with funding from multinational pharmaceutical companies industry associations and corporate law firms.

Dept of pharma wants review of FDI rules

Surajeet Das Gupta & Joe Mathew / New Delhi — 8-Mar-2010

The Alliance has also pointed out that there are serious new entry barriers in the international market such as seizure in transit ever growing intellectual property rights enforcement and protection and attacks on Indias brand equity.

Glaxo chief Witty says ready to ramp up play

Priyanka Golikeri — 9-Mar-2010

Experts feel depleting new molecule pipelines and impending patent expiries are increasing the desperation of pharma biggies such as Pfizer and GSK to rapidly expand their presence in India.

AstraZeneca takes Sun Pharma to court

TNN — 9-Mar-2010

A generic company files an abbreviated new drug application with a Para IV certification before a patented product goes off patent.

FICCI to organise Roundtable on controversial section 3 d of Indian Patents Act

Ramesh Shankar, Mumbai — 9-Mar-2010

Even as the multinational pharma companies are making an orchestrated efforts to remove the controversial section 3d of the Indian Patents Act which prevents incremental pharmaceutical innovations from receiving patent protection the Federation of Indian Chambers of Commerce and Industry is organizing a Roundtable Conference on the issue in New Delhi on March 22.

Glaxo chief Witty says ready to ramp up play

Priyanka Golikeri — 9-Mar-2010

Experts feel depleting new molecule pipelines and impending patent expiries are increasing the desperation of pharma biggies such as Pfizer and GSK to rapidly expand their presence in India.

$280000 a year job offer for Chennai patent holder

IANS — 9-Mar-2010

Patent under the US law is awaited Shivaraman told IANS talking about his innovative polymer templated lithography process which allows fabrication of patterned magnetic media with density of around 30 TB.

AstraZeneca Sues Sun Pharma For Patent Infringement

Pharmaceutical Business Review — 9-Mar-2010

AstraZeneca has filed a patent infringement complaint against India based Sun Pharma for planning to market a generic formulation of its intravenous acid reflux disease treatment Nexium IV.

Sun wins first roundover Wyeths Protonix

Radhieka Pandeya — 10-Mar-2010

The case was filed by US based Wyeth Pharmaceuticals which had sued Sun and Caraco for claiming that their heartburn drug was a generic version of its Protonix drug

Our Indian operations are a great success story

P B Jayakumar / Mumbai — 10-Mar-2010

The patent pool is a good option for finding a cure for these diseases as drugs can be made available to people in least developed countries.

Bidding War Pits Pfizer Against Teva

Mergers & Acquisitions — 10-Mar-2010

In 2008 it created a division called the established products business unit to sell medications that have lost their patent protection.

Culinary manifesto

ET Bureau — 10-Mar-2010

One recent occasion was the donning of geographical indication protection by the venerable Tirupati ladoo.

Natco Pharma looks to relaunch breast cancer drug in India

Radhieka Pandeya — 10-Mar-2010

Natco said it has tied up with Dr Reddys Laboratories Ltd to take this product to the US market where they are looking to challenge Abraxis patent.

IPR is tool for wealth creation

BS Reporter — 10-Mar-2010

The Uttar Pradesh government has advocated preparing a blueprint of not only creating awareness towards Intellectual Property Rights but also wealth creation by the stakeholders.

GlaxoSmithKline stays confident on patent regime

Reghu Balakrishnan — 10-Mar-2010

At a time when multinational innovator drug companies and global pharma associations cry hoarse over the intellectual property regime in India GlaxoSmithKline the second largest pharma firm in the world remains confident over the countrys patent scenario.

Climate change

by Atty. Adrian S. Cristobal Jr. — 11-Mar-2010

One concern especially of developing countries is that the intellectual property system may hinder access to these technologies.

Medicines for all

Business Standard / New Delhi — 11-Mar-2010

This is difficult to understand as there is no intellectual property to guard against foreign takeover the Indian industry being entirely generic.

Pharma drools as US patent expiries

Priyanka Golikeri — 11-Mar-2010

After a brief lull caused by the slowdown the US has once again emerged as El Dorado for Indian drug makers.

LG infringed Whirlpool patent jury finds

Dhanya Skariachan — 12-Mar-2010

A U.S. jury found that LG Electronics infringed on a Whirlpool patent for ice storage bins in some of its refrigerators Whirlpool said on Friday.

Indian pharma eyes $60B in lost patents

Tracy Staton — 12-Mar-2010

While Big Pharma bewails the forthcoming loss of patent protection on many top selling drugs the knock off drug business is rubbing its hands in anticipation.

AstraZeneca in deal with generic drugs maker

Rhys Blakely — 12-Mar-2010

The deal with Torrent Pharmaceuticals gives the Anglo Swedish group access to a fresh portfolio of cheap medicines to sell in developing markets at a time when it faces the loss of patents on several of its blockbuster brands.

Column: Against Tide but at what cost to Rin

Latha R Nair — 13-Mar-2010

An audacious advertisement campaign for Rin started by Hindustan Unilever Limited by pitching and comparing it with Tide Naturals a Procter & Gamble product has become a hot topic of discussion for intellectual property rights enthusiasts.

Venus Remedies gets patent for Sulbactomax

Corporate — 15-Mar-2010

Pharma Company Venus Remedies Ltd on Monday said it has received a product patent for its antibiotic drug Sulbactomax in the country.

Setback for Zydus Cadila in trademark case

ET Bureau — 15-Mar-2010

In a setback to Ahmedabad based drug maker Zydus Cadila the Supreme Court on Monday declined to interfere with a Madras High Court order which prevented the company from selling its anti depressant drug Venz.

Ranbaxy settles spat with Takeda over Actos

Priyanka Golikeri — 16-Mar-2010

Ranbaxy Labs has resolved its patent litigation with Takeda Pharma related to its generic version of Actos.

Ranbaxy Daiichi combining synergies to boost growth

Bianca Ghose — 16-Mar-2010

What Ranbaxy gets is access to Daiichis patent protected products.

Overburdened FDA can scupper a rising bounty

Priyanka Golikeri — 16-Mar-2010

Drugs with sales of $157 billion are going off patent in the next couple of years in the US.

Patent dispute resolution a booster for Ranbaxy

SI Reporter / Mumbai — 16-Mar-2010

Ranbaxy Laboratories has firmed up after settling a patent dispute with Takeda Pharmaceutical Company regarding a generic version of the Japanese companys diabetes drug Actos in the United States.

Court bars Cadila from selling drug

Indu Bhan — 16-Mar-2010

With the Supreme Court refusing to give any relief to Cadila Healthcare Ltd on Monday the pharma major cannot sell its anti depressant drug Venz OD for another three months.

SmartMetrics Lawsuit Against Visa and MasterCard

ET — 17-Mar-2010

For an order pursuant to 35 U.S.C. section 271 declaring that each Defendant has infringed one or more claims of the 464 patent

Pfizer drops Viagra infringement case against Lilly

Tom Hals in Wilmington and Ransdell Pierson in New York — 17-Mar-2010

Pfizer Inc agreed to drop an eight year old patent infringement lawsuit against Eli Lilly & Co over Viagra after a U.S. government agency rejected part of the male impotence drugs patent.

Indian pharma industry should strive to make India number one in volume of production in 5 years Dr Sivathanu Pillai

Peethaambaran Kunnathoor, Chennai — 17-Mar-2010

Regarding pharma industrys growth he said the Indian Patent Act of 1970 has helped rapid expansion of domestic market market development and market orientation research.

Idea in soup over paperless ad

Ratna Bhushan & Joji Thomas Philip — 17-Mar-2010

Ideas trademark Sirji campaign shows Abhishek Bachchans image on a tree advocating the use of mobiles and saving paper to save the planet.

Lets hear it for Brazil

Latha Jishnu / New Delhi — 18-Mar-2010

Brazil plans to break IP rights on American drugs music software and movies as retaliation for its cotton subsidies

Column: Astra versus Sun

VIVEKA ROYCHOWDHRY — 18-Mar-2010

This time AstraZeneca has filed two separate cases against Sun Pharma to block a Para IV filing on Nexium its best selling drug.

Commerce Health ministries initiate to delink trademark aspects from quality of drugs

Joseph Alexander, New Delhi — 18-Mar-2010

The move in general is to suggest required amendments so that trademark and patent issues do not get mixed up in the quality aspect of drugs.

Indian firms overtake US in FDA drug filings

C.H. Unnikrishnan — 18-Mar-2010

A significant portion of filings from India has been made since 2008

Piracy a serious threat to Indian film industry

fe Bureau — 19-Mar-2010

Strong legislative and enforcement responses are needed to tackle the issue of copyright theft.

Apple patent and trademark skirmishes through the years

by Erica Ogg — 19-Mar-2010

Sometimes it doesnt take more than a cease and desist letter or some good backroom negotiating skills for Apple to get what it wants.

Malihabad mangoes under bug threat

Swati Mathur — 19-Mar-2010

With the newly acquired Geographical Indication to the Malihabadi Dussehri coming as a boost to farmers in the area the expectation of large yields could help the trade even further.

DRL gets nod for Allegra D 24 generic

Radhieka Pandeya — 19-Mar-2010

Patent litigation over the drug between DRL and Sanofi is still unresolved

Sales data Obama push healthcare pulse on BSE

Joe C Mathew & P B Jayakumar / New Delhi/mumbai — 20-Mar-2010

Over $86 billion worth of medicines are expected to go off patent in the next two to three years in the US.

Celebrities using trademark route to check name misuse

Rasul Bailay — 20-Mar-2010

Bollywood actress Kajol was shocked to discover television news channels last month running reports on derogatory remarks she purportedly made against the Shiv Sena on Twitter.

Teva drags Famy Care to US court over patent infringement

fe Bureaus — 20-Mar-2010

Mumbai based oral & injectable contraceptive maker Famy Care was sued in a US courtalong with partner Mylan Labs by the largest generic company Teva last week for alleged infringement of Tevas patent for oral contraceptive pills Seasonique and LoSeasonique.

New process patent granted to IIT Madras and MIN for a drug used in dialysis patients with chronic kidney disease

Joseph Alexander, New Delhi — 21-Mar-2010

Two Indian patents have been filed jointly by IIT Madras and MIN on these new developments in 2006 and one patent has already been granted recently.

Weekly News Round Up

by M J Madhavan — 21-Mar-2010

Ranbaxy Laboratories Ltd on Monday said that it has reached an agreement with Japanese pharma major Takeda Pharmaceutical Company Ltd and Takeda Pharmaceuticals North America resolving outstanding patent litigation related to generic version of diabetes drug Actos.

India proposes stringent laws for IP offenders

Joe C Mathew / New Delhi — 21-Mar-2010

Audio video piracy to be included under prevention of dangerous activities Act.

Motherson poised to ride auto boom

Nitin Shrivastava — 22-Mar-2010

The Visiocorp acquisition lifts Motherson to tier 1 status and arms it with superior technology as Visiocorp has more than 330 patents in its name.

FICCI to establish IP Facilitation Centres across the country for MSMEs

Ramesh Shankar, Mumbai — 22-Mar-2010

The IP Facilitation Centres will be well equipped to offer quality services in all areas of intellectual property rights and comprises of technical and legal experts having extensive knowledge in the field of intellectual property rights.

Kesar mango from Gir all set to rub shoulders with Darjeeling tea

Hiral Dave — 22-Mar-2010

Is the only agri product from Gujarat to get registered with Geographical Indication Registry

India ready to move WTO against EU Customs laws

Amiti Sen — 22-Mar-2010

We are very clear that customs officials in the EU countries bent WTO rules when they seized good quality off patent medicines being shipped from India.

Planned EU deal not to hit generic drug cos: Anand Sharma

REUTERS — 22-Mar-2010

Back in 2005 India granted patents on medicines to respect international trade rules and MSF said a new free trade agreement now under negotiation would tighten these rules.

Indian pharma patents to surge with US expiries

Priyanka Golikeri — 22-Mar-2010

Between 2010 and 2015 drugs worth a mindboggling $157 billion are set to go off patent in the US according to industry estimates.

Dish Big TV wrestle over trademark

Ashish Sinha — 23-Mar-2010

According to sources recently ADAG applied for the registration of Big Dish TV to the office of the trade mark registry in Mumbai.

Approach to GM foods should be promotional but cautious: Mashelkar

Express News Service — 23-Mar-2010

Speaking on the issue of intellectual property rights Mashelkar who won the IPR battle for India over Basmati and turmeric which led to the revocation of US patents on these products said that people understand physical property but intellectual property is a product of the mind and the person whose idea it is should have a right to exploit the idea for a certain period of time.

Lupins US arm gets USFDA nod for insomnia tablets

PTI — 23-Mar-2010

The company has received a tentative approval for the companys abbreviated new drug application for Eszopiclone tablets from the USFDA Lupin said in a filing to the BSE

US Healthcare Law: Indian drug firms are not celebrating yet

P B Jayakumar / Mumbai — 23-Mar-2010

Further the provisions in the legislation to allow 12 year exclusivity to new biologics or patented biotech drugs would delay plans of Indian companies to launch generic biologics in the US market say industry circles and analysts.

EU trade pact wont hit Indian generic drug cos: Sharma

Reuters — 23-Mar-2010

The warning highlighted one of the most sensitive issues in trade the extent to which firms intellectual property rights can be waived to help poor countries and whether that stifles research and innovation.

Suven gets patent for Alzheimer Parkinson compound

Press Trust of India / New Delhi — 23-Mar-2010

Suven Life Sciences today said it has received patent from the US Patent Office for a compound used in the treatment of neuro diseases like Alzheimer and Parkinson.

Skinvisible Granted Patent for South Korea

ET — 23-Mar-2010

Skinvisible Inc. announced today that the South Korean patent office has granted a patent for Invisicare® the companys polymer delivery system for topical dermatology products.

Albany Molecular seeks injunction against Dr Reddys

Vidya L Nathan in Bangalore — 23-Mar-2010

Albany Molecular Research Inc along with Sanofi Aventis SAs U.S. unit sought a preliminary injunction against Indias Dr Reddys Laboratories Ltd from distributing a copycat version of allergy drug Allegra D.

Piramal buys Ciplas i Pill for Rs 95 crore

TNN — 24-Mar-2010

In an announcement to the exchange Piramal Healthcare said the company had signed a definitive agreement for the purchase of all intellectual property rights in India related to the brand.

Obamas Health Bill to boost Indian firms

Bianca Ghose — 24-Mar-2010

Branded innovators and Indian generic companies often settle patent litigation cases out of court allowing the generic company to have limited exclusivity on a drug along with the branded company.

No trademark infringement by Google: EU court

Reuters / Luxembourg/ London — 24-Mar-2010

Europes highest court ruled Google Inc did not infringe trademark law by selling keywords to trigger ads after Louis Vuitton and others said the practice undermined their brands.

Ranbaxy gets a reprieve in generic case

Khomba Singh — 25-Mar-2010

The Delhi High Court has turned down a plea by US pharma major Bristol Myers Squibb to ban Indias Ranbaxy Laboratories from launching a generic or copycat version of its patented hepatitis B drug Baraclude.

Bayer drags Cipla to court over patent

Khomba Singh — 25-Mar-2010

German drugmaker Bayer has filed a patent infringement case against Cipla the largest domestic drug seller to stop the Mumbai based company from selling its generic version of controversial cancer medicine Nexavar.

NGOs caution govt on designs of EU through on going FTA negotiations

Ramesh Shankar, Mumbai — 26-Mar-2010

Warning the government about the impact of data exclusivity these groups said that if data exclusivity is introduced it will create a new patent like monopoly by blocking the registration of generic medicines.

We have big R&D plans in the pipeline for India

Soma Das — 26-Mar-2010

Alpna Seth managing director of Biogen Idec one of the top 10 biotech companies globally with annual revenues of $4.4 billion talks about special pricing and patent issues

Indian market is important for us looking at the sheer growth potential

C.H. Unnikrishnan — 26-Mar-2010

However the lack of a strong intellectual property rights regime in a predominantly generics driven Indian market made the going tough for the firm.

US healthcare bill drives up small pharma

Apurv Gupta — 26-Mar-2010

The playing field for the domestic pharmaceutical companies changed completely with the advent of product patent regime.

IPR law firms step up fight against fakes

Manish Ranjan — 26-Mar-2010

Lawyers and a former police officer among those who have joined the war on piracy as firms try to plug losses

EU may recall India made generic drug

Reuters / London — 27-Mar-2010

However the medicine is off patent in some European markets where Acino is among the companies that have been supplying a cheaper generic version.

Genentech Biogen sue GSK on cancer drug Arzerra

Copenhagen, Denmark — 27-Mar-2010

US patent No 7682612 was issued to GenentechInc. and Biogen Idec Inc. on March 23 2010 and contains a claim to a method of treating CLL with anti CD20 antibodies wherein the method does not comprise treatment with radiolabeled anti CD20 antibodies.

India beats back US firms bid to patent Ashwagandha formulations

Kounteya Sinha — 27-Mar-2010

India has foiled a major bio piracy bid on the use of Ashwagandha Indias wonder plant in the treatment of a range of illnesses including depression diabetes insomnia convulsions and gastritis.

Roundtable on controversial Section 3 d of Indian Patents Act to be held in Delhi on March 29

Our Bureau, Mumbai — 27-Mar-2010

The Federation of Indian Chambers of Commerce and Industry is organizing a Roundtable Conference on the controversial Section 3d of Indian Patents Act in New Delhi on March 29.

EU MPs oppose corporate interference in FTA talks

Priyanka Golikeri — 29-Mar-2010

David Martin a MEP part of the campaign, says the EU should not push for provisions in bilateral talks that can impact local manufacturing in developing countries and go beyond what is mandated by the trade related aspects of intellectual property rights agreement of the World Trade Organisation.

Watchdog Blues

Sudhir Chowdhary, BV Mahalakshmi — 29-Mar-2010

An effective way to manage these complexities is to assemble a strong resource pool with a good understanding of the local market conditions intellectual property regulatory pricing and marketing and distribution.

US patent office admits to error in judgment

Rema Nagarajan — 29-Mar-2010

After joining hands with pharma giant Pfizer to campaign against public health safeguard clauses in the Indian patents law the US Patent and Trademark Office has admitted that they had made a mistake in co sponsoring a programme on patent law in India along with the pharmaceutical giant.

Bio piracy threats

Editorial — 29-Mar-2010

Indias successful thwarting of an American firms attempts to patent the well known Indian medicinal plant ashwagandha must be applauded.

Pharma sector: There is room for value buying

Kiran Kabtta Somvanshi — 29-Mar-2010

Impending patent expiries regulated markets gradually opening their markets for generic products and the US passing the much awaited Healthcare Bill in order to cut down healthcare costs are turning out to be a boon for generic companies in India.

Startups look to patenting techs

K Rajani Kanth / Chennai/ Hyderabad — 29-Mar-2010

This patent pending technology has been developed by matrimonial site Coupl.in a Hyderabad based start up set up in October 2009.

Vested interests behind discussion on patents

Rema Nagarajan — 29-Mar-2010

Several civil society groups have come together to question the commerce and industry ministrys alleged complicity in allowing meetings and interactions undermining Indias legal position on intellectual property.

Pharma cos take patent route to consolidate ops in US

Reghu Balakrishnan — 29-Mar-2010

Indian pharma firms seem to be in an upbeat mood as far as strengthening their presence in the US via the patent litigation route is concerned.

On course to benefit from patent expiries

Nitin Shrivastava — 29-Mar-2010

Indian pharmaceutical companies are in for good times with very large generic opportunities awaiting them in regulated markets and a focus on low cost healthcare globally.

For both IPR & access to medicines

TK Arun — 29-Mar-2010

Stefan Oschmann is president Emerging Markets at Merck the worlds second largest pharmaceuticals company after its 2009 merger with Schering Plough with a combined global revenue in 2009 of $27.4 billion.

Indoco Remedies inks drug supply pact with Aspen

BS Reporter / Mumbai — 30-Mar-2010

A dwindling new drug pipeline and drugs losing patent protection are now forcing multinational drug companies to take up generic drug selling which they had shunned earlier.

High risk: trademark cases on the rise in liquor industry

Poornima Mohandas — 30-Mar-2010

Cases of trademark violation have been on the rise in the liquor industry in recent years as companies often copy names bottle and label designs as well as packaging to ride the popularity of other fast moving brands say two industry experts and a trademark lawyer

Indias patent policy is discouraging innovations that can be of help

Joe C Mathew & Vandana Gombar / Mumbai/ New Delhi — 30-Mar-2010

US based Eli Lilly amongst the top 10 global pharmaceutical companies with annual revenues of $21.8 billion in 2009 has planned to continue its focus on innovation driven products instead of opening up to opportunities in off patent generic drugs being tapped by its larger competitors like GSK and Pfizer.

Suven secures product patent

Our Bureau — 30-Mar-2010

Suven Life Sciences Ltd has secured a product patent from the European Patent Office for its New Chemical Entity meant for the treatment of neurodegenerative diseases.

India asks WHO to stay away from counterfeit issues

Joe C Mathew / New Delhi — 30-Mar-2010

According to Indian representatives counterfeit is a juridical term and is linked to intellectual property rights.

Indian Patents Act promotes inventions

Mail Today Bureau — 30-Mar-2010

Concerns raised by US multinational corporations over the Indian Patents Act discouraging innovation have been refuted in a study released on Monday.

Vested interests behind discussion on patents

Rema Nagarajan — 30-Mar-2010

Sanofi moves to block Wockhardt patent challenge

P B Jayakumar / Mumbai — 30-Mar-2010

Battle in US court on anti allergic drug Allegra.

Will raise penetration of Indian generic

ET Bureau — 31-Mar-2010

While the period of data exclusivity for innovators is far longer than the generic players would have wanted the announcements of setting up regulatory pathways in this space is crucial as the value of biologics starting to go off patent from 2014 will be increasingly larger than conventional oral drugs.

US court rejects patents on human genes

BRIDIE SMITH — 31-Mar-2010

A LANDMARK judgment handed down in the US this week on the contentious practice of patenting human genes is expected to send a message to Australian policymakers.

Teva exclusive on hypertension drugs challenged

By Jeremy Pelofsky — 31-Mar-2010

Two generic pharmaceutical manufacturers have challenged the U.S. Food and Drug Administrations decision to give rival Teva Pharmaceutical Industries Ltd six months of exclusive marketing for generic versions of widely used blood pressure medicines.

Drug makers unite to fight frivolous patents

Joe C Mathew / New Delhi — 31-Mar-2010

IPA members to challenge patent applications at pre grant stage

India prepared to take EU to WTO over drugs

Matthias Williams and Manoj Kumar — 31-Mar-2010

India is ready to launch a formal dispute against the European Union at the World Trade Organization over EU seizures of Indian generic drugs the Indian Trade Secretary said on Wednesday.

Not a nice trait to have

Latha Jishnu / New Delhi — 01-Apr-2010

MMB is bolstering its argument with a new weapon a patent that it holds in India for its Bt technology.

Ranbaxy to hire 1500 on expansion to push sales

Khomba Singh — 1-Apr-2010

The company has run into a spate of patent battles over generic drugs there and its Indian manufacturing units have been under the US drug regulators scanner.

AstraZeneca ordered to pay attorneys fees to Dr Reddys

BS Reporter / Mumbai — 2-Apr-2010

Drug major AstraZeneca has been ordered to pay attorneys fees by a US court to Dr Reddys Laboratories for bringing a frivolous and baseless patent infringement suit against the latter.

Sanofi Aventis settles patent row over cancer drug

ET Bureau — 2-Apr-2010

French drugmaker Sanofi Aventis settled its patent row in the US over colon cancer drug Eloxatin with several generic companies but made no mention of Indian drugmaker Sun Pharmaceutical Industries that also sells the drug.

Domestic cos foil global peers rage over patent

Soma Das — 2-Apr-2010

Global Pharma Companies Campaigning Against A Key Provision In Indias Patent Act

Microsoft loses appeal on Word patent verdict

IANS — 02-Apr-2010

Microsoft had filed a review petition in the US federal court of appeals against the ruling as well as fines.

Venus Remedies patent on salbactam with ceftrioxane opposed in Delhi patent

Ramesh Shankar, Mumbai — 3-Apr-2010

The product which is manufactured by several companies under different brand names is indicated for infections.

BusinessEurope pushes for stronger intellectual property terms in FTA

Priyanka Golikeri — 3-Apr-2010

Fears of tough intellectual property provisions in Indias free trade agreement with EU are only getting stronger.

In the pink of health

IIFL — 5-Apr-2010

n Settlement of patent disputes between an innovator company and a generics company with first to file status will be banned if such a settlement involves payment in cash or kind.

India reasserts its reservations on counterfeit drugs at WHO meeting

Joseph Alexander, New Delhi — 5-Apr-2010

These concerns include its association with trademark and the danger that quality safety and efficacy issues could be viewed through the lens of intellectual property India said terming all this as deliberate confusion on the part of those seeking to increase IP enforcement regimes.

The healthcare opportunity

Ram Prasad Sahu / Mumbai — 5-Apr-2010

While generics today have a share just under a fifth in the US market they are likely to grow by over twice that number by 2013 as many of the innovator drugs go off patent and the healthcare bill comes into full effec

Unfurling a new life for Chamba rumals

Reshmi R Dasgupta — 5-Apr-2010

The gaining of GI Geographical Indication status has also earned them protection from cheap knock offs from other regions.

SC admits plea against Cipla on modvat refund claim

Indu Bhan — 5-Apr-2010

The Supreme Court has admitted the excise departments plea alleging that pharma major Cipla Ltd is not entitled to refund modvat credit paid on its destroyed expired medicines.

Fresenius Kabi settles patent dispute with Sanofi Aventis

Marketing — 05-Apr-2010

Drug firm Fresenius Kabi Oncology previously know as Dabur Pharma on Monday said that it has settled the patent litigation with Sanofi Aventis over the cancer drug Eloxatin.

Australia pushes for environment labour IPR in trade pact with India

Amiti Sen — 5-Apr-2010

The proposed free trade agreement between India and Australia has hit rough waters with the latter insisting that issues including environment labour intellectual property government procurement and competition policy be part of the negotiations.

Taro Pharma Receives Patent For T2007

RTT Staff Writer — 06-Apr-2010

Taro Pharmaceutical Industries Ltd. Tuesday said the U.S. Patent and Trademark Office has issued the company a patent for its non sedating barbiturate drug T2007 which is under development.

Court denies Lillys request in 2 patents litigation case of Gemzar

Jerusalem — 07-Apr-2010

Lilly has appealed that decision and oral argument is scheduled for May 7 2010.

Are industrial zones a good idea

Business Standard / New Delhi — 7-Apr-2010

corporate houses mint money by using patents to their advantage.

US opportunity for pharma

Business Standard / New Delhi — 7-Apr-2010

On the export front as far as the regulated markets are concerned the drug majors that have so far relied on their patented blockbusters are rapidly changing their business model in several ways.

Pfizer Novartis and Eli Lilly got bulk of contentious patents

C.H. Unnikrishnan — 7-Apr-2010

Rules against protection being granted to already known and long ago patented drugs were allegedly violated

Court favours Teva in Seasonique patent case against Watson

Jerusalem — 07-Apr-2010

The ANDA sought approval to market a generic version of Seasonique in the US before the patent expires on January 30 2024.

LPOs benefit from Microsofts curbs on legal costs

Adith Charlie — 8-Apr-2010

Microsofts patent portfolio consistently ranks among the top as it manages nearly 23000 issued and 38000 pending patents worldwide.

What invalidating breast cancer gene patents implies

R. PRASAD — 8-Apr-2010

Myriad was holding an exclusive licence.

Tatas create intellectual property clusters in Bangalore Pune

Rakhi Mazumdar — 8-Apr-2010

The Tatas are no slouches in technology as Tata Steel alone owns a bouquet of 850 patents copyrights and applications.

MNCs will get market prices for patented drugs only if govt given quota at a discount

Gireesh Chandra Prasad, KG Narendranath — 08-Apr-2010

The government plans to prevent pharma MNCs from selling their patented drugs which are mostly expensive in India unless they agree to earmark a portion of their supply for public healthcare system at negotiated prices.

Through her research MSU student seeks to revive 700 year old craft

DARSHANA CHATURVEDI — 8-Apr-2010

Her research may or may not fetch her good marks but it will definitely help revive the 700 year old Tangalia craft which is now among the few Gujarati items to have got geographical indication embedded in a sarong like garment worn by the Bharwad women from Motabhai Bharwad community of Saurashtra.

Know the real hapoos by its Ratnagiri brand

Neeta Kolhatkar — 09-Apr-2010

The registration process of Ratnagiris special alphonso mangoes for a geographical indication is in its final stages.

The US healthcare opportunity for India

Ram Prasad Sahu in Mumbai — 09-Apr-2010

With larger companies having a pipeline of Abbreviated New Drug Applications some with exclusivity period and drugs worth $80 billion coming off patent over the next five years investors are betting on Indian companies garnering a chunk of this generic opportunity.

Malihabadi dussehri is the first branded mango

DNA Correspondent — 09-Apr-2010

Alphonsos wont be the first mangoes to get a geographical indication.

Cipla makes cancer drug cheaper

Khomba Singh — 09-Apr-2010

Cipla has launched a copycat version of German pharma company Bayers cancer medicine Nexavar at one tenth the price thumbing its nose again at the pharma multinational by selling drugs at a fraction of the original rates.

Indian drug exporters to benefit from change in EC norms

Press Trust of India / New Delhi — 9-Apr-2010

It was alleged that the Indian pharmaceutical products had patent violations in Europe.

Will India take EU drug seizures issue to World Trade Organisation

Priyanka Golikeri — 10-Apr-2010

The medicines neither enjoyed patent protection in India nor in the countries that were to import them.

Column : Should drugs be allowed evergreening

MG Arun — 10-Apr-2010

The issue of evergreening of drugs or obtaining new patents for minor improvements on a product towards its patent expiry has been a subject of debate in India ever since 2005 when India allowed patenting of products in pharmaceuticals as opposed to the earlier process patent regime.

Suns EPS may take a knock if it stops cancer drug sale

Deepali Gupta — 10-Apr-2010

The stock of Sun Pharma fell for a fourth day in a row as investors are worried about the companys legal tussle with Sanofi Aventis over cancer drug oxaliplatin.

Mycobacterium tuberculosis genome mapping released

Aarti Dhar — 11-Apr-2010

Findings may result in development of urgently needed new TB drugs in India.

Indian drugmakers gear up to challenge frivolous MNC patents

PTI — 11-Apr-2010

Leading domestic drugmakers have decided to collectively challenge frivolous patent applications filed by multinationals in India under the aegis of the Indian Pharmaceutical Alliance.

GSK settles malaria drug patent dispute with Glenmark

Selina McKee — 12-Apr-2010

UK drugmaker GlaxoSmithKline has settled a patent dispute with the US subsidiary of Indias Glenmark Generics over a copycat formulation of its malaria prophylaxix drug Malarone.

Keikaku set to enter India with furniture brand

Anandita Singh Mankotia, Ronojoy Banerjee — 13-Apr-2010

The $1.7 billion Japanese retailer Ryohin Keikaku is all set to enter the Indian retail market with its furniture brand Muji.

CSIR open-source project for TB democratises research

P.T. Jyothi Datta — 13-Apr-2010

The average age of scientists on the Council of Scientific and Industrial Research\'s (CSIR) ‘Connect 2 Decode\' project — to map information on the Mycobacterium tuberculosis (Mtb) genome, is “in the 20s”. Not surprising then, the scientific community explains the project, in lay terms, as a sort of “face-book” for scientists!

Glenmark settles drug patent row with GSK

13-Apr-2010

Close on the heels of Ranbaxy announcing a patent dispute settlement with Japan\'s Takeda Pharmaceuticals for the generic equivalent of Takeda\'s drug Actos, Mumbai-based Glenmark Pharmaceuticals said on Monday its US-based group company has settled a patent dispute with GlaxoSmithKline over the launch of a generic version of anti-malaria drug Malarone.

No suo motu powers to review ‘wrongly’ granted patents

C.H. Unnikrishnan — 13-Apr-2010

The first Indian Administrative Service officer to head India’s intellectual property office, P.H. Kurian has had a tough time since he took charge in 2009—he has had to work towards creating an efficient and transparent patenting process and reform a system that has previously faced allegations of lack of transparency, indecision, even corruption.

Infy awaits nod for 224 patent applications

Press Trust of India — 13-Apr-2010

IT behemoth Infosys Technologies on Tuesday said it is awaiting approvals for 224 patent applications in India and in the US.

Hope floats for India EU free trade pact talks

Pallavi Aiyar / Brussels — 13-Apr-2010

Chapters on government procurement and intellectual property rights the EU is pushing for TRIPS plus protection also remain highly contentious.

Unilever moves SC seeks stay on trademark case

Indu Bhan — 14-Apr-2010

Australia based Unilever Australasia on Tuesday moved the Supreme Court seeking a stay on the proceedings of a trademark violation case filed against it in a Bangalore court.

US generics to help push Glenmark recovery

C.H. Unnikrishnan — 15-Apr-2010

US market for the drug company will grow at 32.7% says an analysis

Beware the EU agenda

Latha Jishnu / New Delhi — 15-Apr-2010

Tough intellectual property rights sought by the EU in its free trade agreement with India have set off global protests

Disability rights activists oppose copyright regime

Deepa Kurup — 15-Apr-2010

The proposed amendments to the Copyright Act 1957 slated to be tabled in the second phase of the budget session of Parliament that begins on Thursday has disability rights activists up in arms.

Draft copyright Bill introduced, could transform film, music biz

Manish Ranjan and Santosh K. Joy — 19-Apr-2010

Draft copyright Bill introduced, could transform film, music biz

Cipla offers govt low cost drug technology to fight cancer AIDS

C.H. Unnikrishnan — 20-Apr-2010

Patent holders drugs for the treatment of life threatening diseases such as cancer and AIDS are expensive and their monopoly in the Indian market will result in denial of treatment for Indian patients says Amar Lulla joint managing director of Cipla

MULTIPLE FILING OF PATENTS

P A Francis — 21-Apr-2010

Adoption of the new patent law in 2005 marked the beginning of a new era in the history of pharmaceutical industry in India.

Piramal Health to buy anaesthetic biz of Pune firm

Reuters / Mumbai — 22-Apr-2010

The acquisition gives Piramal access to key intellectual property developed by BSV for the manufacture of injectable anaesthetics products including process based intellectual property and business contracts the filing said.

Ind. engineers receive patent for trailer design

The Associated Press — 22-Apr-2010

Two engineers at an Indiana trailer manufacturer have been awarded a patent for a new aerodynamic trailer designed to save fuel.

Contract manufacturing of drugs to grow 10 15%

Debasis Mohapatra / Chennai/ Bangalore — 22-Apr-2010

Contract manufacturing in pharmaceutical industry is set to grow 10 per cent to 15 per cent in the near term and is expected to double in the next five years after the approval of US healthcare bill as the bill has opened up opportunities for the use of more generic drugs in the US market.

Number of patent filings declined in FY\'10 due to slowdown

22-Apr-2010

The government on Thursday said filing of patent applications in the country declined by over 6 per cent to 34,496 in 2009-10 over the year-ago period due to the global economic downturn.

Like EU Japan FTA also a priority

Priyanka Golikeri — 22-Apr-2010

Concerns over the Japan FTA include inclusion of strict intellectual property provisions and access to second hand Japanese goods into the Indian market.

IPL cautions Google on copyrighted content

Our Bureau — 22-Apr-2010

The Indian Premier League has requested Internet search engine Google to discontinue services to certain Web links that were using its platform to transmit copyrighted content related to the Twenty20 cricket tournament.

EU approves Novartis Diovan for paediatric use

Martin de Sa\'Pinto — 23-Apr-2010

Novartis hypertension drug approved for use in EU children

A $5 billion Indian pharma entity may not be too far away

23-Apr-2010

In the initial analysis it appears that the nightmares of the patent cliff that the big brand companies are confronted with may be offset to a large extent by the majestic emergence of the Asian markets like India and China followed by other growth markets like Mexico Turkey and Brazil.

Pfizer wins Protonix patent case vs Teva

Bill Berkrot — 23-Apr-2010

Jury finds Protonix patent infringed by Teva

Folk as intellectual property

PTI — 24-Apr-2010

Everything folk should be considered as intellectual property to ensure that forms of art like music theatre and dance passed down orally through generations do not vanish feel contemporary folk artists.

Low IQ on intellectual property rights

Binay Singh — 24-Apr-2010

The World Intellectual Property Day has been observed globally on April 26 every year since 2001 but the knowledge of intellectual property right is still in nascent stage particularly in Varanasi which is one of the ancient seats of learning.

MNC domestic pharma lock horns on patents in India

STAFF WRITER — 24-Apr-2010

MNC durgmakers today hit back at their domestic counterparts over frivolous patent issue and said even the local firms are engaged in filing for intellectual rights for incremental innovations that merely improve the safety or efficacy of an already known drug.

TELCO loses trade mark battle against T SERIES

PTI — 25-Apr-2010

TELCO has lost its trademark violation case against the Super Cassettes Industries in the Delhi High Court which allowed the electronics company to use letter T in its T SERIES mark saying it was not its monopoly.

Indias tryst with TRIPS

Shamnad Basheer — 26-Apr-2010

On World Intellectual Property Day India should remember that it still needs to incentivize innovation

Curing the fear of drug patents

Ranjit Shahani — 26-Apr-2010

Intellectual Property Day some home truths to separate myths from facts.

Emkay reduces Sun Pharmas price target to Rs 1632

ET Bureau — 26-Apr-2010

In the first case New Jersey jury has ruled that Wyeths patent on Protonix is valid and Sun and Teva Pharma has infringed the patent by launching the drug at risk.

Bio piracy: India wins case against 15 patents

sujatha gopal — 26-Apr-2010

The European Patent Office has rejected 15 patent applications of various international companies during the past one year after it found they had used Indias traditional medicinal knowledge to prepare certain products.

Patent office to hire 500 people this yr: DIPP Secretary

Press Trust of India / New Delhi — 26-Apr-2010

The government will hire about 500 people this fiscal for its intellectual property offices a top official said today.

India ropes in US UK to protect traditional knowledge

IANS — 26-Apr-2010

India has joined hands with the US and Britain to protect thousands of medicinal preparations based on traditional knowledge from piracy and patent controversies.

Shire sues Teva over US patent infringement of Intuniv tablet

Dublin, Ireland — 27-Apr-2010

Shire LLC subsidiary of Shire plc global specialty biopharmaceutical company has filed a lawsuit in the US District Court for the District of Delaware against Teva Pharmaceuticals USA Inc and Teva Pharmaceutical Industries Ltd for the infringement of US Patent Nos. 6287599 and 6811794.

Apex court rejects Unilever Australasia plea on trademark

Indu Bhan — 27-Apr-2010

The Supreme Court on Monday has given the go ahead to a cosmetic firm to proceed against Australian based Unilever Australasia plea in a trademark violation case filed in a Bangalore court.

Sun Pharma stocks slip on US court decision

BS Reporter / Mumbai — 27-Apr-2010

In two separate patent cases while a US court asked Sun Pharma to withdraw its version of a cancer drug Eloxatin from the US market another jury which examined patent validity of heart burn drug Protonix ruled against the Indian company

China court rejects Shaolin temple trademark bid: report

AGENCIES — 27-Apr-2010

Persistent attempts by Chinas famed Shaolin temple to stamp its trademark on instant noodles and coffee may have hit a brick wall after a court ruled against the move state media said Tuesday.

Pharma cos public health groups want patent issue out of FTA talk with EU

Soma Das — 27-Apr-2010

Indian pharmaceutical firms and the network of public health groups have separately urged the government to keep patent related issues out of the ongoing talks for the proposed India EU free trade agreement.

Pharma firms see scope in US patent expiry

Joe C Mathew / New Delhi — 27-Apr-2010

Fortune seekers in the Indian pharmaceutical space will find this irresistible.

Economy Govt rules out blanket ban on plastic bags

PTI — 28-Apr-2010

Sanganeri hand block printed textile products from Rajasthan will now be protected as a geographical indication which prohibits its duplication.

Ranbaxy to step up head count launch new drugs

Khomba Singh — 28-Apr-2010

It attempted to grow by challenging patents of established drugs such as Pfizers cholesterol curer Lipitor to make big profits and focused on the western markets.

Special courts planned to clear backlog of IPR cases

C.H. Unnikrishnan — 28-Apr-2010

The move is part of the ongoing intellectual property rights reforms for which the Centre has set aside Rs500 cr

Suven Life gets patent for NCE from India & New Zealand

Our Bureau, Mumbai — 28-Apr-2010

Suven Life Sciences a bio pharmaceutical company has received patent from New Zealand and Indian patent office or its New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid until 2024 and 2025 respectively.

CSIR wing objects to Avesthagen patent claim

Jacob P. Koshy — 28-Apr-2010

Records also show that the company had paid application renewal fees every year since 2003 but hadnt done so for 2009 the deadline for which was 31 August

Zydus launches Tamsulosin in US

BS Reporter / Mumbai/ Ahmedabad — 29-Apr-2010

Ahmedabad based pharma major Zydus Cadila has launched Tamsulosin capsules in the US following nod from the US health regulator today.

Strong medicine

Latha Jishnu / New Delhi — 29-Apr-2010

Ecuador is issuing compulsory licences to bring down the cost of patented medicine.

To stop patent fights India gives US UK access to database

Vineeta Pandey — 29-Apr-2010

Having burnt its fingers on long and expensive litigations to prevent foreign companies from patenting neem and turmeric the Indian government has developed a unique process to save its AYUSH knowledge.

Orchid Chem settles litigation with Forest Labs

Kaustubh Kulkarni — 29-Apr-2010

Orchid Chemicals and Pharmaceuticals Ltd said on Thursday it has settled a patent litigation with Forest Laboratories Inc regarding its generic drug Memantine tablets.

Sanganeri hand block printed textile goods get GI tag

Our Bureau — 29-Apr-2010

Sanganeri hand block printed textile products will now be protected as a geographical indication under Geographical Indication of Goods Registration and Protection Act.

Pharma group to oppose patent claims

Khomba Singh — 30-Apr-2010

A group of Indian pharmaceutical firms will collectively oppose as many as 90 drug patent applications sought by global drugmakers and some local companies terming them as frivolous patent claims.

India fights patent claims on traditional cures

Sanchita Sharma — 30-Apr-2010

India has challenged 36 attempts by international companies to get patents on Indian traditional knowledge at the European Patents Office over the past one year.

India EU discuss all aspects of proposed FTA

Pallavi Aiyar / Brussels — 1-May-2010

The ninth round of free trade agreement talks between India and the European Union concluded in Brussels today.

Knowledge library wards off European patents

Soma Das — 1-May-2010

An electronic facility that India had set up eight years ago to pre empt unfair patenting of the countrys traditional knowledge on curative potency of various biological resources has come handy.

India on US watch list for inadequate IPR protection

Lalit K Jha — 1-May-2010

The United States placed India along with 10 other countries on its priority watch list on Friday for not providing adequate levels of protection or enforcement of Intellectual Property Rights.

Keep IPR away from free trade agreements

P.T.Jyothi Datta — 1-May-2010

Civil rights groups want the Government to keep Intellectual Property Rights outside the ambit of Free Trade Agreements being negotiated between India and several other regions including the European Union and Japan.

India 10 others on U.S. watch list for inadequate IPR protection

PTI — 1-May-2010

The United States placed India along with 10 other countries on its priority watch list on Friday for not providing adequate levels of protection or enforcement of Intellectual Property Rights.

Pfizer Wyeth sue Ranbaxy over drug

P B Jayakumar / Mumbai — 2-May-2010

Pfizer the worlds largest drug company and Wyeth have sued Daiichi Sankyo owned Ranbaxy Laboratories in a US court for infringing the patent rights of Wyeths drug Rapamune.

Patent application details now available online

BS Reporter / New Delhi — 2-May-2010

Patent application details are available online for free from this week.

Counterfeit goods growing problem in India: USTR

Joe C Mathew / New Delhi — 2-May-2010

US watchdog lauds Indias IPR efforts but picks holes in legal framework.

Litigation woes could hit sales hard

Edelweiss — 03-May-2010

The recent jury decision determining that Nycomeds 579 patent on Protonix DR Tablets is not invalid is a setback to Sun Pharmaceuticalscurrent sales from the product.

Cipla demands apology from US university

Joe C Mathew / New Delhi — 03-May-2010

Cipla the countrys leading drug maker has sent a legal notice to George Washington University of the United States on a recent symposium it had organised in India alleging the meet had attempted to influence a high court case involving Cipla and one of the event sponsors the US based Gilead Sciences.

SC notice to Pepsi over TM row with Udaipur firm

PTI — 03-May-2010

The Supreme Court today issued notice to beverages giant PepsiCo India over a petition filed by an Udaipur based firm challenging the order of the Delhi High Court over a copyright row on the multinationals popular soft drink brand 7Up.

EU assures FTA wont lead to costlier life saving drugs

ET Bureau — 4-May-2010

The European Commission has said the proposed free trade agreement negotiations with India will not affect production of cheap life saving medicines in the country.

India EU to hold more discussions tackle FTA hurdles

Asit Ranjan Mishra — 4-May-2010

Both sides resolve to conclude talks before the next India Europe summit in Oct

Pfizer Wyeth sue Ranbaxy over infringement

fe Bureau — 4-May-2010

US based Pfizer and its subsidiary Wyeth have sued Ranbaxy Laboratories in a US court claiming that the Daiichi Sankyo owned drugmaker infringed on Wyeths patent coverage of the drug Rapamune.

Non trade issues not to hamper trade talks with EU

Special Correspondent — 04-May-2010

In the intellectual property rights chapter of the proposed FTA it will be made clear that there should be no limit on Indias capacity to produce and export life saving medicines Ms. Danielle Smadja said here.

Seizure of drugs cases: India plans to drag EU to WTO independent of Brazil

Amiti Sen — 4-May-2010

India is planning to drag the European Union to the World Trade Organisation independently of Brazil despite claims made by the EU that it was changing its customs regulations to prevent seizure of drugs exported by India while in transit to third countries like Brazil and Nigeria.

USTR Releases 2010 Special 301 Report on Intellectual Property Rights

ag-IP-news — 05-May-2010

The Office of the United States Trade Representative released its annual Special 301 Report on the adequacy and effectiveness of US trading partners protection of Intellectual Property Rights.

Public interest groups urge US president to order inquiry into links between USPTO Pfizer in India

Ramesh Shankar, Mumbai — 5-May-2010

A slew of public interest groups in India have asked the US president Barak Obama to order a formal investigation into the links between the United States Patents and Trademark Office in India and the multinational pharma major Pfizer and to take necessary action against the officials concerned for misinforming the Indian media and the general public about its own patent laws and public health safeguards.

Medicines bought in bulk by govt can help cut costs

Subodh Varma — 5-May-2010

Patent rights also give a boost to prices as shown by the case of Glivec an anti cancer drug.

Glenmark takes patent cover with drug deal

ET Bureau — 5-May-2010

Glenmark Pharmaceuticals issued exclusive marketing rights for cholesterol control ezetimibe to another generic company Par Pharmaceutical Companies in an effort to strengthen its patent challenge case against Merck.

Roches patent on HIV drug is dismissed

Radhieka Pandeya — 6-May-2010

The Swiss drug maker has the option of filing an appeal against the patent offices decision on Valcyte with IPAB

Sun stops anti ulcer drug sale in US

Press Trust of India — 6-May-2010

Sun Pharmaceutical Industries on Wednesday said it has stopped the sale of the generic version of Protonix an antiulcer drug in the US market.

Orchid to bloom with US deal

Ravi Ananthanarayanan, Vatsala Kamat and Manas Chakravarty — 6-May-2010

The real benefits of the Orchids deal with Alvogen Inc. will depend on the rate of success in patent challenges and the ability to go to get final marketing approvals

Abbott Eli Lilly sues Watson Pharma for patent infringement on dyslipidemia drug and SERM respectively

Morristown, New Jersey — 07-May-2010

Watson Pharmaceuticals Inc has confirmed that its subsidiary Watson Laboratories Inc filed Abbreviated New Drug Applications for two products a generic version of Abbotts dyslipidemia drug Simcor and Eli Lillys oral selective estrogen receptor modulator Evista with the US Food and Drug Administration.

Pharma cos lose out in patent office judiciary stand off

Deepali Gupta — 7-May-2010

FOR the patent office the past three years have been like the past three overs of a Twenty20 match.

Sun Pharma gets US FDA nod for generic Namenda tablets

Our Bureau, Mumbai — 07-May-2010

Sun was amongst the first ANDA applicants to submit a substantially complete ANDA with a paragraph IV certification to the 703 patent.

Digital DImensions

Sindhu Manjesh — 8-May-2010

Will you be hauled up for making personal copies of your favourite paid for downloads or for converting them to different formats for private use under the provisions of the proposed Copyright Amendment Bill

Sensitisation workshop organised on Intellectual Property Rights

Special Correspondent — 8-May-2010

It targeted Micro Small and Medium Enterprise sectors

Indian Copyright Act: Whose copy is it?

Sindhu Manjesh — 8-May-2010

The Indian Copyright Act 1957 has seen a few amendments in the past in the 80s and 90s but it is widely acknowledged that it is far outdated and does not reflect the reality of a rapidly evolving and interconnected global knowledge economy.

US rakes up Indian counterfeit drugs issue wants data protection

Joseph Alexander, New Delhi — 10-May-2010

Placing India yet again in the priority watch list in 2010 the United States has once again raked up the issue of counterfeit medicines as a grave concern and has strongly sought protection for undisclosed test and other data generated for approval of pharma products.

MSF welcomes Indias decision to reject drug patent to Roche

PTI — 10-May-2010

Medicins Sans Frontieres an international medical humanitarian group today welcomed Indias decision to reject a patent granted to Swiss drug multinational Roche for its AIDS related drug Valganciclovir.

Merck Settles Patent Infringement Case for Zetia® ezetimibe

EDT — 10-May-2010

Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. USA and Glenmark Pharmaceuticals Ltd. have reached an agreement to settle their patent litigation involving Glenmarks challenge to Mercks patent covering ZETIA ® (ezetimibe).

Singapore for greater access to Indian generic drugs

Press Trust of India — 11-May-2010

India on Tuesday signed a pact with Singapore for greater market access for its generic offpatent drugs in the South East Asian nation.

Google Yum Mattel PepsiCo: Intellectual Property

Victoria Slind-Flor — 11-May-2010

GreenShift Corp. a New York based company that developed and commercialized clean technologies sued 15 ethanol producers for patent infringement.

Stocks to watch: Tata Power Fortis Healthcare Jindal Steel MMTC Jubilant Foodworks Glenmark

ET Bureau — 11-May-2010

Merck and Glenmark Pharmaceuticals Inc. and Glenmark Pharmaceuticals have reached an agreement to settle their patent litigation involving Glenmarks challenge to Mercks patent covering ZETIA.

Ranbaxys US arm to face patent infringement suit

Joe C Mathew / New Delhi — 11-May-2010

Ranbaxy Pharmaceuticals Inc had applied for marketing approval of a version of Purdues painkiller Oxycodone.

Glenmark Merck settle patent row over Zetia

Sachin Kumar — 11-May-2010

Glenmark Pharmaceuticals and Merck have agreed to settle their patent litigation on Mercks patent covering Zetia a cholesterol lowering drug.

Ranbaxy Labs: Growth strategy fructifies

Priya Kansara Pandya & Akash Joshi / Mumbai — 12-May-2010

The US Food and Drug Administration allows 180 days of exclusive marketing rights to the first company that successfully challenges a patent on a medicine.

Microsoft loses as Toronto firm wins claim over Word patent

Indo-Asian News Service — 12-May-2010

Ruling against Microsoft the US Patent and Trademark Office on Tuesday confirmed a patent held by Toronto based i4i Inc.

Big pharma aims for reinvention

Andrew Jack — 12-May-2010

With some of his most profitable medicines going off patent and the uncertainty of replacement drugs continuing to rise US healthcare reform has been the least of Andrew Wittys recent worries.

Suven Life gets Canadian and Eurasian patent for NCE

Our Bureau, Mumbai — 12-May-2010

Suven Life Sciences has received third product patent from the Canadian Patent office and sixth from Eurasian Patent office corresponding to the New Chemical Entity for treatment of disorders associated with Neurodegenerative diseases.

Ranbaxy Medicis end drug row

Soma Das — 12-May-2010

Ranbaxy has reached an out of court settlement with Medicis on acne drug Solodyn minocycline hydrochloride last week.

The Roche test

Latha Jishnu / New Delhi — 13-May-2010

The Valcyte case is vital as it bars incremental innovation and recognises the right of patient groups to oppose patents

Aurobindo gets USFDAs tentative nod for Crestor

PTI — 13-May-2010

Aurobindo Pharma on Thursday said it has received tentative approval of the US Food and Drug Administration for the generic version of Crestor tablets used in the cardiovascular therapeutic area.

India Brazil drag EU to WTO

D Ravi Kanth / Geneva — 13-May-2010

Raise trade dispute against EU over seizure of generic drugs.

Balaramapuram Sarees gets IPR protection

UNI — 14-May-2010

Keralas prestigious Balaramapuram Sarees have become the first handloom product in the state to receive the Intellectual Property Rights protection through Geographical Indications Act.

IFPMA defends involvement of IMPACT on counterfeit issue

Joseph Alexander, New Delhi — 14-May-2010

Patents have nothing to do with counterfeiting and counterfeiting has nothing to do with patents.

Authority sets aside patent gives hope to patient groups

Rema Nagarajan — 14-May-2010

For the first time in the country patient groups have won the right as interested parties to challenge the patent granted for a medicine.

Mahabaleshwar strawberry gets GI status

Hrishikesh Joshi / Mumbai/ Pune — 14-May-2010

After Puneri Pagadi Solapurs chadar and towels Yeolas Paithani Alphonso mangoes of Konkan Nashik grapes and wine now Mahabaleshwars Strawberries has joined the illustrious league of Geographical Indication status after receiving the registration from the Ministry of Commerce.

FTA? Nothing free about it

Biraj Patnaik — 14-May-2010

Further over the past few years India has developed a patent regime that gives precedence to patient rights over the interests of pharma companies emerging as one of the major sources for cheap generics being used worldwide.

A patent shortage

Business Standard / New Delhi — 14-May-2010

India needs a more efficient patents office

DCGI associates with commerce ministry to reexamine spurious drugs definition

Nandita Vijay, Bangalore — 15-May-2010

Drugs Controller General of India in association with Union Ministry of Commerce & Industry has started an exercise to reexamine the definition of spurious drugs in the wake of recent seizures of Indian generic drugs by the EU authorities.

Police to ensure proper investigation

Express News Service — 15-May-2010

In the wake of the increasing incidents of infringement on intellectual property rights the state police are initiating various measures to ensure proper investigation into cases registered under the Copyrights Act.

Pharma export council to open offices abroad

P B Jayakumar / Mumbai — 15-May-2010

Indias $12 billion Rs 53500 crore pharmaceutical industry earns 40 per cent of its revenue from exports of off patent generic drugs.

Strategies for growth and survival

P.T. Jyothi Datta — 15-May-2010

This combines with increasing costs and high rates of genericisation drugs going off patent make it a difficult environment for drug companies.

EU confronted on herbal medicines & chemicals ban

Amiti Sen — 15-May-2010

India has taken up with European Union the issue of its traditional medicine and chemical industries that are set to face various import restrictions in the European Union.

Ranbaxy Lupin to benefit most from Japans push for generics

C.H. Unnikrishnan — 16-May-2010

The firms will have an edge over their Indian counterparts that do not have a Japanese parent or subsidiary

Microsoft settles with VirnetX to pay $200 mn

Reuters / New York — 17-May-2010

Microsoft Corp will pay $200 million to VirnetX Holding Corp and obtain a patent licence to settle litigation accusing it of infringing two patents for communicating over the Internet.

Indian pharmas emerging foray

BV Mahalakshmi — 17-May-2010

They are also improving their intellectual property and regulatory markets.

Indian Patent Office sets aside patent granted to Roche for valganciclovir

Our Bureau, Mumbai — 18-May-2010

In a significant decision the Indian Patent Office at Chennai in its decision on April 30 2010 has set aside the patent granted to Roche for valganciclovir.

Venus Remedies gets India patent for painkiller

Reuters / Mumbai — 18-May-2010

Drug maker Venus Remedies Ltd said on Tuesday it secured an Indian patent for its once a day painkiller Aceclofenac injection.

Lupin loses battle to launch antibiotic in US

Soma Das — 18-May-2010

The district court enjoined Lupin from infringement during the extended term of the patent.

AstraZeneca Teva settle generic budesonide capsules patent litigation

London — 19-May-2010

AstraZeneca has entered into an agreement with Teva Pharmaceuticals USA Inc formerly Barr Laboratories Inc to settle patent litigation regarding Tevas proposed generic version of AstraZenecas Entocort EC capsules

World Health Assembly opens with counterfeit issue as part of agenda

Joseph Alexander, New Delhi — 19-May-2010

In response to the Director Generals request for information on use of the term counterfeit medicines and related definitions 55 Member States and the European Commission have so far provided answers and a preliminary summary was presented to the Member States at an open forum held in Geneva on March 26 2010.

India EU consultations on drug seizure to start next week

Press Trust of India / New Delhi — 19-May-2010

India and the European Union will, next week start World Trade Organisation-mandated consultations to resolve a dispute over the seizure of Indian pharmaceutical consignments in Europe.

India EU ready for consultation to resolve drug seizure issue

Our Bureau — 20-May-2010

The seizure of several consignments of medicines was on the patent infringement grounds.

India seeks new WHO policy for fake drugs

Soma Das — 20-May-2010

The government has urged the World Health Organisation to address the issue of spurious substandard drugs through an effective alternative instead of clubbing it as a counterfeit issue.

German Court Revokes Glaxos Advair Patent

By STEN STOVALL — 20-May-2010

GlaxoSmithKline PLC said Thursday that Germanys Federal Patents Court revoked its patent for key product Advair handing a victory to generic drug makers Mylan dura GmbH Hexal AG Neolab Ltd. and Ivax International B.V. and highlighting the world wide generic threat to Glaxos blockbuster lung treatment.

Why MNCs are keen on data protection for pesticides

Harish Damodaran — 21-May-2010

The 20 year protection period in India applies only with respect to product patents filed after January 1 1995.

India asks WHO to drop IMPACT and set up new member driven programme

Joseph Alexander, New Delhi — 21-May-2010

India has urged World Health Organisation to replace WHOs involvement in the International Medical Products Anti counterfeiting Taskforce with an effective programme to address the issue of quality safety and efficacy and to ensure that the new programme avoids conflicts of interests.

Gains in crop protection sector stocks may continue

M.R. Subramani — 21-May-2010

One of the problems faced by the sector is the lack of patent protection in the country.

Mango: The King Is Now G.I. Joe

21-May-2010

According to legend a donkey once walked about a mango tree laden with ripe Dussehris.

Piramal deal will give Abbott India size

Ram Prasad Sahu / Mumbai — 22-May-2010

As part of its strategy to move beyond the proprietary or patented drugs business Abbott recently set up the Established Product Business globally.

Kites flies into copyright controversy

DNA Correspondent — 22-May-2010

Of the many controversies threatening to ground Hrithik Roshan starrer Kites this one has leapt right out of a storyboard.

Ranbaxy to roll out generic version of Lipitor in Canada

Press Trust of India — 22-May-2010

Ranbaxy Laboratories on Friday said it has got the approval of Canadian health regulator to market the generic version of cholesterol lowering medicine Lipitor worlds largest selling drug in Canada.

More foreign suitors expected

Joe C Mathew / New Delhi — 22-May-2010

But acquisitions also likely to get more expensive.

Dr Reddys launches drug to treat organ rejection in US

Priyanka Pulla — 22-May-2010

Dr Reddys can expect an additional $25 million in sales in fiscal 2011 from the tacrolimus capsules

Abbott buys Piramals pharma arm for $3.7bn

TNN — 22-May-2010

The India story is an attractive growth story but globally and in emerging markets there is a new way of selling drugs patented products which we would not have been able to do on our own Ajay Piramal chairman of the Piramal group told TOI.

India keen to play lead role in Nagoya meet

ET Bureau — 23-May-2010

Besides the Biological Diversity Act 2002 and the national Biodiversity Authority India has also put in place a traditional knowledge database the Traditional Knowledge Digital Library.

EU seizure of Indian drugs improper: WHO

Sujay Mehdudia — 23-May-2010

In a statement issued in Geneva the WHO on Thursday rapped the EU for seizing the Indian generic drugs in transit for patent violation.

Many Species One Planet One Future

Narayani Ganesh — 23-May-2010

India is not only being proactive in acknowledging the symbiotic link between biodiversity and climate change it was also trying to bring together the CBD and TRIPPS agreement of the WTO through pushing for an amendment of Article 29.

Rise of Big Pharma will make drugs dearer

Priyanka Golikeri — 23-May-2010

Industry estimates suggest that by 2015 when the Indian pharmaceutical market would be worth $20 billion about 15 per cent of total drugs would be patented molecules.

Venus Remedies: Attractive bet among small cap space

Kiran Kabtta Somvanshi — 24-May-2010

In March 2010 the company got Indian patent for one of its product Sulbactomax and has also filed patent for this product in another 50 countries including the US Europe Australia Japan and Latin American countries.

Discuss FTA talks with EU in Parliament: CPM to govt

ET Bureau — 24-May-2010

On Intellectual Property it said the EU is asking for TRIPS plus provisions and rewriting of Indian patent and copyright laws.

MNCs back in control of 50% of Indian pharma market

Khomba Singh — 24-May-2010

But global MNCs in the face of shrinking revenues and the prospect of further losses when patents of drugs worth $70 billion expires by 2013 began to amplify their presence in generics from 2008.

Half full half empty

Business Standard — 25-May-2010

Pharma majors who have a lot of complaints about the patents regime in India nevertheless appear willing to pay a high price to get in.

Winds of change in pharmaceutical industry

Muralidharan Nair — 25-May-2010

The interest that big pharma firms have evinced in the Indian pharma market has undergone a sea change over the years

Pharma mergers & acquisition wave has roots in product patent regime

Priyanka Golikeri — 25-May-2010

It all began on August 28 2006 when the Pennsylvania US based Mylan Inc bought Hyderabad-based Matrix Laboratories for $736 million.

Pharma MNCs will call the shots soon

Khomba Singh — 25-May-2010

Global MNCs lorded over 75% of the countrys drug market before the Indira Gandhi led government adopted a process of patent regime in 1971.

Tune in for everything on intellectual property

Madhumathi D.S. — 25-May-2010

Its a patently different kind of radio.

Novo sues Lupin to block generic in US

Khomba Singh — 25-May-2010

Danish company Novo Nordisk has sued Mumbai based drugmaker Lupin to prevent it from launching the low priced version of its patented diabetes medicine sold under the brand Prandimet in US.

Sun Pharma chief sees more consolidation ahead

P.T. Jyothi Datta — 26-May-2010

Sun Pharma has stopped selling Protonix generic pantaprazole in the US despite being confident on its litigation due to abundant caution he explained.

Should pharma firms sell out?

Business Standard / New Delhi — 26-May-2010

Two for big pharma firms given the patent laws that came into effect in 2005 and given that they have already expanded both geographically and across therapeutic areas it is harder to look at growth rates far in excess of market growth rates.

Ranbaxy seeks USFDA approval for new drug

Khomba Singh — 27-May-2010

RANBAXY Laboratories has sought the US drug regulators approval to sell a new drug in the worlds largest pharma market that has been manufactured in a unit of its Indian factory which is under scrutiny of the US regulator.

Government doctors asked to promote generic drugs

Special Correspondent — 27-May-2010

According to the World Health Organisation report prepared for the National Rural Health Mission Promoting Rational Drug Use under NRHM generic drugs which are usually produced when a branded drug loses its patent can tremendously increase the availability affordability and efficient use of medicines.

Piramal to launch own drug by 2012

By James Fontanella-Khan and Joe Leahy in Mumbai — 27-May-2010

The countrys low cost research and production facilities and traditionally weak intellectual property regime have encouraged the development of a strong generic pharmaceutical industry but local drugs groups are now keen to formulate their own drugs.

Whos afraid of Synthia

Latha Jishnu / New Delhi — 27-May-2010

Venters patent application for his synthetic cell creation has set off a frenzied debate on monopolies in genetic research

Founders of many Indian pharma companies keen to exit: Malvinder

Khomba Singh — 28-May-2010

Indian generics companies are an attractive target for overseas multinationals which are faced with loss of revenues due to the expiry of patents worth $70 billion by 2013 and a squeeze on margins.

Grape seizures at EU port: India sends delegation to sort out

Asit Ranjan Mishra — 28-May-2010

The commerce ministry has sent a delegation to Rotterdam to try and convince officials at the European port that Indian table grapes were being wrongly seized over the alleged presence of chemical preservatives

Patent linkage impermissible in India: Cipla

Indu Bhan — 28-May-2010

The dispute between Indian drug companies and the Big Pharma over patent linkage has reached the domain of judiciary.

India plans front to nip new piracy law

ET Bureau — 29-May-2010

India will strive to forge a united front against an anti counterfeiting agreement being negotiated by some developed countries which could threaten exports of genuine off patent drugs information technology and other products from emerging markets.

Sellout syndrome

Sanchita Sharma — 31-May-2010

Medicines worth over $ 80 billion are going off patent at the US Patent and Trademark Office between 2011 and 2013 making it lucrative for global pharma majors to increase their presence in India which is the largest producer of generic medicines after the US and European Union.

Much ado on basics of drug policy

Indira Kannan / New York — 31-May-2010

Cipla arm flexing with US university underscores validity concerns on patent issues.

Norms for foreign telecom gear cos may be eased

Joji Thomas Philip — 31-May-2010

The review comes after global network vendors as well as sections of the government including the communications ministry informed the home ministry that the new rules are inconsistent with Indias commitments on intellectual property rights in multilateral global forums such as WTO.

Union govt ready with draft guidelines for 5th amendment of the D&C Rules 2010 for Ayush drugs

Nandita Vijay, Bangalore — 31-May-2010

For the issue of licenses for patent and proprietary drugs safety study report is not required but manufacturers will need to submit a pilot study according to the protocol of Ayurveda Siddha and Unani drugs.

Legally bound

Business Standard / New Delhi — 31-May-2010

Going by official reckoning some 2000 patents related to Indian systems of medicine are granted every year in the US Europe and elsewhere.

Not many Indian pharma cos are left for sale

Vishal Dutta — 31-May-2010

The recent takeovers in the pharma space have raised concerns among Indian players.

India Big pharmas new battle field

BV Mahalakshmi, Sudhir Chowdhary — 31-May-2010

Global pharmaceutical companies are living in an era of change.

More generic cos keen on selling out to MNCs

Khomba Singh — 31-May-2010

Indian generics companies are an attractive target for overseas multinationals which are faced with loss of revenues due to the expiry of patents worth $70 billion by 2013 and a squeeze on margins.

Lupin set to acquire?second generics firm in Japan

C.H. Unnikrishnan — 1-Jun-2010

The Japanese government plans to convert at least 30% of the countrys prescription drug market to low cost generics or off patent drugs by 2012.

Foreign telecom gear cos may get relief

Joji Thomas Philip — 1-Jun-2010

The review comes after global network vendors and sections of the government including the communications ministry informed the home ministry that the new rules are inconsistent with Indias commitments on intellectual property rights in multilateral global forums such as WTO.

As trade pacts kick in farm fears run high

Priyanka Golikeri — 1-Jun-2010

The objective of UPOV 91 is to protect new plant varieties through intellectual property.

Copyright copywrong

Nilanjana S Roy / New Delhi — 1-Jun-2010

The fantasy of any Indian reader whos travelled to countries with bigger and better bookstores is simple: we want to be able to buy the books we love when they come out.

India to oppose pact by US Europe on counterfeiting

1-Jun-2010

The commerce ministry is likely to voice its its opposition to the US and Europe Unions Anti Counterfeiting Trade Agreement arguing its passage would create non tariff barriers for the trade of Indian intellectual properties.

GlaxoSmithKline tries a Linux approach to drugs

Robert A. Guth, The Wall Street Journal — 1-Jun-2010

Similarly large pharmaceutical companies tightly guard their formulas for drugs and other intellectual property.

India gets help in drugs piracy fight

Amiti Sen — 1-Jun-2010

A number of developing countries from East Asia Latin America and Africa have extended their support to India in its fight against an attempt by developed countries to narrow the difference between fake medicines and counterfeits.

News brief

Hindustan Times — 01-Jun-2010

The next batch of nine month postgraduate diploma in Intellectual Property Rights and Patent Management will commence on June 17 2010.

Bajaj Auto gets Chinese patent for ExhausTec technology

PTI — 01-Jun-2010

Two wheeler major Bajaj Auto on Tuesday said its ExhausTec technology used to improve power in single cylinder four stroke engines has been granted a patent in China.

Zydus arm Irish co in patent dispute

Vishal Dutta — 2-Jun-2010

The Rs 3700 crore Zydus Groups US subsidiary Zydus Pharmaceuticals USA has challenged the Irish company Shire Pharmaceuticals over its patented gastro drug Lialda.

Takeda drags Dr Reddys to court over diabetic drug

Soma Das — 03-Jun-2010

The largest Japanese drug firm Takeda Pharma has sued Hyderabad based Dr Reddys Labs for allegedly infringing the formers patent coverage on anti diabetic drug Actos by trying to manufacture and market the same in the US.

Kenya sees cure in Indian generics now

Amiti Sen — 03-Jun-2010

The Kenyan health ministry has conceded that the country should not have passed the anti counterfeit law last year and said it would try and make changes to ensure that imports of legitimate generics were not affected.

Glenmark puts IPO of generics arm on hold

Radhieka Pandeya — 04-Jun-2010

Glenmark Pharmaceuticals Ltd has deferred the planned initial public offering of its wholly owned generics arm Glenmark Generics Ltd because it is no longer in desperate need of money.

Fake drugs are a real menace

Nick Schulz — 04-Jun-2010

Quality and safety concerns hurt Indias pharmaceutical promise.

Trademarks section to move out of IP office

C.H. Unnikrishnan — 04-Jun-2010

India plans to spin off the trademark registry from its intellectual property office which currently deals with trademarks patents and designs.

Karnataka pharma majors bullish over European export prospects

Nandita Vijay, Bangalore — 7-Jun-2010

Liquidity crunch and growing uncertainty in the Euro zone have not deterred the Karnataka based pharma companies from expanding their operations and also patent filing in Europe.

House panel suggests drastic changes to innovation Bill

C.H. Unnikrishnan — 7-Jun-2010

The new draft proposes to give the government the right to use any invention patented by a state funded institution

India to patent yoga asanas

Madan Jaira — 7-Jun-2010

The Council for Scientific and Industrial Research has prepared patent formats of nearly 900 yoga asanas to prevent European and American companies involved in fitness related activities from claiming them as their own.

Scent of the jasmine

K Shashidhar Hemmanna — 8-Jun-2010

Then theres the issue of patenting these flowers.

PM has failed to outline our priorities

Bharat Jhunjhunwala — 8-Jun-2010

The international dimension of health problems arises mainly through patent laws which enable multinational corporations to charge exorbitant prices for patented drugs.

EU firm on strong IP provision in free trade

Priyanka Golikeri — 8-Jun-2010

A key provision in the draft of the India European Union free trade agreement may have implications on the affordability of medicines while also hurting the negotiations between the two trading blocs.

Differences crop up again at Bonn

Urmi A Goswami — 8-Jun-2010

The differences over intellectual property regime continue to be hotly contested with the developed world arguing that intellectual property be protected.

Weve nothing to lose

Hindustan Times — 8-Jun-2010

When an enterprising American wants a patent on the Paschimottanasana we in India say by all means go and grab that copyright.

Ericsson claims pole position in patents for 4G technology

Geeta Nair — 8-Jun-2010

Even though 3G has not yet been launched in many markets telecom companies have already focused attention on a next generation mobile technology LTE .

India China move WTO on Trips plus West agenda

Amiti Sen — 8-Jun-2010

The two countries have asked the WTOs Trips council to include the issue of Trips plus enforcement trend in the agenda for its meeting this week in order to examine the sanctity of an agreement being planned by a group of countries that goes beyond what they have agreed to under the WTO.

AIPS to hold seminars on patent opposition in Mumbai on June 25 and 26

Our Bureau, Mumbai — 9-Jun-2010

Academy of Intellectual Property Studies will organise two back to back seminars on Patent Opposition and How the Indian Patent Office Decided in 2009 which are to be held on June 25 and 26 2010 in Mumbai.

Global drug makers see big business in anti cancer market

C.H. Unnikrishnan — 09-Jun-2010

Though patent rights for some of these expensive anti cancer drugs protect the foreign companies from competition a highly price sensitive market in India and emerging competition from local drug makers makes it imperative for them to adopt aggressive market development strategies.

Glenmark scores over Sanofi Abbott in US patent challenge

ET Bureau — 9-Jun-2010

Glenmark Pharmaceutical has scored in its patent tussle with Sanofi Aventis and Abbott after the New Jersey district court upheld the challenge by the Indian company for a hyper tension drug.

Waking up to ACTA

Latha Jishnu / New Delhi — 10-Jun-2010

It goes well beyond curbing trade in counterfeit goods and is a brazen attempt to create higher stands of intellectual property protection than envisaged in the globally mandated TRIPS agreement of the World Trade Organisation.

Lakhnavi zardozi to get GI tag soon?

Shailvee Sharda — 10-Jun-2010

Metallic wire kora saadi kinari salma badla sequins and stones... lying scattered these sparkling trappings may not mean much.

Dream Theatre bags rights for iconic brands

Bindu D. Menon — 11-Jun-2010

The licensing industry is set to piggy back on the growth of organised retail with a slew of brands making inroads in India.

Publishers plight

Meethil Momaya — 11-Jun-2010

This refers to Copyright copywrong June1.

Gilead Sciences mulls legal action against Lupin

Sakthi Prasad in Bangalore — 11-Jun-2010

U.S. biotechnology firm Gilead Sciences Inc said it may take legal action against Lupin Ltd after the Indian firm submitted an abbreviated new drug application to manufacture and market a generic version of its angina drug Ranexa.

Pfizer recalls 3 drugs made by Indian pharma company

Soma Das — 11-Jun-2010

The first glitches in the big pharma generic drug licensing alliance story have surfaced sooner than expected.

Grant in aid status for NIF soon

Vasundhara Vyas Mehta — 11-Jun-2010

NIF has filed 235 patent applications in India and seven patent applications in US.

Ranbaxy to start supply of API formulations to AstraZeneca

Radhieka Pandeya — 11-Jun-2010

The agreement between the two companies follows from a manufacturing agreement that was part of a bigger patent infringement settlement between Ranbaxy and AstraZeneca in April 2008.

Venus Remedies gets India patent for painkiller

Kaustubh Kulkarni & Bharghavi Nagaraju — 11-Jun-2010

Drug maker Venus Remedies Ltd said on Tuesday it has been granted a patent by Indian authorities for its once a day painkiller Aceclofenac injection.

RIM Motorola enter into license pact settle all litigations

Press Trust Of India — 12-Jun-2010

Blackberry maker Research In Motion and telecom major Motorola have entered into a global settlement and licensing agreement ending all litigations between them.

India raises concerns on proposed ACTA TRIPS Plus measures at WTO forum

Joseph Alexander, New Delhi — 12-Jun-2010

Raising concerns over the efforts by the developed countries to introduce provisions into trade agreements that go beyond the TRIPS agreement India has strongly raised objection to the proposed Anti Counterfeiting Trade Agreement which can adversely affect Indian pharma business.

India protests regional pact on intellectual property rights

Joe C Mathew / New Delhi — 12-Jun-2010

India has protested against the Anti Counterfeit Trade Agreement being negotiated by the United States the European Union and other countries on the grounds that it will strengthen the holders of intellectual property rights beyond reasonable measure.

US court injunction stops launch of Dr Reddys drug

BS Reporters / Mumbai/ Hyderabad — 13-Jun-2010

Analysts were expecting Allegra D24 to generate over $150 million in 3 years.

China Equador stand by India at WTO

Amiti Sen — 14-Jun-2010

China and Equador have come out in support of India in its fight against the European Union at the World Trade Organization for wrongful seizure of its generic or off patent drugs in transit to third countries.

US NGOs urge GWU to stop industry sponsored IP summits in India

Ramesh Shankar, Mumbai — 14-Jun-2010

A group of nine non governmental organisations working in the field of health sector have appealed to the George Washington University to stop its industry sponsored intellectual property summits in India as these summits have become a front for a biased industry agenda.

Bending over backwards to protect Indian yoga

Hannah Gardner Foreign Correspondent — 14-Jun-2010

Foreign countries are trying to patent it.

National Pharmaceutical Pricing Authority may cap cancer drug prices via Para 10

Vivek Seal — 15-Jun-2010

In a bid to control the high cost of cancer related essential drugs the National Pharmaceutical Pricing Authority may enact Para 10 B on specific drugs if negotiations with drug makers to reduce prices fail according to a government official.

Abbott sues Sun Ranbaxy on cholesterol drug patents

Soma Das — 15-Jun-2010

The US based pharma company Abbott has sued two top Indian drugmakers Ranbaxy Labs Ltd and Sun Pharmaceuticals in the US market alleging patent infringement in the cases of two different cholestrol drugs

Wary investors take refuge in pharma stocks

Harish Rao — 15-Jun-2010

Mr Jani also says that companies concentrating on the US generics market will see significant price appreciation because patents on many high potential molecules are going to expire in the coming five years giving them a huge opportunity to become global generic players.

AMRI Receives Approval of Preliminary Injunction Against Dr. Reddys

ag-IP-news — 15-Jun-2010

The positive outcome of this hearing bolsters our belief in the strength of AMRIs intellectual property rights related to Allegra.

Amendment to copyright law opposed by film producers

STAFF WRITER — 16-Jun-2010

A move to amend a 53 year old law to give independent rights to writers lyricists and singers thereby entitling them to royalty today came in for strong opposition from some film producers

Cipla unveils Rs 300 cr plan to foray into biosimilar space

BS Reporter / Mumbai — 16-Jun-2010

Cipla the largest domestic drug maker today said it would invest $65 million in three years to acquire a 40 per cent stake in an Indian biotech company and 25 per cent stake in a similar company in Hong Kong as part of its foray into biosimilars or generics of off patent biotech drugs.

Cipla aims to sell copies of Roche Amgen biotech drugs

Adi Narayan — 17-Jun-2010

Biotechnology drugs account for around 10 15% of the global pharmaceutical market and many of them are off patent or will lose patent protection soon Cipla said.

Suven gets patents for two CNS drugs in Japan

BS Reporter / Hyderabad — 16-Jun-2010

Suven Life Sciences Limited a Hyderabad based biopharmaceutical company has secured two product patents from the Japanese Patent Office for two of its new chemical entities indicated for the treatment of disorders associated with the central nervous system.

Wipro to provide legal process outsourcing to Microsoft

Bangalore — 17-Jun-2010

The business process outsourcing division of Wipro Technologies will provide legal process outsourcing to Microsofts intellectual property and licensing group worldwide the Indian IT bellwether said Wednesday.

India EU to hold talks on drug dispute next month

STAFF WRITER — 17-Jun-2010

At the instance of the WTO India and the European Union will try to resolve a dispute relating to seizure of Indian drugs by some European countries for alleged patent violations next month.

Big Pharma cuts R&D jobs as generics loom

REUTERS — 17-Jun-2010

One factor forcing Big Pharma to rethink its business model is the huge number of patents that are set to expire over the next five years.

Glenmark recalls child epilepsy drug in US

PTI — 17-Jun-2010

Oxcarbazepine is a generic version of Novartis patented drug Trileptal.

Ready for doosra

Anupama Chandrasekaran — 18-Jun-2010

But five years after the first prototype was created and the patent was applied for the product is yet to ring in sales or profits.

Drug developed by RSS body gets US patent

STAFF WRITER — 18-Jun-2010

An anti cancer drug extracted from cow urine and developed by an affiliate of the RSS has got a US patent for the third time for its anti genotoxicity properties a senior official has said.

The drug lords

Anika Gupta — 18-Jun-2010

Most Indian pharma firms dont even dabble in new drug development.

US lawmakers rap corporates for preferring China over India

Lalit K. Jha/PTI / Washington — 19-Jun-2010

American corporate giants faced a tough time on the Capitol Hill as lawmakers grilled them as to why they were opting to do business with communist China over a democratic India.

Developing countries reject WIPOs proposal for increasing reliance of national patent offices on ISERs

Ramesh Shankar, Mumbai — 19-Jun-2010

Twenty developing countries including India have rejected the World Intellectual Property Organizations proposal for increasing the reliance of national patent offices on international search and examination reports issued by International Search Authorities.

US EU cite safety issue in defence of piracy law

Amiti Sen — 19-Jun-2010

A group of developed nations led by the US and the EU has initiated discussions at the World Trade Organisation on legitimacy of their proposed anti counterfeit agreement.

Konkan Railway gets patent for anti collision device in the US

Prakash Kamat — 19-Jun-2010

Konkan Railway Corporation Ltd has been granted the anti collision device patent in the US for its Track Identification System recently.

Tea fights lingerie in patent row

Zia Haq — 19-Jun-2010

India continues to fight off attempts by entities around the world from staking claim to Darjeeling tea the worlds most expensive variety.

Kenyans could soon patent local products

By MWANIKI WAHOME — 20-Jun-2010

Local producers will for the first time be able to acquire patents for commodities that are unique to their geographical areas once a Bill at the Attorney Generals office is enacted.

IIT Bombay streamlines technology licensing

Mihika Basu — 21-Jun-2010

Whats more for the first time IIT B is also advertising all its intellectual property which can be licensed.

Drugmakers rush for a lift from US hormones mart

Priyanka Golikeri — 21-Jun-2010

Indian drugmakers are queuing up to get a piece of the lucrative hormones market in the US which is growing at a fast pace.

Scientist uses waste to make biodegradable plastic sheets

Kautilya Singh — 22-Jun-2010

On June 14 Mathuria applied for a patent at the Controller of Patent Office in New Delhi.

Lunch with BS: Richard Jefferson

Latha Jishnu / New Delhi — 22-Jun-2010

Appalled by the patent thickets that were stifling biotech research Jefferson decided that the basic tools of biotechnology such as his GUS technology that allowed molecular biologists to monitor exactly what was going on when they were trying to implant foreign genes into an organism should be freely available.

Otsuka sues Zydus for Para IV patent infringement of blockbuster drug Abilify

Gireesh Babu, Mumbai — 22-Jun-2010

Zydus has filed ANDA with the US FDA to sell generic products containing 5 10 15 20 and 30 mg of aripiprazole in US market according to the complaint.

Draft legislation ready to spin off trademark division

C.H. Unnikrishnan — 22-Jun-2010

The commerce ministry has prepared a draft law to move the trademark wing of the intellectual property office out of the purview of the controller general of patents designs and trademarks.

Teva execs remark creates furore in Indian pharma

Joe C Mathew / New Delhi — 22-Jun-2010

Domestic drugmakers used to frequent India bashing by research driven global pharmaceutical majors for alleged infringement of patent rights or quality issues were in for a shock last week when the worlds largest generic company Israels Teva made allegations against the industry practices in India and China.

Suven looks for global tie ups for new drugs

C.H. Unnikrishnan — 22-Jun-2010

Hyderabad based drug maker Suven Life Sciences Ltd is looking for partnerships with global pharma firms to market new drug candidates after winning discovery patents for treatments of some of the modern worlds most common ailments.

Sun settles patent row over Parkinsons drugs with Orion

PTI — 22-Jun-2010

Sun Pharmaceutical Industries today said it has settled patent litigation with Finland based Orion over generic versions of Stalevo and Comtan tablets which are used for the treatment of Parkinsons disease.

US asks India to address longstanding impediments to trade

IANS — 23-Jun-2010

US Trade Representative Ron Kirk also listed intellectual property rights and the need for continuing regulatory streamlining and transparency among the impediments at a meeting Tuesday with Indian Commerce and Industry Minister Anand Sharma according to an official US readout.

India to be battleground for off patent biotech drugs

Priyanka Golikeri — 23-Jun-2010

Although the growth opportunity for off patent versions of biotech medicines is huge in the developed world regulatory hurdles there mean India and rest of the developing world could be where the opportunity lies for biopharmaceutical companies.

Trademark battles catch city firms off guard

TNN — 23-Jun-2010

This firm got its name registered as a trademark in India in 2005 and applied for the same with the US Patent and Trademark Office.

Sun Pharmas US outlook improves

Ravi Ananthanarayanan — 23-Jun-2010

Sun Pharma received just one approval from the US Food and Drug Administration to market a generic drug

Developing nations slam WIPO reform suggestions

Joe C Mathew / New Delhi — 23-Jun-2010

The international patent reform plans pursued by the World Intellectual Property Organization have been criticised by several developing countries including India after they felt it may have an impact on the decision making powers of national patent offices

Patent expiry may open $90 bn market for Dr Reddys

Adi Narayan — 23-Jun-2010

Dr Reddys Laboratories Ltd may be the biggest beneficiary among Indian generic drug makers as $157 billion of medicines including Eli Lilly and Co.s Zyprexa lose patent protection within five years HDFC Securities Ltd said.

Mauled Bollywood seeks script change bets on co production

Nandini Raghavendra — 24-Jun-2010

Depending on deal to deal the intellectual property rights or IPR in a co production could be for perpetuity or for a number of years.

An odd royalty calculus

Latha Jishnu / New Delhi — 24-Jun-2010

For years now at least since India passed amendments to the Patent Act to allow product patents in 2005 patents on drugs have coloured and overwhelmed the debate on health issues in the country.

India asks US to remove ISRO DRDO from banned list

IANS — 24-Jun-2010

Asked about Kirks calls to India to address longstanding impediments like investment caps agricultural market access barriers high tariffs and intellectual property rights Sharma said he had conveyed that India was fully TRIPS compliant.

Trademarks office ushers in glasnost

C.H. Unnikrishnan — 24-Jun-2010

Indias Controller General of Patents Designs and Trademarks has placed in the public domain details of pending trademark applications registered trademarks examination reports copy of applications opposition to such applications and other information in a move that is certain to increase transparency into the workings of the department.

India foils Chinese bid to patent pudina

Kounteya Sinha — 24-Jun-2010

India has foiled a major Chinese bio piracy bid to patent the use of medicinal plants pudina mint and kalamegha andrographis for the treatment of H5N1 avian influenza or bird flu.

Rediff wins cybersquatting case against Pakistani individual

Press Trust Of India — 28-Jun-2010

Online services major Rediff.com India Ltd has won a cybersquatting dispute against a Pakistani person who was using an identical domain name and illegally incorporating the Indian firms trademark.

Indias growing CRAMS pie a cause of joy for Jubilant

Nitin Shrivastava — 28-Jun-2010

The Indian pharmaceutical industry is witnessing lot of interest with huge opportunities in the global contract manufacturing and generic space for supply of low cost off patent drugs.

Indias Sun Pharma to stop selling Eloxatin generic

Sumeet Chatterjee — 28-Jun-2010

Sun Pharmaceutical Industries will stop selling generic version of Sanofi Aventis cancer drug Eloxatin in the United States after June 30 following a court order the Indian drugmaker said.

Indian Trademark Rules 2000 Amended

ag-IP-news — 28-Jun-2010

Abu Ghazaleh Intellectual Property announced in a press release that the Indian Trademark Rules 2000 have been amended.

Cipla in talks with Centre to share cancer drug know how

Khomba Singh — 28-Jun-2010

The initial discussions are related to 10 off patented cancer drugs said a person familiar with the matter adding that the talks centred on the number of drugs and the processes involved in transferring knowledge.

Animation industry seeks IP fund

BV Mahalakshmi — 28-Jun-2010

But creating intellectual property was not easy due to a lack of understanding the value of intellectual property rights.

Venus Remedies gets patent for pneumonia drug in New Zealand

Press Trust of India / New Delhi — 28-Jun-2010

Pharma firm Venus Remedies today said that it has received patent for its anti pneumonia drug in New Zealand and hopes to generate handsome revenues there following the grant.

Mid size drug cos look for angel investors

P.T.Jyothi Datta — 28-Jun-2010

Is intellectual property protection still the domain of big fish in the pharmaceutical industry five years after the country brought in the product patent regime?

Pharma research outsourcing faces speed bumps

PB Jayakumar / Mumbai — 29-Jun-2010

Venkat Jasti vice chairman and managing director of Suven Life Sciences is an optimist on new drug discovery.

Teva launches generic of AZs breast cancer drug Arimidex

By Kevin Grogan — 29-Jun-2010

Teva Pharmaceutical Industries says that it has been given the green light by regulators in the USA to sell its generic version of AstraZenecas cancer blockbuster Arimidex.

Kotak Mahindra Bank may edge higher on preferential issue to Japans SMFG

Capital Market — 30-Jun-2010

Swiss drugmaker AstraZeneca has reportedly sued Glenmark Pharmaceuticals in the US last week alleging the infringement of its patent on cholesterol lowering drug Crestor.

Looking Beyond The Hype

Sumit Bhaduri — 30-Jun-2010

Low cost labour in the developing world and uniformity in patent rights in more than 100 nations are the two factors that have had maximum impact on the innovation process.

AstraZeneca sues Glenmark Generics in US for patent infringement of Crestor

Our Bureau, Mumbai — 30-Jun-2010

The Anglo Swedish drug maker AstraZeneca Pharmaceuticals has filed a fresh Para IV patent infringement law suit against Glenmark Generics Inc the North American division of Mumbai based Glenmark Generics Ltd in the US in June 2010 for attempting to manufacture and sale of generic version of its blockbuster cholestrol lowering drug Crestor before expiry of patent validity

New xxx registry has companies worrying over brand poaching

Surabhi Agarwal — 1-Jul-2010

The World Intellectual Property Organization decided in favour of the Tata group Makemytrip.com is still contesting the decision.

Push to launch EU wide patent

Nikki Tait in Brussels — 01-Jul-2010

Top European Union officials and diplomats on Thursday began a new push to introduce a single EU wide patent a move which could slash costs faced by innovative companies trying to protect their inventions but which has proved politically elusive for decades.

Delisting pill yet another time

Ram Prasad Sahu — 1-Jul-2010

The Swedish parent company won an international lawsuit on Tuesday which will help it to keep the patent on the drug till 2016.

Hic! Feni fights to regain turf in Goa

Chandu Gopalakrishnan — 1-Jul-2010

After a very long campaign feni a beverage distilled out of cashew apple got geographical indication in 2009.

AstraZeneca loses ulcer drug appeal

Nikki Tait in Brussels — 2-Jul-2010

On Tuesday the group won an initial court victory in the US in a different patent battle prompting its shares to rise strongly.

Natco Pharmas earnings on track

Jwalit Vyas — 2-Jul-2010

However when a drug goes off patent there is a substantial market size erosion due to the lower price offered for the same drug by several generic manufacturers.

India foils Danish firms bio piracy bid

Kounteya Sinha — 2-Jul-2010

After stopping the Chinese from patenting pudinas health benefits India has now foiled a major bio piracy bid by a Danish company to patent ginger jeera cumin onion and turmerics fat burning properties.

Move to better access to drugs a welcome change

Pillman — 02-Jul-2010

In India Gilead has entered into manufacturing deals with companies like Emcure and Strides but at the same time it is embroiled in litigations with Cipla over Viread.

One man to run the show at Hubli Spices Board

Vincent D\'Souza — 02-Jul-2010

He said the staff crunch will affect the field offices achievements at a time when it is expecting the geographical indication tag for Byadagi chilli.

Fake soft drink unit busted in northeast Delhi

Indrani Basu — 3-Jul-2010

A case of infringement of Indian Copyright Act 1957 and Patents Act 1970 has been filed against the accused.

Basmati trademark registration delay to hurt exports: growers

Shahid Shah — 3-Jul-2010

Decision of trademark registration of Basmati rice is pending in the Sindh High Court for over two years which is likely to have a negative impact on the rice trade of Pakistan a representative rice growers said on Friday.

Producers too want rights over film music

B Ramakrishna / Chennai/ Hyderabad — 6-Jul-2010

Telugu film producers have set forth their claim over film music as a piece of intellectual property arguing that such music is composed in the context of a particular film and so forms part of it.

Industry urges govt to remove clause on\'Patent status in Form 44 of D&C Rules

Ramesh Shankar, Mumbai — 6-Jul-2010

The pharmaceutical industry in the country has urged the union health ministry to remove the clause relating to the Patent status of the drug from the Form 44 of Drugs and Cosmetics Rules on the plea that the clause on the patent status of the drug only favours the patent holder to delay the entry of a generic drug in the market.

Govt expands royalty share in IP Bill to deflect criticism

Nistula Hebbar — 6-Jul-2010

The Bill to channel more patents from Indian universities for use in industry is now better placed to clear Parliament.

Split royalty

The Financial Express — 7-Jul-2010

The reported decision of the government to split the royalty from publicly funded research projects between the researchers the institution and the government in the new Protection and Utilisation of Publicly Funded Intellectual Property Bill which is to be reintroduced in the monsoon session of Parliament is a welcome step that can help accelerate the pace of innovations and encourage patenting.

Foreign parent need not pay for marketing intangibles

Deepshikha Sikarwar — 7-Jul-2010

The officer also ruled that SMC failed to compensate MSIL for the use of its trademark Suzuki which according to him was then a weak brand in India whereas Maruti was a strong brand.

International experts claim ACTA to threaten global access to affordable medicines

Our Bureau, New Delhi — 7-Jul-2010

Akin to the stand taken by India at the international forum a large number of international experts from across the world have slammed the proposed Anti Counterfeiting Trade Agreement as threat to the public interests and noted that the claims by the negotiators were wrong footed.

Online Billfight!

TNN — 8-Jul-2010

They are all a big fraternity during awards but theres a different side to the family when it comes to the proposed amendments to the Copyright Act.

Media companies oppose tax on copyright services

Vrishti Beniwal / New Delhi — 8-Jul-2010

PVR Pictures in its petition alleged that copyrights are treated as goods and the transfer of copyrights are treated as sale of goods which falls within the domain of taxation by states under Article 246 and not the Union.

Fakes a reality check

K. Gopinathan — 8-Jul-2010

Counterfeit phones are thriving as consumers find them a cheap and easy way to possess brands by paying just a fraction of the cost of a genuine one.

Ayurvedic drugs too will need to be clinically tested says govt

C.H. Unnikrishnan — 8-Jul-2010

These are mainly in the nature of confirmatory trials on the safety and efficacy of patent and proprietary medicines most of which are made by altering approved formulations by adding or removing some ingredients.

Students design device to tackle power theft

N Dinesh Nayak — 08-Jul-2010

The students have also applied for patent for this first of its kind technology in the country.

Pfizer launches pneumonia prevention vaccine Prevanar 13

Archana Shukla — 08-Jul-2010

Prevenar 13 offers superior protection from pneumococcal diseases and Pfizer in turn is looking at that vaccine to protect its global revenues which is expected to see a steep fall in the next two years with its blockbuster drug Lipitor going off patent.

Shire files patent lawsuit against Cadila

The Associated Press — 08-Jul-2010

Irish drugmaker Shire PLC said Thursday it has filed a patent infringement suit against Indian generic drug developer Cadila Healthcare Ltd. over the bowel disorder drug Lialda.

UN body shows a global dream to weavers

Adam Halliday — 09-Jul-2010

Will hold sensitisation programme next Monday to educate them on UN recognised patents that could turn their products into global brands

SC reprieve for Daiichi Sankyo

BS Reporter / New Delhi — 9-Jul-2010

Bio similars are low cost versions of patented biotech products.

President urges pharmacy sector to get equipped for future

IANS — 09-Jul-2010

PricewaterhouseCoopers in its recent report has estimated that around $70 billion worth of drugs will go off patent in the US.

Lupin among top five generic drug companies in US

P B Jayakumar / Mumbai — 9-Jul-2010

A generic drug is one produced and distributed without patent protection.

Cipla brass to get new shine CEO to step down

Kiran Kabtta Somvanshi & Deepali Gupta — 09-Jul-2010

Cipla which makes low cost generic version of patented drugs is Indias second largest drug company by market share after Abbott Laboratories recently acquired Piramal Healthcares domestic formulations business to surge ahead of the Indian pharma major.

NTP files patent suits against technology giants

9-Jul-2010

NTP a patent holding firm which won a 600 million dollar settlement from Blackberry maker Research in Motion now has Apple Google HTC Corp. LG Electronics Microsoft and Motorola in its sights.

India capable of producing lower cost HPV vaccine

10-Jul-2010

Vaccine manufacturers in India and other developing nations can produce a lower cost HPV vaccine despite the complicated array of patent protections on the technology according to an Indian origin scientist at the Duke Institute for Genome Sciences and Policy.

Building an emerging market Bric by Bric

Priyanka Golikeri — 12-Jul-2010

Other methods such as getting listed on foreign stock exchanges making foreign acquisitions seeking patent protection for innovations in international markets say Khanna and Palepu are other ways for emerging giants to spread their wings round the globe.

Rs.3000 crore venture capital fund to drive pharma growth

12-Jul-2010

The government is also working on priority basis to build Intellectual Property Rights offices for expeditious approval and rejection of patents.

Music & video piracy up cops blame lax law

TNN — 12-Jul-2010

We usually book the accused under the Copyright Act and slap 420 IPC for cheating.

Tighter import norms: Not just trade use of fakes too a crime

Deepshikha Sikarwar — 12-Jul-2010

The Central Board of Excise and Customs the apex indirect taxes body has amended a three year old notification to tighten the norms for import of products that have intellectual property rights protection said a government official.

Letters: WIPO reforms

Business Standard / New Delhi — 12-Jul-2010

This refers to Developing nations slam WIPO reform suggestions which talks about discussions at the most recent session of the Patent Cooperation Treaty Working Group held in Geneva from June 14 to 18.

Indias patent regime hurting across Asia Pacific

Priyanka Golikeri — 13-Jul-2010

Sitting in a first floor room of a nondescript school building off Thakurdwar Road at Charni Road in south Mumbai Eldred Tellis is a picture of frustration and agony.

Owner of fake softdrink unit held in Delhi

PTI — 14-Jul-2010

A case of infringement of Indian Copyright Act 1957 and Patents Act 1970 has been filed against the accused.

Games merchandise to hit market this week

TNN — 14-Jul-2010

According to Bhanot the IPR for the logo and other Games related designs were registered some years ago but were again taken out as a public notice because the OC had received several complaints about copyright infringement.

Celgene Novartis sue Sun Pharma on Para IV infringement of its extended release ADHD drug Focalin

Our Bureau, Mumbai — 14-Jul-2010

The US based Celgene Corporation and the Swiz pharma major Novartis AG have filed a Para IV patent infringement suit against the US subsidiary of the Mumbai based Sun Pharmaceuticals Industries Ltd with the District Court of New Jersey for allegedly attempting to manufacture and sell the generic version of extended release Focalin used for the treatment of Attention Deficit Hyperactivity Disorder.

Gilead Sues Lupin In Patent Infringement Case Over Generic Drug

DOW JONES NEWSWIRES — 14-Jul-2010

Gilead Sciences Inc. sued Lupin Ltd. in federal court in New Jersey accusing the Indian generic drug maker of infringing its patents for Ranexa an angina treatment.

IDMA seeks Azads intervention in solving several pending issues

Our Bureau, Mumbai — 15-Jul-2010

The Indian Drug Manufacturers Association comprising of around 700 drug manufacturers across the country has sought Union health minister Ghulam Nabi Azads intervention to solve several long pending issues being faced by the pharma industry in the country.

Dr Reddy Laboratories sign MoU with Australian pharma

PTI — 15-Jul-2010

In the EU Arixtra is protected by data exclusivity which will expire in 2012.

Sun Pharma wins legal battle in US against Taro Pharma

Our Bureau, Mumbai — 15-Jul-2010

Sun Pharmaceutical Industries Ltd.has received favourable ruling from the United States District Court for the Southern District of New York against Taro Pharmaceutical Industries.

Time to challenge plus size IPRs

Prashant Goyal — 15-Jul-2010

In an increasingly competitive world the developed countries are pursuing intellectual property rights route to retain competitive edge over developing countries.

Discovery says infringement case v Amazon not new

Tom Hals — 16-Jul-2010

A patent infringement lawsuit filed on Wednesday against Amazon.com was a procedural move and not a new lawsuit according to Discovery Communications Inc, which filed the complaint.

Sun Pharma gets USFDA nod for Flomaxs generic version

Press Trust of India / New Delhi — 16-Jul-2010

The generic version launched by the company is equivalent to Boehringer Ingelheim Pharmaceuticals patented Flomax capsules.

HC boost for innovators orders overhaul of patent process

Nikhil Kanekal — 17-Jul-2010

In a much needed relief to innovators the Delhi high court on Thursday passed a landmark judgement which will bring greater transparency to the process of granting patents and crack down on the practice of filing mischievous pre grant opposition.

Sun Pharma Says U.S. Court Denies Motion Over Protonix Ruling

Bloomberg — 17-Jul-2010

The company continues to believe that the patent is invalid and unenforceable and will pursue all available legal remedies including appeals it said.

Drug dealers venture into production

PB Jayakumar / Mumbai — 18-Jul-2010

Generics are non patented drugs and those without a brand name are referred to as generic generics.

Saving yoga from copyright mongers

Lhendup Gyatso Bhutia — 18-Jul-2010

Somebody in South Korea has filed a patent for baby yoga.

Commerce dept seeks cooperation for IP protection

Joe C Mathew / New Delhi — 18-Jul-2010

The Department of Commerce has called for coordination among various ministries for a consensus on adoption of intellectual property protection measures.

India has formula to zap oil from BP spill

Sanjay Dutta — 19-Jul-2010

Lal holds the patent for Oilzapper and heads the joint venture between Teri and state run ONGC that markets the formulation.

FICCI Maha Judicial Academy to host Judges Roundtable 2010

Our Bureau, Mumbai — 19-Jul-2010

Federation of Indian Chambers of Commerce and Industry in association with Maharashtra State Judicial Academy will be organizing Judges Roundtable 2010 at Uttan Bhayander Maharashtra near Mumbai on July 24 and 25 2010.

Sun Pharma says U.S. court denies motion on Protonix

Bharghavi Nagaraju — 19-Jul-2010

Sun Pharmaceutical said a U.S. court had denied its motion to reverse a jury verdict of infringement against the Indian firm on Pfizers Protonix acid reflux drug patent that the jury had said was valid.

HC asks Singhanias to share Raymond trademark with Chennai pharma co

Almas Meherally — 19-Jul-2010

Bombay High Court has ordered Raymond the textile company of the Singhania group to share its trademark Raymond with a Chennai based privately held pharmaceutical company Raymond Pharmaceuticals.

Punjab to create IPR awareness in 18 clusters

Vijay C Roy / Chandigarh — 20-Jul-2010

Small and medium enterprises face the challenge of extracting the latent value of their intellectual property and using it effectively in their business strategies.

Patent for innovative technology crucial Sam Pitroda

IANS — 20-Jul-2010

Creating an innovative product with new technology is good but to safeguard the patent of such products is far more important said Sam Pitroda the advisor on Public Information Infrastructure and Innovations to Prime Minister Manmohan Singh.

U.N. urged to probe U.S. trade stance on generic drugs

Doug Palmer — 20-Jul-2010

Their ire is directed at an annual report produced by the U.S. Trade Representatives office that ranks countries with the worst records on protecting U.S. intellectual property rights for goods ranging from CDs to medicines.

US court rules against Sun Pharmas appeal

BS Reporter / Mumbai — 20-Jul-2010

Sun Pharmaceutical Industries said the US District Court for New Jersey had denied its appeal to reverse an earlier jury verdict in the patent litigation over the generic version of Wyeths heartburn medicine Protonix.

Konkan Railway has patent on anti crash device

TNN — 20-Jul-2010

Even as the Konkan Railway Corporation Ltd. was granted an Anti Collision Device patent in the United States of America for its Track Identification System recently neither the Central nor its counterpart Western Railway has installed it in any of their trains.

Access to medicine groups call upon WIPO WTO & WHO to reject IP enforcement initiatives

Ramesh Shankar, Mumbai — 21-Jul-2010

International group of access to medicine groups academics and experts who gathered at the University of California at Berkeley Law School have called upon policy makers in governments and international organizations like WIPO WHO and WTO to reject the cynical and dangerous efforts that are being made through the intellectual property enforcement initiatives to prioritize commercial interests over the right to health.

Japans Eisai to make key drug in India Nikkei

Ashutosh Joshi in Bangalore — 21-Jul-2010

Patents for the drug will expire in the United States this November and then in Japan and Europe by 2012.

Govt estimates biotech capacity expansion needs Rs700 crore

C.H. Unnikrishnan — 21-Jul-2010

Some 48 biopharmaceuticals with a combined sales of $73 billion in 2009 are going off patent in the next 10 years which provides a competitive opportunity for Indian firms though production of biopharmaceuticals is more complicated compared with drugs based on conventional chemistry.

India hauls Netherlands to WTO

P. T. Jyothi Datta — 21-Jul-2010

Files case over drug export seizures.

Inflation will moderate to 5 6% by year end: Cabinet Secretary

BS Reporter / New Delhi — 21-Jul-2010

The government said it was readying to split the office of the patents and trademarks controller.

Eisai to cut Aricept costs with move to India

Tracy Staton — 21-Jul-2010

Whats a drugmaker to do when its lead product falls off the patent cliff?

Govt cautions pharma industry against harassment by global players

PTI — 21-Jul-2010

The government on Tuesday cautioned the domestic pharmaceutical industry against attempts by global giants to harass them through their deep pockets and means outside the WTO.

India may complain to WTO if Acta is enforced: Khullar

Asit Ranjan Mishra — 21-Jul-2010

India may complain to the World Trade Organization against the developed nations if they try to enforce intellectual property regulations that go beyond the terms accepted by WTO and the World Intellectual Property Rights Organization.

India EU officials to meet in Sept on drug seizure issue

Press Trust of India / New Delhi — 21-Jul-2010

In an effort to resolve a dispute on seizure of Indian drugs by some European countries officials of the European Union and the Indian government will meet again at Geneva in September at the instance of the WTO.

Vintage Wear

RICHA BHATIA — 22-Jul-2010

Following allegations of trademark infringement the organisers were forced to change the logo supporting it with a disclaimer.

Bacterial miracle

Bachi Karkaria — 22-Jul-2010

His Oilzapper fully deserves its formidable reputation its hordes of awards and heaps of patent fees.

NGOs call upon EU to halt aggressive push for higher IP protection enforcement

Ramesh Shankar, Mumbai — 22-Jul-2010

A string of international NGOs and legal experts who have gathered at the XVIII International AIDS Conference in Vienna have called upon the European Union to immediately stop their aggressive push for higher intellectual property protection and enforcement through various bilateral and multilateral forums that threaten access to safe effective and affordable generic HIV medicines.

T S Vishwanath: Trading on environment

T S Vishwanath — 22-Jul-2010

WTO talks on trade in environmental goods are turning into a market access issue for developed countries

Forest settles Alzheimers drug patent suits

Bill Berkrot and Lewis Krauskopf — 22-Jul-2010

Forest Laboratories Inc said it and Germanys Merz Pharma reached settlement agreements for all patent litigation over their Namenda Alzheimers drug that will keep cheaper generic versions of the medicine off the U.S. market until January 2015.

Chinese origin Made in India fake medicines seized in Nigeria

P.T. Jyothi Datta — 23-Jul-2010

It came as a shocker to V S International founder Mr Vidyut Shah when a fake consignment of his flagship Ciprotab brand valued at about Rs 1 crore was seized in Nigeria late last month.

New hope in stem cell therapy for blindness

Pushpa Narayan — 23-Jul-2010

The two institutions recently got a patent for the process and are now gearing up for human trials.

Civil Society groups urge State Judicial Academy to restructure agenda for Judges Roundtable meet

Ramesh Shankar, Mumbai — 24-Jul-2010

Some of the Civil Society groups in the country have urged the Maharashtra State Judicial Academy to restructure the agenda for the Judges Roundtable on Intellectual Property Rights Adjudication being held in Mumbai on July 24 and 25 to promote public interest and a deeper understanding of intellectual property amongst judicial officers.

India EU FTA talks begin in Brussels next month

BS Reporter / New Delhi — 24-Jul-2010

Besides discussions on trade and investment the negotiations would also take up issues concerning services intellectual property rights competition policy government procurement and geographical indications among others.

Brain League unveils patent expiry search service

Madhumathi D.S. — 25-Jul-2010

Tracking off patent drugs

Private labels knock at chemist stores

BV Mahalakshmi, Sudhir Chowdhary — 26-Jul-2010

The Rs 5000 crore domestic market for common off patent drugs commonly called generic medicines and over the counter products which are targeted at a wide variety of common ailments and lifestyle disorders is an obvious enticement for the warring parties.

ITC Issues Notice of Final Determination in Rambus Matter Regarding NVIDIA Products

press release — 26-Jul-2010

The complaint sought an exclusion order barring the importation sale for importation and sale after importation of products that infringe nine of Rambus patents.

Head over heart for Singh brothers

BS Reporter / New Delhi — 27-Jul-2010

It was Indias largest pharmaceutical company with an interesting range of patent challenges in the West.

Several countries join India EU dispute at WTO as interested or affected parties

Ramesh Shankar, Mumbai — 27-Jul-2010

Several countries such as Brazil Equador Canada China Turkey and Japan have joined as interested or affected parties in the on going dispute between India and European Union at WTO on the seizure of generic medicines in transit via ports and airports in EU countries.

Sapience a software thatmeasures productivity

Shraddha Nair — 27-Jul-2010

InnovizeTech is seeking a global patent for a product that targets banks and insurance firms as consumers

Skinvisibles Invisicare Patent Portfolio Strengthens

press release — 27-Jul-2010

Skinvisible Inc. announced today the Hong Kong Patent Office has issued the Company a patent covering its unique polymer delivery system Invisicare.

Tech power to farmers

Surinder Sud / New Delhi — 27-Jul-2010

This change in attitude has come about partly because of new economic realities and the intellectual property rights regime and partly because of the realisation that the old mindset was preventing new technology from showing its potential impact on agriculture.

Opposition protests disrupt India parliament

Amy Kazmin in New Delhi — 27-Jul-2010

Indias parliament was repeatedly disrupted by opposition protests at high food price inflation on Tuesday raising concerns about further stalling of the Congress party led governments backlogged reform agenda.

Gilead Bayer & Genzyme sue Lupin for alleged Para IV patent infringements in US

Our Bureau, Mumbai — 27-Jul-2010

The Mumbai based Lupin Ltd and its US subsidiary Lupin Pharmaceuticals Inc have been sued by at least three firms in United States at various courts in the nation within a week starting from July 14 for Para IV patent infringement allegedly by the former attempting to manufacture and sell generic version of products before expiry of patent protection according to reports.

Forest Laboratories and Merz Pharma GmbH & Co. KGaA Settle NAMENDA Patent Litigation

ag-IP-news — 27-Jul-2010

Forest Laboratories Inc. Forest Laboratories Holdings Ltd. Merz Pharma GmbH & Co. KGaA and Merz Pharmaceuticals GmbH announced that they have entered into settlement agreements with all remaining defendants in patent infringement litigation related to Forests NAMENDA immediate release tablets.

More items to find way into digital library to check biopiracy

Amiti Sen — 27-Jul-2010

India has begun work to include 220 additional Ayurveda Unani and Siddha text in its Traditional Knowledge Digital Library which will help check rampant biopiracy of the countrys ancient wisdom by developed countries.

AstraZeneca Gains After FDA Staff Recommends Brilinta

Catherine Larkin and Trista Kelley — 27-Jul-2010

AstraZeneca Plc gained in London trading after U.S. regulatory staff said the blood thinner Brilinta is approvable if the drugmaker undertakes a study on its effectiveness in Americans once its marketed.

Take Tata logo off game: HC advises Greenpeace

Utkarsh Anand — 28-Jul-2010

Justice S Ravinder Bhat granted the NGOs 10 days to file a written reply in the defamation and trademark infringement suit against a online game Turtle vs Tata modelled on a popular computer game called Pacman.

US Appeals Court Rules Gemzar(R) Patent Invalid

press release — 28-Jul-2010

Sun Pharma Though Not a First Filer Triggered This Successful Patent Challenge

Astrazeneca files patent lawsuit against Torrent for blockbuster drug Crestor

Our Bureau, Mumbai — 28-Jul-2010

The UK based drug major AstraZeneca has filed a Para IV patent infringement law suit against the Gujarat based Torrent Pharmaceuticals and its US subsidiary for its alleged move to manufacture and sell the generic version of its blockbuster cholestrol lowering drug Crestor before expiry of its patent.

Facebook beats back patent infringement claim

AGENCIES — 28-Jul-2010

Facebook Inc won a legal fight on Wednesday over claims its hugely popular social networking website infringed a patent owned by little known Leader Technologies.

Copyright holder can decide on exhibiting movie: Aamir counsel

Express News Service — 29-Jul-2010

Khans counsel said the actors production house is just enforcing its copyright freedom when it comes to releasing its films and the CCI a central government body has no jurisdiction to initiate any inquiry in this regard.

AstraZeneca files patent suit against Indian partner Torrent over blockbuster cholesterol drug Crestor Eli Lilly loses Gemzar patent appeal

Article — 29-Jul-2010

Anglo Swedish drug major AstraZeneca has filed a Para IV patent infringement law suit against the Gujarat based Torrent Pharmaceuticals and its US subsidiary for its alleged move to manufacture and sell a generic version of its blockbuster cholesterol lowering drug Crestor before its patent expiry.

IPR comes in way of Japan FTA

Amiti Sen — 29-Jul-2010

Negotiations between India and Japan on a pact on trade and investment have got stuck on the issue of intellectual property rights with both sides refusing to budge from their stated positions though most other issues have been resolved.

Giving Americans Bhang For Their Buck

Devin Banerjee — 30-Jul-2010

The U.S. Patent office accepts pot related trademark applications but has never granted one according to a Wall Street Journal report on a short lived medical marijuana specific trademark category.

First in first out?

Bhupesh Bhandari / New Delhi — 30-Jul-2010

In the United States the worlds largest pharmaceutical market any drug maker who is the first to file an application with the Food & Drug Administration to launch the generic version of a drug once it goes off patent gets exclusive rights to sell it for 180 days.

US court rules Gemzar patent invalid says Sun

Our Bureau — 30-Jul-2010

Sun Pharma said that the US Court of Appeals for the Federal Circuit upheld an earlier judgment by another court against Eli Lily stating that certain claims made by Lilly on its cancer drug Gemzar were invalid.

Daiichi Sankyo may raise outlook Eisai Q1 jumps

REUTERS — 30-Jul-2010

Daiichi Sankyo bought a majority stake in Drugmakers including domestic rivals Takeda Pharmaceutical and Astellas Pharma are struggling to develop strong successors to their mainstay drugs which face imminent patent expirations.

WHO echoes Indian view of anti counterfeit laws in Africa hit accessibility of generics

Ramesh Shankar, Mumbai — 2-Aug-2010

The World Health Organisation has echoed the apprehensions earlier expressed by the developing countries like India that the anti counterfeit legislation that was adopted or that is under consideration in some of the East African countries like Kenya and Uganda threatens the accessibility of affordable generic medicines.

DRL scouts for partners to tap Japanese mkt

BV Mahalakshmi — 2-Aug-2010

Currently generic or off patent drugs have only a 17% market share in Japan.

Banarasi silk industry again in danger zone

Binay Singh — 02-Aug-2010

Whatever may be the reason but there is a need to give serious attention to this sector that got the Geographical Indication tag and joined the league of other GI products like Tirupati laddu and Darjeeling tea a year back.

About 79k patent applications lying with govt

Press Trust of India / New Delhi — 2-Aug-2010

About 79000 applications are pending before the government for grant of patents with mechanical engineering and chemicals segment accounting for nearly a third of the requests Parliament was informed today.

Microsoft Wins Patent Lawsuit That Targeted Xbox Game Systems

Susan Decker — 3-Aug-2010

Microsoft Corp. the worlds biggest software maker won a court ruling that its Xbox video game system doesnt infringe a patent over multiplayer gaming ending a six year legal battle.

Takeda sues Wockhardt for para IV patent infringement on diabetes drug Actos

Our Bureau, Mumbai — 3-Aug-2010

The Japanese drug major Takeda Pharmaceuticals and its US subsidiary has filed a Para IV patent infringement litigation in US against the Mumbai based Wockhardt Ltd and its US subsidiaries Wockhardt USA LLC and Morton Grove Pharmaceuticals Inc for alleged initiatives to manufacture and market the generic version of the oral type 2 diabetes drug Actos.

Bitter pill for India EU trade ties

Biswajit Dhar — 3-Aug-2010

Indias ongoing negotiations with the European Union have seen differences over intellectual property rights

Zota targets overseas market for its amino acid combo for alcoholism

Our Bureau, Mumbai — 4-Aug-2010

The Surat based Zota Healthcare Ltd a pharma manufacturing marketing and exports firm is planning to grab the overseas market for the first of its kind anti oxidant combination targeting liver psoriasis caused by alcoholism.

MNCs gaining control on Indian drug market

04-Aug-2010

The parliamentary standing committee on health has asked the government to pay attention to the selling out of major Indian Pharma companies to multinationals whose increasing hold over the drug market it says will make essential medicines costlier.

T S Vishwanath So what do NTBs cost?

T S Vishwanath / August — 5-Aug-2010

Interestingly, the issue of slashing tariffs and non tariff barriers under the WTO negotiations is discussed by the same committee on NAMA which is chaired by Ambassador Luzius Walecha of Switzerland.

Nihilent develops customer loyalty tool for SMEs

BS Reporter / Mumbai/ Pune — 5-Aug-2010

Pune based business consulting and solutions integration company Nihilent has developed a web based tool for the Micro Small and Medium Enterprises that incorporates the patented Customer Loyalty Evaluation methodology and the 14 aspects of customer loyalty.

Military matters

Aroma Sah, Hindustan Times — 05-Aug-2010

The military jacket with its trademark button detailing down both sides of the opening is tipped to be a big trend this autumn.

Beijing could provide the solution

Venkatesan Vembu — 6-Aug-2010

According to officials at Huashi Future Parking Equipment a Shenzhen based company whose chairman Song Youzhou owns the patent on the superbus transport officials from several countries including India had made enquiries about the project.

CWG mess: Gill falls back on God evokes nationalism

ET Bureau — 6-Aug-2010

I plead that in view of the patent failure of the group of ministers to deliver an untainted and effective Games could a high level apex committee on the same lines as the special organising committee which delivered the Asian Games in 1982, be constituted with none other than todays Sardar Dr M S Gill just like Sardar Buta Singh to chair that committee?

Mexico foreign affairs minister to visit India from Aug 16

Huma Siddiqui — 6-Aug-2010

The November 8 9 talks are aimed at clarifying rules on sharing future innovations and existing technologies involving contentious intellectual property rights issues.

Fortis arm plans full service clinical research foray

Joe C Mathew / New Delhi — 6-Aug-2010

The two statutory studies are needed to prove that a generic medicine is equivalent to its originally discovered and patent protected drug in terms of safety and efficacy.

Its official: India foiled Chinas bid to patent pudina

TNN — 7-Aug-2010

The Union health ministry on Friday confirmed a TOI report on how India foiled Chinas bid to patent the health benefits of pudina.

US firm plans to sell Bhang chocolates seeks trademark

PTI — 08-Aug-2010

Chocolates as such are considered intoxicating for many and an American entrepreneur now wants to give it a new high by lacing the bitter sweet dessert with very much an Indian intoxicant Bhang and trademark it too.

Bhang to trigger new patent war?

Chidanand Rajghatta — 9-Aug-2010

An ancient Indian high could soon get bhang alored to the United States if the efforts of an American confectioner prove successful.

Sorry we cant meet you now RIM tells India

Rishi Raj, Nistula Hebbar — 10-Aug-2010

Even as a possible ban on its BlackBerry services looms officials of Research in Motion the Canada based patent holders of the push mail service have cited protocol issues to explain their inability to meet Indian officials.

After Tatas Sholay makers to sue Greenpeace

Kanu Sarda — 10-Aug-2010

The makers of the highest grossing film in India Sholay will take legal action against the international environmental non governmental organisation Greenpeace for gross violation of copyright and trademark and for the wrongful use of its characters.

Glenmark settles patent dispute with Sepracor

BS Reporter / Mumbai — 10-Aug-2010

Glenmark has entered into a settlement agreement with US based Sepracor on a patent litigation suit related to the generic versions of insomnia drug eszopiclone which Sepracor markets under the brand name Lunesta.

Dr Reddys launches cheaper anemia drug

Priyanka Pulla — 10-Aug-2010

Dr Reddys Laboratories Ltd launched a biosimilar or off patent version of an anemia drug that it says will cut treatment costs by about half

Lupin sues Ranbaxy in US for patent infringement

P B Jayakumar / Mumbai — 10-Aug-2010

In a twist to the tale of drug patent infringement cases in the United States Indian drug company Lupin has sued Ranbaxy Laboratories which is now controlled by Japanese drug major Daiichi Sankyo in a US court.

IPRI and the retreat from reforms

Bibek Debroy — 10-Aug-2010

There is something called International Property Rights Index.

Panel asks health ministry to ensure big domestic pharma cos remain in Indian hands

Ramesh Shankar, Mumbai — 11-Aug-2010

The Parliamentary standing committee on Health and Family Welfare led by Rajya Sabha MP Amar Singh has asked the Union Ministry of Health to take up the issue of major Indian pharma companies being taken over by the multinational pharma companies with the Ministry of Chemicals & Fertilizers without any delay to come up with policy options to ensure that major Indian pharma companies remain in Indian hands.

Gufic Biosciences wins trademark infringement suit against Estee Lauder in India

Our Bureau, Mumbai — 11-Aug-2010

The Mumbai based bioscience company Gufic Biosciences Ltd announced here that it has won a favourable decision from the division bench of the Delhi High Court on a trademark infringement litigation against the US based cosmetic major Estee Lauder on a product Skincliniq Stretch Nil.

Getting global trademark to get easier

TNN, — 11-Aug-2010

Rajya Sabha on Tuesday passed the Trademarks amendment Bill of 2009 which enables a person or an enterprise to seek registration of a trademark in any of the 84 member countries of the Madrid Protocol through a single application.

Pharmexcil to conduct global CEO conclave distribute awards on Sept 14

Our Bureau, Mumbai — 12-Aug-2010

The Pharmaceutical Exports Promotion Council is planning to organise a global conclave of CEOs of pharma industry and distribute awards for companies excelled in exports and secured patents remarkably for their products on its sixth annual day to be held on September 14 2010.

Marico Grasim settle trademark case

Sapna Agarwal — 12-Aug-2010

Personal care products maker Marico Ltd has settled a trademark infringement case filed against Grasim Industries Ltd out of court.

Pfizer Sues Actavis Group Over U.S. Lipitor Patent to Block Generic Copy

Phil Milford — 12-Aug-2010

Pfizer Inc. the worlds largest drug company sued Icelands Actavis Group hf asking a judge to block sales of a generic version of the cholesterol drug Lipitor until a patent expires in 2017.

TVS Motor to re start twin spark plug Flame

M Ramesh — 13-Aug-2010

In 2008 rival two wheeler manufacturer Bajaj Auto Ltd sued TVS Motor claiming patent infringement holding that the Flame motorcycle had a twin spark plug a feature that Bajaj said it owned the patent for.

Regulator working on pharma export norms to check fake drug

Radhieka Pandeya & Asit Ranjan Mishra — 13-Aug-2010

Indias drug regulator is drafting guidelines for quality control and packaging of pharmaceutical exports due to concerns about fake medicines.

Patent war: Oracle sues Google

REUTERS — 14-Aug-2010

Oracle Corp sued Google Inc alleging patent and copyright infringement in the development of the popular Android smartphone software.

The purpose of creation

Pavitra Jayaraman — 14-Aug-2010

A lawyer an IIT professor a music composer a film maker meet people behind the copy left movement who champion open licensing

Eli Lilly loses patent case to generics majors

BS Reporter / New Delhi — 14-Aug-2010

Generic drugmakers including domestic companies like Sun Pharmaceutical and Aurobindo will gain as Eli Lilly has lost a US court case over its hyperactivity disorder drug Strattera.

Focus on high margin chronic diseases new products to boost Ipcas topline

Nitin P Shrivastava — 16-Aug-2010

Ipca is looking to increase its abbreviated new drug application filings backed by its own APIs to cash in on the huge generic opportunity arising out of large scale patent expiries in developed countries.

Pfizer deal buzz lifts Biocon to 52 wk high

Bureau — 17-Aug-2010

Lipitor a big Pfizer drug that generates nearly $1.4 billion will go off patent in 2011.

Satyam wins tax case against Upaid in NY court

KV Ramana — 17-Aug-2010

Upaid had earlier filed a forgery and fraud case against Satyam involving the issue of patent infringement.

Nokia Apple Japan Post Faiza Franek Wal Mart: Intellectual Property

Victoria Slind-Flor — 18-Aug-2010

Nokia Oyj removed one patent from its complaint against Apple Inc. with the U.S. International Trade Commission company spokesman Mark Durrant said.

Biocon CMD refrains from commenting on Biocon Pfizer deal speculation

Nandita Vijay, Bangalore — 18-Aug-2010

In fact in 2008 as part of its portfolio development efforts Pfizer set up the Established Product Business Unit which only deals with off patent products new molecules including generics and injectables to be marketed globally

India wins Ponni rice trademark row in Malaysia

G. Srinivasan — 18-Aug-2010

India has won the battle for Ponni rice in a Malaysian court.

Chinese man gets patent for quake proof bed

PTI — 18-Aug-2010

A retired Chinese man has been granted a patent for his innovative design of a bed that can automatically turn into a strongbox and help people survive an earthquake the state media reported today.

Madurai malli Dindigul lock line up for patent

Express News Service — 19-Aug-2010

Three weeks after it filed an application to patent the Thanjavur veena the Tamil Nadu State Council for Science and Technology is preparing a list of 10 other indigenous products to make moves for a similar exercise.

Right to health medicine to be protected at all cost: Scindia

ET Bureau — 19-Aug-2010

India has said that it will not compromise on issues related to health and peoples right to medicine in the bilateral trade and investment agreement being negotiated with the European Union.

PMO renews patent debate

Joe C Mathew / New Delhi — 19-Aug-2010

The Prime Ministers Office has sought the opinion of various stakeholder departments on the need for further amendments to the patent law to introduce some of the controversial provisions that were kept out during the previous amendment to the Indian Patent Act five years ago.

FICCI launches IPR Facilitation Centre in Delhi to assist MSMEs

Our Bureau, Mumbai — 20-Aug-2010

In keeping with its commitment to empower Indian businesses FICCI has launched an IPR Facilitation Centre at Federation House New Delhi in association with the union Ministry of Micro Small and Medium Enterprises.

Need for more stringent anti piracy measures: Kurain

PTI — 20-Aug-2010

The Patent Office on Thrusday called for more stringent anti piracy measures besides developing a societal ecosystem that respects intellectual property rights.

Azad takes on PMO over patents?

Kounteya Sinha — 20-Aug-2010

Dr Gopa Kumar Nair an authority in patents said when a delegation of MNCs meet the PM the latter has to forward the representation received to various ministries.

Court declines to stay CATs order

Special Correspondent — 21-Aug-2010

According to the petitioner the CATs order was patently illegal and vitiated by errors of law and facts patent and apparent on the face of the record.

Munna Bhai Circuit head to trademark office

Rasul Bailay,New Delhi — 21-Aug-2010

Trademark lawyer Neil Mason said the applications suggest Vinod Chopra Films Pvt. Ltd might be looking at licensing both the names for businesses

Is hybrid model a good long term strategy for drug makers?

P.T. Jyothi Datta — 21-Aug-2010

An IMS study reveals an increased pick up in branded innovative products after 2015 as the patent cliff where drugs go off patent is passed and research pipeline matures.

Patent law pits MNCs against local drug firms

HT Correspondent — 22-Aug-2010

The government is examining a set of proposals by global drug manufacturers seeking changes in Indias intellectual property rights laws to reward innovation triggering howls of protest from domestic pharmaceutical companies who said it would keep prices of many critical medicines perpetually high.

Man dupes pharmaceutical company to the tune of 96.52 lakhs

TNN — 23-Aug-2010

The officials from the cyber crime cell of the Pune police on Saturday arrested a technical director of a company manufacturing herbals products for allegedly duping the company to the tune of Rs 96.52 lakh on the pretext of providing patent for the companys 15 products with the help of an Indonesia based pharmaceutical company.

Commerce Ministry may step in to check MNC buys in pharma

P.T. Jyothi Datta — 23-Aug-2010

Some industry watchers say that the ground realities started becoming difficult for local drug companies after India implemented the product patent regime in 2005.

Delhi HCs new age lakshman rekha

Mukesh Butani / August — 23-Aug-2010

Ordinarily marketing intangibles include a bundle of intellectual property rights such brands trademarks knowhow that surrounds knowledge of distribution channels and customer relationship.

Patently wrong

The Financial Express — 23-Aug-2010

It isnt quite clear why the Prime Ministers Office decided to stir a debate on the Organisation of Pharmaceutical Producers of India it comprises mostly MNCs operating in India and their partners here demand to dilute Section 3(d) of the Indian Patent Act.

Copyright to attract service tax: Govt tells HC

Vrishti Beniwal / New Delhi — 23-Aug-2010

The revenue department has contested the petition filed by PVR Pictures in the Delhi High Court against the governments decision to levy service tax on copyright services such as sale of music rights sale of direct to home satellite TV rights and screening in cinemas.

Taiwanese LCD maker files second suit against Sony

Reuters — 24-Aug-2010

Taiwans Chimei Innolux Corp sued Japans Sony Corp for infringing on patents used in PlayStation3 video game consoles televisions computer notebooks and cameras.

Industry Min for compulsory licensing for 3rd party drug making

Press Trust of India / New Delhi — 24-Aug-2010

The Industry Ministry today suggested that local pharma makers should be allowed to produce patented drugs to check medicine prices in wake of acquisition of Indian companies by multinational firms.

Foreign in pharma

Business Standard — 24-Aug-2010

The takeovers can be seen to be a rather hurried attempt by global drug majors to acquire a generics portfolio in order to insure themselves for an immediate future in which the patent pipeline will be running thin and health care cost cutting measures in the developed economies will improve the market for generics players.

Lab rats? Drugs for US children tried on Indians

REUTERS — 24-Aug-2010

A law intended to speed up development of new drugs for US kids has ended up financing clinical trials in poor countries where the medicines might never become available.

Indias first patent tech auction in Ahmedabad this week

Vishal Dutta — 25-Aug-2010

A herbal drink that tastes like beer a bio insecticide product that attracts and kills mosquitoes using bird feather a transdermal patch for contraceptives drug delivery and a technology that can make a snake venom into analgesic that can help cure neuropathic pain: these are a few samples of patented technologies that will go on auction in Indias first ever Tech Transfer 2010 showcase exclusively for patented pharma products in Ahmedabad.

Pill to shield drug makers from MNCs

Mail Today Bureau — 25-Aug-2010

The department on Industrial Policy & Promotion is in favour of making a provision for allowing Indian pharmaceutical companies to manufacture patented medicines in case prices of these drugs spiral out of control due to collusion among multinational companies.

Government starts review of compulsory licensing norms

BS Reporter / New Delhi — 25-Aug-2010

The Department of Industrial Policy and Promotion has started a discussion on various compulsory licensing provisions enshrined under Indias intellectual property laws.

Pharma FDI checks to shield local companies

ET Bureau — 25-Aug-2010

This spawned an entire industry of local drugmakers which thrived by making copycat versions of expensive patent protected medicines by adopting a different manufacturing process.

Local pharma sellout worries industry ministry

Siddhartha Singh & Sushmi Dey — 25-Aug-2010

These proposals include compulsory licensing that allows other manufacturers to produce patented drugs if needed a significant rise in the number of drugs on the essential list and shifting foreign direct investment in local drug makers from the 100% automatic approval route to the Foreign Investment Promotion Board for better scrutiny.

Compulsory licensing of patented drugs under study

Bindu D. Menon — 25-Aug-2010

Recently the Commerce Ministry had raised the issue of acquisition of pharma companies by foreign multinationals and the resultant concerns over its impact on low cost medicines.

High drug prices a worry: Govt

Rupali Mukherjee & Prabhakar Sinha — 25-Aug-2010

Government is considering to bring in tighter foreign investment control in the pharmaceutical sector and to implement compulsory licensing system to check high prices of patented drugs.

Allow firms to make patented drugs

Special Correspondent — 25-Aug-2010

The Industry Ministry has suggested putting restrictions on foreign direct investment in the pharmaceutical sector stating that local pharma makers should be allowed to produce patented drugs to check medicine prices in the wake of multinational companies acquiring Indian companies.

Indian ministry for compulsory licensing for 3rd party drug making

PTI — 26-Aug-2010

The Indian Industry Ministry yesterday suggested that local pharma makers should be allowed to produce patented drugs to check medicine prices in wake of acquisition of Indian companies by multinational firms.

Patents are granted to ensure people have access to latest technology or drug: Controller General of Patents

Our Bureau, Bangalore — 26-Aug-2010

The Controller General of Patents Designs and Trademarks PH Kurian has said that the key task of granting a patent is to allow people to have access to the latest technology or drug.

ET in the classroom: Compulsory licencing

ET Bureau — 26-Aug-2010

ET explains Compulsory licensing a provision that allows governments to override Patent rights

Drug makers drag PMO into dispute over IPR changes

C.H. Unnikrishnan — 26-Aug-2010

Local industry is critical of the PMOs step that seeks amendments to patent law based on foreign firms demands

Ranbaxy settles patent dispute with Roche

ET Bureau — 26-Aug-2010

Daiichi Sankyo owned Ranbaxy Laboratories has settled its patent dispute with Swiss major Roche for the latters drug valganciclovir sold under the brand Valcyte.

Bad medicine

The Financial Express — 26-Aug-2010

The department of industrial policy and promotion has unveiled a discussion paper on the issue of drug prices.

EU to rectify laws stop seizure of off patent drugs says Sharma

shruti Shrivastav — 27-Aug-2010

The European Union has assured India that it will amend its laws to stop the seizure of off patent drugs shipped to Africa and Latin American countries commerce and industry minister Anand Sharma today said.

Panel on drug prices to meet industry today

Joe C Mathew — 27-Aug-2010

The committee on price negotiation of patented drugs constituted by the Department of Pharmaceuticals will meet industry representatives on Friday to identify possible negotiation options that can lower the cost of patent protected and imported medicines for life threatening illnesses in the country.

What is Indian is Indias

Business Standard — 27-Aug-2010

After successfully contesting a patent dispute with China earlier this year regarding formulations based on pudina mint and kalamegha Andrographis India last week won another legal battle in Malaysia against the use of ponni rice as trademark.

AIPS to organise seminar on precedential patent cases on September 23

Our Bureau, Mumbai — 28-Aug-2010

The Academy of Intellectual Property Studies an institute that has been set up in affiliation with the Indian Drug Manufacturers Association is organising a seminar on precedential patent cases on September 23 at AIPS Goregaon West Mumbai.

Indian pharma cos shun EU route goods via SA ports

KARTIKAY MEHROTRA — 28-Aug-2010

Despite Commerce Minister Anand Sharmas assurance that the European Union will amend its laws ceasing the seizure of generic drugs in transit Indian pharmaceutical giants are taking matters into their own hands to ensure safe transit.

T-series: Ruling the Indian music industry

Nandini Raghavendra and Vinod Mahanta — 28-Aug-2010

That Intellectual Property Rights was the next frontier for the music industry to be conquered was what son Bhushan Kumar instinctively understood.

Microsoft co founder starts patent lawsuit

Richard Waters in San Francisco — 28-Aug-2010

Paul Allen co founder of Microsoft on Friday mounted a wide ranging patent case against some of the best known internet and technology companies including Google Apple and Facebook.

Pharma majors pitch for affordable patented drugs

Khomba Singh — 28-Aug-2010

Indian drugmakers have said the price of patented drugs should be fixed based on the cost of developing and producing the medicine in the country and not in the developed world where it costs more to make such medicines affordable for patients here.

Pharma units await clarity on compulsory licensing

Ramnathsubbu — 29-Aug-2010

When the government initiated discussions last week to lay down norms for the issuance of compulsory licensing for medicines under the Indian Patent Act 1970 it rekindled the issue facing the Indian pharmaceutical industry of the affordability of and the access to medicines.

IPR attorney helps get 10 products GI status

A Subramani — 29-Aug-2010

Of the 18 Tamil Nadu products enjoying GI security as on date at least 10 of them got the status because of the efforts of Chennai based advocate and IPR attorney P Sanjai Gandhi.

Protection of public funded intellectual property bill to be made more transparent

Joseph Alexander, New Delhi — 30-Aug-2010

The Ministry of Science and Technology will bring in changes to the Protection and Utilisation of Public Funded Intellectual Property Bill 2008 to make the process of patenting and commercialisation of inventions from public funded projects more flexible and transparent in line with the suggestions from the experts.

Cancer drugs may become cheaper after govt study

Joe C Mathew / New Delhi — 30-Aug-2010

Dpt of pharma seeks to negotiate patented drug prices before they hit Indian market.

Govt speaking in two voices on generic medicines

Priyanka Golikeri — 30-Aug-2010

The governments doublespeak on generic off patent and low cost medicines has the stakeholders in a tizzy.

Zydus Natco launch versions of drug facing court battle

Joe C Mathew / New Delhi — 30-Aug-2010

Ranbaxy which first launched a generic version of Hepatitis B drug Baraclude was taken to court.

Rajya Sabha clears nuclear liability Bill

Our Bureau — 31-Aug-2010

The BJP leader added that inclusion of supplier liability could become a global model pointing out that this is what had happened in the case of the World Trade Organisation and the global patent regime where the country had asserted itself.

A modern fold for ancient knowhow

Biswajit Dhar — 31-Aug-2010

An October meeting could finally resolve how developing nations get to preserve their traditional knowledge

Ideal Cures wins patent revocation case against Colorcon Inc. USA

Our Bureau, Mumbai — 31-Aug-2010

Mumbai based Ideal Cures has won a landmark victory in a patent revocation case against Colorcon Inc. USA.

Alkem Lab develops low cost sweetener

Khomba Singh — 01-Sep-2010

We have filed an application to patent the product as well as the process to make it in India two months back and are in the process of filing for patent in other international markets said Sharad Kasarle vice president of R&D Nutraceuticals at Alkem

Industry needs to enhance knowledge across domains to tap burgeoning opportunity in global arena: Expert

Nandita Vijay, Bangalore — 02-Sep-2010

With drugs going off patent over the next three years valued at around a whopping Rs 320000 crore and also increased penetration of generics in the global market Indian pharmaceutical industry sees a great opportunity and various stakeholders are gearing up to obtain a share in the pie that appears to be lucrative.

The problem with EVMs

Subramanian Swamy — 02-Sep-2010

I have obtained documents from the World Intellectual Property Organisation with its headquarters in Paris to show that ECIL and BEL had applied for a patent for the EVM in 2002.

Chidambaram says he doesnt hold patent on saffron terror

TNN — 02-Sep-2010

Home minister P Chidambaram did not exactly use the phrase saffron terrorism but made it clear it was not his patent and in the past UPA and Congress leaders have found it quite expedient to refer to saffronisation of education to target the previous NDA government.

Govt talks to pharma cos for cancer drugs at Jan Aushadhi

PTI — 03-Sep-2010

The government is in talks with pharmaceutical companies for ensuring availability of cancer drugs at a minimal price at their low cost pharmacy chain Jan Aushadhi stores across the country.

India seeks to insulate FTAs from IP policies of the West

KARTIKAY MEHROTRA — 3-Sep-2010

Prompted by intellectual property agreements among developed economies including the forthcoming Anti Counterfeiting Trade Agreement Indian agreements will make a point to thwart those trade related intellectual property rights plus policies being enforced around Europe the US and Japan when it comes to trade with India.

Avesthagen gets process patent for arthritis drug

Khomba Singh — 3-Sep-2010

Bangalore based drugmaker Avesthagen has got the Indian patent for the process to make a biosimilar drug of Amgens blockbuster medicine Enbrel that is used to treat rheumatoid arthritis a top company executive said.

Celgene seeks to stop Natcos generic Revlimid

03-Sep-2010

Celgene Corp said it plans to file a complaint alleging infringement against India\'s Natco Pharma Ltd which has submitted a request to the U.S. Food and Drug Administration for authorization to make and sell generic versions of Celgenes cancer drug Revlimid in the United States.

India keen to add remedial clause in trade agreements

Ronojoy Banerjee — 4-Sep-2010

Wary of third party free trade agreements impinging upon the countrys interests New Delhi is keen on inserting a remedial clause in all its extant and future FTAs.

Govt wishes to market low cost cancer drugs

Press Trust Of India / New Delhi — 4-Sep-2010

The government is in talks with pharmaceutical companies for ensuring availability of cancer drugs at a minimal price at their low cost pharmacy chain Jan Aushadhi stores across the country.

Bull\'s Eye: Sun Pharma Apollo Tyres Cipla Escorts

ET Bureau — 05-Sep-2010

Sun announces a final approval to market six dosages of a generic version of Strattera with a 180 day exclusivity.

The right path

SUBHA J RAO — 05-Sep-2010

Attorney Sanjai Gandhi on the need to go in for a Geographical Indication certificate and how it protects both manufacturers and consumers.

Bio piracy is biggest concern says Jairam Ramesh

IANS — 06-Sep-2010

Bio piracy which is gradually robbing India of its precious assets and rich bio diversity has emerged as one of the biggest concerns before the union environment and forests ministry.

Govt may cap FDI in pharma at 49%

Sanjay Singh — 06-Sep-2010

The finance ministry as well as the Planning Commission have advised the concerned ministries to expedite the process to ensure that 65 per cent of Indians who according to the World Health Organisation still lack access to essential medicines are not deprived of affordable and high quality medicines.

Reckitt sues copycat Bharti Wal Mart JV

Ratna Bhushan — 6-Sep-2010

Reckitt Benckiser India the maker of Dettol antiseptic soap and Cherry Blossom shoe polish, has served a legal notice to Bharti Walmart demanding that the cash and carry joint company withdraw its Great Value toilet cleaner as it infringes upon the bottle design and cap of Reckitts Harpic brand the domestic market leader in this category.

Pharmexcil suggests DGFT to provide sops to exporters to develop norms for non infringing process for APIs

Suja Nair Shirodkar, Mumbai — 7-Sep-2010

The Pharmaceutical Exports Promotion Council has suggested to the director general of foreign trade to provide incentives to the pharma exporters to develop adhoc norms for non infringing process for bulk drugs to increase the export of pharmaceutical products in the regulated markets.

Priyanka Pulla and C.R. Sukumar

07-Sep-2010

The savoured Haleem dish a mouth watering delicacy of Hyderabad has been awarded the coveted Geographical Indication status clearing the way for a possible patent in the future.

Revenue of $3 bn by 2013 is a directional target

Priyanka Pulla and C.R. Sukumar — 8-Sep-2010

The size of the opportunity remains the same and at the end of it the product does get launched

Cancer drug prices stay firmly high despite many not being patented

Priyanka Golikeri — 8-Sep-2010

At a time when the government is thinking of ways to regulate the price of cancer medicines a research paper by a patient group shows that despite many not on patent ones available their prices remain at stratospheric levels.

We will continue to sell our patented drugs with India specific pricing

Khomba Singh — 8-Sep-2010

The worlds second largest drugmaker Merck & Co is targeting to occupy one of the top two slots in India by 2015.

Suven Life secures patent in Australia Mexico

Our Bureau — 9-Sep-2010

Suven Life Sciences Ltd has secured product patent in Australia and Mexico for one of their new chemical entity for the treatment of disorders associated with neurodegenerative diseases.

FAQs on GI

09-Sep-2010

A trademark is a sign used by an enterprise to distinguish its goods and services from those of other enterprises.

The copyright enforcers

Samanth Subramanian — 9-Sep-2010

Extracting copyright fees for music is a tricky business given the unwillingness of establishments to pay collecting the money requires tact and the ability to endure name calling and sometimes worse

Sun closes in on Taro with Israeli SC ruling

ET Bureau — 9-Sep-2010

Any controlling stake in Taro would help Sun boost generics sales in the US where the market is forecast to jump with nearly $96 billion worth of drugs going off patent in the next few years and President Barack Obama pushing for lower healthcare costs.

Innovation has helped drug firms take on Big Pharma

Radhieka Pandeya — 9-Sep-2010

India has also emerged a leader in novel drug delivery systems and custom synthesis of new molecules

Famed Bhadohi carpet gets GI tag

Binay Singh — 9-Sep-2010

The handmade carpet of Bhadohi was finally granted the Geographical Indication on September 4.

Patents drive up treatment costs of Hepatitis C

Priyanka Golikeri — 10-Sep-2010

As board member of the Network of Maharashtra People Living with HIV Manoj Pardesi is confronted with the twin challenges of helping people fight HIV and Hepatitis C.

Copyright suit against top education institution

Mahesh Buddi — 10-Sep-2010

Police on Thursday night booked criminal cases against the management of a top educational institution for allegedly copying and publishing textbooks of Intermediate brought out by the Telugu Academy.

Natco Pharma open to settle cancer drug patent case with US co

PTI — 10-Sep-2010

Pharma Ltd on Friday did not rule out a settlement over the patent issue with Celgene Corp which has said it would file a complaint against the former for alleged infringement of its cancer drug Revlimid.

New ventures with foreign partners may get easier

Asit Ranjan Mishra — 13-Sep-2010

DIPP now says that the measure patently discriminates against foreign investors who showed confidence in India by investing prior to 2005 and those who came in later.

NGOs patient groups alert PMO not to act on behest of OPPI on patent issues

Ramesh Shankar, Mumbai — 13-Sep-2010

A large number of patient groups, groups working on public health and HIV, public interest organizations, experts and concerned citizens have demanded to the Prime Ministers Office to immediately withdraw the biased and one sided notes which the PMO had reportedly circulated to the union ministries of commerce health legal affairs and chemicals at the urging of OPPI to amend key public health safeguards in the Patents Act including Section 3d and asking for patent linkages and data exclusivity.

Troikaa Pharma gets patent approval for Dynapar AQ in CIS

BS Reporter / Mumbai/ Ahmedabad — 13-Sep-2010

Ahmedabad based mid sized pharmaceutical firm Troikaa Pharmaceuticals Ltd has been granted the patent for Dynapar AQ a diclofenac or painkiller injection for the CIS block earlier this week.

Pot kettle Local pharma in patent rush

Priyanka Golikeri — 13-Sep-2010

Domestic drugmakers may challenge a Roche or a Novartis patent claim by filing oppositions and crying hoarse about trivial or evergreening patenting but when it comes to their own molecular or production process tweaks they havent been shy of laying innovation claims either.

Freer trade may hurt access to India generic drugs

By Laura MacInnis — 14-Sep-2010

Freer trade could harm Indias generic drug business which supplies the bulk of the AIDS medicines sent to developing countries a study backed by the drug purchasing body UNITAID said on Tuesday.

Dr Reddys sued over patent infringement

fe Bureau — 14-Sep-2010

Wyeth a wholly owned subsidiary of US based Pfizer Inc has filed a suit against Hyderabad based Dr Reddys Ltd at the US District Court New Jersey for allegedly infringing formers patent coverage in case of an anti depressant drug Effexor XR Venlafaxine Hydrochloride.

India Japan trade pact to leave IP laws untouched

Joe C Mathew / New Delhi — 14-Sep-2010

The India Japan Comprehensive Economic Partnership Agreement expected to be signed towards the end of this year will not call for any amendments to the existing intellectual property laws in either of the partner countries.

Freer trade may hurt access to India generic drugs

Laura MacInnis — 14-Sep-2010

UNITAID says 80 percent of its AIDS drugs come from India

Indian IP examiners have worlds highest workload lowest pay

C.H. Unnikrishnan — 15-Sep-2010

Quantity linked work assessment system is another reason behind deterioration in the quality of work

Origin myths

15-Sep-2010

Would a Mahabaleshwari strawberry by any other name taste as sweet or a Guntur chilli as spicy?

Venus Remedies gets EU patent for anti infectant

Reuters — 15-Sep-2010

The drugmaker expects Sulbactomax to capture 10% market share of the segment in Europe by 2015

Signs of Recovery Emerge after Economic Crisis Hits Innovation & IP Filings

ag-IP-news — 15-Sep-2010

A new report by the World Intellectual Property Organization analyzing Intellectual Property trends in 2008 and 2009 shows that innovative activity and demand for IP rights dipped during the global economic crisis but began to recover this year.

FTA negotiations to boost trade & investment between EU India

fe Bureau — 16-Sep-2010

India and the European Union are on track to conclude FTA negotiations by early December.

EU awards Venus Remedies patents for anti infection drug

BS Reporter — 16-Sep-2010

Chandigarh based listed pharma player Venus Remedies has obtained the European Union patent for its researched anti infection product Sulbactomax.

India sends 80% of AIDS drugs to poor nations

Rema Nagarajan — 16-Sep-2010

A new study published on Tuesday has established that Indian generic manufacturers supplied more than 80% of donor funded AIDS medicines to developing countries in the last seven years confirming Indias status as the pharmacy of the Third World.

CEPA with Japan lacks transparency: Farmer groups

ET Bureau — 16-Sep-2010

A common platform of several farmers groups the Indian Coordination Committee of Farmers Movements has charged the Central government with complete lack of transparency on the implications of the proposed Comprehensive Economic Partnership Agreement or CEPA with Japan and the inclusion of agriculture on its agenda.

India Brazil to call for dispute settlement panel against EU

D Ravi Kant — 16-Sep-2010

India and Brazil are expected to press ahead with a request for establishment of a WTO dispute settlement panel to adjudicate over the seizure of generic drugs on high seas by EU member countries that allegedly violated global trade rules trade diplomats said.

Commerce Ministry to seek Cabinet nod soon for Indo Japan trade pact

PTI — 16-Sep-2010

The Commerce Ministry will seek the Cabinets approval soon for the India Japan free trade agreement likely to be signed during the Prime Minister Manmohan Singhs forthcoming visit to Tokyo in October.

When drugs are faked

P.T. JYOTHI DATTA — 17-Sep-2010

There is no escape from implementing anti counterfeiting measures besides hurting the image of the industry and the country.

Goas Feni gets a makeover marketed abroad

Smitha Venkateswaran — 17-Sep-2010

Goans now have one more reason to say cheers.

Drug problem

editorial — 20-Sep-2010

Over a 16 month period that ended just over a year ago European Union customs officials seized about 20 shipments of Indian generic drugs as they were passing through various European ports especially Amsterdam and Hamburg while going to Africa and Latin America.

SC issues notices to Ranbaxy in Capsola trademark case

PTI — 20-Sep-2010

The Supreme Court on Monday issued notices to Ranbaxy and three others on a petition filed by life sciences and laboratory solutions firm RFCL in a dispute over the trademark for animal feed supplement Capsola.

Drug marketing approvals may be delinked from patent status

Radhieka Pandeya — 20-Sep-2010

If the demand is accepted DCGI will issue approvals only on grounds of drug quality and efficacy

Now Africa siding with India in generics battle

Amiti Sen — 20-Sep-2010

After a high pitch awareness campaign by India leading African nations Uganda Tanzania and Nigeria are reconsidering provisions of their proposed stringent anti counterfeit legislations that would have hampered pharmaceuticals exports to these countries.

India EU drug row heading towards long drawn battle in WTO

PTI — 20-Sep-2010

Row over seizure of Indian generic drugs by several European countries on the high sea appears to be heading towards a long drawn battle in the WTO as the two sides could not resolve the issue by consultations.

Merck arm sues Sun over cancer drug

P B Jayakumar / Mumbai — 21-Sep-2010

Schering Corporation part of multinational pharma company Merck & Co and London based Cancer Research Technology Ltd have sued Sun Pharmaceutical for allegedly infringing patent rights on the worlds largest selling brain cancer drug Temodar.

Suven Life Sciences gets 2 new US patents

REUTERS — 21-Sep-2010

Suven Life Sciences said on Tuesday it has won U.S. patents for its two new chemical entities pushing its shares up more than 11 per cent.

T Series not affected by copyright royalty

Ashish Sinha — 22-Sep-2010

T Series is confident to continue generating revenues from the FM radio broadcasters despite the drastic reduction of the music royalty rates recently.

Ranbaxy drug gets US nod

ET Bureau — 22-Sep-2010

Ranbaxy Laboratories got the exclusive rights to market a generic version of Japanese firm Eisais blockbuster Alzheimers drug in the US for six months starting November end which could potentially earn around $200 million for the company.

Discover the world of IP management

PATHFINDER — 23-Sep-2010

Individuals with a degree in physics or any other science subject are at an advantage in the field of Intellectual Property Rights

SC asks HC to resolve Montblanc ADD pen dispute in 3 mnths

PTI — 23-Sep-2010

The Supreme Court has directed the Delhi High Court to decide the dispute between German luxury brand Montblanc Simplo GMBH and Mumbai based Add Corporation over trademark infringement within 3 months.

Celebrities may soon endorse Banarasi silk

TNN — 23-Sep-2010

The handwoven Banarasi saree and brocades got the Geographical Indication tag last year.

HC rejects BMS plea on sale of hepatitis B generic by Ranbaxy

Khomba Singh — 23-Sep-2010

The Delhi High Court has turned down Bristol Myers Squibbs request to temporarily stop Ranbaxy from selling its generic version of the American firms patented hepatitis B drug Baraclude in India.

Tuning in to GI Blues

Bachi Karkaria — 23-Sep-2010

Along with Paithanis and Tellicherry pepper lets patent our peculiar peoples traits?

With the door to Doha closed India opens up windows to the world

Nayanima Basu / New Delhi — 23-Sep-2010

Seeing no progress on the stalled multilateral trade talks potential partners are keen on bilateral pacts with India.

Court asks Matrix not to sell generic of Roches cancer drug

Khomba Singh — 23-Sep-2010

The Madras High Court has asked Hyderabad based Matrix Laboratories not to make or sell the generic version of Swiss major Roches cancer drug erlotinib hydrochloride for the next two months.

YouTube wins Spanish copyright case

Alan Rappeport in New York — 23-Sep-2010

A Spanish federal court has dismissed copyright infringement charges against Googles YouTube that could have brought the online video service to a halt by forcing it to monitor every piece of content.

Lupin aims for biotech growth; first drug in 2011

Sachin Kumar — 24-Sep-2010

Having emerged as a strong player in the global generics market pharmaceuticals major Lupin is now eyeing the biotechnology sector.

Indian pharma alive and kicking

ET Bureau — 24-Sep-2010

Globally the pharma sector is seeing consolidation with generic players growing bigger and companies driven by patents too getting into generics.

India EU take another step towards FTA

Pallavi Aiyar / Brussels — 25-Sep-2010

Intellectual property rights is one of these.

CIIs growing proximity with USIBC raises concern among public interest groups

Ramesh Shankar, Mumbai — 27-Sep-2010

The Confederation of Indian Industry association with US India Business Council in organizing a Round Table in Delhi on Compulsory Licensing has come in for severe criticism from the public interest groups and experts as they argue that the USIBC has been a vocal opponent of the health safeguards in Indias patent law.

US NGO pushes for Eli Lillys second patent for cancer drug

Khomba Singh — 27-Sep-2010

A Washington-based NGO has appealed a US court to reverse its order rejecting Eli Lillys second patent for its blockbuster cancer drug Gemzar that could delay the launch of Sun Pharmas generic version in the worlds largest pharma market.

Punjab Govt warns against unauthorised use of national emblem

PTI — 28-Sep-2010

The spokesman said that no person shall use the national emblem for the purpose of any trade business and profession or in the title of any patent or in any trademark or design.

Pratt & Whitneys case against Rolls

Jeremy Lemer — 28-Sep-2010

Pratt & Whitney the jet engine maker has filed a lawsuit against Rolls Royce claiming that its British rival has tried to use patent litigation to thwart some of its most critical engine programmes.

Pharmexci\'s Outstanding Export Performance Awards given to 12 pharma majors 24 cos got patent awards

Our Bureau, Chennai — 28-Sep-2010

The Outstanding Export Performance Awards and Patent Awards for 2009 10 instituted by the Pharmaceuticals Export Promotion Council were presented to leading pharma companies in a ceremony organized by the Pharmaexcil as part of Pharma CEOs conclave in Hyderabad last week.

Gadwal saree gets GI status

Express News Service — 28-Sep-2010

Gadwal saree now figures in the patented items list after getting the Geographical Indication certificate.

Venus bags contract for anti cancer drug from Thailand

Press Trust of India / New Delhi — 28-Sep-2010

Pharma firm Venus Remedies today said it has bagged a contract from Thailand for an anti cancer drug Docetaxel under the government policy.

1 million HIV patients in India have no access to treatment

Press Trust Of India — 28-Sep-2010

Compulsory licensing enables a national government to revoke a license issued to a patent holder and thereby allow other parties to produce and sell a patented product for non commercial purposes.

Department expedites recruitment for IP office

C.H. Unnikrishnan — 29-Sep-2010

The move comes after criticism that the IP office is overloaded with work leading to compromises on quality

India protests against US trade barriers at WTO

PTI — 29-Sep-2010

India at today protested against escalating tariff and non tariff barriers imposed by the on Indian goods and services including enhanced visa fee on Indian short term services providers and the ban in Ohio on state outsourcing projects.

Solvay to open research centre in Guj

PTI — 29-Sep-2010

The centre will focus on high performance polymers organic chemistry nano composite biotechnology and green chemistry and will also host high level competences in the field of science technology patent regulation and procurement Solvay groups region general manager Asia Pacific Roger Kearns said on the ground breaking ceremony of the centre to be worth Rs 45 crore

Nycomed seeks damages from Sun Pharma Teva

REUTERS — 29-Sep-2010

Unlisted Swiss drugmaker Nycomed is seeking for a patent infringement of Pantoprazole from Indias Sun Pharmaceuticals and Tel Aviv listed an official said on Wednesday.

T S Vishwanath: Safeguards against Doha

T S Vishwanath — 30-Sep-2010

The South South trade issue raised by some nations may steer negotiations away from development objectives

Kunnath Pharma gets patent for its Musli Power X tra

Our Bureau, Chennai — 30-Sep-2010

Kunnath Pharmaceuticals of Moovattupuzha in Kerala has been granted a patent by the Patent Controller of India for its product Musli Power X tra sources from the company informed Pharmabiz.

i2india to invest Rs 40 cr in commercialising ideas

BS Reporter / Mumbai — 30-Sep-2010

i2india Holdings Ltd. a company jointly promoted by Tata Sons and Imperial Innovations Plc. of UK among others will invest over Rs 40 crore in the next few months to create commercial value from IPR in India.

Copyright society sends notice to malls auditorium

TNN — 30-Sep-2010

Two malls and an auditorium in the city have been served legal notices by the Indian Performing Rights Society for refusing to pay licence fees before playing music at events to be organised between October 1 and 3.

Performance enhancing drugs for your portfolio

Ram Prasad Sahu / Mumbai — 30-Sep-2010

Rising share in the US generics market and off patent opportunities should benefit top Indian drug makers.

US research funder licenses HIV patent

Andrew Jack in London — 1-Oct-2010

The largest US funder of medical research has licensed the patent rights on an HIV medicine it helped develop to an international agency a move designed to make treatments more widely available and affordable in the developing world.

Tata Steel bags process technology patent may out license to rival cos

Rakhi Mazumdar — 1-Oct-2010

Tata Steel has bagged a commercial patent on a widely used for developing iron at steel plants.

India to move WTO panel against EU

Nayanima Basu / New Delhi — 1-Oct-2010

India may formally approach the World Trade Organizations dispute panel against the European Union following the seizure of low cost generic medicine consignments in European ports meant for other developing countries.

The time to cross our own Mason Dixon Line has come

DEAN WILLIAMS — 03-Oct-2010

The fact that it would eventually become a divide that separated the two warring US ideologies of the abolitionists and slavers was foreseen but only by a fringe.

Microsoft sues Motorola for alleged patent infringement

PTI — 03-Oct-2010

Microsoft Corp has said that it has sued handset maker Motorola Inc for allegedly infringing on the software gaints nine patents in its Android smartphones.

ADMA seeks clarification on Rule 158 (B) treating herbal extracts as ayurvedic drugs

Suja Nair Shirodkar — 5-Oct-2010

Puranik informed that the amended rule refers that the patent and proprietary drugs would now be allowed to be registered as either nutraceauticals cosmetics or ayurvedic extracts.

Copycat incentives

Bibek Debroy — 5-Oct-2010

In 2006 we had a Mashelkar Report on patent law issues.

For Reddys Zyprexa is a half billion $ opportunity

KV Ramana — 5-Oct-2010

Dr Reddys Laboratories is likely to see a major upside coming its way in the form of olanzapine a drug to treat schizophrenia and bipolar disorder.

AstraZeneca sues Torrent for patent violation in US

fe Bureau — 5-Oct-2010

Global pharma giant AstraZeneca has sued Ahmedabad based Torrent Pharma for allegedly infringing its patent coverage related to schizophrenia drug Seroquel XR in the US market.

Google Seeks Dismissal Of Oracle Patent Infringement Suit

Scott Morrison — 05-Oct-2010

Google Inc. has fired back at Oracle Corp. denying all seven of the software makers claims of infringement on patents and copyright and arguing that Oracle is now attacking open source licensing policies it used to support.

No interim relief to BharatMatrimony owners in claim against Google others

Legal Correspondent — 6-Oct-2010

Case relates to complaint on trademark infringement.

Activists decry India EU IPR talks

TNN — 6-Oct-2010

Delhi Network of Positive People is staging a mass demonstration in front of Udyog Bhavan on Wednesday to protest against the inclusion of intellectual property provisions in the EU India free trade agreement which they fear will affect peoples access to affordable HIV AIDS drugs.

Apple Motorola Google TiVo Rambus Teva MGA: Intellectual Property

Ellen Rosen — 07-Oct-2010

A Motorola Inc. unit sued Apple Inc. alleging the maker of the iPad computer tablet and iPhone mobile phone is infringing six of its patents.

Pharma protests Indian licensing proposal

Tracy Staton — 07-Oct-2010

The Indian pharmaceutical industry has been shaken up lately worried that multinational drugmakers will come in and completely take over their drug market.

HIV+ people lead protests against India EU negotiations on free trade agreement

Joseph Alexander, New Delhi — 07-Oct-2010

With India and European Union moving into the final stages of framing the Free Trade Agreement and launching the crucial round of negotiations here a group of public interest organisations and the activists of Delhi Network of Positive People stepped up the campaign against the harmful provisions in the pact.

Biocon shares rise on Pfizer drug deal report

REUTERS — 07-Oct-2010

Emerging markets are a priority for Western drug companies such as Pfizer as they face slowing sales in their home markets and cheap off patent drugs that can be sold in high volumes under a multinational brand are an attractive market opportunity.

India EU dispute on drug seizure resolved

PTI — 07-Oct-2010

India on Thursday said it has resolved a dispute with European Union over seizure of Indian generic drugs by some European countries and will soon withdraw a complaint filed before the WTO on the matter.

Motorola sues Apple for patent violation

Indo-Asian News Service — 07-Oct-2010

Motorola has sued Apple for allegedly violating 18 of its patents relating to wireless email antenna design and other technologies used in the companys iPhone and iPod touch devices.

DIPP rejects MNC firms suggestions on patent law

Joe C Mathew / New Delhi — 7-Oct-2010

The Department of Industrial Policy and Promotion has rejected all suggestions made by the multinational drug majors lobby group Organisation of Pharmaceutical Producers of India before the Prime Ministers Office in August

Build patents regime on fortified law

Shamnad Basheer & Prashant Reddy — 07-Oct-2010

In a move with significant ramifications for policy making and participatory democracy the ministry of commerce recently threw open the issue of compulsory licensing for public debate.

SME NGOs urge for policy measures to ensure issue of compulsory licences

Joseph Alexander, New Delhi — 8-Oct-2010

With the debate on the compulsory licensing gathering momentum after the Department of Industry Policy and Promotion brought out a concept paper small scale pharma sector and the NGOs reiterated their demand for policy measures to introduce the same.

Trouble Stays: 40 nations nearing pact on generics seizure

Khomba Singh — 9-Oct-2010

The drug seizure agreement with the European Union may be an eyewash as another international treaty will allow 40 countries to seize in transit generic medicines.

Biotechnology stuck in IP warp

Ananda Chakrabarty — 10-Oct-2010

The Indian governments approach to intellectual property rights in the biotechnology sector remains old fashioned

HC rejects Fulford plea against United Biotech Oscar Remedies

Sanjay K Singh — 11-Oct-2010

The Bombay high court has dismissed the plea of US drug giant Schering Plough and its India arm Fulford India seeking injunction against United Biotech and Oscar Remedies from using the trademark Netmicin alleging it infringes upon the trademark Netromycin used for its antibacterial drug.

Nearly 250 NGOs across world urge PM to reject IP provisions in FTA with EU

Joseph Alexander, New Delhi — 11-Oct-2010

Hundreds of public interest groups across the world have jointly urged prime minister Manmohan Singh not to sign the proposed free trade agreement with European Union as the Centres role in medicines supply is under threat due to the intellectual property provisions included in the pact.

India positive on resolution of drug seizure row with EU

PTI — 11-Oct-2010

India is optimistic about resolution of drug seizure dispute with European Union but reserves the right to seek redressal from the WTO in case the mutual talks do not yield results a senior official said on Monday.

A regressive idea on patents

11-Oct-2010

Ideas such as compulsory licensing of patents mooted by the government has the potential to derail Indias reputation as a market that values and protects innovations

Eli Lilly sues Dr Reddys over cancer drug patent

KV Ramana — 12-Oct-2010

Eli Lilly the US pharma giant has sued Dr Reddys Laboratories over an alleged patent infringement involving Gemzar.

Reviving Doha

Business Standard / New Delhi — 12-Oct-2010

A trade deal can provide a new stimulus

WTO and Indian economy

U. SANKAR — 12-Oct-2010

The World Trade Organisation was created on January 1 1995 to promote world trade.

GI tag a boost for Uppada sarees

K Rajani Kanth / Uppada (andhra Pradesh) — 12-Oct-2010

The intellectual property right has given weavers a fresh lease of life with the commercial leverage to enhance their incomes

Some good news on generics

Biswajit Dhar — 13-Oct-2010

Two recent instances of international diplomacy provide relief to Indian firms that manufacture generic drugs

Leap from lab idea to business venture NCL paves the way

Pupul Chatterjee — 13-Oct-2010

Apart from starting a company many scientists are also exploring the possibility of possessing intellectual property rights and patents and then licensing them out to already existing commercial houses for projects that may have the potential to be converted into business ideas.

India may move WTO as it seeks to resolve EU dispute

C.H. Unnikrishnan — 13-Oct-2010

Commerce secretary says consultation process is still on but India reserves right to seek settlement panel

Pfizer sues Lupin on anti epilepsy drug

fe Bureau — 13-Oct-2010

The US based global pharmaceutical giant Pfizer Inc has filed a second suit against Mumbai based drumaker Lupin in the US alleging that the latter by attempting to manufacture a generic version of oral solution with pregabalin is infringing the formers patent coverage on its branded drug Lyrica.

Apple gets anti sexting patent

IANS — 14-Oct-2010

Apple has been granted a patent that allows parents to prevent their children from sending and receiving sexually explicit text messages.

Enertopia Partially Owned Partner Files Additional Patent Applications

TheNewswire — 14-Oct-2010

Enertopia Corporation is pleased to announce that its partially owned clean energy partner Global Solar Water Power Systems has filed additional patent applications in order to safeguard certain intellectual property.

Judge watches films to decide if rip off slur valid

Mayura Janwalkar — 14-Oct-2010

In a case of copyright infringement alleged by 20th Century Fox justice Roshan Dalvi asked the representatives of the litigating parties to be present at the high courts video conference room on Wednesday evening where she would watch Phone Booth and Knock Out.

DIPP paper: Compulsory licence is good for public health say domestic pharma firms

P.T. Jyothi Datta — 14-Oct-2010

CLs can ensure patent rights do not prevent access to affordable medicine.

Warner Chilcott settles patent dispute with Lupin

The Associated Press — 14-Oct-2010

Warner Chilcott PLC said Thursday they will settle a pending patent lawsuit over Warners birth control Loestrin 24 and Femcon FE with Lupin Ltd.

Remixing song doesnt amount to copying: Delhi high court

Kanu Sarda — 14-Oct-2010

In a major relief to music companies which are often pulled up for copyright issues Delhi high court has said that the remixed version of a song does not come under the Copyright Act.

Knock Out saved the punch by Bombay high court will be released in theatres today

Mayura Janwalkar — 15-Oct-2010

After a legal battle that stretched beyond court hours Knock Out the Sanjay Dutt starrer which Hollywood studio 20th Century Fox had charged with copyright infringement will be released in theatres on Friday.

MSMEs must innovate to grow: Survey

fe Bureau — 15-Oct-2010

The survey says in order to achieve the Intellectual Property rights policymakers have to be sensitised.

GSK to make India a hub for anti parasite drugs

BS Reporter / Mumbai — 15-Oct-2010

Global drug makers supply select off patent drugs as charity to various WHO programmes against neglected diseases.

National Innovation Foundation spots innovation award winners

Kinjal Desai — 15-Oct-2010

This year for the first time during the award ceremony students who are going to receive the awards will also get a patent form filled for their ideas.

India raises drug seizures issue

Utpal Bhaskar — 15-Oct-2010

Proposed EAC legislation does not make a clear distinction between generic and counterfeit drugs

Infosys applies for 18 patent applications in Q2

PTI — 15-Oct-2010

Domestic IT major Infosys Technologies today said it has applied for 18 patent applications for its different products and services in India and the US during the second quarter ended September 30 2010.

India to pitch for comprehensive biodiversity pact

PTI — 15-Oct-2010

India today said it would pitch for a comprehensive protocol to preserve biodiversity and insist on inclusion of human genetic resource and entire value chain of derivative of bioresource in such a document.

Wockhardt places its French arm under safeguard proceedings

Press Trust of India / New Delhi — 15-Oct-2010

The company also said earlier it had lost patent protection Diacerin an antiinflammatory analgesics and antipyretic drug through a court challenge it said.

India to align copyright norms with global standards

IANS — 15-Oct-2010

India will align its copyright regulations with international norms to curb rising piracy and violations of intellectual property rights.

Measures to tackle bio piracy: Safeguards for Indias traditional medicine and knowledge

Ketki Angre — 16-Oct-2010

Not too long ago, India almost choked at the thought of our very own basmati being someone elses patent.

India seeks to protect bio diversity at Nagoya meet from October 18

Urmi Goswami — 17-Oct-2010

As the world faces its worst losses of animal and plant species negotiators from over 190 countries will be meeting in Nagoya Japan between October 18 to 29 to reach an agreement to protect the diversity of the earths natural resources.

MNCs coming to India to settle copyright cases : SC Judge

17-Oct-2010

Many multi nationals are finding India an attractive destination for initiating legal action in regard to Intellectual property rights because of reasonable costs of litigation and speedy disposal of cases according to Supreme Court judge Justice Dalveer Bhandari.

Bio drugs a blessing but need regulation

Shobha John — 17-Oct-2010

By 2016 many bio pharmaceuticals will come off patent worldwide and India Brazil and China sense a huge opportunity to manufacture and sell bio similars which reportedly have similar properties.

Lupins patent settlement may set new trend in out of court deals

BS Reporter / Mumbai — 17-Oct-2010

Bags right to sell another drug that was not even part of the litigation.

Safe Trials

BV Mahalakshmi — 18-Oct-2010

The other issue of focus is on the need to protect intellectual property of companies which is acquired after years of research.

Venus drug gets patent approval from Australia and Ukraine

PTI — 18-Oct-2010

Drug firm Venus Remedies today said Australian and Ukrainian patent authorities have granted patents for its research product Potentox used in treating pneumonia and febrile neutropenia.

Pfizer Biocon: Catapulting local alliances into a different league

P.T. Jyothi Datta — 19-Oct-2010

The deal to commercialise four of Biocons bio similar insulins reflects Pfizers aggressive outsourcing strategy searching as it is for good bets even as its blockbuster cholesterol drug Lipitor stares at patent expiry later next year.

Biocon Pfizer in $350 million insulin marketing deal

Our Bureau — 19-Oct-2010

Biocon already sells insulin and Glargine in the country and is developing two more analogues Aspart and Lispro which go off patent in 2015 and 2017.

Syndax Pharmas Entinostat receives UK patent

Waltham, Massachusetts — 19-Oct-2010

The patent covers the polymorph representing a preferred stable form of entinostat with key claims covering the polymorph form B and the manufacturing process by which it is derived.

PM warns against aping development model of advanced nations

PTI — 19-Oct-2010

Inaugurating the annual meeting of the Academy of Sciences for the Developing World here Singh said the sharing of intellectual property rights was a major a roadblock in collaborative research efforts for commercial applications. .

Free online trademark search likely from next month

PTI — 19-Oct-2010

An entrepreneur wanting a trademark now will be able to search the registry online without any cost whether a particular symbol or design is available and not booked already.

Pfizer deal highlights Biocons R&D strength

Srividhya Sivakumar — 20-Oct-2010

With leading products in this space lined up for patent expiry from 2015 Biocon would stand to benefit significantly from the alliance due to Pfizers marketing strength and worldwide reach.

Celgene sues Natco Pharma over cancer drug

Our Bureau — 20-Oct-2010

Celgene Corporation has filed a lawsuit against Natco Pharma in a US court in connection with the latters filing of an abbreviated new drug application seeking approval to market Lenalidomide Capsules.

Traditional Knowledge Digital Library an effective deterrent against biopiracy

Our Bureau — 20-Oct-2010

In September 2007 Brazilian firm Ache Laboratories had filed for a patent at the European Patent Office for using grape to treat diabetes obesity and hypertension.

Indian ayurvedic body slams Colgate for patenting lal dant manjan

Sagar Malviya & Maulik Vyas — 20-Oct-2010

Lal dant manjan may make many Indians remember the old Dabur commercial featuring a schoolboy named Raju and his Masterji.

India sees generic drugs row with EU being settled

Jonathan Lynn — 20-Oct-2010

India believes a row with the European Union over seizures of generic drugs will be settled without litigation Trade Minister Anand Sharma said on Wednesday.

India accounts for only 17% of patent applications globally

Our Bureau — 20-Oct-2010

The total number of patents filed in 2010 is likely to touch 40000 of which only 17 per cent account for Indian applications.

Medicis says Genzyme sues for patent infringement

Krishnakali Sengupta in Bangalore — 20-Oct-2010

Medicis Pharmaceutical Corp said Genzyme Corp had sued it in a U.S. court over its wrinkle treatments accusing Medicis of patent violation.

MNCs set to maximize opportunities as Indian pharma gears up to unlock its inherent strength

Nandita Vijay, Bangalore — 21-Oct-2010

In collaboration with Strides Arcolab Pfizer commercializes 40 off patent sterile injectables and oral products in the regulated markets.

Attack of the biosimilars

Pharmaceuticals — 21-Oct-2010

Although biotech based drugs account for only a fifth or so of global drugs sales they are projected to grow at double digit rates as sales of many conventional drugs decline especially with a large number of patent expirations coming.

US drug lobby to meet key govt officials this week

Joe C Mathew / New Delhi — 21-Oct-2010

In a joint response on September 29 PHRMA and its European counterpart had said that a policy to encourage compulsory licences on intellectual property would be counter productive for the domestic drug industry.

NGOs, experts seek PM\'s intervention for imposition of FDI cap of 40% in pharma sector

Ramesh Shankar, Mumbai — 21-Oct-2010

In an open letter to prime minister Dr Manmohan Singh the health interest groups and experts expressed the apprehension that the the purpose of the Pharmaceutical Research and Manufacturers of America visit is to discourage the Indian government from applying a cap on FDI in the pharma sector and from issuing compulsory licenses for patented medicines.

Indias n bill deviates significantly from global standards

PTI — 21-Oct-2010

Deal with the problem of intellectual property rights violations Burns said.

Why drug patents are needed

Ananda Chakrabarty — 21-Oct-2010

India has been reluctant to liberalise pharma patent laws losing out on innovation.

Govt may make registration of drug brands mandatory

Khomba Singh — 21-Oct-2010

Delhi based lawyer Prathiba Singh said the Supreme Court had given an order around ten years ago asking the national drug regulator and the trademark office to coordinate registration of drug brands to prevent the confusion.

Rejuvenating Strategic Partnership

Richard Fontaine — 22-Oct-2010

It should raise its caps on foreign investment enhance its rules for protecting patents and other intellectual property and reduce barriers to defence and other forms of trade all of which would allow a major expansion in the bilateral economic relationship.

Consumer pharmaceuticals

22-Oct-2010

But as many big selling drugs near the end of their lives the patent cliff has made chief executives rush to diversify away from big name drugs.

Measures to derive maximum benefits of GI tag discussed

TNN — 22-Oct-2010

The seminar was on post GI registration of handmade carpet of Bhadohi.

PM to meet Wen in Hanoi amid rising tensions

Elizabeth Roche — 23-Oct-2010

It covers almost 90% of trade and a vast gamut of services investment intellectual property rights customs and other trade related issues.

PhRMA objects to compulsory licence idea shows concern over enforcement of patent laws

Joseph Alexander, New Delhi — 23-Oct-2010

Expressing concerns on many fronts including pending cases of patents in Indian courts and compulsory licence issue the Pharmaceutical Research and Manufacturers of America has urged the Government to create a conducive environment for innovation so that India does not miss out the opportunities in the global competition.

Strong IPR rules must to bring funds: Big Pharma

fe Bureau — 23-Oct-2010

With around a fortnight to go before Presidentbegins his visit to India USbased pharma giants have warned that New Delhi could lose out in the acute global competition in attracting investment from them if the country refuses to strengthen regulatory protection for patented drugs.

Form bloc to oppose new patent regime advises legal guru

ET Bureau — 23-Oct-2010

India should join forces with other developing countries at the World Trade Organisation to oppose the stringent intellectual property regime being framed by a number of developed countries which could affect exports of generic drugs and software from the country a top legal expert has said.

Scaled down Acta will still hurt Indian pharma’

ENS Economic Bureau — 23-Oct-2010

An American expert on intellectual properties conceded that even a scaled down version of the Anti Counterfeit Trade Act will make Indian pharmaceutical companies presence difficult to maintain in the international marketplace.

Trouble ahead as US hints at tighter norms for generics

ET Bureau & Agencies — 23-Oct-2010

Generic or off patent drugs constitute a major chunk of Indias Rs 40000 crore exports of medicines.

Drug patents

Govind Diwakar — 23-Oct-2010

This is with respect to the article on drug patent laws.

Higher margins boost Dr Reddys ne

Mobis Philipose — 24-Oct-2010

According to Motilal Oswals estimates the stock trades at 31.1 times core earnings estimated for this year and 25.5 times FY12 earnings after adjusting for the DCF value of the upsides from patent challenges low competition opportunities in the US and the impact of bonus debentures.

Obamas visit to Mumbai: Filled with symbolism and business

Our Bureau — 24-Oct-2010

But business ties between the two countries are not without concerns the recent anti outsourcing sentiments in the information technology sector and pro Intellectual Property Rights efforts in the pharmaceutical sector to name a few.

Hepatitis B patent brings Asia to BigDNA

Andrew Bolger, Scotland Correspondent — 24-Oct-2010

BigDNA a Scottish developer of vaccines has been granted a patent in Japan to tackle a disease that could provide access to a huge market in Asia.

Ranbaxy Dr. Reddys Cadila look attractive: Jitendra Sriram HSBC

ET Now — 25-Oct-2010

The patent expiry cycle is probably going to peak out till another two years out so you will have a lot of drugs which are coming off patent which offers a wide potential for Indian pharma to actually go out and sell in the developed world.

SENSIO Granted Patent in India

press release — 25-Oct-2010

SENSIO Technologies Inc. today announced that the Indian Patent Office has granted patent no. 242873 covering the SENSIO S2D Switch.

Biopiracy the new threat to global food supply

IANS — 25-Oct-2010

A handful of multinational corporations are pressuring governments to allow what could become the broadest and most dangerous patent claims in history warned the group while releasing a report on the subject at the UN Convention on Biodiversity being held here Oct 18 29.

Multinationals seeking to control global farming

Joydeep Gupta — 25-Oct-2010

The gene giants are stockpiling patents that threaten to put a choke hold on the worlds biomass and our future food supply.

Cleaning Up the Patent Office

Nilofer D\'Souza — 25-Oct-2010

To seed innovation and attract more patent applications India needs an efficient system.

With drugs costing Rs9 lakh should govt invoke compulsory licensing?

Priyanka Golikeri — 25-Oct-2010

With patented medicines for treatment of HIV AIDS cancer and hepatitis C beyond the reach of many patients due to their exorbitant prices some say there is a case for invoking the provision of compulsory licensing.

Tamil writer claims copyright to Enthiran plot

Express News Service — 26-Oct-2010

Producing copies of the printed text of both publications as proof Tamilnadan urged the police to file a criminal complaint under section 63 of the Indian Copyrights Act.

Registry moved for removal of GI tag for Tirupati Laddu

Vinson Kurian — 26-Oct-2010

An application has been registered with the Geographical Indications Registry seeking removal of the entry pertaining to Tirupati Laddu GI.

Obama aide rosy on Indo US trade

HT Correspondent — 26-Oct-2010

Kumar who previously headed the worldwide consumer pharmaceuticals business of Johnson & Johnson said there were still some gaps in Indias patent regime although India has done a fabulous job compared to some other countries.

PhRMA changes stand on generics says generics cannot be termed as spurious

Joseph Alexander, New Delhi — 26-Oct-2010

Toning down its earlier stand on counterfeit drugs issue the Pharmaceutical Research and Manufacturers of America has categorically spelled that the generic medicines cannot be branded as spurious and intellectual property rights issue cannot be mixed up with generic drugs.

US lobbying for strong IPR regime in India

PTI — 26-Oct-2010

The US is lobbying for an intellectual property rights regime in India that protects American patents a senior official of the Obama Administration said on Tuesday.

Rich reluctant to pay for medicines biodiversity deal stuck

Patent Firm in Pune — 26-Oct-2010

The issue of these firms patenting what has been traditional knowledge in developing countries for centuries has been an emotive one in India since attempts to patent Basmati rice neem and turmeric hit the headlines.

Italian luxury brand Canali strikes the Indian chord

Moinak Mitra — 27-Oct-2010

It could well be the next geographical indication if the Canali family has its way.

Glenmark profit rises on India US sales

C.H Unnikrishnan — 28-Oct-2010

A first to file generic drug offers market exclusivity for at least six months for a generic company in the US where the law permits a low cost drug to enter the market soon after the expiry of the inventors patent protection.

India takes lead for guiding developing countries to drive WHO focus on public health instead of IPR

Joseph Alexander, New Delhi — 28-Oct-2010

India has taken the lead to get together a number of generic drug producing nations to call for better definitions to ensure quality strengthening of regulatory authorities in the respective countries and bringing focus of the world to public health instead of intellectual property.

New border measures

T S Vishwanath — 28-Oct-2010

The developed worlds new focus on IPR safeguards and fossil fuel subsidies is sparking fresh concerns in developing nations.

The great patent battle

The Economist — 28-Oct-2010

History buffs still wax poetic about the brutal patent battles a century ago between the Wright brothers and Glenn Curtiss another aviation pioneer.

Curbing broadcast signal piracy

MINT — 29-Oct-2010

The Geneva based World Intellectual Property Organization has for long been grappling with the issue of signal piracy and the rights of broadcasting organizations to address it.

Juicy bites from Washington

Rasheeda Bhagat — 29-Oct-2010

In China too weve faced problems but they had to with intellectual property rights people copying our labels stickers logos

Curbing broadcast signal piracy

PN Vasanti — 29-Oct-2010

The Geneva based World Intellectual Property Organization has for long been grappling with the issue of signal piracy and the rights of broadcasting organizations to address it.

India EFTA FTA likely by year end

PTI — 29-Oct-2010

India and European Free Trade Association comprising Switzerland Iceland Norway and Liechtenstein are likely to firm up a free trade agreement by end of the year.

The right medicine

SWATI PIRAMAL — 29-Oct-2010

Many big pharma companies are facing a patent cliff and on the flip side new drug approval by regulators like USFDA is much more expensive and takes longer.

Why EU seizes Indian drugs

U S Bhatia — 30-Oct-2010

Indias status as the pharmacy of the world is at stake

Poscos patented proposal pipped ArcelorMittal

Shubhashish / Mumbai — 30-Oct-2010

The reason why the Union steel ministry preferred a joint venture between government owned Steel Authority of India Ltd and Koreas Posco in preference to a similar proposal from ArcelorMittal the worlds largest producer in the sector was technology.

Biocon to invest $161 mn in Malaysia

ET Bureau — 30-Oct-2010

Biosimilars are similar acting copies of original biologic medicine and can enter the market when the originals go off patent they are said to cost much less than the innovator drugs.

India makes case against ACTA at WTO meet

BS Reporter / New Delhi — 30-Oct-2010

India has made a strong case against Anti Counterfeit Trade Agreement a new international treaty being framed by a group of developed nations in the annual meeting of the World Trade Organizations Council for Trade Related Aspects of Intellectual Property Rights held in Geneva on October 27.

Micromax loses its Bling brand name

Gulveen Aulakh & Harsimran Julka — 31-Oct-2010

The Delhi High Court has restrained Indias second largest mobile phone brand Micromax from selling or advertising one of its largest selling women oriented mobile phones Bling as it acceded to a trademark violation filed by Delhi based mobile phone maker Bling Telecom.

Nagoya Protocol a big victory for India

Priscilla Jebaraj — 31-Oct-2010

In order to bring the American companies into the ramifications of this agreement the U.N.s Convention on Biological Diversity must be linked to the World Trade Organisations intellectual property agreement.

Old knowledge to get India money

Chetan Chauhan — 31-Oct-2010

India has already established Traditional Knowledge Digital Library where over 2000 sources have been digitised to check patent of this knowledge in the western world.

Click through license

Chanpreet Khurana — 01-Nov-2010

But if we are to create a level playing field for Indian technology products companies we need to give them that intellectual property rights or IPR protection.

Parliamentary panel finds 10 to 12 Indian pharma cos seriously into new drug discovery research

Our Bureau, New Delhi — 1-Nov-2010

The Parliamentary Standing Committee on Chemicals and Fertilisers assessed that the research and development in the Indian pharma industry was picking up and at least 10 to 12 leading companies are into new drug discovery now.

Business method patents

Anu Vaidyanathan — 1-Nov-2010

Bottom line with innovation is in the patent and IP portfolio..

Why European Union seizes Indian drugs

U S Bhatia — 01-Nov-2010

Indias status as the pharmacy of the world is at stake says U S Bhatia.

Azad for Revisiting FDI Norms in Pharma Sector

2-Nov-2010

He said that the Indian Drugs and Cosmetics Act does not recognise data exclusively and patent linkage.

A Singapore sling

2-Nov-2010

The government enacted the Indian Patents Act in 1970.

Patent should revert to research firms: Ghulam Nabi Azad

Vineeta Pandey — 02-Nov-2010

Union health minister Ghulam Nabi Azad feels public funded patents of Indian research organisations which have been sold to Indian private sector companies should go back to the organisations of these companies are taken over by multinationals

Drug research heads to Asia as local markets boom

Ben Hirschler — 3-Nov-2010

Asian drugmakers traditionally reliant on manufacturing bulk ingredients and making cheap generic medicines are these days pouring money into researching their own products as well as mounting risky patent challenges against brand name drugs.

Trade grows but hurdles remain

Asit Ranjan Mishra — 4-Nov-2010

Anwarul Hoda professor at the Indian Council for Research on International Economic Cooperation said in a probable free trade agreement between the two sides the high standards that the US may demand in the fields of intellectual property rights labour and environment may be difficult for India to comply with.

The upside of plagiarism and why copying isnt going to die

R Jagannathan — 4-Nov-2010

IPR intellectual property rights is a relatively recent development probably less a few hundred years old.

EU issues note to address drug seizure concerns of India

Amiti Sen — 4-Nov-2010

The European Union has offered fresh suggestions to prevent wrongful confiscation of Indian generic drugs during transit through European countries a move that hints at its seriousness about settling the issue.

Breaking news: IPO releases revised manual of patent practice & Procedure (MPPP).

07-Nov-2010

The Manual is divided into 21 chapters and 3 schedules which represent areas subject to regulation by the IPO.

Brazil India and South Africa call for flexibility on compulsory drug licensing

5-Nov-2010

Brazil India and South Africa joined forces to reject pressure for the extension of intellectual property rights and called for effective use of flexibilities such as compulsory licensing.

CellTrusts Sean Moshir Responds to Indian Government\'s Plans for Proxy SIM Cards for Secure Communication

Lora Friedrichsen — 5-Nov-2010

CellTrust Corporation the recognized leader in mobile secure messaging and secure applications for mobile phones responded today to the recent announcement by the Indian government that it plans to create guidelines and regulations for using proxy SIM cards for secure communication in the country.

Legal support to free and open source software projects

T. Ramachandran — 07-Nov-2010

SFLC will bring to notice violations of licence terms

Chasing pirates: Inside Microsofts war room

Ashlee Vance, New York Times — 07-Nov-2010

As long as intellectual property is the lifeblood of this company we have to go protect it

All eyes on Obamas healthcare resolve

P.T. Jyothi Datta — 8-Nov-2010

While patents allow a patent holder exclusive monopoly on the product for 20 years a CL allows governments to break the patent and allow a third party to make the same medicine.

Amitabh Bachchan to get copyright

Mail Today — 8-Nov-2010

The Bachchan baritone is all set to go exclusive.

Patently strategic

Chitra Narayanan — 8-Nov-2010

A patent is not just a protective tool but a good business strategy for tech driven or knowledge driven entrepreneurs.

EU states to push for single patent regime

Nikki Tait in Brussels — 08-Nov-2010

The push to establish a single European Union wide patent regime is set to gain momentum as a group of EU countries asks Brussels to consider introducing the measure even if all 27 member states do not sign up.

Glenmark moves closer to HIV drug launch

ET Bureau — 9-Nov-2010

Indian drugmakers have mastered developing low cost version of off patent drugs and Crofelemer would be the countrys first new drug if it is successfully launched.

Develop IPR regime for incremental innovation: Pitroda

Our Bureau — 9-Nov-2010

There is a need to develop a global Intellectual Property Rights regime that encourages incremental innovation said Mr Sam Pitroda Advisor to the Prime Minister of India on Public Information Infrastructure and Innovations

Glenmark moves closer to HIV drug launch

ET Bureau — 9-Nov-2010

Indian drugmakers have mastered developing low cost version of off patent drugs and Crofelemer would be the countrys first new drug if it is successfully launched.

Public interest groups ask Centre to reject lobbying by Obama administration against generics

Joseph Alexander, New Delhi — 9-Nov-2010

Public interest groups in India have called upon the Centre to strongly reject the lobbying by the Obama administration and its industry organisation the US India Business Council against the production of safe effective and affordable generic medicines in India.

Corporatised piracy new bug in MS play

NYT News Service — 9-Nov-2010

As long as intellectual property is the lifeblood of this company we have to go protect it Mr Finn says

India to soon ink trade agreements with Japan European Union

Priyanka Golikeri & Sreejiraj Eluvangal — 09-Nov-2010

Fresh from an exhilarating visit by US president Barack Obama that created much good will on both sides India seems keen to push its advantage as far as it will go.

Takeda Pharma says no interest in generic drug mkt

Ju-min Park — 10-Nov-2010

In late October Takeda Pharmaceutical reported a 12 percent decline in first half profit as a key drug lost patent protection but it lifted its full year earnings outlook as a stronger yen helped cut overseas costs.

An Indian Microsoft or Google is inevitable

Sujit John — 10-Nov-2010

Within global technology enterprises the youth enthusiasm in their India centres is translating into these centres contributing the most towards potentially patentable ideas.

DuPont to focus on agri energy saving

Shubham Mukherjee — 10-Nov-2010

Though Dupont Indias R&D centre is yet to receive a patent it has nine applications in the pipeline.

Exemption Rules To Be Included In Dpco 2002

BUSINESS STANDARD — 10-Nov-2010

According to the new DPCO a copy of which is with the Business Standard the production of a new drug patented under the Patents Act 1970 and not produced elsewhere if developed through indigenous research and development for a period of 15 years from the date of commencement of its commercial production in the country can be exempted from the Order.

Global regulatory agencies bogged down by staff shortage to oversee patent expiry drugs

Nandita Vijay, Bangalore — 10-Nov-2010

With patent expiry drugs expected to reach record levels in the near future global regulators are expected to vet increased number of applications and their task could only expected to get humongous as these agencies are unable to hire additional manpower to shoulder sudden surge in workload.

Cadila Pharma Files For Seventy Patents In The Us

BUSINESS STANDARD — 10-Nov-2010

Cadila Pharmaceuticals Ltd has applied for 70 product patents in the United States.

Green Technology Patent Program Extended for 1 Year by U.S

Susan Decker — 10-Nov-2010

The U.S. Patent and Trademark Office is extending by one year its program that expedites review of applications for inventions intended to improve the environment and reduce greenhouse gas emissions.

CSMCRI in talks with oil companies for manufacturing bio diesel

Sohini Das / Mumbai/ Ahmedabad — 10-Nov-2010

We have recently been granted the US patent for our technology and now we can share our intellectual property rights with an interested party who can manufacture the jatropha based bio diesel on a larger scale informed P K Ghosh director of CSMCRI which has been producing bio diesel on a small scale so far.

Knowledge on IPR should reach all levels

Express News Service — 11-Nov-2010

Anyone can create wealth by their own innovations and continuous improvements which will ultimately improve productivity said N R Madhava Menon while inaugurating the national seminar on IPR in the Knowledge Era organised jointly by the Institute of Management in Kerala and the Kerala State Council for Science Technology and Environment at the Science and Technology Museum.

EU patent talks end in deadlock

Nikki Tait in Brussels — 11-Nov-2010

Europe was urged by senior politicians and officials to break the political deadlock over a single European Union wide patent regime after ministerial talks failed on Wednesday night.

Climbing Mount Publishable

Global science — 11-Nov-2010

They spent the most published the most and patented the most.

Cong MP cautions govt against more takeovers of Indian pharma cos by MNCs

Ramesh Shankar, Mumbai — 12-Nov-2010

Dr Mirdha who is a members of the Parliamentary Standing Committee on Health & Family Welfare reminded the government through her letter that the domestic industry reached the current state of development due to a variety of policy formulations in early 70s such as FERA drug policy process patents etc.

Ranbaxy Q3 net jumps to Rs.313 cr on surging sales

AGENCIES — 12-Nov-2010

Valacyclovir an anti herpes drug was a first to file has the right to the grant of a patent for the invention product of the company in the USA.

Lambretta to seek claim from SCL

Press Trust of India — 12-Nov-2010

Italian two wheeler maker Lambretta Consortium on Thursday said it will seek claim of over euro10 million from Scooters India Ltd following a favourable court order in Europe regarding their trademark infringement dispute.

Amitabh to move court against copyright infringement

Indo-Asian News Service — 12-Nov-2010

Bollywood megastar Amitabh Bachchan seems to be irked by constant copyright infringements and the illegal use of his name for the promotion of products.

Workshop on post GI intervention starts

TNN — 12-Nov-2010

It may be mentioned here that the Banarasi saree and brocade got the GI status on September 4 2009.

Royalty issue in software

Mohan R Lavi — 13-Nov-2010

In a critical judgment the Delhi Tribunal ruled that the income received for supply of software is assessable as royalty under Section 91 vi in the hands of MSS as a copyright subsists in a computer programme and it is also a literary as also a scientific work.

Big pharmas Brazilian prescription

Andrew Jack — 14-Nov-2010

Mr Pedrosa is seeking regulatory approval for seven products combining low cost off patent drugs.

Ind Swift Labs registers 74% growth in PAT for Q2 of FY 2010 11

Announcement / Corporate — 15-Nov-2010

Ind Swift Laboratories Limited one of Indias leading pharma company reported growth of 74% in net profit for the quarter ended September 30 2010.

As of now India not for WTO dispute body on drug row with EU

Press Trust of India / New Delhi — 15-Nov-2010

On an indication that the drug seizure dispute with the European Union would be resolved has not sought setting up of a settlement body in the World Trade Organisation Parliament was informed today.

Copyright and Patent

Dr Anu Vaidyanathan — 15-Nov-2010

A look at the tradeoffs in the software context.

Meet to provide insight into European patenting norms

TNN — 16-Nov-2010

Experts from European countries will provide their perspectives on the European patenting norms with reference to information technology and automobile sector at an event at the National Chemical Laboratory here on Tuesday at 3.30 pm.

Vidarbha rice innovator gets recognition after 20 long years

Report — 16-Nov-2010

Experts say the least the government could do now is help him protect his intellectual property.

Hyderabad Haleem gets geographical copyright

16-Nov-2010

Haleem a famous and nutritious dish available in Hyderabad during Ramadan has been awarded geographical copyright.

Indian IT firms look West for patents

Swati Garg / Kolkata — 17-Nov-2010

At a time when the debate on intellectual property rights has taken centre stage globally current Indian patent laws have ensured an outflow of innovation and ownership registration in the information technology sector.

Estee Lauder loses Cliniq trademark case

Indu Bhan — 20-Nov-2010

The Supreme Court on Friday rejected global cosmetics major Estee Lauders trademark infringement case against Gufic.

Hey you copy cat!

20-Nov-2010

One can charge the accused with regards to the Indian Copyright Act 1957 but there needs to be solid proof and this is very difficult when it comes to creative fields.

Karnataka DC cautions SMEs over new regulatory challenges in global markets

Nandita Vijay, Bangalore — 20-Nov-2010

Changing dynamics in the global pharma scenario are expected to post serious challenges to the Indian small & medium enterprises players in future.

Estee Lauder loses Cliniq trademark case

Indu Bhan — 20-Nov-2010

The Supreme Court on Friday rejected global cosmetics major Estee Lauders trademark infringement case against Gufic.

TVS asked to show it didnt infringe patent

C.H. Unnikrishnan & Shally Seth — 20-Nov-2010

A division bench of the Madras high court last week asked TVS Motor Co. Ltd to prove that the technology used in its Flame brand of motorcycles did not infringe on a patent held by Bajaj Auto Ltd.

Dr Reddys gets USFDA nod

Express news service — 21-Nov-2010

Drug firm Dr Reddys Laboratories on Saturday said it has received approval from US health regulator to launch generic Zafirlukast tablets used for treating asthma in the American market.

Fight against HIV virus to don green hues

Shimona Kanwar — 22-Nov-2010

A patent has been filed as this is the first such compound which has shown a protection rate of 78.17% against the HIV virus the standard percentage is 89.75.

New centre to help city students file patents

Snehal Rebello — 21-Nov-2010

When Jayesh Varavadekar and his classmate Prathamesh Wadekar filed their first patent for a biofuel product last year they spent a month trawling through scientific databases to ensure the product was indeed a first.

Sun Pharma loses generic challenge in US court

Joe C Mathew / New Delhi — 22-Nov-2010

Sun Pharmaceutical Industries has lost an opportunity to launch the generic version of a schizophrenia drug that had generated revenue of $4 billion in the United States market in 2009.

Claris Lifesciences Rs.300 crore IPO to open on November 24

Our Bureau, Mumbai — 22-Nov-2010

All of its products are off patent products a significant majority of which are capable of being directly injected into the body and are predominantly used in the treatment of critical illnesses.

Surats rich Zari craft gets Geographical Indication status

Press Trust Of India — 22-Nov-2010

After Tangaliya the grand and glittering centuries old Zari making craft of Surat district in Gujarat has been granted Geographical Indication status offering it the much needed succour from infringement.

Pharmaceutical Industry Is Facing Biological Warfare

HESTER PLUMRIDGE — 22-Nov-2010

It is a new battle for the drugs industry and it will be hard fought.

Advair Poses Generics Hurdle

JEANNE WHALEN — 22-Nov-2010

As Patent Nears End Glaxo Blockbuster Asthma Drug Is Proving Tough to Copy

Art of the royalty

RISHIKESH BAHADUR DESAI — 23-Nov-2010

Bidri art has gained the Geographical Indication tag to certify that this product cannot be made anywhere else except Bidar.

Channels get I-T notice over deductingtoo little tax

Khushboo Narayan & Anushree Chandran — 24-Nov-2010

Further it is the channel that deducts taxes on IPR intellectual property rights licensed to them and not YRF.

Film producers get leg up on copyright row

Charu Sudan Kasturi — 24-Nov-2010

The HRD ministry should remove a proposed amendment of the Copyright Act allowing film directors to jointly own movies along with producers the Parliamentary standing committee on HRD has said.

US trade representative finds fault with India China intellectual property regimes

C.H. Unnikrishnan — 24-Nov-2010

The US trade representative has expressed concern at shortcomings in the intellectual property rights regimes of both China and India when it comes to investment in pharmaceuticals while noting improvements put in place by both Asian countries.

Healthy portfolio driving profits

Ram Prasad Sahu / Mumbai — 25-Nov-2010

This means that injectables do not face the sharp price erosion as is the case with oraldrugs when products go off patent thus allowing for better margins.

Oracle wins $1.3 bn from SAP in copyright case

Bloomberg / San Francisco — 25-Nov-2010

Oracle Corp won a $1.3 billion jury verdict against rival SAP AG the worlds largest maker of business application software for copyright infringement by a now defunct software maintenance unit.

New GSK plant in US poses multiple challenges to Dr Reddys

C.H. Unnikrishnan — 25-Nov-2010

GSK has taken a hit on market share and profitability of the brands after they lost patent protection a few years ago.

Tying the Indo US trade knot

T S Vishwanath / New Delhi — 25-Nov-2010

From a US perspective the important issues would be in the area of intellectual property rights besides other areas such as greater market access in some areas that India may consider sensitive.

Facebook to patent the word face?

AGENCIES — 25-Nov-2010

It may sound ridiculous at first but Facebook is planning to trademark the word face because it wants to stop other companies using the term in a way which damages its own brand.

Blockbusters set to witness new order

Rupali Mukherjee — 26-Nov-2010

While some companies such as Dr Reddys Glenmark Pharmaceuticals and Biocon have fast tracked their research in biosimilars off patent biotech drugs others like Cipla have tied up with Chinese companies to make a foray in the highly complex but fast growing segment.

India EU pact wont be ready before Dec summit

Asit Ranjan Mishra — 26-Nov-2010

Negotiations have really not taken speed on crucial issues like government procurement intellectual property rights labour standard and sustainable development she said.

The US model of private health insurers is inefficient expensive

TNN — 26-Nov-2010

I am not against intellectual property.

Panel for key changes to copyright Bill

C.H. Unnikrishnan — 26-Nov-2010

Aparliamentary standing committee headed by Oscar Fernandes which reviewed the proposed Copyright Bill 2010 has suggested key changes in draft amendments based on the feedback it has received.

Dr Reddys expands horizon

Ujjval Jauhari / Mumbai — 27-Nov-2010

Entry into the penicillin segment would help: the aim is to be further achieved by new launches in low competition products as well as patent challenge ones.

Time to patent the Kalenjin champagne

Lotuliangelech Domolina — 29-Nov-2010

Over the years Kenya has produced excellent athletes who have excelled in global competitions with the latest being world record holder David Rudisha.

Free trade pact with EU making good progress

Nayanima Basu / New Delhi — 29-Nov-2010

Negotiations for the ambitious free trade agreement between India and the 27 nation economic bloc of the European Union are likely to be wrapped up by early next year.

PhRMA signs cooperation agreement with Chinese pharma assn SINO PhIRDA

Joseph Alexander, New Delhi — 29-Nov-2010

After expressing reservations on the regulatory environment and patent laws of India the Pharmaceutical Research and Manufacturers of America representing the powerful multinationals has now tied up with Chinese pharma industry by signing a cooperative framework.

80% Kullu shawls have made in Ludhiana stamp

Dinker Vashisht — 29-Nov-2010

India had argued at the World Trade Organisation forum that since the basmati variety was endemic to India and Pakistan only these two countries could be allowed a patent it.

Venus gets patent for Vancoplus in South Africa New Zealand

PTI — 29-Nov-2010

Drug firm Venus Remedies today said it has received patents in South Africa and New Zealand for its product Vancoplus used in treatment of bacterial infections.

Ranbaxy gets nod for Alzheimers drug

Radhieka Pandeya, — 29-Nov-2010

Ranbaxy Laboratories Ltd Indias largest pharmaceutical company by revenue has received the US drug regulators nod to launch its generic version of Pfizer Inc. and Eisai Co. Ltds Alzheimers drug Aricept two people familiar with the development said.

CEAT Ltd acquires global rights of Brand CEAT from Pirelli

PTI — 29-Nov-2010

Pirelli is the owner of the Ceat trademark in the rest of the world.

Immunitor Awarded the Key U.S. Patent Related to Oral Vaccine Technology Platform

press release — 29-Nov-2010

Immune Network Ltd. advises that its potential acquisition Immunitor USA Inc. has been issued a key patent by the U.S. Patent and Trademark Office.

Pharma pains not over more revamp on anvil

Report — 29-Nov-2010

In their latest quarter Pfizer AstraZeneca Eli Lilly laxoSmithKline and Roche reported sales that were hurt by generics and their shares fell signalling their valuations may not have the patent loss impact fully baked in.

Protecting innovation

Lalit Bhasin — 29-Nov-2010

The link between economic growth and innovation is by now well established.

Analysts see $250 millon revenues from Ranbaxys Aricept deal

Our Bureau — 30-Nov-2010

Ranbaxy Laboratories can earn $230-250 million in revenues in the next six months from the US following approval of its off patent version of Alzheimers medicine Aricept by the US Food and Drug Administration say analysts.

Stepped up talks revive hope of India EU FTA

Pallavi Aiyar / Brussels — 30-Nov-2010

With the pressure on for the European Union and India to come up with a significant announcement at the upcoming EU India summit on December 10 a flurry of activity surrounding the ongoing negotiations for a bilateral free trade agreement is giving momentum to the process.

India China set to dominate global generic market: Report

PTI — 1-Dec-2010

India and China are all set to dominate the global generic off patent drugs market as low manufacturing and R&D cost would prompt key pharma players to set up their base here a report said.

Awareness about HIV yes but what of claims?

Ashish Jadhav — 01-Dec-2010

On May 2 2007 he had advertised in a prominent daily in Pune saying he had a patent for the treatment in India and Africa.

India to dominate world generic market

Agencies — 01-Dec-2010

India and China are all set to dominate the global generic off patent drugs market as low manufacturing and R&D cost would prompt key pharma players to set up their base here a report said.

EU offers out of WTO settlement on drug seizure row

Press Trust of India / New Delhi — 1-Dec-2010

The Government today said the EU wants to settle the row over seizure of Indian generic drugs by some European Union members without involving WTO.

Stay Focussed

01-Dec-2010

On occasion the issue is patents.

Products built on Indian innovations flowing into world markets

Kala Vijayraghavan, Lijee Philip and N Shivapriya — 2-Dec-2010

Julia Roberts embracing Hinduism may not exactly be the best case study for reverse innovation but 20 years after yoga and ayurveda went global a medley of products built on Indian innovations are slowly finding their way into world markets.

SC quashes Bayer petition to block Cipla generic drug

Khomba Singh — 2-Dec-2010

The countrys top judicial authority has dismissed German pharmaceutical firm Bayer AGs attempt to block Indian drug regulator from allowing Mumbai based Cipla Ltd to launch a low cost version of its patented cancer medicine .

Complete formalities on Novartis patent claim: SC

PTI — 03-Dec-2010

The Supreme Court on Friday directed the Centre pharma major Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others to complete their pleadings in the matter of Swiss firm Novartis AG challenging denial of patent for its blood cancer drug Glivec.

Brainvisa case: Court partly rejects discharge plea

Ashish Jadhav & Sandip Dighe — 4-Dec-2010

All the five accused are being prosecuted for the offence under section 406 420 to read with 34 of the Indian Penal Code 1860 and section 65 66 of the Information Technology Act 2000 and section 63 63 B of the Indian Copyright Act 1957.

India regulators need to inspect Chinese production facilities before imports: Dr G.G Nair

Peethaambaran Kunnathoor, Chennai — 4-Dec-2010

Indian regulatory authorities should insist on inspection of Chinese manufacturing premises for GMP GLC standards as they do in the case of Indian drug manufacturers said Dr Gopakumar G Nair Patent Attorney & Advisor Pharmexcil.

Reduce software piracy to boost economy create new jobs

PTI — 05-Dec-2010

Lack of awareness about Intellectual Property Rights and threats posed by pirated software as well as rapid growth of consumer PC markets such as India and China have resulted in increasing software piracy.

Protecting trade secrets

Anurag K Agarwal / New Delhi — 6-Dec-2010

Violations of business and intellectual property rights are on the rise and pose a huge challenge to corporations and innovators.

Brain League launches reference manual on Indian Patent Law & its Practice

Our Bureau Bangalore — 07-Dec-2010

Brain League has launched a reference manual on Indian Patent Law & its Practice.

Pharmexcil CIPI to work together to promote pharma exports of SMEs

Suja Nair Shirodkar, Mumbai — 7-Dec-2010

The Pharmaceuticals Export Promotion Council of India and Confederation of Indian Pharmaceutical Industry have decided to join hands to work together on promoting of pharma exports of SMEs.

Drug cos want IP issues kept out of pact with EU

P.T.Jyothi Datta — 7-Dec-2010

Domestic drug makers are worried that Indias proposed Free Trade Agreement with the European Union would give away more than is beneficial to the country and its pharmaceutical industry.

India EU Trade Agreement expected to be ready early 2011

PTI — 07-Dec-2010

An ambitious Trade and Investment Agreement between India and European Union that could help in increasing bilateral trade by about 40 per cent to touch 100 billion Euros is expected to be finalised early next year.

The Mint Report for 07 December 2010

8-Dec-2010

Generic drug sales may be safe from trade deal with the EU Air India to finally get fresh bailout funding bank stocks drag down Indian bourses

EU pact wont hurt generics

Amiti Sen — 8-Dec-2010

The proposed India EU trade and investment agreement will not curtail Indias right to produce and export cheap life saving medicines.

Oxycodone boost

Nitin P Shrivastava — 8-Dec-2010

The stock of Glenmark Pharma has been on a roll driven by improving revenue visibility on account of robust growth in its domestic formulations business and strong product pipeline in the US generic market.

India, EU reach consensus on TRIPS imbroglio

Nayanima Basu / New Delhi — 8-Dec-2010

Decision to be mentioned in the text of the FTA.

EU pact wont be tighter against drugs

Asit Ranjan Mishra — 8-Dec-2010

Indias pharma firms and activist groups have been vociferous opponents of the proposed bilateral pact on the grounds that it will require India to make a so called TRIPS plus commitment

Bid to browbeat judiciary not a new trend: retired HC judges

A Subramani — 8-Dec-2010

Sitting inside a glass bubble we strain every nerve to decipher grievances ranging from common road problems to complex patent issues.

Mumbai firm wins trademark case against Estee Lauder

P B Jayakumar / Mumbai — 8-Dec-2010

Gufic Biosciences a small cap Mumbai based pharmaceutical company has successfully survived a trademark infringement suit in the Supreme Court filed by US based multinational cosmetic major Estee Lauder.

A powerful push for US firms patent

C.H. Unnikrishnan — 8-Dec-2010

US commerce secretary writes to Indias Anand Sharma seeking fair consideration of Gileads appeal for drug patent

Venus completes phase III trials of anti bacterial molecule

Press Trust of India / New Delhi — 08-Dec-2010

The molecule is under patent protection in India China and major markets of the world it added.

PM leaves for Brussels tomorrow for India EU summit

PTI — 08-Dec-2010

The differences broadly relate to social issues like environment and labour standards as well as intellectual property rights.

Generic drugs not on India EU trade talks agenda: Khullar

Our Bureau — 08-Dec-2010

The Indian Drug Manufacturers Association had told Business Line recently that intellectual property rights related issues should not form part of the FTA.

US looks to India to strengthen co-operation in Ayurveda-Siddha Unani herbal and botanical products of global standard

Nandita Vijay, Bangalore — 9-Dec-2010

But the reality is that Indian ASU industry is shrugging away from the data generation and protection of Intellectual Property he added.

Saldanha hits paydirt with a risky strategy

PB Jayakumar / Mumbai — 9-Dec-2010

Glenmark Generics has first to challenge patent opportunities in the case of about six drugs which are going off patent before 2015 in the US.

ITPC wants India to remove IP clauses on HIV medicines from EU India trade pact

Our Bureau, Mumbai — 9-Dec-2010

The current working text of the agreement still contain clauses on intellectual property protection that go beyond Indias obligations under the WTO TRIPS Agreement.

EU India close to solving dispute over drug seizures

Pallavi Aiyar / Brussels — 9-Dec-2010

In the clearest indication from the European Commission yet that a resolution to the ongoing dispute between New Delhi and Brussels regarding generic drug seizures had been reached a senior EC official told reporters on Wednesday that the EU was open to changing the offending regulation.

FTA will hurt livelihoods in India, Europe: civil society

Special Correspondent — 10-Dec-2010

Halt ongoing negotiations says open letter

Indian generics to be safe from seizure while passing through EU

Amiti Sen — 10-Dec-2010

Pharmaceutical exporters can breathe easy as the European Union has finally agreed to Indias demand to amend its Customs regulations to stop confiscation of drugs en route to African and Latin American countries.

EU promises to amend norms on seizure of drugs in transit

Our Bureau — 10-Dec-2010

The European Union has assured India that it will amend its regulations on the seizure of drugs in transit to Indias satisfaction while ruling out any such confiscation in the meanwhile.

No compromise on IPR in FTA with EU: Govt

ENS Economic Bureau — 10-Dec-2010

India today made it clear that it will make no compromise on intellectual property rights in the on going India EU FTA talks and emphasised that it will not accept any TRIPS plus commitments as initially mooted by the European Union.

Pharma cos opt for designer drugs for better brand recall

Vishal Dutta — 10-Dec-2010

Pharma companies are experimenting with design to distinguish products from round and rectangular pills sold at drug stores.

EU India FTA by March 2011

Varghese K George — 10-Dec-2010

Negotiations between India and the European Union for a Free Trade Agreement are on track and expected to be concluded by March April 2010 said government sources.

Farmers’ interest safe in India EU pact says PM

Sachin Parashar — 11-Dec-2010

Both sides agree that the Intellectual Property Rights chapter will be based on and reflect legislative developments in the EU and India

Experts highlight importance of patents for college students

Abhinav Malhotra — 12-Dec-2010

Saying that India was lagging behind China in terms of patent applications country manager IBM Bhooshan Kelkar also pointed out India was on the 20th spot and China ranked sixth on the list of countries that filed the highest number of patents every year for the innovations made.

CPI(M): why this veil of secrecy over FTA with EU

Special Correspondent — 12-Dec-2010

The Communist Party of India on Saturday expressed concern over the veil of secrecy around negotiations for the India European Union Free Trade Agreement and re emphasised that the Manmohan Singh government did not have the mandate to conduct parleys on it without discussion within the country.

Merck scouting for Indian partners

Khomba Singh — 13-Dec-2010

What is new is that the number of products going off patent in next 3 5 years is unprecedented.

Anand Sharma & Karel De Gucht: Partners in trade partners for growth

Anand Sharma & Karel De Gucht — 13-Dec-2010

The EU India Summit last Friday sent a clear signal that the European Union and India are jointly tackling one of the key challenges facing us all: how to find new sources of economic growth.

More than 20,000 patent applications piled up at Chennai office severe shortage of examiners

Peethaambaran Kunnathoor, Chennai — 13-Dec-2010

More than 20000 applications scores of them are from abroad for patent registration for pharmaceutical and biotechnology inventions are pending with the Patent Office in Chennai.

EU pledge to India over generics seizures

Lynne Taylor — 14-Dec-2010

The European Commission has agreed to amend its customs regulations so that Indian made generic drugs bound for Third World countries will no longer be seized while they are in transit through European countries.

Handicrafts of the region aspiring for GI tag

TNN — 13-Dec-2010

After the world famous Banarasi and brocade and handmade carpet some other products with specific distinctions of this region of eastern UP are also looking forward to getting the tag of Geographical Indication.

Now Merck sues Hetero Drugs over Finasteride

BV Mahalakshmi — 14-Dec-2010

Global research driven pharmaceutical company Merck & Co has filed a patent infringement case over the active pharmaceutical ingredient Finasteride against Hyderabad based Hetero Drugs in the United States District Court for the District of New Jersey.

Shah Rukh gets HC go ahead to remake Yeh Jo Hai Zindagi

Sunil Baghel — 15-Dec-2010

Doordarshans Friday night hit to get a makeover Bombay High Courts interim order rejects copyright complaint filed by writer Sharad Joshis daughter

Ranbaxy may be on the road to recovery

Ranju Sarkar / New Delhi — 16-Dec-2010

Ranbaxys stock has shot up by more than 50 per cent in a year thanks largely to these off patent launches.

Nokia is suing Apple in Britain Germany and the Netherlands for allegedly infringing its patents with technology used in the iPhone iPad and iPod Touch.

Press Association — 16-Dec-2010

The actions add 13 further Nokia patents to the 24 already asserted against Apple in the US International Trade Commission and the Delaware and Wisconsin Federal courts the worlds largest handset maker said.

New policy for pharma firms

Special Correspondent — 16-Dec-2010

Inaugurating a conference on Intellectual Property Right challenges and the way forward for pharmaceutical industry he said the new policy would address issues faced by pharmaceutical companies and ensure availability of drugs at the right price.

Generex receives Canadian patent for Buccal drug delivery platform technologies

Worcester, Massachusetts — 17-Dec-2010

Generex Biotechnology Corporation announced that it has received a new patent for its Buccal drug delivery platform technologies.

Embrace open source philosophy Kalam tells scientists researchers

Deepa Kurup — 17-Dec-2010

In the wake of the failure of market forces in this sector the OSDD is exploring new models of drug discovery and looking at innovative patent regimes Mr. Kalam said.

Patent office to start backlog clearance drive of 3749 pending cases soon

Suja Nair Shirodkar, Mumbai — 17-Dec-2010

The Indian patents office has initiated a clearance drive to dispose the backlog of the 3749 applications pending with it on or before July 3 2009.

Sitar legend hails change in copyright law

TNN — 18-Dec-2010

Sitar legend Pandit Ravi Shankar has written to the PM congratulating him on amendments to the copyright law that the government plans to introduce shortly.

Pharma healthcare grew this year on M&As booster dose

Munish Shekhavat & Ajay Tyagi / PTI — 18-Dec-2010

Besides hectic activity on the mergers and acquisitions front the Indian pharma firms had to face hostility from European Union authorities seizing generic drug bound for Africa for alleged patent violations.

Generics Glitter

BV Mahalakshmi — 20-Dec-2010

The loss of exclusivity for some iconic pharmaceutical brands is bringing in a new wave of innovation.

Petitions to withdraw GI tags for Darjeeling Tea Tirupathi Laddu

Vinson Kurian — 20-Dec-2010

A case for removal of the GI entries seems to have been mounted on the basis of lack of proper credentials of the applicant as rightful owner of GI.

Unlike generics biosimilars can thwart Indias copycat kings

Priyanka Golikeri — 21-Dec-2010

While they remain good at the chemistry of molecular tweaking of patented drugs they seem to have run into a high technology wall when trying to do the same with biologic medicines.

Ashok Leyland wins LUXURA trademark infringement suit

Our Legal Correspondent — 22-Dec-2010

Chennai based commercial vehicles company Ashok Leyland Ltd which has been making and selling buses and trucks for more than six decades has won a suit filed in the Madras High Court against infringement of its registered trade mark LUXURA by two firms one in Bangalore and the other in Mumbai.

Teva settles diabetes drug patent litigation

Globes\' correspondent — 23-Dec-2010

Teva Pharmaceutical Industries Ltd.said today that it reached a settlement on two Type 2 diabetes drugs.

Copywrong!

Vickey Lalwani — 23-Dec-2010

The government is amending its copyright laws to protect singers and lyricists.

First healthcare SEZ to go onstream in Jan 2011

BS Reporter / Chennai — 23-Dec-2010

It has so far bagged two patents along with filings completed for another eight patents with the Indian Patent Office he added.

Dilip Chhabria Design violated trademark

Agencies — 23-Dec-2010

The Madras High Court has granted an injunction to Hinduja group flagship company Ashok Leyland prohibiting two Bangalore and Mumbai based firms from infringing the registered trademark of the company.

USV looks to monetising US patent on kidney drug

P.T. Jyothi Datta — 23-Dec-2010

Armed with a patent in the US for its improved version of kidney medicine sevelamer the Rs 1020 crore drug maker USV is evaluating its options to take the product further.

Protect interest of intellectual property inventors: CSIR

Press Trust of India / New Delhi — 23-Dec-2010

Council of Scientific and Industrial Research Director General Samir K Brahmachari today said the interest of the intellectual property inventors should be protected and not that of investors.

Glenmark Generics gets US FDA approvals for three ANDA

Our Bureau, Mumbai — 23-Dec-2010

Earlier this Glenmark entered into a settlement and license agreement with Sepracor to resolve a United States patent infringement suit related to Glenmarks filing an ANDA for Eszopiclone with the US FDA.

Insights caFE

P. Raghavan, Rakesh Basant — 24-Dec-2010

Intellectual Property Protection Regulation and Innovation in Developing Economies: The Case of Indian Pharmaceutical Industry

Drug panel to recommend some generics have no brand names

Radhieka Pandeya — 24-Dec-2010

Consultative committee wants change to apply to single ingredient generics but move may face legal challenge

Takeda settles diabetes drug patent suits with 11 generic firms

BS Reporter / Mumbai — 24-Dec-2010

Japans Takeda Pharmaceutical Company has settled patent infringement suits out of court with 11 generic drug companies including Ranbaxy Laboratories Torrent Pharmaceuticals Dr Reddys Laboratories Wockhardt and Aurobindo Pharma over its flagship diabetes drug Actos and its variants.

Takeda settles diabetes drug patent suits with 11 generic firms

BS Reporter / Mumbai — 24-Dec-2010

Suven Life Sciences gets 4 product patents

Our Bureau — 24-Dec-2010

Suven Life Sciences Ltd has secured four product patents two each from New Zealand and Eurasia for its new chemical entities.

Engineered in India

D. Murali — 27-Dec-2010

Indias low R&D spend in fundamental research lack of global product companies and small spend in IP and patent development need to be addressed to compete with developed markets and China to build the product ideation ecosystem.

Patent dissatisfaction

Business Standard / New Delhi — 27-Dec-2010

Indias patent laws allow the patent examiners to delay or reject patent applications if they are satisfied that the application or any specifications or attached documents do not comply with the requirements of the Patents Act or Patent Rules.

Venus gets patent for antibiotic drug from Russia Ukraine

PTI — 27-Dec-2010

Drug firm Venus Remedies today said it has received patent grants for its antibiotic drug Sulbactomax from Russian and Ukrainian authorities.

Local engineer patents new technology for engine efficiency

Himanshu Bhatt — 27-Dec-2010

In a depressing environment of spiraling fuel prices the news that a new technology increases power efficiency of two and four stroke engines by 20 to 40 per cent is very inspiring.

Markets have a subdued closing

SI Reporter / Mumbai — 28-Dec-2010

And drug firm Venus Remedies gained 1.4% at Rs 269 after receiving patent grants for its antibiotic drug Sulbactomax from Russian and Ukrainian authorities.

BHEL & Bharat Electronics two PSUs in top R&D spenders in India

Vivek and Biswarup Gooptu — 28-Dec-2010

Rao is proud of the fact that in the past year BHEL has filed patent and copyright applications at the rate of one every working day.

Pharmexcil urges modern ayurvedic drug units to work together to exploit global markets

Gireesh P K, Hyderabad — 28-Dec-2010

The Pharmaceuticals Export Promotion Council has urged the pharmaceutical companies and ayurvedic units in the country to join hands to reap the opportunities available for the ayurvedic drugs in the international market.

Clinical drug trials on humans set to become more stringent

Radhieka Pandeya — 28-Dec-2010

Thats a big loss of time because the patent clock is already ticking for your product.

Biocon is at a strong price disadvantage to global players : Kiran Mazumdar Shaw

ET Now — 29-Dec-2010

That is absolutely the intention and we are reading ourselves for being able to be ready with our product development upon patent expiration.

UPA bosses step in to solve copyright dispute

Report — 29-Dec-2010

The government has assured the Indian film industry that its grievances over the copyright amendment bill will be addressed and resolved soon.

Innovate or perish

ET Bureau — 29-Dec-2010

So Indian companies will have to make do with either commoditised tech or proprietary technology that is not premium enough for the holder of its intellectual property to monetise it on its own.

Bollywood producers hope to amicably resolve copyright issue

IANS — 30-Dec-2010

After deferring their Jan 6 strike Bollywood producers Wednesday hoped to soon resolve the raging controversy over the proposed amendment to the Copyright Act that mandates producers sharing 50 percent of music royalties with lyricists and composers.

Sony slaps patent violation complaint against LG Electronics

PTI — 30-Dec-2010

Japanese major Sony Corp has filed a patent infringement complaint against rival and South Korean conglomerate LG Electronics related to certain mobile phones and modems.

Suven Life Sciences gets two patents for their NCEs

BS Reporter / Mumbai — 30-Dec-2010

Suven Life Sciences a biopharmaceutical company was granted patent for two of its products for their New Chemical Entities for the treatment of disorders associated with Neuro degenerative diseases according to the press release filed with the BSE.

Pharma: Walking the tightrope between affordability profits

P.T. Jyothi Datta — 31-Dec-2010

Also upping the ante of stake holders is a host of FTAs India is getting into and domestic drug industry representatives and health advocacy workers urge the Government to keep intellectual property out of trade negotiations

The pharma story: A decade of transition

P B Jayakumar / Mumbai — 31-Dec-2010

India enforced process patent in early 1970 which allowed domestic companies to legally copy and manufacture patented drugs.

Pharma: On a healthy wicket

Srividhya Sivakumar — 1-Jan-2011

The year promises to see a higher generic incursion led by expiring patents and receding product pipelines of global pharma companies.

Three sector picks for 2011

Outperformer — 02-Jan-2011

Expiring patents of global pharma companies

Three sector picks for 2011

Outperformer — 02-Jan-2011

Expiring patents of global pharma companies

Govt explores capping FDI in pharma

C.H. Unnikrishnan — 02-Jan-2011

DIPP had in September come out with a discussion paper on implementing compulsory licensing provisions in the country to ensure the availability of low cost versions of patented drugs in the country.

Indian pharma remains top in US generics

P B Jayakumar / Mumbai — 3-Jan-2011

Generics are reverse engineered cheap versions of branded patented drugs.

India rejects Abbot labs patent application

Press Trust Of India — 03-Jan-2011

India has rejected a drug patent application of a US multi national pharma company paving way for easy access to an important life saving medication for HIV patients across the globe.

Lupin settles litigation with Japanese firm

Press Trust of India / New Delhi — 03-Jan-2011

Drug firm Lupin today said it has settled ongoing litigation over Lunesta tablets used in treating insomnia with Japan based Dainippon Sumitomo Pharma.

Elder Pharma gets Japanese approval for API facility

Press Trust of India / New Delhi — 3-Jan-2011

The company has developed two products going off patent in the Japanese market in 2014.

Inflicting bitter medicine

4-Jan-2011

For one they have the potential to prevent technology and intellectual property rights transfers to Indian shores from abroad.

Pharma rides high

Business Standard / New Delhi — 4-Jan-2011

Over the next few years a large number of best selling drugs are going to go off patent in the developed countries offering a golden opportunity for a generics player like India.

The pitfalls of bilateral deals

4-Jan-2011

As regards intellectual property rights negotiations with the EU have also brought concerns about intellectual property rights arising in particular from the position that Indias intellectual property laws need to be amended to meet the demands of global pharmaceutical majors.

Govt may cut FDI to 49 per cent in pharma industry

Sanjay Singh — 4-Jan-2011

Earlier the PMO had also sent a note based on the recommendations submitted by global drugmakers which seeks key changes such as a legislative review of the Indian patent laws data exclusivity and implementation of patent linkages.

SMEs can benefit from use of IPRs: Expert

ENS Economic Bureau — 4-Jan-2011

Intellectual property rights are exclusive legal rights granted to a number of distinct types of intangible assets such as inventions over which a patent can be obtained and words and symbols over which a trademark protection can be sought.

Trailer Agreement on employees can protect Patents IPs of cos: Dr KC Kankanala

Nandita Vijay, Bangalore — 4-Jan-2011

With Indian companies increasingly getting into knowledge oriented cutting edge work patents and Intellectual Property are seen as the logical options to protect their interest not only from competition but also from their own employees.

Pfizer drags DRL to court over Lipitor copy launch

Khomba Singh — 4-Jan-2011

Pfizer has taken Dr Reddys Laboratories to court to delay the launch of the Indian drug makers low cost version of atorvastatin in the US market.

Pharma companies are eyeing lucrative biotechnology space

Debasis Mohapatra & Raghuvir Badrinath / Bangalore — 4-Jan-2011

Patent protection on the first batch of biotech drugs that entered regulated markets in the late 1980s is set to expire.

Microsoft patent to help you date celebrity look alike

TOI Tech — 04-Jan-2011

Wish you could search for your favourite celebrity look alike on all those online dating sites?

Merck KGaA focuses on diabetes in India lines up five products

C.H. Unnikrishnan — 5-Jan-2011

While a significantly large population and progressing economy are the key attractions for global drug makers in India a saturated growth and less number of high value and patent protected products for launch in the US and European markets are the other compelling factors that drive them into this market.

Natco seeks Pfizer nod for drug clone

Khomba Singh — 5-Jan-2011

Pfizer has time till May to reply as Indian patent law allows an innovator company to respond within six months of receiving a notice for voluntary license.

Dr Reddys generic version of Lipitor hits Pfizer roadblock in US

Our Bureau — 5-Jan-2011

Global pharma major Pfizer has filed a petition in a US court against Dr Reddys Laboratories Ltd for patent infringement on the generic version of atorvastatin which is being sold under the brand Lipitor.

Kraft sues Britannia over Treat O biscuit being a copy of Oreo cookies

Ratna Bhushan — 05-Jan-2011

US based packaged food maker Kraft Foods on Tuesday sued Nusli Wadia owned Britannia Industries for trademark and copyright violations of its popular Oreo cookies.

Dr Reddys to contest Pfizers patent suit

Press Trust Of India / New Delhi — 6-Jan-2011

Dr Reddys Laboratories will contest the patent infringement case filed against it by the global pharmaceutical giant Pfizer over its cholesterol lowering drug Atorvastatin said a company spokesperson today.

Intellectual property

Madhukar Sabnavis / New Delhi — 7-Jan-2011

The film Social Network may be a fictional or realistic account of the creation of Facebook.

Saving yoga from patents

Uttara Choudhury — 8-Jan-2011

I had taken my son to a birthday party in Manhattan when an Israeli woman in a flowing kurta gave me a beatific smile and said Yoga is very interesting.

Student gets patent for innovative product

Nikhila Henry — 8-Jan-2011

Kondamudi Swarnarekha a student of BV Raju Institute of Technology is not just another techie in the making.

Azad calls upon pharma industry to grab US$ 80 billion off patent opportunity

Our Bureau, Mumbai — 10-Jan-2011

Union minister of health and family welfare Gulam Nabi Azad called upon the pharma industry in the country to grab the opportunity being unfolded in the wake of around 60 products worth more than a whopping US$ 80 billion going off patent in a couple of years in the US and other regulated markets.

India rejects US companys patent for anti HIV drugs

NDTV Correspondent — 10-Jan-2011

What serves as one of the biggest threats against people living with HIV AIDS is multinational drug companies producing lifesaving drugs pushing for patents so generic companies cannot produce them at much lower prices.

Discontent brews over Darjeeling tea label

Manisha Pande — 12-Jan-2011

The Tea Boards control of the GI tag makes small farmers unhappy.

Infosys cash dips by 3.77 pc to Rs 14819 crore in Q3

PTI — 13-Jan-2011

Besides during the third quarter Infosys applied for 17 patent applications in India and US. With this Infosys has an aggregate of 270 patent applications in India and the US and has been granted 18 patents by the US Patent and Trademark office.

India needs robust legal framework in order to advance

Mr Ranjit Shahani — 13-Jan-2011

In India some progress has been made in this area following the amendment to the India Patent Act in 2005.

Many artifacts of region await GI status

Binay Singh — 13-Jan-2011

In the days to come eastern UP is going to be a hub of GI tagged properties.

US to work with India to crackdown on pirated movies API

PTI — 14-Jan-2011

Observing that both the pirated Bollywood movies and the counterfeit pharmaceuticals have been causing huge financial losses Matthew King Deputy Director Homeland Security Investigations National Intellectual Property Rights Co ordination Center told foreign journalists that such a crackdown would intensify in 2011.

Ranbaxy plant a step closer to rehabilitation by US FDA

Radhieka Pandeya — 14-Jan-2011

FDA may also want to speed up the process due to the approaching patent expiry of Pfizers blockbuster statin Lipitor said a Mumbai based analyst who didnt want to be named.

Govt may limit FDI in pharma sector at 49%

Rupali Mukherjee — 14-Jan-2011

The Indian Patent Law allows product patents for all new molecules which have been patented after the year 1995.

Copyright infringements fakes dog FMCG sector

Viveat Susan Pinto / Mumbai — 14-Jan-2011

When US-based Kraft Foods dragged biscuit major Britannia to court last week alleging trademark and copyright infringement of its Oreo brand of cookies many in the fast moving consumer goods industry werent surprised.

Insurer liable till vehicle owners name is in register

BS Reporter / New Delhi — 17-Jan-2011

The companies entered into a Trade Mark Licence Agreement under which the US firm had granted the Indian firm licence to use the trademark Penn for use in certain territories for certain products like golf balls accessories and inflatable balls.

Indian companies urged to go for IPR

Special Correspondent — 17-Jan-2011

Speakers on Monday said that Intellectual Property Rights could be used as a strategic weapon in the competitive world to prevent its abuse and urged the Indian companies to go for it.

Govt probes irregularities in patent given to B Braun

Thomas K Thomas — 18-Jan-2011

The Department of Industrial Policy and Promotion has undertaken disciplinary action against top officials of the Patents & Designs office in Chennai for alleged irregularities in granting patent to German medical device maker B Braun for an intravenous device.

Glenmark loses patent case to Abbott in US

PTI — 18-Jan-2011

Indian drug firm Glenmark has lost a patent case against US firm Abbott Laboratories over hypertension drug Tarka.

Trademark patent seekers get access to database

Vikas Dhoot — 18-Jan-2011

Patent and trademark seekers will no longer have to wait for weeks to get the go ahead for their applications from the governments patent registrar .

Indian Patents Act Undergoes Changes

ag-IP-news — 18-Jan-2011

Abu Ghazaleh Intellectual Property announced in a press release that the Department of Industrial Policy and Promotion of the Indian Ministry of Commerce and Industry has published a notification in the official Gazette of India which is a draft of certain rules and does not carry the force of the law as yet these may be called Draft Patent Rules mendment 2010.

Dont swallow this pill

Unni Karunakara — 19-Jan-2011

But the Indian press now reports that the PMO under pressure to conclude the deal has asked the concerned government department to reconsider intellectual property provisions it had earlier rejected.

Lincoln Pharma wins patent for NDDS

BS Reporter / Mumbai/ Ahmedabad — 19-Jan-2011

Ahmedabad based Lincoln Pharmaceuticals Limited has received a patent for a Nasal Drug Delivery System in India that helps in arresting or preventing vomiting and nausea that will particularly help in chemotherapy induced nausea.

Glenmark Pharma gets FDA approval to market generic malaria drug

PBR Staff Writer — 19-Jan-2011

Glenmark Pharmaceuticals has received US Food and Drug Administration approval for marketing atovaquone amd proguanil hydrochloride tablets to treat malaria.

Changing our tune

Shamnad Basheer — 21-Jan-2011

The Copyright Act protects Indian composers at home but not abroad.

Signature campaign against copyright Bill

Abhilasha Ojha — 21-Jan-2011

The objective of the amendment is that opening up of markets without any boundaries or territories for films books and music

Writ petition says IP tribunal incompetent

Khomba Singh — 21-Jan-2011

A group of patent lawyers have filed a writ petition challenging the legality of the countrys highest technical body for intellectual property disputes saying the members are incompetent to hear IP cases.

Intellectual Property tribunals legality questioned

P. T. Jyothi Datta — 21-Jan-2011

The writ petition alleges that the Board suffers from a lack of relevant IP expertise and that many of its orders are routinely overturned by High Courts.

THE PATENT PRESSURES

P A Francis — 21-Jan-2011

India EU Trade and Investment Pact is going to be concluded some time in March this year and the prime minister is expected to visit Europe for signing the same.

Wockhardt gets USFDA approval to market generic Protonix

PTI — 21-Jan-2011

Drug firm Wockhardt today said it has received final approval from the US health regulator US Food and Drug Administration to market generic pantoprazole tablets used for treating ulcers and hyperacidity in the American market.

FTA with EU only by year-end

Special Correspondent — 21-Jan-2011

Although negotiations on the much awaited India European Union Free Trade Agreement are likely to be concluded by summer this year the formal signing will only happen by the end of this year at the India EU summit.

EU still pushing data exclusivity through FTA India stands firm

Joseph Alexander, New Delhi — 22-Jan-2011

European Union is still pushing India to accept TRIPS plus data exclusivity provisions through the proposed Free Trade Agreement though India is still firmly against it if the latest draft chapter on intellectual property rights is any indication.

Indian movies without songs possible?

Leena Mulchandani — 22-Jan-2011

Its supposed to amend the copyright laws in India but The Copyright Bill 2010 might just also amend the way movies are made.

Maharashtra plans to patent Worli sea link

ET Bureau — 23-Jan-2011

The Maharashtra State Road Development Corporation is in talks with a few international legal consultants to patent its iconic Bandra Worli Sea Link project with the intention to generate additional revenue.

The copyright wars

Satya Prakash — 23-Jan-2011

As India emerges as one of the biggest world publishing markets intellectual property rights become a more contentious issue with authors artists and other creative persons asserting their rights and the government attempting to bring the industry practices in tune with the international treaties in a more globalised environment.

India raise concern over WHOs failure to replace IMPACT with working group on counterfeit drugs

Joseph Alexander, New Delhi — 24-Jan-2011

India has raised strong concern over the delay in setting up a working group by the World Health Organisation to address the problems of counterfeit and substandard medicines and adopt changes in the policy instead of leaving the task with controversial International Medical Products Anti Counterfeiting Taskforce.

Music industry readies copyright database

Reuters / London — 24-Jan-2011

The music industry is working to create a global repertoire database to make it easier and faster for new online music services to come to market.

Natco may seek compulsory licence for Bayers cancer drug

Khomba Singh — 24-Jan-2011

Natco Pharma plans to seek a compulsory licence from the government to make Bayer AGs Nexavar in India invoking a provision in local laws that allows generic drugmakers to make and sell patented drugs cheaply if the medicine is unaffordable.

US generics demand to drive Indian pharma growth: Fitch

24-Jan-2011

It said that Indian pharmaceutical companies expect about $ 96 billion worth drugs to go off patent in the US in 2011 2013.

India EU negotiators to meet in Kerala to resolve FTA issues

PTI — 25-Jan-2011

Inclusion of intellectual property rights and social issues like environment and labour standards in the proposed Bilateral Investment and Trade Agreement are some of the main areas on which a consensus are yet to be achieved.

Punjabs history came in way of GI pleas

Jasneet Bindra — 25-Jan-2011

Punjab suous history has been a major roadblock in its run for geographical indication.

Quality issues may hit pharma cos US prospects

P.T. Jyothi Datta — 25-Jan-2011

Quality concerns could upset the apple cart for Indian generic drug makers exporting to the US even as they look to tap the $96 billion worth opportunity emerging from drugs going off patent between 2011 and 2013.

US suggests removal of some key clauses in patent manual

C.H. Unnikrishnan — 25-Jan-2011

The changes being sought may not be in agreement with the terms of Indias laws on Intellectual property

Dont swallow this pill

pritiradhakrishnan — 27-Jan-2011

Troubling news reports indicate that a newly minted Free Trade Agreement between the European Union and India would permit companies to circumvent visionary safeguards built into Indias 2005 Patents Act widely seen as one of the most progressive patent laws in the world.

Data exclusivity still key hurdle to India EU FTA

Nayanima Basu & Joe C Mathew / New Delhi — 27-Jan-2011

Despite all official assurances the path towards a free trade agreement between India and the European Union this year remains ambiguous as both sides are unwilling to relax their stand on the biggest stumbling block the issue of data exclusivity.

Plea seeks to expose patent tribunal anomaly

A Subramani and Pushpa Narayan — 27-Jan-2011

A technical member of the Intellectual Property Appellate Board he was appointed to the post after he took credit for the cases argued during the British era.

IPA concerned over PMO\'s efforts to destabilize Indias IPR regime at the behest of EU

Ramesh Shankar, Mumbai — 27-Jan-2011

The Indian Pharmaceutical Alliance an association of leading Indian pharma companies has raised alarm over the recent media reports that efforts are going on in the Prime Ministers Office to destabilize Indias IPR regime at the behest of European Union which the IPA cautioned the government will have serious implications on the public health access to medicines and the domestic generic industry.

BJP drags PM into CVC row says govt claim patent lie

PTI — 27-Jan-2011

BJP on Thursday slammed the government for claiming in the Supreme Court that the committee which chose P J Thomas as the CVC last year was not aware of corruption charges against him and sought an answer from Prime Minister Manmohan Singh for the patent lie.

A manufacturing strategy for India

ARUN MAIRA — 28-Jan-2011

In fact the Chinese government is framing IPR rules to further its own interests suspecting that the rules being imposed on it have been devised principally to protect foreign companies interests.

HC seeks Centre\'s response on patent board anomaly plea

TNN — 28-Jan-2011

The Madras high court has asked the additional solicitor general of South India M Ravindran to ascertain the Centres response to a public interest writ petition highlighting serious anomalies in the affairs of the Intellectual Property Appellate Board here.

Pharma exports may touch a record Rs 50000 cr in 2010 11

Joe C Mathew / New Delhi — 28-Jan-2011

Industry analysts say the growth will be driven by the US revenues where $36.7 billion worth drugs are expected to go off patent in 2011.

Cadila Healthcare: Buy

Srividhya Sivakumar — 29-Jan-2011

Good results bright prospects in the domestic and export markets and better growth expectations from its joint venture companies make Cadila Healthcare a good investment bet for the long term.

Hardware and software of innovation

D. Murali — 29-Jan-2011

There is much that is dysfunctional in the US but there is also a great deal to be optimistic about writes Adam Segal in Advantage How American innovation can overcome the Asian challenge.

Vexed issues delaying free trade talks

Asit Ranjan Mishra — 31-Jan-2011

A free trade agreement with Australia will provide India access to markets in East Asia, allowing it to counterbalance the growth of strategic and economic rivals such as China in the region said the commerce ministry official cited earlier.

Dr Reddys says U.S. court clears generic Allegra sale

Bharghavi Nagaraju — 31-Jan-2011

The U.S. District Court of New Jersey lifted an injunction passed last June against the Indian drugmaker from selling a copycat version of the drug Dr Reddys said in a statement.

Lupin global ride hinges on the Power of Five

Priyanka Golikeri — 31-Jan-2011

The Mumbai based company is banking heavily on products belonging to therapeutic areas such as oral contraceptives ophthalmics dermatology biosimilars off patent versions of biologic drugs and asthma to be the driving force.

Ind Swift net profit up by 83.10%, Exports up 37.87%

Announcement / Corporate — 31-Jan-2011

The Company is now in agreement with global players for the supply of blockbuster drugs like Clarithromycin Atorvastatin Fexofenadine Letrozole Anastrozole Rosuvastatin Pioglitazone Clopidogrel etc. to regulated markets on patent expiry.

Dr Reddys gets court nod to launch Allegra D 24 tablets in US

PTI — 31-Jan-2011

In September 2009 AMRI filed a patent infringement lawsuit against Dr Reddys for alleged infringement of one of AMRIs patents related to the manufacturing process for the active ingredient in Allegra D 24.

The decade in science

Jacob P. Koshy — 1-Feb-2011

Over at least the past seven years several multinational firms including Microsoft Corp. and International Business Machines Corp. have been setting up their key research centres in India often recruiting the brightest of Indian scientists and researchers to power their patent pipeline.

India EU free trade pact to be concluded this year: Sharma

Laxmi Devi — 1-Feb-2011

India today exuded confidence that negotiations for the proposed comprehensive market opening pact with the 27 nation European Union will conclude in 2011.

Artists and musicians told to come together to safeguard their work

Special Correspondent — 2-Feb-2011

A discussion on copyright in Chennai on Tuesday witnessed the forceful articulation of the need for artists and musicians to come together to safeguard their creative works.

Pirated counterfeit products value to touch $1.78 tn in 2015

PTI — 03-Feb-2011

A number of G 20 economies may be missing out on higher FDI as a result of concerns over IPR Intellectual Property Rights enforcement.

Natco to take on Bayer on cancer drug Nexavar

KV Ramana — 3-Feb-2011

Generic pharmaceuticals maker Natco Pharma is gearing up to take on German healthcare giant Bayer AG.

India is developing good competition policy says WTO official

PTI — 03-Feb-2011

India is developing an effective competition policy and is also making significant efforts to strengthen its intellectual property rights regime a top WTO official has said.

Indian cos eye $4bn generic opportunity

Rupali Mukherjee — 4-Feb-2011

Around $3 4 billion worth opportunity will be up for grabs in the wake of blockbuster drugs going off patent losing patent protection in the US over 2011 2012.

SC to hear Novartis plea on cancer drug patent

Press Trust of India / New Delhi — 04-Feb-2011

The Supreme Court will start final hearing next month on a plea by Swiss pharma firm Novartis AG challenging the order of an appellate board which upheld the governments denial of patent to its blood cancer drug Glivec.

SC to hear Novartis plea on cancer drug patent

Press Trust of India / New Delhi — 04-Feb-2011

The Supreme Court will start final hearing next month on a plea by Swiss pharma firm Novartis AG challenging the order of an appellate board, which upheld the governments denial of patent to its blood cancer drug Glivec.

Move faster on trade barriers US Commerce Secy to tell New Delhi

Indira Kannan / New York — 5-Feb-2011

Answering a question from Business Standard the Secretary said the US had brought up the issue of tariff and non tariff barriers including restrictions on Foreign Direct Investment and concerns about Intellectual Property Rights during President Barack Obamas visit to India last November and will raise these again next week.

MSMEs should focus on intellectual property rights

TNN — 6-Feb-2011

With micro small and medium enterprises in Orissa giving more emphasis on production than on innovation and intellectual property rights the state government has called for a shift in focus.

Nobodys about to kill books

Rahul Matthan — 7-Feb-2011

There is a proposal to amend the Copyright Act that will make it legal to import into India any book that has been validly published outside India even if an Indian publisher has been granted the exclusive licence to publish it in India.

Mussels: From delicacy to arthritis cure

Ullekh N P — 7-Feb-2011

According to the research institute this product made by extracting anti inflammatory ingredients from green mussels could be a substitute for the regular aspirin containing anti inflammatory arthritis drugs with undesirable side effects.

Delhi high court stops parasite Chinese company from using L&T logo

Rakesh Bhatnagar — 7-Feb-2011

The Delhi high court wants Intellectual Property Rights and Enforcement Rules 2007 and Customs Act 1962 implemented in letter and spirit so that overseas sly operators can be stopped from cashing in on the goodwill and reputation of established Indian brands and duping consumers.

A poetic justice for copyright violations

Sandhya Soman — 8-Feb-2011

In every lecture that she delivers whether in Rome or Bangalore professor Mira T Sundara Rajan shows a photo of her great grandfather the poet C Subramania Bharati.

US asks India to lower tariffs remove barriers

Elizabeth Roche — 8-Feb-2011

Further changes to US export control policies towards India will continue in the months ahead says Locke

Lincoln Pharma bets big on Pa 2 paracetamol tablets

BS Reporter / Mumbai/ Ahmedabad — 8-Feb-2011

The company received patent for a nasal drug delivery system in India last month.

DIPP bats for FDI curbs in pharma

Surajeet Das Gupta / New Delhi — 9-Feb-2011

It said 61 drugs worth over $80 billion are going off patent making it possible for domestic companies to produce cheaper versions of those drugs.

Natco challenges Gileads patent on Tamiflu

BS Reporter / New Delhi — 9-Feb-2011

Hyderabad based Natco Pharma has challenged the patent for Tamiflu a drug to treat bird flu in the US.

China ranks 4th in patent application India lags

PTI — 09-Feb-2011

India remains a laggard in research and technological innovation as compared to China which has become the worlds fourth largest filer of patent applications in 2010 according to the data released by World Intellectual Property Organization today.

Drugmakers rattled by EU austerity moves

Priyanka Golikeri — 10-Feb-2011

Adithya Bhat manging director of business consulting firm Protiviti Consulting said the pricing pressures and austerity measures notwithstanding Indian companies can make the most of drugs going off patent in the EU.

WIPO to organise traditional knowledge meet in March

Press Trust of India / New Delhi — 13-Feb-2011

The World Intellectual Property Organisation a specialised UN agency along with Indian government will organise a three day meet on traditional knowledge including ayurvedic medicine and unani next month.

Gary Locke US Commerce Secretary

Nayanima Basu / New Delhi — 14-Feb-2011

It is the US Trade Representative that leads on trade negotiations in general.

Ahmedabad gives herbal hues to Levis

TNN — 15-Feb-2011

The company is certified by Global Organic Textile Standarda leading processing standard for textiles made from organic fibres worldwide and has a US and India patent for herbal dyeing.

Pharma sector injects fresh life into M&A space

Rupali Mukherjee — 15-Feb-2011

When Ajay Piramal promoter and chairman of Piramal Healthcare struck a deal with US based pharma biggie Abbott Inc for selling assets of the domestic formulation unit at over 9 times its sales little did he know it will set a benchmark.

Rahul Khullar Trade deficit is still worrying

Asit Ranjan Mishra & Anil Padmanabhan — 16-Feb-2011

Next week India plans to sign bilateral trade agreements with Japan and Malaysia to reduce barriers and increase trade even as the World Trade Organizations Doha round of trade talks make little progress.

Q&A: Brian Ager DG European Federation of Pharmaceutical Industries and Associations

Pallavi Aiyar / February — 16-Feb-2011

India is an important trade partner and growing economic power.

Textiles pharma sectors to gain most from trade pact with Japan

Our Bureau — 17-Feb-2011

Indian pharmaceuticals will get access to a highly developed Japanese market and for the first time ever Japan has committed to give the same treatment for Indian generics off patent drugs as their domestic industry the statement said

Ind-Swift Labs gets approvals for two products from PMDA Japan

Our Bureau, Mumbai — 17-Feb-2011

It is for the first time that a large number of drugs patented by Japanese companies are going off patent.

Tatas Mount Everest loses trademark dispute with Bisleri over Himalayan

Ratna Bhushan — 17-Feb-2011

Tata Groups Mount Everest has no exclusive right on the word Himalayan the countrys trademark dispute authority said following a petition from Ramesh Chauhans Bisleri International.

Controls on MRLs move to bar off patent Endosulfan to impact farmers

Announcement / Corporate — 17-Feb-2011

In a media briefing held in Kolkata today a panel of agronomists and farmers expressed concern over the mounting pressure exerted on India not to oppose the European Union proposal to list endosulfan as a Persistent Organic Pollutant.

Roger L Williams United States Pharmacopeia

K Rajani Kanth / Hyderabad — 18-Feb-2011

Indian manufacturers are critically important for the US market.

Satyam to pay $125 million to settle US suit

ET Bureau — 18-Feb-2011

Close on the heels of a settlement of a class action law suit in the US for $125 million Mahindra Satyam is planning to sue the former Satyam management and the companys erstwhile auditor PriceWaterhouse for a possible monetary damages claim.

Problems in trade talks with EU

KAVALJIT SINGH — 18-Feb-2011

EU is pushing India to relax controls on capital flows and conditions on investment such as export obligation and local content requirement.

Global consolidation hits Indian contract drug manufacturing cos

Khomba Singh — 18-Feb-2011

Mergers & acquisitions in the global pharmaceutical industry that have led to reduction in outsourced research work have hit Indian contract drug manufacturing and research services or CRAMS companies.

Court restores status quo on Maricos trademark Manjal

Bindu D. Menon — 18-Feb-2011

The Madras High Court has restored status quo in the dispute regarding the wrongful removal of Maricos trademark Manjal from the trademarks register.

World Cup: Sponsors in fierce off field copyright battles

Gouri Shah — 19-Feb-2011

Copyright Integrity International the intellectual property rights firm enlisted by the International Cricket Council to protect sponsor interest is seeing some fierce rivalry off the field over the tournament that will kick off on Saturday in Dhaka.

Consensus on import duty key to Doha round success

Namrata Acharya / London — 19-Feb-2011

Zeroing in on an agreeable rate of exchange on import duties among member nations was key to concluding the talks on a global free trade agreement or the Doha round at the World Trade Organisation a top WTO spokesperson said today.

Abbott Ranbaxy settle patent suit

Khomba Singh — 19-Feb-2011

Abbott Laboratories has settled a patent litigation case against Ranbaxy Laboratories allowing the Indian pharmaceutical firm to launch a generic version of the US drugmakers cholesterol lowering medicine Tricor.

2(m) or not 2(m)

Nilanjana S Roy / New Delhi — 19-Feb-2011

How a copyright amendment might change the way we read write and publish in India.

A balanced IPR regime Key to promote technology driven agriculture

Rana Kapoor — 20-Feb-2011

As the world moves towards a knowledge driven economy protection of intellectual property rights has become a key motivator for innovation.

Q&A: Roger L Williams MD & CEO United States Pharmacopeia

Neha Shukla — 20-Feb-2011

Any company in the US market can get into trouble in terms of good manufacturing practices or affiliated standards

GIB to give live into about train positions

Neha Shukla — 20-Feb-2011

This will be made possible through the geographical indication board which will be installed at the station in near future.

India US to discuss trade irritants

Nayanima Basu / New Delhi — 21-Feb-2011

The focus areas are standards anti dumping duties and practices small scale industries and protection and enforcement of intellectual property rights.

Indian bottled water: just the tonic

Anjli Raval — 21-Feb-2011

Indias Intellectual Property Appellate Board which deals with trademark related issues said in a recent order that Tatas Mount Everest Mineral Water division could not trademark the term for its products.

Sanofi Aventis plans to buy Generics OTC brands

Khomba Singh — 21-Feb-2011

French drugmaker Sanofi Aventis plans to buy branded generics and over the counter consumer healthcare brands in India as part of its strategy to scale up sales from new avenues a top company executive said.

Meet the Indian inventor who has 42 patents

Shobha Warrier — 22-Feb-2011

In 2005 when Rediff.com met Arvind Thiagarajan he was 25 year old young inventor with a couple of patents to his credit.

Ind Swift project gets Japan govts nod

BS Reporter / New Delhi/ Chandigarh — 22-Feb-2011

For the first time a large number of drugs patented by Japanese companies are going off patent.

CSIR slows down patent filing of its processes discoveries products with few takers

Joseph Alexander, New Delhi — 23-Feb-2011

With huge number of patented processes leads discoveries and products developed by its different institutes relating to pharmaceuticals available but not having many takers the Council of Scientific and Industrial Research has slowed down the patent filing process.

Looking into takeovers of Indian pharma firms by MNCs: Govt

PTI — 23-Feb-2011

Concerns have been expressed that the recent takeovers of Indian pharmaceuticals companies by multi national firms would result in their gaining market supremacy affecting the prices of generic off patent drugs Minister of State for Commerce and Industry Jyotiraditya Scindia said in a written reply to Rajya Sabha.

Looking into takeovers of Indian pharma firms by MNCs: Govt

PTI — 23-Feb-2011

Aurobindo gets tentative USFDA nod for generic Venlafaxine

PTI — 24-Feb-2011

The company claimed that it had filed for the approval under Paragraph IV certification which would have given it 180 days of marketing exclusivity but it is currently under litigation in the US District Court of New Jersey.

Medicine patents: Drugmakers find find it hard to do business

Kenji Hall — 24-Feb-2011

Among pharmaceutical industry insiders it is known as the patent cliff.

Global drug makers making strong comeback in India

PB Jayakumar / Mumbai — 24-Feb-2011

Armed with a product patent regime and a string of large acquisitions multinational drug companies are making a strong comeback in India.

Venus Remedies gets patent for anti biotic drug from Mexico

Press Trust of India / New Delhi — 24-Feb-2011

Drug maker Venus Remedies today said it has been granted patent for its anti biotic product Sulbactomax by the Mexican authorities.

EUs pharma trade hoax

Tahir Amin/Priti Radhakrishnan — 25-Feb-2011

The proposed India EU trade pact is riddled with intellectual property provisions that would harm Indias 2005 Patent Act.

Novartis asked to end challenge to Indian patent law

Kevin Grogan — 25-Feb-2011

Novartis has been urged to drop its persistent legal actions in India regarding patent coverage for its anticancer drug Glivec and a challenge to the countrys patent laws over fears the latter could hinder access to medicines

Remainders of the day a case for parallel imports

Guest View | Shamnad Basheer — 26-Feb-2011

Provided that a copy of a work published in any country outside India with the permission of the author of the work and imported from that country shall not be deemed to be an infringing copy

Strategic use of IP would aid Indias growth

PTI — 27-Feb-2011

Against the backdrop of rising number of patent filings in India a top Microsoft official has said that strategic use of intellectual property would help in supporting the countrys overall growth.

After GI chikankari to get craftmark logo

Express News Service — 27-Feb-2011

After the Geographical Indication registration chikankari craft of Lucknow will now get a distinct identity by getting a brand name and a logo.

Biotech sector to see uptick in M&As: Grant Thornton

BS Reporter / Chennai/ Hyderabad — 28-Feb-2011

Reeling under the pressures of imminent patent expiries the developed markets have relied on the acquisition or alliance route to sustain the growth.

New forum for IPR attorneys

TNN — 28-Feb-2011

With a view to better the functioning of various Intellectual Property Rights fora such as patent copyright trademark and national bio diversity authority a new association was launched here on Friday.

Apex court rejects Maricos claim on low absorb trademark

PTI — 1-Mar-2011

The Supreme Court has dismissed the appeal of Marico Industries maker of cooking oils Saffola and Sweekar challenging the use of the slogan low absorb by Agro Tech Foods an affiliate of American foods giant ConAgra Foods.

SC dismisses Marico claim to low absorb trademark

PTI — 1-Mar-2011

The Supreme Court today dismissed the appeal of Marico Industries the maker of cooking oils Saffola and Sweekar challenging the use of the slogan low absorb by Agro Tech Foods an affiliate of American foods giant ConAgra Foods.

Global health networks urge Novartis to end litigation on Glivec

P.T. Jyothi Datta — 1-Mar-2011

Novartis had challenged the rejection of its patent application in India.

Google Microsoft join hands on patent

Bloomberg — 2-Mar-2011

Microsoft Corp and Google Inc rivals in the online search market joined to challenge the validity of a Texas companys patent on mapping technology.

India EU kick off fresh talks on free trade agreement

Pallavi Aiyar / Brussels — 02-Mar-2011

The chapter on intellectual property rights has generated some controversy with civil society groups claiming a deal that would bind India to TRIPS plus commitments would be detrimental to developing countries and their access to life saving drugs.

Growth of emerging economies to continue in coming years

PTI — 02-Mar-2011

The remarkable growth of emerging economies like China India and Brazil has fundamentally changed the global economic landscape a US trade report has said adding that their growth is projected to continue in the coming years.

Good news for king of fruits

Paul Fernandes — 02-Mar-2011

While Goas feni has secured geographical indication the registration of plant varieties is on a different keel.

HIV+ patients protest against controversial EU India FTA

TNN — 3-Mar-2011

Thousands of HIV positive people from India and across Asia marched from Ramlila ground to Jantar Mantar on Wednesday to protest against the free trade agreement between European Union and India which has provisions that would restrict access to affordable medicines.

Thousands of HIV+ People organise protest march in Delhi against India EU free trade agreement

Our Bureau, Mumbai — 4-Mar-2011

The most damaging measure to access to affordable medicines is so called data exclusivity which would act like a patent and block generic versions from the market even for drugs that are already off patent or do not merit a patent to begin with under Indias strict patent law.

Kraft takes a bite of local biscuit market

TNN — 04-Mar-2011

Incidentally Oreos launch in India was preceded by Kraft dragging Britannia to court over a trademark infringement case against the latters Treat O biscuit.

Dr Reddys eyes $1 bn revenue in next 3 years

PTI — 06-Mar-2011

The company had filed 141 ANDAs to the US FDA till December 2010.

US to press India for trade opening

Press Trust of India / Washington — 06-Mar-2011

Other barriers range from prohibitions and restrictions on foreign investment in key sectors to inadequate protection and enforcement of intellectual property rights it said.

MNC pharma firms campaigning against Indian cos says govt

PTI — 07-Mar-2011

The government today said multi national companies are campaigning against domestic pharma industry as their interests were getting impacted due to increasing global presence of Indian firms in the generic segment.

Pochampally Ikat hit by triple whammy

Itishree Samal / Hyderabad — 8-Mar-2011

The intricate tie and dye craft of silk and cotton weaving had received geographical indication status in 2005.

Cheap generic drugs eat into pharma cos sales

News Service — 08-Mar-2011

At the end of November Pfizer stands to lose a $10 billion a year revenue stream when the patent on its blockbuster cholesterol drug Lipitor expires and cheaper generics begin to cut into the company s huge sales.

Senate passes America Invents Act

PTI — 9-Mar-2011

The United States Senate has voted overwhelmingly to approve a legislation to make the first reforms to its patent system in nearly six decades.

Ideal Cures wins pre grant opposition against BPSI Holdings

Suja Nair Shirodkar, Mumbai — 9-Mar-2011

Mumbai based Ideal Cures has won a pre grant opposition under section 25(1) of the Indian Patent Act against BPSI Holdings Inc parent company of Colorcon.

Popular drugs a waste of money?

Kounteya Sinha & Mahendra Kumar Singh — 10-Mar-2011

They are some of the most common drugs consumed in India.

Free trade deal with Europe will help MNCs sue India globally

Priyanka Golikeri — 10-Mar-2011

If India signs the free trade agreement with the European Union in its current form the country would be opening its doors for getting sued internationally by foreign companies.

Its a tough fight for survival

Binay Singh — 10-Mar-2011

Despite boasting of geographical indication certification the handmade carpet of Bhadohi has not benefited much.

Compulsory licensing norms soon

Asit Ranjan Mishra — 10-Mar-2011

Foreign lobby groups oppose allowing govt to order manufacture of drugs without the patent holders consent

Efforts on to make patent offices totally transparent: DIPP

Press Trust of India / New Delhi — 10-Mar-2011

With an aim to bring total transparency in the working of Indian patent offices the government is considering to make reports of examiners on applications public.

SCMS bags patent

Express News Service — 11-Mar-2011

The SCMS lnstitute of Biotechnology has received the patent from the Government of India for developing a process for producing stevioside powder a natural remedy for diabetes from stevia leaves popularly known as honey leaves said Prof Pradeep

Cadila Healthcare: Marginal benefits from Taxotere

Malini Bhupta / Mumbai — 12-Mar-2011

Hospira Cadila Healthcares joint venture partner has received the final approval to market the generic Taxotere an oncology drug that went off the patent in November 2010.

India patent office head count to jump 170 pc

PTI — 12-Mar-2011

The India patents design and trade marks office is increasing its head count by 170 per cent to 457 in the next three months to cope with the growing pressure in number of applications.

Blockbuster Botoxs India connection

Sanchita Sharma — 13-Mar-2011

This prompted Allergan to get a patent for marketing bimatoprost as a eyelash growth cosmetic product.

Glenmark gets most approvals to sell generic drugs in US

Khomba Singh — 14-Mar-2011

In the first eleven months of the fiscal Glenmark secured nods to sell as many as 21 new generic medicines or low cost versions of off patent drugs in the US compared to 16 medicines by Aurobindo Pharma and 12 drugs by Sun Pharma the top Indian generic firm to receive USFDA approvals for the year ended March 2010.

Govt will protect interests of drug industry: Scindia

Press Trust of India / New Delhi — 14-Mar-2011

Amid concerns expressed by the Indian industry the government today said in Parliament that it will protect the interest of the domestic drug industry while finalising the free trade pact with European Union.

India EU settle generics dispute pave way for FTA talks in April

Amiti Sen — 15-Mar-2011

India has sorted out most of its differences with the European Union on production of low cost generic medicines ahead of a crucial meeting on a proposed free trade pact next month a government official told ET.

Over 83000 patent applications pending for scrutiny

PTI — 14-Mar-2011

Over 83000 patent applications are pending for examination due to shortage of manpower Parliament was informed today.

Health ministry sets up taskforce to address issues of pharma industry

BS Reporter / New Delhi — 16-Mar-2011

Also the committee would evolve strategies to further the interests of Indian pharma industry in the light of issues related to Intellectual Property Rights and recommend strategies to capitalise the opportunity of drugs going off patent over the next 5 years a health ministry statement said.

Govt constitutes taskforce to evolve strategy for pharma ind

PTI — 16-Mar-2011

In order to give a boost to the Indian pharmaceuticals industry the government today constituted a taskforce to evolve a long term strategy for the sector including addressing issues relating to Intellectual Property Rights.

Research cost health data key to enforcement

C.H. Unnikrishnan — 16-Mar-2011

The enforcement of compulsory licence provisions for patented drugs in India will remain a damp squib in the absence of proper healthcare data available with the government and an accurate account of patent holders research cost on the drug according to senior officials at the patnt office responsible for granting such licences.

Indias trade barriers hampering economic ties: EU

IANS — 17-Mar-2011

Indias restrictive trade policy is hampering the economic ties with the European Union says a report.

Time for European lessons

T S Vishwanath — 17-Mar-2011

The latest matter to hit the headlines is the single patent regime.

Govt for legalising parallel import of copyright works publishers oppose

Shamnad Basheer — 17-Mar-2011

India is no exception and the industry is now up in arms against a government proposal to legalise the parallel import of copyright works through Copyright Amendment Bill 2010.

Tamiflu patent: Gilead sues Natco Pharma

PTI — 17-Mar-2011

Gilead Sciences a California based bio pharmaceutical research firm along with its patent partner Roche Holding AG sued the Indian generic drug maker Natco Pharma here for allegedly infringing a US patent for Tamiflu a drug used in the treatment of bird and swine-flu infections.

Biocon boost from Optimers patent

TNN — 18-Mar-2011

Biocons drug development partner Optimer Pharmaceuticals has received a US patent for fidaxomicin an antibiotic used in the treatment of clostridium difficile infection.

The war of generics

Our Bureau — 21-Mar-2011

Everyone wants to have his way on any drug that is going off patent.

Microsoft sues Barnes & Noble over Nook reader

Bill Rigby — 21-Mar-2011

Microsoft Corp filed lawsuits for patent infringement on Monday against bookseller Barnes & Noble Inc over its Nook electronic book reader widening the software companys legal assault on devices running on Google Incs Android system.

Apple sues Amazon.com over APP STORE trademark

Reuters — 22-Mar-2011

Apple Inc has sued Amazon.com Inc in a bid to stop the online retailer from improperly using Apples APP STORE trademark according to a court filing.

India to showcase mission to protect traditional knowledge

PTI — 22-Mar-2011

India will showcase its unique mission to curb bio piracy and share its experience of protecting traditional knowledge in front of representatives from 38 countries at an international conference here.

Ranbaxy shares dive 7% as Mylan sues USFDA over Lipitor approval

Rupali Mukherjee — 22-Mar-2011

Ranbaxy Laboratories scrip plunged nearly 7% at around Rs 436 on the Bombay Stock Exchange close to the months lowest on Monday on speculation that its plans in launching generic Lipitor may hit a roadblock.

Willing to share TKDL model to protect traditional knowledge\'\'

PTI — 22-Mar-2011

India today offered to share its experiences in protecting traditional knowledge from being used to get patents with countries desirous of doing so.

Ranbaxy: Is the market overreacting to Mylans suit

Srividhya Sivakumar,BL Research Bureau — 23-Mar-2011

The stock price of Ranbaxy falling seven per cent on Monday following reports of Mylan suing the US FDA may be an overreaction

India to help world protect ancient medicines

fe Bureau — 23-Mar-2011

On Tuesday India offered to share its expertise with other countries on effectively protecting the commercially valuable traditional systems of medicine such as Ayurveda from being patented by individuals and companies.

India to help world protect ancient medicines

fe Bureau — 24-Mar-2011

India equipped to protect over 2 lakh formulations under Traditional Knowledge Digital Library

Our Bureau — 23-Mar-2011

The Union Minister of Science Technology and Earth Sciences Mr P.K Bansal said on Tuesday that India is equipped to protect over 2 lakh formulations under the Traditional Knowledge Digital Library.

India EU trade deal threatens access to life saving drugs

ANI — 23-Mar-2011

An expert has warned that a new trade agreement between India and Europe would block access to life saving drugs for billions of people living in developing countries.

Intellectual property rights need to be propagated

Our Correspondent — 23-Mar-2011

Lack of awareness on intellectual property rights is deep in tier II cities and is holding back the growth of small and medium scale enterprises said Mr N.V. Srinivasan Chairman Indo American Chamber of Commerce here recently.

Now get live info of your trains position

TNN — 24-Mar-2011

The Geographical Indication Board which was in stalled at the Charbagh station on a trial basis is now fully functional.

Authorised clones may hit Ranbaxys FTF bet

Priyanka Golikeri — 24-Mar-2011

The proverb all that glitters is not gold seems apt for Ranbaxy Laboratories amid a flurry of patent expiries that are slated in the US market.

Banaras brocade Bhadohi carpets to achieve new height internationally

TNN — 25-Mar-2011

The Chennai based office of the Geographical Indications Registry Ministry of Commerce and Industry Government of India organised a seminar cum workshop on awareness about GI and GI authorised users on Friday.

Free trade pact with four European nations this year

Sujay Mehdudia — 25-Mar-2011

India and the Europe Free Trade Association are likely to conclude a free trade agreement entailing a comprehensive bilateral trade and investment agreement by this year after fast tracking of the negotiations between the two groups.

GI tag: Varanasi Bhadohi lead in UP

TNN — 25-Mar-2011

While Varanasi Bhadohi region takes a lead in Uttar Pradesh by getting two GI tags for its famed products Banaras brocade and saree and handmade carpet of Bhadohi Karnataka is the leader in producing maximum number of GI registered products in the country.

Panel: Apple did not infringe Nokia patents

Bloomberg — 26-Mar-2011

Apple Inc won a US trade ruling in a patent fight brought by Nokia Oyj over technology used in mobile telephones.

FTA will enhance R&D in Indias pharma sector

BV Mahalakshmi — 28-Mar-2011

Brian Ager the Director General of European Federation of Pharmaceutical Industries and Associations says that its global R&D pharmaceutical industry has no desire to restrict access to essential medicines.

Natco Pharmas medicine gets orphan drug designation from USFDA

Our Bureau — 28-Mar-2011

The drug has been granted patents in nine countries including the US.

A pill for generic troubles

Biswajit Dhar — 29-Mar-2011

Despite positive signals recent trends in the generic pharmaceuticals industry have been most disheartening

GI status to spice up branding of unique crop varieties

P K Krishnakumar — 29-Mar-2011

The Spices Board under the ministry of commerce has registered pepper cardamom chilli ginger and turmeric as products that have unique flavour and attributes because they are grown in a specific geographical region of India.

India is big contributor of patents

TNN — 29-Mar-2011

HPs Bangalore centre has become one of the largest and most diverse sites of HP in the world.

Endosulfan ban: no clear battle lines drawn

Priyanka Pulla — 30-Mar-2011

Endosulfan is now off patent and brings in far lower margins.

India will not provide data exclusivity: Anand Sharma

BS Reporter / New Delhi — 30-Mar-2011

The government on Tuesday took a firm stand on protection of intellectual property rights and the aspect of data exclusivity for drug manufacturers saying that the country would not extend data exclusivity that would hamper the domestic pharma industry.

SPIC urges PM to order inquiry into barcoding being made mandatory for pharma exports

Ramesh Shankar, Mumbai — 1-Apr-2011

High quality drugs produced by Indian companies earlier have been categorized as counterfeits in the West if manufactured without approval from Patent holders with the purpose of stalling export of affordable generics from India.

Marrying the medicines of the world

Subir Roy / Bangalore — 1-Apr-2011

The patent pipeline particularly for blockbuster drugs that help fund future research is drying up.

Jasmine fragrance spreads overseas

KARWAR — 01-Apr-2011

Bhatkal jasmine should be included in geographical indication list to safeguard the interest of growers.

A big part of HP Unix work happens in India

TNN — 2-Apr-2011

We encourage all of our engineers to patent any innovation or technology they have.

PM panel to review India EU free trade pact on Wednesday

PTI — 04-Apr-2011

Ahead of crucial talks on India EU free trade agreement in Brussels the Prime Ministers Trade and Economic Relations Committee will review the issue on Wednesday.

Patient info in clinical trial not to be shared: CIC

PTI — 5-Apr-2011

Data about patients participating in clinical trials cannot be shared the Central Information Commission has held while dismissing an RTI plea seeking details of stalled Human Papilloma Virus vaccine trials in the country.

Panel to address issues of pharma industry

Nivedita Mookerji / New Delhi — 5-Apr-2011

An expert panel comprising top representatives of the health ministry the Department of Industrial Policy and Promotion, the National Pharmaceutical Pricing Authority various drug industry bodies and business chambers has been formed to bring out a report on a long term policy for the pharma sector.

Pharma firms turn to innovative marketing to boost demand

Priyanka Pulla — 5-Apr-2011

Drug makers are estimated to lose as much as $140 billion by 2016 because of the expiry of patent protection according to a 2007 report by market researcher Datamonitor.

Tweaking designs of products no longer under patents route to a profitable technology venture

Omkar Sapre — 5-Apr-2011

Tweaking designs of imported technology products that have gone off patent and reselling them in the local market can turn out to be a moneyspinner for technopreneurs.

Nortel patents: Google bids big

Indo-Asian News Service — 05-Apr-2011

Fallen telecom giant Nortel on Monday said that Google is bidding $900 million to buy its patent portfolio.

Reverse Engineering of Off Patent Tech

TNN — 05-Apr-2011

Tweaking designs of imported technology products that have gone off patent and reselling them in the local market can turn out to be a money spinner for technopreneurs.

Amend drug seizure rules to end WTO case: India to EU nations

PTI — 06-Apr-2011

India today said it will withdraw its case from the WTO against EU on wrongful seizure of drug consignments of Indian companies only when all the members of the 27 nation bloc amend their rules to prevent recurrence of such incidents.

PM led council to deliberate on India Australia FTA

Sanjeeb Mukherjee / New Delhi — 6-Apr-2011

A council headed by Prime Minister Manmohan Singh would deliberate on the feasibility of starting a dialogue on a Free Trade Agreement between India and Australia besides a more comprehensive agreement with Indonesia.

India against inclusion of data exclusivity in any FTA

PTI — 06-Apr-2011

India today said it was against the inclusion of data exclusivity provision in any of its free trade agreements as it would hurt the interests of the domestic generic drugs industry.

4000 pirated books worth 25 lakh seized 7 arrested

TNN — 7-Apr-2011

A case under various sections of the Indian Copyright Act has been registered against the suspects at the Deccan Gymkhana police station.

Drug firms may have breached patent norms

C.H. Unnikrishnan — 7-Apr-2011

Companies required to file information on working status of patents which is key to compulsory licensing

Drug MNCs violating patent law?

Rupali Mukherjee — 7-Apr-2011

Five pharma MNCs including Pfizer Bayer Roche Schering and Bristol Myers Squibb have been accused of violating patent laws with regard to top selling patented anti cancer and hepatitis drugs sold in the country.

Govt to soon announce manufacturing policy

PTI — 08-Apr-2011

The government on Friday said it will soon unveil a national manufacturing policy which aims at attracting overseas investments and increase the share of the sector in the economy.

Ranbaxy stocks up as USFDA opposes Mylans request

ET Bureau — 08-Apr-2011

The US drug regulator has opposed American firm Mylans request to strip Ranbaxy Laboratories of its six month exclusive rights to sell a low priced version of the worlds best selling drug Lipitor in the US.

India will not accept any intellectual property talks outside WTO: Anand Sharma

ET Bureau — 9-Apr-2011

India will not accept any attempt made by groups of countries to discuss intellectual property rights outside the multilateral forum of the world trade organisation commerce and industry minister Anand Sharma has said.

Keep off the doodle copycats

Anu Vaidyanathan — 10-Apr-2011

What users may not know is that this doodle stands patented.

MSF asks EU to confirm it will not push India to accept data exclusivity

Ramesh Shankar, Mumbai — 11-Apr-2011

Deeply concerned over the new measures Europe is pushing to restrict the production of affordable generic medicines in India Médecins Sans Frontières has asked the EU to confirm that it will no longer push for India to accept data exclusivity.

Sun Pharma Merck venture to target emerging markets

Our Bureau — 11-Apr-2011

Branded generics are off patent drugs or medicines similar to an innovative drug, but after the exclusive patent period had lapsed that are nevertheless sold under a brandname.

44000 files of trademark registrations missing probe on

Harish V Nair — 11-Apr-2011

In what could have a bearing on a large number of trademark disputes more than 44000 files have gone missing from Mumbai Delhi Chennai and Kolkata branches of the Trade Marks Registry.

PharmaSecure in talks to offer anti counterfeit solutions

Press Trust of India / Mumbai — 12-Apr-2011

PharmaSecure PAS India is in talks with several leading pharma companies to offer its anti counterfeit solutions of tracking and tracing medicines ahead of the government deadline of July 1.

No new norms on compulsory licensing

Asit Ranjan Mishra — 12-Apr-2011

Current guidelines under the TRIPS agreement Indian Patents Act are sufficient to issue such licences says DIPP

Indian pharma in tough battle for generic riches

Reuters — 12-Apr-2011

Indian makers of generic drugs have a fight on their hands as they scramble for access to the $100 billion worth of drugs coming off patent over the next two years.

Takeda Pharma files patent infringement suit against Dr Reddys

PTI — 12-Apr-2011

Global pharma major Takeda Pharmaceutical Co has filed a patent infringement suit against Indias second largest drug maker Dr Reddys Laboratories in a New York Court over the latters efforts to manufacture a generic version of acid reflux treatment drug Dexilant.

Designs on industrial products

T S Vishwanath / New Delhi — 14-Apr-2011

WIPO is mulling a treaty to harmonise protection of industrial designs at all levels

Dr Reddys launch generic version of Allegra in US

PTI — 14-Apr-2011

In a bid to tap the $452 million Fexofenadine drug market Dr Reddys Laboratories today announced the launch of generic version of Allegra Fexofenadine HCl tablets in the US market.

Govt plans to make public details of patented drugs

Khomba Singh — 14-Apr-2011

The government will make public details of every medicine patented in the country to bring transparency a move that will also help Indian drugmakers to challenge patent holders and sell low cost version of high priced patented drugs

Cos flock to courts to resolve patent suits

Chitra Unnithan — 14-Apr-2011

Mumbai based drugmaker Lupin filed a second suit last week in the US against Ranbaxy Laboratories to prevent the Gurgaon based drugmaker from launching fenofibrate a generic version of Lupins cholesterol lowering drug Antara in the US.

Now copyright free maps of States districts panchayats

S. Anandan — 15-Apr-2011

Even as the Malayalam Loves Wikipedia campaign launched to expand the knowledge repositories of Malayalam Wikipedia with copyright free Malayalam related photographs continues to evoke overwhelming response from Wiki users and contributors a project meant to make available online free to use national map and maps of States districts and panchayats is making silent but significant strides.

Now copyright free maps of States districts panchayats

S. Anandan — 15-Apr-2011

India EU free trade pact talks to conclude by year end

PTI — 15-Apr-2011

The European Union has exuded confidence that negotiations for the proposed free trade agreement between the 27 nation block and India would be concluded by the end of this year.

Patent office may outsource art searches to IITs

Soma Das — 15-Apr-2011

Shortly after putting in place a mechanism to outsource prior art searches to Council of Scientific and Industrial Research the Indian patent office is in talks with premier educational institute IITs for similar ties.

Innovation Society eyes 3000 patents in 2 yrs

Express News Service — 15-Apr-2011

The Gujarat Innovation Society to be inaugurated on Friday has a target of 3000 patent applications to be filed from the state in the next two years.

Pvt pharma firms knock CSIR to develop TB drug

TNN — 15-Apr-2011

In a first two pharmaceutical companies have expressed their desire to be a part of Council of Scientific and Industrial Researchs open source drug discovery project for tuberculosis.

Drug makers may go for more compulsory licences

P.T. Jyothi Datta — 15-Apr-2011

The doors seem to have opened for more domestic drug companies to seek compulsory licences say industry experts after the Centre recently reiterated that it would assess each case for a CL independently under the Indian Patent Act that is equipped to handle such issues.

Pharma MNCs take JV route for India

Reghu Balakrishnan / Mumbai — 17-Apr-2011

With the rising significance of India as one of the largest generic drug markets and escalating valuations which makes the pharmaceutical space here a tough acquisition target global pharma majors remain active for entering partnerships joint ventures and alliances with their Indian counterparts.

India EU FTA to be stitched up within this year

Special Correspondent — 18-Apr-2011

Union Commerce and Industry Minister Anand Sharma on Monday said talks between India and European Union had been intensified in an attempt to stitch up a free trade agreement within this year.

Orchid Chemicals settles case with Pfizer Inc stock down

ET Bureau — 19-Apr-2011

Hyderabad based Orchid Chemicals has reached an out of court settlement with world s largest drugmaker Pfizer Inc to sell a low cost version of the American firms patented anti depressant drug Effexor XR in the US market this fiscal.

US Supreme Court hears Microsoft patent case

PTI — 19-Apr-2011

The US Supreme Court immersed itself in patent rules in a case pitting Microsoft against a Canadian technology company that claims some versions of Word violated its patent.

Patenting: India in poor position

Special Correspondent — 19-Apr-2011

Ignorance lack of initiative are among the reasons

Indigenous software helps keep global bio pirates at bay

Kounteya Sinha — 20-Apr-2011

Special symbols to denote ancient Indian medicinal formulations are helping identify and catch bio pirates who are trying to illegally patent existing knowledge.

Kallam Anji Reddy | We are dominating the generics industry

Viswanath Pilla & Anil Penna — 20-Apr-2011

When Big Pharma discovered drugs way back I am talking about 25 years back when someone started to make generics they first said how can you equate a copycat to us even though the patent has expired.

CSIR to ink patent deal with Japan today

TNN — 20-Apr-2011

Council of Scientific and Industrial Research will on Wednesday sign an access agreement with Japan Patent Office for Traditional Knowledge Digital Library.

US drug recall not to have big financial impact on Lupin

P.T.Jyothi Datta — 20-Apr-2011

Drug maker Lupins recent voluntary recall of a batch of its hypertension drug Lisinopril in the US will not have a major financial impact on the company.

Apple sues Samsung says stop copying us

Dan Levine & Miyoung Kim / Reuters — 20-Apr-2011

Samsung phones tablet copy iPhone and iPad lawsuit Apple attacks design interface application icons of Galaxy models

India videographs 200 yoga postures to prevent patent piracy

PTI — 20-Apr-2011

India has made available a database describing 1300 yoga postures and videography of 200 popular among these as part of efforts to prevent patent pirates from exploiting it for commercial purposes.

Firms pin hopes on proposed change in Copyright Act to tackle piracy

Yogendra — 21-Apr-2011

The anti piracy task force is working on a manual for law enforcement agencies to act against pirates

The companys off patent drugs business the cash cow supporting research was facing price pressures in some key markets.

Gauri Kamath — 21-Apr-2011

In the 1980s he founded what would become Indias secondlargest generics pharma company.

India EU FTA talks in crucial phase

Surojit Gupta — 21-Apr-2011

Negotiations between India and the European Union for a Free Trade Agreement have entered a crucial phase and contours of the deal have started to emerge but there are still some issues which need to be resolved EU official say.

Software firms pin hopes on proposed change in copyright Act to nail piracy

Yogendra — 21-Apr-2011

Dont ask for pirated software.

Govt to reconstruct 44000 missing trademark files

PTI — 21-Apr-2011

The Government today said it will issue a public notice by next week to reconstruct 44000 missing files from the trademarks office.

Halt India EU FTA talks immediately

Sujay Mehdudia — 22-Apr-2011

Ska Keller a Green member of the European Parliament has warned that the proposed free trade agreement between India and European Union will have serious consequences for the Indian people.

Dr Reddys reach settlement with Wyeth over Effexor

PTI — 22-Apr-2011

Dr Reddys Laboratories has reached a deal in New Jersey Federal Court yesterday with Wyeth LLC a wholly owned subsidiary of US based Pfizer over a patent litigation involving generic version of blockbuster anti depressant drug Effexor XR sources close to the development said.

Google loses Linux patent lawsuit

Joseph Menn in San Francisco — 23-Apr-2011

Google has lost a Texas lawsuit that claims the core of Linux infringes on a privately held patent raising fears of a wave of similar claims against other users of the open source operating system

MNC may need govt nod to buy local pharma firm

Khomba Singh — 25-Apr-2011

The government may approve acquisitions of local drugmakers by global firms on a case by case basis on certain conditions to ensure availability of medicines at affordable prices despite calls for restrictions on such deals in the wake of a spate of takeovers in the last three years.

MNC may need govt nod to buy local pharma firm

Khomba Singh — 25-Apr-2011

MNC may need govt nod to buy local pharma firm

Khomba Singh — 25-Apr-2011

The government may approve acquisitions of local drugmakers by global firms on a case by case basis on certain conditions to ensure availability of medicines at affordable prices, despite calls for restrictions on such deals in the wake of a spate of takeovers in the last three years.

Pfizer deal allows Dr Reddys to sell anti depression pill

Bloomberg / Mumbai — 25-Apr-2011

The company has previously settled patent infringement suits regarding Effexor it filed against Teva Pharmaceutical Industries and Anchen Pharmaceuticals and Impax Laboratories Inc.

Ranbaxy launches generic Olanzapine tablets in Spain

PTI — 25-Apr-2011

Drug major Ranbaxy Laboratories today said it has launched generic Olanzapine tablets used in treating central nervous system disorders in Spain.

The Round that went in circles

26-Apr-2011

What Pascal Lamy calls an unbridgeable political gap seems to be the final nail in the Doha trade talks coffin

Adobe India doles out up to 200% bonus for innovative employees

Shruti Sabharwal — 26-Apr-2011

A patent is a measure of technical excellence and that probably is the biggest high.

GIIP wants govt to make major changes in Patent Act to promote IP in country

Suja Nair Shirodkar, Mumbai — 26-Apr-2011

With a view to promote interest in Intellectual Property law and its scope in the country Global Institute of Intellectual Property wants the government to bring in substantial changes in the present IP law.

BHU attaches no special significance to day

Binay Singh — 26-Apr-2011

The Banaras Hindu University that has its own Intellectual Property Rights Policy and IPR Cell held no special programmes to mark the World Intellectual Property Day on Tuesday.

India should demand review of TRIPS: Isaac

Express News Service — 26-Apr-2011

India should demand the review of TRIPS a move which will be supported by a large number of countries especially in the sectors of common property patents and the pharmaceutical sector Finance Minister T M Thomas Isaac has said.

Lupin In License Pact With Abbott On Cholesterol Drug

Rumman Ahmed — 26-Apr-2011

Indias Lupin Ltd said Tuesday it and its units have agreed to buy licenses from U.S.based Abbott Laboratories and Frances Laboratoires Fournier S.A. for various patents on anti cholesterol drug fenofibrate in an attempt to ring fence its Antara brand from generic competition.

Suven Life bags seven patents for new molecules

Reuters — 26-Apr-2011

Suven Life Sciences said on Tuesday it has secured seven product patents for its new chemical entities in different geographies.

Innovation deficit hurts India Inc

M. D. Nair — 27-Apr-2011

In all the surveys on innovations and outcomes India ranks low in the pecking order below even countries such as Brazil not to speak of China.

Purdue Pharma sues Ranbaxy over sale of cheaper pain drug in US

Khomba Singh — 27-Apr-2011

American drugmaker Purdue Pharma has sued Ranbaxy Laboratories to prevent Indias largest drugmaker from selling a generic or low priced version of its bestselling medicine pain reliever Oxycontin in the US.

TRIPS Plus measures outside WTO framework not acceptable: Anand Sharma

Our Bureau, Mumbai — 27-Apr-2011

Union commerce and industry minister Anand Sharma has reiterated Indias stand that it will not accept any Trips plus decision that is taken outside multilateral framework.

Intellectual Property Association of South India launched

PTI — 27-Apr-2011

There was a need for creating more awareness about intellectual property rights trademarks and patents to help the growth of the countrys economy Madras High Court Judge Justice P Jyothimani said today.

PM to review next month proposed trade pact with EU

PTI — 27-Apr-2011

Prime Minister Manmohan Singh will review the proposed bilateral trade and investment agreement between India and the EU at the meeting of the Trade and Economic Relations Committee on May 29.

Basmati exporter files two patents on parboiling technology

Our Bureau — 27-Apr-2011

Method reduces husk splitting; pares brokens range to 4-8%

PMs Trade and Economic Committee to review trade treaties

Sujay Mehdudia — 28-Apr-2011

Even as a large number of consumer and NGO groups have come out in support of more transparency in sharing information on trade treaties the Prime Ministers Trade and Economic Relations Committee is meeting on Friday to review various treaties including the India EU free trade agreement.

Scientists oppose European stem cell patent ban

Bureau Report — 28-Apr-2011

Research scientists hit out on Wednesday at a European Court of Justice case they say could block development of embryonic stem cell based therapies in Europe.

Nagesh Kumar: An innovation led growth model

Nagesh Kumar — 30-Apr-2011

R&D subsidy to industry and protecting indigenous innovation can give India competitive edge

Glaxos Growth is Not an Accident: Andrew Witty

Sudeshna Sen — 30-Apr-2011

Andrew Witty global CEO of GlaxoSmithKline is a self confessed Indophile.

India to launch FTA negotiations with Australia

The Hindu — 30-Apr-2011

No IPR obligations beyond domestic laws

Domestic drug makers set to invoke compulsory licensing route by June

Joe C Mathew & Nayanima Basu / New Delhi — 2-May-2011

Compulsory licensing provisions under the Indian Patent Act will be put to test soon as local drug makers are planning to use it to make low cost versions of patented drugs.

India not to dilute stand on intellectual property rights

IANS — 2-May-2011

India has decided not to dilute its stand or take a position on intellectual property rights especially on pharmaceuticals beyond its domestic law and the current international commitments.

Technical institutes make beeline for patents

Vijay C Roy / New Delhi/ Chandigarh — 2-May-2011

Realising the importance of Intellectual Property Rights universities technical and educational institutes in Punjab are getting their innovations patented.

Alkem ties up with Swedens Karo Bio

02-May-2011

There will be a royalty payment to Karo once revenues are generated on the patent protected product Mr Shenoy said without giving details.

An end to endosulfan?

Business Standard — 3-May-2011

Those voicing the interests of Indian farmers and the endosulfan industry have alleged that the hue and cry against it is the handiwork of NGOs funded by European patent holders of newer chemicals.

IPAB centre likely to come up in Mumbai Delhi and Kolkata

Khomba Singh — 3-May-2011

The government may need to set up permanent centres of the countrys nodal body monitoring disputes related to intellectual property rights and patents in Delhi Mumbai and Kolkata to expedite resolution of cases.

US puts India Pak and China on IPR violation watch list

PTI — 03-May-2011

United States has placed India Pakistan China and nine other countries on the top priority watch list with regard to violations of intellectual property rights.

ICMR seeks cos to commercialize its two new inventions against cancer dengue vector

Joseph Alexander, New Delhi — 4-May-2011

The Indian Council of Medical Research has developed an anti neoplastic compound for possible treatment of cancer and an herbal composition against dengue vector.

US court dismisses Mylan challenge on Ranbaxy Lipitor rights

BS Reporter / New Delhi — 4-May-2011

In a major reprieve to Ranbaxy an American court has dismissed a petition from rival pharmaceutical firm Mylan to challenge the formers exclusive marketing rights over the generic version of Pfizers Lipitor.

Patent suit filed against Dr Reddyâ€™s

KV Ramana — 4-May-2011

Yet another US drugmaker has sued Dr Reddys Laboratories alleging patent infringement.

No time for copyright say Indian designers

IANS — 4-May-2011

The more the fashion weeks the more the exposure and the more the chances of designs being copied.

Tea Board launches Ozone friendly tea, certification marks

Athraja de Silva — 05-May-2011

Sri Lanka Tea Board ceremonially launched the new logo for Ozone Friendly Ceylon Tea together and Agro climatic regional names logos as Certification Marks under Geographical Indication to protect and add value to premium Ceylon Tea.

Regulatory overkill stifling drug discovery: Experts

Our Bureau — 05-May-2011

Lead time was important for getting patents for original drug research she said.

India EU trade pact talks enter final phase

Nayanima Basu / New Delhi — 05-May-2011

Talks to close a broad based comprehensive trade pact with the European Union has reached its final stage while both sides would be sitting for another round of negotiations by the middle of this month to agree on crucial areas where there are still some gaps.

Govt asks exporters to move up the value chain

Sidhartha — 05-May-2011

Indias medium term export strategy is according top priority to changing the value proposition for pharmaceuticals electronics and auto component exports besides suggesting a plan to get a toehold into the high technology space.

Himalaya launches Liv.52 HB for treatment of Hepatitis B

Announcement / Corporate — 05-May-2011

The Himalaya Drug Company one of Indias leading herbal health and personal care companies launched Liv.52 HB the first herbal drug for the effective management of Hepatitis B virus infection.

Chinese tech giants Huawei Technologies and ZTE in rare mobile phone patent court battle

AP — 6-May-2011

Two of Chinas biggest technology companies have launched a court battle in Europe over mobile phone patents in a rare public clash between firms Beijing is promoting as national champions.

Sharing the spoils

6-May-2011

In the lucrative US pharmaceutical market generic and patent holders of drugs have increasingly chosen to settle patent challenge disputes than to fight them in court

Zydus Cadila aims to be a $3 bn company by 2015

PTI — 06-May-2011

Biosimilars or Follow on biologics are terms used to describe officially approved new versions of innovator biopharmaceutical products following patent expiry.

Ranbaxy may pay $1bn to USFDA

TNN — 6-May-2011

Gurgaon based pharma major Ranbaxy Laboratories is said to be negotiating a settlement with US Food and Drug Administration to clear two of its manufacturing plants from which the US agency had halted sales.

Cultural rights in the digital age

SHARANYA MANIVANNAN — 7-May-2011

A pioneering academic in the field of intellectual property Canada based Dr. Mira T. Sundara Rajan is a polymath with an illustrious lineage.

Suven Life sued for Ovide patent violation by Taro

KV Ramana — 7-May-2011

US-based Taro Pharmaceuticals North America has sued Hyderabad based custom research and manufacturing services major Suven Life Sciences alleging an infringement of patent involving its head lice killer lotion Ovide.

Learning with the Times: Endosulfan has chronic adverse effects on humans

TNN — 9-May-2011

Endosulfan is a pesticide which was introduced in the 1950s and soon became a leading chemical to fight a broad spectrum of insects.

The push and pull in generic drugs

10-May-2011

On the one hand is the crucial process of drug discovery on the other the need to make medicines affordable

No cheer for vodka brand that copied rivals bottle

Sunil Baghel — 11-May-2011

Two vodka manufacturing companies Gorbatschow Wodka and John Distilleries fought an intellectual property rights see box case in the Bombay High Court over the design of their products bottles.

Border push in EU FTA to hit pharma exports

Priyanka Golikeri — 12-May-2011

In the quid pro quo of the free trade agreement currently being negotiated with the European Union India could end up giving in to a provision which could hamper its exports of pharmaceuticals.

NBRI to scout for commercial partners for herbal innovations

Virendra Singh Rawat / New Delhi/ Lucknow — 12-May-2011

NBRI would apply for national license and patent for the herbal drink before it scouts for suitable private partner for technology transfer.

Dr Reddys Q4 net profit doubles tops forecast

Reuters — 13-May-2011

Indian generic drug makers including Dr Reddys and rival Ranbaxy are poised to gain as drugs worth about $100 billion lose patent protection over the next two years but they have to contend with intense competition rising lawsuits from rivals and a stricter U.S. health regulator.

SC bans production sale and use of Endsosulfan for eight weeks

PTI — 13-May-2011

Endosulfan is an off patent organochlorine insecticide and acaricide.

Emerging economies: outside in and inside out

13-May-2011

China recently filed 977000 domestic patent applications.

ICMR looks for partners to commercialise herbal composition to treat filariasis

Joseph Alexander, New Delhi — 13-May-2011

An Indian patent has been filed.

Commerce min mulls registrar for traditional knowledge

ENS Economic Bureau — 14-May-2011

To protect traditional knowledge in the field of medicine and music the ministry of commerce and industry today came out with a discussion paper suggesting that a registrar should be appointed to help knowledge holding community reap benefits of such information and prevent its unauthorised commercial use.

MSN Labs to enter pain management market

PTI — 16-May-2011

The company so far has filed over 100 Indian and over 40 international patents.

Rajkumar Dogra a naval soldier & general manager is now a patent lawyer

Amit Shanbaug — 16-May-2011

This time as a patent lawyer a profession drastically different from his previous two occupations naval soldier and general manager.

Indian American couple pleads guilty for selling fake drugs

PTI — 17-May-2011

An Indian American couple in New Jersey has pleaded guilty before a US court for selling counterfeit prescription drugs made in India federal authorities said.

Glenmark Pharma in $613 million licensing deal with Sanofi

ET Bureau — 17-May-2011

Mumbais Glenmark Pharmaceuticals has licensed a new biotech drug to Frances Sanofi which has the potential to generate revenues of $613 million or 2734 crore.

Government moots patents for jugaad

TNN — 17-May-2011

If the government has its way the small scale industrys spirit of jugaad could soon be giving competition to Phunsuk Wangdus Aamir Khans character in the hit movie 3 Idiots 400 patents.

Lincoln Pharma launches anti malarial drug ‘ARH 1’

Our Bureau, Mumbai — 19-May-2011

The company has applied for a patent of ARH 1 in India as well as internationally.

Drug exporters need more time to implement barcode: Pharmexcil

Peethaambaran Kunnathoor, Chennai — 20-May-2011

As regards infringement of patent Bhavin said whoever without authority makes or uses or offers to sell or sells or imports any patented invention during the term of the patent it is infringement.

More foreigners than Indians receiving patents in India\'

PTI — 22-May-2011

There are more foreigners than Indians receiving patents in India prompting the government to say much needs to be done to encourage more domestic innovations.

Biodiversity of the state needs to be protected

Express News Service , The New Indian Express — 24-May-2011

The chairman of Andhra Pradesh State Biodiversity Board R Hampaiah said that several countries have claimed patents on turmeric garlic basmati and several other agricultural products and animals like the Ongole Bull.

Venus gets European patent for painkiller injection

Press Trust of India / New Delhi — 24-May-2011

Drug firm Venus Remedies today said it has received patent from the European Patent Office for ACHNIL its once a day painkiller injection.

Levis takes on private labels with Denizen

Purvita Chatterjee — 24-May-2011

In fact the decision to change the name of Signature to Denizen came about after Levis started fighting patent cases across markets for the brand name of Signature.

Suven struggles to find partner to take Alzheimers drug to next stage

Viswanath Pilla — 25-May-2011

They still have to learn how to monetize various stages of clinical trials and how to protect their intellectual property rights.

Takeda to buy Swiss drugmaker Nycomed for $13.6 bn

James Topham and Ritsuko Shimizu / Reuters — 25-May-2011

Takeda known for its top selling diabetes drug Actos which faces the upcoming expiry of its US patent will also gain a portfolio of over the counter consumer products.

India EU free trade pact in final stage: Sharma

PTI — 25-May-2011

Indicating that differences persist between India and the European Union over their proposed free trade agreement the Commerce and Industry Minister Mr Anand Sharma said even the best of astrologers would not know about the timeline.

Details of patented drugs to be made public

C.H. Unnikrishnan — 25-May-2011

To increase transparency Indias patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Microsoft chief Steve Ballmer says China piracy very costly

AFP — 27-May-2011

It kept the country on this years priority watch list for weak protection of intellectual property rights.

Heard on the Street: Suven Life Sciences climbs on Patent acquisitions

ET Bureau — 27-May-2011

Suven Life Sciences Climbs 5% on Foreign Patent Acquisitions

India for concluding package for LDCs by December under Doha round

Sujay Mehdudia — 28-May-2011

Doha Round would not be concluded this year as planned in Davos

Fresenius Kabis India unit now global R&D hub

ET Bureau — 28-May-2011

Fresenius Kabi Oncology has also entered into a contract R&D and manufacturing agreement with its parent Fresenius Kabi Germany and its affiliates for future products without affecting existing product business and intellectual property rights, it said in a disclosure to stock exchanges.

Mylan plans direct entry into India

C.H. Unnikrishnan — 28-May-2011

Mylan which acquired the generic business of German drug giant Merck KGaA in 2008 in a global deal is currently the largest generic or off patent drug maker in the world.

Great job offers to students with campus patents experience

TV Mahalingam, ET Bureau — 29-May-2011

Swarup credits his blue chip job to both his degree in industrial production and a patent for an invention a refrigerator cum water purifier that has been filed in his name at the US and Indian patent offices.

Global Fund calls for clauses in FTA to ensure access to medicines for AIDS malaria TB

Joseph Alexander, New Delhi — 30-May-2011

Both call for the use of measures to contain costs and foster an open competitive market for health commodities including the use of TRIPS flexibilities patent pooling and voluntary licence agreements between patent holders and generic manufacturers.

Drug makers Teva Pfizer settle patent dispute

ET — 31-May-2011

Teva Pharmaceutical Industries Ltd. said Tuesday it has settled a patent lawsuit brought by Pfizer Inc. over a drug for treating seizures and pain caused by shingles.

Is Indian pharmaceutical industry losing its sheen? Promoters exit for attractive alternatives

Gauri Kamath — 1-Jun-2011

For years the Rs 871 crore JB Chemicals and Pharmaceuticals a Mumbai based generics drug company rode on the success of its cough and cold syrup Doktor Mom in Russia.

New Indian Express sued over promotion of Sunday Standard

Anushree Chandran & Abhilasha Ojha — 1-Jun-2011

Last year we filed a suit against them in the Bombay high court for infringement of the trademark said the executive.

Lupin strengthens biological products pipeline

Our Bureau — 01-Jun-2011

In licensing pact with Sydney based NeuClone for cell line technology

Indian pharma ingredient firms in Japanese generics race

Reghu Balakrishnan / Mumbai — 2-Jun-2011

Japan which has a government funded National Health Insurance scheme covering every citizen wanted to shift from costly patented products to cheaper generic versions.

IPR rules and their uncertain effects

Madhukar Sinha — 2-Jun-2011

If TRIPS has not yielded some of the expected benefits the Anti Counterfeiting Trade Agreement that seeks cross border IPR protection only gives rise to another set of concerns.

Creating an eye capturing business

K Rajani Kanth / Hyderabad — 3-Jun-2011

Professor Daugmans patent will expire in July 2011 post which it will be an open market technology.

Troikaa is looking for licensing partner in EU

Sohini Das / Mumbai/ Ahmedabad — 3-Jun-2011

We charge a slight premium of Re 1 per dose as we have developed a patented technology or novel drug delivery system.

Siemens sues Samsung LG on LED patent breaches

Reuters — 06-Jun-2011

Siemens lightbulb unit Osram is suing the Samsung and LG groups of companies for alleged infringement of patents on light emitting diodes technology the German group said on Monday.

Eli Lilly to settle dispute over drug copies

Andrew Jack in London — 08-Jun-2011

Eli Lilly is poised to make a cash payment to settle a long running dispute with Indian generic drugmakers over low cost copies of the US companys medicines that were impounded within the European Union.

BARCODE FOR EXPORTS

P A Francis — 8-Jun-2011

As per a DGFT notification barcoding is going to be mandatory on all pharmaceutical products exported out of the country from July 1.

We should increasingly work with China in the field of chemicals

Promit Mukherjee — 8-Jun-2011

No patented chemicals have ever come under attack because all patented chemicals are held by Europe.

Health groups call for moratorium on FTAs TRIPS plus measures by developed nations

Ramesh Shankar, Mumbai — 8-Jun-2011

Even as the global community meets in New York for the United Nations General Assembly High Level Meeting on HIV and AIDS from 8 to 10 June 2011 networks of People living with HIV health groups and treatment activists from around the world are calling for an immediate moratorium on all Free Trade Agreements and TRIPS plus measures.

India to be firm on IPR at AIDS meet

Joe C Mathew / New Delhi — 8-Jun-2011

India is readying to take a zero tolerance position in the ongoing tussle between the developing and the developed world on a regime for Intellectual Property Rights at a three day United Nations General Assembly High Level Meeting on AIDS scheduled in New York from Thursday.

AIDS groups criticise US/EU/Japan for putting profits of MNC drug makers before patients

ET Bureau — 08-Jun-2011

TRIPS prescribes certain minimum patenting standards that all member organizations have to respect.

State sets up innovation council

BS Reporter / Chennai/ Bangalore/ Mysore — 9-Jun-2011

So far industries and businesses had to make repeated trips to Chennai for obtaining trademark rights under the Intellectual Property Rights after prolonged procedures.

90% of Indian grants are yet to reach the market

C.H. Unnikrishnan — 9-Jun-2011

Of the 37334 patents granted enforced till Mar 2010 only 4189 have been commercially introduced says report.

India calls upon international community to dismantle trade IP barriers to ensure flow of HIV drugs

Our Bureau, New Delhi — 10-Jun-2011

India has called for proactive and collective action from the international community to dismantle trade and intellectual property right barriers and improve the availability of accessible affordable and quality drugs for the needy and impoverished across the world.

Indian CRAM market to clock $ 7.6 billion by 2012

Jyothi Datta — 10-Jun-2011

The growth of the outsourcing opportunity is being propelled by the loss of patent protection to the tune of $ 97 billion over 2011 2015 steady erosion in new product launches in relation to research spend and new launches not matching up to the earlier block busters drugs.

Huge opportunities exist in overseas markets for SMEs in pharma sector: Pharmexcil

Peethaambaran Kunnathoor, Chennai — 11-Jun-2011

He said in the case of Generic Opportunity 450 molecules worth US$ 350 billion are going off patent in the coming years.

US FDA restricts sale of cholesterol lowering drug Simvastatin

BS Reporter / Mumbai — 11-Jun-2011

The patented version of Simvastatin Zocor manufactured by Merck was approved in 1991 and went off patent in 2006.

NPPa: Central agency must decide patented drug prices

Joe C Mathew / New Delhi — 12-Jun-2011

Medicine price regulator National Pharmaceutical Pricing Authority has proposed the formation of a centralised agency to negotiate the prices of patented medicines.

Indian scientists develop technology to manage ballast water

P. Sunderarajan — 13-Jun-2011

In the new development that promises to be of far reaching significance the scientists have got a patent from the United States Patent Office for a treatment technology for the ballast water that is not only highly effective but is also all more eco friendly as it does not use any chemicals.

Some discoveries cant be patented

Dr David G. Green — 14-Jun-2011

Sir The government thinks its patent box scheme under which earnings from patents will be subject to 10 per cent corporation tax will help to make the UK the most competitive tax regime in the Group of 20.

Dr Reddys sees negligible effect of FDA curbs on simvastatin

KV Ramana — 14-Jun-2011

Dr Reddys Laboratories sees the impact of fresh regulations by the US Foods and Drug Administration on prescription of 80 mg dose of cholesterol lowering statin drug simvastatin due to risk of muscle injury to be negligible on overall revenues

Country and region-specific Ceylon Tea

14-Jun-2011

The tea industry in Sri Lanka is moving closer to protecting the value of Ceylon Tea by initiating action to obtain a Geographical Indication for the commodity from the World Trade Organization and for international registration in about 50 markets initially a very costly and time consuming initiative

FDA warns Dr Reddys over Mexico plant standards

Reuters — 14-Jun-2011

Indian generic drugmakers including rival Ranbaxy are poised to benefit as drugs worth about $100 billion lose patent protection over the next two years.

Nokia Apple settle patent suits

PTI — 14-Jun-2011

Nokia Corp on Monday said it has agreed to settle all patent litigations with iPhone maker Apple Inc a move that will bolster the Finnishs firm profitability in the second quarter.

Copyright issue goes global

Subhash K Jha — 15-Jun-2011

Javed Akhtars efforts to secure rights for songwriters composers and authors in India was commended by Bee Gees singer Robin Gibb

Indian regulator calls for central drug pricing

Lynne Taylor — 15-Jun-2011

Moreover patented drugs should be exempt from all duties and taxes and their marketing approval should be linked to the pricing negotiations so that import licenses for the product will only be granted after the price has been agreed, it says according to a report in Indias Business Standard newspaper.

Patent expiry outsourcing to drive pharma growth: Study

BV Mahalakshmi — 15-Jun-2011

Patent expiry and outsourcing are expected to be the primary growth drivers for the Indian pharmaceutical industry a Care research says.

Patent office yet to upload information on working patents in India

Suja Nair Shirodkar, Mumbai — 15-Jun-2011

According to Dr Gopakumar G Nair patent attorney and CEO Gopakumar Nair Associates this step is taken to ensure that the companies utilise the patents they have been granted rather than keeping it without use.

Kurian quits as patents office chief

C.H. Unnikrishnan — 15-Jun-2011

Kurian introduced transparency in the process of clearing patent trademark applications and granting IP rights a function that is becoming increasingly critical as Indias integration with the global economy

Limited patents

Robert Cyran — 16-Jun-2011

Nokias innovative past has hitched a ride on Apples future.

Scientists come up with new molecule that may lead to better drug for TB

Special Correspondent — 16-Jun-2011

After filing for a patent in February the scientists have also sent a 64 page proposal to the ICMR to push the case for funded research to take the project forward.

Controller general of patents P H Kurian resigns set to return to Kerala

Our Bureau, Mumbai — 16-Jun-2011

The controller general of patents designs and trademarks at Indias Intellectual Property office P H Kurian has resigned from this post and is all set to return to Kerala where he was industries secretary before moving to the IP office in February 2009.

Nortel Delays Mobile Patent Auction One Week As Bidders Get Ready

Tom Krazit — 17-Jun-2011

Nortel will delay the start of a closely watched auction of 6000 mobile patents by a week as it evaluates what it called a significant level of interest from those hoping to bolster their portfolios

Akhtar takes copyright issue to global platform

IANS — 17-Jun-2011

Well known Bollywood writer Javed Akhtar has taken his fight for royalty to lyricists to an international platform.

Oracle seeks billions in lawsuit against Google

Reuters / San Francisco — 17-Jun-2011

Oracle Corp is seeking damages in the billions of dollars from Google Inc in a patent lawsuit over the smartphone market according to a court filing.

Why copy pasting is a brilliant business strategy

Vivek Kaul — 17-Jun-2011

The US Patent office had issued Patent 6269361 also known as the 361 patent to Overture in July 2001

Nokia loses UK court bid to cancel patent for IPCom

Bloomberg/New York — 17-Jun-2011

Nokia Oyj the worlds biggest maker of mobile phones by volume lost a UK court bid to invalidate a European patent that Germanys IPCom GmbH & Co claims is vital to the Finnish companys handset sales.

Celeb jewellery makers patented designs stolen sold

Chandrima Pal — 17-Jun-2011

While I dont really care for most of the designs, what I am concerned about is the patented bangle which I was supposed to unveil at the upcoming gem and jewellery show

Piramal Health looks at buyout for expansion

Reghu Balakrishnan / Mumbai — 17-Jun-2011

Increase in outsourcing from developed to developing countries will continue as the innovator companies will lose patent protection from any of the blockbuster drugs over the next few years thereby forcing them to look for various alternatives such as cost control and introduction of generics to their portfolio the report said.

Exploring innovation potential in software

D. Murali — 19-Jun-2011

They define describe contextualise get IPRs intellectual property rights and then get to the development part.

Confusion abounds in haste to make officials property returns public

Special Correspondent — 20-Jun-2011

Indian Foreign Services IPRs are easy to access

FTA with Japan holds promise

C.P. RAVINDRANATHAN — 20-Jun-2011

Textiles leather products pharmaceuticals and chemicals exports from India could look up as a result.

Europe should be generics global powerhouse - EGA

Kevin Grogan — 20-Jun-2011

Europes generic drugmakers are in danger of falling behind the likes of India and South Korea if they do not receive more support from the continents legislators.

Delhi HC awards punitive damages for infringement of trademark to Pfizer

Suja Nair Shirodkar, Mumbai — 21-Jun-2011

Creating a benchmark that will help to deter companies from using phonetically and deceptively similar trademark the Delhi HC recently awarded payment of Rs.1 lakh as punitive damages to a subsidiary of Pfizer.

Effective intellectual property protections are key to future

Suresh Sati & Roger Bate — 21-Jun-2011

India is on the brink of finalising a free trade agreement with the European Union.

Raymond moves HC wants FIR quashed in tech patent case

Sunil Baghel — 21-Jun-2011

Textile major Raymond Ltd and its Chairman Emeritus have moved the Bombay High Court seeking to quash an FIR registered against them following a complaint by one Bhogilal Patel last November.

Depomed diabetes drug gets another generic threat

Reuters — 21-Jun-2011

Depomed said it would continue to vigorously enforce its intellectual property rights to Glumetza tablets.

USFDA approves generic Levofloxacin Indian firms to benefit

PTI — 21-Jun-2011

The approval is for the generic tablet oral solution and injectable solution dosage forms of Levofloxacin US Food and Drug Administration said in a statement

Avesthagen granted US patent

Press Trust of India / Bangalore — 21-Jun-2011

Avesthagen has been granted patent by the US for breakthrough sunflower transformation and eco friendly safe selection method that can replace the traditional antibiotic marker technology in GM crops.

Strides anti infective gets US nod

Our Bureau — 21-Jun-2011

The product patent held in the US by Johnson & Johnsons company Ortho McNeil Janssen expired on June 20.

India pitches for stake in $50 bn pharma mkt in China

Press Trust of India / Beijing — 22-Jun-2011

With China set to open up $50 billion pharmaceutical market India has made a strong pitch saying the burgeoning Indian pharma sector could step in for supplying affordable life saving medicines to its neighbour.

India EU agreement may restrict low cost drugs

Khomba H — 22-Jun-2011

Data exclusivity delays registration of generic versions of a medicine by up to 10 years even for drugs that do not deserve a patent under Indias law.

T S Vishwanath: The grand key to Africa

T S Vishwanath — 23-Jun-2011

Therefore when fully completed this FTA would be a comprehensive agreement covering intellectual property rights goods and services.

Lupin Natco tie up to market generic of GSK cancer drug

Our Bureau — 23-Jun-2011

Tykerb tablets go off patent in 2017

Health groups welcome exclusion of data exclusivity from India EU free trade pact

Ramesh Shankar, Mumbai — 24-Jun-2011

The NGOs working in the health sector have welcomed Indias formal announcement that it will not accept data exclusivity as part of a Free Trade Agreement currently being negotiated with the European Union.

KSCSTE on a mission to promote IP literacy in Kerala

T. Nandakumar — 26-Jun-2011

The Patent Information Centre Kerala an initiative of the Kerala State Council for Science Technology and Environment has drawn up an ambitious programme aimed to broad base IP literacy in Kerala and maximize the number of patents filed by universities research institutions grassroots innovators, educational institutions and individuals.

ICMR to commercialise its patented technology to isolate VSELs from bone marrow cord blood

Ramesh Shankar, Mumbai — 27-Jun-2011

The Indian Council of Medical Research will soon commercialise its newly developed patent protected technology in which it has found a simple method to isolate Very Small Embryonic Like stem cells from bone marrow and cord blood without the use of sophisticated and expensive infrastructure.

Intellectual rights protection forecast: Technical workforce gives India cutting edge in cloud computing innovation

Horacio Gutierrez — 27-Jun-2011

There was a time when cloud was nothing more than the result of water droplets suspended above the surface of the Earth.

Cookie time

Rohit Nautiyal — 28-Jun-2011

Cadbury India retaliated and sued Britannia for trademark and copyright infringement of intellectual property rights.

U.S. Court Orders Seizure of Cipla Pet Drugs

INTI LANDAURO And ASHUTOSH JOSHI — 30-Jun-2011

A U.S. court ordered the seizure of a pet drug made by pharmaceutical companies Cipla Ltd. and Velcera Inc. after ruling the drug violated a patent held by a unit of French giant Sanofi SA the French company said in a statement Thursday.

Cipla wins pre-grant opposition against Novartis for dispersible tabs containing deferacirox

Suja Nair Shirodkar, Mumbai — 30-Jun-2011

The Chennai patent office has granted a pre grant opposition in favour of Cipla for dispersible tablets containing \'deferacirox\'.

India needs to nurture culture of innovation

Rahul Wadke — 30-Jun-2011

It is one of the top patent producers in the world.

Pfizer sues Aurobindo Pharma over Lipitor

Press Trust of India / Hyderabad — 30-Jun-2011

Global pharma giant Pfizer Inc has sued city based Aurobindo Pharma over the generic version of Lipitor sources close to the development said today.

Nothing wrong in guarding ones forte

S. Murlidharan — 30-Jun-2011

A drug company is normally allowed a 20 year monopoly in most of the countries in the wake of the WTO norm to this effect when it successfully obtains a patent for its invention.

Wockhardt gets USFDA nod for generic eye drops

PTI — 01-Jul-2011

The patent covering this product is under litigation in the US courts and Wockhardt will launch the product after resolution of the same the company said.

Pfizer files lawsuit against Aurobindo Pharma

PBR Staff Writer — 1-Jul-2011

Drug maker Pfizer has filed a lawsuit against India based drug manufacturer Aurobindo Pharma over generic Lipitor which is indicated as a treatment for cholesterol and for lowering stroke heart attack or other heart complications in patients type 2 diabetes.

DRL haunted by past follies?

Swati Bharadwaj-Chand — 3-Jul-2011

Over the past two years lawsuits against DRL over alleged patent infringements in US courts have been piling up as it makes an aggressive play for the US generics market.

Scotch Whisky gets GI status in India

Agencies — 3-Jul-2011

India has granted geographical indication of origin status to Scotch Whisky a legal protection that will help prevent the sale of counterfeit products in the Indian market as well as reinforce the authenticity of the product for the consumer.

The Copyright Amendment Bill 2010: on the death of books and the digital environment

Aparna Viswanathan — 04-Jul-2011

The Copyright Amendment Bill 2010 introduces the parallel importation of books in accordance with Article 6 of the Trade Related Intellectual Property Rights Agreement a provision intended to provide readers in developing countries with books at cheaper prices.

Opportunities outweigh risks

fe Bureau — 4-Jul-2011

Key risks: longer ANDA approval timelines rising FDA scrutiny.

India rejects clause on litigation

Asit Ranjan Mishra — 4-Jul-2011

India should reject the EUs demand for inclusion of intellectual property in the definition of investment and the so called investor to state arbitration clause according to Leena Menghaney public health lawyer and India campaign coordinator for non-profit Medecins Sans Frontieres.

Home grown jugaad set for patent cover

Sidhartha — 4-Jul-2011

Indias spirit of jugaad is finally going to get legal backing.

Glenmark settles litigation with Daiichi

Our Bureau — 04-Jul-2011

Glenmark has settled its litigation with Daiichi Sankyo Inc and Genzyme Corporation over the sale of Glenmarks generic version of Colesevelam Hydrochloride in the US.

Google suffers major blow in Nortel patent loss

IANS — 04-Jul-2011

Google which initiated the bidding war for precious Nortel patents in April has suffered a huge blow with an Apple led consortium walking away with 6000 patents for $4.5 billion last week.

Millions will die if India stops AIDS drugs U.N.

Nita Bhalla — 05-Jul-2011

The EU India trade deal includes measures that could delay or restrict competition from generic medicines by extending patent terms requiring data exclusivity and tightening border enforcement rules.

Drug cos eye US entry after FDA checks

Khomba Singh — 5-Jul-2011

The US drug regulator has inspected the manufacturing plants of at least half a dozen Indian drugmakers raising hopes that these companies will be able to export medicines to the worlds largest drug market reports Khomba Singh from New Delhi.

India has to play a critical role in HIV prevention

Special Correspondent — 05-Jul-2011

Mr. Sidibe hoped India would resist pressure from other countries to place limits of TRIPs trade related aspects of intellectual property rights flexibilities.

India grants Scotch GI status to check counterfeit

PTI — 5-Jul-2011

India has granted geographical indication of origin status to Scotch whisky a legal protection that will help prevent the sale of counterfeit products in the Indian market as well as reinforce the authenticity of the product for the consumer.

A deal still on the drawing board

Biswajit Dhar — 6-Jul-2011

The India EU free trade agreement is yet to see daylight.

Chinas raw deal

T S Vishwanath — 7-Jul-2011

The World Trade Organisation is turning into an important platform to target export bans on raw materials by member countries.

Government finalises rules of nuclear liability law

PTI — 07-Jul-2011

Government has finalised the much awaited rules of implementation of the nuclear liability law a move that could pave way for expansion of the atomic power sector by procuring equipment from foreign suppliers.

Create scalable organisations that last

Sanjay Anandaram — 8-Jul-2011

Recently India granted geographical indication of origin status to Scotch whisky a legal protection that will help reinforce the authenticity of the product and enhance the market potential.

Indian drug makers bet big on local biosimilar market

Reghu Balakrishnan / Mumbai — 8-Jul-2011

By 2015 biologics with an estimated sales value of more than $60 billion are due to lose patent protection rising to over $100 billion by 2020.

Lalbaugcha Raja makers get patent for popular idol

Vinay Dalvi — 8-Jul-2011

In its 77th year the immensely popular Lalbaugcha Raja that attracts millions of devotees each year has finally been protected by a patent.

Ranbaxy US FDA inch closer to settlement

Rupali Mukherjee & Partha SinhaRupali Mukherjee & Partha Sinha — 9-Jul-2011

Ranbaxy holds the 180 day exclusivity rights for marketing a generic version of Lipitor in the US through a deal with current patent holder Pfizer.

Pressing for strong IPR regime in FTA with India: EU tells WTO

PTI — 10-Jul-2011

The European Union has informed the WTO that it is pressing for inclusion of strong IPR regime in the free trade agreement under negotiations with India even as the Commerce Ministry has maintained that New Delhi will not yield to the EU on this issue.

Trade barriers should not prevent affordable health services

PTI — 11-Jul-2011

India today cautioned against moves to enforce Intellectual Property Rights with the proposed anticounterfeiting task force saying trade barriers should not prevent equitable and affordable public health services.

Industry vehemently objects to the implementation of Utility Models in India

Suja Nair Shirodkar, Mumbai — 11-Jul-2011

Objecting strongly to the governments plan to introduce a new IPR in the country in the form of Utility Models or Petty Patents the Indian pharma industry has urged the government to re consider it as they fear that it will affect the impact of the well accepted patent laws in India.

Drug makers bet on local biosimilar markets

Reghu Balakrishnan / Mumbai — 11-Jul-2011

A recent Standard Chartered Bank report, said By 2015 biologics with an estimated sales value of $60 billion are due to lose patent protection rising to $100 bn by 2020.

India seeks Polands help for removal of EU trade curbs

Press Trust of India / New Delhi — 11-Jul-2011

India today sought help from Poland which holds the European Union Presidency for resolving trade obstacles for Indian agri exports to 27 EU countries.

BRIC nations pledge cheaper drugs for developing nations

Kounteya Sinha — 12-Jul-2011

According to Indian health minister Ghulam Nabi Azad Intellectual Property Right barriers including patents and data exclusivity cause delays in generic competition in the market which is one of the most efficient ways to bring prices down.

India China to oppose barriers to affordable drugs

Ananth Krishnan — 13-Jul-2011

India China and other members of the BRICS group of countries have agreed to stand together to oppose any moves by developed nations to tighten Intellectual Property Rights rules that could threaten access to affordable drugs in developing countries officials said on Tuesday following two days of talks.

Why India ranks low in INNOVATION

Sreelatha Menon — 13-Jul-2011

Just 200 patent applications were made in 10 years.

ComMin for patent protection to Jugaad technology items

PTI — 13-Jul-2011

The Commerce Ministry has favoured patent protection to low cost innovations like onion seed transplanter and clay refrigerator mitticool.

Dr Reddys Labs launches three generic products in USA

Deepika Amirapu — 13-Jul-2011

Indian drug firm Dr Reddys Laboratories has received the final approval from the USFDA to launch Fondaparinux Sodium injection used for treating and preventing deep vein thrombosis the company said in a statement.

EU not to seize Indian drug despatches using Europe as transit

PTI — 13-Jul-2011

European Union members will not seize Indian medicines passing through Europe on allegations of intellectual property right violations as per an understanding reached between India and EU.

Gilead Sciences Inc allows 4 Indian pharmaceutical companies Ranbaxy Laboratories Matrix Laboratories Hetero Drugs and Strides Arcolab to sell HIV Generics

OUR BUREAU — 13-Jul-2011

California based Gilead Sciences Inc has allowed four Indian companies to make and sell low cost versions of three of its new HIV drugs under a firstof its kind agreement between an innovator pharmaceutical firm and a United Nations backed patent sharing body.

Roche & Helsinn sue Dr Reddys for patent infringement

Press Trust of India — 13-Jul-2011

Roche Palo ALTO and Helsinn Healthcare SA filed a patent infringement litigation against Dr Reddys Laboratories for antinausea drug Aloxi.

EU not to seize Indian drug despatches using Europe as transit

PTI — 13-Jul-2011

European Union members will not seize Indian medicines passing through Europe on allegations of intellectual property right violations as per an understanding reached between India and EU.

Tattoo design registered on SRKs name!

Meena Iyer — 14-Jul-2011

The D tattoo worn by King Khan in the upcoming Don 2 has been registered for copyright protection against his name.

Granules India forms JV firm with Belgian company for APIs

Prabhu Mallikarjunan — 15-Jul-2011

Belgian chemical company Ajinomoto Omnichem and Indian drug maker Granules India Ltd formed a 50 50 joint venture on Thursday to produce active pharmaceutical ingredients and intermediates for third parties seeking to tap demand for contract manufacturing in the generic drugs market.

Hilton loses trademark battle over title in India

PTI & Nikhil Kanekal — 15-Jul-2011

Hilton International Corp. which owns the international chain Hilton Hotels and Resorts lost a case in the Supreme Court on Monday thereby losing the exclusive right over the Hilton trademark in India.

Kootol targets Microsoft Apple others over patent

Josh Lowensohn — 15-Jul-2011

More than 30 companies including the likes of Microsoft Apple and IBM have been targeted by India based Kootol Software for allegedly violating technology covered in a patent application.

Balancing public private interests must in intellectual property issues

Our Bureau — 15-Jul-2011

A fine balance between protection of private and public interests is vital in intellectual property management according to Ms Justice Prabha Sridevan Chairman Intellectual Property Appellate Board.

ICMR planning to acquire patents of traditional healing techniques for Andaman tribals

Kounteya Sinha — 16-Jul-2011

Traditional healing techniques using indigenous medicinal plants practiced efficiently for hundreds of years by some of Indias most elusive tribes residing in the Andaman and Nicobar Islands is all set to become public.

India a focus area for patents says GE

BS Reporter / Chennai/ Hyderabad — 16-Jul-2011

US based technology company General Electric is looking to increase patent filings from its research and development centres in India along with those in China and Brazil as the intellectual property regimes are strengthened in these countries.

Samsung wants Siemens unit banned in US

Reuters — 18-Jul-2011

Samsung LED Co Ltd said it had filed a complaint with the US fair trade commission to ban imports of LED products from Siemens light bulb unit Osram and affiliates Osram Opto Semiconductors and Osram Sylvania Inc.

India EU trade deal to benefit textile garment exporters

Nayanima Basu / New Delhi — 18-Jul-2011

European Union negotiators arrive in Delhi today to continue the final leg of talks.

Auto wine duties hold up EU FTA

Sidhartha — 18-Jul-2011

We have told them that we are unable to offer any concessions since we have not included these two sectors in our FTAs said a government official.

Govt to encourage SMEs to go in for patents

PTI — 18-Jul-2011

The government in collaboration with the UN body World Intellectual Property Organisation has commissioned a study to ascertain whether Indias small and medium enterprises are prepared to adopt the global IPR regime.

Google slogan: Android Asia Action

Vivek Sinha — 19-Jul-2011

Schmidt was unfazed by the patent suits filed against the firm by rivals such as Apple Microsoft and Oracle.

DoP takes steps to assess current status of regulatory matters relating to exports

Joseph Alexander, New Delhi — 20-Jul-2011

The DoP has plans to fund IPA to set up a cell to deal with all issues related to IPR regulatory issues and other trade barriers.

Focus on pharmaceutical M&As back after Lupin negotiation buzz

Reghu Balakrishnan / Mumbai — 20-Jul-2011

Apart from the lack of strong product pipeline and expiry of patents MNCs were hit by the strong stance taken by US FDA against innovative product approvals Krishnakumar added.

Patents and lawsuits threatening the free world of software

ET Bureau — 21-Jul-2011

Could something as pesky and well trivial as a patent ruling topple the mighty Android from its perch as the mostused operating system for smartphones.

Patents Granted in Indian Patent Office Plunge

Guest Barista — 21-Jul-2011

The Indian patents system having its seeds laid in the British era 1852 and undergoing sporadic replantations the 1912 1970 2005 Patents Act & amendments was appearing to grow tall and bear fruits until a noticeable downfall last year.

Dr Reddys scouts ally for new chemical entity Balaglitazone

KV Ramana — 22-Jul-2011

The product pipeline today covers about 63% of patent expiries.

GlaxoSmithKline launches two cancer drugs at reduced prices

Our Bureau — 22-Jul-2011

Both patent protected products will be imported from the UK.

US to play key role in Dr Reddys generics business

BS Reporter / Chennai/ Hyderabad — 23-Jul-2011

About 63 per cent of the companys new productline in generics pertains to those drugs that would be off patent by 2013 in the US GV Prasad vice chairman and chief executive officer of the Hyderabad based pharmaceutical major said at the AGM here.

CSIR keen to revive sick Bengal PSU pharma cos

PTI — 24-Jul-2011

The CSIR has formed a separate company CSIR Tech to commercialise its patents and knowledge which will act as a technology business incubator.

Lupin settles patent suit with Medicis, signs R&D pact

Press Trust of India / New Delhi — 25-Jul-2011

Drug maker Lupin today said it had settled all patent litigation over Solodyn tablets with Medicis Pharmaceutical Corp and signed a pact with the US based firm for development of multiple therapeutic compounds.

Low cost innovations make life easier for rural poor

T E Narasimhan / Chennai — 26-Jul-2011

This water is filtered in a specially designed integrated filtration system including a patented membrane from NCL which filters out all suspended matter including bacteria and viruses.

CCSHAU Hisar gets a process patent

Madhvi Sally — 26-Jul-2011

Chaudhary Charan Singh Haryana Agricultural University CCSHAU Hisar has been issued a patent on a biotechnological process which enhances in vitro plantlets regeneration inair yarn plant announced the Vice Chancellor Dr. K.S. Khokhar.

Music companies not composers own song rights: Bombay HC

Shibu Thomas — 27-Jul-2011

The judge however clarified that the owners of the copyright composers and lyricists do not lose all their rights when they allow it to be recorded.

GI tags sought for M.P.s Nimari chilli Malwi potato

PTI — 26-Jul-2011

If things go according to plan Madhya Pradeshs famously bitter Nimari chillis and the Malwi potatoes that are favoured by potato chip manufacturers will soon get international recognition.

Pharma companies may get tax sops for clinical trials patent filings

Khomba Singh — 27-Jul-2011

The Department of Pharmaceuticals is planning to recommend extension of tax benefits given to drugmakers for in house R&D and research work done outside the firm such asclinical trials bio equivalence studies regulatory approvals and patent filings which could benefit most Indian drug companies.

Himalaya Drug positions Liv. 52 HB as safe and cost effective for India’s 4 crore HBV patients

Nandita Vijay, Bangalore — 28-Jul-2011

Himalaya Drug Companys Liv. 52 HB is Indias first US patent pending herbal formulation for Hepatitis B Virus infection.

EUs demand for additional concessions stalls trade talks

Asit Ranjan Mishra — 28-Jul-2011

The agreement is being opposed by non governmental organizations over concerns that the proposed trade related aspects of intellectual property rights in the deal will affect Indias ability to produce and export life saving generic drugs to developing and poor countries.

GI tag for Gir Kesar mango Bhalia wheat

Daniel P George — 28-Jul-2011

Gir Kesar mango and Bhalia wheat from Gujarat have been accorded the geographical indication tag by the Geographical Indications Registry in Chennai.

EU agrees to stop confiscation of Indian generic drugs

ET Bureau — 29-Jul-2011

Indias long drawn dispute with theEuropean Union over confiscation ofIndian generic drugs in transit to other countries at European airports has been temporarily settled.

India EU ink deal to end drug seizure for now

TNN — 29-Jul-2011

Finally EU has come around and we have agreed on an interim settlement... which means EU will not make any detention within its territory of pharmaceutical products coming from India.

India EU reach understanding on seizure of Indian generic drugs at EU ports

Our Bureau, Mumbai — 30-Jul-2011

India and the European Union have reached an interim settlement on the long pending issue of seizure of Indian generic drug shipments at the EU ports en route to Latin American and other countries on charges of counterfeiting and patents infringement.

Rovio sues Hulu for patent infringement

Reuters — 30-Jul-2011

Rovi Corp sued Hulu, accusing the online video site of infringing patents that cover electronic program guides.

India Japan implement economic pact aim to double trade

IANS — 01-Aug-2011

It covers more than 90 percent of trade a vast gamut of services investment intellectual property rights customs and other trade related issues.

The Pagadi Unravelled

Shruti Nambiar — 1-Aug-2011

On September 4 2009 Geographical Indication Status a sign used on goods that have a specific geographical origin was accorded to a traditional Maharashtrian headgear.

Junagadh Kesar mango gets GI tag as Gir Kesar

PTI — 1-Aug-2011

The famous saffron coloured Kesar variety of mango largely grown around the foothills of Girnar mountains in Gujarats Junagadh district has got global recognition as Gir Kesar mango after being granted the Geographical Indication tag.

HC decides on own letters patent jurisdiction

TNN — 1-Aug-2011

In a significant judgment the high court of Bombay at Goa recently held that a letters patent appeal intra court appeal lies before a division bench of the court from a judgment of a single bench judge in a civil writ petition under Article 226 of the Constitution.

DoP to take up issue of non-tariff barriers by EU with commerce ministry for further actions

Joseph Alexander, New Delhi — 2-Aug-2011

In the case of bulk drugs third party audits are being insisted upon as a result the companies are forced divulge their intellectual property infringing on the right to protect the data.

EU wants GI protection for 190 products

Joe C Mathew / New Delhi — 2-Aug-2011

Anticipating a huge market opportunity once the comprehensive free trade agreement being negotiated is ratified the European Union has sought geographical indication protection for 190 products in India.

Lupin looks to acquire large LatAm firm

C.H. Unnikrishnan — 2-Aug-2011

Lupin Ltd Indias fifth largest drug maker is planning to acquire a large Latin American pharmaceutical company to enter a region where cheaper generic drugs outsell medicines sold by patent holders.

India EU FTA negotiations at advanced stage: Scindia

Press Trust of India / New Delhi — 02-Aug-2011

Negotiations on a comprehensive free trade pact between India and the European Union which began in June 2007 have reached at an advanced and delicate stage Parliament was informed.

Natco Pharma files Indias first compulsory licence plea

Khomba Singh — 2-Aug-2011

Natco Pharma has applied for the countrys first compulsory licence to sell a generic version of Bayers patented medicine a development whose outcome is expected to determine how global drug makers price their costly drugs in India.

EU for duty cuts in auto sector in FTA with India

Press Trust of India / New Delhi — 3-Aug-2011

The government today said the European Union had requested India to cut import duties in several sectors including automobile in the proposed comprehensive market opening pact.

Pfizer files patent suit against Hetero

BV Mahalakshmi — 03-Aug-2011

Pfizer Inc has filed a patent infringement suit against Hyderabad based Hetero Drugs in a US court raising opposition against Indian pharma firm Heteros attempt to enter the lucrative market of its blockbuster drug Sildenafil citrate commonly called as Viagra used for treatment of impotence and rare disease pulmonary arterial hypertension.

AstraZeneca Indias Balganesh to head CSIR project

Jacob P. Koshy — 03-Aug-2011

None of the entities can claim exclusive patent rights but because companies do not have to make huge and risky investments in research, they are more likely to agree to non-exclusive marketing licensing arrangements with CSIR and thus keep the cost of drugs low.

Venus Remedies gets US patent nod for research product

Press Trust of India / New Delhi — 3-Aug-2011

Venus Remedies today said it has received its first patent approval from the United States Patent and Trademark Office for its product Vancoplus used for treating bacterial infections.

Copyright judgment garners flak from industry

Pooja Maheshwary — 04-Aug-2011

Last week the High Court had stated that the Indian Performing Right Society Limited that safeguards the copyright of music composers and lyricists is not entitled to demand royalty or licence fees from FM radio channels for the music they broadcast.

Ranbaxy dips 4% on Pfizers Lipitor move

Rupali Mukherjee — 5-Aug-2011

Ranbaxy scrip suffered losses and closed lower on the BSE on Thursday on fears that Pfizer was reportedly planning to launch an overthe counter version of cholesterol lowering drug Lipitor once the drug loses patent protection in US in November this year.

Venus Remedies appoints consultants to out license two products

Our Bureau — 05-Aug-2011

After having got a product patent in the United States on its dry powder injectable antibiotic Vancoplus the Chandigarh based Venus Remedies expects to out license the product this financial year.

Access to affordable generics poses huge challenge in public healthcare: KDPMA chief

Nandita Vijay, Bangalore — 6-Aug-2011

While issues like unreliable supply system irrational prescription dispensing usage unfair health financing mechanism inadequate funding for research in neglected diseases have resulted in the high cost of drugs the patent regime enforced from 2005 has been one of the key deterrents for drug affordability.

EU demanding access to Indian service market is barrier to FTA

PTI — 07-Aug-2011

The European Unions demand that it be given access to Indian market in services like banking postal legal and accounting would be a major road block for the India EU free trade pact under negotiations since June 2007 sources said.

Digital library to the rescue of traditional patents

Jaideep Shenoy — 08-Aug-2011

Indias resilience in standing up to attempts by powers that be to seek patents for turmeric basmati rice wheat and all time favourite snack the idli has paid off big time at least for now.

DoP to convey concerns of industry over proposed FTAs TPPA to commerce ministry

Joseph Alexander, New Delhi — 10-Aug-2011

The Department of Pharmaceuticals will take up issues with the Commerce Ministry regarding the proposed Trans Pacific Partnership Agreement which is likely to have adverse impact on the Indian pharma products and other such Free Trade Agreements in the pipeline.

Final hearing in Novartis Glivec case begins in SC

Nikhil Kanekal — 10-Aug-2011

Novartis contends that its patent on the drug should be extended as it has increased its efficacy by 30% meaning that a persons capacity to absorb the newer version of the drug is that much better

MSF raises concern over commerce ministrys move to introduce Utility Model for patenting

Ramesh Shankar, Mumbai — 10-Aug-2011

The Médecins Sans Frontières an independent international medical humanitarian organization has expressed concern over the union commerce ministrys proposal to introduce Utility Model as an alternate tool for the protection of Intellectual Property Rights in India.

Apple blocks Samsung from selling galaxy tablet in EU

Reuters / Seoul/ San Francisco — 11-Aug-2011

The court order comes a week after Samsung was forced to delay the Australian launch of its latest Galaxy tablet because of a separate lawsuit alleging Samsung infringed on a number of Apples patents.

Hearing on Novartis case on Section 3(d) of Indian Patents Act begins in Supreme Court

Ramesh Shankar, Mumbai — 12-Aug-2011

The Supreme Court has started hearing the controversial Novartis case in which the Swiss multinational pharmacuetical company has challenged the manner in which Section 3(d) of Indias Patents Act is applied.

Hindustan Unilever loses trademark case for Sunlight brand to little known Kerala based Thai Group

Paramita Chatterjee & Ratna BhushanParamita Chatterjee & Ratna Bhushan — 12-Aug-2011

The oldest brand in the portfolio of Anglo Dutch consumer products giant Unilever took a bath last week when its Indian affiliate Hindustan Unilever Ltd lost a trademark case for a 127 year old soap called Sunlight to a little known southern soap maker.

ICARs IPR will be globally showcased through new company AGRINDIA

Prabha Jagannathan — 12-Aug-2011

The Union Cabinet has approved the proposal of Ministry of Agriculture Department of Agricultural Research & Education for setting up of a new company called AGRlNDIA.

Health ministry goes big on yoga funds studies on its benefits

Kounteya Sinha — 13-Aug-2011

Meanwhile the Traditional Knowledge Digital Library has completed documenting 1300 asanas which will soon be uploaded making them public knowledge in order to protect them from western pirates.

MNCs looking at more global partnerships with Indian cos to launch more products

A Raju, Hyderabad — 13-Aug-2011

Global pharma majors are in the midst of a crisis with a decline in the number of blockbuster drugs low R&D productivity and patent expiries

Gandhi Rice as trademark opposed by Indian lawyer

Hary M. Pillai — 14-Aug-2011

Lalit Bhasin a leading lawyer in India has taken upon himself to prevent an attempt for commercial exploitation of the name of father of the nation Mahatma Gandhi.

Novartis imatinib patent battle resumes in Indian Supreme Court

Article — 15-Aug-2011

The controversial Novartis case in which the Swiss major Novartis challenged the manner in which Section 3(d) of Indias Patents Act is applied is now the subject of hearings at the Indian Supreme Court.

Bhalia wheat gets GI tag

PTI — 15-Aug-2011

Bhalia a long grain wheat variety rich in protein and grown under conserved soil moisture conditions in Bhal region of Gujarat has received the Geographical Indication tag a move which is likely to benefit more than 5000 farmers in the State.

European Union not keen to relax FTA visa curbs

Sidhartha — 15-Aug-2011

The European Union is pushing for more foreign investment in a slew of sectors banking insurance legal accounting postal maritime and security services but is unwilling to allow a bigger number of Indian professionals to work in the 27 member union.

Gopal Subramanium to represent Novartis

Joe C Mathew / New Delhi — 15-Aug-2011

Patent case of the Swiss pharma major will be his first private assignment after resigning as Solicitor General.

Monsanto expects a surge in demand for maize

Nidhi Nath Srinivas — 16-Aug-2011

It is attractive because of well developed intellectual property rights and a robust regulatory process.

Google Motorola deal more a patents buy say tech analysts

Our Bureau — 16-Aug-2011

Googles $12.5 billion purchase of Motorola Mobility is more a patents play than a hardware deal say technology analysts.

Motorola buy may not hurt Android partners in India

Leslie D`Monte / Mumbai — 17-Aug-2011

After the completion of the deal Google would own both hardware and software units while simultaneously acquiring Motorola Mobilitys 17000 patents and an additional 7500 patent applicationsan arsenal that can help Google fight the Nokia Apple Microsoft trio which recently outbid it in acquiring Nortels patents.

India on global R&D map

Pranav N Desai — 16-Aug-2011

Technological capabilities are enhanced by a learning that is determined not only by codified knowledge in R&D output such as publications patents and designs but also by interactive learning processes of international collaboration inward and outward foreign direct investments and by the general socio economic environment.

Patent search

Robert Cyran — 17-Aug-2011

Google is spending $12.5 billion on insurance for itself but its partners may not feel at ease.

Motorola India may gain from Google deal

TNN — 17-Aug-2011

Googles takeover of Motorola Mobility is expected to impact the Indian operations of Motorola Mobility.

What Motorola India gets from Google deal

TNN — 17-Aug-2011

Googles takeover of Motorola Mobility is expected to impact the Indian operations of Motorola Mobility.

What Motorola India gets from Google deal

TNN — 17-Aug-2011

Googles takeover of Motorola Mobility is expected to impact the Indian operations of Motorola Mobility.

Lincoln Pharma launches ayurvedic product

BS Reporter / Mumbai/ Ahmedabad — 18-Aug-2011

Ahmedabad based Lincoln Pharmaceuticals Ltd. recently announced the launch of its ayurvedic product named ISL Granuels that will serve the mother and child healthcare segment.

UTILITY MODEL PATENTS

P A Francis — 18-Aug-2011

Indias commerce ministry is reported to be considering a proposal to introduce a Utility Model for patents in the country as a new tool for granting intellectual property rights.

WHO disqualifies 3 vaccines of Panacea Biotec

ET Bureau — 19-Aug-2011

Panacea Biotec scrip fell 20% to Rs 144.90 on Thursday after the biotechnology firm disclosed that WHO has disqualified its three combination vaccines from supplying to the organisation.

Ranbaxy Laboratories may sell Lipitor rights if FDA delays nod

Bloomberg — 19-Aug-2011

Ranbaxy Laboratories may sell rights to make a generic version of Pfizer Incs Lipitor the worlds best selling medicine should it fail to win timely US approval for the cholesterol pill Credit Suisse AG said.

In search of the right medicine

19-Aug-2011

Drug price regulation will be better served when the Pharmaceuticals Policy sees the light of day and takes structural changes in industry into account.

Suven Life secures four product patents

BS Reporter / Chennai/ Hyderabad — 19-Aug-2011

Hyderabad based Suven Life Sciences has won four product patents for its new chemical entities designed for treatment of neurodegenerative diseases.

Cipla Dr Reddys under DCGI scanner for selling banned drugs

Khomba Singh — 19-Aug-2011

The countrys drug regulator has sent show cause notices to Cipla and Dr Reddys Laboratories for selling drugs banned by the government and is planning similar action against a few other top drug makers.

PM calls for pvt investments in scientific research

Our Bureau — 21-Aug-2011

Urging the private sector to contribute significantly in spheres of research and development Dr Singh lamented the fact that the number of patents filed by Indians were very low compared with other developed nations or developing nations.

Google Motorola and the patent wars

L Gordon Crovitz — 24-Aug-2011

The costs of the broken US patent system are often abstract but this month Google put a price tag on it: $12.5 billion.

Patent ruling clears way for Tatas to market ultra strong steel in Europe

Vidya Ram, Roudra Bhattacharya — 24-Aug-2011

Tata Steels plans for marketing a new ultra high strength steel for the automotive industry gained impetus on Wednesday after a European patent court revoked a rivals patent.

Bharti Airtel Vodafone Essar Reliance communication and BSNL ask Trai to stay out of dealings with VAS firms

Joji Thomas Philip — 25-Aug-2011

The telco also pointed out that it would not just be counter productive but also extremely unscientific to determine a defined revenue percentage share on content because value of such applications were intellectual property rights driven and not on dry cost basis.

Google Motorola could be peak of patent price spike

Reuters — 25-Aug-2011

Now that Google has agreed to a $12.5 billion deal to buy Motorola Mobility scooping up a trove of 17000 phonerelated patents to give itself some ground to defend its Android operating system the most motivated buyer looks to be off the market.

Cipla Lupin deny report on Takeda talks

Reuters — 25-Aug-2011

Emerging markets are set to become the main driver for the global pharmaceuticals industry as patents run out on many top drugs and sales stall in Western markets but acquisitions in those economies have not always come easy.

Cipla looking at global alliances to sell its products

Our Bureau — 25-Aug-2011

On the Unitaids patent pool Dr Hamied said there were issues regarding the markets open to a company that uses patents from the pool.

Apple wins ban on 3 Samsung phones in 10 European nations

Reuters — 26-Aug-2011

Apple won an injunction in a Dutch court on Wednesday to stop Samsung Electronics from marketing three smartphone models in some European countries after alleging a breach of patents.

Copycat climate

26-Aug-2011

Its ironic that Chinas telecom companies are on a patent overdrive.

Granules India to augment APIs production expand market share of best sellers

Deepika Amirapu — 26-Aug-2011

They manufacture several off patent drugs such as Paracetamol Ibuprofen Metformin and Guaifenesin on a large scale for customers in the regulated and semi regulated markets.

Cipla may team up with MNCs

TNN — 27-Aug-2011

Hamied said that the government should work on three things to address the healthcare concerns of the country one bring in compulsory licensing when a government allows a pharma company to manufacture a patented drug without the consent of the patent owner two prevent a monopoly and thirdly prevent frivolous evergreening and incremental innovations by MNCs.

Payment for copyrighted goods not royalty: ITAT

M Padmakshan — 29-Aug-2011

However in its ruling a twomember bench of the ITAT said that the payment was not royalty because it was for the software which was a copyrighted article and not for the copyright itself.

India EU to renew trade talks in Brussels

Asit Ranjan Mishra — 29-Aug-2011

Differences over services agriculture chemicals intellectual property rights and government procurement are also yet to be resolved.

Kutchi shawl likely to get GI tag

PTI — 29-Aug-2011

A Geographical Indication tag is on the cards for the colourful Kutchi shawls woven with motifs by artisan communities for past several generations in Kutch district of Gujarat.

US patent expiries unlikely to be a big opportunity

Priyanka Golikeri — 30-Aug-2011

In the next four years drugs with sales worth $157 billion will lose patent in the US opening the doors to generic competitors.

India EU to renew trade talks in Brussels

Asit Ranjan Mishra — 30-Aug-2011

Indian and European Union negotiators will renew talks for a trade and investment agreement in Brussels on 12 14 September but experts said their differences are too wide to be overcome without a political push.

Teva Pharma wins 1st round of patent battle against Natco

Soma Das — 31-Aug-2011

In a setback to Hyderabad based Natco Pharma the Israeli drug giant Teva Pharma claims to have won the first round of patent battle over the blockbuster multiple sclerosis drug Copaxone Glatiramer Aceatte in the United States.

Venus secures market for anti cancer product

BS Reporter / New Delhi/ Chandigarh — 31-Aug-2011

The molecule patent protection of Sanofi Aventis has recently expired in major European countries while in rest of the countries the expiry of patent is due in November 2013.

Pfizer Dr Reddys settle patent suit over Lipitor

Khomba Singh — 01-Sep-2011

Pfizer Inc and Dr Reddys Laboratories have settled a patent infringement suit related to the Indian drug makers launch of a generic version of the blockbuster drug Lipitor in the US.

Pollution board chief cashed in on own patent

Nitin Sethi — 01-Sep-2011

Central Pollution Control Board chairman SP Gautam sold a patent he held privately on a technology to the apex authority on a revenue sharing basis and then passed a directive in his official capacity asking the leather industry to buy the expensive and untested know how.

Strategic Analysis of Indian Biosimilar Market - Impending Patent Expiries Encourage Companies to Ramp up Biosimilar Manufacturing Capabilities

Eastern Daylight Time — 01-Sep-2011

Impending Patent Expiries Encourage Companies to Ramp up Biosimilar Manufacturing Capabilities

Kuthampully sarees get an IP address weave history

Viju B — 01-Sep-2011

K Sreedharan got a booking order for 30 Kuthampully sarees from a Non Resident Indian settled in Canada last year.

No deal in sight WTO tries to stay relevant

Sidhartha — 01-Sep-2011

When WTO chief Pascal Lamy comes to Asia next week he will make another pitch to revive the decade old Doha Round of trade liberalization talks and also seek inputs from India and China on additional work programme.

DoP to set up NFDC to help SMEs to grab market with many patent expiries expected soon

Joseph Alexander, New Delhi — 02-Sep-2011

With large number of drugs losing patents in the near future throwing up huge opportunities for Indian manufacturers of generic formulations the Department of Pharmaceuticals wants to set up at least one National Formulation Development Centre to assist the small and medium scale units to grab a decent pie from the emerging world market.

Piracy often brings down price of product

Vivek Kaul — 02-Sep-2011

The story goes that Kumar under his T Series brand initially brought out pirated cassettes of Hindi films for which HMV had the copyright.

Pharmaceutical mega brand buyouts a sweet pill

Reghu Balakrishnan / Mumbai — 2-Sep-2011

It may be Doktor Mom in Russia or Farex in India.

Health Ministry wants FDI safeguards to keep drug prices low

Aarti Dhar — 3-Sep-2011

As many as 61 drugs worth $80 billion are likely to go off patent in the U.S. between 2011 and 2013 making it possible for Indian companies to produce cheaper generic versions.

Govt alarmed as MNC buyouts set to push up drug prices

Kounteya Sinha — 04-Sep-2011

The price of India made low cost generic drugs could be sky high soon.

Legal fraternity slams draft Bill to regulate practice

Joe C Mathew / New Delhi — 04-Sep-2011

The government is planning a new accreditation and regulatory mechanism for legal services that has not been defined under the Advocates Act 1961.

Removal of parallel imports clause may stir up debate

C.H. Unnikrishnan — 4-Sep-2011

The provision for importing books without infringing copyrights would have also helped students gain access to the latest affordable versions of text books from across the world.

Indians find cancer fighting protein in human body

Snehal Rebello — 05-Sep-2011

Last October the team filed a patent for the chemically synthesised protein portion.

Medicines for all

5-Sep-2011

It has been pointed out that between 2011 and 2013 a large number of drugs are likely to go off patent in the US making it possible for local firms to produce cheaper generic versions.

SC judge under attack from health activists

Manoj Mitta — 6-Sep-2011

Two years ago, Justice Markandeya Katju of the Supreme Court had withdrawn from hearing a patent dispute vitally concerning pharmaceutical majors.

Suven gets four patent approvals for CNS molecules

PTI — 6-Sep-2011

Drug firm Suven Life Sciences on Monday said it has received four product patents in Australia and New Zealand for its new chemical entities which could be used for treating various central nervous disorders.

A victory for Novartis could spell death for millions

Priscilla Jebaraj — 6-Sep-2011

The Swiss pharma giant fighting in Supreme Court for patent on anti cancer drug

Novartis’ case against Section 3(d) of Indias Patents Act enters final stage in Supreme Court

Ramesh Shankar, Mumbai — 6-Sep-2011

The next hearing in the case will take place on September 6 2011.

Teva defense of Copaxone starts today

World News — 7-Sep-2011

The first trial in Tevas legal action against generic drugmakers seeking to market copycat versions of its big selling multiple sclerosis drug Copaxone in the USA is due to start later today.

Aurobindo Pharma ties up with Russian firm

Namrata Nandakumar — 8-Sep-2011

Drug maker Aurobindo Pharma Ltd has formed an equal partnership with OJSC Diod a Russian maker of healthcare equipment and nutrition supplements to manufacture and market generic or off patent drugs taking advantage of changes in Russias public healthcare policy that seek to make that country less dependent on imports.

Macleods Novartis settle drug patent row

Soma Das — 8-Sep-2011

One of the fastest growing Indian drug makers Macleods Pharma has settled a patent dispute with Swiss pharma giant Novartis over the herpes drug Famvir Famciclovir in the US.

Trexime patent: Dr Reddys files appeal in US court

Our Bureau — 8-Sep-2011

Pharma major Dr Reddys Laboratories Ltd has filed an appeal in the district court of Texas in a patent infringement case with Pozen Inc on the generic version of Trexime sumatriptan naproxen sodium.

Ranbaxy Laboratories to roll out Lipitor Clone in US on Nov 30

ET Bureau — 09-Sep-2011

Ranbaxy Laboratories rose more than 4% after a top company executive said the drugmaker is on track to launch a low cost version of the worlds largest selling drug Lipitor in the United States.

Banarasi saree glitters in new found demand

Binay Singh — 10-Sep-2011

The benefits of Geographical Indication certification have thus started showing for the handloom industry of this region.

Is the Google Motorola deal helping Microsoft?

BALAJI NARASIMHAN — 12-Sep-2011

The search giant acquired Motorola for patents but if it doesnt move carefully the play may help its competitor more than itself

Ciplas margin focus likely to yield benefits in the long term

Ravi Ananthanarayanan — 12-Sep-2011

The triggers for this change are fewer blockbuster products in the global research pipeline patent expiry of blockbuster products and a sluggish developed world economy.

Guj share in total Indian patents filed is 0.9%

Jitendra Dave, DNA — 12-Sep-2011

For a state that often boasts of its entrepreneurial spirit Gujarat lags behind others when it comes to research innovation and protecting innovations.

India EU free trade talks resume today

Nayanima Basu / New Delhi — 12-Sep-2011

India and the European Union are resuming talks on a free trade agreement from tomorrow.

Wockhardt sees big opportunity in off patent drugs

Press Trust of India / Mumbai — 12-Sep-2011

Troubled pharma player Wockhardt today said it sees huge opportunity in off patent medicines over the next few years.

Govt not properly briefed on Glivec patent suit: Drugmakers

Khomba Singh — 13-Sep-2011

The case was scheduled to resume hearing on September 6 but has been postponed after one of the judges recused himself from the case.

Novartis executive to join Gates foundation

Andrew Jack in London — 13-Sep-2011

The decision is likely to herald fresh support for the drug companies commitment to tough intellectual property laws and support further Gates funding of their research including for Novartis which is already one of the most active in researching drugs and vaccines for diseases of the developing world.

Bharat Biotech in strategic play with Rotovac vaccine

Viswanath Pilla — 14-Sep-2011

The company which has 47 global product patents ploughs back 30% of its revenues into R&D.

Singing a different tune

Ratnottama Sengupta — 15-Sep-2011

While this comes as relief to the rights owners producers and music companies lyricists and composers are hoping that the amendment to the Copyright Act of 1957 will retain their rights as first owners.

Google AOL Others Sued For Infringing Old Lycos Patents

Eric Savitz — 15-Sep-2011

And the great patent wars roll on.

Patiala prof gets copyright for his Hindi to Punjabi software

Jasneet Bindra — 15-Sep-2011

The copyright has been granted after more than a year by the Ministry of Human Resources and Developments Copyright Registrar office.

Patent distribution should be transparent Chandy

PTI — 15-Sep-2011

Kerala Chief Minister Oommen Chandy today said there should be a transparent mechanism to distribute patents developed by research institutions under government run institutions.

Desi cos to gain as Big Pharma goes generic

Rupali Mukherjee — 15-Sep-2011

Faced with losses once its blockbusters start losing patents Big Pharma is now devising strategies to counter the impact.

Apple cant take away our leadership in India Samsung

Pankaj Doval — 16-Sep-2011

Samsung and Apple may be embroiled in numerous patent suits across the globe but the Korean consumer electronics gianta has said it has a clear edge in India and will retain its stronghold due to its wider reach and product portfolio and stronger brand profile.

India rejects Wests criticism of trade policy

PTI — 16-Sep-2011

India today rejected the criticism of its trade policy especially by the US at the WTO and asked the members to judge the country by what it has done over the years.

Apple Microsoft fear: Google buys 1023 IBM patents

AFP — 16-Sep-2011

Google confirmed that it has added 1023 more IBM patents to its technology arsenal to fend off legal attacks by rivals such as Apple and Microsoft.

Wockhardt Danone deal gets CCI nod

Joe C Mathew / New Delhi — 17-Sep-2011

The agreement also involves transfer of nutrition related intellectual property owned by Wockhardt EU a wholly owned subsidiary that holds intellectual property rights for Wockhardt Group businesses including pharmaceuticals and healthcare.

Patent issues lack of commitment risk Hulu sale

Reuters — 17-Sep-2011

The auction of online video site Hulu has been slowed by recent developments which could derail it completely according to sources familiar with the process.

GNA Patent Gurukul to conduct seminar on ‘current pharma patent regulatory opportunities and challenges in Europe’

Our Bureau, Mumbai — 17-Sep-2011

GNA Patent Gurukul will be organising a one day seminar on current pharma patent regulatory opportunities and challenges in Europe on October 13 at IDMA Mumbai.

Indian generic drug firms pharma MNC patent fight to determine price of medicines

Khomba Singh — 18-Sep-2011

Last month former Solicitor General Gopal Subramanium launched an impassioned argument in the Supreme Court against the rejection of a patent to Glivec a leukemia drug made by pharma MNC Novartis.

Bristol Myers to launch critical drugs in India

Joe C Mathew / New Delhi — 18-Sep-2011

BMS had reentered India in 2004 after the country changed its patent laws to recognise product patents.

Evolution of IP valuation

D. Murali — 19-Sep-2011

Within the semi conductor industry a lot of patent wars and acquisitions have been fought and survived reminds Anu.

US terms telecom IT procurement policy against WTO guidelines

Surajeet Das Gupta / New Delhi — 19-Sep-2011

The American government has challenged the protection given to domestic manufacturers by the Indian government in the areas of information technology and telecom as breaching World Trade Organisation rules.

Sanofi wins U.S. cancer drug patent ruling

Elena Berton — 19-Sep-2011

French drugmaker Sanofi has scored an important victory in a patent dispute with Sun Pharmaceuticals that will keep generic copies of its Eloxatin colon cancer drug off the United States market until August 2012.

US court rules against Sun Pharma over cancer drug

PTI — 19-Sep-2011

French drugmaker Sanofi today said a US court has ruled in its favour in a patent litigation against Sun Pharmaceuticals over Eloxatin oxaliplatin a drug used to treat colon cancer.

China India making inroads in biotech drugs

Gardiner Harris — 19-Sep-2011

Already the Obama administration has been trying to stop an effort by poorer nations to strike a new international bargain that would allow them to get around patent rights and import cheaper Indian and Chinese knock off drugs for cancer and other diseases as they did to fight Aids.

Godrej Consumer Products wins case against a cybersquatter

ET Bureau — 19-Sep-2011

Godrej proved that the domain name registered by US based cybersquatter Chris Peri of Illinois was identical to its trademark and misleading the statement said.

Patent trolls cost inventors half a trillion dollars

David Goldman — 21-Sep-2011

Patent trolls companies that license patents but do not actually sell anything have long been looked on with fiery scorn in Silicon Valley.

Sun Pharma resolves US units regulatory concerns

P. T Jyothi Datta — 19-Sep-2011

Co loses patent case to Sanofi on colon cancer drug

Lupin enters oral contraceptives market in the US

Our Bureau — 20-Sep-2011

A couple of the OC filings would be patent challenges, he said

Samsung eyes iPhone 5 legal action

Song Jung-a in Seoul — 21-Sep-2011

Samsung Electronics is considering a legal move to block sales of Apple s long awaited iPhone 5 in some countries as the patent battle between the two technology companies steps up a gear.

Sharma writes to PM on pharma M&A concerns

Asit Ranjan Mishra — 21-Sep-2011

The Indian generic pharma industry has in recent years posed a major challenge to the MNCs through production and export of low cost high quality medicines as well as patent challenges.

China and India making inroads into biotech drugs

Gardiner Harris — 21-Sep-2011

This could not only transform the care of patients in much of the world but also ignite a counterattack by major pharmaceutical companies and richer countries.

DuPont unit accuses Kaveri of gene piracy

C.H. Unnikrishnan — 21-Sep-2011

Pioneer Overseas Corp. has accused Hyderabad based Kaveri Seeds of copying the gene structure of a variety of corn developed by the Iowa US based firm.

Bionic boon for the blind

Durgesh Nandan Jha — 22-Sep-2011

He holds the patent for the device along with his colleagues.

Google Oracle patent talk makes slow progress

Bloomberg — 22-Sep-2011

Google and Oracles chief executive officers made little headway this week in negotiations aimed at resolving a lawsuit accusing the Web search company of patent infringement a person briefed on the talks said.

Why the world may prefer India to China

Bala V Balachandran — 22-Sep-2011

Although the rate of patenting has been slow in India it hasnt led to unhindered copying of intellectual property.

Speedy Singhs gets copyright protection

Swati Deshpande — 22-Sep-2011

The producers of the yet to be released Bollywood movie Speedy Singhs starring Akshay Kumar has landed a speedy relief even before any legal trouble can brew over copyright.

Eli Lilly scouting for partner to market oncology drugs

KV Ramana — 22-Sep-2011

There are several products that would go off patent and we are working on them.

US patents from MNCs have shot up while those filed by Indian companies and institutions are declining

Hari Pulakkat — 22-Sep-2011

With a global R&D budget of $6 billion it is no surprise that IBM is the worlds largest patent generator.

Ind Swift set to tap global generic opportunity

Our Bureau — 23-Sep-2011

Patents are set to see their patents expire in the US over the next four years opening up an opportunity of about $ 99 billion.

Samsung to step up Apple patent war

Associated Press — 24-Sep-2011

A top Samsung executive says the company will take a bolder stance in its patent battle with smartphone and tablet rival Apple which Samsung claims has been free riding on its patented wireless technologies.

French Cognac gets GI status

Daniel P George — 24-Sep-2011

The Geographical Indications Registry office in Chennai on Tuesday granted the French Cognac geographical indication status along with Villianur Teracotta Works and Tirukanur Papier Mache Craft both handicrafts from Puducherry.

R&D expenditure of 30 cos soars by 19% to Rs.3770 cr in 2011 with no new molecules yet

Sanjay Pingle, Mumbai — 26-Sep-2011

The Indian majors like Dr Reddys Labs Lupin Glenmark Pharmaceutical Aurobindo Pharma and Sun Pharma received higher approvals for ANDAs from US FDA during the first 8 months of 2011.

India EU trade talks high on Agenda

Pallavi Aiyar & Nayanima Basu / Brussels/ New Delhi — 26-Sep-2011

According to the agenda, apart from tariffs on wines and spirits and automobiles there are wide gaps on intellectual property rights IPR specifically issues related to geographical indications liberalisation of services and government procurement.

EU agrees for ambitious comprehensive pact with India

PTI — 26-Sep-2011

But India and the EU have been at odds over intellectual property rights in patent areas involving life saving generic HIV AIDS drugs and other medicines which are produced by Indian companies it added.

India Generics Companies Lead Pharmaceutical Innovation in Asia Pacific According to Thomson Reuters

EDT — 26-Sep-2011

The change in approach is highlighted by the 72 percent increase in the number of Paragraph IV patent challenges raised by Indian companies between 2009 and 2010.

Dr Reddys calls off deal to buy JBCPLs Russia business

Viswanath Pilla — 27-Sep-2011

The changes will result in cost savings in government procurement of drugs and make medicines more affordable by giving consumers access to generics that are cheaper than patented drugs.

Dr Reddys Laboratories abandons deal to buy JB Chemicals brands in Russia CIS

ET Bureau — 27-Sep-2011

Indian pharmaceutical firm Dr Reddys Laboratories called off a deal to acquire prescription portfolio of JB Chemicals and Pharmaceuticals in Russia owing to differences over valuation and other operational issues a senior company official said.

CCI should clear pharma M&As

Joe C Mathew & Nayanima Basu / New Delhi — 27-Sep-2011

The committee is also of the view that India must desist from any move to dilute the public interest clauses enshrined in the patent law.

Patent tribunals admission places question mark against tribunals

C.H. Unnikrishnan — 27-Sep-2011

The case filed by P PIL questioned the independence of Ipab on the grounds that it was in violation of the constitutional separation of powers doctrin

India to be among top 10 pharma markets by 2015: E&Y

PTI — 27-Sep-2011

Emerging markets India and China will figure in the top 10 pharma markets of the world by 2015 an Ernst & Young report has said.

Europe threatens to break off India free trade talks

AFP — 27-Sep-2011

But India and the EU have already been at odds over intellectual property rights involving life saving generic HIV AIDS drugs and other medicines which are produced by Indian companies.

Microsoft Samsung Patent Deal: Great News for Windows Phones

Jared Newman — 28-Sep-2011

The success of Samsungs Galaxy S Android phones just became a cash cow for Microsoft thanks to a patent cross licensing agreement in which Microsoft gets paid for every Android phone or tablet Samsung sells.

Patent office to examine conflict between WIPO guidelines and Patents Act

Hary M. Pillai — 28-Sep-2011

The Delhi High Court recently remanded back to the Controller General of Patents Designs Trademarks and Geographical Indication a petition in which the court felt existed a conflict between the WIPO Guidelines and the Patents Act and Rules.

GSK open to acquiring reasonably priced company: GSK open to acquiring reasonably priced company: Andrew Witty CEO

ET Bureau — 28-Sep-2011

And as these companies stare at their expiring patents emerging markets can no longer be ignored.

Glenmark Pharma launches anti malaria drug in the US

Reuters — 28-Sep-2011

The Indian drugmaker had settled a patent litigation with GlaxoSmithKline in April 2010, which allows Glenmark to launch the generic tablets in the US on royalty bearing licence in the third quarter of calendar year 2011.

Samsung seeks Dutch ban on 3G iPhone iPad

Roberta Cowan , Reuters — 28-Sep-2011

Samsung Electronics Co and Apple Inc fought the latest battle of their patent wars on Monday when the Korean firm urged a Dutch court to ban Apples iPads and iPhones in the Netherlands

Mosaid: Google is $11m patent buyer

Reuters — 29-Sep-2011

Canadian patent licensing company Mosaid has named Google as the buyer of five non strategic patent families it said it had sold two week ago for $11 million.

Govt buries plan to empower CCI on IPR disclosures

Vikas Dhoot — 29-Sep-2011

In a major reprieve for innovation led firms in India the government has quietly dropped a controversial plan to empower the competition regulator to make intellectual property rights holders share their knowledge with competitors in specific circumstances.

Microsoft Samsung to share mobile patents

Bloomberg — 29-Sep-2011

Microsoft Corp the software maker seeking to challenge Apple Inc and Google Incs dominance in smartphones agreed to share patents with handset maker Samsung Electronics Co.

Bitter pill for Big Pharma

Bhupesh Bhandari / New Delhi — 30-Sep-2011

There is evidence IPA Secretary General D G Shah says that Indian companies that got acquired by Big Pharma have scaled down their patent challenges in the West.

Intellectual property laws in India suck: Rick Goings Tupperware

Ratna Bhushan & Bhanu PandeRatna Bhushan & Bhanu Pande — 30-Sep-2011

One thing that irks Goings about the country however is its intellectual property rights laws.

Drug makers seek sops to crack off patent opportunity

KV Ramana — 1-Oct-2011

The much hyped off patent opportunity worth $30 40 billion is likely to remain a tough nut to crack for the Indian pharmaceutical industry considering the roadblocks in the form of insufficient infrastructure and lack of proper policy framework at the government level.

Khadi cloth still not protected by IPR

Our Bureau — 1-Oct-2011

Did you know that the popular Darjeeling tea Tirupathi laddu Kancheepuram Silk saree Pochampalli Ikat and basmati rice are all protected under the Geographical Indications but the Khadi cloth is yet to get protected in India?

For pharma MNCs India is an effective pill not a placebo

D. SAMPATHKUMAR — 02-Oct-2011

The strategic environment has got murkier for pharma MNCs with fairly new drugs working for fewer people and litigation problems to contend with too.

Branded generics strategy important to drive growth

Viswanath Pilla & Namrata Nandakumar — 3-Oct-2011

So most of them are facing the prospect of large revenue producing products coming off patent facing generics competition and at the same time their late stage pipelines are not adequate to fill the revenue yet.

Kodak weighs options to clear path for sale

TNN — 3-Oct-2011

Eastman Kodak Co the unprofitable 131 year old camera maker is weighing options including a bankruptcy filing because of concerns raised by possible buyers of its patent portfolio said three people with direct knowledge of the process.

National Pharmaceutical Pricing Authority may get power to verify landed cost of drugs

Khomba Singh — 3-Oct-2011

The drug price watchdog may get powers to verify landed cost of drugs that are under its control.

India looking to conclude FTA with EU this year: Anand Sharma

PTI — 04-Oct-2011

India today said it is looking to conclude the proposed comprehensive free trade pact with the European Union this year as the negotiations are in advanced stage with the 27 nation bloc.

Sanofis acquired companies to retain local indentity

C. H. Unnikrishnan — 5-Oct-2011

Sanofi has undergone an impressive transformation over the last two and a half years and it had already put the bigger threat of patent expiry of some of its blockbuster drugs in the US and other key markets in the past he said

Hyderabadi biryani looks for GI tag

TNN — 5-Oct-2011

Well the much relished dish is likely to get a Geographical Indication GI status soon that will have a logo or hologram to assure foodies that its the original Hyderabadi biryani laid out on the plate.

MSF contends Novartis plea that case against sec 3d will not impact access to medicines

Ramesh Shankar, Mumbai — 7-Oct-2011

On Novartis statement that Section 3d as it relates to evergreening is not applicable at all to Glivec the MSF countered that Novartis is seeking a patent in India on the salt form of imatinib Glivec.

Government moves to overhaul patent regime

HT Correspondent — 07-Oct-2011

The government has invited comments from the public on reviewing the organisational structure of the office of the controller general of patents designs trademarks and geographical indications CGPDTM to make it more responsive to the needs of Intellectual Property holders and users while enhancing the effectiveness and efficiency of its operations.

Patent and Trademarks may be split into separate entities

PTI — 7-Oct-2011

With a pileup of over 4.40 lakh applications for trademarks and 76000 for patents the government is mulling separate establishments for handling the claims for the two key Intellectual Property Rights IPRs.

DIPP moves note on making patents office independent

ET Bureau — 8-Oct-2011

Indias intellectual property office overseeing patents and trademarks should be granted autonomy to make it more responsive and effective a government department has suggested.

The murky world of intellectual property

C.GOPINATH — 09-Oct-2011

Patents are bought and sold through layers of shell companies and people will not talk for fear of being dragged to court.

India pitches for including IPR equitable access in climate talks

fe Bureau — 11-Oct-2011

Taking a hard stance for the coming climate talks in Durban this December the government has submitted a proposal to the secretariat of the United Nations Framework Convention on Climate Change to include three contentious issues of unilateral trade measures intellectual property rights and equitable access to sustainable development for inclusion in the talks’ provisional agenda.

India to retain 100% foreign pharma investment

Lynne Taylor — 11-Oct-2011

India will continue to permit 100% foreign direct investment in new pharmaceutical industry projects but foreign takeovers of Indian drugmakers will come under tighter scrutiny the cabinet agreed yesterday.

Pharma acquisitions to be routed through CCI

Special Correspondent — 11-Oct-2011

Move after concerns raised over acquisitions of Indian pharma companies by multinationals

Investors to lose from changes in pharmaceutical FDI policy

Ravi Ananthanarayanan — 11-Oct-2011

They are launching off patent drugs expanding their field force entering new product categories and markets and even going to rural markets.

Aurobindo first major generic drugs maker to tap into Patent Pool

P.T. Jyothi Datta — 11-Oct-2011

Generic drugs maker Aurobindo Pharma Ltd has signed an agreement with the global Medicines Patent Pool for the manufacture of several antiretroviral medicines making it one of the first major generic companies to tap into the patent pool.

Aurobindo Pharma gets royalty free licence for AIDS drug

Joe C Mathew / New Delhi — 12-Oct-2011

Aurobindo Pharma has become the first major generic drug maker to gain royalty free production and supply rights for five AIDS medicines through an agreement with Geneva based Medicines Patent Pool.

Pharma brand launches in local market dips

Khomba Singh — 12-Oct-2011

New brand launches in the local drug market have declined over the last few years as the number of original drugs going off patent has come down and as Indian companies look at new business models to boost sales and increase profits.

Dunlop India transferring trademarks to Ruia flagship

Aveek Datta — 13-Oct-2011

Dunlop India Ltd is transferring its rights to around 100 odd trademarks including Dunlop Falcon and Monotona to Ruia Sons Pvt. Ltd the flagship holding company of Pawan Kumar Ruia an entrepreneur who controls the beleaguered tyre maker.

Four growth drivers beyond patent for pharma companies like Sun Pharma Sanofi

Gauri Kamath — 13-Oct-2011

It is not just Big Pharma that has to prepare for life after the patent cliff patent expiries on a slew of blockbuster drugs.

Dangers of FDI in pharma

S. Srinivasan — 13-Oct-2011

No matter what the Maira panel would have us believe foreign pharma firms will continue to buy out low cost domestic manufacturers and raise prices.

Public interest groups call for moratorium on pacts by patent pool with Indian generic companies

Joseph Alexander, New Delhi — 13-Oct-2011

A host of public interest organisations have joined this coalition that has written to the UNITAID and the Medicine Patent Pool.

Apple must show valid patents in Samsung case: Judge

Reuters — 14-Oct-2011

A US judge said that Samsung Electronics Galaxy tablets infringe Apple Incs iPad patents but added that Apple has a problem establishing the validity of its patents in the latest courtroom face off between the technology giants.

US patent process may turn cheaper for pharma cos

G. Naga Sridhar — 14-Oct-2011

Indian pharma companies especially smaller ones can look forward to a cheaper patent filing and litigation process in the US.

US judge says Samsung tablets infringe Apple patents

Reuters — 17-Oct-2011

A US judge said Samsungs Galaxy tablets infringe Apples iPad patents but also that Apple might have a problem establishing the validity of its patents.

Samsung loses Dutch bid to ban Apple products

Reuters — 15-Oct-2011

A Dutch court on Friday turned down Samsung Electronics request for an injunction against all of Apples mobile products that use 3G telecommunications technology denying it revenge over a similar move by Apple.

Kodak to license over 1000 patents to Imax

AP — 17-Oct-2011

Eastman Kodak Co said that it will license thousands of patents to Imax in a deal that will supply the troubled photography company with millions of dollars.

Panel warns on pharma MNC demands

Soma Das — 18-Oct-2011

The committee acknowledges that prices of medicines have shot up in those countries where such IPR principles advocated by innovator pharma companies mostly from the US have been introduced.

After US Dr Reddys eyes Europe for Arixtra play

KV Ramana — 19-Oct-2011

Dr Reddys Laboratories is looking to take its limited competition candidate fondaparinux sodium generic Arixtra to the European market.

Pharma MNCs pills make Indian rivals sick

Ram Prasad Sahu / Mumbai — 19-Oct-2011

Severe price cuts help multinationals ramp up growth gain market share.

How to register a trademark?

Edlyn G D\'Souza — 19-Oct-2011

If youre starting a new business or trade a logo name or signature is the first thing you choose to separate yourself from the rest.

Ra.One copyright issue heats up HC reserves order

DNA Correspondent — 21-Oct-2011

Thus we moved the single bench of the high court which rejected our claim on October 12 and thus we moved an appeal.

BlackBerry maker accused of infringing BBX trademark

Pav Jordan and Alastair Sharp — 21-Oct-2011

BBX the operating system that Research In Motion is counting on to revive its floundering BlackBerry franchise has run into trouble even before the company could install the system in its smartphone line.

Health groups ask govt to issue compulsory licenses to make HCV drugs affordable

Our Bureau, Mumbai — 22-Oct-2011

A group of health activists in the country demanded to the government to either reject the patents given to Hepatitis drugs or to issue compulsory licensing to make these drugs accessible to the common people as Hepatitis C virus is emerging as a growing public health threat in India.

Desi Boyz title in copyright violation row

Rosy Sequeira — 25-Oct-2011

A scriptwriter has moved the Bombay high court alleging copyright violation in the title of the Akshay Kumar John Abraham starrer Desi Boyz which is slated for release next month .

Tide Water buys rights to Veedol trademark

Manish Basu — 25-Oct-2011

Tide can now expand Veedol sales across the world after buying trademark rights from BP.

Apple wins slide to unlock patent

Joe Aimonetti — 25-Oct-2011

Many of the patent applications and grants we come across involving Apple relate to theoretical products that may never see the light of day.

Govt to give fin support to develop Intellectual Prop Rights

PTI — 25-Oct-2011

The government will provide financial support to educational institutes and industry associations for conducting programmes to create awareness on Intellectual Property Rights.

Dr Reddys to push complex products, increase R&D spend

KV Ramana — 26-Oct-2011

We do not want to limit ourselves just to the opportunities coming up through patent expiries.

Darjeeling tea gets EUs protected tag

TNN — 27-Oct-2011

The European Union EU has registered Indias Darjeeling tea with a Protected Geographical Indication.

Lupin gets USFDA nod for oral contraceptive tablets

PTI — 28-Oct-2011

The approval for generic version of LoSeasonique tablets is the third approval for the Mumbai headquartered firm in the oral contraceptives portfolio.

Copyright issue: Hearing on Desiboyz adjourned

PTI — 28-Oct-2011

The lawyer of the Bollywood director Rohit Dhawan today told the Bombay High Court that he would file reply to the petition by a Latur based script writer claiming copyright on the title and the story of the Dhawans upcoming film Desiboyz.

Civil society groups ask WHO members to drop IMPACT avoid counterfeit term

Joseph Alexander, New Delhi — 31-Oct-2011

The term Counterfeit is defined by the WTO TRIPS Agreement as referring to a specific category of trademark violation1 and in some legislation to all other intellectual property violations as well.

Can Kodak rescue itself via a patent bonanza?

Associated Press — 31-Oct-2011

Kodak the company that invented the first digital camera in 1975 and developed the photo technology inside most cellphones and digital devices is in the midst of the worst crisis in its 131 year history.

Piramals US arm settles case with Baxter on inhaled anesthetic agent

Our Bureau — 01-Nov-2011

Suprane is Baxters product of Desflurane an anesthetic agent typically used in hospital settings.

Pharma sector unlikely to sustain current premium over Sensex

Nirmal Bang — 02-Nov-2011

We believe the international growth drivers led by the US generics market which is in a multi year cyclical upturn given the impending patent cliff and emerging markets owing to favourable demographics and similarity with the domestic market still hold and would partially cushion any erosion in PE multiple.

Investors want to see Kodaks cash

Reuters — 02-Nov-2011

Wall Street will be focused on how much cash Eastman Kodak has left on its balance sheet along with hints of progress on a multibillion dollar patent sale when

Bitter row over Agras trademark sweet

IANS — 02-Nov-2011

No trip to Agra is complete without two essentials a glimpse of the Taj Mahal and a sampling of the famous Agra ka petha.

Sanofi battles through patent expiries restructuring looms

Kevin Grogan — 03-Nov-2011

Sanofi has posted financials for the third quarter this morning which show that net profit slipped 3.0% to 2.40 billion euros while sales edged up 5.0% to 8.75 billion euros.

Kodak may need patent sale new debt to survive

Liana B. Baker — 4-Nov-2011

Eastman Kodak Co spooked investors on Thursday by warning it may need to raise new debt or complete a multibillion dollar patent sale to survive the next 12 months sinking shares by as much as 11.7 percent.

Ranbaxys plan for Lipitor fuels speculation

Joe C Mathew / New Delhi — 4-Nov-2011

With hardly four weeks for patent expiry of the worlds largest revenue earning drug Lipitor in the US speculation is rife as to how Ranbaxy will exploit this.

Apple Samsung patent battle worries Brussels

Alex Barker in Brussels and Richard Waters in San Francisco — 04-Nov-2011

Europes competition watchdog is investigating the increasingly aggressive legal tactics being used in Samsungs patent battle with Apple in what could pave the way for an in depth antitrust probe into the hotly contested intellectual property agreements that underpin the smartphone technology market.

Strong policy support, incentives are better option to pharma sector than FDI cap: Dr G G Nair

Suja Nair Shirodkar, Mumbai — 5-Nov-2011

Pharma industry wants the government to give more incentives to this sector so that it would not be forced to look at the foreign direct investment route for growth.

Cadbury secures favourable HC order in trademark case

PTI — 06-Nov-2011

Cadbury India Ltd the domestic arm of U.S. confectionery major Kraft Foods Inc has secured a relief from the Delhi High Court which restrained a local garment manufacturer from promoting its apparel under the phonetically identical trademark Cadbeery.

Kodak could run out of US cash in 12 without help - Moodys

Liana B. Baker — 07-Nov-2011

Without an infusion of cash from a sale of patents or some hundreds of millions of dollars in additional financing Eastman Kodak Co would run out of cash in the U.S. in 2012 according to a research note published on Monday by the credit agency Moodys.

Partnership is the new norm in pharma sector

Joe C Mathew / New Delhi — 7-Nov-2011

Eight years earlier Ranbaxy the countrys largest drug company created a stir by challenging the patent on the worlds highest revenue earning medicine Lipitor in the US.

DIPP amends FDI policy on options in equity instruments by deleting Clause 3.3.2.1

Suja Nair Shirodkar, Mumbai — 7-Nov-2011

According to Dr Gopakumar G Nair intellectual property and patent and trade mark attorney the real strength of India over the years have been a strong autonomous and non corrupt RBI.

Mango Mazaa producer barred from branding it after Maaza

PTI — 07-Nov-2011

An Indian soft drink producer has been restrained by the Delhi High Court from naming its product as Mango Mazaa deceptively similar to multinational Coca Colas mango flavoured drink Maaza.

Google accuses Microsoft of abusing patents system

ANI — 08-Nov-2011

A Google lawyer has accused software giant Microsoft of abusing the patent system by using them only its products stop succeeding.

Huawei in Android patent talks with Microsoft

ANI — 08-Nov-2011

Chinas leading telecom company Huawei has confirmed that it is in talks with Microsoft over the use of Android software.

Ranbaxy Labs posts loss of Rs.465 crore

Kaustubh Kulkarni/Reuters — 10-Nov-2011

Lipitors patent protection expires 30 November after which two new versions of the drug are expected to be sold by Ranbaxy and Watson Pharmaceuticals.

Gulf turmoil hit Indian tea exports

Mithun Dasgupta — 13-Nov-2011

But there is some good news for exporters of Darjeeling tea with the European Union registering the product as a Protected Geographical Indication which aims to protect product names from misuse and imitation.

Utility patenting: Indias next move?

C.H. Unnikrishnan — 14-Nov-2011

The patent model suggests less stringent intellectual property protection to support incremental research

India can boast of a healthy patent pipeline

Our Bureau — 14-Nov-2011

System to access patent information on cards

Intellectual property protection is key for investment in India

Surabhi Agarwal — 15-Nov-2011

Is the lack of a strong regime on software piracy and intellectual property hurting the Indian information technology industry in terms of attracting business?

Look out! Here comes Apples killer location services patent

Erik Sherman — 16-Nov-2011

Apple has raised bludgeoning competitors with patents on key technologies to a fine art.

Pharma brand launches slump this year

Ram Prasad Sahu / Mumbai — 16-Nov-2011

The number of new molecules companies could target have come down and drug firms are careful of new launches due to patent regime restrictions.

Coimbatore man applies for patent to 20 varieties of idlis

Kumar Chellappan — 16-Nov-2011

If variety is the spice of life then nobody other than Kovai Iniyavan of Coimbatore has truly lived upto the adage.

Bayer to bring innovative products into India

Our Bureau — 16-Nov-2011

Germany headquartered Bayer AG is committed to bringing more products into India said Chairman Dr Marijn Dekkers even as he underlined the need to protect intellectual property rights in the country.

Music industry to crackdown on copyright violations in Goa

IANS — 17-Nov-2011

A music copyright vigilante authority has threatened to launch Halla Bol along Goas coastal belt known for its music blaring beach shacks scorching raves and techno night party hang outs this year even as the tourist season is all set to begin in a few days.

Now Hyderabad patent to auto meter tampering

Rahul Devulapalli — 17-Nov-2011

In the city your auto fare could vary depending on the brand of clothes you wear and not according to the rates on the fare chart issued by the Road Transport Authority.

US oral contraceptive mkt draws Indian pharma

Reghu Balakrishnan / Mumbai — 17-Nov-2011

Indian pharmaceutical companies which always wanted a big share in the global copycat drug market are betting high on the oral contraceptive market in America.

Lupin set to buy Japanese firm I\'rom Pharma

Our Bureau — 17-Nov-2011

Country is worlds second largest individual drugs market

Microsoft seeks patent on employee spy system

Iain Thomson in San Francisco — 18-Nov-2011

Microsoft has filed a patent for a system that monitors the behavior of employees via computers phone calls and physical gestures and alerts human resources if anyone is behaving outside of preferred norms.

Zydus Cadila faces patent suit in US over drug Asocol

ET Bureau — 18-Nov-2011

US based Warner Chilcott Plc has moved court against Zydus Cadilas plan to produce a bowel inflammation drug Asocol.

India EU finalise give & take in FTA

Nayanima Basu / New Delhi — 22-Nov-2011

Negotiations for the ambitious India EU free trade agreement is on in full steam and in the final stages of give and take even as the euro zone crisis has gripped all its 27 member countries.

Abbott Dabur GSK eye Jagdales energy drinks biz

Boby Kurian & Reeba Zachariah — 23-Nov-2011

The brand a patented fruit-based electrolyte drink competes in the broader energy drinks segment that include players like Gatorade from PepsiCo.

DoP looks to speed up functioning of panel on patented drug pricing ahead of pharma policy

Joseph Alexander, New Delhi — 23-Nov-2011

After toying with the idea of fixing the prices of patented drugs through negotiations before marketing them in the country for nearly five years the Department of Pharmaceuticals now wants to speed up the working of the expert committee set up to suggest a mechanism in this regard.

Betting on innovation

T S Vishwanath — 24-Nov-2011

A recent report by the World Intellectual Property Rights The Changing Face of Innovation provides some interesting insights to answer this question.

Pfizer fights to retain Lipitor market share

Divya Rajagopal — 24-Nov-2011

Pfizer has offered to deliver Lipitor at a cut price of $4 directly to patients in its fight to retain market share of the worlds largest selling drug just days before the US patent for the medicine is due to expire.

MNC monopoly mars critical drugs

Joe C Mathew / New Delhi — 25-Nov-2011

Study says formulation for some critical ailments enormously priced.

Bayer withdraws writ petition against Natco

C.H. Unnikrishnan — 25-Nov-2011

In a new twist to the ongoing legal battle between German drug multinational Bayer Healthcare AG and Hyderabad based cancer drug maker Natco Pharma Ltd over the compulsory licensing of Bayers cancer drug Nexavar the Delhi high court last week dismissed the foreign companys writ petition as withdrawn.

THE END OF LIPITOR

P A francis — 25-Nov-2011

Worlds top pharmaceutical company Pfizer Inc.stands to lose patent rights for its largest selling drug Lipitor in the US on November 30.

PU claims breakthrough in anti ageing research

Ritu Sharma — 27-Nov-2011

For this formulation and research it has already applied for patents with the Indian Patent Application.

Patent firm IPCom says to stop HTC German sales

Reuters — 28-Nov-2011

German patent firm IPCom plans to halt as quickly as possible the sale of all HTC smartphones in Germany another blow to the Taiwanese firm just two days after it shocked markets by cutting its fourth quarter outlook.

Supreme Court to hear Novartis case on Section 3(d) of Indian patent law on Nov 29

Ramesh Shankar, Mumbai — 28-Nov-2011

The next hearing of Novartis vs Union of India case in Supreme Court regarding interpretation on Section 3(d) of the Indian patent law will be held on November 29 2011.

Higher US drug sales pep up revenue show

Ram Prasad Sahu / Mumbai — 28-Nov-2011

Going ahead growth is likely to be sustained due to the upcoming launches of cholesterol lowering drug Lipitor and anti psychotic medicine Geodon among others.

Apple wins patent for intelligent dock connector

Joe Aimonetti — 29-Nov-2011

Apple has just been granted a patent that details an intelligent dock connector able to properly adjust power levels for multiple connected devices from a single outlet source.

Supreme Court set to hear plea on patents

Menaka Rao — 28-Nov-2011

The Supreme Court will start hearing in a case that could decide the cost of treating HIV Aids in the country.

Copyright society moves HC against govt circular

DNA Correspondent — 29-Nov-2011

A non government organisation with over 2500 members which is the sole copyright society in India has moved the Bombay High Court challenging the circular issued by the state de recognised the society and directing auditoriums not to pay its fees.

Samsung wins appeal in Apple tablet battle

AFP — 30-Nov-2011

The Federal Court granted an interim order against the sale of the Galaxy 10.1 in October ruling that Apple had established a prima facie case that the South Korean company had breached touchscreen technology copyrights.

Lipitor goes off patent today Pfizer vs Ranbaxy led Indian pharmas war for blockbuster drugs intensifies

Divya Rajagopal — 30-Nov-2011

Indian pharma companies quest to make millions from the sale of copycat versions of blockbuster drugs may turn out to be a flop show as innovative companies raise defences to protect their turf.

Ranbaxy gets USFDA approval for generic Lipitor

PTI — 01-Dec-2011

Ranbaxy and Pfizer had settled all of their litigations worldwide over the Lipitor patent in 2008.

Samsung scores win in patent case

Reuters — 1-Dec-2011

Samsung Electronics is set to resume selling its Galaxy tablet computer in Australia as early as Friday after the South Korean technology firm won a rare legal victory in a long running global patent war with Apple.

Civil society groups hold protest demonstration in Mumbai against Novartis

Our Bureau, Mumbai — 1-Dec-2011

Novartis has taken the Indian government to the Supreme Court challenging the legal interpretation of a critical public health safeguard in the countrys patent law Section 3d that principally limits the patenting of new uses and new forms of old medicines in India.

Jets patent challenge against Virgin dismissed

P.R. Sanjai & C.H. Unnikrishnan — 01-Dec-2011

The British carrier can now get the design and technology for its upper class seats patented in India

US patents: Ittiam Systems has more than twice that of Infosys

Hari Pulakkat — 1-Dec-2011

Ittiam has an impressive pipeline of 60 patent applications pending for approval.

AU faculty to patent six compounds against HIV

Rajiv Mani — 1-Dec-2011

In a major breakthrough against the dreaded AIDS virus a young faculty from department of Chemistry Allahabad University along with scientists from National AIDS Research Institute Pune would soon be patenting six new compounds that have proved patent against the dreaded AIDS spreading HIV.

Apple vs Samsung suit full of secret combat

Dan Levine and Carlyn Kolker — 02-Dec-2011

The biggest legal battle for the technology industry is playing out in a federal court in Silicon Valley where Apple is trying to stop Samsung from selling Galaxy phones and tablets in the United States.

NGOs experts to hold national consultation on generic drug production and challenges

Joseph Alexander, New Delhi — 02-Dec-2011

A number of public interest groups and health activists will hold a two day national consultation here from December 6 on Generic drug production and access to medicines: Current challenges and prepare a roadmap to ensure affordability and accessibility of drugs in the country.

Ranbaxy hits US with Lipitor copy

C.H. Unnikrishnan & Namrata Nandakumar — 02-Dec-2011

Ranbaxy and Watson Pharmaceuticals Inc. are the two companies allowed to sell generic versions of Lipitor for now.

Indian yoga guru sues student for copying technique

Agencies — 02-Dec-2011

Kolkata born Bikram Choudhury is the founder of Bikram Yoga and has copyrighted his unique hot yoga classes.

Richcore Lifesciences launches first ever enzymatic clean technology Ecosol

Nandita Vijay, Bangalore — 3-Dec-2011

Richcore currently enjoys a little safety with its patents and first mover advantage in developing traction for its novel applications he said.

Oranges: India ranks 64th in productivity

06-Dec-2011

Coorg orange grown in the Kodagu Hassan and Chikmagalur districts of Karnataka is awarded Geographical Indication owing to its characteristics such as medium sized fairly tight skinned orange yellow fruits having dark orange pulp being tender juicy with a rich flavour and excellent blend of acid and sugar.

Elder Pharma to foray into Japanese market by FY12 end

Press Trust of India / New Delhi — 06-Dec-2011

Drug firm Elder Pharmaceuticals today said it planned to enter the Japanese pharma market during the current fiscal as it had received accreditation from the Japanese Ministry of Health for its Patalganga facility.

Amul sues Nestle for copying A+ brand

Ratna Bhushan — 06-Dec-2011

We own the rights to use a+ as a trademark and therefore do not see why anyone should object to our using it.

Bayer Indias Cipla settle trademark suit

Zeba Siddiqui in Bangalore — 7-Dec-2011

Bayer AGs healthcare unit said it settled trademark infringement cases with Indian drugmaker Cipla and Vanuatu based website operator Archipelago Suppliers concerning the German drugmakers pet products.

How policies can bypass Indias parliament

Alam Srinivas — 07-Dec-2011

The Congress led coalition pushed through critical amendments to the existing patents laws through an ordinance which was later passed by parliament with many amendments.

Expert calls to set up IPR cells at varsities

Jaideep Deogharia — 7-Dec-2011

Mesra has got seven patents BAU has obtained registration for four varieties of rice from the patent office.

Drug firms to gain from US patent expiries

Joe C Mathew / New Delhi — 7-Dec-2011

Lipitor like exclusivity awaits Indian drug companies as 46 patents expire in 2012-15.

India stands to gain from patent cliff

Shilpa Kannan — 8-Dec-2011

The patent cliff has begun.

Samsung wins round in long legal fight with Apple

Reuters — 09-Dec-2011

Samsung Electronics Co won a round of its bruising global patent fight with Apple Inc on Friday when an Australian court lifted a ban on the sale of its Galaxy tablet computer in time for the busy Christmas shopping season.

Eatery wins war to rid patent cover off low sugar sweet

TNN — 11-Dec-2011

A popular eatery chain in thecity haswon a patent war with an entrepreneur duo who had patented a lowsugar low glycemic preparation as their own and restrained the food chain from preparing similar delicacy.

NGO asks European Commission not to push India to accept IP provisions in EU India FTA

Ramesh Shankar, Mumbai — 12-Dec-2011

In a letter to to EC Commissioner for Trade Karel De Gucht the NGO DNP+ has expressed concern over the ECs alleged secret efforts to bring back intellectual property provisions like data exclusivity and investment provisions into the negotiations.

Kazaa creator sues Internet giants for patent infringement

ANI — 12-Dec-2011

A US based entrepreneur and a creator of file sharing application Kazaa Kevin Bermeister has sued several Internet giants including Google and YouTube for infringing their eight patents in their cloud computing products.

India still needs a WTO

Suman Bery — 13-Dec-2011

The Doha Round has been left behind but Indias trade requires a solid institutional structure

Madras HC dismisses Roche case against Intas

P.T. Jyothi Datta — 13-Dec-2011

Single sale of cancer drug by a retailer not authorised by Intas

Glenmark in legal row with Napo Pharma

Special Correspondent — 14-Dec-2011

It was a collaboration that would have resulted in a proud first for the Indian pharmaceutical industry but has landed in a legal tangle instead.

Hoffman La Roche loses patent suit against Matrix Pharmaceuticals

Divya Rajagopal — 14-Dec-2011

Swiss drug company Hoffman La Roche has lost a patent infringement suit against Matrix Pharmaceuticals to prohibit the Indian firm from selling its anti cancer drug Tarceva.

Investors seem to shrug off Glenmarks crofelemer dispute

Ravi Ananthanarayanan — 14-Dec-2011

Glenmarks performance is expected to benefit from growing contribution from generic product sales in the US market similar to that of other Indian firms targeting a number of drugs going off patent.

NEW POLICY & PATENTED DRUGS

P A Francis — 14-Dec-2011

After almost a decade of preparing notes and drafts officials in the Department of Pharmaceuticals could come out with a draft proposal for a new drug pricing policy last month.

HC order hits Dunlops brand transfer plan

Arnab Dutta & Manish Basu — 16-Dec-2011

Tyre maker Dunlop India Ltds plan to transfer its rights to 100 odd trademarks to private firms owned by its promoter Pawan Kumar Ruia has been nixed at least for the time being by a Calcutta high court order.

ITC to review ruling on HTC patent suit vs Apple

Reuters — 17-Dec-2011

The International Trade Commission said on Friday it will revisit in part a decision by an ITC administrative law judge who had found no violation by Apple of four HTC patents that include technologies for power management and phone dialing.

Chennai HC rejects Roches patent suit against Matrix in light of lack of jurisdiction

Our Bureau, Mumbai — 17-Dec-2011

Dr Gopakumar G Nair intellectual property and patent and trade mark attorney pointed out that under the recent judgement the HC held that Matrix by approaching the IPA Board Chennai did not give rise to a cause of action from Roche against Matrix as mere filing of an application for revocation in IPA Board Chennai cannot give rise to a cause of action especially since IPA Board has its headquarters at Chennai.

With new generic rivals Lipitors sales halved

LINDA A. JOHNSON — 19-Dec-2011

Two generic versions costing about a third less hit the market right away one made by Indias Ranbaxy Laboratories Ltd. and the other an authorized generic made by Pfizer and sold by its partner Watson Pharmaceuticals Inc.

Apple vs Samsung: Samsung files new claims

Reuters — 19-Dec-2011

Samsung Electronics has filed new claims in its patent war with Apple Inc over alleged patent infringements in Germany a spokesman for the company said on Monday.

BT sues Google in US over patent infringement

Reuters / London — 20-Dec-2011

British telecoms firm BT has launched legal action against Google in the United States over patent infringement in a number of key areas for the technology group such as mobile map services.

Kodak patent ruling delayed amid cash worries

AP — 20-Dec-2011

A US arbiter for trade disputes is delaying a ruling on Eastman Kodak Co.s high stakes patent infringement claim against smartphone makers Apple Inc. and Research in Motion Ltd.

Now Mysore Silk too will have fusion labels

Vinobha K T — 21-Dec-2011

KSIC which has obtained the geographical indication registration for Mysore silk in 2005 is the sole proprietor of the brand he said adding that traders merchants or unlicensed manufacturers are prohibited form using the brand name Mysore Silk he added.

Delhis Nehru Place among top 30 markets that violate IPR

Press Trust of India — 21-Dec-2011

An official US report has identified Nehru Place in New Delhi among the top 30 notorious IT markets of the world dealing in goods and services infringing intellectual property rights.

Apple wins patent row on some HTC phones

Bloomberg / Washington — 21-Dec-2011

Apple Inc won a patent infringement ruling that bans some HTC Corp smartphones from the US starting next year bolstering efforts to prove that devices running Google Incs Android operating system copy the iPhone.

Microsoft wins patent decision against Android

Bloomberg — 21-Dec-2011

Microsoft Corp won a ruling that Motorola Mobility Holdings Incs Android phones violate one of its smartphone patents while failing to convince a judge that six others are being infringed as well.

Pharmaceutical stocks to gain on depreciating rupee patents

21-Dec-2011

While the pharma sector has outperformed the broader market valuations have come off the peak

Android patent rulings signal trouble for Google

Bloomberg — 21-Dec-2011

Google Inc is facing potential setbacks in its efforts to get smartphone makers to stick with the Android operating system as legal rulings begin to roll in on patent infringement claims by Apple Inc and Microsoft Corp.

Ranbaxy Laboratories: Settlement takes away gains from Lipitor launch

Kiran Kabtta Somvanshi — 22-Dec-2011

Drug maker Ranbaxys fortunes have reversed swiftly with the cost of settlement with the USFDA almost wiping off the gains from the exclusive launch of Lipitor.

The health of nations

T S Vishwanath — 22-Dec-2011

Multilateral forums should address the fear that strong pharma patent protection can affect public health in developing countries

Negative factors economic slowdown seriously retard growth of Indian pharma: Dr MD Nair

Our Bureau, Bengaluru — 22-Dec-2011

Economic downturn reduced investments high costs of R&D and low productivity patent cliffs pressure on drug prices poor image of the industry and stricter regulatory controls have seriously affected the pharma sector pointed out Dr MD Nair pharma consultant.

Goan Fenny set to lose its odour for better status

PTI — 22-Dec-2011

Fenny which is usually brewed from cashew or coconut has already attained Geographical Indication status following a protracted struggle by its ardent supporters.

China tops U.S Japan to become top patent filer

Lee Chyen Yee | Reuters — 22-Dec-2011

China became the worlds top patent filer in 2011 surpassing the United States and Japan as it steps up innovation to improve its intellectual property rights track record a Thomson Reuters research report showed on Wednesday.

Roche drags DRL to court over patents

TNN — 23-Dec-2011

In yet another legal blow to pharma major Dr Reddys Laboratories Swiss healthcare giant Roche Holding AGs two US based arms have slapped a lawsuit on the Hyderabad based company for infringing on a US patent for anti viral drug Valcyte.

Patent firm sues German retailers over HTC phones

Reuters — 23-Dec-2011

Patent firm IPCom has sued German retailers for patent infringement for continuing to sell phones made by HTC the No. 4 smartphone maker globally.

Healthy year for pharma sector on right policy prescriptions

P. T. Jyothi Datta — 24-Dec-2011

Quality pricing intellectual property issues are challenges in the new year

EU ruling on transit goodscase cheers Indian drug cos

P. T. Jyothi Datta — 25-Dec-2011

May end instances of non member consignments being seized

Compliance quality issues cast shadow on pharma deals

Namrata Nandakumar & C.H. Unnikrishnan — 26-Dec-2011

Quality and compliance issues over previous deals with Indian firms have hit the revenues of global drug makers

Tilaknagar Industries wins trademark battle in Bombay HC

India Infoline News Service — 27-Dec-2011

TI is a leading player in the IMFL industry with a dominant presence in South India and continues to successfully extend its footprints on a pan India basis

Government eases norms for gold silver mix in Kanchipuram sarees

SANGEETHA KANDAVEL & SANJAY VIJAYAKUMAR — 27-Dec-2011

Since 2005 Kanchipuram silk sarees have been protected by Geographical Indication label which not only certifies their geographical origin but also confirms adherence to some production standards.

Soon database on Indian bio resources

Dipannita Das — 27-Dec-2011

The Unit for Research and Development of Information Products here has prepared a database of patents granted world wide to Indian bio resources including food crops forest trees marine organisms microbial resources livestock other animals and agro resources.

Yahoos unit Overture Services Inc faces patent roadblock for paid search technology

Sanjay Vijayakumar & Sangeetha Kandavel — 27-Dec-2011

In a setback to internet major Yahoo the Intellectual Property Appellate Board in Chennai has rejected a patent filed for a paidsearch technology by its unit Overture Services Inc, after opposition from Rediff.com India.

IP office recast may roll back reforms fear stakeholders

David Shaftel & C.H. Unnikrishnan — 28-Dec-2011

Some 400 000 trademark applications are pending and the IP office has resorted to outsourcing or temporary hiring

Patents Bickerings With Rivals May Hurt Apple

BLOOMBERG BUSINESSWEEK SAN FRANCISCO — 29-Dec-2011

Steve Jobs the co founder of Apple Inc. told his biographer that hed rather wage thermonuclear war with Google than make deals to share its technology with the maker of the Android operating system

Patents office appoints 94 examiners to speed up process

Himanshu Darji & Vishal DuttaHimanshu Darji & Vishal Dutta — 29-Dec-2011

The Indian Patents Office has appointed 94 design examiners to speed up the process of granting patents and clear a backlog of one lakh applications over the next three years.

Another Bt cotton variant falls to fraud charges

Zia Haq — 30-Dec-2011

Relying on Monsantos technology could have possible because its intellectual property rights protection of 15 years had ended freeing violators from legal tangles sources said.

Breaking the deadlock in WTO talks

30-Dec-2011

The eighth World Trade Organization ministerial conference concluded on 17 December with the chairman citing an improved atmosphere but no concrete moves forward on the Doha Round trade talks.

Shasun plans tie up with MNCs

Gireesh Babu / Chennai — 30-Dec-2011

Shasun Pharmaceuticals Ltd is planning to expand its contract manufacturing business by partnering with multinational companies to manufacture their patented products for Indian and Asian drug markets.

Dr Reddys plans Lipitor generic launch in June

KV Ramana | Hyderabad — 30-Dec-2011

Dr Reddys Laboratories will hit the US market with its much hyped Lipitor generic in the first quarter of next fiscal.

Bobbili veena gets special GI tag

TNN — 31-Dec-2011

Now the famed Bobbili veena has earned a Geographical Indication certification from the central government.

Indian pharma companies obtains 144 ANDA approvals from US FDA in 2011

Sanjay Pingle, Mumbai — 2-Jan-2012

Research based Indian pharma companies are set to capture a major share of the US domestic market with increasing number of filing of Abbreviated New Drugs Applications.

HC rules in favour of Indian Co in trademark copyright case

PTI — 2-Jan-2012

The Bombay High Court has dismissed the Netherlandbased liquor groups plea seeking to restrain Tilaknagar Industries Ltd here from using trademarks Mansion House and Savoy Club on products sold in India.

Google Apple working on tech to make passwords redundant

ANI — 02-Jan-2012

Last week Apple applied to the US patent office to register facial recognition software so instead of sliding to unlock the iPhone iPad or iPod Touch one could simply point it at ones face.

Getting your trademark - I

02-Jan-2012

With manufacturing costs going up and the value of the money depreciating companies are constantly competing to gain market share at the expense of the other.

Complex therapies in US lure pharma firms

Priyanka Golikeri | Bangalore — 3-Jan-2012

The US market for pharmaceuticals is not just about patent expiries and billion- ollar drugs.

No surprise that Nehru Place is one of the 30 markets violating IPR

Shelley Singh — 3-Jan-2012

Nearly half the worlds personal computers use software that is pirated.

Database helped thwart UK patent bid

TNN — 4-Jan-2012

India through the Traditional Knowledge Digital Library submitted its prior art evidences on April 25 2011.

A European pill best avoided

S. Srinivasan — 4-Jan-2012

The more stringent intellectual property regime under consideration will impact generics producers.

British firms bid to patent ginger foiled

TNN — 4-Jan-2012

India has foiled an attempt by a British pharmaceutical company to claim a patent on using ginger for the treatment of cold.

Pfizer fastest growing drug MNC in India

Joe C Mathew / New Delhi — 5-Jan-2012

Globally the bulk of Pfizer revenues come from exclusive sale of patent protected medicines and not branded generics.

Smartphone battle: Google buys 217 IBM patents

Reuters — 05-Jan-2012

Google confirmed that it has added more IBM patents to its technology arsenal as smartphone rivals increasingly battle in courts over innovations.

Modi groups firm barred from using Morgardshammar trademark

PTI — 6-Jan-2012

Modi groups Morgardshammar India a rolling mill equipment manufacturer has been restrained from using the Morgardshammar trademark by the Delhi High Court.

Awareness about IPR is important

Express News Service , The New Indian Express — 9-Jan-2012

A proper awareness about intellectual property rights is as important as awareness about land property rights said Raju Narayana Swamy secretary Department of Youth Affairs.

Indian innovator harnesses sea waves for power

ANS — 10-Jan-2012

The World Intellectual Property Organisation Geneva a United Nations agency also approved and published the patent specifications for GPT.

India US trade talks postponed indefinitely

Asit Ranjan Mishra & Elizabeth Roche — 10-Jan-2012

A recent report by the USTR in December identified Nehru Place in New Delhi as among the 30 most notorious IT markets of the world dealing in goods and services that infringe intellectual property rights.

Markets cannot manage a knowledge economy

Ananya Dutta — 11-Jan-2012

Citing the example of Trade related Intellectual Property Rights (TRIPS) agreement he said that it was not developmentally oriented.

Outlook for Indian pharma companies remain stable: CARE

Divya Rajagopal — 11-Jan-2012

According to Care drugs worth $235 billion are expected to go off patent in the next five years leaving the market open for off patent or generic drugs.

Scientists follow ancient literature to seek treatment for Parkinsons

12-Jan-2012

But there are other molecules (not being disclosed yet as patent is pending) which are being tried on human cell lines.

Darjeeling Tea tag: EU India meet in February

Sutanuka Ghosal — 12-Jan-2012

EU has registered the term Darjeeling as a protected geographical indication (PGI) for black tea originating from the West Bengal region.

IBM keeps top patent spot for 19th year as Asian rivals gain

Bloomberg / New York — 12-Jan-2012

International Business Machines Corp won a record number of US patents in 2011 its 19th straight year on top as some Asian competitors advanced in the rankings at the expense of Microsoft Corp and Intel Corp.

Microsoft reaches patent deal with LG

IANS — 13-Jan-2012

Microsoft Thursday announced a patent licensing agreement with LG Electronics covering tablets smartphones and other consumer devices running Googles Android or Chrome operating system.

Sony Music Entertainment files trademark for Kolaveri Di

Vishal Dutta — 13-Jan-2012

Viral super hit Why this kolaveri di may soon become the first song in India to have its first line trademarked.

Novartis cuts 2000 US jobs after patent loss

AFP — 13-Jan-2012

After cutting 2000 positions in late October mainly in Switzerland and the US the Basel based company has again downsized its American operation.

KBL receives trademark registration for Jalverter

BS Reporter / Mumbai/ Pune — 14-Jan-2012

Kirloskar Brothers Limited a fluid management company on Friday announced that it was granted registration of its trademark Jalverter a patented multipurpose off grid solar inverter by the Office of the Registrar of Trade Marks India.

Bayer asked to give cost data

CH Unnikrishnan — 14-Jan-2012

Natco Pharma had sought compulsory licensing of cancer drug saying most patients found it too expensive

GI tag to boost Darjeeling tea exports

Indrani Dutta — 16-Jan-2012

Darjeeling tea exports are set to increase by volume and value following its registration as a protected geographical indication PGI product from India.

Healthcare workers stress need for independent data on medicine prices

P. T. Jyothi Datta — 16-Jan-2012

Patent drugs and their pricing have not been addressed medicines for critical and highly prevalent conditions in India such as cancer mental illness malaria and diabetes are not covered and the proposed system of fixing the average of the top three brands as the ceiling price could lead to cartelization the representative pointed out.

India EU free trade agreement talks at final critical stage

Elizabeth Roche — 17-Jan-2012

Indian automobile and wine groups are opposed to major concessions to EU firms

Man gets patent for 22 note harmonium

Prachi Pinglay — 17-Jan-2012

The humble harmonium is finally set to get its due.

Agra inlay craftsmen seeks Geographical Indication tag for their products

Sanjay Vijayakumar — 18-Jan-2012

A Geographical Indication tag not only certifies a works geographical origin but also confirms adherence to some production standards.

Compulsory license ensures patent rights & public health Expert

Nandita Vijay, Bengaluru — 18-Jan-2012

Compulsory license specifically under Section 92A of the Patents Amendment Ordinance 2004 for export of pharmaceutical substances ensures a balance between patent rights and public health is maintained according to Bindu Sharma Patent Attorney Origiin IP Solutions LLP.

Sony to trademark Why this kolaveri di

Zeebiz Bureau — 18-Jan-2012

Music label Sony Music Entertainment is planning to trademark the songs first line Why this kolaveri di.

Agra inlay craftsmen seeks Geographical Indication tag for their products

Sanjay Vijayakumar — 18-Jan-2012

Agra craftsmen practising the marble inlay work found in famous works of architecture such as the Taj Mahal and Fatehpur Sikri have sought the Geographical Indication tag for their product.

Battle set for Kodaks patent portfolio

Richard Waters and Chris Nuttall — 19-Jan-2012

Eastman Kodaks bankruptcy is set to trigger a battle between some of the largest smartphone makers and other technology groups for control of a patent portfolio that is considered core to digital photography according to US patent experts.

Pharma stocks offer safety and upside

Devangshu Datta / New Delhi — 19-Jan-2012

Its global which means an understanding of the complexities of patent law is necessary.

Several knotty issues in trade talks with EU

Neeraj Thakur — 20-Jan-2012

Trade negotiations at the upcoming India European Union summit have assumed significance as the euro region caught in an economic maelstrom looks for greater access to Indian markets.

Strides sells Australia SE Asia business to Watson Pharma

BS Reporter / Bangalore — 25-Jan-2012

Rs 1965 cr deal helps it rake in 3.5 times its investment within four years

Ranbaxy to pay heavily for future US violations

Joe C Mathew / New Delhi — 27-Jan-2012

The 180 day market exclusivity is granted to the first company that challenges the patent of a medicine in the US.

Samsung loses again in German patent suit against Apple

Reuters — 27-Jan-2012

Samsung Electronics Co Ltd said on Friday that a German court has ruled against it in a patent suit with Apple Inc over mobile technology the latest verdict in an intensifying global legal battle between the two technology giants.

Ranbaxy stock tanks on court filing in US

C.H. Unnikrishnan & Bloomberg — 28-Jan-2012

For 13 of these the company was the first to challenge patents according to a presentation on its website.

Maharashtra leads in filing patents

Kounteya Sinha — 28-Jan-2012

Maharashtra beats all other states hollow when it comes to filing patents.

With GI powers rich pickings for Mysore farmers

M Raghuram — 28-Jan-2012

Farmers groups of farmers and farmers co operatives in the state will get rights to grow sell and export and process at least 11 horticultural products so far registered under geographical Indication.

India EU say making good progress on trade pact

PTI — 29-Jan-2012

Also the 27 nation bloc has been pressing India to agree for an intellectual property rights regime over and above what the country has agreed multilaterally in the World Trade Organisation.

US settlement puts Indias Ranbaxy on the ropes

Agence France Presse — 29-Jan-2012

Indian drugs giant Ranbaxy faces a tough road ahead after US authorities imposed stiff conditions to settle a long legal battle over manufacturing safety violations at its plants analysts say.

Nestle Amul trademark battle is for Re 1 brand

Vishal Dutta — 30-Jan-2012

The slugfest between diary giants Amul and Nestle for ownership of A PLUS is afterall for a brand that is worth Re 1.

Wake up call for Indian drug makers

P.T.JYOTHI DATTA — 31-Jan-2012

India is a huge source for generic drugs or less expensive medicines that are not covered by patent protection unlike original innovative medicines.

Strides margin to improve on Ascent sale

Ujjval Jauhari / Mumbai — 1-Feb-2012

Glaxo sources products from Strides for emerging markets while Pfizer is commercialising off patent products primarily injectibles licensed supplied by Strides for regulated markets like the US.

Indian ideas power US business innovations says a study by IIM-Ahmedabad

Chitra Unnithan — 01-Feb-2012

Over 50% of total patents filed for industrial innovations in the US have Indian brains behind them says a study by Indian Institute of Management Ahmedabad.

Patent plaintiffs target Facebook as IPO approaches

Dan Levine — 1-Feb-2012

As it prepares for one of the biggest IPOs ever Facebook is coming under the same fierce attacks being waged against other big technology companies: patent lawsuits.

Indian ideas power US business innovations

Chitra Unnithan — 1-Feb-2012

Over 50% of total patents filed for industrial innovations in the US have Indian brains behind them says a study by Indian Institute of Management Ahmedabad.

EU antitrust regulators probe Samsung over mobile patents

Bloomberg / Brussels — 1-Feb-2012

Samsung Electronics Co is being probed by European Union antitrust regulators over licensing of patents to other mobile phone manufacturers.

Indian ideas power US business innovations

Chitra Unnithan — 1-Feb-2012

Over 50% of total patents filed for industrial innovations in the US have Indian brains behind them says a study by Indian Institute of Management Ahmedabad.

Raghavendra Rathore to copyright bandhgalas

Rochelle Pinto — 01-Feb-2012

Cases of designer copying designer in the fashion industry are too common to count.

Govt planning to patent products manufactured by tribals

PTI — 01-Feb-2012

Aiming to preserve the indigenous knowledge of tribals and products manufactured by them with the help of natural resources government is planning to patent some of these under the Intellectual Property Rights.

Can Ranbaxy recover from its US debacle?

Joe C Mathew / New Delhi — 2-Feb-2012

The generic company that wins a chance to sell its drug by successfully invalidating the patent of someone elses medicine will have the sole rights to market the low cost version of that drug for six months immediately after the products goes off patent.

Ahead of talks with EU concerns remain on drug export seizures

P. T. Jyothi Datta — 2-Feb-2012

Despite the assurance from European Union authorities that Indian drug consignments would be allowed to transit Ajanta Pharmas shipment was detained on alleged intellectual property violations in late 2011.

Apple loses bid against Galaxy Tab 10.1N Nexus

Bloomberg — 2-Feb-2012

The Munich Regional Court rejected the motion today in a case where Apple invoked a patent granted last year protecting technology related to touchscreens for tablets and smartphones.

Patent war intensifies as Facebooks IPO approaches

Reuters — 2-Feb-2012

As it prepares for one of the biggest IPOs ever Facebook is coming under the same fierce attacks being waged against other big technology companies: patent lawsuits.

Patent office appoints 150 patent examiners to expedite process of patent examinations

Suja Nair-Shirodkar, Mumbai — 3-Feb-2012

To address the growing pressure from the increasing number of patent applications filed in the country the Controller General of Patents Designs and Trademarks recently issued an order to appoint 150 examiners of patents.

Opposition to Monsanto patent on Indian melons

Gargi Parsai — 05-Feb-2012

Activist Vandana Shiva and an Europe based NGO have jointly opposed a patent awarded to an American company on virus resistance traits taken from indigenous melon varieties in India.

IP office initiates process to link database to NIIPM for better dissemination of patent info

Suja Nair Shirodkar, Mumbai — 6-Feb-2012

The Indian Patent office recently initiated the process to link all its database on both published as well as granted patent applications filed for examination within the country to National Institute of Intellectual Property Management Nagpur.

EU extends special status for Darjeeling tea

Our Bureau — 06-Feb-2012

Darjeeling tea has become the first product from India to be protected as a geographical indication in the European Union according to the Tea Board.

Protest against EU India free trade agreement swells as summit kicks off in Delhi

Ramesh Shankar, Mumbai — 10-Feb-2012

Even as the EU India free trade agreement summit kicks off in Delhi the voice against the proposed agreement is getting louder in the country as there is apprehension among the people that the agreement will have a negative impact on access to affordable medicines across developing countries.

Prospects poor for original drug discovery in India finds study

Jacob P. Koshy — 10-Feb-2012

A study attempted to gauge the innovativeness of outsourced pharma and biotech work to India.

Bandgalas and Jodhpurs patently Rathores: Designer copyrights his two iconic items

Deepti Jakhar — 10-Feb-2012

In a world where getting inspired and borrowing from each others collections are almost de rigueur fashion designer Raghavendra Rathore has decided to patent the two styles he revived to life the Jodhpurs and the bandgalas.

No exotic cheese names for Amul if India accepts EU demand

Joe C Mathew / New Delhi — 10-Feb-2012

All this will happen if India accepts an EU demand for high level geographical indication protection for about 130 products that fall in the agriculture wine and spirit categories.

Compulsory licensing to help patients & players says Natco

KV Ramana — 10-Feb-2012

Hyderabad based Natco Pharmaceuticals is making a first of its kind effort to get a compulsory licence for the generic version of Bayers liver and kidney cancer drug Nexavar in India alongside pursuing opportunities in the generic pharmaceutical markets.

Beyonce Jay Z seek to patent daughters name

ANI — 10-Feb-2012

Beyonce and Jay Z have reportedly filed an application to trademark their daughter Blue Ivy Carters name.

TNAU develops ready to cook pearl millet mix

TNN — 11-Feb-2012

The Tamil Nadu Agricultural University has been granted a patent for producing a ready to cook mix from pearl millet.

Google gets U.S. EU nod to buy Motorola Mobility

Diane Bartz and Foo Yun Chee — 14-Feb-2012

It was one of a series of approvals on Monday that underscored the scramble by technology companies to acquire big pools of patents.

Patent office asks industry to engage only sector specialised patent agents for speedy clearance of applications

Suja Nair Shirodkar, Mumbai — 14-Feb-2012

The Indian Patent office has asked the industry to appoint only sector specialised patent agents for the purpose of patent filings to avoid complications while examining the patent cases filed for examination.

Apple launches new legal attack on Samsung phones

Reuters / New York — 14-Feb-2012

Apple Inc raised the stake in an intensifying global patent battle with Samsung Electronics by targeting the latest model using Googles fast growing Android software a move which may affect other Android phone makers.

India can win melon patent

TNN — 14-Feb-2012

India should invoke provisions of Biodiversity Convention to fight the patent issued by European Patent Office to Monsanto on virus resistance traits of melons allegedly taken from indigenous varieties in India according to ecologist S Faizi.

Google gets US EU approval to buy Motorola Mobility

Reuters / Washington/ Brussels — 15-Feb-2012

It was one of a series of approvals on Monday that underscored the scramble by technology companies to acquire big pools of patents.

Wyeth makes $960 mn claims on Protonix patent case: Sun Pharma

PTI — 15-Feb-2012

Sun Pharmaceutical Industries on Wednesday said that US based Wyeth Pharmaceuticals has sought damages worth USD 960 million related to their ongoing patent dispute over a generic version of Protonix drug.

Baroda College of Pharmacy files for four patents

Syed Khalique Ahmed — 15-Feb-2012

Baroda College of Pharmacy has filed for four provisional patents for the inventions its faculty and students are currently working on.

Apple loses iPad copyright battle in China

Saibal Dasgupta — 15-Feb-2012

A move is afoot to block the worldwide distribution of iPads from their manufacturing base in China after its maker Apple Inc lost a copyright battle to a Chinese company.

Navara rice farmers seek government support for marketing

PTI — 15-Feb-2012

Navara rice associated with Ayurveda and considered to be an energetic food for people of all ages was the first farm product that received Geographical Indication Registration in the country considering its importance.

Apple wins over Motorola in slide to unlock ruling

16-Feb-2012

Apple has won a patent dispute against Motorola Mobility regarding a slide to unlock feature on smartphones.

Wyeth claims $960 mn from Sun Pharma in Protonix case

Reuters — 16-Feb-2012

Wyeth Pharmaceuticals Inc is seeking $960 million in damages from Sun Pharmaceutical Industries for alleged patent infringement in launching a generic version of acid reflux drug Protonix in the United States the Indian company said.

Will India hold on to its status as Pharmacy of the developing world?

17-Feb-2012

Up until year 2000 drugs for HIV AIDS were mostly patented and cost more than $10000 per patient per year.

India is underperforming in terms of innovation potential

Staff Correspondent — 18-Feb-2012

Entrepreneurs having insufficient knowledge of IPR would lose interest in applying for patent rights.

Patent granted to kit prepared by Haryana Univ for testing urea in milk

Express news service — 19-Feb-2012

The newly established Lala Lajpat Rai University of Veterinary and Animal Sciences Hisar has been granted a patent by the Government of India for commercial production for the Urea Detection in Milk technology developed by its Veterinary Public Health and Epidemiology College of Veterinary Sciences for testing Urea in milk.

AstraZeneca India job cuts likely to hurt drug research

Jacob P. Koshy — 20-Feb-2012

Manpower reduction by global pharma firms means loss of potential training experience for Indian scientists.

Patent office to clear backlog of pending patent applications by 2016

Suja Nair Shirodkar, Mumbai — 20-Feb-2012

With a view to safeguard the interest of the patent applicants the Indian Patent office informed that efforts are being taken to clear the huge backlog of about one lack pending patent applications latest by 2016.

Strategy for intellectual property a necessity

TNN — 21-Feb-2012

With an aim to protect intellectual property industrialists must register patents industrial designs trademarks copyrights and geographical indices said Karamjit Singh Saluja deputy director federation of Indian micro small and medium enterprises.

Pharmaceutical and healthcare sector to dominate M&As in 2012: Grant Thornton

ET Bureau — 21-Feb-2012

India will see the largest number of merger and acquisitions in the pharmaceutical and healthcare sector this year despite stricter regulations according to consulting firm Grant Thornton.

Bayer case may set cost precedent

C.H. Unnikrishnan — 21-Feb-2012

Germanys Bayer HealthCare AG will be forced to disclose cost data for cancer drug Nexavar next week when Indias patent office holds the second hearing for compulsory licensing of the drug sought by local drug maker Natco Pharma Ltd likely setting a precedent for similar revelations to be extracted from other foreign drug makers.

Sun Pharma may opt for out of court settlement

Reghu Balakrishnan / Mumbai — 22-Feb-2012

The recent patent litigation suit with the highest ever damage claim against an Indian pharmaceutical company is likely to end in a whimper.

Sun Pharma shares rise over import of cancer drug Lipodox

NDTV Correspondent — 23-Feb-2012

Doxil is a drug innovated by J&J which is facing manufacturing constraints.

Lupin settles patent dispute with 2 US firms

PTI — 23-Feb-2012

Lupin has reached a patent litigation settlement agreement with US based firms Santarus Inc and Depomed Inc involving diabetes drug Glumetza.

Kadaknath set to become global brand

DNA — 26-Feb-2012

The Intellectual Property Facilitation Centre a wing of Confederation of Indian Industries has applied for Kadaknaths inclusion in the Geographical Indication Registry.

MSF seeks Novartis shareholders to urge company to drop ongoing patent case against India

Ramesh Shankar, Mumbai — 24-Feb-2012

The international medical humanitarian organization Médecins Sans Frontières has called upon the shareholders of Swiss pharmaceutical company Novartis to urge the company to drop its ongoing court case against the Indian government as the case could have a severe impact on access to affordable medicines for people across the developing world.

Protest against Novartis attempt to obtain patent for Glivec in India

PTI — 24-Feb-2012

Several NGOs protested at the annual meeting of Novartis yesterday against the attempt by the Swiss pharmaceutical groups India company to obtain a patent for its anti cancer drug Glivec.

Novartis AGM hit by shareholders protest over continuing litigation against Sec 3(d) of Indias Patents Act

Our Bureau, Mumbai — 24-Feb-2012

The Swiss pharmaceutical giant Novartis\' Annual General Meeting at Basel in Switzerland on February 23, was hit by protests both inside and outside the AGM on its continuing litigation against the Section 3(d) of Indias Patents Act which prohibits evergreening the practice of multinational pharmaceutical companies to extend their patent terms by making small trivial changes to existing medicines and thereby preventing access to generic affordable drugs.

Indian Glivec case concerns raised at Novartis AGM at Basel

P. T. Jyothi Datta — 24-Feb-2012

Drop the legal case in India on Glivec Mr Patrick Durisch with Berne Declaration a Swiss public interest non government organisation urged the Novartis management.

GENFIT\'s drug candidate GFT505 gets patent protection from major countries

Lille, France — 25-Feb-2012

Following on from GFT505 patents already delivered in the United States Europe China Russia and Australia the Canadian Japanese and Indian patent offices have granted new patents to GENFIT.

Hearing on Novartis case on Sec 3(d) of Indias Patents Act in SC to be delayed

Ramesh Shankar, Mumbai — 27-Feb-2012

The hearing on Novartis case on Section 3(d) of Indias Patents Act in Supreme Court is likely be delayed from 28 February to sometime in March as the Mumbai terror attack trial is running late in the court.

Yahoo threatens Facebook as social media patent war looms

Reuters — 28-Feb-2012

Yahoo has demanded licensing fees from Facebook for use of its technology the companies said on Monday potentially engulfing social media in the patent battles and lawsuits raging across much of the tech sector.

More firms restrained by Delhi court in Aji No Moto trademark infringement case

Shobha Roy — 28-Feb-2012

The next time you buy Aji No Moto for cooking your favourite Chinese dish be careful of whether you are buying the trademark product or monosodium glutamate which some companies have loosely preferred to call as Aji No Moto.

Bayer-Natco case: Judgment will set benchmark in amended Indian Patent Act

P. T. Jyothi Datta — 28-Feb-2012

The final patent related hearing on Bayers advanced kidney cancer drug Nexavar following Natcos plea for a compulsory license on the medicine concluded on Tuesday at the Patent Office.

Natco ruling is a watershed

P. T. JYOTHI DATTA — 28-Feb-2012

The day of the nation wide trade union strike few people are on the roads and in offices in Mumbai.

Price erosion may hit Lipitor sales of Indian firms

Reghu Balakrishnan / Mumbai — 29-Feb-2012

Lipitor has been sold by three players in the US after it lost patent protection in November last year.

Big pharma companies must allow generic firms to sell cheap HIV drugs to poor nations

Divya Rajagopal — 1-Mar-2012

Last month when Emcure Laboratories became the third company to tap an open patent pool it was more validation of a novel mechanism that seeks to address a conundrum central to the industry:

Is Yahoo trying to boost acquisition value by demanding licensing fees from Facebook?

Reuters — 29-Feb-2012

Yahoo could be trying to boost its acquisition value by demanding licensing fees from Facebook for the use of its technology as the one time Web pioneer considers strategic M&A options according to patent experts.

Patent rights?

T S Vishwanath — 1-Mar-2012

WIPO must protect the developmental needs of countries with genetic resources as it pushes for inventions and innovation in industry

Biosimilar products development gets a USFDA norms boost

Rituparna Chatterjee — 1-Mar-2012

Robert Siminski a Detroit based patent attorney specializing in pharmaceuticals and biotech issues recalls how anxiously biotech experts at Indian firms whom he had met at the India Bio conference in Bangalore early last month were looking forward to the US Food and Drug Administrations draft guidelines for biosimilar product development.

Emcure signs deal to manufacture Roches anti cancer drugs

Divya Rajagopal — 02-Mar-2012

Instead it has taken Indian generic makers to court for violation of Intellectual Property Rights rather than signing any voluntary license deals.

Kodak sells online business to Shutterfly patent sale still pending

Sue Zeidler — 02-Mar-2012

Eastman Kodak Co has agreed to sell its online photo services business to Shutterfly Inc for $23.8 million kicking off the bankrupt photography pioneers relaunch as a much slimmer company although a patent sale seen crucial to its turnaround may still be months away.

Final hearing on Novartis case on Sec 3(d) of Patents Act to begin in SC on March 28

Ramesh Shankar, Mumbai — 02-Mar-2012

The Supreme Court has rescheduled the final hearing of the Novartis versus the government of India case for March 28 2012.

India foils Swiss MNCs bio piracy bid

Kounteya Sinha — 3-Mar-2012

India has successfully foiled a bio piracy bid by a Swiss multi national firm to patent an age old Indian home remedy milk as a laxative

India opposes pharma piracy pact by 10 nations

Amiti Sen — 3-Mar-2012

The ACTA was signed by ten WTO countries including Australia Canada Korea Mexico New Zealand Japan Morocco Singapore the US and Switzerland in October last year to check global trade of counterfeit goods and pirated copyright protected works through stricter enforcement laws.

2 generics give pharma sector $400 mn boost

Namrata Nandakumar — 5-Mar-2012

Foreign pharmaceutical companies may continue to fret over drugs going off patent but drug makers in India are not only raking in profits selling generic versions of such drugs but are also pushing up the growth rates of Indias pharma exports.

Novartis India keeps fingers crossed as SC hears Glivec patent case

Divya Rajagopal — 5-Mar-2012

Novartis India will take a last shot at protecting its patent for anti cancer drug Glivec in Supreme Court later this month in a ruling that will have a significant impact on all innovators past and present even as activists seek affordable drugs in developed countries occupy Novartis offices in the US.

Ranbaxy takes Atorvastatin to more countries

Our Bureau — 06-Mar-2012

Pfizers patent expires in Italy on May 8 and in the Netherlands and Sweden on May 06.

Indias Supreme Court to Hear Dispute on Drug Patents

VIKAS BAJAJ and ANDREW POLLACK — 06-Mar-2012

But most of that medicine has been generic copies of brand name drugs protected by patents in Europe and the United States.

iPad dispute signals new era in trademark troubles

AP — 6-Mar-2012

iPotato isock icouch istove i you name-it.

Ranbaxy takes Atorvastatin to more countries

Our Bureau — 6-Mar-2012

Ranbaxy Laboratories Ltd announced that it has launched the generic versions of Atorvastatin tablets in Italy Sweden and the Netherlands.

Samsung files fresh patent suit against Apple in South Korea

Reuters — 07-Mar-2012

Samsung Electronics Co said on Wednesday it has filed another lawsuit against Apple Inc in South Korea claiming the iPhone 4S and iPad2 infringed on three of its patents.

Smartphones tablets and the patent wars

Sunil Abraham — 08-Mar-2012

Some prefer Steve Jobs patron saint of perfection others prefer Nicholas Negroponte messiah of the masses.

No science in \'cut and paste\'

Rahul Siddharthan — 9-Mar-2012

There is an urgent need for an institutional mechanism to deal with plagiarism and other violations of academic ethics.

Apple barred from pursuing Kodak patent claims now

Reuters — 9-Mar-2012

The infringement claims center on a Kodak patent that lets consumers preview digital photographs on LCD screens.

Copies of patented cancer drugs ahead?

Priyanka Golikeri — 9-Mar-2012

Hope floats for liver and kidney cancer patients who find the available patented medication unaffordable out of reach.

Partnership is better alternative to acquisition

C.H. Unnikrishnan & Namrata Nandakumar — 11-Mar-2012

Not having strong patent regime in the country was a barrier in entering India earlier.

Glivec ruling to determine India investment: Novartis

PTI — 11-Mar-2012

Novartis is seeking clarity on whether we can rely on patents in India and whether we as a research based organisation can continue to invest in the development of better medicines for India.

NGOs reject Novartis claim of no impact on availability of cancer drug because of court dispute

Ramesh Shankar, Mumbai — 12-Mar-2012

Public interest groups working in the health sector in the world have pooh poohed the Swiss pharmaceutical company Novartis argument that there will be no impact on the availability of generic version of its blood cancer drug Gleevec as a fallout of the on going case in Supreme Court in India.

Patent office may give verdict today

Joe C Mathew / New Delhi — 12-Mar-2012

In a move that could set the tone for future pharma patent battles Indias intellectual property rights watchdog may decide tomorrow the fate of the countrys first compulsory licence application.

Yahoos 10 patents that it claims Facebook infringed

Dan Farber — 12-Mar-2012

With Facebook on the road to IPO Yahoo has placed ten of its patents in its path.

Geographical indications tag for made in Kutch shawl

TNN — 13-Mar-2012

The colourful Kutchi shawl has been given the geographical indications tag.

Is the Pfizer-Biocon deal coming apart?

DNA Correspondent — 13-Mar-2012

Pfizer stood to gain from greater access to the $14 billion market for insulins used to control diabetes ahead of 2015 when a number of products are expected to lose patent protection.

Health groups hail verdict pharma body disappointed

Our Bureau — 13-Mar-2012

Natcos baby step may pave the way for a giant leap of sorts where many more drug patents are subjected to this stick to help bring down highly excessive prices for a country like India says Mr Shamnad Basheer an intellectual property expert.

Yahoo sues Facebook over patents

Reuters — 13-Mar-2012

Yahoo Inc sued Facebook Inc over 10 patents that include methods and systems for advertising on the Web opening the first major legal battle among big technology companies in social media.

Yahoo points up patent-law failure

John Shinal — 13-Mar-2012

The patent lawsuit filed by Yahoo Inc. against Facebook Inc. is more than just a desperation move by a company thats become an also ran in an industry it once helped create.

Cancer ruling opens door for cheaper drugs in India

Kaustubh Kulkarni and Henry Foy — 13-Mar-2012

Indias move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments including modern HIV AIDS drugs in a major blow to global pharmaceutical firms experts say.

Litigation clouds Sun Pharmaceutical

Ujjval Jauhari & Ram Prasad Sahu — 13-Mar-2012

Whichever way the judgement in the Protonix case goes it is likely to be a trendsetter for companies looking to launch generic drugs in the future in prized markets such as the US.

Indias first compulsory licence granted to Natco for Bayers cancer drug

Our Bureau — 13-Mar-2012

The countrys first compulsory licence has been granted by the Indian Patent Office to Hyderabad based drug maker Natco.

Biocon Pfizer call off $350m insulin deal

Our Bureau — 13-Mar-2012

Worlds largest drug maker Pfizer has called off a $350 million deal to sell Indian biotech company Biocons insulin products globally.

Indias patent ruling on cancer may open door for cheaper HIV drugs

Reuters — 13-Mar-2012

Oracle trial against Google set for April

Bureau Report — 14-Mar-2012

A US judge scheduled a trial between Oracle Corp and Google Inc for April 16 2012 over claims Google violated Oracles intellectual property rights relating to the Java programming language according to a ruling on Tuesday.

$350-mn Pfizer-Biocon pact off

BS Reporters / Bangalore/ Mumbai — 14-Mar-2012

Indias largest biopharmaceutical company Biocon suffered a severe jolt on Tuesday as its $350 million pact with global pharmaceutical major Pfizer was called off hardly 18 months after the deal was signed.

Patent disregard for patients

P. Bhaskara Narayana — 14-Mar-2012

The Glivec case points to the need to go beyond encouraging innovation and providing affordable life saving medicines.

Pharma Street splits not unusual

Reghu Balakrishnan / Mumbai — 14-Mar-2012

Indian pharmaceutical companies much sought partners for global majors due to the low cost factor have seen quite a few deals fall apart in the recent past.

Long term damage to future health of world to be dramatic

Ranjit Shahani — 14-Mar-2012

It was with great anticipation that the innovative pharmaceutical industry welcomed the introduction of product patent laws in 2005.

A historic move to make drugs affordable

G. Ananthakrishnan — 14-Mar-2012

Compulsory licensing is perfectly legal and built into the patents regime to balance corporate profit and public interest.

Road to cheaper drugs

Rupali Mukherjee — 14-Mar-2012

More generic companies could invoke the compulsory licensing clause of the Indian Patents Act following Mondays decision to allow Natco Pharma to sell copycat drugs of Bayers patented cancer drug at 97 % reduction.

Yahoo! sues Facebook for infringing patents

Reuters / San Francisco — 14-Mar-2012

Yahoo!Inc sued Facebook Inc over 10 patents that include methods and systems for advertising on the Web opening the first major legal battle among big technology companies in social media.

At Pfizer signs of priority change

Priyanka Golikeri & KV Ramana — 14-Mar-2012

Does Pfizers decision to call off its deal with Bangalore based Biocon indicate a change in the US firms game plan for India?

Should compulsory licensing be allowed?

Amit Sengupta — 14-Mar-2012

The decision by the Indian Patent Office to issue a compulsory licence to Natco for Bayers anticancer drug Sorafenib means the drug will now be available at Rs 8800 per month a 97 % reduction from Bayers Rs 2.8 lakh.

Apple Motorola discussed patent settlement: EU

Bloomberg — 14-Mar-2012

Apple Inc held talks with Motorola Mobility Holdings Inc at the end of last year on a potential cross licensing settlement to end a dispute over smartphone patents according to a European Union document.

Pill patents

Jeff Glekin — 14-Mar-2012

India has joined Thailand and Brazil in granting a licence to a local generic drug maker at the expense of a global player.

Older than DRL, little-known Natco comes into limelight

TNN — 14-Mar-2012

It may be older than Hyderabads most wellknown drug giant Dr Reddys Laboratories but recognition has come rather belatedly in the day for Hyderabad based Natco Pharma.

Sector divided over nod to Natco to sell Bayers drug

Press Trust Of India / New Delhi — 14-Mar-2012

Indias decision to allow Natco Pharma to sell Bayers patented cancer drug Nexavar has divided the pharmaceutical industry.

Natco Pharmas invoking of compulsory licensing could trigger cheaper drug production

Rupali Mukherjee — 14-Mar-2012

The governments decision to bust the price as well as monopoly of Bayers anti cancer drug through the process of compulsory licensing now opens up the field for the generic industry to follow suit and could well pave the way for the availability of cheaper drugs for lifestyle diseases.

Nearly 75000 patent applications pending for review

Our Bureau — 14-Mar-2012

Inadequate manpower has led to piling up of nearly 75000 patent applications awaiting review by the designated authority.

Five GI tags in their kitty state craftsmen close ranks for more

ADAM HALLIDAY — 14-Mar-2012

As the Kutchi shawl receives a Geographical Indication along the lines of Kancheepuram Silk” and Darjeeling Tea similar applications for the Patan Patola and Jamnagar Bandhani have also been filed on behalf of weavers associations over the last few months.

A life saver

Shamnad Basheer — 15-Mar-2012

Compulsory licence can go a long way to ensure access to cheaper drugs.

Samsung loses bid to ban iPhone iPad in Netherlands

Reuters — 15-Mar-2012

Samsung Electronics Co said on Thursday a Dutch court rejected its 3G patent bid to ban sales of Apples iPhone and iPad in the Netherlands.

Local regulations keep foreign pharma companies on tenterhooks

Khomba Singh — 15-Mar-2012

The grant of the countrys first compulsory drug licence and recent attempts at populist policy initiatives have raised fears of overseas pharmaceutical firms.

Heritage brands big earners in pharma

Rupali Mukherjee — 15-Mar-2012

In an age where billions of dollars are being spent on research for new molecules and drugs it appears that old is still gold in the Indian pharmaceutical market.

Breaking the patent

Business Standard / New Delhi — 15-Mar-2012

Last week India issued its first compulsory licence.

Kodak gearing up for robust patent sale: Sources

Reuters — 15-Mar-2012

Bidders are lining up in earnest now that Eastman Kodaks patent sale is set to resume.

The generics boom in India

15-Mar-2012

The year 2012 is turning out to be an uncomfortable year for big pharma.

Natco examining other drugs to identify compulsory license targets

Khomba Singh — 15-Mar-2012

Having won a landmark decision Natco Pharma is collecting data to identify other life saving drugs where they can apply for compulsory licensing.

MSF asks Indian generic cos to obtain more CLs to make drugs affordable & accessible

Ramesh Shankar, Mumbai — 16-Mar-2012

Médecins Sans Frontières has urged other Indian generic companies to come forward to apply for compulsory licenses including on HIV medicines if they cant get appropriate voluntary licenses from the patent holders to make these life saving patented drugs available to the common people of this country.

Kodak gearing up for robust patent sale sources

Reuters — 16-Mar-2012

Bidders are lining up in earnest now that Eastman Kodaks patent sale is set to resume.

Cheap generics drugs no panacea for Indias poorest

Reuters — 18-Mar-2012

Cheap generic drugs were meant to change the life of Nandakhu Nissar whose mouth is swollen by a cancerous tumour.

India bats for generic drugs seeks Africas support

18-Mar-2012

Commerce Minister Anand Sharma Sunday said that India will resist any attempt made to malign the countrys generic drugs industry as it provided a means for poor sections of the society to access cheap medicines.

Cheap generics no panacea for poor

Reuters / Mumbai — 20-Mar-2012

Cheap generic drugs were meant to change the life of Nandakhu Nissar whose mouth is swollen by a cancerous tumor.

Bitter pill

Manoj C G — 21-Mar-2012

The Left has expressed concern about the recent spate of mergers and acquisitions of Indian pharmaceutical companies by foreign multinationals.

Apple vs Android: The costly patent war

Reuters — 21-Mar-2012

Before his death Apple Incs Steve Jobs famously promised to go thermonuclear against smartphones running Googles Android software saying they use technology ripped off from the iPhone.

Bharti, Vodafone, RCom, Tata sued over music copyright

Yogesh Pawar — 21-Mar-2012

The high court order last week restrained the ISPs from reproducing adopting distributing communicating transmitting disseminating or displaying in any manner infringing the copyright in sound recordings belonging to the IMI member companies.

Force India slapped with big pay out

Agencies — 22-Mar-2012

The pay out was demanded by the High Court in London on Wednesday following a copyright infringement case according to a lawyers statement seen by AFP and media reports.

Complaints against Chinese companies for counterfeiting Indian products

Our Bureau — 22-Mar-2012

Several complaints including from leading companies such as Raymond and Boroplus have been received by the Indian Embassy in Beijing against counterfeiting of their products.

Government probes copyright violation of brands like Onida home appliances Boroplus antiseptic cream by Chinese firms

ET Bureau — 22-Mar-2012

India is investigating cases of rogue Chinese companies allegedly copying trusted Indian branded products including Onida home appliances Boroplus antiseptic cream Raymond suitings and even Kama Sutra condoms and selling them in China and abroad.

Roche to slash prices of expensive cancer drugs in India

PTI — 23-Mar-2012

This development comes close on the heels of India permitting Natco Pharma to manufacture and sell cancer treatment drug Nexavar at a price over 30 times lower its patent holder Bayer Corporation.

Agent Vinod gets HC relief in copyright case

Express news service — 23-Mar-2012

Saif Ali Khan starrer Agent Vinod will hit theatres on Friday with its popular Pungi baja de number intact as the Bombay High Court on Thursday granted no relief to Iranian music company Barobax Corp that alleged a copyright infringement in the use of the song.

Microsoft drops patent suits against TiVo

Bloomberg — 23-Mar-2012

TiVo Inc said Microsoft Corp agreed to drop patent infringement litigation that could have led to a US import ban on TiVos television set top boxes.

Move to cut cancer drug price not linked to Bayer case: Roche

Thomas K. Thomas — 23-Mar-2012

Pharmaceutical major Roche said that its decision to slash the price of two expensive cancer drugs in India is not linked to the Bayer Natco case.

Patent office to undergo major technological up gradation under new Chief

Suja Nair Shirodkar, Mumbai — 24-Mar-2012

Major technological up gradation is being planned in the patent office to enhance the quality of its services according to the new controller general of patents who took charge last week in Mumbai.

Google patents environment based ads

Indo-Asian News Service — 24-Mar-2012

Google has been awarded a patent on technology that will serve up targeted advertising based on a smartphone users environment The Telegraph reported Friday.

Facebook buys IBM patents

AFP — 24-Mar-2012

Facebook confirmed Friday that it has added a trove of IBM patents to its arsenal on an increasingly lawsuit strewn technology battlefield.

Force India to appeal copyright case against Caterham

Agence France-Presse — 25-Mar-2012

Force India said Sunday they would appeal for a higher pay out after Caterham were found to have copied bits of their Formula One car comparing the case to the explosive Spygate scandal.

Hollywood studios body inks IPR deal with Tollywood

Our Bureau — 25-Mar-2012

The Motion Pictures Association of America the association of all major studios in Hollywood, has signed an agreement with Tollywood the Telugu film industry to work in the area of protection of intellectual property rights.

Take permission for new Zanjeer Javed Akhtar

Priya Shahi — 26-Mar-2012

After almost 40 years the man who penned the unforgettable dialogue Mere paas maa hai is asking the producers of the remake of the classic Zanjeer Kya tere paas copyright hai?

Natco-Bayer CL judgment: Temper enthusiasm with reality

P.T. Jyothi Datta — 26-Mar-2012

Patients in the advanced stage of kidney cancer can take some solace from the fact that a key drug in their treatment will now be available at a much lower price.

Novartis challenges patent rejection in India

26-Mar-2012

The Swiss pharmaceutical company Novartis is about to challenge patent rejection in India before the Supreme Court of India. The court case is to begin on March 28.

The international trade climate change interface is emerging as a new issue

27-Mar-2012

In fact the interface between international trade and climate change is fast emerging as a new issue even though it does not find mention in the originally drafted rules of the General Agreement on Tariffs and Trade or the World Trade Organization.

India defends compulsory licensing of patent drugs

Asit Ranjan Mishra — 27-Mar-2012

Countrys intellectual property rights are in tune with trade related aspects of WTO deal says commerce minister

US protests patent issuance to Natco to sell copied versions of Nexaver

Amiti Sen — 27-Mar-2012

The US has criticised Indias decision to issue its first compulsory licence to domestic drug company Natco for selling copied versions of Bayers anti cancer drug Nexaver arguing that it would discourage new investments and dilute the international patent regime but India said it has not broken any rules.

Patent office may grant CL in future if circumstances demand so Patent Controller

Suja Nair Shirodkar, Mumbai — 27-Mar-2012

With respect to safeguarding of public interest and to ensure availability of life saving drugs at affordable prices Patent office informed that they may certainly consider accepting Compulsory Licence applications in future also if circumstances demand so.

Google proposes Android revenue for Oracle: Report

Reuters — 28-Mar-2012

Google proposed to pay Oracle a per centage of Android revenue if Oracle could prove patent infringement of the mobile operating technology at an upcoming trial but Oracle rebuffed the offer as too low according to a court filing late on Tuesday.

Apple Sony sued for infringing a patent

Reuters — 28-Mar-2012

Apple Inc Sony Corp and four other companies were sued by Graphics Properties Holdings Inc formerly known as Silicon Graphics Inc for allegedly infringing a patent through their sale of mobile phones and other electronic devices.

Facebook investors warned of unfavorable outcome in Yahoo patent lawsuit

ANI — 28-Mar-2012

Social networking giant Facebook has warned investors of an unfavorable outcome in connection with a patent lawsuit brought against the firm by Yahoo.

Kolaveri against piracy

R. Balaji — 29-Mar-2012

The order provides for quick action against the offender rather than react after somebody has infringed on the rights of intellectual property owners.

AOL patents valued at $290m

Bloomberg — 29-Mar-2012

AOL Incs patent portfolio would be valued at about $290 million in a sale less than a third of the amount that shareholder Starboard Value LP has estimated it could generate according to patent advisory firm M Cam Inc.

AOL patents valued at $290m

Bloomberg — 29-Mar-2012

Natco formulates a new opportunity

B Dasarath Reddy / Hyderabad — 29-Mar-2012

The drug prices of global pharma companies have no justification whatsoever not just in India but around the world says V C Nannapaneni chairman of Natco Pharma a Hyderabad based pharma company.

White hot rivalry to curb gains from generic Seroquel

Priyanka Golikeri — 30-Mar-2012

Cut throat competition is seen limiting the opportunity on blockbuster anti psychotic drug Seroquel the patent on which expired on March 26 in the US.

Youngest patent holder on wheelchair

Ajay Singh — 30-Mar-2012

Drawing inspiration from scientist Stephen Hawking a wheelchair bound nine year old boy here has invented a game of six player circular chess.

Apple mulls settling patent fights with Samsung

IANS — 30-Mar-2012

Top executives at Apple and Samsung have met recently about a potential patent settlement a media report said Thursday.

Supreme Court reschedules final hearing on Novartis’ case on Sec 3(d) of Patents Act to July 10, 2012

Ramesh Shankar, Mumbai — 30-Mar-2012

The Supreme Court has once again rescheduled the final hearing of the much awaited case involving the Swiss pharma major Novartis and the government of India.

The new world is about brands and not intellectual property

Sridhar K. Chari — 31-Mar-2012

Kapur says the website Qyuki will provide an interactive platform to create media and also bypass gatekeepers

EU antitrust regulators may probe Motorola Apple Microsoft dispute

Reuters — 31-Mar-2012

EU antitrust regulators may open an investigation into a patent dispute between Apple Inc Microsoft Corp and Motorola Mobility Holdings Inc to ensure patent holders do not thwart rivals the EUs antitrust chief said on Friday.

Ideal Cures gets US patent for sodium alginate based aqueous film coating technology

Our Bureau, Mumbai — 31-Mar-2012

Mumbai based Ideal Cures recently secured a US patent for its innovation sodium alginate based aqueous film coating technology claimed as both cost effective and non toxic.

A Strike against Pharma MNCs

EDITORIALS — 31-Mar-2012

The grant of a compulsory licence to Natco Pharma a relatively small Indian pharmaceutical company to manufacture and sell the cancer drug sorafenib has been rightly hailed as a major step forward for public health and the wider availability of life saving medicines.

EU\'s Almunia: may probe Motorola, Apple, Microsoft dispute

Reuters — 31-Mar-2012

Tech patents: Touch is forbidden

Reuters — 01-Apr-2012

You can look but you cant touch great advice in most museums and every strip club.

Licence must for playing music in public places

TNN — 02-Apr-2012

The Indian Performing Right Society Limited which is authorized by the government to issue public performance license said gross violation of the Copyright Act 1957 is going on in the state as far as commercial establishments and playing music in public places are concerned.

Australia settles patent suit in US wi fi case

Bureau Report — 2-Apr-2012

Australias scientific research agency has reached a multi million dollar out of court settlement in the United States over the use of its wireless internet technology which underpins wi fi platforms worldwide.

Innovation: A journey from the mind to the marketplace

R A Mashelkar — 02-Apr-2012

Going beyond mere research laboratories India must build a powerful national innovation ecosystem comprising robust physical intellectual and cultural constructs

Microsoft shuts German distribution on patent row

Reuters — 02-Apr-2012

Microsoft is moving its European software distribution to the Netherlands from Germany after being caught up in legal disputes over patents with Motorola Mobility Inc in Europes biggest economy.

Twitter to patent refresh page gesture?

Reuters — 02-Apr-2012

Many are trying, thanks to software patents.

Ranbaxy starts generic Lipitor shipments from India

02-Apr-2012

Ranbaxy Laboratories Ltd has started exports of a copycat version of blockbuster cholesterol drug Lipitor from a new facility in India that has been approved by the US Food and Drug Administration.

Settlement talks fail in Google vs Oracle patent case

PTI — 3-Apr-2012

A federal judge in the heart of Silicon Valley has said that Google and Oracle have failed to settle a patent dispute out of court and that the case will head to civil trial.

Apple secures 17 patents including wireless sync

Don Reisinger — 03-Apr-2012

The companys new patents range from a single security model for booting a computing device to a design patent on its current iPod Shuffle.

EU probes Google\'s Motorola in Apple, Microsoft patent war

AFP — 03-Apr-2012

European regulators opened Tuesday two antitrust investigations against Motorola Mobility bought by US Internet giant Google in the latest chapter of an escalating patent war with Apple and Microsoft.

Suven Life gets 4 patent approvals for neuro drug

Press Trust of India / New Delhi — 03-Apr-2012

Drug firm Suven Life Sciences today said it has received four product patents in China and Korea for its new chemical entities which could be used for treating various central nervous system disorders.

Patent controller to meet stakeholders today at his office

Suja Nair Shirodkar, Mumbai — 3-Apr-2012

With a view to understand the demands of the industry the patents office has organised a high profile meeting with the stakeholders in Mumbai on April 3.

BlackBerry maker RIM sued by NXP over patents

Reuters — 4-Apr-2012

A Dutch semiconductor company said on Tuesday it had filed a patent infringement suit against Research In Motion Ltd adding to the BlackBerry makers troubles and sending its shares tumbling.

Patent war: Facebook goes against Yahoo

Reuters — 4-Apr-2012

Facebook fired back in its legal battle with Yahoo by accusing the web pioneer of infringing 10 of Facebooks patents according to a court filing.

UK court rules against Force India in copyright violation case

P.R. Sanjai — 5-Apr-2012

A UK court on 30 March dismissed his auto sports company Force Indias three year old plea of copyright violation against UK based Aerolab SRL the respondent in the case and a former designer of Force India cars.

UK court rules against Force India in copyright violation case

P.R. Sanjai — 5-Apr-2012

US court picks terms in Apple Samsung patent case

Reuters — 5-Apr-2012

A US judge largely sided with Apple on Wednesday over how several technical terms will be defined in its patent fight against Samsung over smartphones and tablets.

Facebook launches patent counter-attack

Reuters / San Francisco — 5-Apr-2012

Facebook fired back yesterday in its legal battle with Yahoo by accusing the Web pioneer of infringing 10 of Facebooks patents according to a court filing.

Apple drops patent claim against Motorola Mobility

Bloomberg — 05-Apr-2012

Apple Inc dropped a claim that Motorola Mobility Inc infringed one of its five patents at issue in a federal lawsuit in Chicago while reserving its rights to revive the case after appealing a pre trial ruling.

Drug prices need to be monitored not controlled

George Mathew — 7-Apr-2012

Ranjit Shahani vice chairman and MD of Novartis India and president of the Organisation of Pharmaceutical Producers of India the representative body of MNC pharma firms spoke to George Mathew on the issue of intellectual property rights and public health. Excerpts:

Joe C Mathew: Drug policy gets a dose of reality

Joe C Mathew — 7-Apr-2012

The patent office has shown why India won?t become hostage to high priced multinationals under a TRIPs compatible regime.

Reverse innovation

09-Apr-2012

The government policies should strengthen the essential core of eco system for innovations namely the large and growing markets liberal investment policies and protection of intellectual property rights.

AOL to sell 800 patents to Microsoft for $1bn

Agencies — 09-Apr-2012

AOL Inc said it agreed to sell more than 800 of its patents and related patent applications to Microsoft Corp and grant the software maker a non exclusive license to its retained patent portfolio for about $1.056 billion in cash.

Cipla pins hopes on European inhaler market

Reghu Balakrishnan — 09-Apr-2012

Cipla Ltd a domestic pharmaceutical major is set to tap the European inhaler market with generic drug launches in those markets.

What makes Germany hub of tech patent battles

Kevin J O\'Brien — 09-Apr-2012

Is Germanys system of litigating disputes over patents bad for business?

Russia seeks details of dilution in Indian tea speciality tag

Arun S and Vishwa — 09-Apr-2012

Russia has sought detailed information from India on complaints over alleged dilution of the speciality tag for Darjeeling Assam and Nilgiris teas.

Venus Remedies gets Australian patent approval for Vancoplus

PTI — 10-Apr-2012

Drug firm Venus Remedies today said it has received approval from the Australian Patent office for its product Vancoplus used for treating bacterial infections.

Only strong patent protection can drive investments from West into India: Nobel Laureate Kurt Wuthrich

Our Bureau, Bengaluru — 10-Apr-2012

Patent protection in India would help drive future research initiatives.

AOL strikes $1.1-bn patent deal with Microsoft Corp

Michael J. De La Merced — 10-Apr-2012

AOL agreed on Monday to sell a portfolio of over 800 patents and license about 300 more to Microsoft for $1.056 billion amid an arms race within the technology industry over intellectual property.

Yahoo files patent applications for e book advert

ANI — 10-Apr-2012

Internet firm Yahoo has filed applications for two different patents aimed at serving customers advertisements within e-books.

Copyright case against Madhur Bhandarkar for Fashion

PTI — 11-Apr-2012

A complaint against Bollywood filmmaker Madhur Bandarkar for allegedly stealing the plot and idea of his movie Fashion from a book without giving credit to its author was on Wednesday referred to a designated special court in Delhi dealing with copyright cases.

Govt may allow third-party audits for drug quality

Namrata Nandakumar — 11-Apr-2012

Third party audits in drug factories a practice accepted in developed countries including the US is likely to be allowed initially for traditional medicines and may then be extended to modern drugs

WiLAN: US patent office upholds V-chip claims

Reuters — 11-Apr-2012

The US Patent and Trademark Office has confirmed the validity of WiLAN Incs patent for V chip technology which enables objectionable television content to be blocked the Canadian company said on Tuesday.

Nilgiri planters to boost speciality tea output

Vishwanath Kulkarni — 11-Apr-2012

Further the NPA plans to leverage the Geographical Indication status granted to the Nilgiris tea and brand them accordingly in the overseas market.

Dr Reddys seeks nod for fondaparinux launch in Europe

KV Ramana — 11-Apr-2012

A drug marketed by GlaxoSmithKline Arixtra has been off-patent since 2002.

Chart of the day | Generic Preference

Yogesh Kumar — 12-Apr-2012

In 2011 the spend on generic medicines rose by $5.6 billion Rs28,840 crore today compared with $7.6 billion in 2010 but accounts for nearly half of incremental growth in total spends.

US judge backs Microsoft in Motorola patent dispute

Bureau Report — 12-Apr-2012

A judge in US District Court in Seattle granted Microsoft a preliminary injunction and temporary restraining order against Motorola in Germany the software company said.

Oracle Google prepares for trial in World Series of IP cases

Karen Gullo — 12-Apr-2012

Oracle Corp. will ask a jury next week to find that Google Inc. stole its intellectual property to make Android software in a trial that a federal judge called the World Series of IP cases.

Pharma leads Indias patent charge as tech telecom lag behind

Soma Das — 12-Apr-2012

Top patent seekers from US Japan and China who file the maximum patent applications hail from IT telecom and consumer electronics while those from India are from an entirely different field: Pharmaceuticals.

Patent case: Microsoft wins ruling against Motorola

Reuters — 12-Apr-2012

Microsoft Corp said on Wednesday it won a ruling in a Seattle court effectively preventing phone company Motorola Mobility from immediately obtaining an injunction in Germany that could stop Microsoft from selling its Xbox and other software products there due to a patent disagreement.

GSK, Teva in talks to buy Micro Labs India business

Reghu Balakrishnan / Mumbai — 13-Apr-2012

Multinational drug majors who are leaving no stone unturned in their efforts to strengthen their India presence are back in the buyout market scouting for the next big M&A opportunity.

German court rules in Motorolas favour in Apple patent row

AFP — 13-Apr-2012

Motorola scored a victory in a patent war with rival Apple on Friday when a German court upheld a decision banning it from offering services for syncrhonising e mails on its devices in Germany.

Oracle gets ready to battle Google

Reuters — 13-Apr-2012

Oracle Corp is set to go to trial next week against Google Inc in a high stakes dispute over smartphone technology the biggest case in what is shaping up to be an intense year in court for the enterprise software giant.

Bhandarkar amused over `Fashion` copyright case

IANS — 14-Apr-2012

Filmmaker Madhur Bhandarkar is amused by the copyright infringement case filed against him for 2008 film Fashion.

Gujaratis patent to rein in blue chip majors

Bhavesh Shah — 14-Apr-2012

Yogesh Rathod a Mumbai based Gujarati has got an US patent that will force blue chip companies like Twitter Facebook Apple Oracle and others to shell out billions of dollars as royalty to him every year.

Chinas smartphone firms warned of patent disputes

IANS — 15-Apr-2012

Chinas smartphone companies are at risk of becoming embroiled in disputes over intellectual property rights since many important patents are held by international companies like Google and Microsoft experts have said.

Ajay Piramal set to buy European drug firm to conduct basic phrmaceutical research

ET Bureau — 16-Apr-2012

Indian drug companies have now started investing in basic drug research after years of spending money on a business model which copied patented drugs and relied on litigation and aggressive marketing to push the product after patent expiry.

Indian competition regulator likely to take hands-off approach to pharma

Freny Patel — 16-Apr-2012

Pharmaceutical acquisitions where there is overseas investment have come under regulatory scrutiny in India recently to ensure that the existing price control regime is maintained.

Lenovo, ZTE, Huawei warned of patent disputes in phone market

IANS — 16-Apr-2012

Motorola wins patent war against Apple

Reuters — 16-Apr-2012

A German court on Friday upheld a ban on push emails in Apples iCloud and MobileMe services in Germany ruling in favor of rival Motorola Mobility.

Oracle says Googles own emails show its guilt

Bureau Report — 17-Apr-2012

An Oracle attorney cited emails between top executives at Google as prime evidence that Google took its intellectual property to gain an edge in the lucrative smartphone market, at the start of a high stakes trial between the two tech giants.

Drug makers will post 15-34% growth in Q4 revenue, say analysts

Namrata Nandakumar & C.H. Unnikrishnan — 17-Apr-2012

Indias drugs sector is heading into a year of fewer patent expiries critical for an industry that thrives on selling copies of successful medicines but is set to end the previous fiscal year with a strong showing in the final quarter supported by growth in the domestic market and a favourable rupee movement.

Caraco can sue Novo Nordisk to narrow drug description: US Supreme Court

Reuters — 17-Apr-2012

The US Supreme Court ruled on Tuesday in favor of Caraco a unit of Sun Pharmaceuticals an Indian generic drugmaker in a case over how companies can fight brand name rivals in an effort to get their cheaper medicines to market.

US top court rules for Sun Pharma unit on patent

Reuters — 17-Apr-2012

The U.S. Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how companies can fight brand-name rivals in an effort to get their cheaper medicines to market.

Apple and Samsung chiefs to meet to sort patent dispute

18-Apr-2012

The chiefs of Apple and Samsung have agreed to meet in a bid to resolve a patent case between the two in a California court.

Twitter to limit use of patents in lawsuits

Reuters — 18-Apr-2012

Twitter said on Tuesday that it would structure its patents so they could not be used for offensive litigation purposes without permission from the people who developed them.

Sun Pharmaceutical Industries gets favourable US Supreme Court verdict in patent case

PTI — 18-Apr-2012

Sun Pharmaceutical Industries today said the US Supreme Court has given a favourable verdict in its patent case against Novo Nordisk over generic Prandin tablets used for treating diabetes.

IITs start filing patents to safeguard technical innovations

PTI — 18-Apr-2012

IITs have now started filing patents to safeguard their technological innovations which previously were published as research and development papers.

Nestle wins Nespresso patent battle

Reuters — 19-Apr-2012

Nestle has won a case against rivals including Sara Lee at the European Patent Office concerning its fast growing Nespresso coffee machines and capsules.

Twitter gives peace a chance in patent wars

Reuters — 20-Apr-2012

All we are tweeting is give peace a chance.

MNC drug brands show healthy growth trend in India market

Joe C Mathew / New Delhi — 20-Apr-2012

Incidentally Januvia enjoys a product patent and hence has no generic competition in India.

Nokia loses wireless patent ruling

Bloomberg — 20-Apr-2012

Nokia Oyj lost a ruling in a German court today in a patent lawsuit brought by IPCom GmbH & Co.

AOL patents: Facebook lost to Microsoft on price

Bloomberg — 20-Apr-2012

Facebook Inc the biggest social networking service made an offer for AOL Incs patent portfolio before losing out to Microsoft Corps $1.06 billion bid two people with knowledge of the matter said.

Nokia loses IPCom patent case in German court

Reuters — 21-Apr-2012

Nokia lost a court case on Friday after a regional court in Mannheim Germany found the Finnish mobile phone company had violated patents belonging to German patent firm IPCom.

Future of Indian pharma lies beyond generics

Ajay Dsouza — 22-Apr-2012

The Indian pharmaceutical industrys emergence on the global landscape as a strong generics player was due in no small measure, to the Indian Patents Act 1970 which allowed only process patents in pharmaceutical products.

Dont shut door on cheap drugs

P. Bhaskara Narayana — 23-Apr-2012

Even with patent laws the Government can permit marketing of generics so that patients benefit from cheaper costs.

Facebook pays Microsoft $550 mln for AOL patents

Reuters — 24-Apr-2012

Facebook will pay Microsoft Corp $550 million for hundreds of patents that originated with AOL beefing up its intellectual property arsenal.

Microsoft Xbox infringes Motorola patent

Reuters — 24-Apr-2012

Microsoft infringed Motorola Mobilitys patents in making its popular Xbox gaming consoles a judge for the US International Trade Commission ruled.

Apples iPhone iPad infringes Motorola patents

Reuters — 25-Apr-2012

Apple Inc infringed on a Motorola Mobility Holdings Inc patent in making its popular iPhones iPads and other products a judge for the International Trade Commission ruled on Tuesday.

Nokia HTC win European patent ruling

Bureau Report — 26-Apr-2012

Helsinki: Finlands Nokia and Taiwans HTC won a key European ruling that a patent of German firm IPCom which was threatening sales of their phones in Germany was invalid in its current form.

Efforts on for five more Geographical Indication tags for region

Rajeev Dikshit — 26-Apr-2012

Now, five more handicraft items of the region are in the quest for the Geographical Indication.

India to have national intellectual property rights strategy

IANS — 26-Apr-2012

The Indian government has set up a sectoral council to prepare national intellectual property rights strategy with a view to incentivise innovation a senior official said Thursday.

Affordable health to weigh in health patent regime: Govt

PTI — 26-Apr-2012

The international IP regime that exists today provides enough flexibility to model a domestic legal framework to the local conditions that exist within a country says secretary in DIPP Saurabh Chandra

Patients before patents in healthcare

P.T. JYOTHI DATTA — 27-Apr-2012

Close on the heels of the Indian Patent Office issuing a compulsory licence to Natco the Kenyan High Court ruling on the countrys anti counterfeit law has said that the citizens right to health is supreme.

Tata Steel plans to license patents to other steel firms

Aveek Datta — 27-Apr-2012

The company plans to commercially exploit a few of its over 1200 patents in India and abroad by licensing them out to other steel manufacturers

Patent laws, IPR should be taken to traditional sectors too

Staff Reporter — 27-Apr-2012

The scope and significance of intellectual property rights and patent laws should be taken to and promoted among the under privileged sections apart from ensuring their application in traditional systems V.N. Rajasekhara Pillai Principal Secretary has said.

Indian cheap anti cancer drug gives hope

Amarnath K. Menon, India Today — 27-Apr-2012

It is the first case of grant of cl in the past seven years since the amended Patents Act came into effect.

Yahoo escalates patent battle with Facebook

AP — 28-Apr-2012

Yahoo is bringing out more artillery in its patent battle with Facebook.

In patent wars Apple prefers to settle versus battle

Bloomberg — 28-Apr-2012

Apple CEO Tim Cook was asked on yesterdays earnings call whether it would be in the companys best interests to clear the decks of all its various patent suits.

US puts India China Pakistan on IPR watch list

PTI — 01-May-2012

The US Government has put India China and Pakistan along with 10 other countries on the intellectual property watch list for failing to prevent the theft of copyrighted property.

Misinformed campaign against Glivec

RANJIT SHAHANI — 01-May-2012

More than ten years have passed since Digamber Bhalerao walked into my office with his wife looking for Novartis to support his drug treatment for his CML.

Intellectual Property Magic of value creation

MADHU SOODAN POUDYAL — 01-May-2012

The World Intellectual Property day was observed this year with the slogan Visionary innovators.

India needs to do more on IPR: US govt report

HT Correspondent — 2-May-2012

The United States on Monday said that though India has acted against movie and music piracy it needs to do more on protection and enforcement of intellectual property rights.

Pfizer profits solid despite Lipitor loss

Ransdell Pierson — 2-May-2012

Pfizer Inc. reported higher than expected quarterly earnings as improved profit margins and strong sales of its Lyrica nerve-pain drug partly offset plunging demand for its Lipitor cholesterol fighter now facing cheaper generic rivals.

L&T filed 162 patent applications for its electrical and automation products in 2011-12

Rachita Prasad — 02-May-2012

Larsen & Toubro filed 162 patent applications for its electrical and automation products during 2011 12 the 11.7 billion engineering and construction conglomerate said Wednesday

Nokia files patent suit against RIM HTC and Viewsonic

PTI — 3-May-2012

Finnish telecom giant Nokia has filed a suit against Blackberry maker RIM HTC Corp and Viewsonic Corp in the US and Germany alleging infringement of its patents by these companies.

Cipla slashes generic price of Bayers cancer drug Nexavar

PTI — 03-May-2012

Separately Cipla is fighting a patent infringement suit by Bayer over generic Nexavar in an Indian court.

Desi companies dominate US generic space

Rupali Mukherjee — 4-May-2012

India is playing a dominant role in the US generic pharma space having cornered over half the certified dossiers filed globally for active pharmaceutical ingredients.

Bayer appeals against compulsory licence order

C.H. Unnikrishnan — 5-May-2012

German drug maker Bayer HealthCare AG has appealed against the compulsory licence granted to Natco Pharma Ltd to manufacture and market cancer drug Nexavar by Indias Controller General of Patents.

Cipla may cut prices of other cancer drugs too

Rupali Mukherjee — 05-May-2012

Domestic pharma major Cipla may extend its affordable and humanitarian pricing strategy on other anti cancer drugs in its portfolio even as domestic generic companies are still trying to grapple with the huge cuts and evaluate their pricing options.

US to keep an eye on Indias compulsory drug licensing move

Joe C Mathew / New Delhi — 6-May-2012

Puts India on priority watch list which means US trade body doubts India over intellectual property rights

Infosys patent filings up 50% in FY 2012

Venkatesh Ganesh — 6-May-2012

Infosys has increased its patent filings by 50 per cent over FY11.

Apple wins ruling sanctions in Samsung suit

Bloomberg — 07-May-2012

After the Indian government recently lifted a patent license Indian pharma major Cipla has announced a massive reduction of up to 76 per cent in its cancer drug prices.

The man who made cancer drugs affordable and made millions

Patralekha Chatterjee — 07-May-2012

Big Pharma accuses him of exploiting others intellectual property to swell his own coffers undermining investment in drugs of the future.

Patently right

Business Standard / New Delhi — 07-May-2012

Apropos the article The myth of coalition compulsions it is misleading of Ravi Shanker Kapoor to say compulsory licensing for pharmaceutical products is restrictive.

Indias patent protection regime to be key issue in talks with US

Vidya Krishnan — 07-May-2012

Next months dialogue takes place ahead of a hearing in SC on an appeal by Novartis seeking an extension of its patent on Glivec

Satyamev Jayate in copyright trouble with Euphoria

IANS — 07-May-2012

Aamir Khans show Satyamev Jayate which has garnered a positive response from TV viewers has got stuck in a copyright issue filed against Ram Sampath the music composer of the title track by Palash Sen the lead singer of Euphoria.

Bayer challenges Nexavar generic licence order

PTI — 07-May-2012

Drugmaker Bayer has filed an appeal against an Indian Patents Offices order which allowed domestic drug maker Natco Pharma to sell a generic version of the German firms cancer drug Nexavar in India with the Intellectual Property Appellate Board.

Extend drug patent life to rejuvenate R&D

Mr Dale A. Frost — 8-May-2012

Furthermore it fails to acknowledge the primary problem which is not money.

Google infringed Oracle Java copyrights - jury

Reuters Malathi Nayak SAN FRANCISCO — 8-May-2012

Inc infringed some of Oracle Corps copyrights on the Java programming language a U.S. jury found on Monday after days of deliberation.

Sorafenib: A tale of moves and counter-moves

P.T. Jyothi Datta — 8-May-2012

Three drug companies and three prices on their respective versions of Sorafenib a medicine used to treat advanced kidney cancer.

Biocon-Mylan partnership has a potential of $33 billion from biosimilar drugs

Divya Rajagopal — 8-May-2012

Biocon will also have to face Roche pharma which has the patent for this drug and recently it tied up with Pune based Emcure to sell cheaper and locally branded versions.

Cipla eyes price cuts on more cancer drugs

Kaustubh Kulkarni and Tony Munroe — 8-May-2012

Cipla which is engaged in several long-running legal battles with foreign drugmakers will mount a challenge to a rivals patent only if it believes its chances of winning are at least 75 percent Hamied said.

GSK not under compulsion to buy Indian companies: Hasit Joshipura

Khomba Singh — 8-May-2012

Global pharma companies have been aggressively looking to buy Indian firms to mitigate revenue loss due to patent expiry of their top selling brands and also tap the fast growing Indian drug market.

India has stable IPR regime: Sharma tells U.S.

Sandeep Dikshit — 8-May-2012

Opposes decision to put India on watch list

Abbott to Pay $1.6 Billion to Settle Depakote Drug Allegations

Jef Feeley and Margaret Cronin Fisk — 8-May-2012

Abbott Laboratories said it reached an agreement to pay $1.6 billion to settle federal and state claims resulting from an investigation into its epilepsy medication Depakote the second largest drug marketing settlement in U.S. history.

Inspiration not copying

KV Lakshmana — 8-May-2012

Copying is our birthright can well be our motto given how people from all walks of life are getting inspired by others.

Google’s Android Infringed Oracle’s Java, Jury Says

Karen Gullo — 8-May-2012

A federal judge said Oracle Corp. cant seek $1 billion in damages from Google Inc.

Compulsory licensing sets off a wave of price cuts in cancer drugs

C.H. Unnikrishnan — 09-May-2012

In 2010 about 600000 people in the country died of cancer according to a recent joint study by the Tata Memorial Hospital and the Centre for Global Health Research

Health panel rap to drug regulator, boost for consumers

P.T. Jyothi Datta — 9-May-2012

On an average DCGI is approving one drug every month without trials.

India protests USs move to put it on IP rights watch list

Asit Ranjan Mishra & Vidya Krishnan — 09-May-2012

The government strongly objected to the US placing India on a priority watch list in its latest trade representatives report which raises concerns over the countrys enforcement of IP rights.

Patented drugs: No application pending for compulsory license, says government

PTI — 09-May-2012

Amid concerns that more domestic pharma companies could seek compulsory licenses to replicate patented drugs the government said no such application is pending for approval.

Ranbaxy net jumps on generic Lipitor

Kaustubh Kulkarni/Reuters — 10-May-2012

The sales in the north American market more than doubled to Rs. 2093 crore in the period the first full quarter of sales of its copycat version of blockbuster Lipitor.

ACTA as the villain

T S Vishwanath — 10-May-2012

The Anti-Counterfeiting Trade Agreement is finding more detractors than supporters

Cancer drugs still way too costly

P.T. JYOTHI DATTA — 10-May-2012

At Rs 7000-8000 a month after compulsory licence cancer medicines are still very expensive for ordinary Indians.

Ranbaxy appears to be making progress, margins likely to rise

Mark to Market | Mobis Philipose — 10-May-2012

Reported revenue and profit were higher than Street estimates aided largely by sales of generic Lipitor

Lipitor clone delivers for Ranbaxy

Priyanka Golikeri — 10-May-2012

The generic version of Lipitor atorvastatin the top selling anti cholesterol drug whose global sales once peaked at $13 billion is turning out to be a money spinner for Ranbaxy in the US.

AOL revenues beat forecast

Reuters — 10-May-2012

AOL Inc reported better-than-expected quarterly results and said it intends to hand over to shareholders 100 per cent of the proceeds from its patent sales to Microsoft.

Ranbaxy needs to strengthen base business for double-digit growth

ET Bureau — 10-May-2012

Sales from Lipitor generic Atoravastatin helped Ranbaxy to post a stellar performance in the March quarter.

Cipla breached patent rights by slashing cancer drug price: Bayer

PTI — 10-May-2012

German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent protected cancer drug Nexavar last week.

Abraham Lincoln tried to patent Facebook-like idea

ANI — 10-May-2012

In 1845 Abraham Lincoln had tried to patent an idea very similar to Facebook it has been revealed.

Import of patented goods without IPR authorisation allowed

PTI — 10-May-2012

Imports of goods protected by patent or trademarks are permitted even without authorisation of the Intellectual Property Rights holder according to the Finance Ministry.

Quo Vadis, Indian Pharma?

RAMESH ADIGE FORMER PHARMA EXECUTIVE — 11-May-2012

The government needs to think out of the box to help pharma grow while keeping medicines affordable

Compulsory licencing of Bayers cancer drug is a triumph

Dinesh Narayanan, Forbes India — 12-May-2012

The third one is the health systems agenda and the changes that are required particularly the universal healthcare agenda that is currently being debated.

Saregama Balaji Telefilms spar over The Dirty Picture track

Arnab Dutta — 12-May-2012

The question on infringement of IPRs though hasnt yet been answered the appeals courts order from 24 April was only an interim measure to protect the interests of the firm claiming damages.

Biotech body criticises Bayer on cancer drug

Our Bureau — 12-May-2012

The All India Biotech Association Southern Chapter has come out strongly in favour of the Indian Patents Office order in favour of Natco Pharma Ltd.

Ailing Nokia falls back on patents legacy

Reuters — 14-May-2012

Desperate for cash to tide it over until sales ramp up of new products Nokia Oyj NOKIV.

India US see differences widen over trade diplomatic issues

Asit Ranjan Mishra & Elizabeth Roche — 14-May-2012

India US see differences widen over trade diplomatic issues

Pharma Inc GoM meet to tackle thorny pricing

Soma Das, MG Arun — 14-May-2012

The meeting assumes significance in the light of the ongoing debate on the high prices of certain medicines leading to the patent office recently resorting to compulsory licensing a governmental intervention that allowed domestic drug maker Natco offer a cancer drug at a fraction of the original cost charged by the innovator Germanys Bayer.

Good that copyright bill being taken up in Parliament: Akhtar

PTI — 14-May-2012

Veteran lyricist Javed Akhtar says he is happy that the copyright bill of which he has been a strong advocate has received the governments nod and hopes it will be passed by Parliament soon.

Over 1 lakh requests pending with patent offices

PTI — 14-May-2012

The government today said more than one lakh patent applications are pending with the Controller General of Patents Designs and Trade Marks.

Novartis Sues Lupin Torrent Over Blood-Pressure Medicine

Phil Milford and Sophia Pearson — 15-May-2012

Novartis AG sued Lupin Ltd. and Torrent Pharmaceuticals Ltd. for infringing patents on its Exforge HCT blood pressure medicine.

Too vague patents created the monster

Mr Joshua Shapiro — 15-May-2012

Sir Global enterprises themselves have created the mess that you detail in “The curse of innovation” by Richard Waters.

As China opens to basmati imports exporters scout for interpreters

Sanjay Sharma — 15-May-2012

Rice exporters in Karnal the hub of basmati rice exporters in Haryana are looking for Chinese language interpreters to explore possibilities of starting exports to China.

Apple granted patent for iOS steering-wheel remote

Joe Aimonetti — 15-May-2012

According to a recent patent grant Apple has been interested in solving an awkward issue faced by many drivers using their iOS devices in their cars.

Protests in US over high pricing of Novartis anti-cancer drug Glivec

Divya Rajagopal — 15-May-2012

Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous multi billion dollar anti cancer drug Glivec a development which challenges pharma MNCs claims of cheap access and affordability for patented drugs.

Apple wins review of tablet patent in Samsung dispute

Bloomberg, / Washington — 15-May-2012

Apple Incmaker of the iPhone and iPad can pursue efforts to win a sales halt of Samsung Electronics Cos Galaxy Tab 10.1 tablet computer in the US while a patent infringement case is pending a US appeals court ruled.

Kodak seeks expressions of interest for patents

Bloomberg — 15-May-2012

Eastman Kodak the photography pioneer that filed for bankruptcy in January is seeking expressions of interest in its digital imaging patents by today the first step in an auction of the technology.

Oracle patent claims vs. Google sent to jury

Reuters — 16-May-2012

A California jury began another round of deliberations on Tuesday in a high profile trial over allegations that Googles Android mobile platform violates Oracles intellectual property rights.

India and China to be a popular outsourcing destinations of choice for CMOs: GBI Research report

Our Bureau, Mumbai — 16-May-2012

Furthermore the introduction of the new patent regime in India during January 2005 encouraged multinational pharmaceutical companies looking to outsource their manufacturing of branded drugs with the protection of Intellectual Property Rights.

HTC Corp sales delayed due to patent dispute

Reuters — 16-May-2012

U.S. sales of two new smartphones from Taiwans HTC Corp will be delayed due to a patent dispute with Apple Inc a fresh blow to the company as it tries to turn around declining sales in what was once its largest market.

Ind Swift Wockhardt launch Atorvastatin tablets in UK

PTI — 16-May-2012

Drug firm Ind-Swift Laboratories today said it has launched generic formulations of the worlds best selling drug Atorvastatin in the UK in collaboration with Wockhardt UK on the first day of its patent expiry.

We are focused on drug discovery: Ajay Piramal

Piyush Pandey — 18-May-2012

Piramal Healthcare chairman Ajay Piramal on Wednesday announced the acquisition of US healthcare data services firm Decision Resources Group for $653 million.

Rajya Sabha nod for Copyright Amendment Bill

TNN — 18-May-2012

The Rajya Sabha on Thursday approved the Copyright Amendment Bill which seeks to remove operational difficulties and address newer issues related to the digital world and worldwide web.

US says will bar some Motorola Mobility phones

Reuters — 19-May-2012

Some Motorola Mobility smartphones infringe on a Microsoft patent and will be barred from importation in to the United States a US trade panel said on Friday.

DRL launches Plavix copy in US with exclusivity

C.H. Unnikrishnan — 19-May-2012

DRL will sell the larger dose of the drug known as clopidogrel by its generic name in the US market from Friday

Bayer demands withdrawal of Natco Pharma\'s compulsory licence

Khomba Singh — 19-May-2012

German drugmaker Bayer AG has demanded the withdrawal of the countrys first compulsory licence given to Natco Pharma arguing that a three-fourth reduction in the price of the anti-cancer drug by another Indian firm has made the permit redundant and its patent itself is vulnerable to being revoked.

Taking copyright law a step too far?

Karunya Keshav — 20-May-2012

Theres confusion as Internet service providers block access to legitimate websites

Google-Motorola deal gets nod in China

AFP — 21-May-2012

Google on Saturday said that Chinese regulators approved its $12.5 billion deal to buy Motorola Mobility clearing the path for the internet titan to complete the acquisition early next week.

Copyright Bill likely to be tabled in Lok Sabha today

NDTV Correspondent with PTI inputs — 21-May-2012

The much-delayed Copyright Bill providing for certain important amendments to the Copyright Act is expected to be tabled in the Lok Sabha today.

Samsung chief sees settlement with Apple

Reuters — 21-May-2012

The chief executives of Apple Inc and Samsung Electronics Ltd are used to running the show at their global tech empires but they will be in for a different experience when they arrive at a San Francisco federal courthouse on Monday.

Glenmarks different route to US drug market

Sushmi Dey / New Delhi — 21-May-2012

At a time when most Indian drug makers are launching generics to monetise patent expiries in the US Glenmark has chosen to walk a road less travelled.

Indias drug regulation overdose

The WALL STREET JOURNAL — 21-May-2012

As a rule India does not allow products to be registered quickly even if they are approved by stringent foreign agencies such as the US Food and Drug Administration.

Should drug prices be regulated?

Patralekha Chatterjee — 21-May-2012

That is good news for those of us who pay for medicines out of our pocket.

Patent ruling casts shadow over Kodak

Richard Waters in San Francisco — 22-May-2012

Eastman Kodak has lost a preliminary ruling in a key patent infringement case against Apple and Research In Motion casting a cloud over an upcoming patent auction that will help to determine whether it can emerge intact from bankruptcy.

Intellectual Property Appellate Board rules Ayur can’t be trademark

R. Sivaraman — 22-May-2012

Can anyone in India the home of Ayurveda claim exclusive intellectual property rights over the word Ayur for selling a product? Or contend that Ayur a word derived from Ayush is an invented word that can be used as a trade mark?

Copyright Amendments: Rendering justice after decades of denial

TNN — 22-May-2012

Broadcasters have welcomed the proposed amendments to the Copyright Act of 1957 pointing out that this would have a far reaching impact in curbing exploitative practices by the owners of sound recordings for decades against both artistes and broadcasters.

Venus Remedies gets patent in South Africa for antibiotic

Press Trust of India / New Delhi — 22-May-2012

Venus Remedies today said it has received patent approval in South Africa for an antibiotic combination to be used for treating bacterial infections.

Judge directs truce talks in Apple-Samsung patent fight

AFP — 22-May-2012

The chiefs of iPhone maker Apple and smartphone giant Samsung were to be in patent war truce talks on Monday at the direction of a judge who asked them sidestep a court battle.

Suven Life Sciences gets four patent approvals

Press Trust of India / New Delhi — 22-May-2012

The company has received the approval for molecules which could be used in the treatment of CNS disorders like Parkinson Alzheimers disease and Schizophrenia.

Bollywood cheers as Lok Sabha passes copyright bill

Team DNA — 23-May-2012

On the last day of the budget session the UPA government quickly pushed through a few important social sector Bills including the Copyright Act 2012.

Kodak patent deemed invalid in fight with Apple: RIM

AFP — 22-May-2012

A US judge on Monday said a Kodak patent allegedly infringed upon by Apple and Blackberry-maker Research In Motion (RIM) was not valid, dealing another blow to the struggling photography pioneer.

Copyrights and wrongs

M J Antony / New Delhi — 23-May-2012

The Supreme Court denies the Copyright Board the power to grant temporary licences

Loopholes in pharma pricing policy

S. Srinivasan — 24-May-2012

The list of price-controlled drugs is narrow in scope.

No truce in Apple-Samsung patent war

AFP — 24-May-2012

Two days of court directed peace talks between the chiefs of iPhone maker Apple and smartphone giant Samsung ended with no sign of a truce in the legal battle headed for court in Silicon Valley.

Google didn’t infringe Oracle patents: Judge

Bloomberg — 24-May-2012

Google the largest Web search provider didnt infringe Oracles patents in developing Android software a federal jury found in the second phase of an intellectual property trial in San Francisco.

Apple-Samsung talks fail

AFP — 24-May-2012

Two days of court directed peace talks between the chiefs of iPhone maker Apple and smartphone giant Samsung ended with no sign of a truce in the legal battle headed for court in Silicon Valley.

Huawei seeks EU action against InterDigital patent fees

Reuters — 25-May-2012

Huawei has called for EU antitrust regulators to intervene in a dispute with InterDigital saying the firm is demanding exploitative fees for use of its 3G mobile phone patents.

Motorola devices infringe on Microsoft patent: Court

Reuters — 25-May-2012

A German regional court ruled in a hearing on Thursday that Motorola Mobility infringed Microsoft patents by offering the option on its mobile phones to send a longer text in a batch of several messages.

Motorola devices infringe on Microsoft patent: Court

Reuters — 25-May-2012

Proposal to give patent to \'Jugaad\' technology on back-burner

PTI — 27-May-2012

Apprehending claims of innovation in frivolous products the government has put on the back burner the proposal of granting patents to home grown products and technology known as Jugaad.

US FDA may impose huge drug user fee on generic imports soon, India to hit badly

Suja Nair Shirodkar, Mumbai — 28-May-2012

The US FDA may introduce a Generic Drug User Fee Act soon to curb import of cheap generic drugs into that country.

Prize funds: These alternatives to patents might be the way forward to cheaper healthcare

ET Bureau — 28-May-2012

Nobel laureate Joseph Stiglitz advocates a shift from the patents regime to a prize based system for new drugs.

Ranbaxy gets US nod for acne treatment

Reuters / Mumbai — 29-May-2012

The product was jointly developed by Canadian group Cipher Pharmaceuticals and Galephar Pharmaceutical Research while Ranbaxy holds the US marketing rights.

Teva Pharmaceuticals not to launch Atorvastatin, generic version of Lipitor

Khomba Singh — 29-May-2012

Israels Teva Pharmaceuticals will not launch atorvastatin the generic version of the worlds best selling drug Lipitor that will help Indian companies Ranbaxy Laboratories and Dr Reddys Laboratories garner larger sales of the medicine in the US.

Patent law together with IPR imperative for a democratic market based society

29-May-2012

A patent law along with an intellectual property law in various categories of copyright trademark right of publicity and others are imperative for shaping an open democratic and market based society corporate affairs minister Dr M Veerappa Moily said while highlighting the importance of a patent system in a democracy at an Assocham event held here in New Delhi today.

Technicolor dissects iPhones in hunt for patent payoff

Bloomberg / Paris — 30-May-2012

When Apple Incs next iPhone hits store shelves Technicolors engineers will rush to get the handset not to make calls or play games but to rip it apart.

HTC phones pass US customs review

Reuters — 30-May-2012

Earlier in May HTC had said that US sales of two new smartphones the HTC One X and HTC EVO 4G LTE would be delayed due to a requirement for customs inspections after the Taiwanese company lost a patent dispute with Apple.

How P H Kurien took on global patents system to make very costly drug affordable for poor

Arvind Panagariya — 30-May-2012

It is said that only God and a few good men and women run India.

Apple-Samsung trials seen solving copycat spat CEOs couldn’t

Bloomberg — 31-May-2012

Apple and Samsung Electronics the worlds top two smartphone makers are heading to trials that may resolve global patent disputes their chief executive officers couldnt settle on their own.

Patent wars: French co Technicolor dissects smartphones

Bloomberg — 31-May-2012

When Apples next iPhone hits store shelves Technicolor SAs engineers will rush to get the handset not to make calls or play games but to rip it apart.

Google files patent claim against Microsoft Nokia

AP — 01-Jun-2012

Google Inc on Thursday accused Microsoft Corp and Nokia of conspiring to use their patents against smartphone industry rivals and said it has filed a formal complaint with the European Commission.

Nokia: Android phones have major patent issues

Reuters — 01-Jun-2012

Nokia struck back at Google over its accusation that the cellphone maker was colluding with Microsoft to make money out of their patents.

Patents: A prize for inventors will help

S.MURLIDHARAN — 01-Jun-2012

A potentially game changing idea is that if an inventor is rewarded with a huge cash award upfront in exchange for his invention becoming available immediately for public use unseemly patent battles waged across continents will be a thing of past.

Nokia hits back at Google in latest patent war tussle

Reuters — 2-Jun-2012

Nokia struck back at Google on Friday over its accusation that the cellphone maker was colluding with Microsoft to make money out of their patents.

Steve Jobs quotes set to feature in Apple-Motorola patent trial

Reuters — 3-Jun-2012

Steve Jobs gave a lot of juicy quotes before he died and Apple Inc has failed to keep some of them out of an upcoming patent trial against Googles Motorola Mobility unit according to a court ruling.

Judge won\'t bar Steve Jobs quotes from patent trial

Dan Levine SAN FRANCISCO (Reuters) — 2-Jun-2012

Steve Jobs gave a lot of juicy quotes before he died and Apple Inc has failed to keep some of them out of an upcoming patent trial against Googles Motorola Mobility unit according to a court ruling.

Cisco sues TiVo over DVRs

Reuters — 04-Jun-2012

Cisco Systems Inc has filed a lawsuit to void four TiVo Inc patents related to digital video recorders escalating a battle over who has the right to profit from sales of the popular machines.

Updating our copyright laws

04-Jun-2012

Public discourse on the omnibus copyright law changes approved by Parliament last month has largely focused on the controversy in the film industry over the provision that gives music composers and lyricists the right to claim royalties if their music is used in any other form a ring tone for example apart from the film for which the composition was made and sold.

Is Sun Pharma getting back on the acquisition track?

Mark to Market | Ravi Ananthanarayanan — 04-Jun-2012

If Sun Pharmas base business gets a boost from successful patent challenges and litigation that would be a plus.

WHO will set generics apart from counterfeits

Vineeta Pandey — 04-Jun-2012

World Health Organisation has adopted a resolution to clearly define counterfeit medical products so as to set them apart from genuine generic drugs.

In search of the right drug pricing formula

NALINAKANTHI V. — 04-Jun-2012

The government can make drugs affordable to all without forcing the pharma companies to compromise either on quality or their profitability.

Domestic pharma industry: Emerging growth avenues

Rupali Mukherjee — 04-Jun-2012

The domestic pharma industry may maintain a strong growth momentum spurred by patent expiries of blockbuster drugs emerging licensing deals and increasing generic penetration in regulated markets over the next two three years.

A mission to defend traditional knowledge

Sidhartha — 5-Jun-2012

In a few weeks negotiators from the group of like minded countries such as India Columbia Peru and New Zealand will converge on Bali to decide on what traditional knowledge is.

EMC will file 100 patents from India by next year

Beryl Menezes — 6-Jun-2012

EMC a global IT storage solutions provider is betting big on the Indian data market and has invested $2 billion in the six years of its operations in the country which is the largest investment by an IT multi national company in India.

Pfizer job cuts highlight Irish exposure to patent expiries

Conor Humphries — 06-Jun-2012

Pfizer Inc will cut 177 jobs in Ireland following the expiration of patents on blockbuster cholesterol drug Lipitor highlighting the exposure of Irelands export driven economy to the patent cliff facing many in the pharmaceutical sector.

Column: Relevance of changes in Indian copyright law

Pavan Duggal / New Delhi — 06-Jun-2012

Copyright (Amendment) Bill 2010 seeks to provide lyricists & artists a level playing field with respect to music companies and producers.

Dr. Reddys inks drug deal with Merck Serono

Viswanath Pilla — 7-Jun-2012

Merck will handle commercialisation in most parts of the world and will pay Dr. Reddy’s royalties

China amends patent law in fight for cheaper drugs

Tan Ee Lyn in Hong Kong and Beijing, Ben Hirschler in London — 08-Jun-2012

China has overhauled parts of its intellectual property laws to allow its drugmakers to make cheap copies of medicines still under patent protection in a move likely to unnerve foreign pharmaceutical companies.

GSK Pharmas pricing strategy may not extend to alliance products

BUSINESS LINE — 08-Jun-2012

Two years ago British drug-maker GlaxoSmithKlins Chief Executive Andrew Witty had told an Indian audience in Nashik the company would pursue customised pricing of its medicines in middle and low income countries.

US judge cancels Apple-Google phone patent trial

Reuters — 08-Jun-2012

A federal judge canceled a scheduled June 11 trial between Apple Inc and Google Incs Motorola Mobility unit over patents related to mobile phones and tablet computers and expects to dismiss the case because neither can prove damages.

Apple may block Samsung Galaxy SIII sales in US

Reuters — 08-Jun-2012

Samsung attorney William Price also said the technology covered by Apples patents such as auto correcting typed text are not responsible for sales of Galaxy phones.

Cipla losses appeal in US court for animal healthcare product

Reuters — 8-Jun-2012

Drugmaker Cipla said on Thursday a US appeals court had upheld a district courts ruling which last year declared a patent infringement by Cipla over animal healthcare drug PetArmor Plus.

Animal health product: Cipla looking at appeal options against US court order

Our Bureau — 9-Jun-2012

Cipla is examining options of appealing against a US Federal Circuit order in a patent infringement case involving the sale of an animal health product.

Action on Nexavar does not violate any treaty: Anand Sharma

PTI — 9-Jun-2012

India on Friday said it had not violated any multi-lateral trade agreement by issuing compulsory licence for patented anti cancer drug Nexavar to be produced and sold at a much cheaper cost in the country.

Copyright amendment: bad, but could have been much worse

Sunil Abraham — 10-Jun-2012

When the Copyright Act 2012 was passed unanimously by the Lok Sabha on May 22 it meant that there was little reason for celebration some not so great news and a lot of pretty bad news.

US body to bring out drug reference standards for biologics

G. Naga Sridhar — 10-Jun-2012

The United States Pharmacopeial Convention is working on developing reference standards for biologics an emerging class of drugs.

Apples war with Google heats up

Poornima Gupta — 11-Jun-2012

When Apple Inc. kicks off its annual conference for software developers on Monday all the power players in the Apple universe will be on hand save the one that is in many ways driving the agenda: Google Inc.

Pharma companies need aggressive R&D and patent filing: Experts

PTI — 11-Jun-2012

Indian pharmaceutical companies need to go for aggressive research and patent filing like China and Japan and unless spending on R&D is scaled up it would be difficult to create new molecules industry experts said.

TCS ups patent filing; applies for 460 last year

T.E. Raja Simhan — 11-Jun-2012

Tata Consultancy Services has significantly increased its patent filings in 2011-12.

Venus Remedies gets US patent for antibiotic product

PTI — 12-Jun-2012

Drug firm Venus Remedies today said it has received patent from the US Patent Office for new antibiotic product which targets drug resistant infections.

Kodak files for auction of digital imaging patents

Reuters — 12-Jun-2012

Eastman Kodak filed a motion on Monday seeking approval of bidding procedures for bankruptcy auction of its digital capture and Kodak imaging systems and services patent portfolios which together comprise more than 1100 patents.

US firm sues Zydus Cadila subsidary for infringement of patents

BS Reporter / Mumbai/ Ahmedabad — 12-Jun-2012

A complaint for infringement of patents with regard to drug for treatment of acne has been filed against Zydus Pharmaceuticals USA Inc a fully owned subsidiary of Ahmedabad based pharma major Cadila Healthcare Ltd in a district court of US.

See what is hurting Apple in smartphone wars

Reuters — 13-Jun-2012

Apple has spent nearly three years fighting its rivals in a global smartphone patent war.

Indian companies eye $1billion generic opportunity

Rupali Mukherjee — 13-Jun-2012

In the wake of patent expiries on three blockbuster drugs over the last six seven months an opportunity worth nearly $1.3 billion is up for grabs for domestic generic players.

Compulsory pharma licensing, the Indian case of Natco vs Bayer, and the South African context

Adams & Adams — 13-Jun-2012

Indias controller of patents granted the countrys first compulsory licence in the case of Natco Pharma Limited vs Bayer Corporation.

HTC blocked from using Google patents in Apple dispute

ANI — 13-Jun-2012

Taiwanese manufacturer of smartphones and tablets HTC has been blocked from using five patents it secured from Google last year to sue tech giant Apple according to a report.

China breaks patent barriers on drugs

Subodh Varma — 14-Jun-2012

In a move full of intriguing possibilities China has changed its patent laws to allow domestic drug makers to manufacture patent protected drugs in case of state emergencies unusual circumstances or in the interests of the public.

Apple bid to block Samsung Galaxy SIII in US stalled

AFP — 14-Jun-2012

Apples effort to stop South Koreas Samsung from launching its newest iPhone challenger in the US has been derailed by complex maneuvering in the patent war between the companies.

No WTO violation by issuing licence for Nexavar: Sharma

Press Trust of India / Sao Paulo — 14-Jun-2012

Natco Pharma was allowed to sell the cancer treatment drug at a price 30 times lower than charged by patent holder Bayer Corp.

Indian drug firms want norms eased in Brazil

Sidhartha — 14-Jun-2012

The Indian government and pharmaceutical companies have made a strong pitch for easing f norms in Brazil arguing that they are slow and hamper access to the local market.

Apple patent bid hints at changeable iPhone lens

Agence France-Presse — 15-Jun-2012

A US patent application made public on Thursday hinted that Apple may be toying with the idea of letting picture loving iPhone users change lenses for the smartphone cameras.

India cites WTO accord on drugs patent waiver

Sidhartha — 15-Jun-2012

India has responded aggressively to protests from developed countries such as the United States over waiving patent rights on a cancer medicine manufactured by Bayer and Hyderabad based Natco Pharma to sell the drug at a lower cost.

Alembic settles patent case with Novartis for generic capsules

Press Trust of India — 15-Jun-2012

Alembic Pharmaceuticals on Friday said it along with US Breckenridge Pharmaceutical Inc has settled patent case with Novartis for Rivastigmine Tartrate capsules used for treating dementia.

Apple Motorola patent lawsuit revived by US judge

Reuters — 15-Jun-2012

A US judge has agreed to hear Apples request for an injunction against the sale of some Motorola phones giving the iPhone maker a chance to head off a damaging ruling in the smartphone patent wars.

India, Brazil to set up industry-level working group to sort out hurdles faced by pharma exporters

Joseph Alexander, New Delhi — 16-Jun-2012

Commerce Minister stressed that the provision in TRIPs of invoking the route of compulsory licensing for making available cheaper drugs though introduced at the behest of developing countries was in fact used more often by developed countries.

Alembic settles patent dispute with Novartis

BS Reporter / Mumbai/ Ahmedabad — 16-Jun-2012

Vadodara based pharmaceuticals products maker Alembic Pharmaceuticals Ltd along with a US based Breckenridge Pharmaceutical Inc has settled a patent dispute with Novartis AG regarding Rivastigmine Tartrate Capsules a generic version of Exelon.

Ethnic variety on display

Special Correspondent — 18-Jun-2012

The geographical indication received by the handloom products of Kasaragod Balaramapuram Chendamangalam and Palakkad have given a boost to the efforts of the institute.

We will look at inorganic growth wherever there\'s a strategic fit

Sushmi Dey / New Delhi — 18-Jun-2012

At a time when most domestic drug companies are looking West in the wake of the number of patents expiring there Lupin Ltd the Mumbai based transnational drug maker is eyeing a big pie of the Indian market along with its continued growth strategy in America.

Intel to buy InterDigital patents for $375 million

Reuters — 19-Jun-2012

InterDigital Inc said on Monday it had agreed to sell to Intel Corp about 1,700 wireless technology patents for $375 million sending InterDigital shares up 27 per cent.

Intel to buy InterDigital patents for $375 million

Reuters — 19-Jun-2012

InterDigital said on Monday it had agreed to sell to Intel about 1700 wireless technology patents for $375 million sending InterDigital shares up 29 percent.

Venus Remedies up 38% on winning US patent

SI Reporter / Mumbai — 19-Jun-2012

The company has received patent from the US Patent Office for new antibiotic product CSE 1034 which targets drug resistant infections.

Kodak sues Apple for interfering in patent sales

Reuters — 20-Jun-2012

Photography pioneer Eastman Kodak sued Apple to stop it from interfering with plans to sell a large patent portfolio a significant part of its bankruptcy restructuring.

Apple Inc to pay damages to Samsung Electronics over patent violation

AFP — 20-Jun-2012

A Dutch court ordered Apple Inc to pay damages to Samsung Electronics Co Ltd over a patent violation in the Netherlands the latest twist in the global legal battle waged by the two rival phone and computer makers.

Patent war: Apple-Google lawsuit hearing to begin today

Reuters — 20-Jun-2012

Apple will try to salvage a high profile lawsuit against Googles Motorola Mobility unit on Wednesday at a crucial hearing in the smartphone patent wars between the two tech companies.

Indian drug outlook favourable: ICRA & Moodys

Ashwin Walunjkar — 20-Jun-2012

Outlook on the Indian pharmaceutical industry remains favourable says ICRA & Moody report released on Wednesday

Court reserves order against Bhandarkar in copyright case

IANS — 20-Jun-2012

A Delhi court has reserved its order for June 27 on an authors plea for lodging a first information report against Bollywood filmmaker Madhur Bhandarkar for copying the plot of his 2008 film Fashion from her book.

Microsoft demurs at Motorola patent settlement offer

Reuters — 21-Jun-2012

Microsoft Corp has brushed off an offer by Motorola the phone maker bought by Google Inc to settle patent disputes with Motorola that are threatening to halt imports of Android devices and Xbox game consoles into the United States.

Apple grilled in Google smartphone patent case

Reuters — 21-Jun-2012

A US judge on Wednesday strongly questioned Apples bid for an injunction against Googles Motorola Mobility unit as the iPhone maker tries to salvage its position on a key front in the smartphone patent wars.

Big pharma firms may learn to live with compulsory licensing

C.H. Unnikrishnan — 21-Jun-2012

Taking a cue from India countries have initiated changes in patent laws to lower healthcare costs say experts.

Microsoft rejects Motorolas patent offer

Reuters — 21-Jun-2012

Microsoft has brushed off an offer by Motorola the phone maker bought by Google to settle patent disputes with Motorola that are threatening to halt imports of Android devices and Xbox game consoles into the United States.

Patent war: Apple told to pay damages to Samsung

Reuters — 21-Jun-2012

A Dutch court ordered Apple to pay damages to Samsung Electronics Ltd over a patent violation in the Netherlands the latest twist in the global legal battle waged by the two rival phone and computer makers.

Jay Z in copyright lawsuit

IANS — 21-Jun-2012

Singer Jay Z has been sued for copyright infringement.

Apple filing could delay Kodak patent sale

Jonathan Stempel REUTERS — 22-Jun-2012

Apple Inc on Thursday asked a federal judge to move a lawsuit against it by Eastman Kodak Co to a new court which could derail the photography pioneers plan to quickly sell a large patent portfolio through the bankruptcy process.

Teva Patents Are Infringed in Sandoz Mylan Patent Suit

Joel Rosenblatt — 23-Jun-2012

Patent claims that Teva Pharmaceutical Industries Ltd. brought against Novartis AGs Sandoz unit Mylan Inc. and Momenta Pharmaceuticals Inc. are infringed valid and enforceable a federal judge ruled.

Apples patent case against Motorola dismissed

Reuters — 23-Jun-2012

A US judge on Friday ruled that Apple cannot pursue an injunction against Googles Motorola Mobility unit effectively ending a key case for the iPhone maker in the smartphone patent wars.

India EU to take stock of proposed free trade pact on Tuesday

PTI — 24-Jun-2012

India and EU are scheduled to take stock of the much delayed negotiations on the proposed free trade agreement at a meeting here on Tuesday.

Teva shares jump on positive Copaxone patent ruling

Reuters / By Steven Scheer — 24-Jun-2012

Teva Pharmaceutical Industries rose more than 11 percent on Sunday after a U.S. court upheld Tevas patents for multiple sclerosis drug Copaxone well into 2015.

India Brazil & China defend generic drugs at WTO

Amiti Sen — 25-Jun-2012

India Brazil and China have defended the right of poor countries to access cheap generic medicines at the World Trade Organisation resisting attempts by the US Japan and some other developed countries to club counterfeits or copies of patented drugs with fake or spurious ones.

Now GTU to train its students on filing patent applications

Bharat Yagnik — 25-Jun-2012

After successful completion a five different training session on Patenting in Engineering and Patenting in pharmaceuti cals at different places in the state the GTU has decided to train its students on how to file application for patents.

Natco loses patent case against Teva of anti sclerosis drug

Press Trust of India / Hyderabad — 25-Jun-2012

Natco Pharma Ltd has lost a patent litigation against Israels Teva Pharmaceutical Industries Ltd in the US over multiple sclerosis treatment drug Copaxone.

Natco, Mylan to appeal against New York district court verdict

Deepika Amirapu — 25-Jun-2012

Indias Natco Pharma and USAs Mylan are considering to appeal against the judgement by a district court in New York that dealt the two companies a severe blow denying them permission to make a me too version of generic giant Teva Pharmaceuticals Copaxone.

India to talk retail FDI at EU free-trade meet

Neeraj Thakur — 26-Jun-2012

India is taking an aggressive stance in the free trade agreement negotiations with the European Union.

Indian scientist gets U.S. patent for cancer treatment

M. Sai Gopal — 27-Jun-2012

Nano particle carries anti cancer drug and releases it only in the cancerous cell.

Court bans Samsung Galaxy Tab 10.1 sales in US

Reuters — 27-Jun-2012

A US judge on Tuesday granted Apples bid to stop Samsung Electronics from selling its Galaxy Tab 10.1 tablet in the United States giving the iPhone maker a significant win in the global smartphone and tablet patent wars.

Indian pharma eyes US generic gold rush

Sushmi Dey / New Delhi — 27-Jun-2012

Bulk drug filings from Indian cos in US have increased significantly.

Delhi HC restrains Indian firm from using trademark Maersk

Soibam Rocky Singh — 28-Jun-2012

The Delhi High Court has restrained an Indian mining and exploration firm from using the word Maersk as part of its corporate name on a plea filed by Danish business conglomerate AP Moller Maersk A/S claiming exclusive right over the service mark.

Qualcomm plans new subsidiary to guard patents

Reuters — 28-Jun-2012

Cellphone chip supplier Qualcomm plans to spin off its research and development activities and its product and services businesses into a wholly owned unit to better protect its patent portfolio.

HC dismisses Sun Pharmas appeal on Acucal trademark

Vishal Dutta — 28-Jun-2012

Sun Pharmaceuticals appeal in a trademark suit seeking injunction against Ahmedabad based West Coast Pharmaceuticals Ltd has been dismissed by the Gujarat High Court.

Pfizer complains against Zydus on US patent violation

Sohini Das / Ahmedabad — 29-Jun-2012

For the second time in a month a complaint of infringement of patent has been filed against Zydus Pharmaceuticals a wholly owned subsidiary of Ahmedabad based pharma major Cadila Health care at a US district court.

Obamacare will be good for Indian pharma and IT

Shishir Asthana / Mumbai — 29-Jun-2012

The US Supreme Court passed the landmark ruling dubbed Obamacare thereby upholding the controversial massive reform of health care coverage which was initiated by President Barack Obama.

Apple scores second courtroom win vs Samsung

Reuters — 30-Jun-2012

A US judge on Friday granted Apple Incs request for a pre trial injunction against the sale of Samsung Electronics Co Ltds Galaxy Nexus phone handing the iPhone maker its second legal victory against Samsung in a week.

Pfizer takes Alembic to US court on drug patent

BS Reporter / Ahmedabad — 30-Jun-2012

Pfizer the pharmaceutical giant has gone to a US court to stop or at least delay Gujarat based Alembic Pharmaceuticals from trying to sell a generic version of the formers anti depressant drug branded Pristiq.

Patent licensing: Google unit under lens in US

Reuters — 30-Jun-2012

US antitrust regulators are investigating whether Google unit Motorola Mobility is living up to licensing commitments made when its patents were adopted as industry standards two people familiar with the probe said on Friday.

Drug patents expiry to give generic pharma market shot in arm

PTI — 01-Jul-2012

The patent expiry of several major blockbuster drugs coupled with other factors will fuel growth of global generic pharmaceuticals market by 2017 research firm Frost & Sullivan said.

Indian pharma firms prefer alliance pill for expansion

Ujjval Jauhari & Ram Prasad Sahu / Mumbai — 01-Jul-2012

Marketing alliances in emerging markets continue to be at the heart of the expansion strategy of Indian generic players.

Author alleges copyright violation by US website

TNN — 1-Jul-2012

G Reghunath Pillai an inspector with Kerala Road Transport Corporation while penning a book on undesirable truths would not have dreamt that his creation would make him face one in the future.

Apple settles China iPad trademark dispute for $60 mln

Reuters — 2-Jul-2012

Apple Inc has paid $60 million to Chinas Proview Technology to settle a dispute over the iPad trademark a Chinese provincial court said on Monday.

USPTO official lambasts issuance of compulsory licensing by Indian patent office

Ramesh Shankar, Mumbai — 2-Jul-2012

The first ever compulsory licensing issued by the Indian Patent Controller on March 9 2012 to an Indian generic company to manufacture generic version of Bayers cancer drug Nexavar has come in for severe criticism by the US Patent and Trademark Office.

Indian simvastatin makers line up atorva products

KV Ramana — 02-Jul-2012

Indian generic companies are realigning strategies in the US statin market with atorvastatin the top selling drug in the category going off patent.

Healthcare industry is a rip-off

Pradeep S Mehta — 2-Jul-2012

The absence of regulatory oversight in the health industry needs urgent attention.

Apple wins as Samsung loses bid to lift Galaxy Tab ban in US

Reuters — 3-Jul-2012

A U.S. judge on Monday rejected a request by Samsung Electronics Co. to lift a ban on U.S. sales of its Galaxy Tab 10.1 another setback for the South Korean firm in its tablet patent battle with iPad maker Apple Inc.

Govt to discuss FDI export barriers in pharma sector

Arun S — 2-Jul-2012

The fear is that takeovers of existing companies would increase the prices of many drugs and reduce generics off patent drug production.

Apple pays $60m to settle iPad patent row

Saibal Dasgupta — 3-Jul-2012

Apple paid $60 million to settle a legal dispute with Chinese computer maker Shenzhen Proview Technology over the iPad trademark.

Pharma research to get Rs 2000-cr shot in arm

Our Bureau — 03-Jul-2012

The Commerce and Industry Minister Mr Anand Sharma said on Tuesday that his Ministry is actively considering a Rs 2000 crore venture capital fund to be used mostly to boost Research and Development in the pharmaceutical industry.

Kodak wins patent fight with Apple

AFP — 03-Jul-2012

Beleaguered photography pioneer Kodak has said that a US bankruptcy court has approved its bid to auction off more than 1,100 patents despite objections by Apple and FlashPoint over a small number of them.

Samsung Galaxy Nexus sales ban to continue

Reuters — 4-Jul-2012

A US judge on Tuesday rejected a request by Samsung Electronics to lift a pre-trial injunction against sales of its Galaxy Nexus phone another legal setback for the South Korean firm ahead of an upcoming court battle with Apple.

Kochiite patents six-stroke engine

Special Correspondent — 4-Jul-2012

Anil Cleetus Chanayil a city based motor mechanic-turned-engine designer has won an Indian patent for designing a six-stroke engine which he says will be easy on the environment and light on the bike user s pocket.

Apple suffers UK patent defeat to HTC over technology used in mobile tools

Reuters — 04-Jul-2012

Taiwans HTC on Wednesday won a London court ruling against U.S. tech giant Apple Inc over a series of patent infringement claims linked to technology used in its mobile devices.

Apples request to ban HTC smartphones rejected

Reuters — 4-Jul-2012

A US trade panel has turned down Apples request to immediately ban some HTC smartphones from being imported into the United States because of accusations that they infringe on an Apple patent.

European Union rejects anti counterfeiting law

Rupali Mukherjee — 04-Jul-2012

The European Parliament on Wednesday rejected the anti counterfeiting trade agreement which if passed would have limited the access of legitimate generic medicines exported from developing countries like India.

Kendriya Vidyalaya set to patent new uniforms for its students

Hema Rawat — 04-Jul-2012

The Kendriya Vidyalaya Sanghathan has decided to patent the new school uniforms that it will introduce for Class 1 students across the country with effect from the current academic session.

Apple planning Google Glass rival?

ANI — 4-Jul-2012

Software giant Apple has been awarded a patent for a wearable display device by the US Patent and Trademark Office that sounds similar to Googles Project Glass.

Indian pharma: Pricey patented drugs do not seem the norm

ET Bureau — 5-Jul-2012

There seems considerable policy action in the Indian pharmaceutical scene.

Last hurdle for EU patent

T S Vishwanath — 5-Jul-2012

A single EU patent regime may trip at its final stage if the Members of European Parliament are not satisfied

US ups the ante on Nexavar Generic threatens to take India to WTO

DIVYA RAJAGOPAL — 5-Jul-2012

The US House of Representatives and the US Patent and Trademark Office have threatened to drag India to the World Trade Organisations dispute panel for issuing the firstever compulsory licence to a domestic company to manufacture generic version of Bayers cancer drug Nexavar saying the move violates international trade laws.

Pureit patent revocation to have minimal impact

BS Reporter / Mumbai — 5-Jul-2012

The recent revocation of a patent granted to Hindustan Unilevers Pureit water filters will have a minimal impact on the brand according to company executives.

EU parliament rejects anti-generics ACTA

Priyanka Golikeri — 05-Jul-2012

In a huge boost to makers of generic medicines the European Union parliament on Wednesday rejected a treaty agreement that could have given these companies and the patient groups fighting for low cost medicines a severe migraine.

European parliament says no global anti-piracy law

Reuters — 5-Jul-2012

The European Parliament rejected a global agreement against copyright theft on Wednesday handing a victory to protesters who say the legislation would punish people for sharing films and music online.

US threatens to take India to WTO over Nexavar Generic

DIVYA RAJAGOPAL — 5-Jul-2012

Patent war: Apple vs Samsung, Motorola & others

Reuters — 5-Jul-2012

Mobile technology has been a hotbed of patent litigation in recent years.

Register your trademark or risk losing it altogether

Omkar Sapre — 06-Jul-2012

Opting for a well-known brand can have its pitfalls particularly if it sounds similar to a big multinational brand.

Final hearing on Novartis patent petition put off

Our Bureau — 06-Jul-2012

The final hearing on drug maker Novartis petition challenging the rejection of its patent application for cancer drug Glivec has been adjourned to late next month.

Yahoo, Facebook have settled patent fight: Source

AP — 7-Jul-2012

Facebook and Yahoo have agreed to settle a patent dispute and avert a potentially bitter battle over the technology running two of the Internets most popular destinations according to a person familiar with the matter.

US retailers sue Pfizer charge generic Lipitor delay

AP — 7-Jul-2012

Five large US drug and grocery chains are suing Pfizer Inc. and a second drugmaker alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor.

SC to start final hearing on Novartis’ case on Sec 3(d) of Patents Act on August 22

Our Bureau, Mumbai — 7-Jul-2012

The final hearing on the controversial case on Sec 3(d) of Indian Patents Act will begin in the Supreme Court on August 22.

Yahoo and Facebook settle patent suits

Michael J De La Merced — 08-Jul-2012

The agreement does not include any cash payout by Facebook seen as a win for the social networking company.

US retailers sue Pfizer over generic Lipitor delay

PTI — 08-Jul-2012

Five large US drug and grocery chains are suing Pfizer Inc and a second drugmaker alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor.

Alcatels Chennai centre leads in patent filing

Staff Reporter — 09-Jul-2012

75 patents have been filed over the last six years

Indian pharma cos secure approval for 88 ANDAs from US FDA in first half of 2012

Sanjay Pingle, Mumbai — 9-Jul-2012

The higher number of approvals from highly regulated markets will help to spread market presence in the lucrative markets and it will help to en cash upcoming opportunities with the expiration of patents.

Cipla Q1 data to reflect generic supply to Teva

Sushmi Dey / New Delhi — 9-Jul-2012

With the expiry of its patent on the blockbuster drug Teva launched its generic version in March and is currently enjoying a 180-day exclusivity on sales.

Apple loses British suit over Samsung Galaxy Tab

AFP — 09-Jul-2012

South Koreas Samsung won a patent battle on Monday against US rival Apple with a British judge ruling that Samsungs Galaxy tablet was not cool enough to be confused with Apples iPad.

Pharma cos may have to shift business strategy due to slow growth: Report

DIVYA RAJAGOPALDIVYA RAJAGOPAL — 10-Jul-2012

In the last three years Indian drug makers have relished the opportunity emerging from patent expiry of blockbuster drugs such as Lipitor.

Ranbaxy planning expansion in US

Press Trust of India / New Jersey — 10-Jul-2012

Despite extra oversight from US regulators over quality questions.

Iron grip prised loose

Deepa Kurup — 10-Jul-2012

More compulsory licensing of patent protected medicines coupled with state procurement and distribution could be a panacea for the healthcare system

Alcatel-Lucent files 75 patents from India

BS Reporter / Chennai — 11-Jul-2012

France based Alcatel Lucent has filed 75 patents on various technologies which were developed by its research and development centre in Chennai.

Alcatel-Lucent files 75 patents from India

BS Reporter / Chennai — 11-Jul-2012

France based Alcatel Lucent has filed 75 patents on various technologies which were developed by its research and development centre in Chennai.

Locals go FTF to break Big Pharma hold on generics

Priyanka Golikeri & KV Ramana — 11-Jul-2012

Despite making a significant dent Indian drug makers have been lagging the multinational players in the lucrative US market but all that is set to change with a lot of off patent opportunities coming up and companies increasingly going for the first to file status.

All about the patent wars

Rajni Bakshi — 11-Jul-2012

The course of the patent wars is almost certain to remain tortuous writes Rajni Bakshi.

Laws needed to protect knowledge

Special Correspondent — 12-Jul-2012

M. Ajith, Assistant Controller of Patents and Designs Chennai pointed out that patent was a territorial right valid for a period of 20 years.

India refuses to hike cancer drug price

Narayan Lakshman — 12-Jul-2012

Stands up to White Houses strong arm tactics against manufacturers of generic equivalent

We are confident of doubling our US sales in 3-5 years: Glenn Saldanha

Ujjval Jauhari & Ram Prasad Sahu / Mumbai — 13-Jul-2012

Our strategy has never focused on the patent cliff.

Worldwide sales of generics to double through 2016

Ransdell Pierson/Reuters — 13-Jul-2012

Worldwide sales of generics a mainstay in poorer countries will almost double to between $400 billion and $430 billion by 2016 driving overall spending growth on pharmaceuticals IMS said

US accuses India of WTO rules violation over Nexavar: Report

Press Trust of India / Washington — 13-Jul-2012

The US administration has accused India of violating WTO norms by allowing Hyderabad based Natco Pharma to make generic version of cancer drug Nexavar according to a media report.

India\'s patent office calls proposals for a data search system

Omkar Sapre — 13-Jul-2012

Indias patent authority has called for proposals to provide one point access to databases of patent and non patent literature of all countries and to develop a customised search platform to enable patent examiners search through these databases.

US pushing India to hike cancer drug price

IANS — 14-Jul-2012

Even as President Barack Obama is plugging his signature law to lower health care costs at home his administration is pressurising India and other countries to impose higher prices even for lifesaver cancer drugs.

Full confidence in Indian legal system, says Germany

PTI — 14-Jul-2012

His remarks came in the backdrop of a German company Bayers case in Delhi High Court over a patent infringement suit against an Indian company on March 15 2010 in response to a decision of the Drug Controller General of India to grant Cipla marketing authorisation for a generic version of Nexavar a cancer drug.

RIM hit with $147.2 million verdict in wireless patent lawsuit

Reuters — 14-Jul-2012

A northern California jury directed Research in Motion Ltd to pay $147.2 million in patent litigation over a remote management system for wireless devices according to an attorney for the plaintiff Mformation Technologies Inc.

Is pharma steering India\'s tryst as a major R&D hub?

Rohit Joshi & Siddharth Tak — 15-Jul-2012

Rather than innovating new drugs our companies replicate branded drugs when their patent expires.

US steps up lobbying efforts against compulsory licensing

C.H. Unnikrishnan — 16-Jul-2012

The move has irked activists patent experts and drugmakers in India who have written to the government protesting the USs campaign.

We re sovereign and progressive: Sharma to Barack Obama

Press Trust Of India / New Delhi — 17-Jul-2012

We are fully compliant when it comes to TRIPS Trade Related Aspects of Intellectual Property Rights.

HTC files counterclaims against Apple with patents from HP

Steven Musil — 17-Jul-2012

The Taiwanese handset maker is ratcheting up its patent battle with allegations that an array of Apple products infringe on two recently acquired patents.

Decision on Nexavar not against the law

Sujay Mehdudia — 17-Jul-2012

Asserting that India has not taken any arbitrary decision or gone against the law in issuing compulsory licence for the generic production of patented anti cancer drug Nexavar Commerce and Industry Minister Anand Sharma said the U.S. and European companies had done the same on number of occasions.

Judge rejects secrecy bids in Apple vs. Samsung battle

Reuters — 18-Jul-2012

A U.S. judge rejected several requests by Apple Inc and Samsung Electronics Co Ltd to keep portions of key documents out of public view in their high stakes patent litigation battle set for trial later this month.

Google unit Motorola Mobility says will avoid US import ban on smartphones

Reuters — 18-Jul-2012

Google unit Motorola Mobility said on Tuesday it has taken steps to avert an interruption of US imports and sales of its smartphones after the devices were found to infringe on a Microsoft patent.

18 Motorola phones face ban in US

Reuters — 18-Jul-2012

Google unit Motorola Mobility has said it has taken steps to avert an interruption of US imports and sales of its smartphones after the devices were found to infringe on a Microsoft patent.

WTO for cheaper drugs in developing countries

Virendra Singh Rawat / New Delhi/ Lucknow — 18-Jul-2012

TRIPS is a WTO-administered international agreement that sets down minimum standards for many forms of intellectual property regulation on WTO members.

Apple vs Samsung: Key documents to go public

Reuters — 18-Jul-2012

A US judge rejected several requests by Apple and Samsung Electronics to keep portions of key documents out of public view in their high stakes patent litigation battle set for trial later this month.

Apple vs Samsung: Plea to use Steve Jobs’ comments rejected

Reuters — 19-Jul-2012

A US judge on Wednesday approved Apples request to bar disparaging statements by Steve Jobs about Googles Android operating system from an upcoming patent trial against Samsung Electronics.

Apple sued by HTC over patent infringement

AFP — 19-Jul-2012

Taiwans leading smartphone maker HTC has that it was suing technology giant Apple in the United States claiming it has infringed on its patents.

Natco targets drugs ripe for compulsory licensing

Viswanath Pilla — 20-Jul-2012

Natco Pharma Ltd which has started selling a generic version of Bayer AGs patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm plans to use the so called compulsory licensing route to try and win the right to copy more patented drugs said vice chairman and chief executive officer Rajeev Nannapaneni.

Growth rates in US markets will decline: Dr Reddy\'s

BS Reporter / Hyderabad — 20-Jul-2012

Patent expiries which peaked this year will decrease over the next few years says CEO G V Prasad

Settlement of Somaxon Pharmaceuticals patent suit in US soon: Zydus

Vishal Dutta — 20-Jul-2012

Ahmedabad based Zydus Cadila says it agreed to settle a patent litigation suit with US based Somaxon Pharmaceuticals for insomnia drug Silenor.

Pharmexcil to present patent awards to cos during AGM on Sept 26-28

Our Bureau, Hyderabad — 21-Jul-2012

The Pharmaceutical Export Promotion Council Of India will present patent awards to the companies who have shown excellence during the financial year 2011 2012 at its annual general meeting event to be held from September 26-28 this year.

42,000 patent applications filed last year: Sharma

PTI — 21-Jul-2012

The government Saturday said 42000 patent applications were filed in 2011 indicating the rising trend of such filings.

Theres an Indian hand in $147-mn patent blow to BlackBerry maker

Indira Kannan / Toronto — 22-Jul-2012

The patents related to wireless mobile device management and the software found to infringe Mformations patent was RIMs BlackBerry Enterprise Server used by corporate enterprise customers to manage and secure their BlackBerry devices.

Health Ministry identifying more essential drugs for compulsory licence as debate still rages on

Joseph Alexander, New Delhi — 23-Jul-2012

Even as the debate over India giving compulsory licence heating up with US official too raising apprehensions Union health ministry made it clear that it is strongly in favour of invoking the provision of compulsory licences in the case of more essential medicines.

Apple vs Samsung patent trial begins in Australia

Reuters — 23-Jul-2012

Apple and Samsung Electronics began the latest round of their long running global patent war on Monday as an Australian judge began hearing evidence for an anticipated three month trial.

Kodak loses patent case against Apple, RIM

Reuters — 23-Jul-2012

Eastman Kodak has lost an appeal of a patent dispute over digital image preview technology with Apple and Research In Motion, which could set back the onetime photography giants efforts to raise money in bankruptcy by selling patents.

Apple and Googles Motorola unit file separate patent appeals

Bloomberg — 23-Jul-2012

Apple and Googles Motorola Mobility unit filed separate appeals of a federal judges June 22 order dismissing their mutual patent infringement claims.

Logistics majors focusing on patents to keep technology edge

Mamuni Das — 23-Jul-2012

Players in the highly competitive logistics sector are grappling with protecting innovations through the use of patents.

Indian drug firms lobby against EU’s new directive

Vidya Krishnan — 24-Jul-2012

Indian drug companies are lobbying against a move by the European Commission to check the import of counterfeit drugs through a directive that comes into effect in about a year from now.

Apple Samsung disagree on patent values: Source

Reuters — 24-Jul-2012

Apple Chief Executive Tim Cook and top Samsung Electronic executives disagreed last week on the value of each others patents at a settlement conference ahead of a high profile US trial according to a source familiar with the matter.

EU stalls treaty talks to allow copyright waiver for print disabilities

Priscilla Jebaraj — 25-Jul-2012

India and other developing countries support such a legally binding treaty.

Patent row: Apple Inc seeks $2.5-bn damages

Reuters / New York — 25-Jul-2012

Apple claims it is entitled to $2.525 billion of damages in its high stake battle against Samsung Electronics over patents for technology used in smartphones and tablets such as the iPhone and iPad.

EU members oppose treaty on visually challenged

Aakshi Magazine — 25-Jul-2012

A historic treaty set to end the book famine faced by the visually challenged is being opposed by EU members at the 24th meeting of the standing committee for copyright and related rights at the World Intellectual Property Organisation in Geneva.

Indian pharma firms prefer alliance pill

Ujjval Jauhari & Ram Prasad Sahu / Mumbai — 25-Jul-2012

Marketing alliances in emerging markets is at the heart of the expansion strategy.

Manpower shortage hits patents processing

Shishir Arya — 25-Jul-2012

Though Union Commerce Minister Anand Sharma while inaugurating the National Institute of Intellectual Property Management in the city last week expressed concern over less number of patents being filed from the country the government too appears slow when it comes to examining the applications.

Samsung patent royalty demands unfair: Apple

Reuters / San Francisco — 26-Jul-2012

Apple Inc said Samsung Electronics Co Ltd is demanding from the iPhone maker a far higher patent royalty than Apple pays to other companies at a rate the South Korean company has never sought from any other licensee.

Venus Remedies novel antibiotic product Potentox receives US patent

Our Bureau, Mumbai — 26-Jul-2012

The United States Patent and Trademark Office has granted 3rd US patent for Venus Remedies Limited a research based global pharmaceutical company for its novel antibiotic product Potentox.

HCL Infosystems acquires educational content provider Edurix

PTI — 26-Jul-2012

IT firm HCL Infosystems has acquired educational content provider Edurix a move that will help strengthen its education and learning business.

Sudarshan Chemicals wins patent case against Clariant

BS Reporter / Mumbai/ Pune — 26-Jul-2012

The court will now assess damages to be paid by Clariant to Sudarshan as a result of its wrongful threats.

Re-hearing on post grant opposition against Roches patent for Pegasys to be held on July 30 at IPAB

Ramesh Shankar, Mumbai — 27-Jul-2012

The crucial hearing in the post grant opposition against the patent granted to Roche for Pegasys Peg intergferon alpha 2B a key drug used for Hepatitis-C treatment will be held on July 30-31 by the Intellectual Property Appellate Board in Chennai.

US doublespeak on patent waiver bared

Sidhartha — 27-Jul-2012

The United States, which is crying foul over a patent waiver for a cancer drug in India has itself resorted to similar steps to reduce disruptions in supply of two medicines and that too through an executive order.

Kodak Apple patent fight to remain in bankruptcy court

Reuters — 27-Jul-2012

Apple Inc lost on Thursday a bid to transfer its patent dispute with Eastman Kodak Co out of bankruptcy court a move that could have complicated the photography companys plan to sell the technology.

Indian patenting system needs to improve, says WIPO chief

PTI — 27-Jul-2012

The Geneva based WIPO an arm of the United Nations Organisation helps member countries in legal and technical matters pertaining to intellectual property.

Price controls ahead for patented drugs

Kaustubh Kulkarni — 28-Jul-2012

The government is planning to rein in prices of expensive patented drugs to make medicines affordable to the poor.

Google asks court to dismiss authors\' copyright case

AFP — 28-Jul-2012

Google asked a US court Friday to dismiss a lawsuit over the internet giants massive book scanning project saying the effort is not a substitute for books themselves.

Apple to face Samsung over patent trial on Monday

Agency inputs — 29-Jul-2012

Samsung and Apple will be at logger heads over a crucial patent trial in US federal court on Monday.

Taiwan univ sues Apple over Siri patents

AFP — 30-Jul-2012

Taiwans National Cheng Kung University has filed a suit against US tech giant Apple claiming the companys Siri intelligent assistant has infringed on two of its patents.

‘Patent’ defect left unattended in truck amounts to negligence: Court

New Delhi-based chartered accountant — 30-Jul-2012

A public carrier is liable to compensate the shipper for the losses suffered by it on account of damage of goods if the reason for the accident is a patent defect a defect that could have been detected and rectified given reasonable care in the mechanical system of the truck.

Apple may launch Google Glasses rival reveals patent filing

ANI — 31-Jul-2012

Tech giant Apple has raked up speculation that it could be creating an augmented reality head mounted display to compete with Googles Project Glass technology after it reportedly filed for a US patent.

Apple vs Samsung trial: Jury selection begins

AFP — 30-Jul-2012

Jury selection was set to open on Monday in a US federal court in the blockbuster patent case pitting Apple against Samsung which accuse each other of copying patents for smartphones and tablets.

Tirupati temple to keep laddu patent

Maneesh Chhibber — 31-Jul-2012

The Venkateswara temple in Andhra Pradesh Indias richest temple Monday scored a sweet legal victory: the Geographical Indications Registry upheld its claim of a patent over the famous Tirupati laddu.

Natco in patent war with BMS

Rupali Mukherjee — 1-Aug-2012

Natco which successfully managed to reduce prices of Bayers cancer drug Nexavar by 97% through the countrys first compulsory licence recently is headed for another major confrontation.

Apple claims Samsung copied iPhone technology

AP — 1-Aug-2012

An attorney for Apple told a jury on Tuesday that bitter rival Samsung faced two options to compete in the booming cellphone market after Steve Jobs introduced the iPhone to critical acclaim in 2007: Innovate or copy.

Film ‘Mirattal’ gets copyright cover

TNN — 2-Aug-2012

Another Tamil film has just prior to its release obtained a John Doe protection order from the Madras high court barring anyone from uploading the film or any portion of it on websites without the authorisation of its producers.

U.S. bankruptcy judge lets Kodak sell key patent

Reuters — 02-Aug-2012

Eastman Kodak Co can proceed with the sale of a key digital imaging patent a bankruptcy judge ruled on Wednesday saying that Apple Inc waited too long to raise a claim of infringement.

Apple \'bet company\' with iPhone launch

ANI — 02-Aug-2012

In the 2.5 billion dollar patent trial between tech giants Apple and Samsung a US court has heard that the former was literally betting the company when it introduced the iPhone.

Govt steps up efforts on intellectual property

Surabhi Agarwal & Asit Ranjan Mishra — 02-Aug-2012

India has been under international pressure especially from the US to put in place a robust IPR regime that will not only make multinationals operating in the country more comfortable about their patents but will also boost domestic innovation.

Rovi signs patent licensing pact with Google

Reuters — 3-Aug-2012

Rovi Corp signed an agreement with Google Inc to allow the technology giant to use its interactive program guide patent portfolio for set-top boxes sending its shares up 4 percent in premarket trade.

Sun Pharma considering buying German drug firm

Bloomberg / Paris/Mumbai — 3-Aug-2012

Sun Pharmaceutical Industries Ltd Indias largest drug maker by market value is looking for acquisitions in Europe including a possible takeover of German generic drug maker Stada Arzneimittel AG people familiar with the matter said.

Apple applies for iPad Smart Cover patent

IANS — 3-Aug-2012

Apple has applied for a patent on iPad Smart Cover with an embedded secondary display designed to enhance the functionality of the tablet computer.

Whirlpool Videocon spar over design infringement

BS Reporter / Mumbai — 3-Aug-2012

The Mumbai High Court in an order dated July 25 restrained consumer durables major Videocon Industries Ltd from selling its Pebble brand of washing machines which it said was an imitation of rival Whirlpool of India Ltds Ace brand.

Belgium hopes talks on India-EU FTA will conclude by year end

PTI — 03-Aug-2012

Belgium today hoped the ongoing negotiations for India EU free trade agreement will conclude by end of this year as it sought access to the countrys public procurement market.

Generic business may hit drug exports of Indian firms like Cipla and Natco

Khomba Singh — 3-Aug-2012

The government is apprehensive that the Indian drug companies strategy of launching generic version of patented drugs could trigger retaliation from overseas countries that may hit the countrys ambitious drug export plans.

Apple asks for verdict after Samsung\'s \'misconduct\'

AFP — 03-Aug-2012

With a major patent trial barely underway Apple has asked a judge to rule against Samsung saying lawyers for the South Korean firm improperly disclosed information excluded in court in a bid to sway jurors.

IPAB adjourns hearing on post grant opposition against Roches patent for Pegasys

Ramesh Shankar, Mumbai — 3-Aug-2012

The re hearing in the post grant opposition against the patent granted to Roche for Pegasys a key drug used for Hepatitis C treatment has been adjourned by the Intellectual Property Appellate Board in Chennai without fixing any new date for next hearing.

Google inks patent licensing pact with Rovi

Reuters — 03-Aug-2012

Rovi signed an agreement with Google to allow the technology giant to use its interactive program guide patent portfolio for set top boxes sending its shares up 4 per cent in premarket trade.

Kodak posts larger 2nd-quarter loss on eve of patent auction

Reuters — 4-Aug-2012

Eastman Kodak Co on Friday posted a wider second quarter loss as it prepares for a crucial auction in which it hopes to sell more than 1100 patents to help repay its bankruptcy creditors.

Judge scolds Samsung, lets patent trial proceed

AFP — 4-Aug-2012

The judge in a massive smartphone patent dispute reprimanded Samsung Friday for releasing excluded evidence but denied a bid by Apple to order a verdict in the case.

Pharma cos set to gain from US nod for asthma drug

Press Trust of India / New Delhi — 05-Aug-2012

Indian drug makers including Aurobindo and Glenmark are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and allergies in the US market.

Apple applies for iPad Smart Cover patent

IANS — 05-Aug-2012

Apple has applied for a patent on iPad Smart Cover with an embedded secondary display designed to enhance the functionality of the tablet computer.

Apple vs Samsung: Can look and feel be patented?

Bloomberg / San Francisco — 05-Aug-2012

Apple has become the most valuable company by creating products that stand out for design and ease of use stemming from scores of smaller innovations such as rubberbanding rather than epic underlying technology breakthroughs.

Apple versus Samsung patent trial: World starting to learn how Steve Jobs made the company successful

New York Times — 06-Aug-2012

Back in the early 1930s a magician by the name of Horace Goldin went to court to defend his signature illusion: sawing a woman in half.

Apple reveals origin and history of iOS in Samsung patent trial

ANI — 06-Aug-2012

Tech giant Apples Senior Vice President Scott Forstall has revealed all the secrecy hard work and innovation that went into developing the iOS user interface in its 2.5 billion dollar patent trial with South Korean mobile maker Samsung.

Apple, Samsung take legal battle to hot tub

Reuters — 06-Aug-2012

Apple and Samsung Electronics are embroiled in a high stakes patent battle in several countries around the world but only in Australia are they also engaged in hot tubbing.

Patent war: iPhones created design crisis for Samsung, says Apple

Reuters — 7-Aug-2012

Apple Inc trotted out a veteran designer to bolster its claims that Samsung Electronics copied the iPhone after the smartphones 2007 launch triggered a crisis in design for the South Korean electronics giant.

Apple, Google bid on Kodak patents: Report

Reuters — 7-Aug-2012

Eastman Kodak which is planning to auction 1,100 digital patents received two bids from investor groups including Apple Inc and Google Inc of between $150 million and $250 million the Wall Street Journal reported on Monday.

French agency fined for pirating Ray classic

Debashis Konar — 7-Aug-2012

A French agency that was illegally selling DVDs of the award winning Ashani Sanket has been ordered to pay a compensation of euro 10000 around Rs 6.8 lakh to producer Sarbani Bhattacharya for infringing her film rights.

AOL, Vringo reach partial patent settlement

Associated Press — 08-Aug-2012

AOL Inc. confirmed Monday that it has reached a partial patent settlement with ringtone company Vringo Inc. related to online search and advertising.

US STAND ON CL UNFAIR

P A Francis — 8-Aug-2012

The grant of compulsory licence by Indias Patent Controller in March this year to Natco for the manufacture of generic version of Bayers cancer drug Nexavar has attracted severe criticism from the US Patent and Trademark Office last month.

Apple faces lawsuit in China over FaceTime application

Press Trust of India / Beijing — 08-Aug-2012

Within weeks of settling a high profile dispute over its iPad trademark US high tech giant Apple now faces a lawsuit by a man in Taiwan over its FaceTime application which he claims is a violation of his patent.

Plea against Tirupati Laddu GI tag rejected

Vinson Kurian — 8-Aug-2012

Rectification applicant fails to prove locus standi and interest with registered good

Must watch: The lighter side of Apple vs Samsung patent trial

NDTV Correspondent — 08-Aug-2012

The court proceedings began last Monday in the blockbuster Apple Samsung trial a high stakes legal contest over infringement of patents for hot selling smartphones and tablet computers.

Samsung phones confusingly similar to iPhone

Reuters — 08-Aug-2012

The focus of the courtoom battle between Apple and Samsung Electronics shifted to the iPhones iconic display on Tuesday as the US company called a former employee and award-winning graphic designer to back up claims that Samsung gadgets look confusingly similar.

Dr Reddys prescription to stay ahead of the generic pack

B Dasarath Reddy / Hyderabad — 9-Aug-2012

The company has differentiated itself by focusing on internal processes and staying away from costly acquisitions.

Apple faces lawsuit in China over FaceTime

PTI — 9-Aug-2012

Within weeks of settling a high profile dispute over its iPad trademark Apple now faces a lawsuit by a man in Taiwan over its FaceTime application which he claims is a violation of his patent.

Alembic enters into license agreement with Accu Break of US

BS Reporter / Mumbai/ Ahmedabad — 9-Aug-2012

ABP patented Accu Break can be split easily by hand into smaller doses to provide maximum flexibility.

RIM vs Mformation: Judge overturns jurys decision

Reuters — 09-Aug-2012

Research in Motion said a US judge had ruled the company had not infringed on Mformation Technologiess patent and overturned an award of $147.2 million that a jury said the Canadian firm should pay.

Apple now sued over FaceTime in China

PTI — 09-Aug-2012

Within weeks of settling a high profile dispute over its iPad trademark Apple now faces a lawsuit by a man in Taiwan over its FaceTime application which he claims is a violation of his patent.

RIM off the hook for $147 mn in US patent case

AFP — 10-Aug-2012

Research In Motion will not have to pay a $147.2 million damages award after an American judge tossed out a jury verdict in a patent case brought by Mformation Technologies.

Nokia sells 500 patents, Qt software to counter losses

Tarmo Virki — 10-Aug-2012

The patent deal nets Nokia $22 million while still leaving it with one of the strongest portfolios in the wireless industry

CNN Time magazine suspend Fareed Zakaria for plagiarism

PTI — 11-Aug-2012

Noted Indian American journalist and author Fareed Zakaria has been suspended by his employers CNN and Time magazine after he admitted to plagiarism and apologised for the ethical lapse.

Kodak receives low bids for patents: WSJ

Reuters — 11-Aug-2012

As Eastman Kodaks patent auction draws to a close the bankrupt photography company has only received lowball bids for the patents that it believes are worth $2.6 billion the Wall Street Journal reported citing unnamed sources.

Samsung takes on Apple over value of phone features

Reuters — 11-Aug-2012

An Apple Inc expert witness testified on Friday that consumers would be willing to pay $100 for three patented smartphone features that are at issue in its high stakes trial against Samsung Electronics Co Ltd.

Jobs confronted Samsung over Galaxy: Witness

Bloomberg / San Francisco — 13-Aug-2012

Steve Jobs Apples late co founder confronted Samsung Electronics executives in 2010 after the South Korean company introduced its Galaxy smartphone Apples patent licensing director testified.

Patent office issues list of pending patent applications deemed as TK

Suja Nair Shirodkar, Mumbai — 13-Aug-2012

With a view to foster transparency in the system the Controller General of Patents Designs & Trade Marks has made available a list of all the pending patent applications that implicate traditional knowledge.

Apple alleges Samsung sales result of copying

Reuters — 14-Aug-2012

Apple Inc is claiming that more than a quarter of Samsung Electronics $30.4 billion in US smartphone and tablet sales result from copying of the iPhone and iPad or infringe on other patents a damages expert for the US company said on Monday.

Kodak extends patent auction deadline as talks continue

Caroline Humer — 14-Aug-2012

Eastman Kodak extended its patent auction on Monday saying it would not announce a winner as planned because it was still in discussions with bidders.

Over 12,000 food, pharma patents pending test; Delhi accounts for half

Our Bureau, Mumbai — 14-Aug-2012

As on December 31 2011 12,690 applications seeking patent for food products medicines and pharmaceutical inventions were pending with the Office of the Controller General of Patents Designs & Trade Marks.

Santarus sues Dr Reddys over heartburn drug

Prateek Kumar in Bangalore — 15-Aug-2012

U.S. drugmaker Santarus Inc said it filed a lawsuit against Dr. Reddys Laboratories accusing the Indian drugmaker of infringing its patents on heartburn drug Zegerid.

Apples iPhone iPad violate three Samsung patents: Samsung expert

Reuters — 15-Aug-2012

A Samsung Electronics Co Ltd expert witness testified that Apple Incs iPhone and iPad violate three of Samsungs patents as the South Korean electronics company went on offense in the third week of a high stakes trial.

Apples iPhone iPad violate three Samsung patents: Samsung expert

Reuters — 15-Aug-2012

Watson sues FDA on generic diabetes drug ruling

Esha Dey in Bangalore and Anna Yukhananov in Washington — 15-Aug-2012

Generic drugmaker Watson Pharmaceuticals Inc sued the U.S. Food and Drug Administration challenging a ruling against Watsons generic version of a big selling diabetes drug Actos.

India needs umbrella body on telecom standards to foster creation of IPR and develop indigenous products

Abhay Karandikar — 16-Aug-2012

Telecom technology development is heavily driven by intellectual property rights innovations patents and contributions to standards.

Big Pharma lobbies hard to curb generics

Rupali Mukherjee — 16-Aug-2012

Indias tag of pharmacy of the developing world is at a serious threat.

Prices of patented medicines may come down by a third if panel\'s recommendation accepted

Khomba Singh — 16-Aug-2012

An inter ministerial group tasked with regulating prices of patented medicines has recommended using a per capita income linked reference pricing mechanism a proposal that may reduce prices of several patented drugs by up to one third but will hit the profitability of foreign companies.

Apple Samsung chiefs told to resolve patent spat

AFP — 16-Aug-2012

A US judge today urged the chiefs of Apple and Samsung to negotiate a truce in their high profile patent trial here saying it was time for peace.

Linking patented drug price to per capita income may hit generic drug makers: Experts

Khomba Singh — 17-Aug-2012

A government panels proposal to link the price of patented drugs to per capita income is likely to shut out the option of compulsory licensing for generic drug makers experts and industry executives warn.

Samsung settles global patent case with German firm

AFP — 17-Aug-2012

South Koreas Samsung Electronics said it has reached a deal with German lighting group Osram to settle all their global patent lawsuits as it continues a high stakes US court battle with Apple.

Ranbaxy launches generic diabetes treatment tablets in US

Press Trust of India / New Delhi — 17-Aug-2012

Ranbaxy is among the three companies including Teva and Mylan to have 180 days of marketing exclusivity for the drug in the US market.

Apple paid $1.4 billion in patent royalties: Samsung

Reuters — 17-Aug-2012

A financial expert said Apple has overstated Samsung Electronics Ltds profit margins for mobile products an issue that goes to the heart of damages in the high profile patent trial between the two tech companies.

Cipla bats for automatic compulsory licensing

Our Bureau — 18-Aug-2012

The Government needs to bring in an automatic system for compulsory licensing if it wants to make medicines both affordable and accessible said drug maker Ciplas Chairman and Managing Director Y.K. Hamied.

Motorola files new patent case against Apple

TOI Tech — 18-Aug-2012

Google owned Motorola Mobility has filed a new case against Apple at the US International Trade Commission claiming patent violation.

Novartis patent case up for hearing in the Supreme Court this week judgment to have far reaching impact

Reuters — 20-Aug-2012

The Supreme Court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the countrys healthcare sector and potentially curb its global role as a supplier of cut price generic medicines.

Apple & Samsung not burying the patent hatchet yet

Bloomberg / San Francisco — 20-Aug-2012

Apple and Samsung Electronics reported they made no progress towards narrowing their dispute over smartphone and computer tablet patents increasing the chances a jury will decide the matter starting August 21.

Novartis fights India for cancer drug patent

Kaustubh Kulkarni and Ben Hirschler — 20-Aug-2012

Indias highest court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the countrys healthcare sector and potentially curb its global role as a supplier of cut price generic medicines.

Google\'s list of paid bloggers not sufficient, judge says

Reuters — 20-Aug-2012

Google Inc failed to comply with a court order to disclose the bloggers and other commentators on a patent and copyright case who might have been influenced by payments from the Web company a judge said on Monday.

IPAB to hear Bayer’s appeal on granting compulsory license on August 21

20-Aug-2012

The Intellectual Property Appellate Board is going to hear German drug company Bayers appeal against granting of compulsory license on its anti-cancer drug Nexavar on August 21 2012 reports Pharmabiz.

Apple vs Samsung: Patent verdict to decide future of tab, smartphone industry

New York Times — 20-Aug-2012

This week nine jurors are expected to hunker down in a federal courthouse here to decide a case that could change how the worlds smartphones and tablet computers look and work.

Showdown for Big Pharma in Supreme Court

Reuters — 20-Aug-2012

Novartis fights India for cancer drug patent

Kaustubh Kulkarni and Ben Hirschler — 20-Aug-2012

Apex court will hear final arguments starting this week in a landmark case over drug patents

Apple, Samsung show no progress in patent case

Bloomberg — 20-Aug-2012

Apple and Samsung Electronics reported they made no progress toward narrowing their dispute over smartphone and computer tablet patents increasing the chances a jury will decide the matter starting August 21.

Apple-Samsung patent trial over iPhone technology wraps up

AP — 21-Aug-2012

The multibillion dollar patent dispute between the worlds biggest smartphone makers is wrapping up.

Final hearing on Novartis’ case on Sec 3(d) of Patents Act to begin in Supreme Court on Aug 22

Ramesh Shankar, Mumbai — 21-Aug-2012

The controversial imatinib mesylate (Glivec) case between the Swiss pharma major Novartis AG and the Union of India & Others will be heard by the Supreme Court on August 22. In this long pending case, Novartis is challenging Section 3(d) of Indias Patents Act which prohibits evergreening the practice of multinational pharma companies to extend their patent terms by making small and trivial changes to existing molecules and thereby preventing manufacture of generic drugs.

When its about tech its not just Samsung

AP — 21-Aug-2012

After three weeks of listening to technology experts patent professionals and company executives debate the complicated legal claims of Apple and Samsung a jury of nine men and women are set to decide one of the biggest technology disputes in history.

Chinas patent targets mask weak innovation, says study

Reuters — 21-Aug-2012

Chinas ambitious drive to produce millions of new patents in the next few years as part of a switch from a made in China to designed in China economic model will curtail innovation standards a European study warned on Tuesday.

Kodak patent auction to be probed

Reuters — 21-Aug-2012

Kodak which filed for bankruptcy in January began selling 1100 digital patents in early August and extended the auction last week citing ongoing discussions with bidders.

Suven Life may tie-up for Alzheimer\'s drug

BS Reporter / Chennai/ Hyderabad — 21-Aug-2012

Other patented molecules are still at a preclincal stage.

Google sues Apple over Siri voice control software

Daily Telegraph — 21-Aug-2012

Licensing remains the bone of contention; search giant cites violation of as many as seven patents by Apple

Intellectual Property Appellate Board postpones Bayers compulsory licence appeal

Khomba Singh — 21-Aug-2012

Indias Intellectual Property Appellate Board has postponed German company Bayer AGs appeal against the grant of a compulsory licence of its patented drug Nexavar to Natco Pharma to September 3 a Natco official said.

Maharashtra to adopt South Africa variety of grapes

Tushar Pawar — 22-Aug-2012

In India grapes do not come under patent crop law.

All eyes on the Novartis case

Shishir Asthana / Mumbai — 22-Aug-2012

SC judgment will impact business of pharma MNCs in India

Indian campaigners say Novartis’ win in landmark drug patent case would be \'death sentence\' for poor

Agencies — 22-Aug-2012

Health campaigners in India have warned that granting Swiss pharmaceutical company Novartis an Indian patent for the cancer drug Glivec would mean handing down a ‘death sentence’ for the poor and ill in the developing world.

Apple-Samsung patent case: Alchemy of damages takes the stage

Reuters — 23-Aug-2012

Between the hotshot designers and brainy engineers Apple Inc questioned for three weeks in the companys bitterly fought patent battle against Samsung Electronics Co Ltd a marketing expert from MIT took Apples lawyers all of three minutes.

Copyright violation: Court verdict to provide relief to news channels

TNN — 22-Aug-2012

In a verdict that will bring relief to news channels the Delhi High Court has said trivial infractions where a small audio clipping is played in the background cant be termed copyright violation.

Nearly 6.50 lakh trademarks applications pending with govt

Press Trust of India / New Delhi — 22-Aug-2012

There has been a nearly 100% rise in the number of requests since 2001-02.

Supreme Court defers Novartis patent appeal to September 11

Khomba Singh — 22-Aug-2012

Supreme Court on Wednesday deferred Swiss company Novartis case against Indian government over the interpretation of Section 3 (d) of the Indian patent laws to September 11.

Apple Samsung make final pitch to US jury

Reuters / San Jose (California) — 23-Aug-2012

Apple and Samsung are going toe to toe in a patents dispute that mirrors the struggle for industry supremacy between the two companies which control more than half of worldwide smartphone sales.

FDA withdraws nod to 27 Ranbaxy ANDAs

Priyanka Golikeri — 23-Aug-2012

The US Food and Drug Administration has withdrawn approval given to 27 generic products of Ranbaxy Laboratories.

Apple patent infringement case: Jurors to resume deliberations

AP — 23-Aug-2012

Jurors were set to begin their second day of deliberations Thursday in a multibillion dollar patent infringement case pitting Apple against Samsung over the design of iPhones and iPads.

Madras HC stays GSKs use of Horlicks Nutribic

Shilpa Phadnis — 23-Aug-2012

The Madras High Court on Thursday passed an interim order restraining directors employees agents distributors and retailers of GSK Consumer Healthcare makers of brand Horlicks from manufacturing selling and advertising Horlicks Nutribic brand of biscuits for trademark and copyright violations of Britannias NutriChoice biscuits.

Glenmark gets favourable interim order against Napo Pharma

P. T. Jyothi Datta/M. Ramesh — 23-Aug-2012

Dispute over exclusive rights on anti-diarrhoeal drug

Pfizer settles Impax patent suit over generic Detrol LA

Nate Raymond in New York — 24-Aug-2012

Pfizer Inc has settled a lawsuit accusing Impax Laboratories Inc of infringing patents covering the overactive bladder drug Detrol LA.

Pharmaceuticals: June quarter shows the way

Malini Bhupta / Mumbai — 24-Aug-2012

Also with several blockbuster drugs going off patent globally generics companies are reaping rich dividends by launching these drugs in the US.

Kodak to sell retail print, document imaging businesses

Reuters — 24-Aug-2012

The once dominant photography firm already in the midst of auctioning off its digital patent portfolio hopes to complete the sales by mid-2013 Chief Executive Antonio Perez said in a conference call on Thursday.

Apple, Samsung infringed each others patents: South Korea court

Reuters — 24-Aug-2012

Samsung Electronics Cos flagship Galaxy smartphone looks very similar to Apples iPhone but the South Korean firm has not violated the iPhone design a Seoul court ruled on Friday.

Indian companies get US FDA approval for generic versions of four blockbuster drugs: Jena

Our Bureau, New Delhi — 25-Aug-2012

During the last two years the US Food and Drugs Administration has given approval to the generic versions of four blockbuster drugs to Indian companies the Parliament was informed.

Samsung to contest US court verdict in favour of Apple

AFP — 25-Aug-2012

South Koreas Samsung Electronics said Saturday it will contest a US court ruling that it must pay rival technology giant Apple damages of more than $1 billion for patent violations.

OurView | Users, the ultimate losers

Shyamal Banerjee — 26-Aug-2012

While billions of dollars are at stake, it’s thousands of Android users who may have to suffer as prices increase, while competition and innovation decrease

Flip-flop in the pharma sector

Kumkum Sen — 27-Aug-2012

The pharma sector is one such where the products are seldom purchased by choice therefore market forces do not impact prices except for generic drugs.

Viewpoint: Apples victory over Samsung is patently absurd

T K Arun,ET Bureau — 27-Aug-2012

Samsung is unlikely to be significantly hurt by the fine of $1.05 billion.

Apples victory boosts Microsoft as Asian vendors scramble

Lee Chyen Yee — 27-Aug-2012

Interest in alternative from Microsoft may intensify as industry officials fear more patent suits from Apple

Karnataka State Road Transport Corporation files for tagline patent

Aparajita Ray — 27-Aug-2012

After confirming that it was not a KSRTC bus the transport organization filed a patent for its brand.

Apple vs rest: Some kinds of patent protection go against common good

ET Bureau — 27-Aug-2012

These questions suggest themselves in the wake of a US court finding in favour of Apple in its lawsuit against Samsung for patent and design violations in smartphones and tablets.

API market loses out to formulations

Sushmi Dey / New Delhi — 27-Aug-2012

Change in trend attributed to the high-margin business of finished products

Apple patent victory muddies the future of innovation

New York Times — 27-Aug-2012

Apples victory on Friday in a patent lawsuit against Samsung could if upheld give its rivals a kick in the pants to create more original products.

Apple’s verdict will not impact sales in India, says Samsung

S. Ronendra Singh — 27-Aug-2012

Samsung Electronics on Monday said that the verdict in a US court against it on a patent dispute with Apple will not impact its sales of smartphones and tablet computers in India.

What Apple\'s $1bn-patent win means for smartphone market

27-Aug-2012

It was the $1 billion question Saturday: What does Apple Incs victory in an epic patent dispute over its fiercest rival mean for the US smartphone industry?

We don’t want anything to limit choice: Google

Our Bureau — 27-Aug-2012

Google whose Android platform could be impacted because of the victory of Apple against Samsung has come up with a guarded reaction on the development.

Apple patent win may delay Samsung launches

Bloomberg — 27-Aug-2012

Apple Inc won more than $1 billion after a jury found Samsung Electronics Co infringed six of seven patents for its mobile devices in a verdict that may lead to a ban on US sales of handheld electronics a judge deems to violate Apples rights.

How Apple overwhelmed Samsung\'s patent case tactics

Reuters — 27-Aug-2012

But given the extensive business ties between the two companies Samsung is one of Apples key component suppliers a negotiated solution seemed most likely.

Punjab National Bank forwards Ind-Swift case for debt recast

K Ram Kumar — 27-Aug-2012

But once orders started drying up they ventured on their own to manufacture and market generic drugs (which are copies of branded drugs whose patent has expired).

Apple patent win may slow Google

AFP — 27-Aug-2012

Apples decisive victory in a landmark US patent case against Samsung could reshape the hot sector for mobile devices and slow the momentum of Google and its Android system, analysts say.

Apples win dents Androids standard-essential patent hopes

Reuters — 28-Aug-2012

Standard essential patents arent providing as much leverage in the smart device wars as Google may have hoped when it paid $12.5 billion to acquire Motorola Mobility.

Desi Boyz makers face trouble over copyright

Prachi Kadam — 28-Aug-2012

Andheri Magistrate Court issues summons against Rohit Dhawan and an arrest warrant against producer Krishika Lulla after writer Shyam Devkatte scales up his copyright battle.

Preserved Apple

Richard Beales — 28-Aug-2012

Apple won big with Fridays $1 billion US patent judgment against Samsung.

Hisars Varsity gets patent for pest control technique

PTI — 28-Aug-2012

Hisar based Chaudhary Charan Singh Haryana Agricultural University today said it has been issued a patent on a technique useful for controlling the population of an insect Helicoverpa armigera commonly called sundi.

Apple\'s victory dents Android\'s patent hopes

Reuters — 28-Aug-2012

Standard essential patents arent providing as much leverage in the smart device wars as Google may have hoped when it paid $12.5 billion to acquire Motorola Mobility.

Android’s standard-essential patent hopes hit

Reuters — 29-Aug-2012

But that wasnt Apples only victory.

Samsung lawyers find blunders in verdict

Reuters — 29-Aug-2012

The jurys haste takes some of the shine off Apples patent victory.

After patent war, Samsung to take on Apple with \'phablet\' & bendable screen smartphones

Reuters — 29-Aug-2012

Samsung Electronics Co unveils the second generation of its popular Galaxy Note phone cum tablet at Europes biggest electronics show in Berlin later on Wednesday as the South Korean firm comes under pressure to innovate after losing a US patent battle with Apple Inc.

Mobile patent case: New York Times leads group defense

AP — 29-Aug-2012

The New York Times is girding for a legal battle that many larger organisations have avoided.

Indian drug companies like Glenmark, Dr Reddy\'s, Sun Pharma break into world’s fastest growing list

Rupali Mukherjee — 30-Aug-2012

In yet another instance of India Inc occupying a larger seat in the global league tables three out of the top 10 fastest growing generic companies globally are now from India.

Sony not worried by Android legal woes

Reuters — 30-Aug-2012

Sony Mobile which uses Google Android software for its smartphones has not seen much impact from patent problems of the software platform.

Apple vs Samsung: Keeping patent for 20 years patentee pay renewal fees of $880 after 3.5 years

Krishnamurthy Subramanian — 30-Aug-2012

The litigation resulted because Apple accused Samsung of ripping off the feel of its iPhone and iPad among various other patent violations.

Apple Samsung \'war\' overshadows tech show

AFP — 30-Aug-2012

The repercussions of Apples billion dollar patent victory over Samsung were still being felt at Europes biggest consumer electronics show as the South Korean firm launched a host of new gadgets.

Drug makers may have to tweak domestic business model

C.H. Unnikrishnan — 30-Aug-2012

Drug makers in India will soon have to restructure their domestic business models to factor in a drop in margins as prices begin to fall when the country’s new drug pricing policy takes shape.

\'Domestic drug company\'s need to focus on pharmerging mkts\'

Rupali Mukherjee — 30-Aug-2012

This is in the wake of lucrative patent opportunities dying away post 2015, with few blockbuster drugs losing patent protection in the US.

Japanese court to rule on Apple-Samsung patent dispute

PTI — 31-Aug-2012

A Japanese court today will issue a ruling in a bitter patent dispute between Apple and its South Korean rival Samsung the latest case in a global war between the two technology giants.

Google, Apple CEOs in talks on patent issues

Reuters — 31-Aug-2012

Google Inc Chief Executive Larry Page and Apple CEO Tim Cook have been conducting behind the scenes talks about a range of intellectual property matters including the mobile patent disputes between the companies people familiar with the matter said.

Samsung wins patent case against Apple in Japan

AP — 31-Aug-2012

A Tokyo court on Friday dismissed Apple Incs claim that Samsung had infringed on its patent the latest ruling in the global legal battle over smartphones that pits the two technology titans against each other.

Apple files new Samsung patent action in US

AFP — 1-Sep-2012

Apple has filed a fresh patent infringement action in the United States against Samsung alleging that the South Korean company is continuing to steal its technology despite a recent court ruling.

Pharma Department proposes negotiating patent drug rates with firms

PTI — 02-Sep-2012

The Department of Pharmaceuticals is understood to have proposed direct negotiations with companies for reducing prices of patent drugs to the rate comparable to the lowest available in the global market.

Apple verdict: Days of design innovation over?

Reuters — 02-Sep-2012

In a pre-iPhone age, mobile phones came in all shapes and sizes.

The Compulsions and Repercussions of Compulsory Licensing

Shobhika Puri — 02-Sep-2012

The recent erosion of investor confidence in India that is doing the rounds in corporate circles is due to a variety of self-defeating strategies that have been adopted by the government.

Patients lose out to patents & profits

Deepa Kurup — 02-Sep-2012

A 2012 WHO study ranks India third behind Myanmar and Bangladesh among countries that fail to provide health cover to people.

Intellectual property rights for plants animals by western firms a cause of concern?

Swati Deshpande — 02-Sep-2012

As emerging trends point to intellectual property rights in plants animals genes found in developing countries being patented by western firms retired Supreme Court judge Justice B N Srikrishna recently sounded a warning note for the need to have strong laws to control intellectual property.

Pharma manufacturers should understand the principles of intellectual property rights: G Selvaraj

Peethaambaran Kunnathoor, Chennai — 4-Sep-2012

He said under intellectual property law owners are granted certain exclusive rights including manufacture and distribution of inventions sue in case of unlawful or deceptive copying of their innovations etc.

IPAB concludes hearing on Bayer CL appeal

C H Unnikrishnan — 4-Sep-2012

The patent office had in February issued a compulsory licence to local drug maker Natco Pharma Ltd to make and sell a low-cost generic version of Bayer’s cancer drug

India Looks To Expand Drug-Price Controls .

RUMMAN AHMED — 5-Sep-2012

The new proposals would extend price restrictions beyond generic medicines to apply for the first time to patented drugs.

Exide Industries wins 15 year trademark spat

Ashwin Mohan — 5-Sep-2012

In a huge relief for leading battery-maker Exide Industries the company averted serious competition as it won a 15 year old trademark suit against global battery giant Exide Technologies.

Will India keep Novartis at bay?

Sushmi Dey / New Delhi — 06-Sep-2012

The company wants to patent and sell its anti cancer drug imatinib mesylate known as Glivec in India but so far its efforts have failed.

Samsung faces probe over Apple\'s antitrust complaint

Reuters — 06-Sep-2012

South Korean regulators are investigating complaints filed by Apple that Samsung Electronics is abusing its dominant position in wireless technology the Korea Fair Trade Commission said on Thursday.

Hearing on post-grant opposition to Roche\'s Pegasys to be held by IPAB on Sept 6

Ramesh Shankar, Mumbai — 06-Sep-2012

The post grant opposition on this case was filed by Sankalp Rehab Trust.

India to hunt for patented technology to bridge innovation gap

PTI — 06-Sep-2012

Seeking to accelerate innovation India will launch a global hunt for patented technology to fill in the gaps in its initiatives and hand them over to small industries to speed product development.

Slow rise in generics share may hold up pharma cos\' plan in Japan

B Dasarath Reddy / Chennai/ Hyderabad — 7-Sep-2012

Drug laws in Japan make it tough for generic makers to enter the country

Move against tiny photocopy shop raises copyright debate

Aesha Datta — 07-Sep-2012

The recent crackdown on the Rameshwari Photocopy Service aka the D-School photocopy shop, has fuelled a debate regarding what’s “unlawful” about photocopying for educational purposes.

iPhone 5: Chinese company may sue Apple

TOI Tech — 07-Sep-2012

It may still be few days for Apples next generation iPhone unveiling however the much awaited phone is already facing lawsuit threat in China.

Fixing of patented drug prices only after negotiating with pharma cos’

PTI — 07-Sep-2012

A panel set up to look into the pricing mechanism for patented drugs has said that prices have to be decided after deliberations with manufacturers if the government is to adopt price negotiation model Parliament was informed today.

Patent drug prices to be set in negotiations with pharma companies

PTI — 07-Sep-2012

Cipla wins patent case over Tarceva

C.H. Unnikrishnan — 8-Sep-2012

Cipla Ltd won a landmark patent case against Swiss drug maker F Hoffmann-La Roche Ltd in the Delhi high court on Friday over the Indian companys generic copy of lung cancer drug Tarceva after a four-year court battle.

Could patenting fundamentals be right?

Raghavendra S. — 09-Sep-2012

Ruling upholding Apples design patents may be a setback impacting consumer choice and welfare

Venus gets patent from Canada for antibiotic drug

Press Trust of India / Chandigarh — 10-Sep-2012

The company already has a patent for the drug in US South Africa New Zealand Ukraine and Australia.

Cipla’s patent win against Roche boosts hopes of generic drugmakers

DIVYA RAJAGOPAL — 10-Sep-2012

The Delhi High Court ruling favouring Indias second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fighting similar patent infringement cases.

Govt looking at riders for foreign investment in pharma

Our Bureau — 10-Sep-2012

Some multinational companies operating here are unhappy with tough decisions in recent years by the patent office and Indian courts in rejecting drug patents recognised in many Western nations.

Venus bags first patent from Canada for antibiotic drug

Charanjit Ahuja — 10-Sep-2012

Chandigarh based Venus Remedies Limited a leading research based global pharmaceutical company has secured its first patent from Canada for its novel antibiotic adjuvant entity Vancoplus.

Novartis India share gains 5.5% ahead of Supreme Court hearing on Glivec in patent case

Reuters — 10-Sep-2012

The Indian unit of Novartis AG has challenged the countrys patent office decision to refuse to grant a patent for its cancer drug Glivec.

IPAB adjourns hearing on post-grant opposition to Roche\'s Pegasys to Sept 21

Ramesh Shankar — 11-Sep-2012

Intellectual Property Appellate Board in Chennai has once again adjourned the hearing in the post grant opposition case against the patent granted to Roche for Pegasys to September 21.

Novartis argues for Glivec patent at Supreme Court

Reuters — 11-Sep-2012

Swiss drugmaker Novartis told Indias top court it had demonstrated the improved efficacy of its cancer drug Glivec as the final hearing began on Tuesday of a patent case that could change the rules for the countrys healthcare sector.

iPhone 5: Samsung to sue Apple over LTE patent

Zeebiz Bureau — 11-Sep-2012

The persistent battle between tech giants Apple and Samsung takes a new turn almost every day.

Off-patent pain drug can kill resistant TB

ANI — 11-Sep-2012

Their findings point to a potential new therapy for the more than 500000 people worldwide whose TB has become resistant to standard drug treatments.

Rice exporting firm seeks patent for parboiling unit

Express news service — 12-Sep-2012

The wheat eating belt of north India likes it raw when it comes to rice.

Neck-deep in debt, Deccan Chronicle Holdings Ltd pledges trademarks too

Swati Bharadwaj Chand — 12-Sep-2012

Its not just shares movable assets and immovable properties that the promoters of beleaguered Deccan Chronicle Holdings Ltd have pledged and mortgaged to raise funds.

Novartis case opens in SC

BS Reporter / New Delhi — 12-Sep-2012

Company ready to promise assistance scheme for patients will continue even after litigation

Patent expiries: Dr Reddy\'s, Lupin to foray into specialty pharma Aurobindo Pharma to focus on services

Deepika Amirapu — 12-Sep-2012

Indias top pharmaceutical companies are preparing for life after high revenues from expiring patents drops off at the end of this year.

Salman Khan’s ‘Ek The Tiger’ courts copyright controversy

Zeenews Bureau — 12-Sep-2012

After a series of Bollywood films embroiled in script cheating controversy, like ‘Jannat 2’, ‘Desi Boyz’ and others, Salman Khan’s ‘Ek Tha Tiger’ is the latest film to have landed in copyright row

PRICING PATENTED DRUGS

P A Francis — 12-Sep-2012

A fundamental flaw in the current drug pricing policy in India is the absence of regulation on high priced patented drugs.

University of California sues Facebook Wal-mart over patents

Reuters — 13-Sep-2012

The patents for interactive technology including hypermedia display and interaction were issued to the university and licensed to Eolas a Texas company chaired by Michael Doyle.

As hearing continues in SC on Glivec; health groups & experts ask Novartis to drop the case in India

Ramesh Shankar, Mumbai — 13-Sep-2012

Even as the Supreme Court has started hearing the arguments on the controversial Glivec patent case some health groups and health experts in the world have written an Open letter to Novartis asking the Swiss drug major to drop the case in India.

Lupin shares drop after US ruling on birth control drug

Reuters — 13-Sep-2012

The ruling could prevent Lupin from launching a generic version although Barclays Capital said that the drug maker plans to appeal the verdict given the company believes it has a strong basis for invalidating the patent.

We haven\'t broken any law: Siddharth Roy Kapur

Press Trust of India / Gurgaon — 13-Sep-2012

Barfi producer Siddharth Roy Kapur who has been sent a legal notice from British manufacturers Murphy Radio for alleged trademark infringement says they have not broken any law by using it in the film.

Apple wins German patent case against Motorola

AFP — 14-Sep-2012

A German court found Google-owned IT company Motorola guilty of infringing Apple patents on the design of smartphones and tablets a court spokesman said on Thursday.

Of patients, patents and profits

Patralekha Chatterjee — 14-Sep-2012

Most Indians depend heavily on local low cost generic drugs.

Google India should not deprive Consim benefit of trademark policy

PTI — 14-Sep-2012

The Madras High Court bench on Thursday upheld a single judge order that Google India Private Ltd not deprive Chennai based Consim Info Pvt Ltd benefit of their trademark policy and protect their trademarks including Bharat Matrimony, Tamil Matrimony and Telugu Matrimony.

Piramal Health set to unveil patented drug in Europe

Swetha Kannan — 14-Sep-2012

After 10 years of trials Piramal Healthcare is ready to roll out its first patented product in Europe next month.

With patient welfare pitted against corporate social irresponsibility, lives are at stake

14-Sep-2012

In doing so the multinational has questioned the applicability of section 3d of the Indian Patent Act meant to counter abusive patenting practices such as evergreening or the indefinite extension of patent monopolies through routine modifications of known compounds.

DoP to seek public opinion on pricing for patented drugs

PTI — 14-Sep-2012

The Department of Pharmaceuticals will seek views from stakeholders on how patented drugs must be priced in the country and will put up draft guidelines in public domain by next week a senior official said today.

Apple wins German patent case against Motorola

AFP — 15-Sep-2012

A German court found Google owned IT company Motorola guilty of infringing Apple patents on the design of smartphones and tablets a court spokesman said on Thursday.

Hearing in Glivec patent case to resume on Sept 18 in Supreme Court

Our Bureau, Mumbai — 15-Sep-2012

Hearing in the controversial Glivec patent case remained inconclusive in the Supreme Court with the Novartis lawyer Gopal Subramaniam continuing his arguments in the court.

Apple did not violate Samsung patents: US judge

Reuters — 15-Sep-2012

Apple did not violate patents owned by Samsung Electronics in making the iPod touch iPhone and iPad a judge at the International Trade Commission said in a preliminary ruling on Friday.

Bayers appeal for stay on compulsory licence to Natco Pharma rejected

R. Sivaraman — 15-Sep-2012

The Intellectual Property Appellate Board has rejected pharma major Bayer Corporations petition seeking a stay on the compulsory licence granted to Hyderabad based Natco Pharma Ltd.

Bayer plea against Natco on cancer drug dismissed

R. Sivaraman — 16-Sep-2012

Pharma major contested grant of licence to Hyderabad firm for making a drug to treat liver and kidney cancer

Start-ups fight back as patent wars intensify

Reuters — 17-Sep-2012

The patent wars that have embroiled many of the worlds technology giants in recent years are spreading to a new set of combatants start up companies and their venture capital backers.

Intellectual Property Appellate Board dismisses Bayers appeal against Natco

Rupali Mukherjee — 17-Sep-2012

The Intellectual Property Appellate Board has dismissed Bayers request for a stay order against the compulsory license granted by the Patent Controller to Natco on cancer drug Nexavar earlier this year.

Bayer vows to defend IPR rights on cancer drug

Press Trust of India / New Delhi — 17-Sep-2012

Allellate boardrefuses to stay the compulsory license granted to Natco for its patented cancer drug Nexavar

Benefits of TRIPS not being utilised by industries

Express News Service — 19-Sep-2012

The benefits and safeguards that have been provided under the Trade Related Intellectual Property Rights are not being utilised properly by our industries according to P H Kurien Principal Secretary Department of Information Technology and former Controller General of Patents Designs and Trademarks India.

Benefits of TRIPS not being utilised by industries

Express News Service — 19-Sep-2012

HC restrains Indian firm from using Morgardshammar trademark

PTI — 19-Sep-2012

Modi groups Morgardshammar India a rolling mill equipment manufacturer was today barred by the Delhi High Court from using the Morgardshammar trademark and name of Morgardshammar AB a subsidiary of Danieli group of Italy.

US probes Apples patent infringement

IANS — 19-Sep-2012

A US trade panel Tuesday launched a probe after the Motorola company alleged that its patents were infringed by Apple Inc.

Dabur sues Amar Remedies for passing off Siwak as Meswak

ET Bureau — 19-Sep-2012

Dabur has filed a case against Amar Remedies for infringing on the intellectual property rights to its brand Meswak.

Niche plays as patent cliff looms

Ujjval Jauhari & Ram Prasad Sahu / Mumbai — 20-Sep-2012

Efforts of Indian pharma majors in US helped improve share of key cos in US generics prescription mkt.

Setback for Apple in German patent case against Samsung

Reuters — 21-Sep-2012

A German court ruled against Apple Inc in two patent cases against Samsung Electronics and Motorola Mobility owned by Google.

Apple has ceded the crown to Samsung in emerging markets: Analyst

James B Stewart, New York Times — 22-Sep-2012

By many measures Samsung Electronics should be on the ropes.

Just what the doctor ordered

23-Sep-2012

The Indian pharma industry won an important battle: the Intellectual Property Appellate Board dismissed German drugmaker Bayer AG\'s petition seeking a stay on the \'compulsory licence\' (CL) issued to Natco Pharma for selling generic copies of the cancer drug Nexavar in India.

Italian firm wins trademark case against UK Modi controlled firm

PTI — 23-Sep-2012

Rolling mill equipment maker Morgardshammar AB a subsidiary of the Italy based Daineli Group won a trademark case with the Delhi High Court restraining the UK Modi controlled firm from using the trade name Morgardshammar.

Discussions essential to influence drug-price policy: P.H. Kurian

Staff Reporter — 23-Sep-2012

Call to oppose lobbying by MNCs to dilute price control order.

A bitter pill

Kaushik Sunder Rajan — 24-Sep-2012

At issue is a key provision in Indias 2005 Patent Amendment Act section 3(d).

Drug patents on the rise: 3,488 in five years

Sushmi Dey / New Delhi — 24-Sep-2012

It was in 2005, India changed its patent law and started granting patents in medicines.

Smartphone wars: Patents are the new weapons

STEVE LOHR, New York Times — 25-Sep-2012

In patent law youre at the cutting edge of everything and thats shifting all the time.

Orchid Pharma plans entry into therapeutic new segments

BS Reporter / Chennai — 25-Sep-2012

The company has received patents for this and has a niche biotech lab and pilot facility available which is a kind of 30 people outfit in Sholinganallur near Chennai.

Apple loses patent case against Samsung Motorola in Germany

ANI — 25-Sep-2012

A German court has dismissed tech giant Apples claims that Google owned Motorola and Korean firm Samsung infringed some of its multi touch patents.

Madras court allows GSK to resume distribution of biscuits

Mihir Dalal — 25-Sep-2012

The Madras high court allowed GlaxoSmithKline Consumer Healthcare Ltd to resume the sales and distribution of Horlicks Nutribic biscuits after it ordered a halt last month on a complaint of trademark infringement by Britannia Industries Ltd.

India Courts Drug Disaster

ROGER BATE — 26-Sep-2012

Not to be outdone by the Supreme Court the India Patent Office also is getting in on the drug-pricing game too.

Googles Eric Schmidt criticises raging mobile patent war

Agence France Press — 27-Sep-2012

Google executive chairman Eric Schmidt on Thursday criticised raging patent disputes in the global mobile industry warning that they stifled innovation and reduced consumer choice.

European Trade Council, German Tea Association uphold Darjeeling tea\'s authenticity

Sutanuka Ghosal — 27-Sep-2012

The European Trade Council and the German Tea Association have agreed to confer the protected geographical indication status on Darjeeling tea the first commodity from India to get such a tag.

LG accuses Samsung of infringing OLED patents

Agence France-Presse — 27-Sep-2012

South Koreas LG Display one of the worlds top flat screen TV makers said Thursday it had filed a patent infringement suit against Samsung Electronics over the use of advanced displays.

The booming business in biosimilars

Sushmi Dey / New Delhi — 27-Sep-2012

Various drug makers are set to cash in on the opportunity.

Copyright issue gets louder at live concerts

Kanu Sarda — 27-Sep-2012

In an attempt to protect the interest of music composers and authors the Delhi high court has ruled that playing music of other composers in live concerts and at disc jockey nights in clubs hotels and restaurants is illegal and an infringement on the Copyright Act.

Ministerial panel recommends price control for 348 essential drugs

Reuters — 27-Sep-2012

Patented drugs are not covered by this policy though India is considering a mechanism to regulate prices of medicines which are covered by patent protection.

LG: Samsungs Galaxy series phones infringe our patents

AFP — 27-Sep-2012

South Koreas LG Display, one of the worlds top flat screen TV makers said Thursday it had filed a patent infringement suit against Samsung Electronics over the use of advanced displays.

Bayer AG disappointed after losing India patent fight

AFP — 28-Sep-2012

Pharmaceutical giant Bayer AG on Wednesday said it was disappointed with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and kidney cancer.

Essential drug prices to come down by 20%

Amit Mitra — 28-Sep-2012

There will be an average reduction of 20 per cent in prices of the 348 essential medicines under the new pricing mechanism recommended by the Group of Ministers on Thursday.

Google cant patent injunction against Microsoft in Germany: US court ruling

Reuters — 29-Sep-2012

A US appeals court on Friday ruled that Google Incs Motorola Mobility unit cannot enforce a patent injunction that it obtained against Microsoft Corp in Germany, diminishing Googles leverage in the ongoing smartphone patent wars.

Pharma industry need to look sustaining growth post 2015 when patent expiries stop

Nandita Vijay, Bengaluru — 29-Sep-2012

Baring Private Equity Partners India perceives that India pharma will now need to look at sustaining its growth momentum post 2015 when there will be no major drugs going off patent.

Whirpool and LG settle refrigerator patent disputes

Reuters — 29-Sep-2012

Whirlpool Corp the worlds largest appliance maker and LG Electronics Inc settled three pending patent infringement lawsuits involving refrigerators the companies said on Friday.

Lupin aims to double sales in Japan to $500 mn in next 5 yrs

Press Trust of India / New Delhi — 30-Sep-2012

In order to achieve its desired growth in the Japanese market the company may even consider selective acquisitions.

Infosys way ahead of Indian peers in patent race

Bibhu Ranjan Mishra / Bangalore — 30-Sep-2012

Accenture the only global IT firm that filed more patents in last five years.

Drug groups eye Indian legal case

Ft.com — 1-Oct-2012

Chennai may be a long way from the Leverkusen headquarters of Bayer BAY but the German pharmaceutical group is involved in a legal dispute in the southern Indian city that is being watched by its peers around the world.

iPhone 5: Samsung files patent lawsuit against Apple

Reuters — 2-Oct-2012

Samsung Electronics said on Tuesday that it filed a new lawsuit against Apple in a US court contending the iPhone 5 infringed on Samsungs patents.

Google backs off patent complaint against Apple

AFP — 3-Oct-2012

Google owned Motorola Mobility withdrew a patent complaint filed with a US commission but remained quiet as to the reason for the legal ceasefire.

Drug makers eye M&As to tap markets at home and away

Sushmi Dey / New Delhi — 3-Oct-2012

Amid concern multinational companies may buy out Indian drug makers and dominate the pharmaceutical industry here analysts say it is time domestic companies considered acquisitions and alliances both at home and abroad.

European Union wants India to allow extended patent life for drugs

Amiti Sen — 3-Oct-2012

The European Union is making frantic efforts to convince India to liberalise its patent regime as part of the proposed bilateral free trade agreement.

DLF files five patents on building safety and security

Ravi Teja Sharma — 03-Oct-2012

Indias largest real estate developer DLF has filed five patents that are related to inventions for safety and security of its buildings and its residents.

Google withdraws US patent complaint against Apple

Reuters — 4-Oct-2012

Google subsidiary Motorola Mobility has dropped a complaint of patent infringement against Apple without explanation.

Tata group\'s Advinus Pharma ties up with Takeda Pharma for drug R&D

DIVYA RAJAGOPAL — 4-Oct-2012

Tata group promoted Advinus Pharma has entered into a joint drug discovery deal with Japanese pharma giant Takeda Pharma indicating multinational companies growing interest in Indian drug research and holding out hope for startup firms engaged in research.

Google denied summary judgment in patent dispute with Vringo

Reuters — 4-Oct-2012

Mobile phone software maker Vringo Incs shares jumped 39 percent on Wednesday after a judge denied Google Inc a motion for summary judgment in a patent dispute.

Cipla wins patent opposition against Pfizers cancer drug

Reghu Balakrishnan / Mumbai — 04-Oct-2012

The Delhi patent office judged that Pfizers patent of Sutent does not involve any inventive step.

Pfizer to appeal India decision to revoke cancer drug patent

PTI — 05-Oct-2012

Pfizer Ltd the India unit of US drugmaker Pfizer Inc will challenge the countrys patent office for revoking a patent for its cancer drug Sutent.

Motorola wins patent case against Microsoft in Germany

Reuters — 05-Oct-2012

Mobile phone maker Motorola achieved a rare victory against software giant Microsoft in a patent case before a German court on Friday the latest in a wave of patent lawsuits by technology firms fighting over market share.

Turf war in the pharma industry

Sushmi Dey / New Delhi — 07-Oct-2012

The swadeshi versus videshi battle has broken out afresh in the Rs 67000 cr Indian drug market as mutinationals step up their efforts to enter the branded generic space to compete with domestic drug makers.

No decision immediately on controlling prices of imported patented drugs

Joseph Alexander, New Delhi — 8-Oct-2012

Though mentioned in the draft pharmaceutical pricing policy 2011 the government is unlikely to rush to a decision on the price negotiation mechanism of imported patented drugs as it is still examining the report by an expert panel in this regard.

\'India needs to work on ensuring intellectual property rights\'

PTI — 09-Oct-2012

A senior US diplomat has stressed the need for conducting a detailed study on the impact of intellectual property on Indias economy saying the country should examine ways to ensure IP rights in all businesses.

Tech fighters in a patent war

New York Times — 10-Oct-2012

Apple has been involved in 148 smartphone patent lawsuits since 2006.

Patently against public health?

P.T. JYOTHI DATTA — 10-Oct-2012

The amended Patent Law is in a sense being pushed poked and prodded by drug companies testing its resilience.

Widening scrutiny of Google’s smartphone patent licensing

New York Times — 11-Oct-2012

For more than a year the Federal Trade Commission has been conducting a broad antitrust investigation into the way Google runs its internet search and search advertising businesses.

SRK to be a trademark!

Mehul S Thakkar, Mumbai Mirror — 11-Oct-2012

The actor has sent an application to the Trade Mark Registry that his often used initials not be used without his permission

Roamware wins patent for its predictive intelligence technology

Mahesh Kulkarni / Bangalore — 11-Oct-2012

Roamware a provider of mobile operator service solutions on Thursday announced that it has won a patent on Predictive Intelligence a technology that will help operators vastly improve their customer experience management capabilities and give local and roaming subscribers a much better service usage experience.

Apple-Samsung patent issue: US appeals court lifts ban on Samsung-Google phone

AFP — 11-Oct-2012

A US appeals court Thursday lifted a sales ban on Google branded Samsung smartphones in a patent fight with Apple saying there was no evidence sales were driven by features copied from the iPhone.

Court lifts ban on Samsung Galaxy Nexus in US

AFP — 12-Oct-2012

A US appeals court Thursday lifted a sales ban on Google branded Samsung smartphones in a patent fight with Apple saying there was no evidence sales were driven by features copied from the iPhone.

Cadila Pharma files for cancer vaccine patent

Vishal Dutta — 12-Oct-2012

Ahmedabad-based Cadila Pharmaceuticals has developed a cancer vaccine and has filed for its therapeutic patent with Controller General of Patents Designs and Trademarks Office.

Microsoft to sue Google with Motorola in German patent row

Reuters — 13-Oct-2012

Microsoft Corp said on Friday it plans to add Google Inc as a defendant in Germany in one of its patent actions against Googles phone maker Motorola Mobility the first time the two tech giants have come into direct legal conflict over Google\'s Android mobile software.

Lupin identifies cancer drugs as focus area in Japan

Press Trust of India / New Delhi — 14-Oct-2012

The company is present in Japan through two wholly owned subsidiaries

Opportunities back home for Indian pharma

NALINAKANTHI V. — 14-Oct-2012

Higher affordability, increase in penetration and greater awareness can drive growth.

Peoples biodiversity festival rejects IPR regime

Our Bureau — 15-Oct-2012

The Peoples Biodiversity Festival an event held in the city during the Convention for Biological Diversity says it rejects Intellectual Property Rights regime over peoples natural resources.

US market to give Indian pharma a booster shot

Kiran Kabtta Somvanshi — 16-Oct-2012

Pharma companies are expected to continue their strong performance in the September quarter driven by good performance in the US (aided by certain exclusive launches) and modest growth in the domestic pharma market.

India may win patent claims due to Traditional Knowledge Digital Library: Manmohan Singh

PTI — 16-Oct-2012

India could win 105 claims on international patents due to its Traditional Knowledge Digital Library Prime Minister Manmohan Singh said here today, opening the high level segment meeting at the Conference of Parties to Convention on Biological Diversity.

Chidambaram asks NABARD to help innovators get patents

PTI — 17-Oct-2012

Finance Minister P Chidambaram Wednesday asked NABARD to help innovators in getting patent of their products and also help them replicate their ideas for benefit of masses.

Indian fashion designers should audit their intellectual property: Safir Anand, Anand and Anand

Maulik Vyas — 18-Oct-2012

As the Indian fashion industry gains attention from international brands and labels Indian fashion designers are also becoming more savvy of their legal rights to protect their designs.

India fights to protect its traditional home remedies

AFP — 18-Oct-2012

Earlier this year India successfully fought off Nestles attempt at the European Patent Office to secure a patent saying that using cows milk as a laxative was mentioned in ancient texts and was therefore not new

Indian Drugs Manufacturing Association reviewing government directive on drug branding

DIVYA RAJAGOPALDIVYA RAJAGOPAL — 19-Oct-2012

The government wants to tackle the issue of trademark disputes that comes under their purview when companies with similar sounding brand names come to them for resolution.

The rise of the patent brigade

VENKATESH GANESH — 19-Oct-2012

In 2011 the total number of patent applications for in India was estimated to be 37000 according to controller general of patents designs and trade marks ministry of commerce and industry data.

Apple loses tablet copyright appeal against Samsung

Reuters — 19-Oct-2012

Apple lost its appeal of a ruling that its rival Samsungs Galaxy tablet computer did not copy Apples registered tablet designs in a British court on Thursday

Google considering settlement in patent antitrust case: Report

Reuters — 20-Oct-2012

Google is considering a settlement with the Federal Trade Commission over potential claims it broke antitrust law in its handling of patents for mobile devices, the Wall Street Journal reported on Friday.

Samsung doesn’t infringe Apple patent: Dutch court

Roberta Cowan — 24-Oct-2012

The court says Samsung does not infringe an Apples patent by using multi-touch techniques

Staff shortage dogs patent office as govt sits on compensation plan

C.H. Unnikrishnan — 24-Oct-2012

More than 100 people recruited as patent examiners declined to join several others may quit

Samsung violates Apple patents: US judge

Reuters — 25-Oct-2012

South Koreas Samsung Electronics the worlds top maker of smartphones infringed Apple patents to make its smartphones and tablets a US trade panel judge said in a preliminary decision issued on Wednesday.

Samsung infringes on four Apple patents

Bloomberg — 26-Oct-2012

Samsung Electronics Co lost the first round of a US trade case brought by Apple Inc its second big defeat this year in America as the companies battle worldwide over smartphone and tablet computer technology.

Govt scraps patent for jamun-based diabetes drug

Sidhartha — 27-Oct-2012

After combating bio piracy of neem and haldi in the US and Europe India has now woken up to the problem in its own backyard.

Venus Remedies gets patent from Mexico for antibiotic drug

Press Trust of India / Chandigarh — 29-Oct-2012

The drug has already received seven patent grants

Gaurav Misra: Pricing drugs, culturally

Gaurav Misra — 29-Oct-2012

The price of life saving drugs is an emotive issue.

Wait for Indian generic launches gets longer

Sushmi Dey / New Delhi — 29-Oct-2012

USFDA has extended the timeline for granting tentative approval to generic drug applications filed under Para IV of its rules by 10 months.

US is in the pink for local drugmakers

Priyanka Golikeri — 31-Oct-2012

September was at once the best and worst month of the year for local drugmakers according to analysts.

India EU may go in for partial free trade pact

PTI — 01-Nov-2012

A day ahead of Prime Minister headed panel taking up the long-pending India-EU free trade agreement, the two sides today indicated they may open their markets in a gradual way instead of signing a full-fledged pact in the wake of differences on several key issues.

UK judges order Apple to apologise again over patent dispute with Samsung

AFP — 02-Nov-2012

US tech giant Apple has until Saturday to re-write an inaccurate statement relating to its patent dispute with South Korean rival Samsung British judges have ruled.

Microsoft faces patent infringement lawsuit over live tiles in Windows 8

ANI — 02-Nov-2012

A small technology company based in Portland has filed a patent infringement lawsuit against software Microsoft over the live tiles feature included in its latest operating system Windows 8.

LG Electronics settles LED patent dispute with Siemens\' Osram unit

Reuters — 02-Nov-2012

South Koreas LG Electronics Inc said on Friday it and its component unit LG Innotek Co Ltd had agreed with Siemens light bulb unit Osram to settle all LED patent suits.

IPAB order not a healthy signal say drug makers

P.T.Jyothi Datta — 2-Nov-2012

The Intellectual Property Appellate Boards decision to set aside Roches patent on its Hepatitis C drug Pegasys comes even as the amended Patent Act gets tested from several quarters.

Patents appeal board revokes patent on Roche hepatitis drug

Reuters — 02-Nov-2012

Patents appeal board has revoked a patent granted to Roches hepatitis C drug Pegasys citing a lack of evidence the drug is superior to existing treatments and its high price.

PM for early conclusion of trade talks with EU, Asean

BS Reporter — 3-Nov-2012

The two sides also differ on inclusion of intellectual property rights and data security in the agreement.

Indias patent fix

Sushmi Dey / New Delhi — 04-Nov-2012

While the government has been battling patents on traditional Indian remedies abroad the Patent Office back home has granted a handful of such patents causing an embarrassment of sorts

India to be among top 10 pharma markets globally by 2020

PTI — 05-Nov-2012

Indias pharmaceutical industry is on good growth trajectory and is likely to be among the top 10 global markets in value terms by 2020 according to a CII PwC report released on Monday.

Pattamadai mats likely to get GI mark soon

R. Sivaraman — 6-Nov-2012

In line of Tirupathi laddu and Kanchipuram silk saris the famous mats Pattamadai pai from Tirunelveli district and traditional lamps from Nachiarkoil in Thanjavur district are to get the geographical indication mark very soon.

US judge tosses Apple suit against Motorola

AFP — 6-Nov-2012

A federal judge has tossed out an Apple lawsuit accusing Google-owned Motorola Mobility of trying to charge the iPhone maker too much for licenses to essential technology for mobile devices.

Glenmark settles patent case with Janssen in US

C.H. Unnikrishnan — 06-Nov-2012

Settlement allows Glenmark to enter the market with a generic version even before the patent expiry of Janssens drug

REVOKING PEGASYS & SUTENT

P A Francis — 7-Nov-2012

Indias patent office took two significant decisions of cancelling patents issued to two leading International pharmaceutical companies namely Pfizer and Roche during the last 30 days.

Patent expiration hit sales, profits of top 10 MNCs in 9 months of 2012, Novartis in No1 position

Sanjay Pingle, Mumbai — 7-Nov-2012

Financial performances of 10 leading global pharmaceutical companies have received a major setback during the first nine months of the current year ended September 2012 on account of patent expirations stiff generic competition austerity measures in regulated markets and US healthcare reform.

Apple violated patents in FaceTime, fined $368 million

Reuters — 08-Nov-2012

Shares of VirnetX Holding jumped 27 percent after a jury asked Apple to pay about $368 million to the internet security software maker for infringement of four patents.

Sun Pharma Q2 profit down 46%

Our Bureau — 08-Nov-2012

Drug maker Sun Pharmaceutical saw a 46 per cent dip in its net profit in the July September quarter because of Rs 584 crore set aside towards potential damages it may have to pay in a patent infringement case on heart burn drug Protonix in the United States.

Apple to court: Include Android 4.1 in patent suit

AFP — 08-Nov-2012

A US judge on Wednesday was considering a request by Apple that would pull Google from the sidelines in a long-running patent war with Samsung over mobile gadgets powered by Android software.

Pharma firms quit AP for greener pastures

Koride Mahesh — 11-Nov-2012

Thanks to a lack of incentives from its government and the ongoing power crisis in the state the pharmaceutical sector in Andhra Pradesh is shrinking.

Shares of HTC limit up after settling patent issues with Apple

Reuters — 12-Nov-2012

Shares of HTC Corp jumped by their permitted daily limit on Monday after the Taiwanese smartphone maker and Apple Inc announced a global patent settlement and 10-year licensing agreement.

R&D spending of 30 pharma companies surge by19.6% in FY 2011-12

Sanjay Pingle, Mumbai — 12-Nov-2012

The Indian pharmaceutical segment has established strong presence in the international market with higher investments in Research and Development during last decade and launched several new affordable high quality generic products.

Samsung ‘has no intention’ to settle patent suits with Apple

ANI — 15-Nov-2012

South Korean electronics maker Samsung has said that it will not follow HTCs lead and settle its patent lawsuits with Apple.

Traditional knowledge and limits to GI

Nitya Nanda, Indrani Barpujari — 15-Nov-2012

It is often considered that geographical indications can be used to protect traditional knowledge and communities.

iPhone 5, Android 4.1, Galaxy S III, Note 10.1 dragged into patent fight

Reuters — 16-Nov-2012

A US judge on Thursday allowed Samsung Electronics to pursue claims that the iPhone 5 infringes its patents while also allowing Apple to add claims that the Samsung Galaxy Note 10.1 Galaxy S III and Android 4.1 operating system violate its patents.

Set up an authority for fast approval of patents: Assocham

PTI — 16-Nov-2012

Government should set up a National Intellectual Property Right Strategy Authority in order to expedite clearances of patent applications industry body Assocham has said.

Apple quietly acquires 1,024 Nortel patents from own consortium

NDTV Correspondent — 16-Nov-2012

Apple may be getting ready to step on the patent offensive once again after acquiring over a 1000 patents from a consortium led by the Cupertino based giant itself.

\'Amul\' loses trademark battle against US giant in Gujarat HC

PTI — 16-Nov-2012

The Gujarat High Court has refused to set aside an order which cancelled Amuls registration of its trademark Trix on which a US firm has claimed its right.

Hearing in controversial Glivec case between Novartis & Union of India enters crucial stage

Ramesh Shankar, Mumbai — 17-Nov-2012

Hearing in the controversial imatinib mesylate (Glivec) case between the Swiss pharma major Novartis AG and the Union of India & Others is continuing in the Supreme Court of India which is expected to conclude by the end of this month.

\'GMO poses threat to GI tag of crops\'

Kevin Mendonsa — 17-Nov-2012

The entering of Genetic Modified Organism crops into the district poses threat to Geographical Indication crops said K N Ramachandra convener of Southern Action on Genetic Engineering.

Apple awarded patent for virtual page turn feature for iBooks

ANI — 18-Nov-2012

Tech giant Apple has awarded a patent this week for a \'page-turn\' feature that is used in iBooks.

WHO meet on fake medicines whips up controversy on NGO participation

P.T. Jyothi Datta, A.M. Jigeesh — 19-Nov-2012

A World Health Organisation meet on tackling fake medicines in Buenos Aires has drawn attention of a different kind involving India.

Apple now gets the virtual \'page turn\' patent

IBNLive.com — 19-Nov-2012

Apple which was recently granted the design patent on rectangular shape with rounded edges has now been given the exclusive rights to the page turn in an e-reader app reports The New York Times.

HTC \'happy\' with Apple settlement, slams media estimates

Reuters — 20-Nov-2012

Taiwan\'s HTC Corp is happy with its patent settlement with Apple Inc, but regards media reports on details of the licensing agreement as \"outrageous\", chief executive Peter Chou told reporters on Tuesday.

US ITC will review Apple Samsung patent decision

Reuters — 20-Nov-2012

The US International Trade Commission will review a judges decision which found that Apple did not violate patents owned by Samsung Electronics in making the iPod touch iPhone and iPad.

Microsoft-Google trial ends first phase

Reuters — 21-Nov-2012

A Google expert witness testified on Tuesday that Microsoft will make roughly $94 billion in revenue through 2017 from its Xbox game console and Surface tablet that use Google\'s patented wireless technology.

NSF introduces Atorvastatin Calcium Reference Standard Kits to maintain highest quality standards for Indian mfrs

Ann Arbor, Michigan — 21-Nov-2012

NSF International an independent global public health organization that develops high quality reference standards has released Atorvastatin Calcium Reference Standard Kits which are traceable to official US and European pharmacopoeial standards.

Samsung gets review in patent case with Apple

Bloomberg — 21-Nov-2012

Samsung the world\'s biggest maker of smartphones, will get another chance to convince a US trade agency that Apple\'s iPhone and iPad infringe its patents.

Samsung now accuses iPad Mini, new iPad, iPod Touch of patent infringement

Tech — 22-Nov-2012

Over the last few months Apple and Samsung have been seen including new products in their legal battles.

CEWiT research may get incorporated into the global standards of 4G

Sangeetha Kandavel — 22-Nov-2012

India needs to emulate China in creating enough patents to avoid paying royalties.

India approves policy to cap prices of 348 drugs

Reuters / NEW DELHI/ MUMBAI — 22-Nov-2012

India approved a new drug pricing policy designed to increase the number of drugs deemed essential that are subject to price caps two ministers told reporters.

Microsoft files patent for augmented reality smart glasses

23-Nov-2012

A patent applied for by the US tech firm describes how the eyewear could be used to bring up statistics over a wearers view of a baseball game or details of characters in a play.

Patent paradox

Staff Writer — 23-Nov-2012

Patent approvals fall across sectors in 2011.

Ranbaxy shares down over 3% after drug recall in US

PTI — 23-Nov-2012

Ranbaxy was the first company to launch generic Lipitor in the US market after Pfizers patent expired last year.

Patent clearance slower in India, says scientist

Express news service — 24-Nov-2012

A leading Scientist working with the Tata Consultancy Services Dr Hiranmay Ghosh on Friday said that the pace of clearing patents in India was slower than in developed countries like the US.

Appellate Board sets new ground rule for GI tags

Vinson Kurian — 23-Nov-2012

The Intellectual Property Appellate Board has set aside grant of Geographical Indication registration for Payyannur Pavithra ring.

Apple iPad mini infringed patent, claims Samsung

ANI — 24-Nov-2012

Adds the iPad mini to a list of products it claims violate patents on radio signalling technologies

IPAB dismisses Astra Zeneca’s cancer drug patent appeal

P. T. Jyothi Datta — 28-Nov-2012

Company was refused patent in 2007

CLSA raises target price of Lupin Cipla Sun Pharma

30-Nov-2012

CLSA has increased target prices of pharmaceutical majors Lupin Cipla and Sun Pharmaceuticals.

Global patent filings on the rise

Our Bureau — 2-Dec-2012

Filing of patents by researchers across the global has increased.

Delhi HC asks Cipla to prove its drug doesn’t infringe Roche patent

C.H. Unnikrishnan — 3-Dec-2012

A division bench asked Cipla to prove that its anti-lung cancer drug doesn’t infringe a patent belonging to Roche

Birla Institute of Technology Patna hosts intellectual property meet

TNN — 6-Dec-2012

The importance of patents for business houses to avoid litigation was stressed by S K Jain, department of management studies IIT Delhi, at a workshop on Intellectual Property Rights organized at the Birla Institute of Technology Patna on Wednesday.

Doha climate talks: Rich nations reject India\'s offer on intellectual property concerns

Nitin Sethi — 6-Dec-2012

The developed world rejected Indias offer of a diluted reference to concerns about intellectual property rights in the climate negotiations as the talks in Doha peaked

Google, Apple team up to buy Kodak\'s 1,100 patents for $500 million

9-Dec-2012

Apple and Google have joined forces to offer more than $500 million to buy Eastman Kodak\'s patents out of bankruptcy, said people familiar with the situation.

Essential drug prices may come down

Rupali Mukherjee — 10-Dec-2012

After going through various twists and turns over the years as well as being in the cold storage for sometime the National Pharmaceutical Pricing Policy 2012 which caps prices of essential drugs has been finalised, and is expected to be notified over the next few days

UN Climate Change Negotiations 2012: India satisfied at negotiations; manages to retrieve key issues it lost in Copenhagen & Durban

Urmi A Goswami — 11-Dec-2012

The lack of an aggressive effort to reduce greenhouse gas emissions and financial support for developing countries at Doha notwithstanding India has cause not to be dissatisfied with its performance at the recently concluded negotiations.

Goan gets patent for mechanical device invention

11-Dec-2012

In a development that should bring some cheer to the Goan engineering community, a Goan has been granted a patent from the Indian patent office.

India revokes patent for Merck asthma drug

AFP — 12-Dec-2012

India has revoked a patent for an asthma drug held by US based Merck following a challenge from local pharmaceutical giant Cipla marking a new blow to global drug firms in the Indian market.

Microsoft, Motorola file to keep patent case details private

Reuters / Seattle — 16-Dec-2012

Microsoft Corp and Google Inc\'s Motorola Mobility unit have requested a federal judge in Seattle to keep secret from the public various details from their recent trial concerning the value of technology patents and the two companies\' attempts at a settlement.

Tirur betel farmers scramble for GI tag to secure Pakistan market

K R Rajeev — 17-Dec-2012

Beeran Kutty is now pinning his hope on the Kerala Agricultural Universitys plan to secure geographical indications tag for the Tirur betel leaves an attempt by the varsitys Intellectual Property Rights Cell to help farmers protect their rights over the unique produce.

Pfizers Sutent patent case against Cipla adjourned

Our Bureau — 17-Dec-2012

Delhi court awaits Patent Controller hearing today

Microsoft, Motorola unlikely to reach settlement in patent case

Reuters — 18-Dec-2012

Microsoft Corp and Google Inc\'s Motorola phone unit remain millions of dollars apart in their respective valuations of video and wi-fi patents at issue in a pivotal case before a federal judge in Seattle.

Sun Pharma’s US arm Caraco to buy URL’s generics business

CH Unnikrishnan — 18-Dec-2012

Generic assets of URL Pharma will be owned and managed by Sun’s US unit Caraco after deal is completed

Microsoft signs new patent deal with German Android device maker

ANI — 18-Dec-2012

Software giant Microsoft has negotiated a fresh licensing agreement with the German maker of Android-based devices.

Samsung ends \'patent war\', withdraws bid to ban Apple devices in Europe

ANI — 19-Dec-2012

South Korean mobile maker Samsung has withdrawn its bid to get Apple devices banned in Europe.

ITC judge sides with Apple against Google on phone patent

Reuters — 19-Dec-2012

Googles Motorola Mobility unit cannot assert a patent against Apple Inc which covers a sensor that stops phone users from dialing wrong numbers on touchscreen devices a US trade judge ruled.

Kodak in $525 million patent deal, eyes bankruptcy end

Agence France Presse — 20-Dec-2012

US photography giant Eastman Kodak said today it had agreed sell its digital imaging patents for $525 million to help it emerge from bankruptcy protection.

Owner of OpenTV slaps Netflix with patent lawsuit

Reuters — 20-Dec-2012

The owner of interactive television pioneer OpenTV sued Netflix Inc on Wednesday, alleging the company infringed on patents that cover technology underpinning the fast-growing Internet video sector.

Apple \'pinch-to-zoom\' patent deemed invalid

AFP — 20-Dec-2012

A filing on Wednesday in a high-stakes legal battle between Samsung and Apple revealed that a \"pinch-to-zoom\" patent central to the case has been deemed invalid.

Samsung to face charges from EU in Apple patent case

Reuters — 20-Dec-2012

The European Commission is set to charge South Korean electronics group Samsung in an antitrust patent case, the European Union\'s competition chief Joaquin Almunia said.

Apple patent case: EU charges Samsung with abuse of sector-essential telecom patent

Reuters — 21-Dec-2012

The European Commission charged Samsung Electronics on Friday with abusing its dominant position in seeking to bar rival Apple from using a patent deemed essential to mobile phone use.

Nokia settles Wi-Fi patent dispute with RIM

Reuters — 21-Dec-2012

Struggling Finnish mobile phone maker Nokia has settled its patent dispute with BlackBerry maker Research in Motion in return for payments, as it tries to exploit its trove of technology patents to boost its finances.

India thwarts US company bid to patent pomegranate

Vanita Srivastava — 23-Dec-2012

India has foiled an attempt made by a US company to claim a patent at the United States Patent and Trademark Office on the use of pomegranate for the treatment of ulcers.

\'Patent cliff\' forces pharma companies to eye new markets

Rupali Mukherjee — 24-Dec-2012

The drying up of blockbuster drug pipeline and lower R&D productivity of Big Pharma may start impacting domestic generic companies forcing them to look at alternative research models and focus on emerging markets for growth.

Samsung hits back at Ericsson in patent battle

AFP — 26-Dec-2012

South Koreas Samsung Electronics said Wednesday it had filed a complaint to seek a US import ban on some Ericsson products in an escalating patent battle with the Swedish mobile giant.

Nokia signs patent-licensing deal with BlackBerry maker RIM

Bloomberg — 27-Dec-2012

Nokia the Finnish mobile phone maker struggling to reverse a slide in sales agreed to a patent licensing deal with BlackBerry maker Research In Motion ending all legal disputes between the companies.

2012 of Pharma industry ends with debate over patents

27-Dec-2012

2012 was occupied by Pharma industry bodies & patient groups debated over the contours of the pricing policy.

Apple fined over $165,000 for copyright violation in China

Agencies — 28-Dec-2012

Technology major Apple Inc has been fined USD 165,908 by a court here for allegedly selling unlicensed electronic versions of books online.

Bristol-Myers sues DRL in US for patent infringement

Press Trust Of India / Hyderabad — 28-Dec-2012

US-based drug maker Bristol Myers Squibb Company has filed a patent infringement case against Dr Reddys Laboratories over the cancer drug Ixempra.

Apple to drop patent claims against new Samsung phone

Reuters — 29-Dec-2012

Apple Inc has agreed to withdraw patent claims against a new Samsung phone with a high-end display after Samsung said it was not offering to sell the product in the crucial U.S. market.

Sylvester Stallone wins copyright infringement case

PTI — 30-Dec-2012

Hollywood action star Sylvester Stallone did not steal the plot for The Expendables from another screenwriter a federal judge has ruled.

FDI in pharma, the wrong prescription

S. Srinivasan — 30-Dec-2012

FDI in pharma is not what we need.

China patent office world’s biggest India at 7th rank

Vanita Srivastava, Hindustan Times — 31-Dec-2012

The Chinese filed the most patent applications in 2011 overtaking the US for the first time says the World Intellectual Property Indicators 2012 released by the World Intellectual Property Organisation in December.

Suven Life gets three patent approvals for CNS molecules

Amit Shanbaug — 31-Dec-2012

Suven Life Sciences Ltd announced on Monday that the grant of three product patents two from Eurasia and one from Canada corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2027.

Nestle wins trademark battle against Cadbury over kitkat bar’s shape

ANI — 3-Jan-2013

Nestle has won a trademark lawsuit against Cadbury over their rights to KitKat chocolate bar\'s four-fingered and three-dimensional shape.

Need to create intellectual property with proprietary rights: Pallam Raju

OUR BUREAU — 3-Jan-2013

There is a need to create intellectual property with proprietary rights, according to M.M Pallam Raju, Union Minister for Human Resources.

The great Indian patent saga

Shruti Verma Khare — 4-Jan-2013

The outcome of Novartis & Bayer fights for patents will set new benchmarks for the industry.

RIM settles patent dispute with Nokia

TNN — 4-Jan-2013

BlackBerry maker Research in Motion paid rival Nokia 50 million euros to settle a patent dispute, the Financial Times reported on Thursday citing US regulatory filings.

India must expand knowledge base and focus on R&D, says HRD Minister

PTI — 4-Jan-2013

YDERABAD: There is a need to create intellectual property with proprietary rights by enhancing the knowledge base and help the country emerge as a major power, Union HRD Minister M M Pallam Raju said today.

Google-FTC agreement could impact other patent disputes

Reuters — 7-Jan-2013

While the focus of last week\'s agreement between the Federal Trade Commission and Google Inc was search, the deal\'s restrictions on how Google uses its patents could have a broader impact on the technology industry.

MNC R&D centres are now increasing their filing of patents from India

Chiranjoy Sen — 7-Jan-2013

The Philips R&D centre started in 1996 in a small building at the heart of Bangalore.

Regulatory hurdles dampen MNC appetite for pharma buyouts

Reghu Balakrishnan / Mumbai — 7-Jan-2013

The pharmaceutical sector in India among the fastest growing markets globally in the segment is likely to witness less demand from multinational corporations for larger buyouts in 2013.

Google withdraws ITC patent claims against Microsoft

Steven Musil — 08-Jan-2013

Motorola Mobility parent drops two patents from its infringement case over video coding patents used in Xbox and smartphones.

Patent \'Cliff\' a Challenge, but Manageable

Javier E. David — 08-Jan-2013

Eli Lilly will be \"very challenged\" by the loss of exclusivity on several blockbuster drugs, CEO John Lechleiter told CNBC on Tuesday, but added the company is engaged in other ways to revive growth next year.

Ya Allah!! A Dutch artist wants to patent your name for his art

IANS/RIA Novosti — 09-Jan-2013

A Dutch artist has made a bid to register the name \"Allah\" as a trademark, saying it is an \"incredibly beautiful name\".

Indian Patent Office issues draft guidelines on examination of biotech applications

Nandita Vijay, Bengaluru — 9-Jan-2013

The Indian Patent Office has issued draft guidelines on examination of biotechnology applications.

Intellectual property rights to play key role in value-addition to exports

A. J. Vinayak — 09-Jan-2013

India should look at intellectual property rights to add value to exports.

Indian court to rule on generic drug industry

NIRMALA GEORGE AP — 09-Jan-2013

The implications of this case reach far beyond India, and far beyond this particular cancer drug,\" said Leena Menghaney, from the aid group Doctors Without Borders.

Tech patent war: Justice Department against sales bans

Reuters — 09-Jan-2013

The fight has also embroiled Samsung Electronics, HTC and others who use Android technology.

Google\'s Motorola drops patent claims vs Microsoft

Reuters — 10-Jan-2013

Google unit Motorola Mobility has asked a trade panel to drop two key patents from an infringement complaint that it filed against Microsoft, according to a filing at the International Trade Commission.

Meerut scissors make the cut for GI tag

Renuka Phadnis — 10-Jan-2013

For the first time, a handmade tool from micro and small and medium enterprises in India has been registered for a geographical indicator tag an official of a body promoting this sector said on Wednesday.

Soon MSMEs can buy, sell licences for patented products online

Special Correspondent — 10-Jan-2013

MSMEs will get concessional rates for trading on the portal

IBM tops as tech titans scramble for US patents

AFP — 11-Jan-2013

The list of the top 50 patent recipients included 17 US firms and 26 that are based in Asia

2012 patent rankings: IBM on top again, Google, Apple surge

STEVE LOHR — 11-Jan-2013

In the yearly count of patents granted in the United States the corporate front-runner for 2012 is scarcely a surprise.

IKEA stares at trademark hurdle

Sounak Mitra & Surajeet Das Gupta / New Delhi — 11-Jan-2013

IKEA Home D?cor Pvt. Ltd, registered with the RoC, Chandigarh, since July 2011, has the trade mark registration for the brand IKEA

Berhampur charts silk route to recognition

Hrusikesh Mohanty — 12-Jan-2013

Four products of Ganjam district the Berhampuri patta saree joda or silk dhoti kewda flower and kewda flower rooh or essence have been registered under the Geographical Indications of Goods Act.

Kodak patent sale plan gets U.S. bankruptcy court approval

Reuters — 12-Jan-2013

The price is a fraction of the more than $2 billion which Kodak had hoped to fetch for the patents when it filed for bankruptcy in January 2012.

Govt moves to make three key cancer drugs cheaper

Abantika Ghosh — 12-Jan-2013

Compulsory licensing by the government allows a domestic company to manufacture and sell a generic version of a patented drug with or without the consent of the patent-holder.

Compulsory licence likely for three cancer drugs

Divya Rajagopal — 14-Jan-2013

The government has appointed a panel to look into issues related to compulsory licensing of drugs and whether cheaper versions of cancer medicines Trastuzumab, Ixabepilone and Dasatinib can be launched under the provision, a person with knowledge of the development said.

India to hit Roche, BMS with compulsory licenses on 3 cancer drugs

Tracy Staton — 13-Jan-2013

Officials aim to usher in cheap copies of Herceptin, Sprycel, Ixempra

Samsung urges U.S. court to keep allowing Galaxy phone sales

Erin Geiger Smith — 15-Jan-2013

Samsung Electronics Co Ltd has urged a U.S. appeals court to stand by its denial of Apple Inc\'s request to ban sales of the Galaxy Nexus smartphone while Apple challenges its patent, according to a document filed late last week.

Drug pricing: Govt decides to bypass three patents

Reghu Balakrishnan / Mumbai — 15-Jan-2013

The governments move to issue compulsory licences for three more patented cancer drugs is a jolt to multinational pharmaceutical companies.

Meerut scissors may get Geographical Indication (GI) mark

Pankaj Shah — 17-Jan-2013

The famous Meerut scissors which have 360 year old history are in the process of getting the coveted Geographical Indication mark enabling artisans get a premium for their unique product and protecting their age-old tradition against copy-cats.

Naga shawl among 18 handicraft items zeroed in for GI tag status

Shobha Roy — 20-Jan-2013

National Institute of Fashion Technology is in the process of registering the well known traditional crafts of the country’s north-eastern States under the Geographical Indication Act.

India lags behind in applications for patents: Prez

Press Trust of India / Vidyanagar(WB) — 20-Jan-2013

Noting that India \"lagged behind\" others in applying for patents, President Pranab Mukherjee today said there is a need to carry out more research and scientific inventions in the country.

We must protect traditional Indian products in the international market to boost growth

21-Jan-2013

One such policy is the recognition of geographical indications.

Final hearings in Bayer\'s appeal against India’s first-ever CL on Nexavar to begin at IPAB soon

Ramesh Shankar, Mumbai — 21-Jan-2013

The final hearings in the German pharma major Bayers appeal against Indias first ever compulsory licence issued on sorafenib tosylate will begin at the Intellectual Property Appellate Board Chennai on January 23.

Global firms turn to ITAG Business Solution for patenting, IP rights issues in India

Anuradha Himatsingka — 22-Jan-2013

Kolkata based intellectual property firm, ITAG Business Solution has been approached by global as well as Indian corporate giants for matters as diverse as finding buyers of new technological inventions to fighting patent issues to filing of new patent of Indian firms seeking markets over-seas with their exclusive product range.

Hindustan Unilever enters into new technology, trademark license agreement with Unilever

Namrata Singh — 22-Jan-2013

HUL will enter into a new agreement effective February 1 2013 with Unilever for the provision of technology trade mark license and other services.

Pharma MNCs use RTI law to protect market for patented drugs & delay entry of generics

ET Bureau — 24-Jan-2013

Pharmaceutical multinationals have begun using the Right to Information law to launch pre-emptive legal action against local generic players to protect the market of patented drugs and delay the entry of low cost generic medicines in the 60,000-crore domestic drug market.

Varanasi eyes GI tag for local handicraft

TNN — 24-Jan-2013

An awareness workshop on Geographical Indications was organised jointly by National Bank for Agriculture and Rural Development Lucknow Human Welfare Association and GI Registry office Chennai at Parade Kothi on Wednesday.

US panel reviews patent ruling against Samsung

AFP — 24-Jan-2013

The US International Trade Commission on Wednesday ordered review of a ruling that Samsung violated Apple patents for smartphones and tablet computers.

US panel reviews patent ruling against Samsung

AFP — 24-Jan-2013

The US International Trade Commission on Wednesday ordered review of a ruling that Samsung violated Apple patents for smartphones and tablet computers.

India foils US firm bid to patent turmeric

Vanita Srivastava — 28-Jan-2013

The claim made by a US multinational company on the usefulness of turmeric apple, basil for the treatment of inflammation psoriasis and gastritis has been foiled by India thanks to the efforts of the Traditional Knowledge Digital Library.

Free trade pact with EU on verge of completion : Anand Sharma

Asit Ranjan Mishra, Elizabeth Roche — 28-Jan-2013

Global economic recovery remained fragile though there was some hope for cautious optimism, Sharma said

Firms go beyond patent cliff for growth

Sushmi Dey / New Delhi — 29-Jan-2013

Indian pharma companies have depended heavily on drugs coming off patent in the US to fuel their growth.

Glenmark readies to enter one more niche segment in US

Sushmi Dey / New Delhi — 29-Jan-2013

Prodded by patent cliff & increasing competition it files application for foray into injectible oncology segment.

Higher yields & farmer preferences show, Bt cotton detractors spreading patent falsehoods

Swaminathan S Anklesaria Aiyar — 30-Jan-2013

India\'s cotton yield was 225 kg per hectare in 1990-91.

Patent Gurukul to meet experts to discuss impact of recent patent office notification in Mumbai

Our Bureau, Mumbai — 30-Jan-2013

With a view to get better clarity on the recent notification issued by the Patent office, the Patent Gurukul will soon be meeting experts from the field to discuss and brainstorm on the concept of traditional knowledge and biodiversity in Mumbai on February 15.

Apple loses a U.S. appeals bid in Samsung patent fight

Dan Levine — 1-Feb-2013

A U.S. appeals court on Thursday rejected Apple Inc\'s request to revive its bid for a sales ban on Samsung\'s Galaxy Nexus smartphone dashing the iPhone maker\'s attempt to recover crucial leverage in the global patent wars.

$19 bn worth biologics to go off patent in US this year

BS Reporter / Chennai/ Hyderabad — 1-Feb-2013

Twenty one biologics with a market value of about $54 billion will be losing patent protection by 2019 in the US alone.

Microsoft sued over search-related patents

Reuters — 1-Feb-2013

A lawsuit filed on Thursday alleges Microsoft Corp has been infringing patents that allow Internet search engines to most effectively place advertisements.

Opportunities for biosimilars as patent protection drops: report

Amit Mitra — 01-Feb-2013

Significant opportunities are expected to open up for pharmaceutical companies in the biosimilar segment, with biological drugs with a market value of over $50 billion slated to shed their patent protection in the US alone in the next six years.

US exports may drive top Indian pharma cos to grow 20% in 2013

Press Trust of India / Mumbai — 03-Feb-2013

Patent expiry opportunities, coupled with efforts to contain healthcare spends, are likely to drive the generic market in developed countries.

Financial Times: Whose intellectual property?

Paranjoy Guha Thakurta — 03-Feb-2013

The battle could be reaching a conclusion as a bench of the Supreme Court starts hearing the case on 4 Feb

Organic route to promote Geographical Indications crops

TNN — 5-Feb-2013

The horticulture department in Mysore is going all out in its efforts to protect Geographical Indications crops Nanjangud Rasabale Mysore Mallige and Mysore veeledele which are on the verge of extinction.

Stay on hearing over ‘Financial Times’ trademark

Utkarsh Anand : New Delhi — 6-Feb-2013

The Supreme Court Tuesday stayed the proceedings before the Karnataka High Court pertaining to determination of the validity of registration of the trademark Financial Times in India.

Window of opportunity on FTA closing: EU ambassador

Elizabeth Roche — 07-Feb-2013

EU ambassador Joao Cravinho says differences on auto, wine and spirits, services sectors remain to be resolved

UK court revokes Glaxo patent on malaria drug on Glenmark petition

C. H. Unnikrishnan — 07-Feb-2013

After the order to revoke Glaxo’s patent, Glenmark’s generic unit launched a copy of the drug in the UK.

Obama nominates openly gay lawyer for patent appeals court

Dan Levine | Reuters — 8-Feb-2013

President Barack Obama nominated Thursday an openly gay attorney to serve on the U.S. appeals court for patent cases after a previous gay nominee for that court stalled.

Microsoft wins latest round in Motorola patent case

AFP — 8-Feb-2013

A federal judge on Thursday tossed out more than a dozen patent infringement claims filed against Microsoft by Google-owned Motorola Mobility.

Apple applies for patent on use of \'images for authentication\'

ANI — 08-Feb-2013

Tech giant Apple has applied for a patent on the use of images to authenticate the user of a Mac or some other \'i\' product.

Call to establish intellectual property exchange in India

Our Bureau — 08-Feb-2013

The country has been falling back in terms of patent filings and protection.

Indian technology companies sharpen focus on patents

Leslie D’Monte & | Ruchita Saxena — 10-Feb-2013

Firms also tap non-linear businesses to shield themselves from risks to traditional offshoring delivery models

Apple patent filing suggests new take on passwords

AFP — 11-Feb-2013

Patent filings published this week show that the technology firm is considering image and object-based passwords to make their mobile devices more secure and to make pass codes easier to remember but harder to hack.

An emerging R&D superpower

Biswajit Dhar — 11-Feb-2013

Seen from the vantage of patent filings and research output—proxies for innovation—China is outpacing the US

Apple and Samsung: frenemies for life?

Reuters | San Francisco/Seoul — 11-Feb-2013

Recent rulings suggest smartphone patent wars are now grinding towards a stalemate

The \'Rajakumari\' of black pepper

Shenoy Karun — 12-Feb-2013

It seems that Rajakumari pepper can go on claiming a geographical indication tag from Chennai-based Geographical Indication Registry.

Cipla gets relief in patent battle with Pfizer

Sushmi Dey | New Delhi — 12-Feb-2013

The patent office said Pfizer’s claimed patent for Sutent, a cancer drug, did not involve any inventive step

Facebook faces lawsuit over infringing ‘Like’ button patent

ANI — 12-Feb-2013

Facebook has been by the family of a deceased Dutch programmer over the use of the ‘Like’ button on the social networking site.

Indian generics in need of policy tonic

P. T. Jyothi Datta — 12-Feb-2013

If I win a case and the product is off patent, anyone can market it.

Meerut\'s scissor units get Geographical Indicator tag

Shivendra Kumar Singh — 12-Feb-2013

Now, with a Geographical Indicator status Meeruts scissor industry has got a new lease of life.

Pfizer to appeal patent order on cancer drug

Sushmi Dey | New Delhi — 12-Feb-2013

The ruling by the Patent Controller is a repeat of an earlier order in response to a post-grant opposition filed by domestic drug maker Cipla.

Japanese pharma firms keen on trade and technical tie-ups with Indian companies

Our Bureau, Mumbai — 13-Feb-2013

Because of patent expirations of blockbuster drugs, Indian firms are expected to actively participate in the production of generic version of these products.

BDR Intl to launch first copy of Pfizer’s Sutent after patent revocation

C.H. Unnikrishnan — 13-Feb-2013

Firm says its generic version will be priced at least 75% lower than the price of Pfizer’s brand

Apple loses rights to iPhone trademark in Brazil

Associated Press : Rio De Janeiro — 14-Feb-2013

Brazil\'s patent authority has bitten Apple.

Google hits back against BT with patent lawsuits

Reuters — 14-Feb-2013

Google Inc and its Motorola Mobility unit struck back on Wednesday against BT Group Plc, filing patent lawsuits against the British telecommunications group more than a year after BT launched its own lawsuit against Google.

Gilead, Teva reach settlement in Viread patent lawsuit

Sakthi Prasad in Bangalore — 19-Feb-2013

Gilead Sciences Inc said it has agreed with Israel\'s Teva Pharmaceuticals Industries Ltd to settle a lawsuit relating to patents protecting Viread, a treatment for HIV infection and chronic hepatitis B.

DIPP seeks details on 3 cancer drugs for compulsory licencing

PTI — 21-Feb-2013

Kick starting the process for a possible issuance of compulsory licences for anti-cancer drugs, the DIPP has sought details from the Health Ministry regarding three medicines sold by multinationals Roche and Bristol-Myers Squibb in India to make them affordable.

Jasmine gives regular drink an incredible aromatic lift

Vikram Doctor — 22-Feb-2013

It is a well-timed book since the Madurai malligai has just received a Geographical Indications tag that recognises its special characteristics, the second variety to get one after the Mysore jasmine.

Apple patent application reveals ‘slap wrap’ iWatch’

ANI — 22-Feb-2013

A patent application filed by Apple has revealed that its iWatch could the ‘slap wrap’ mechanism to mount a flexible touchscreen on a user’s wrist.

The best way to expand in India is through partnerships, says Merckâ€™s Schechter

DIVYA RAJAGOPAL & Satish John — 22-Feb-2013

Merck\'s executive vicepresident and president, global human health division , says the global pharma major is committed to India despite the challenges posed by the country\'s intellectual property rights regime

Herbal sector object to draft norms for patenting of traditional knowledge

Our Bureau, Bengaluru — 23-Feb-2013

Scientists representing herbal sector have strongly objected to the draft guidelines for patenting traditional knowledge and biological material issued by the Controller General of Patents Designs and Trademarks (CGPDTM) for which comments are solicited before March 15, 2013.

IPAB to pronounce its order in Bayer\'s appeal against India’s first-ever CL on Nexavar on March 4

Ramesh Shankar, Mumbai — 26-Feb-2013

The eagerly-awaited order in the German pharma major Bayer\'s appeal against India’s first-ever compulsory licence issued on sorafenib tosylate (Nexavar) will be pronounced by the Intellectual Property Appellate Board (IPAB), Chennai on March 4.

Fix prices of costly patented drugs by negotiated pricing: panel

Vidya Krishnan — 26-Feb-2013

Pharma department invites comments from stakeholders on recommendations made by panel.

Music, movie industry to warn copyright infringers

Associated Press — 27-Feb-2013

Internet users who illegally share music, movies or TV shows online may soon get warning notices from their service providers that they are violating copyright law.

Patents \'spike drug prices\'

KATHARINE CHILD — 27-Feb-2013

They blame the patenting system, which they say makes it easy to patent new changes to existing drugs.

India Plans Price Controls for Patented Drugs

RUMMAN AHMED — 27-Feb-2013

An Indian government panel Wednesday published a set of proposals to control the prices of patented drugs, a plan which has drawn fire from the pharmaceutical industry.

Link patented drug prices to per capita income: Panel

Reuters — 27-Feb-2013

A government panel has proposed that prices of patented medicines be based on the country\'s per capita income, a move that would substantially reduce prices of costly drugs made by global pharmaceutical firms.

India still lagging in innovation, R&D spend

Venkatesh Ganesh — 27-Feb-2013

Despite India having better scientific research institutions, R&D and innovation capabilities are lower than other BRICS countries, according to the Economic Survey.

GlaxoSmithKline unit joins patent pool for AIDS drugs

Ben Hirschler — 27-Feb-2013

GlaxoSmithKline\'s HIV/AIDS drugs business is to share intellectual property rights on children\'s medicine in a patent pool designed to make treatments more widely available in poor countries.

Congress to consider bill to stop abusive patent lawsuits

Reuters — 28-Feb-2013

Two Congressmen introduced a bill on Wednesday that would penalize companies that file frivolous patent infringement lawsuits, derided by critics as \"patent trolls.

Congress to consider bill to stop abusive patent lawsuits

Reuters — 28-Feb-2013

Two Congressmen introduced a bill on Wednesday that would penalize companies that file frivolous patent infringement lawsuits, derided by critics as \"patent trolls.

Suspense as Ipab set to rule on Bayer-Natco row

KV Ramana — 28-Feb-2013

The Intellectual Property Appellate Board has concluded the hearings (that beganon January 23) on the issue of the compulsory licensing of Bayer’s anti-cancer generic drug Nexavar (sorafenib tosylate).

New compulsory licences policy raises monopoly concerns

DIVYA RAJAGOPAL — 28-Feb-2013

Public health policy experts, domestic drug makers and aid organisations are concerned over government\'s proposal to dilute the provisions of compulsory licences (CL) on the basis of price, a move they say will encourage monopoly and block access to key life saving drugs for Indians.

Samsung\'s claim against Apple rejected by Japan court

AFP — 28-Feb-2013

A Japanese court Thursday rejected a claim by Samsung that Apple stole its technology, in the latest round of a global legal battle between the smartphone giants over patents.

Fix prices of costly patented drugs: Panel

Sushmi Dey | New Delhi — 28-Feb-2013

The government should start negotiating with pharmaceutical companies for fixing the prices of patented drugs, an official committee has said.

Call to amend patenting laws to boost research in Ayurvedic medicines

Swati Chandra — 28-Feb-2013

The rules and regulations of patenting of traditional knowledge and biological material are affecting the research activities in the field of Ayurvedic medicines.

Stocks to Watch: US court ruling to impact Lupin

K.S. Badri Narayanan — 3-Mar-2013

The stock of Lupin is likely to come under pressure as the company failed to get a verdict in its favour in the US court to prevent Mylan Inc from selling a generic version of the drug Antara, used to treat high cholesterol levels.

India’s First Compulsory Licence Upheld, But Legal Fights Likely To Continue

Patralekha Chatterjee — 4-Mar-2013

India’s Intellectual Property Appellate Board (IPAB) today upheld the country’s first compulsory licence on a pharmaceutical product.

Bayer plea dismissed, Natco allowed to sell patent cancer drug

BS Reporter | Chennai — 5-Mar-2013

The Intellectual Property Appellate Board (IPAB) today upheld a compulsory licence issued by the Controller of Patents to Hyderabad-based Natco Pharma Ltd, a generic drug maker, to manufacture and sell a cancer drug of Bayer Corp in India.

DPCO not to disturb existing norms on price control of patented drugs

Joseph Alexander, New Delhi — 06-Mar-2013

The new Drug Price Control Order (DPCO), being finalized in tune with the new pharmaceutical pricing policy, may not include any provisions on fixing and monitoring the prices of imported patented drugs, notwithstanding the recent developments.

Bayer to move HC to protect patent drug

Sushmi Dey | New Delhi — 6-Mar-2013

A day after the Intellectual Property Appellate Board (IPAB) reinforced the first compulsory licence granted in India on an anti-cancer medicine, German multinational Bayer said it would approach the Mumbai High Court with a petition.

Pfizer painkiller gets longer patent protection

AP — 6-Mar-2013

Shares of Pfizer jumps nearly 2% on the news before giving up part of that gain

India needs a better deal from trade pacts

Bipul Chatterjee & Purna Chandra Jena — 06-Mar-2013

Second, though trade in goods is the first stage in economic integration, services, investment, competition, government procurement, safeguards, intellectual property rights and dispute-settlement mechanisms to address non-tariff barriers are essential ingredients for a mutually beneficial international economic cooperation deal.

India needs a better deal from trade pacts

Bipul Chatterjee & Purna Chandra Jena — 06-Mar-2013

Patent drug pricing to distract from compulsory licences

Sushmi Dey | New Delhi — 06-Mar-2013

The latest recommendations by a government panel on the proposed patented drug pricing policy are seen as a threat to compulsory licensing, which has just begun in India.

Patients win over patents

Srividhya Ragavan — 7-Mar-2013

Justice Prabha Sridevan’s judgment permitting the production and sale of a generic version of a cancer drug is a victory for patients.

Samsung loses latest Apple patent suit in UK

Reuters — 07-Mar-2013

Apple won a patent infringement lawsuit on Thursday in an English court, which exonerates the iPhone maker from charges it unlawfully used Samsung technology.

Bayer to appeal against India\'s patent ruling on Nexavar

PTI — 07-Mar-2013

Bayer AG has said it will approach the High Court in Mumbai against a ruling by Intellectual Property Appellate Board that upheld the compulsory licence issued to India’s Natco Pharma to make and sell a low-cost generic of the German drug major’s patented cancer drug Nexavar.

Apple granted patent for iPhone 5\'s integrated touch display

Anupam Saxena — 08-Mar-2013

The US Patent and Trademark Office has granted Apple a patent (number 8390582) related to a display with integrated touch.

Call for compulsory licensing of breast cancer drug

P. T. Jyothi Datta — 8-Mar-2013

Mark Women’s Day 2013 with a compulsory licensing of breast cancer drug Trastuzumab, so that a less expensive version of this life-saving medicine can enter the market.

GNA Patent Gurukul submits revisions to norms for processing of patent applications relating to TK

Nandita Vijay, Bengaluru — 8-Mar-2013

GNA Patent Gurukul has submitted the required revisions to the guidelines for processing of Patent Application relating to Traditional Knowledge to the Controller General of Patents: Design and Trademarks (CGPDTM).

US judge will not suspend Apple Siri patent case vs Samsung

Reuters — 9-Mar-2013

A US judge on Friday refused to suspend Apple Inc\'s patent lawsuit against Samsung Electronics Co Ltd, a case that includes search technology in Apple\'s Siri voice assistant.

Nokia\'s patent claims against HTC dismissed by German court

Agence France-Presse — 11-Mar-2013

Taiwan\'s top smartphone maker HTC said Saturday a German court had dismissed two patent infringement complaints brought against the company by Finnish phone giant Nokia.

Google Maps facing ban in Germany over Microsoft patent case

ANI — 11-Mar-2013

Web giant Google is facing a ban on its application Google Maps in Germany over a patent dispute with Microsoft.

India for flexible IP regime for small, medium enterprises in developing countries

Ramesh Shankar, Mumbai — 11-Mar-2013

At the World Trade Organisation (WTO)\'s TRIPS Council meeting, India is arguing for a flexible Intellectual Property (IP) regime for the small and medium enterprises in developing countries for their technological progress.

US loses race on home turf as patent policy boomerangs

Subir Ghosh — 11-Mar-2013

The bullying tactics employed by the US in ensuring that it rules the patents regime and therefore the world, is backfiring badly on itself. US companies, in fact, are losing the race even in the US where foreign companies have forged ahead in registering patents.

Activists want compulsory licence for cancer drug

Jyotsna Singh — 11-Mar-2013

Trastuzumab, used to treat breast cancer, is priced at Rs 6-8 lakh for a full course.

Abraham Lincoln only US president ever to receive patent

ANI — 11-Mar-2013

Former US President Abraham Lincoln was the only president ever to have received a patent.

Leaked IP Chapter Of India-EU FTA Shows TRIPS-Plus Pitfalls For India, Expert Says

Patralekha Chatterjee — 12-Mar-2013

Indian negotiators are reportedly under tremendous pressure to give in to the European demands for a more rigid intellectual property rights regime in the ongoing discussions on EU-India free trade agreement, suggests a leaked draft text of the chapter on IP which is being negotiated.

Nokia Loses \"Flagship\" Patent Battle Against HTC

SiliconIndia — 12-Mar-2013

The Finnish manufacturer, Nokia has lost two patent suits against HTC, including one involving the use of Google Play on HTC’s Android devices.

PATENT DISPUTES & DENIED JUSTICE

P. A. Francis — 13-Mar-2013

The amended Indian Patent Act was notified in January 2005 allowing grant of product patent in pharmaceutical industry under pressure from the World Trade Organization.

Trade panel delays decision on Apple, Samsung patent fight

Reuters — 14-Mar-2013

The U.S. International Trade Commission said on Wednesday that it would delay a decision on allegations that Apple infringed upon patents owned by Samsung Electronics in making the iPod touch, iPhone and iPad.

Nintendo infringed 3D patents: US jury

Reuters — 14-Mar-2013

A federal jury in New York found that video game company Nintendo infringed an inventor\'s 3D display technology patent with its handheld 3DS videogame system.

NGOs urge Indian govt to reject EU\'s demand to sign FTA before April deadline

Ramesh Shankar, Mumbai — 14-Mar-2013

The IP provisions could potentially block the export of generic medicines from India –a lifeline for millions of people across the developing world.

Number of patent applications up nearly 50% this year

Our Bureau — 14-Mar-2013

Patent applications in India have witnessed a substantial increase over the last five years, D. K. Rahut, Deputy Controller of Patents and Designs, Intellectual Property Office, Kolkata, said on Thursday.

India undermining intellectual property: Pfizer

PTI — 14-Mar-2013

Months after its patent for a cancer medication was revoked by India, American firm Pfizer % has told US lawmakers that New Delhi is undermining intellectual property by misuse of its compulsory licence provisions.

Glenmark in patent challenge on Bayer skin drug

Our Bureau — 15-Mar-2013

Drug-maker Glenmark faces legal action in the US from Bayer Healthcare Pharmaceuticals, regarding the latter’s skin drug Finacea.

Bayer Sues in U.S. to Stop India Generic Drug Co.

Lisa Shuchman — 19-Mar-2013

A subsidiary of Bayer AG, the Germany-based pharmaceutical company, has filed suit in federal court in Wilmington, Delaware, against Glenmark Generics, an international generic drug manufacturer, seeking to stop the Mumbai-based company from selling a generic form of a medication used to treat a skin disorder.

BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug

DIVYA RAJAGOPAL — 19-Mar-2013

A small Mumbai-based pharma firm has applied for a compulsory licence (CL) for an anti-cancer drug owned by American drug giant Bristol-Myers Squibb (BMS), a move that is likely to intensify the battle between domestic and foreign firms over the controversial facility

Pharma MNCs are patently upset

Amiti Sen — 19-Mar-2013

They are lobbying abroad to squeeze India’s market access, forcing India to abandon compulsory licensing.

Nokia wins patent ruling against HTC in Germany

Reuters — 20-Mar-2013

A German court ruled in favour of Finnish mobile phone maker Nokia, saying some devices made by Taiwan\'s HTC infringed on its power-saving patent.

US experiencing real frustration in trade ties with India, says top Obama official

PTI — 20-Mar-2013

The US is experiencing real \"frustration\" when it comes to some of the trade and business economic relationship with India, a top Obama administration official told American Senators today.

Winning the intellectual battle for economic liberalization

Rajeev Mantri | Harsh Gupta — 21-Mar-2013

That socialist era hasn’t quite passed and may be upon us once again. Citizens should be wary

Ericsson confident of winning Samsung patent case

Reuters — 21-Mar-2013

Swedish telecoms gear maker Ericsson said on Wednesday it was confident it would win a dispute over patents with Samsung after the Korean firm filed a counter-claim in a U.S. court.

BDR Pharma lines up more compulsory licences: Sources

Reporter\'s Diary — 22-Mar-2013

Indian generic drug maker BDR Pharma\'s plans could draw new battles lines over intellectual property rights.

India Board Rules against Bayer in Patent Case

Moneylife Digital Team — 22-Mar-2013

An Indian patent appeals board upheld the decision to allow Natco Pharma to sell a generic version of Bayer AG’s cancer drug, Nexavar. Bayer AG, Germany’s largest drug-maker, said it would continue to fight to overturn the decision.

Nestle to shell out more in royalty

TNN — 23-Mar-2013

The company has a General Licence Agreement that allows it to access Nestle Groups intellectual property rights including access to over 6,000 brands and technologies.

Microsoft did not violate Google patent for Xbox: ITC judge

PTI — 23-Mar-2013

Microsoft Corp did not violate a patent owned by Google subsidiary Motorola Mobility when it made its popular Xbox, an administrative law judge at the International Trade Commission said in a preliminary decision issued on Friday.

Jury orders Cisco to pay $70 million in patent case

Reuters — 23-Mar-2013

Cisco Systems Inc committed fraud against patent licensor XpertUniverse Inc in an intellectual property dispute, a jury found on Friday, ordering the networking company to pay $70 million in damages, according to court filings.

Why this royal treatment for MNCs?

AARATI KRISHNAN — 24-Mar-2013

MNCs are licensing technology and brands to Indian arms to gain access to a market that is growing faster than their home markets.

India’s IP growing pains

Stephen Ezell — 25-Mar-2013

As it celebrates its 65th year as an independent country, India seems poised for an economic take-off.

Nutra Pharma Patent and Trademarks Published in India

CORAL SPRINGS — 25-Mar-2013

Nutra Pharma has received notification that their patent for their pain drug and their trademarks for Nyloxin have been published in India\'s Official Journal.

Drugmaker AstraZeneca settles Crestor patent case

AFP — 25-Mar-2013

Firm says that the deal will protect its sales of the anti-cholesterol drug until 2016.

Court stops firm from using trademark \'Nautanki\'

Mamta Sharma — 26-Mar-2013

A local court has passed an exparte interim injunction on Saturday against Viacom 18 Media Private Ltd to the effect that it shall not use the trademark, \"Nautanki\", and the accompanying logo for the comedy show, \'Nautanki - The Comedy Theatre\', run on their Hindi entertainment channel, Colors.

BRICS and mortar for India’s global role

Samir Saran, Daniel Rubin — 26-Mar-2013

The grouping’s members can not only learn from each other’s development experiences and understand views on subjects like climate change but also define new rules for health care, education and Intellectual Property Rights.

Micromax told to pay royalty to Ericsson

Abhinav Garg & Javed Anwer — 26-Mar-2013

The smartphone patent war has finally reached India.

Indian pharma sector fears India-European Union FTA could imperil local industry

Soma Das — 27-Mar-2013

Drugmakers and healthcare activists are worried that the India European Union Free Trade Agreement which is in the works, may contain a provision that could imperil local industry and have urged the government to keep patent infringement issues out of FTAs.

Apple in court in China over \'Siri\' claim

Reuters — 27-Mar-2013

Apple appeared in a Shanghai court today, accused by a Chinese firm of copying software used for the \"Siri\" personal assistant on its hugely popular iPhones.

Big Pharma waits nervously on India drug patent verdict

Rupali Mukherjee — 27-Mar-2013

The spate of patent defeats and an aggressive generic industry has made Big Pharma jittery. Ahead of a crucial court ruling on April 1, Swiss major Novartis said on Wednesday that going by the recent decisions in cases of protecting intellectual property rights, the \"most likely\" scenario is that the company may lose patent protection on its blockbuster cancer medicine Glivec.

Amul red flag over Europe trade deal

Nupur Anand — 28-Mar-2013

Amul India’s largest dairy co-operative of India has expressed concerns over the free trade agreement being negotiated between India and European Union.

Drugs for Indian Poor Spark Pfizer Anger at Lost Patents

Eva von Schaper — 28-Mar-2013

In trying to get sophisticated medicines to its neediest citizens India is increasingly pitting its generic pharmaceutical industry against international drugmakers threatening their growth in emerging markets

Micromax ordered to pay Ericsson royalty

Mahesh Sharma — 28-Mar-2013

Indian manufacturer agrees to work out a royalty deal with the Swedish network equipment maker, which had filed a lawsuit--seeking US$18 million in damages--against the company over patent infringement.

Glivec verdict may decide future course of action for drug makers

Vidya Krishnan — 28-Mar-2013

Novartis appeal rejection may hurt India’s reputation, but activists say will boost cause of affordable drugs.

HC dismisses plea challenging probe against Bloomberg Finance

P Vasanth Kumar — 30-Mar-2013

The Karnataka high court dismissed two petitions challenging investigation against the chairman, the global head and the legal advisors of New York-based Bloomberg Finance LP on a complaint related to hacking of two e-mails of a Bangalore -based company.

Apple patents iPhone with wraparound display

AP — 30-Mar-2013

Apple is seeking a patent for an iPhone that has a display that wraps around the edges of the device, expanding the viewable area and eliminating all physical buttons.

Supreme Court may pronounce final verdict in Glivec case on April 1

Our Bureau, Mumbai — 30-Mar-2013

The long-drawn patent battle between the Swiss pharma major Novartis and the government of India over the sustainability of Section 3(d) of India\'s Patents Act which prohibits \'evergreening\' will come to an end soon as the Indian Supreme Court is all set to the pronounce its much-awaited verdict in the imatinib mesylate (Glivec) case on April 1, it is learnt.

US Patent Office denies \'iPad Mini\' trademark

AFP — 31-Mar-2013

The US patent and trademark office has denied Apple\'s application for a trademark to safeguard its widely popular iPad mini tablet, saying the case to own the phrase was too weak.

Innovate at your own risk

SWATI PIRAMAL — 31-Mar-2013

With a weak legal system, India’s pharma innovators may not consider it worthwhile to invest in new inventions.

Novartis warns India over drug patent

Andrew Jack in London and Amy Kazmin in New Delhi — 31-Mar-2013

Novartis, the Swiss pharmaceuticals group, has threatened to stop supplies of new medicines to India if the country’s top court refuses on Monday to grant a patent for Glivec, its cancer drug.

Waiving drug patents global trend

Sidhartha — 01-Apr-2013

For the past several months, Indian officials and ministers have spent a lot of time explaining to their overseas counterparts that India has only used provisions of an international treaty to waive Bayer Corporation\'s patent right on a cancer drug.

Apple seeks patent for an iPhone with \'wraparound\' display

Associated Press — 01-Apr-2013

Apple is seeking a patent for an iPhone that has a display that wraps around the edges of the device, expanding the viewable area and eliminating all physical buttons.

Patent war over drugs goes chronic

Rupali Mukherjee — 01-Apr-2013

Turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly priced life-saving drugs for cancer and HIV, is now spilling over to other chronic ailments like diabetes, and threatening to change dynamics of the nearly Rs 70,000 crore Indian pharma market.

Novartis wants Indian patent system to improve, compares with China

ET Bureau — 1-Apr-2013

Novartis India Ltd a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, Ranjit Shahani its vice chairman said on Monday, after the Supreme Court rejected its plea for patent protection of its drug Glivec.

Novartis wants Indian patent system to improve, compares with China

ET Bureau — 1-Apr-2013

Supreme Court dismisses plea of Novartis for patent of cancer drug

TNN — 01-Apr-2013

The Supreme Court on Monday dismissed the plea of Swiss pharma giant Novartis AG for getting its blood cancer drug Glivec patented in India.

What is section 3(d) of the Indian Patent Act

ET Bureau & Agencies — 1-Apr-2013

Swiss pharma major NovartisBSE -0.50 % AG on Monday lost a seven-year long legal battle for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs, with the Supreme Court rejecting the multinational company\'s plea.

Novartis India says will continue to file for patents

Kaustubh Kulkarni — 1-Apr-2013

Novartis India Ltd a unit of Swiss drugmaker Novartis AG will continue to file for patents in India its vice chairman said on Monday after the country\'s top court rejected its plea for patent protection of its drug Glivec.

Glivec patent denial may affect investments to India

Vidya Krishnan — 1-Apr-2013

US Chamber of Commerce says decision to hurt businesses’ ability to invest in medical, technological advancements

Thumbs up from pro-health groups, domestic drug makers

Our Bureaus — 1-Apr-2013

Marks affordable access to medicines in developing countries

Stung by landmark Indian patent defeat, western drugmakers will be wary but cannot afford to quit

Reuters — 02-Apr-2013

Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world\'s eighth largest market for medicines by 2016.

Apple seeks patent for its wraparound display

AP — 02-Apr-2013

Apple is seeking a patent for an iPhone that has a display that wraps around the edges of the device, expanding the viewable area and eliminating all physical buttons.

Novartis lost patent case on technical ground

ET Bureau — 02-Apr-2013

The Supreme Court judgment denying Novartis a patent for the beta crystalline form of its leukaemia wonder drug Imatinib Mesylate (sold as Glivec) is not a blow against research and innovation

European Union sets tough conditions under FTA

Asit Ranjan Mishra, Vidya Krishnan — 02-Apr-2013

EU has proposed its customs authorities will have the right to seize drugs in transit in case of IPR infringements

India\'s Patent law: Some provisions of the Patents Act 1970

02-Apr-2013

Patents are a key incentive for any innovator.

Merck unit sues Glenmark Pharmaceuticals for infringing patent on diabetes drugs

DIVYA RAJAGOPAL — 2-Apr-2013

US-based MSD Pharma, the third-largest pharma company in the world by revenues, has asked the Delhi High Court to bar Mumbai-based Glenmark from selling two popular anti-diabetic drugs, triggering yet another legal battle between an Indian generic company and a member of Big Pharma.

Now, domestic companies in patent war

Rupali Mukherjee — 3-Apr-2013

In a twist in patent wars, a domestic generic company has dragged another to court.

US trade office reviewing Supreme Court\'s Novartis patent ruling

Reuters — 3-Apr-2013

The United States said on Tuesday it was considering its response to the Supreme Court ruling that US drug manufacturers warn is the latest sign of a deteriorating environment for intellectual property rights in the country.

Glivec lesson for pharma: Patented drugs must be priced smartly

Kiran Mazumdar Shaw — 3-Apr-2013

To ensure access to healthcare for all, India must harness innovation in discovering drugs, in developing therapeutics and in delivering affordable healthcare.

Destroying patent model is no solution’

Raghuvir Srinivasan — 3-Apr-2013

Cross-subsidy is one solution to make medicines affordable: Novartis MD

Cancer patients will get cheaper drugs

NDTV — 2-Apr-2013

The Supreme Court verdict against Novartis has made sure that the cancer patients will keep getting the drubgs at cheaper price. (Audio in Hindi)

In Conversation with Dr. Gopakumar G Nair, Mrs. Jyotsna Govil, Advt. Anand Grover, Mrs. Usha Ohari, Dr. Suresh Advani and Advt. Pratibha Singh

Indian drugs will now face backlash, warn analysts in US after Novartis ruling

Namrata Brar — 03-Apr-2013

Has India\'s Novartis ruling just killed its own innovation dreams?

Novartis verdict will encourage genuine innovation: Prathiba M Singh

03-Apr-2013

Prathiba M Singh, advocate for Ranbaxy and Cipla, fought the Glivec patent case against Novartis.

US business groups say verdict to impact pharma innovation in India

Indira Kannan | Toronto — 4-Apr-2013

Business groups in the US have sharply criticised the Supreme Court of India judgment against Swiss drugmaker Novartis in denying patent protection to the company’s anti-cancer drug Glivec.

Leukaemia patients caught in patent war

Bushra Baseerat — 4-Apr-2013

Blood cancer patient M Srinivas, 38, is battling for life at a city hospital in Tarnaka after a life-saving drug, Dasatinib, was taken off the shelves recently, thanks to a bitter battle between a multinational and a Hyderabad-based pharma company over patent rights.

Compulsory licensing could be big business for drug makers

Sushmi Dey — 4-Apr-2013

With over 500,000 people dying of cancer every year in India, the argument over compulsory licensing seems to be headed in one direction in favour of those who can produce inexpensive life-saving drugs.

Six products from state get geographical indication tag, south tops list

Daniel P George — 4-Apr-2013

The trademarks and geographical indication authorities on Wednesday awarded the unique tag to 21 products after a spurt in applications for the special status in the first three months of the year.

EU, Australia, Canada may follow India\'s Patent Law

DIVYA RAJAGOPAL — 4-Apr-2013

India\'s strong stance on minor drug innovations could reverberate in national parliaments and courthouses of the developed world as Australia, the EU and Canada get ready to discuss and ban patent protection for frivolous improvements.

SAIL unit seeks patent cover for its products

Jaideep Deogharia — 05-Apr-2013

From electrical towers, railway wagons, offshore platforms to nuclear reactors, the 24 steel products developed by the research and development centre for iron and steel has a wide area of application.

Growing brood of patent agents indicator of India’s ready-to-take-off IPR industry

Atul Sethi — 05-Apr-2013

23-year-old R Srinivas is a Botany graduate who spends most of his time reading up the Indian Patents Act nowadays.

Glenmark-Merck Patent row: Delhi HC refuses interim relief to Merck

Harish V Nair — 05-Apr-2013

Diabetes patients will continue to get cheap medicines manufactured in India thanks to Delhi high court which for the time being ruled in favour of an Indian company caught in a row over patent rights with a US pharmaceutical major.

Apple\'s patent claim rejected in Germany

AFP — 6-Apr-2013

Germany\'s patent court invalidated on Friday a patent held by Apple and contested by rivals Motorola and Samsung on its \"slide to unlock\" function for smartphones, but the ruling can still be appealed.

System lacuna a bitter pill for patent holders

Jayati Ghose — 6-Apr-2013

No ‘linkage’ between regulators, patents office

Is Section 3 (d) of Patents Act good for innovation? - Yes

Gopakumar G. Nair — 6-Apr-2013

It is heartening to note that Section 3(d) has so far been largely implemented in India by the office of the Controller General of Patents, and has now been elegantly upheld by the Supreme Court.

And now, patents for genes

Livemint — 07-Apr-2013

India must quickly tighten its position on patenting genes and explicitly defining incremental innovation

Patent justice

Sakthivel Selvaraj — 7-Apr-2013

The Supreme Court’s patent denial to Novartis for its anti-cancer drug Gleevec leaves the door open for Indian pharmaceutical companies to produce their own versions of the drug.

If you erode patents, where will innovations come from?, asks Dr Brian Druker

Chidanand Rajghatta — 7-Apr-2013

As a physician I want to see patients get the best treatment at an affordable cost.

First patent war in India’s diabetes market gets intense

C.H. Unnikrishnan — 07-Apr-2013

HC has rejected interim relief to Merck against Glenmark saying it had not made a strong case for an injunction.

India: pariah or pathbreaker of pharma world?

8-Apr-2013

The Supreme Court ruling last week dismissing Swiss drug major Novartis AG’s bid for a patent for its cancer drug Glivec hinged on the interpretation of Section 3(d) of India’s patent law which defines what are not “inventions” under Indian law, and therefore not patentable.

Patent industry gets ready with budding agents

Atul Sethi — 8-Apr-2013

Twenty-three-year-old R Srinivas is a botany graduate who spends most of his time reading up the Indian Patents Act nowadays.

Indian pharma is high on profit, low on R&D

Business Standard — 8-Apr-2013

The Indian pharmaceutical sector is in the news, with generic makers winning a series of administrative and judicial victories against patent-holders.

Patent loss pushes Lipitor to 17th rank in 2012, Abbott\'s Humira is world\'s largest selling drug

Sanjay Pingle — 8-Apr-2013

The most significant development in the global pharmaceutical market in 2012 is the displacement of Lipitor of Pfizer from its number one pharmaceutical product by Humira of Abbott.

Pharma verdicts bring major changes in patents

Niraj Mishra | ENS - NEW DELHI — 8-Apr-2013

The recent landmark judgements by the Supreme Court and the Delhi High Court in the Novartis and the Merck cases respectively have brought about largescale changes in the global pharma industry relating to the manufacture, marketing and even patent protection laws.

Fear in Indian pharma over EU\'s demand to seize drugs in transit

Sushmi Dey — 8-Apr-2013

Indian pharmaceutical firms have faced trouble over IPR-related issues in European ports in the past as well

Most big patented drugs skip India

Rupali Mukherjee — 8-Apr-2013

Big pharma may be crying hoarse over India\'s \"weak\'\' intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country.

Global trademark registration: India joins Madrid Protocol

PTI — 08-Apr-2013

India on Monday joined the Madrid Protocol which will enable domestic companies and entrepreneurs to obtain cost effective global trademark registration.

Purdue sues Dr Reddy’s for patent infringement

ENS Economic Bureau — 9-Apr-2013

In yet another patent infringment suit, Dr Reddy’s Laboratories Ltd was dragged to court, by Purdue Pharma LP, which filed a petition in New Jersey Federal Court for alleged infringement of its insomnia drug — Intermezzo.

Novartis case: Anand Sharma defends India\'s patent regime, advocates affordable healthcare solutions

ET Bureau — 9-Apr-2013

A week after the Supreme Court rejected Swiss pharma firm Novartis\' patent plea for Glivec, commerce and industry minister Anand Sharma on Monday strongly defended India\'s decision not to give patent protection to the drug at the World Intellectual Property Organisation in Geneva.

The Indian way in pharma regulation

Subir Roy — 9-Apr-2013

The Supreme Court verdict denying a patent to Novartis for an updated version of the firm\'s anti-cancer drug Glivec may have a far greater impact in India and outside than was earlier realised, when India became TRIPS compliant by amending its patent Act in 2005.

SIGNING FTA WITH EU

P A francis — 10-Apr-2013

The free trade agreement between Indian government and the European Union is expected to be finalized by the middle of this month.

Trade deal with European Union will TRIP patent law

Dinesh C. Sharma — 10-Apr-2013

When Prime Minister Manmohan Singh meets German Chancellor Angela Markel this week, the long pending India-EU Broad Based Trade and Investment Agreement will be high on his agenda.

Drug patent row: U.S. firm files appeal against interim order

PTI — 10-Apr-2013

U.S. pharmaceutical major Merck Sharp and Dohme (MSD) has filed an appeal before the Delhi High Court, challenging its single bench order refusing to grant interim relief to it on a patent row against Glenmark Pharmaceuticals.

After Glivec verdict, India might face patent regime heat

Sushmi Dey | New Delhi — 10-Apr-2013

Stir has already begun with Anand Sharma defending govt\'s patent regime at WIPO Geneva this week

Should pharma MNCs be peeved?

Bhupesh Bhandari — 11-Apr-2013

In spite of all their complaints, pharma MNCs have been gaining market share in India.

Patients or patents?

Vidya Krishnan & Jacob Koshy — 12-Apr-2013

India’s top court misses an opportunity to answer this question decisively with an all-too-specific judgement in the contentious Glivec case

Lawyers can be patent agents without clearing exam: HC

A Subramani — 12-Apr-2013

A controversial amendment to the Patents Act, 1970, through which a lawyer\'s automatic right to appear before tribunals as \'patent agent\' was taken away by the Centre and the controller of patents,

Law change linked to EU\'s demand for wider patent term

Sushmi Dey — 12-Apr-2013

Currently, article 33 of the WTO\'s agreement on TRIPs provides for 20 years of patent protection from the date of filing of patent application.

India refutes US charges over trade barriers

Asit Ranjan Mishra — 12-Apr-2013

Commerce ministry says India’s policies are consistent with its international and bilateral obligations

Drug patent row: HC seeks Glenmark’s response by May 22

PTI — 12-Apr-2013

The Delhi High Court today sought the response of Glenmark Pharmaceuticals on US drug major Merck Sharp and Dohme’s appeal against the single judge bench order refusing to restrain the Indian firm from manufacturing and selling anti-diabetes drugs Zita and Zita-Met.

No patent extension clause in free trade deal: EU

Vidya Krishnan — 12-Apr-2013

Pact with India won’t impose data exclusivity, demand anything that goes beyond trade-related IPR, says EU official

A patent victory under threat

Brook K. Baker — 12-Apr-2013

Proposed clauses in the EU-India FTA could undo all gains from the Supreme Court’s Glivec ruling.

India-EU FTA won\'t hit generic drugs industry: EU envoy

Nayanima Basu — 13-Apr-2013

EU had demanded an amendment to the Indian patent law, in the wake of a patent being rejected to Novartis, for its cancer drug, Glivec.

MSD-Glenmark case replay of Bayer-Cipla patent feud

Jayati Ghose — 13-Apr-2013

In the 2010 Bayer-Cipla case on \"patent linkage\", a single-judge bench of the Delhi High Court and, subsequently, a division bench had refused to ask the government to link the patent status of a drug to grant of marketing approval for generic versions.

Patent expiry hits profitability of top 15 global pharma cos in 2012, Novartis overtakes Pfizer in sales

Sanjay Pingle — 15-Apr-2013

International pharmaceutical companies\' are passing through difficult phase and are facing challenging operating environment with loss of patent exclusivity and limited R&D success.

Impromptu poet with a trademark headgear

Rajagopalan Venkataraman — 15-Apr-2013

There was a special reason why singer P B Sreenivas who passed away on Sunday afternoon was attired in a headgear, similar to the Mysore Peta. The man with the lilting voice felt he looked infinitely better when he wore it.

Indian perfume-maker wins right to ‘Gatsby’ trademark

R. Sivaraman — 15-Apr-2013

Who would have thought Scott Fitzgerald’s Gatsby, a fictional character portrayed as a decadent dandy in the 1920s, will leave an ‘intellectual’ legacy to fight over?

U.S.Supreme court weighs patentability of human genes

Reuters — 15-Apr-2013

Soon after learning that his son had autism, Hollywood producer Jon Shestack tried to get researchers investigating the genetic causes of the disorder to pool their DNA samples, the better to identify genes most likely to cause that disorder.

With 219 patents, Novartis might have little to complain about

Sushmi Dey — 15-Apr-2013

Data contradicts Swiss drug major\'s claim that India does not respect IPR

Why Novartis case will help innovation

Achal Prabhala, Sudhir Krishnaswamy — 15-Apr-2013

The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness

India, EU talks on FTA expected to make headway

Press Trust of India — 15-Apr-2013

Reduction on import duty in the auto sector & raise in the FDI cap for the insurance sector are high on EU\'s demands

Delhi HC order on Januvia revives MNCs\' clamour for patent linkage

Ramesh Shankar, Mumbai — 16-Apr-2013

The Delhi High Court\'s recent interim order in the Merck versus Glenmark case over the diabetes drug Januvia has once again revived the multinational drug companies\' clamour for patent linkage in the country, for linking marketing approval of a product to its patent status.

Only 3% of patents filed by MNC pharma firms under dispute: Study

DIVYA RAJAGOPAL — 16-Apr-2013

On April 1, when the Supreme Court rejected Swiss pharmaceutical major Novartis\' plea for a patent on an updated version of its cancer drug Glivec, it evoked different reactions:

US justices wary of wide human gene patent ruling

Reuters — 16-Apr-2013

US Supreme Court justices on Monday signaled reluctance to issue too broad a ruling about patents on human genes, and some indicated they might seek a compromise distinguishing between types of genetic material.

Novartis patent verdict not a problem, other issues pose risks to Indian pharma innovation

Hari Pulakkat & DIVYA RAJAGOPAL — 16-Apr-2013

The recent Supreme Court judgement against Novartis has reopened old debates on drug patents, affordable healthcare and India as a destination for pharma innovation.

Big pharma\'s uncertain future in India

Sushmi Dey — 16-Apr-2013

Multinationals are worried about the country\'s patent regime, but India is too big a market to be ignored.

EU court rejects Spain, Italy challenge to landmark patent law

AFP — 16-Apr-2013

Spain and Italy had complained against a provision requiring that a patent be translated into only three languages—English, French and German

Another India-EU meet in June to thrash out FTA irritants

ET Bureau — 17-Apr-2013

India and European Union will hold another ministerial meeting in June to trash out the contentious issue dogging the free trade pact that has been in the works for nearly six years, suggesting that the Brussels ministerial failed to achieve any significant progress.

DISALLOW PATENT LINKAGE

P A Francis — 17-Apr-2013

The issue of linking grant of marketing approval to the patent status of a drug is being raised by the multinational drug companies once again in the country.

India, EU eye more sops, fail to clinch trade deal

TNN — 17-Apr-2013

India and the European Union failed to clinch a deal on the Bilateral Trade and Investment Agreement that has been in the works for six years as both sides sought more concessions for the deal to go through.

Bring down patent walls in pharma, free the knowledge locked up by patent holders

Rajni Bakshi — 19-Apr-2013

Following the Supreme Court judgment rejecting Novartis\' claim for a patent, there has been impassioned debate about patents versus patients, and profits over people.

India now in position of a thought leader on pharma patents: Kiran Mazumdar Shaw

Kiran Mazumdar Shaw — 19-Apr-2013

Weeks after the Supreme Court ruling on Novartis AG\'s cancer drug, Glivec, one thing is clear: India is now in the position of a thought leader on pharmaceutical patents.

Madras HC bars Ravikumar Distilleries from using trademark

Our Bureau — 21-Apr-2013

In response to the petition filed by the IMFL manufacturer Golden Vats Pvt Ltd regarding trademark violation by the Puducherry-based listed entity Ravikumar Distilleries Ltd, the Madras High Court has granted an interim injunction restraining the latter from using the brand Golden Vat.

Copyright organisation asks colleges to buy licence to photocopy book portions

Soma Das & Urmi Goswami — 22-Apr-2013

This summer, many students cramming for their exams are confused whether their photocopied notes are legal or not.

GI tag to add grandeur to Mamallapuram sculptures

Express News Service - CHENNAI — 23-Apr-2013

Efforts are afoot to get the Geographical Indication (GI) tag for the stone sculptures made in Mamallapuram and wooden sculptures of Thammampatti, the State Assembly was told on Monday.

VirnetX sues Microsoft over Skype patent infringement

ANI — 23-Apr-2013

Internet security software company VirnetX has filed a lawsuit against Microsoft, saying the software giant’s Skype service violates six of its patents.

Parliamentary panel asks govt to protect dairy sector under India-EU FTA

PTI — 23-Apr-2013

A Parliamentary panel today urged the government to take adequate steps for protecting the interest of domestic dairy sector under the proposed India-EU bilateral free trade agreement (FTA).

FTA talks with EU on the fast track, Sharma tells LS

ENS Economic Bureau - NEW DELHI — 23-Apr-2013

Commerce and Industry Minister Anand Sharma on Monday informed the Lok Sabha that the negotiations between India and the European Union (EU) for a free trade agreement (FTA) have been intensified.

Apple wins patent case on eve of results

Bloomberg | Washington — 24-Apr-2013

Averts iPhone 4 import ban after Motorola Mobility loses case

IPAB complains lack of manpower, infrastructure as major hurdles

BS Reporter | Chennai — 24-Apr-2013

It also complained on the allocation of insufficient funds, which lead the Board to reduce the circuit sittings in the last quarter of the financial year 2012-13

German court dismisses Nokia patent claims against HTC

AFP — 24-Apr-2013

Taiwan\'s top smartphone maker HTC said Wednesday it was \"delighted\" after a German court dismissed another patent infringement complaint brought against it by Finnish phone giant Nokia.

Lucknow zardozi gets GI registration

Virendra Singh Rawat | New Delhi/ Lucknow — 24-Apr-2013

The world famous textile embroidery handicraft of ‘Lucknow Zardozi’ is now a brand.

Microsoft signs Android patent deal with ZTE

ANI — 25-Apr-2013

Microsoft has signed a patent deal with China’s smart phones maker ZTE linked to its use of the Android and Chrome operating systems.

Microsoft gets upper hand in first Google patent trial

Bill Rigby — 26-Apr-2013

Microsoft Corp came out on top in the first of two patent trials versus Google Inc\'s Motorola Mobility unit on Thursday, as a federal judge in Seattle ruled largely in its favor.

An asymmetric deal

Devashish Mitra — 26-Apr-2013

India has limited bargaining power in negotiating the EU-India FTA.

Ever-greening of patents cannot be permitted: DIPP

PTI — 26-Apr-2013

Amid concerns expressed by multi-national companies over the Supreme Court\'s judgement in the Novartis India today said its laws are WTO compliant and no country could allow \"ever-greening\" of patents.

WTO unimpressed with patent violation charges against India

Amiti Sen — 26-Apr-2013

No country has objected to India issuing compulsory licence or refusing patent for drugs: WTO chief Pascal Lamy.

Motorola buy delivers Google more heartbreak than patent help

Bloomberg — 29-Apr-2013

Microsoft owes only pennies in royalties per sale of Xbox and Windows instead of billions Google sought in patent case

Indian tech start-ups filing patents to get government funding

Harsimran Julka — 1-May-2013

The Centre has announced a scheme through which it will provide financial support to young technology companies filing international patents a move that underscores the growing support for emerging ventures in the country.

Patented drug entry could be delayed in India: Deloitte

PTI — 1-May-2013

Launch of patented drugs in India could be delayed due to the government’s “thought process on linking patented drug prices to the country’s per—capita income”, according to a report by consultancy firm Deloitte.

Teva settles patent dispute with Orchid Pharma

C R Sukumar — 1-May-2013

Israeli drugmaker Teva Pharmaceutical Industries has settled patent dispute with the Indian pharmaceutical firm Orchid Chemicals & Pharmaceuticals pertaining to Parkinsons disease drug Azilect in the US market.

U.S. trade office hits out at Novartis ruling

Narayan Lakshman — 2-May-2013

Appears to confirm that India’s law creates a special, additional criterion for select technologies

US slams patent, trade policies

Sidhartha — 2-May-2013

A United Nations report projected that FDI in Africa will touch $100 billion in 2014 where India trails France United States United Kingdom, China, Malaysia and Korea. Airtel can look at more in market acquisitions in Africa while it looks to stabilize the $10.7-billion buyout of Zain\'s continental unit three years ago.

Bajaj Auto wins 7-year patent spat against LML

Ashwin Mohan — 2-May-2013

In a boost for India\'s leading two-wheeler manufacturer Bajaj Auto, the Chennai bench of the IPAB or the Intellectual Property Appellate Board has dismissed an appeal filed by rival LML Ltd which had sought the revocation of a patent granted to Bajaj Auto on air & fuel intake systems for engines.

How patent wars are hurting IT companies

Reuters — 4-May-2013

Patent demands are taking a big toll on technology companies, with results that range from forcing companies to tweak their products to exiting their business altogether, according to a study from the Santa Clara University School of Law.

A reflection of tradition

ANASUYA MENON — 05-May-2013

A sale of traditional Aranmula mirrors is on at the Kairali outlet.

EU regulator takes aim at Google over Apple mobile patent lawsuit

Reuters — 06-May-2013

The European Commission said it believed Motorola Mobility, a unit of Google, was abusing its market position by seeking and enforcing an injunction against Apple in Germany over patents essential to mobile phone standards.

Bajaj’s two-wheeler patent not to be revoked

R. Sivaraman — 06-May-2013

The Intellectual Property Appellate Board here on Thursday dismissed an application of LML seeking to revoke patent granted to Bajaj Auto Ltd. in respect of an improved two-stroke engine for its two-wheelers.

Google files patent for Policy Violation Checker tool

ANI — 07-May-2013

Google has reportedly filed a patent for a tool that will detect potentially problematic phrases or words from electronic correspondence which in turn will help companies or individuals avoid lawsuits.

German beer company allowed to retain trademark

Sruthisagar Yamunan — 8-May-2013

What could happen if you get a trademark registered and do not use it for a long time?

Don\'t link compulsory licensing with price: Pharma companies

Soma Das — 8-May-2013

Indian drug makers have urged the government to retain the option of compulsory licensing of a patented drug even as it considers a policy that will allow it to negotiate with drug companies on prices of patented drugs.

Top generic drugmakers look to US as patents end

Reuters — 08-May-2013

India\'s top drugmakers, among the world\'s biggest producers of cheap generic medicines, are looking beyond their own shores to generate revenue, seeking to profit from big-selling drugs going off-patent this year in the lucrative U.S. market.

India, EU yet to reach consensus on vexed issues for FTA

Press Trust of India — 08-May-2013

India and the EU, which are negotiating a free trade agreement since 2007, have yet to reach a consensus on vexed issues including duty cuts in automobile sector, Parliament was informed today.

MSF wants newly appointed WTO DG to ensure access to medicines for all WTO member states

Our Bureau — 10-May-2013

Médecins Sans Frontières an international medical humanitarian organisation, wants the incoming director general Roberto Azevedo of the World Trade Organisation to focus on making access to affordable medicines a priority.

Kebabs from Lucknow may get geographical indication recognition soon

Rajiv Srivastava — 11-May-2013

Soon after the Lucknow Zardozi was accorded geographical indication recognition, the delicious kebabs from the city of nawabs, the petha and marble from Agra and dress material and cotton bedsheets from Mau are next in line to get the GI tag a form of Intellectual Property Right from the Controller General of Patents Designs and Trademarks.

Suven Life gets three patent products for CNS molecules

PTI — 11-May-2013

Life Sciences today said it has received a total of three product patents for CNS molecules, which could be used for treating various central nervous system disorders.

Court dismisses Roche\'s patent petition against Intas

BS Reporter — 14-May-2013

According to Roche Intas was in the process of selling erlotib the generic version of the drug in TN.

Bangalore Blue Grapes gets Geographical Indication status

Rhik Kundu — 15-May-2013

Bangalore Blue Grapes, exclusively grown in districts around the city, has been given the Geographical Indication status.

US keenly watching Indian moves on compulsory licensing in pharma sector

Joseph Alexander, New Delhi — 15-May-2013

Placing India again in the \'Priority Watch List in 2013\', the United States has expressed concerns on the Supreme Court decision on the patent issue in the pharmaceutical sector and said it would be keenly watching the developments concerning the compulsory licensing.

Apple to make Galaxy S4 part of patent battle

TOI Tech — 15-May-2013

Apple plans to include the newly launched Galaxy S4 in its patent battle against South Korean giant Samsung. According to Foss Patents, after analyzing.

Brain League expects developing nations to follow India, may frame tough patent laws

Nandita Vijay, Bengaluru — 18-May-2013

Brain League, the Intellectual Property company serving national and global markets, sees that many developing countries could follow India model in enacting tough drug patent laws.

When it is right to copy

Apar Gupta — 18-May-2013

Intellectual property litigation is not a binary battle between the rights-holder and the infringer.

Japan FTA widening trade deficit, government says

TNN — 18-May-2013

The government on Friday admitted that the trade agreement with Japan was resulting in greater benefit to exporters from the East Asian giant, reflected in widening trade deficit.

ICAR moves to patent Goa’s Feni manufacturing process

PTI — 21-May-2013

After obtaining Geographical Indication status for the famous Goa Feni researchers and producers in the coastal State are now trying to patent the process to manufacture this local brew, which is also known for its medicinal benefits.

Apple wants patent lawsuit to include Samsung Galaxy S4

AFP — 23-May-2013

Apple has asked a federal judge in Silicon Valley to add Samsung\'s new flagship Galaxy smartphone to the list of devices targeted in a patent lawsuit involving Siri personal assistant software.

Patent row: Delhi HC to hear diabetes drug case

CNN-IBN — 23-May-2013

The patent battle between US pharmaceuticals major Merck Sharp and Dohme and Indian firm Glenmark Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on Thursday.

Apple wants to include Samsung Galaxy S4 in patent lawsuit

AFP — 23-May-2013

Apple has asked a federal judge in Silicon Valley to add Samsung\'s new flagship Galaxy smartphone to the list of devices targeted in a patent lawsuit involving Siri personal assistant software.

Indian pharma under the microscope

Vidya Krishnan, C.H. Unnikrishnan — 23-May-2013

The local drug industry also faced intellectual property related issues while exporting drugs.

Microsoft did not violate Google patent: ITC

Reuters — 24-May-2013

Microsoft Corp did not violate a patent owned by Google subsidiary Motorola Mobility when it made its popular Xbox, the International Trade Commission said on Thursday.

ndian pharma companies filed 417 DMFs in US during 2012 and 79 in Q1 of 2013

Sanjay Pingle, Mumbai — 27-May-2013

ndian pharmaceutical companies filed 417 Drug Master Files with the US FDA during the year 2012 as against 404 DMFs in the previous year. The DMF filings during the year 2010 and 2009 were at 311 and 271 respectively.

Apple patent case against Samsung set for additional US review

Bloomberg — 29-May-2013

US trade panel seeks more information before deciding whether Samsung should be barred from entering the US.

Pfizer, pharma sector spar over patent protection issues

P. T. Jyothi Datta — 29-May-2013

Multinational drug-maker Pfizer and a key association of the Indian pharmaceutical industry have locked horns over the protection of intellectual property in India.

Patents that have brought the Everest closer

Leslie D’monte — 29-May-2013

Several new products under patent aim to make the climb to world’s highest peaks safer and easier.

Can genes be patented?

Devangshu Datta — 30-May-2013

Angelina Jolie has inadvertently highlighted a key question about patenting.

Surti zari set for global presence

Melvyn Reggie Thomas — 31-May-2013

Surtizari one of the oldest crafts of Gujarat is all set to mark its exclusive presence in the country and abroad with 21 zari manufacturers from the city getting nod from Chennai based Geographical Indication Registry to manufacture zari and sell their products using the official logo SuratZari Craft.

Apple Inc vs Samsung group: Panel to review split ruling in patent fight

Reuters — 31-May-2013

A trade panel that specializes in patent cases will reconsider a split decision made by one of its judges in a long-running patent battle between Apple Inc and Samsung group.

US drug firm raises red flag over ‘blatant’ patent violation

Gaurav Choudhury — 02-Jun-2013

US pharmaceutical giant Merck Sharp and Dohme said it is concerned about the blatant patent violation in India over two of its blockbuster anti diabetes drugs Januvia and Janumet.

Shire, Teva settle generic Intuniv patent infringement lawsuit

Philadelphia — 03-Jun-2013

Shire LLC a subsidiary of Shire plc. has settled its litigation against Teva Pharmaceuticals USA Inc. in connection with Teva’s Abbreviated New Drug Application for a generic version of Shire’s Intuniv extended release tablets for the treatment of Attention Deficit Hyperactivity Disorder.

Commerce Dept bats for pharma exporters

Our Bureau — 3-Jun-2013

The Commerce Department has come out in strong support of the Indian pharmaceutical industry facing criticism from the media on quality issues following a series of action taken by the US drug controller against top Indian companies.

White House issues orders to curb \'patent trolls\'

AFP — 04-Jun-2013

The White House issued a series of executive orders aimed at curbing so called patent trolls who use the legal system to stifle innovation especially in the tech sector.

Pfizer gets relief in patent revocation case for anti-cancer drug \'Sutent\'

PTI — 04-Jun-2013

In a relief to pharma major Pfizer, the Intellectual Property Appellate Board here has set aside the revocation of the patent of the company\'s anti-cancer drug \'Sutent.\'

More drug companies join patent pools to aid drug discovery for neglected diseases

Rema Nagarajan — 04-Jun-2013

As drug pipelines dry up and finding new treatments for diseases afflicting the developing world remains a challenge, governments, drugs companies, research institutes and donors are forging partnerships to boost drug discovery.

iPhone 4 imports banned in US patent case

AP — 5-Jun-2013

A US trade agency on Tuesday issued a ban on imports of Apple\'s iPhone 4 and a variant of the iPad 2 after finding the devices violate a patent held by South Korean rival Samsung Electronics.

Apple Inc. infringes Samsung patent on older iPhones, iPads: US agency

Associated Press — 5-Jun-2013

Samsung Electronics scored a victory over rival Apple Inc in their long-running dispute over mobile device patents after a US trade agency issued an order banning older but still-popular Apple products from the US market.

Pfizer\'s slams India\'s patent regime, says Indian standards are vague and malleable

Soma Das — 5-Jun-2013

American drugmaker Pfizer Inc has slammed the patent regime in India telling a domestic industry body in a letter that all patents that the company has managed to get in the country do not have any meaning.

iPhone 4 imports banned in US patent case

AP — 05-Jun-2013

A US trade agency on Tuesday issued a ban on imports of Apple\'s iPhone 4 and a variant of the iPad 2 after finding the devices violate a patent held by South Korean rival Samsung Electronics.

Now, an exchange for trading patent rights

New York Times News Service — 05-Jun-2013

Patent rights, which are usually bought and sold in private transactions, are set to be publicly traded on a new exchange.

Samsung gets a bite on Apple in epic patent war

Chidanand Rajghatta — 6-Jun-2013

A US trade panel has ruled that homegrown legend Apple has infringed on a patent held by South Korean giant Samsung, providing a surprising new twist to the ongoing war between the two electronic majors.

Mumbai firm loses Maggi trademark to Nestle

Sruthisagar Yamunan - CHENNAI — 6-Jun-2013

The Intellectual Property Appellate Board has held as invalid a Mumbai-based firm’s claim over the trademark Maggi a world famous brand name that has been popularised by Swiss firm Nestle.

Apathy leaves tangaliya in tangles

Rupam Singh Gupta — 7-Jun-2013

It has been almost four years since tangaliya, a 700-year-old indigenous craft of Saurashtra, got the geographical indication tag.

US lawmakers express concern over Indian economic policies

PTI — 7-Jun-2013

US lawmakers and some top business organisations of the country have alleged that the \"restrictive\" and \"protectionist\" policies of India is hampering bilateral trade, an issue said to be of deep concern for the Obama administration.

Google files \'facial password\' patent to increase Android security

ANI — 07-Jun-2013

It says examples of the requests that might be made include, a frown, a tongue protrusion, an open-mouth smile, a forehead wrinkle, an eyebrow movement.

Motorola settles patent dispute with TiVo

AP — 07-Jun-2013

Motorola Mobility said that it has reached a settlement with digital video recording pioneer TiVo ahead of a patent trial that was to start in a Texas court next week.

Google files \'facial password\' patent to increase Android security

ANI — 7-Jun-2013

It says examples of the requests that might be made include, a frown, a tongue protrusion, an open-mouth smile, a forehead wrinkle, an eyebrow movement.

Delhi University students impleaded on copyright row

Shubashree Desikan — 9-Jun-2013

With the publishers taking up the case against course packs, students have also jumped into the fray to represent their side.

Tata Motors moves court against trademark infringement

Press Trust of India — 09-Jun-2013

Tata Motors has filed a complaint before a Delhi court alleging infringement of its trademark and copyright by unknown persons manufacturing and marketing spurious ancillary automobile products under its name.

Copy right?

Shubashree Desikan — 09-Jun-2013

With the publishers taking up the case against course packs, students have also jumped into the fray to represent their side.

New US biz centre to boost ties with Indian SMEs

Vijay C Roy | Chandigarh — 10-Jun-2013

ABC\'s activities will include dissemination of catalogues of US and Indian products to potential buyers, and staging of workshops and seminars on topics ranging from trade and finance to IPR.

Is it all right for firms like Myriad Genetics to patent genes?

Hari Pulakkat — 10-Jun-2013

The US Supreme Court will rule on Monday on a case challenging some patents by Myriad Genetics, a company that offers predictive genetictesting services for breast cancer

India needs to show the world it respects intellectual property rights: Kiran Mazumdar-Shaw

PTI — 10-Jun-2013

India needs to show the world that it respects intellectual property rights if it wants global pharmaceutical firms to invest in India, according to Biocon Chairman and Managing Director Kiran Mazumdar-Shaw.

Patents must balance profit with social cost

The New Indian Express — 12-Jun-2013

The US Supreme Court’s verdict on a rather unique case, which seeks to answer the question if human genes can be patented, will soon be available.

A Strategy for Combating Patent Trolls

CHARLES E. SCHUMER — 12-Jun-2013

With so many weak patents being used just to get a payoff, it\'s time to make patents stronger.

Sun Pharma in action after reaching settlement on patent lawsuit

Capital Market — 13-Jun-2013

Sun Pharmaceutical Industries after market hours on Wednesday, 12 June 2013 announced that it together with its subsidiaries, has settled an ongoing litigation pending in the United States District Court, District of New Jersey regarding Sun Pharma subsidiary\'s generic pantoprazole.

Goa government seeks geographical indication status for azulejos, crochet, coconut craft

Anisha Francis — 13-Jun-2013

The office of the development commissioner for handicrafts has sought GI status for three handicraft items they claim are unique to Goa—azulejos crochet and the centuries-old handicraft of coconut carving.

Eastern Mills in carpet city Bhadohi has loose ends to tie up as IKEA bolsters link

Nivedita Mookerji | Bhadohi (near Varanasi) — 13-Jun-2013

The group, which started supplying to the global retail major four years ago, is seeing winds of change at its factories.

Sun to pay Pfizer, Takeda Rs 3K cr over Protonix patent

Ashish K Tiwari — 13-Jun-2013

Sun Pharmaceutical Industries will pay as much as Rs 3,178 crore this year as its share of the settlement reached with US-based Pfizer Inc and Japans Takeda Pharma in the case of patent infringement relating to generic Protonix a blockbuster acid reflux medicine.

Sun Pharma sues Novartis in US court

Sushmi Dey | New Delhi — 13-Jun-2013

Demands rights to Gleevec generic before Novartis\' patent expires

US court says human genes cannot be patented

AP — 14-Jun-2013

The US Supreme Court ruled on Thursday that companies cannot patent parts of naturally-occurring human genes, a decision with the potential to profoundly affect the emerging and lucrative medical and biotechnology industries.

Pfizer’s India patents, revenue grow despite adverse testimony

C.H. Unnikrishnan — 14-Jun-2013

Firm says India’s patent regime protectionist, but has been one of the top patent winners in pharma in the country.

GI certificate for Toda embroidery formally handed over to tribals

Special Correspondent — 13-Jun-2013

Toda tribal representatives on Thursday formally received a Geographical Indication certificate for their unique embroidery, which is known for its striking colours.

\'Happy Birthday\' song in court over copyrights issue

PTI — 14-Jun-2013

The beloved 120-year-old ditty \'Happy birthday to you\' is in court over copyright issues after a documentary film company filed a USD 5 million lawsuit to bring the popular song into public domain.

Patent ruling a boost to genetic research

The New Indian Express — 15-Jun-2013

The US Supreme Courts ruling that DNA in the human genome is a “product of nature” that cannot be patented is of great significance.

Now, licence to play copyrighted music in public places

Express News Service - BANGALORE — 15-Jun-2013

Next time you hear your favourite song playing at a bar, restaurant or even an airplane remember that the shopowner might well be in contravention of the Copyright Act of 1957 which makes it mandatory for public establishments playing copyrighted music to procure a public performance licence.

Patent body dismisses HUL\'s appeal on hair-conditioner

T E Narasimhan — 15-Jun-2013

The Intellectual Property Appellate Board has dismissed an appeal by fast-moving consumer goods company Hindustan Unilever Ltd for recognising the company\'s patent claim for a hair-conditioning agent.

J&J’s Depuy Synthes Wins $16 Million in Patent Case

Phil Milford — 16-Jun-2013

Johnson & Johnsons DePuy Synthes unit, a maker of artificial spinal repair products, won $16 million in damages from Globus Medical Inc.

US Supreme Court\'s judgment on gene patents is neither ethical nor logical

Noah Feldman — 17-Jun-2013

Can you patent genes? In Association for Molecular Pathology vs Myriad Genetics, the US Supreme Court answered this imponderable question with a split decision you can\'t if they are naturally occurring and you\'ve simply discovered the gene but if you\'ve crafted a synthetic gene you\'ve invented it and you can keep the patent.

Venus Remedies gets patent for Potentox from Mexico

PTI — 17-Jun-2013

Venus Remedies Limited, a research-based global pharmaceutical company, has received patent from Mexico for its novel antibiotic product Potentox.

Copyright issue plagues Shah Rukh Khan’s Om Shanti Om

MAYURA JANWALKAR — 18-Jun-2013

Nearly six years after the movie\'s release, Ajay Monga — claiming to be the original script writer of the Shah Rukh Khan-Deepika Padukone starrer Om Shanti Om, that released in November 2007 — has sought restoration of a suit he had filed earlier alleging infringement of his copyright.

In India, copycat drug firms get off lightly compared with US

Jayati Ghose — 18-Jun-2013

Indian drug major Sun Pharmaceutical Industries last week agreed to pay $550 million to New York-based Pfizer as part of an out-of-court settlement of the Protonix patent infringement lawsuit.

Drug price control formula leaves companies shaky, cos approach pharma department

Soma Das — 19-Jun-2013

The government\'s interpretation of \'brand\' while fixing price caps of essential drugs has prompted leading domestic manufacturers to approach the pharma department and seek a halt to immediate implementation of the new drug price control order.

IIT-D scholars patent prosthetic limb guided by good leg

Naveed Iqbal — 19-Jun-2013

Two young scientists from IIT-Delhi have received a provisional patent for the prototype of a prosthetic limb that will enable amputees to walk \"without having to drag their leg\".

Dr Reddy’s sued for infringement of thyroid injection patent

PTI — 19-Jun-2013

U.S. drug maker AbbVie filed petition in U.S. court

Ranbaxy, 8 other companies fined Rs 1,000 crore

TNN — 20-Jun-2013

EU antitrust regulators on Wednesday imposed fines totalling 146 million euros (Rs 1,150 crore) on nine global drugmakers, including Ranbaxy, for blocking the supply of cheaper versions of Danish company Lundbeck\'s antidepressant drug citalopram.

The patent truth

Ritu Kamal — 20-Jun-2013

The US Supreme Court\'s judgment on gene patents is fair to patients.

Zydus infringed Takeda Pharma\'s patent : US court

Sohini Das | Ahmedabad — 20-Jun-2013

Zydus Pharmaceutical USA, a subsidiary of Ahmedabad-based Cadila Healthcare, has lost a patent infringement suit in the US.

FTC is said to plan inquiry of frivolous patent lawsuits

Edward Wyatt, The New York Times — 20-Jun-2013

The chairwoman of the Federal Trade Commission is expected on Thursday to recommend a sweeping investigation of \"patent trolls,\" companies that buy large portfolios of technology patents and use them to sue software designers and makers of products like smartphones and tablet computers, people briefed on the inquiry said.

Patent justice

21-Jun-2013

The U.S Supreme Courts landmark ruling that DNA segments are a product of nature and hence not patent-eligible has worldwide significance because it settles the controversial issue of patenting human genes in the one jurisdiction where it has come to matter the most.

India pushes back against US industry\'s charges

Indira Kannan | Toronto — 21-Jun-2013

Just ahead of the next round of the strategic dialogue with the United States, the Indian government is pushing back against allegations from American industry groups that it engages in discriminatory trade practices and does not respect global intellectual property standards

Developed markets turn spotlight on generic drug settlements

Ravi Ananthanarayanan — 23-Jun-2013

Increasing scrutiny poses uncertainty for Indian generic firms, adding to the list of uncertainties for investors.

Intas settles patent litigation with Hoffmann-La Roche for capecitabine tablet

Vishal Dutta — 24-Jun-2013

Ahmedabad-based drug maker Intas Pharmaceuticals Ltd and its US-based wholly owned subsidiary Accord Healthcare Inc. has entered into a settlement and license agreement with Hoffmann-La Roche Inc. to resolve pending patent litigation on XELODA Tablets.

US Secretary of state\'s complex task in today\'s talks

Jyoti Malhotra | Toronto — 24-Jun-2013

US Admn seems divided on supporting India membership in APEC; Afghan and trade issues also to come up.

European wines seek geographical indication tag with India proposing a steep duty cut

ET Bureau — 24-Jun-2013

Popular European wine brands are making a beeline for geographical indication registration in India.

Google patents photo-capturing walking stick

ANI — 24-Jun-2013

Google has got its new invention, a walking stick that takes pictures whenever it hits the ground, patented.

Court upholds Apple’s $ 625 mn patent victory

DPA — 25-Jun-2013

The US Supreme Court yesterday upheld lower court rulings that cleared Apple of three patent violations that carried fines of 625 million dollars.

India counters US over patents

Sidhartha — 25-Jun-2013

The government has taken on the United States, defending its intellectual property regime, and has gone to the extent of suggesting that Washington could draw from the Indian experience in checking frivolous patents.

Breakingviews - India should take U.S. pharma complaints seriously

Katrina Hamlin — 25-Jun-2013

U.S. drug giants are once again pushing for stronger patent protection in India. Their arguments may be transparently self-serving - but there are still good reasons for India to take note.

Shilpa Medicare in pact with medicines patent pool for entering HIV space

P. T. Jyothi Datta — 26-Jun-2013

The United Nations-backed Medicines Patent Pool, Shilpa Medicare and Gilead Sciences have entered into an agreement to increase the access to medicines for HIV/AIDS treatment.

Merck Sharp and Dohme Corporation gets relief on diabetes drug patent row

TNN — 26-Jun-2013

The Delhi high court has restrained an Indian pharmaceutical company from launching its diabetes drug allegedly having identical molecule and derivative salt of the patented drug manufactured by US drugmaker Merck Sharp and Dohme Corporation.

NPPA formula for fixing ceiling prices of essential drugs under new DPCO confusing

Ramesh Shankar, Mumbai — 26-Jun-2013

Even as the drug price regulator NPPA has started fixing ceiling prices of 348 essential drugs as per the new DPCO 2013, confusion prevails over the formula being used by the NPPA for calculation of ceiling prices as the industry says that it is contrary to the formula specified in the NPPP 2012 and the DPCO 2013.

India ready to discuss patent policies with US lawmakers: Nirupama Rao

PTI — 26-Jun-2013

Asserting that the Indian Patents Act related to pharmaceutical products is not discriminatory against foreign companies, the Indian ambassador to the United States, Nirupama Rao, offered concerned lawmakers to discuss the issue for the sake of long-term bilateral and strategic partnership between the two countries.

GI Tag: Varanasi-Mau-Bhadohi leading in UP

Saurabh Gupta — 26-Jun-2013

Varanasi, Bhadohi and Mau clusters, the three very renowned districts of Uttar Pradesh, are now having the Geographical Indications tag.

WIPO reaches agreement on treaty for blind

Pankaj Mishra — 26-Jun-2013

India has 63 million visually impaired people, of whom about 8 million are blind, according to WHO

Intellectual Property creation witnessing steady growth in India: Report

PTI — 26-Jun-2013

The country\'s contribution to Intellectual Property creation is witnessing a steady growth, however, investments in R&D and patent activities in the country are still relatively slow when compared to developed nations, a report says.

India ready to discuss patent policies with U.S. lawmakers

PTI — 26-Jun-2013

Asserting that the Indian Patents Act related to pharmaceutical products is not discriminatory against foreign companies, Indian Ambassador to the United States, Nirupama Rao, offered lawmakers concerned to discuss the issue for the sake of long-term bilateral and strategic partnership between the two countries.

Apple loses bid to add Galaxy S4 to Samsung patent lawsuit

Bloomberg — 27-Jun-2013

Judge rules that adding another product to the Apple-Samsung patent lawsuit is a tax on the court’s resources

Sun, Merck sign patent licensing agreement for Januvia

Archana Shukla ,CNBC-TV18 — 27-Jun-2013

Merck Sharp & Dhome and Sun Pharma, who have a co-marketing tie up for Merck\'s diabetes drug Januvia, have now included a patent licensing agreement in their arrangement in a bid to strengthen their case.

Indian varsities account for 5% of patents

DNA Correspondent — 27-Jun-2013

Universities in India are not only gradually upgrading their innovation radars, but are also increasingly filing patent applications on innovations.

Patent Fight Short Circuits \'Laser Peg\' Toy Plan

Ashley Lagzial — 30-Jun-2013

It took several years for inventor Jon Capriola to get his toy to market.

US ups its pressure on India over generics industry

Regulatory — 01-Jul-2013

Follows complaints from Pfizer about the country’s patent laws.

IP environment deteriorating in India: US pharma industry

Press Trust of India | Washington — 2-Jul-2013

India however maintained that the India Patent Act was in accordance with the TRIPS Agreement & the Paris Convention.

Apple applies for \'iWatch\' trademark in Japan

Associated Press - TOKYO — 3-Jul-2013

Apple Inc. has applied for a trademark in Japan for \"iWatch\" as rumors suggest it may be developing a smart wristwatch.

Apple\'s Siri in China court over alleged patent infringement

Agence France-Presse — 03-Jul-2013

A case against US technology giant Apple brought by a Chinese firm for alleged patent infringement in its digital personal assistant \"Siri\" has begun in a Shanghai court, state media said on Wednesday.

EU threat to Indian farmers

K P Prabhakaran Nair — 3-Jul-2013

The protective cover given to the EU products under the Geographical Indication tag with over 3,000 registered GIs, of which 130 are for dairy products, will make things worse for Indian dairy products.

Venus Remedies surges after Japan grants patent for \'Elores\'

SI Reporter | Mumbai — 03-Jul-2013

The company is expecting to launch this product in Japanese market by end of 2015.

US patent for Gujarat weed that gives IQ high

Tushar Prabhune — 07-Jul-2013

Sounds unbelievable, but the humble seaweed growing in abundance along Gujarat\'s 1,600-km coastline can yield a health drink that boosts brain functioning and increases immunity.

Protect innovation to secure growth

Ron Somers — 6-Jul-2013

There are grave concerns about intellectual property protection in India.

Trademark registration goes global from Monday

A Subramani — 07-Jul-2013

Come Monday, the Madrid Protocol for a single window trademark registration for 90 member-countries will come into operation.

SSWL soars on bagging patent for semi-full face wheels

SI Reporter | Mumbai — 9-Jul-2013

The patent is for the company\'s innovative design concept in semi-full face wheels.

The Holy Grail of new drug development

9-Jul-2013

Pioneering Indian pharmaceutical companies started on the journey of new drug development in the early 1990s when India announced its decision to sign the WTO agreement and bring in a product patent regime in drugs from January 1 2005.

Falling standards of pharma companies is industry\'s big bane: GV Prasad, Chairman, Dr Reddy’s Lab

CR Sukumar & Raji Reddy Kesireddy — 10-Jul-2013

The pharmaceutical industry is facing pressure from regulators in the US because companies have allowed standards to decline, the head of one of India\'s biggest drug makers has said.

Generic Pharma Association study says patent settlements netted $25.5 bn in savings for US health system

Our Bureau, Mumbai — 10-Jul-2013

Generic pharmaceuticals launched prior to patent expiration due to a patent settlement helped the US health system save $25.5 billion from 2005-2012 and brought generic medicines to market on average 81 months sooner than patent expiry, according to a new analysis conducted for the Generic Pharmaceutical Association by the IMS Institute for Healthcare Informatics.

Monsanto’s climate-resilient crop patent claims rejected

Sanjay Vijayakumar — 10-Jul-2013

India\'s patent appeals board has denied Monsantoa patent for a genetically-engineered method of increasing climate resilience in plants.

Anand Sharma defends India’s IP Law at Indo-French CEOs meet

ET Bureau — 10-Jul-2013

Commerce and industry minister Anand Sharma defended India\'s intellectual property regime in his address at the Indo-French CEOs forum in Paris on Monday.

Monsantos climate-resilient crop patent claims rejected

Sanjay Vijayakumar — 10-Jul-2013

India\'s patent appeals board has denied Monsanto a patent for a genetically-engineered method of increasing climate resilience in plants.

Visa issues, patents to dominate India-US trade talks

Amiti Sen — 11-Jul-2013

While concerns on visa restrictions for Indian professionals top the country’s agenda in the India-US high-level bilateral trade talks that started on Thursday, Commerce Minister Anand Sharma will also make a case for allowing LNG exports to India and the need to finalise a social security agreement that would save over $1 billion of annual contributions made by temporary Indian workers.

US to probe China\'s Sany Heavy for alleged patent infringement

Reuters — 12-Jul-2013

The US International Trade Commission will launch a probe into Sany Heavy Industry Co Ltd after Manitowoc Co Inc accused China\'s biggest maker of construction equipment of infringing its crawler crane patents.

Metro planning to patent indigenous electrical design

Rumu Banerjee — 12-Jul-2013

It was lack of space at the upcoming Chirag Dilli Metro station that made Delhi Metro think up an indigenous electrical solution it is now planning to patent.

US welcomes India\'s decision on PMA, express concerns over IPR

Press Trust of India | Washington — 12-Jul-2013

Welcoming the recent Indian decision to put a hold on its policy of Preferential Market Access the United States has expressed its concern over continued investment climate in India and its policies related to Intellectual Property Regime.

Glenmark confirms patent challenge for its generic versions of VIMPAT in the US Court

Vishal Dutta, ET Bureau — 12-Jul-2013

Mumbai-based Glenmark Generics Ltd confirms that it has filed Abbreviated New Drug Applications for Lacosamide tablets and oral solution with the US drug authorities with a Paragraph IV certification for the Orange-Book listed patent.

Chidambaram tells US India respects IPRs

Arun Kumar | IANS - WASHINGTON — 12-Jul-2013

Chidambaram stressed the \"importance of India becoming a manufacturing hub for meeting its own domestic needs and for rebalancing the global economy\".

US visa is non-tariff barrier for IT, says FM

BS Reporter | Washington — 13-Jul-2013

He said Indian law affirms intellectual property rights and the process of granting compulsory licence and patent registration were World Trade Organisation-compliant and subject to judicial review.

SMS, RTI potent tools of drug companies fighting patent battle

Soma Das, ET Bureau — 15-Jul-2013

As patent wars heat up in the pharma space, mobile phone messages and Right to Information filings have emerged as potent weapons in the hands of multinationals keen to delay competition from low-cost generic versions of their patented products in India.

India has weak intellectual property rules: Michael Froman

Nayanima Basu | New Delhi — 15-Jul-2013

Michael Froman, who was appointed the US Trade Representative on June 21, is President Barack Obama\'s principal advisor, negotiator and spokesperson on international trade and investment issues.

Glenmark Pharma inches up after confirming patent fight for a generic in US

Capital Market — 15-Jul-2013

The announcement was made after market hours on Friday, 12 July 2013.

NGOs call upon Indian govt to reject US pressure on economic policies including CL on life-saving drugs

Ramesh Shankar, Mumbai — 16-Jul-2013

A coalition of over 75 civil society groups in the country, under the banner of Forum Against Free Trade Agreements in India, has called upon prime minister Dr Manmohan Singh to review its forthcoming economic engagements with the USA, and to reject pressure from the US government and business lobby groups on India’s economic policies, including its recent decision to allow compulsory licensing for life-saving drugs.

IPAB lays rules for granting of interim orders

Sruthisagar Yamunan - CHENNAI — 16-Jul-2013

In a major judgement that has come as a respite to patent law practitioners in the country, the Intellectual Property Appellate Board has asserted that it indeed had powers to grant interim orders on applications and has framed guidelines to be followed for issuing the same.

Mylan says court dismisses some of Teva\'s patent claims on MS drug

Pallavi Ail in Bangalore and Bill Berkrot in New York — 17-Jul-2013

A federal court in New York ruled that Mylan Incs generic application for a multiple sclerosis drug has not infringed some of Teva Pharmaceutical Industries patents Mylan said.

The growing trust deficit in India

Pramath Raj Sinha — 18-Jul-2013

The recent Merck Sharp and Dohme vs Glenmark case highlights an important regulatory gap between Indias drug licensing authorities and its patent offices.

Forgotten email patent holder pings Chennai

Karthikeyan Hemalatha — 19-Jul-2013

He has a patent for email and is fighting to be recognized for it.

UCB files cases against Ranbaxy, Aurobindo, Glenmark, Sun Pharma, others on patent issue

PTI — 22-Jul-2013

UCB, a global biopharma company, alongwith others has filed separate cases against as many as 15 drug makers, including India\'s Ranbaxy, Aurobindo, Zydus, Sun PharmaBSE -1.08 %, GlenmarkBSE 0.83 % and Alembic Pharmaceuticals for allegedly infringing its patented drug Vimpat.

Health ministry ups ante against patents

Sidhartha — 23-Jul-2013

The health ministry has asked for a cancellation of patent to Trastuzumab a medicine which treats a form of breast cancer using a rarest of the rare provision in the Indian Patents Act.

UCB drags 15 cos to court for patent violation

fe Bureau : Hyderabad — 23-Jul-2013

Belgium-based UCB Inc, a global biopharmaceutical company focusing on central nervous system and immunology treatment and research, has filed separate patent infringement cases against as many as 15 drug makers in a Delaware court to prevent generic drug makers such as Ranbaxy, Aurobindo, Sun Pharma, Glenmark, Sandoz, Glenmark, Watson from entering the market with versions of its epilepsy treatment drug Vimpat.

Price control, IP Act & regulatory framework: Revisiting some imp issues about Indian pharma

Ramesh Adige — 23-Jul-2013

Pricing of patented medicines, though, continues to evade an equitable solution and discussions are ongoing.

Natco drops Albupax launch despite overcoming patent, safety hurdles

C.H. Unnikrishnan — 23-Jul-2013

While Natco has been unable to launch its biosimilar version of the breast cancer drug, three other firms have introduced theirs.

Google buys speech rec patents from SR Tech

Richard Chirgwin — 24-Jul-2013

A company established last year to negotiate royalties from patents filed by previously low-profile individuals from Cincinnati has vaulted into public eye courtesy of Google, which has bought rights to two of its patents.

S. Africa group writes to USTR in support of Indian drugs

P. T. Jyothi Datta — 25-Jul-2013

As India’s intellectual property protection policy comes under intense criticism in the United States a pro-health group, South Africa’s Treatment Action Campaign, has come out in support of the Indian generic drugs industry.

New techs to drive patent filings in India

BS Reporter | Hyderabad — 26-Jul-2013

Patent filings in India would be more and more driven by new technologies, which are either kept secret or patented. In line with this, there will be a big shift towards protection of innovation rather than just granting the patents, said Chaitanya Prasad, Controller General of Patents, Design and Trade Marks, Indian Patent Office.

Small Indian retailer locked in trademark fight with Gap

Abhaya Srivastava — 28-Jul-2013

In March, the owners of Green the Gap were slapped with a legal notice by Gap asking them to change their name within 14 days.

Domestic IPR: Dependence on imported equipment proves costly

T. E. Raja Simhan — 28-Jul-2013

Large-scale dependence on imported equipment deprived the Indian telecom industry from developing its own Intellectual Property Rights.

Natco Pharma up 20% post US ruling on Copaxone patent case

29-Jul-2013

We are pleased to announce the US Court of Appeals for the Federal Circuit ruling, reversing a district court\'s finding related to Teva\'s US patent for Copaxone,\" Natco said in its filing

Obama’s recent orders on ‘patent trolls’ could impact biotech cos more than pharma cos

Nandita Vijay — 30-Jul-2013

Intellectual Property has been a strategic tool for business advantage in the developed regions for quite a while now.

Patents are not just about pharma

RISHIKESHA T. KRISHNAN — 30-Jul-2013

Innovators in IT and other sectors need protection as well.

Mirna Therapeutics Announces Important Expansion of microRNA Patent Portfolio

AUSTIN, Texas--(BUSINESS WIRE) — 30-Jul-2013

U.S. Patent and Trademark Office Allows microRNA Mimic Composition of Matter Patent.

India asks US to tighten patent regime to curb misuse

Amiti Sen — 31-Jul-2013

Our intellectual property rules are in compliance with global rules, says Govt.

GI tag for Nagpur orange, Dharmavaram saris

Sharath S. Srivatsa — 1-Aug-2013

The juicy Nagpur orange, the famous tribal Warli art, Dharmavaram saris and Kerala’s Kaipad rice have been cleared for inclusion in Geographical Indications registry in the country.

India Asks U.S. To Stiffen Their Own Laws on Patent Regime

SiliconIndia — 01-Aug-2013

For some time now the U.S. government was criticizing India’s laws on intellectual property rules.

Delhi HC reserves verdict on MSD-Glenmark drug patent row

PTI — 01-Aug-2013

US firm had earlier appealed against the order refusing to restrain Glenmark from manufacturing Zita and Zita-Met.

In desi Viagra market, companies fight over names

Manish Raj — 2-Aug-2013

Kamagra Silagra, Edegra, Penegra, Zenegra the complete list can fill reams.

IPAB upholds patent on basic compound of GSK\'s breast cancer drug

Rupali Mukherjee — 02-Aug-2013

The Intellectual Property Appellate Board (IPAB) has upheld a patent granted on the original compound (lapatinib) of GSK\'s breast cancer drug, Tykerb, which ensures monopoly rights on the drug till 2019 in the domestic market.

Organic kaipad rice set to get pride of place

Byju Aryad | ENS - KOCHI — 02-Aug-2013

Kaipad, a rice variety from the state, will soon receive a Geographical Indications tag.

GSK’s breast cancer drug patent upheld till 2019

Rupali Mukherjee — 3-Aug-2013

The Intellectual Property Appellate Board has upheld a patent granted on the original compound (lapatinib) of GSK\'s breast cancer drug, Tykerb, which ensures monopoly rights on the drug till 2019 in the domestic market.

Apple import veto risks undermining patent protection push

James Politi — 04-Aug-2013

President Barack Obamas move to overturn a looming import ban on older iPhone and iPad models favoring Apple over Samsung in a long running legal battle risks undermining the US administration\'s aggressive push for stricter intellectual property regimes around the world.

India partly revokes Roche cancer drug patent

Reuters — 04-Aug-2013

India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a spokesman for the drugmaker confirmed on Sunday.

Roche lost Herceptin patent due to procedural problems

Vidya Krishnan — 4-Aug-2013

Health ministry says patent for the breast cancer drug had lapsed due to procedural delays on the part of the Swiss company.

Patent Office clarifies action on Roche application

Our Bureau — 05-Aug-2013

Says drug-maker ignored opportunities to be heard.

Kolkota Patent Office denies reports of partly revoking patent to Roche’s cancer drug

Our Bureau, New Delhi — 05-Aug-2013

Patent authorities in India have denied reports that India had partly revoked patent granted to Roche for its breast cancer drug herceptin.

Low IPR awareness costing Indian SMEs heavily

Komal Amit Gera | Chandigarh — 05-Aug-2013

All states in India now have patent facilitation centres and SMEs need to consult them to find out how they can benefit from them

Javed Akhtar\'s on a copyright mission

Subhash K Jha — 6-Aug-2013

After taking up the issue of copyright and royalty rights for Bollywood writers, Akhtar now wants to highlight cross-border copyright infringement

Apple vs Google: Court ruling revives patent case

Reuters — 08-Aug-2013

A US appeals court ruled that Apple should be able to renew its arguments at the International Trade Commission that Google\'s Motorola Mobility unit violated two patents relating to the iPhone.

India revokes patents on Allergan eye drugs Ganfort and Combigan

Reuters — 9-Aug-2013

India revoked patents on two of Allergan Inc\'s eye drugs on Thursday, the latest in a series of intellectual property setbacks suffered by Western drugmakers.

Allergan loses patents for two drugs

R. Sivaraman — 09-Aug-2013

Ajantha Pharma alleged that the patent was obtained on false representation

IPAB revokes two patents of Allergan\'s ophthalmic drugs

BS Reporter | Chennai — 09-Aug-2013

The Intellectual Property Appellate Board has revoked two patents related to two ophthalmic drugs of US-based Allergan Inc, finding that the claimed inventions were obvious.

Sun Pharma posts R1,276 cr Q1 loss on patent settlement

ENS Economic Bureau — 10-Aug-2013

India\'s largest pharmaceutical firm by market capitalisation, Sun Pharmaceutical Industries, on Friday reported a net loss of Rs 1,276.1 crore for the April-June quarter, resulting from an exceptional charge on account of the settlement in a patent infringement litigation related to generic versions of Protonix.

New vaccine adjuvant from \'Ashwagandha\' gets US patent

Vishwas Kothari — 10-Aug-2013

The US patent office has granted patent to an innovative industry-academia research project that has led to a new vaccine adjuvant extracted from \' Ashwagandha\', also known as Indian Ginseng, a medicinal plant used in Ayurveda as an immunity enhancer.

Apple wins patent fight against Samsung

ANI — 11-Aug-2013

As the ITC has sent the findings to President Barack Obama to be reviewed within 60 days and if he gives his veto, Samsung might as well be out of the US market.

Sun Pharma to pay Rs 2,517 crore to settle patent suit

PTI — 11-Aug-2013

Drug firm Sun Pharmaceutical Industries has said it will pay its dues of Rs 2,517.41 crore soon as part of settlement agreement with Wyeth(now a division of Pfizer Inc.) and Altana Pharma AG (now known as Takeda GmbH).

Drug companies seek PM role in new pricing enforcement

Soma Das — 12-Aug-2013

Top domestic drugmakers have urged the prime minister\'s office to intervene in the manner the new drug pricing control order is being implemented, complaining that \'all sections of the pharmaceutical industry are frustrated\'.

iWar and Peace

Reynolds Holding — 12-Aug-2013

Apple appeal may bring smartphone patent ceasefire

Ajanta Pharma succeeds in revoking 2 Allergan patents

Our Bureau, Mumbai — 12-Aug-2013

In yet another landmark victory to the Indian patent scenario, Ajanta Pharma, a specialty focused pharmaceutical formulation company, emerged successful in revoking two composition patents of Allergan Inc. used for eye-related treatments.

Sudarshan Chemicals wins UK patent case

Dileep Athavale — 13-Aug-2013

The High Court of UK has exonerated Pune-based pigments and performance colorant manufacturer Sudarshan Chemicals in a patent-related appeal raised by German chemicals major Clariant Produkte (Deutschland) and awarded costs and damages for wrongful threats to Sudarshan.

Roche misses renewal deadline, loses Herceptin patent in India

C.H. Unnikrishnan — 13-Aug-2013

If Roche does not restore the patent in six months, manufacturers can legally produce the drug in the country

Panel for FDI ban in pharma companies

Mahendra Singh — 14-Aug-2013

A Parliamentary panel has recommended a ban on foreign direct investment in existing pharmaceutical companies, a suggestion which is going to provide ammunition to the commerce and industry ministry that has been opposing the entry of overseas players that are acquiring stakes in Indian drug manufacturers.

No plans to restore Herceptin patent in India, says Roche

C.H. Unnikrishnan — 15-Aug-2013

Move marks change in strategy by Roche, which was otherwise aggressive in protecting patents

No hostile climate for US-based companies: Nirupama Rao

PTI — 15-Aug-2013

In the op-ed,\'India honors not dishonors patent laws\', Rao said the most prominently cited example of alleged patent infringement is actually a case study in patent protection.

Swiss drug major Roche to drop anti-cancer drug Herceptin patent in India

DIVYA RAJAGOPAL — 16-Aug-2013

Swiss drug major Roche has decided not to pursue its patent for anti-cancer drug Herceptin, the patent which had come up for extension till 2019, paving the way for generic drug makers to manufacture this drug.

Roche\'s patent pain to be Biocon\'s gain

Reghu Balakrishnan — 17-Aug-2013

Indian firm to soon launch copycat of anti-breast-cancer drug.

Cipla chief calls for ‘obligatory’ drug licensing

PTI — 17-Aug-2013

The Chairman of pharmaceutical firm Cipla has asked the Indian government to push for ‘obligatory licensing’ of drugs to improve access to essential medicines in the Third World.

Novartis lashes out at India for not respecting IPR

PTI — 18-Aug-2013

Hitting out at India’s way of dealing with Intellectual Property Rights issues, drug major Novartis has said India is losing investments in research and development from MNCs to China due to lack of an ecosystem that fosters innovation.

IPAB revokes one more patent of Aloys Wobben in a petition of Enercon India

BS Reporter | Chennai — 18-Aug-2013

This is the fourth patent of Wobben the Appellate Board revokes since the beginning of June this year.

AOL patent sale case dismissed

Reuters — 20-Aug-2013

A federal judge on Monday dismissed a lawsuit accusing AOL and some of its executives of fraud for repurchasing 14.8 million shares in 2011 without disclosing that the company would sell a $1 billion portfolio of patents to Microsoft months later

1.58 lakh patent applications pending for examination: Govt

PTI — 20-Aug-2013

As many as 1.58 lakh patent applications are pending for examination before the government due to manpower shortage, Parliament was informed on Tuesday.

Serum, Univ of Pune bag US patent for new vaccine adjuvant from Ashwagandha

Nandita Vijay, Bengaluru — 21-Aug-2013

Serum Institute of India and the Interdisciplinary School of Health Sciences, University of Pune’s work leading to an innovative product and technology using Ashwagandha or Withania somnifera as vaccine adjuvant has received the US patent.

Compulsory Licenses and “Statements of Working” in India

Michael Lin — 21-Aug-2013

This brief note provides an update of the quickly-changing Compulsory License and Statement of Working situations in India.

Individual cases to dictate MNC drug cos’ approach to patents

DIVYA RAJAGOPAL — 22-Aug-2013

Swiss drug maker Roche\'s move to give up its India patent for anti-cancer drug Herceptin is unlikely to set a precedent for multinational drug manufacturers, a lobby group of MNC drug manufacturers said.

Ratlami Sev all set to get global recognition

Vivek Trivedi, Daily News & Analysis — 23-Aug-2013

Ratlami Sev renowned for its unique crispiness and non-staining quality is all set to attain global recognition as an application has been filed for receiving Geographical Indication certification for this product.

Google buys patents from Apple Inc product manufacturer Hon Hai

Reuters : San Francisco — 24-Aug-2013

Taiwan\'s Hon Hai Precision Industry said it sold Google Inc part of a patent portfolio involving the superimposition of virtual images on real-world photos.

Judge upholds $1.17 billion patent verdict against Marvell

Bernard Vaughan — 24-Aug-2013

A federal judge on Friday upheld a $1.17 billion award a jury imposed on chipmaker Marvell Technology Group Ltd for infringing two patents held by Carnegie Mellon University.

Patent litigation case: Apple, Samsung do not have to disclose profit details

Reuters — 24-Aug-2013

Apple Inc and Samsung Electronics Co Ltd do not have to make public the financial details submitted to a US court during high-profile patent litigation, a federal appeals panel ruled on Friday.

Microsoft, Motorola set for second round of trial over patents

Bill Rigby | Dan Levine — 25-Aug-2013

The argument between the companies is just one facet of a wide-ranging global patent war surrounding smartphone and Internet technology.

IPA slams US over charges on Indian patent law

Press Trust of India | New Delhi — 25-Aug-2013

Says, America can go to WTO\'s dispute settlement mechanism

Indian Pharmaceutical Alliance slams US over charges on Indian patent law

PTI — 25-Aug-2013

Indian Pharmaceutical Alliance has contested US allegations that India\'s patent Act is discriminatory and said America can go to WTO\'s dispute settlement mechanism if such is the case.

Techie\'s plastic-to-fuel device passes patent office tests

Manish Raj, TNN — 26-Aug-2013

Is necessity the mother of invention? Well, not always.

Dictionary words in software patent guidelines puzzle industry

C.H. Unnikrishnan | Leslie D’Monte — 26-Aug-2013

Terms not defined in draft guidelines on patents for computer-related inventions leaves room for misinterpretation.

RCI getting ready to patent its technology

Jatinder Kaur Tur — 27-Aug-2013

Research Centre Imarat is all set to go for patenting of its products and technologies, its director G Satheesh Reddy said during the organization\'s silver jubilee celebrations.

Applications for registering trademark increasing 12% annually

Press Trust of India | Chennai — 27-Aug-2013

The Controller General of Patents, Designs and Trademarks under the Commerce Ministry has received over 1.94 lakh applications from industries for registering their trademarks in the last fiscal and it is growing at 12% annually, a top official said today.

Right prescription for pharma

S. Srinivasan — 28-Aug-2013

The Parliamentary Standing Committee report is correct in recommending a cautious approach to FDI in pharma.

Chennai region has the highest number of patents filed in India

Express News Service - CHENNAI — 28-Aug-2013

Chennai region has the highest number of patents filed in India and it accounts for 30 to 35 per cent of the total patents filed last year, according to Chaitanya Prasad, controller general of patents, designs, trademarks and registrar of geographical indications.

More companies take to trademarks

Our Bureau — 28-Aug-2013

An increasing number of Indian companies are registering their trademarks.

Patent regime not discriminatory, India tells Novartis

Special Correspondent — 28-Aug-2013

Commerce Secretary S. R. Rao has asserted that global firms, including Swiss drug major Novartis AG, have benefited more from the country’s rules.

Govt refutes Novartis\' allegations on patents

PTI — 28-Aug-2013

Tearing into the allegations made by Novartis on India\'s \'discriminatory\' patent practices, the government has said global firms, including the Swiss drug major, have benefited more from the country\'s rules cornering over 80 percent of the patents granted.

Indian patent regime a thorn in the flesh of global drug makers: Arun Narasani

Nandita Vijay, Bengaluru — 29-Aug-2013

Brain League IP Services and Origin IP Solutions LLP have expressed that India needs to be taken seriously by global pharma majors when it comes to revoking of patents.

Indian patent law doesn\'t discriminate against US companies: IPA

Soma Das, ET Bureau — 29-Aug-2013

India\'s intellectual property policy doesn\'t discriminate against US firms, Indian Pharma Alliance (IPA) representing major domestic drugmakers has told Pfizer\'s Intellectual Property chief Counsel Roy Waldron.

Exhibition of Bengal sarees, handicrafts begins

Press Trust of India | New Delhi — 30-Aug-2013

An exhibition of exquisite and exclusive handicrafts and handloom creations from West Bengal is on here in the run up to the Durga Puja.

Cost cutting: Silicon Valley patent office shelved

AP — 02-Sep-2013

Silicon Valley\'s high-tech firms are fighting what they consider a deeply personal federal cut this summer that shelves a planned patent office in this innovation-fueled region.

Kolkata doctors patent neem extract to fight cancer

Prithvijit Mitra — 3-Sep-2013

A neem extract, which fortifies the immune system and helps fight cancer, has been patented by the Chittaranjan National Cancer Research Institute.

Nokia patent move may mean big payoff post Microsoft

Dan Levine — 4-Sep-2013

Nokia may have sold its handset business to Microsoft Corp but by hanging on to its valuable patent portfolio the Finnish company could also get a big future payoff at the expense of Android phone makers.

Why Nokia didn\'t sell patents to Microsoft

Reuters — 04-Sep-2013

Nokia may have sold its handset business to Microsoft, but by hanging on to its valuable patent portfolio, the Finnish company could also get a big future payoff at the expense of Android phone makers.

Patent lies and convenient truths

Shamnad Basheer — 4-Sep-2013

The attempt by U.S. pharma majors to falsely depict India as an under-protector of intellectual property smacks of hypocrisy

Roche had lost patent on breast cancer drug, Herceptin in Europe earlier

Rupali Mukherjee — 04-Sep-2013

Multinational pharmaceutical company Roche which decided to drop monopoly rights on its blockbuster breast cancer drug, Herceptin in India, had lost the same patent in Europe earlier

Salim-Javed settle with producers over copyright of Zanjeer

PTI — 4-Sep-2013

Under section 38(3)(c) of the Act, a court can grant permanent injunction in cases where the defendant invades plaintiff\'s right, and the invasion is such that compensation in money would not afford adequate relief.

Microsoft wins jury trial over Google’s patent licensing

Bloomberg — 5-Sep-2013

The jury in Seattle acts in its first day of deliberations and awards Microsoft about $14.5 million in damages: reports

Losing ground to Big Pharma, bit by BIT

Prabhash Ranjan/ Deepak Raju — 6-Sep-2013

India needs to revisit its bilateral investment treaties programme to ensure that multilateral gains on patents are not lost.

Siddhivinayak Temple trust moves to patent ' Mahaprasad'

DNA — 11-Sep-2013

The Siddhivinayak Temple Trust proposes to patent the mahaprasad laddus that it sells to devotees, who visit the city’s most popular shrine to Lord Ganesh.

Panel backs compulsory licence on cancer drug

Vidya Krishnan — 11-Sep-2013

If the DIPP approves the recommendation, it will be India’s second compulsory licence.

Mylan will not shy away from pursuing ‘frivolous’ patents

P. T. Jyothi Datta — 11-Sep-2013

Multinational drug-maker Mylan has hinted that it is willing to get its hands dirty in India, even if this meant pursuing frivolous or invalid patents to bring in less-expensive generic medicines.

Wockhardt stock soars on patent row settlement

Sushmi Dey | New Delhi — 11-Sep-2013

Deal allows drug major to sell generic version of Neudexta from 2026.

Samsung sued by Dyson over patent violation

Reuters — 12-Sep-2013

British manufacturer Dyson said it had begun legal action against Samsung Electronics, to protect against what it claims is a "cynical rip off" by the Korean group of the British firm's patented technology.

ApplGoogle back in court over mobile phone patent lawsuit

Reuters — 12-Sep-2013

Apple and Google subsidiary Motorola Mobility on Wednesday squared off in court over whether a judge should reopen a lawsuit in which the companies accuse one other of illegally using their patented mobile phone technology.

Apple, Google back in court over mobile phone patent lawsuit

Diane Bartz — 12-Sep-2013

Apple and Google subsidiary Motorola Mobility on Wednesday squared off in court over whether a judge should reopen a lawsuit in which the companies accuse one another of illegally using patented mobile phone technology.

BDR Pharmaceuticals plea for compulsory licence on cancer drug rejected

DIVYA RAJAGOPAL — 12-Sep-2013

The Indian Patent Office has rejected Mumbai-based BDR Pharmaceuticals application for compulsory licence on cancer drug Dasatinib according to an affidavit filed by Bristol Myers Squibb, the patent holder for the drug.

Interesting turn in Dasatinib patent war

Rupali Mukherjee — 12-Sep-2013

The BMS affidavit is an attempt ``to mislead the court through false information'', when the order by the Patent Office has not been communicated officially, yet. This may influence the court decision, Andreya Fernandes of the law firm said.

Who used my Ajinomoto, the real maker asks

Viveat Susan Pinto | Mumbai — 13-Sep-2013

The latter is a registered trademark of Ajinomoto Co Inc, a Japanese food ingredients major, which has been operating in the domestic market for the last 10 years.

Petition against trademark on temple dismissed

Express News Service - KOCHI — 13-Sep-2013

The Kerala High Court on Thursday dismissed a plea against a decision by the Controller General of Patents, Designs and Trademarks granting certificate of trademark on the picture of the deity at Attukal Devi Temple and the description that the temple is the ‘Sabarimala of women.’

Indian pharma draws more scrutiny as US exports rise

Reuters | Mumbai — 14-Sep-2013

India produces nearly 40% of generic drugs and over-the-counter products and 10% of finished dosages in the US.

Amended Patents Act: Of medicines and increased back-room activities

P. T. Jyothi Datta — 15-Sep-2013

Multinational pharmaceutical companies such as Novartis have been major beneficiaries of India’s patent regime.

Foreign drug makers won 77% of all patents in last 3 years

C.H. Unnikrishnan — 15-Sep-2013

India issued 1,001 drug patents between April 2010 and March 2013, of which 771 were given to foreign drug makers.

India's War On Intellectual Property Rights May Bring With It A Body Count

16-Sep-2013

Last month, drug maker Roche withdrew its patents for the breast-cancer drug Herceptin in India — and thus gave tacit approval to other companies to make low-cost generic versions of the drug.

US drug regulator red flags Ranbaxy, Strides

HT Correspondent — 16-Sep-2013

The US drug regulator has blacklisted Ranbaxy Laboratories’ Mohali plant, its third factory to face such an import ban, dealing a body blow to the company’s reputation and bringing its share prices crashing by 30.3% on Monday.

Nagpur firm's drug developed for crop protection gets US patent

Press Trust Of India | Ahmedabad — 16-Sep-2013

He claimed that this drug can reduce use of pesticides to the tune of Rs 50,000 cr.

In pursuit of geographical indication tag

S M Arun — 17-Sep-2013

Geographical Indication tag has been sought for four products Erode turmeric, Salem mango, Hosur rose and Namakkal makkal stone work that have a distinctive character compared to similar products from other parts of the state.

Are Indian pharma companies being victimised by US FDA?

Shishir Asthana | Mumbai — 17-Sep-2013

US FDA has increased its focus on Indian pharma cos but is it deliberate.

Princeton Sues Princeton for a Share of Its Patent Millions

David Voreacos and Susan Decker — 19-Sep-2013

More than three decades ago, Princeton University professor Edward Taylor invented the compound that became the anticancer drug Alimta.

Teva drug copy to boost Natco Pharma sales

Bloomberg — 19-Sep-2013

Natco says sales will jump 62% in two years once it starts selling generic version of Copaxone to treat multiple sclerosis

Ranbaxy to contest US pharma company to protect drug patent

Our Bureau — 20-Sep-2013

Ranbaxy Laboratories Inc, the US-based wholly-owned subsidiary of Ranbaxy Laboratories Ltd, has received a Paragraph IV Certification Notice of filing from Watson Laboratories Inc of an Abbreviated New Drug Application to the US Food and Drug Administration for a generic version of Absoric (isotretinoin capsules), the company said in an official statement on Thursday.

Watson Laboratories send patent challenge notice to Ranbaxy for acne drug

PTI — 20-Sep-2013

Drug firm Ranbaxy Laboratories has said its US arm has received a notice from Watson Laboratories Inc, challenging the patent of acne treatment drug Absorica.

Genzyme Corporation files patent infringement suit against DRL

PTI — 22-Sep-2013

Genzyme Corporation, a fully-owned subsidiary of drug major Sanofi-Aventis, has filed a suit against Dr. Reddy's Laboratories alleging that the Indian drug maker infringed patents of its blockbuster cancer drug Mozobil on three counts.

Pharmaceutical Price Regulation - Is the government being two-faced?

DNA/Saurav Datta — 23-Sep-2013

Pharmaceutical Prices Regulation- the government’s deception needs to be called out.

Dr Reddy's plunges nearly 2% on patent infringement suit

ECONOMIC TIMES.COM — 23-Sep-2013

Dr Reddy's Laboratories Ltd plunged as much as 1.85 per cent in a weak market on Monday, after Genzyme Corporation, a fully-owned subsidiary of drug major Sanofi-Aventis, filed a suit against Dr. Reddy's Laboratories.

Samsung, LG end patent dispute on display technology

AFP — 24-Sep-2013

South Korean electronic giants Samsung and LG have agreed to end a year-long battle over display technology patents that spawned a series of lawsuits.

Kerala man gets US patent for device that generates power 'anywhere, anytime'

Indo-Asian News Service — 24-Sep-2013

MC David, a 57-year-old amateur magician from Kerala, has secured a US patent for an invention that generates electricity "anywhere, anytime".

HTC violates Nokia's patents: US judge

Reuters — 24-Sep-2013

HTC Corporation infringed on two Nokia patents in making its mobile telephones and tablets, a judge said in a preliminary ruling issued on Monday for the US International Trade Commission.

Samsung, LG end patent dispute over display tech

AFP — 24-Sep-2013

South Korean electronic giants Samsung and LG have agreed to end a year-long battle over display technology patents that spawned a series of lawsuits.

Suven Life Sciences gains after securing three product patents

Capital Market — 25-Sep-2013

Suven Life Sciences rose 2.29% to Rs 44.65 at 11:13 IST on BSE after the company said it has secured three product patents corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases.

US wants MNCs to have right to sue India abroad

Rupali Mukherjee — 25-Sep-2013

Most bilateral investment treaties include a broad definition of investment, covering just every aspect from financial transactions to intellectual property to any form of asset, Dhar added.

Cautious moves

Sujay Mehdudia — 26-Sep-2013

Governments should safeguard public interests while negotiating Free Trade Agreements, says a CUTS study.

Forest files patent suits against Lupin, Ranbaxy and others

Press Trust of India | New Delhi — 26-Sep-2013

Joint lawsuits have been filed in the Court for the District of Delaware.

Refrain aggressive buying of large-cap pharma firms: G Chokkalingam, Centrum Wealth Management

ET Now — 26-Sep-2013

G Chokkalingam: I am nervous on very large-cap pharma companies because ever since the courts have revoked patent for pharma companies, we have seen a lot of qualitative restriction, especially from the US for Indian pharma companies.

Japan fines Apple for patent infringement

IANS - TOKYO — 26-Sep-2013

Saito filed an application with Tokyo Customs for an injunction against iPod imports for the patent infringement in 2007, said the report.

Tech giants fear spread of patent wars to Europe

Danny Hakim — 27-Sep-2013

The European headquarters of Google Inc in Dubin, Ireland. Google is concerned about a proposed change in the European Union's patent court system.

Obama to raise industry concerns at patent regime in India with Singh

BS Reporter | New Delhi — 27-Sep-2013

Alliance for Free Trade with India today urged the US President to 'stand up for the American industry'.

Dr Reddy’s loses insomnia drug patent case in US court

Our Bureau — 27-Sep-2013

A US Court of Appeals has ruled that Dr Reddy’s Laboratories Ltd infringed on the patent of insomnia drug Lunesta of Sunovion Pharmaceuticals.

Samsung moves to appease EU on Apple patent fight

AFP — 27-Sep-2013

South Korea's Samsung has answered accusations by Brussels that the company abused its dominant market position by taking out unfair injunctions against rival Apple, the European Commission said on Friday.

New ordinance against piracy

TNN — 28-Sep-2013

However, the Copyright (Amendment) Act 2012, which came into force in July 2012 following the President's assent, has the provision for punishment up to two years along with a fine for dealing in fake cassettes, CDs and DVDs.

DRL would infringe on Lunesta patent: US court

Press Trust Of India : Hyderabad — 28-Sep-2013

The United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd would infringe on the patent of Sunovion Pharmaceuticals blockbuster drug Lunesta.

Indian pharma market isn’t going to be that rosy

Ramnath Subbu — 29-Sep-2013

Glenn Saldanha, Chairman & Managing Director, spoke to The Hindu on a range of issues in the pharmaceutical industry.

TN distillery stopped from brewing French Cognac

Express News Service - CHENNAI — 30-Sep-2013

The Madras High Court has restrained a firm in the State from manufacturing and selling a branded liquor saying the brand name ‘French Cognac’ enjoyed Geographical Indication protection and that it exclusively belonged to a French company.

Patent battles healthy for pharma

Rajeshwari Hariharan — 30-Sep-2013

The Indian pharma space has seen a number of battles between innovators and generic companies the Novartis war and Merck - Glenmark being one of the recent ones

Nilambur teak to get geographical indication tag soon

T P Nijish — 30-Sep-2013

Nilambur teak will soon become the first forest resource from India to get GI (geographical indication) tag of World Trade Organisation.

‘Patan Patola’ gets GI registration

R. Sivaraman — 30-Sep-2013

Patan Patola a double-sided saree from Gujarat and a favourite of Congress president Sonia Gandhi has got recognition from Geographical Indication Registry.

Patent battles healthy for pharma

Rajeshwari Hariharan — 30-Sep-2013

The Indian pharma space has seen a number of battles between innovators and generic companies — the Novartis war and Merck-Glenmark being one of the recent ones.

Restricting FDI in pharma may prove counter-productive

Subir Roy | Kolkata — 1-Oct-2013

One way India can ensure supply of cheap generics is by reviving the half-dead state-owned pharma companies.

US, EU irked by India’s compulsory licence plan for green technologies

Amiti Sen — 02-Oct-2013

The US and the EU have raised strong objections to India’s decision to allow compulsory licensing in the green technology sector.

India's IPR regime - Moving beyond the myths of US pharma

Hemant Krishan Singh & Aman Raj Khanna — 03-Oct-2013

It is time for the Indian government to address the growing trust deficit with foreign pharmaceutical manufacturers on the question of IPRs and improve the enforcement of patent protection.

Ispat Nigam Limited eyes patent route to consolidate position

Manish — 03-Oct-2013

State-run steel major Rashtriya Ispat Nigam Limited which expects to complete its 6.3 million tonnes per annum expansion plan soon, now also aims to strengthen its research and development wing to consolidate its position in the steel industry.

Kalanamak rice, ‘Buddha’s gift’, awarded GI tag

Manish Raj — 4-Oct-2013

If you think Basmati rice, a subject of many patent battles, is the best, here is Kalanamak rice

The right cure for pharma frauds

KPMG — 06-Oct-2013

Drugs estimated at $116 billion are going off-patent in the next five years.

Indian pharma majors step up R&D spend by 19.7% in 2012-13

Sanjay Pingle, Mumbai — 7-Oct-2013

Expenditures on Research & Development by 30 leading Indian pharmaceutical companies have gone up significantly by 19.7 per cent during the year ended March 2013 over the previous year.

US patents granted to inventions to contain suicide bombers

Bloomberg — 7-Oct-2013

Among the recently granted US patents is an invention to contain suicide bombers, technology that prevents you from getting shot, and a way to rest in peace.

Samsung gadgets to face US import ban over Apple patent row

ANI — 09-Oct-2013

Apple won a case at the US International Trade Commission that found Samsung had infringed the two patents.

Madras HC sets aside IPAB order in Enercon GmbH patent case

Gireesh Babu | Chennai — 11-Oct-2013

Court has directed IPAB to look at maintainability of petition filed by Indian partner and submit its decision within two months.

New Ferrari revealed in patent images

Autocar India — 14-Oct-2013

Several official illustrations, which appeared online after being submitted for design registration, show the new Ferrari in detail.

Nokia India tax dispute: India to discuss case WTO cooperation with Finland

fe Bureau — 15-Oct-2013

Nokia's dispute with Indian tax authorities is likely to figure in a high level bilateral meeting.

Invention to detect fake currency gets US patent

Laxmi Ajai Prasanna — 15-Oct-2013

Rarely though there is a 400 per cent increase in counterfeit currency circulation in the country according to the national financial intelligence unit.

Samsung offers concessions to EU in patent case

AP — 17-Oct-2013

The European Commission is calling for comments or objections to a proposal by Samsung to end one type of patent dispute over mobile telephones in Europe for the coming five years.

Samsung offers to stop patent lawsuits in Europe

AP — 18-Oct-2013

Samsung Electronics has offered not to launch any patent lawsuits over key mobile telephone technology in Europe for the coming five years, in hopes of avoiding a fine from the European Commission.

PGI for patent cell to market research

Shimona Kanwar — 19-Oct-2013

In a recent open house the PGI faculty sought the director's permission to allow their medical research to be translated into marketable commodities for affordable healthcare.

When patents, not patients, matter more

Narayan Lakshman — 19-Oct-2013

Neither the long-term health of their clientele nor the affordability or true effectiveness of a drug matches profit-making as a motivator for drug companies.

?'India is committing selective genocide in healthcare'

Rema Nagarajan — 20-Oct-2013

The recent release of the documentary Fire in the Blood has revived the debate on whether patents block access to life-saving medicines.

'India has failed to recognise IP rights;deterring investors'

PTI — 21-Oct-2013

A US trade body has asked India to spur innovation and strengthen its intellectual property laws, saying failure to recognise IP rights was dissuading investors and keeping Indian economy in a logjam.

India yet to seriously take up loopholes in new EU regulation on customs enforcement

Joseph Alexander, New Delhi — 22-Oct-2013

India is yet to seriously take up with the European Union the alleged loopholes in the recent EU regulation on customs enforcement of intellectual property rights even as the public interest groups claimed that the new regulation was nothing better than the original one of 2003 that led to the seizure of Indian generic drugs and could pose serious hurdles again for Indian industry.

US pharma firms lobby to protect patents in India

Amiti Sen — 23-Oct-2013

US pharma majors are putting pressure on the Government to stop issuing permits to domestic companies for making low-priced copies of patented life saving drugs.

Emerging markets like Brazil, South Africa initiate reforms in patent laws in line with India’s IP policy

ET Bureau — 24-Oct-2013

Days before the Supreme Court ruled that Novartis’ cancer drug Glivec is not a new invention good enough to be granted patent in April, a top executive of Pfizer had told a US Congress sub-committee, “India’s action reverberates far beyond its borders.”

GIPC urges India to strengthen IP laws to utilize its vast knowledge pool and create more jobs

Our Bureau — 25-Oct-2013

The US Chamber of Commerce’s Global Intellectual Property Centre has urged India to encourage innovation in the country and strengthen its Intellectual Property laws to utilize its vast knowledge pool and create more jobs.

Samsung files patent to rival Google Glass

ANI — 26-Oct-2013

The South Korean firm's patent, filed on March 8, shows that it is working on a device it calls 'Sports Glasses' that are likely its response to Google's Internet-connected eyewear.

Getting IP owners to blow the whistle can check piracy

TNN — 26-Oct-2013

Containing infringement of intellectual property rights and piracy will require efforts to educate people about its impact.

Samsung files patent to rival Google Glass

26-Oct-2013

The South Korean firm's patent, filed on March 8, shows that it is working on a device it calls 'Sports Glasses' that are likely its response to Google's Internet-connected eyewear.

IPAB refuses use of TM 'Sony' by Indian firm

Gireesh Babu — 28-Oct-2013

Sides with Sony Corp in trademark case.

IPAB refuses use of trademark 'Sony' by India's AB Textiles

Gireesh Babu | Chennai — 29-Oct-2013

The IPAB came down heavily on the decision of the deputy registrar in refusing the Japanese firm's opposition and allowing the textile firm to register the trade mark.

Nokia wins mobile patent judgment in UK against HTC

Reuters — 30-Oct-2013

Finnish telecoms group Nokia scored another victory on Wednesday in its patent battle against Taiwan-based rival HTC Corporation with a British court ruling in its favour over mobile telecoms technology.

BDR’s compulsory licence bid for MNC cancer drug rejected

Rupali Mukherjee — 31-Oct-2013

India's second compulsory licensing application filed by domestic company BDR Pharma on dasatinib, an anti-cancer drug patented by Bristol-Myers Squibb, has been rejected by the Indian Patent Office, denying millions of patients access to the affordable version at a fraction of the cost of the patented one.

Samsung extends patent licence deal with Nokia

Reuters — 4-Nov-2013

Finland's Nokia said Samsung Electronics has extended a phone patent licence agreement between the two companies for five years.

GI tag: applications filed for eight articles

Special Correspondent — 05-Nov-2013

Applications have been submitted for getting Geographical Indication (GI) tag for eight articles, according to P.Sanjai Gandhi, Geographical Indication (GI) Attorney and Additional Government Pleader.

In patent fight, IBM's arsenal dwarfs Twitter's

Reuters — 05-Nov-2013

International Business Machines Corp's patent demand against Twitter Inc as it approaches an initial public offering highlights how few patents the social media company possesses compared with the established tech players.

Strong patent regime needed for GM crops, says MoS Tariq Anwar

IANS — 05-Nov-2013

Congress 2013 began here Tuesday with union Minister of State for Agriculture Tariq Anwar calling for a strong patent regime to regulate genetically modified (GM) crops in the country.

Japan's Eisai to launch breast cancer drug in India

DIVYA RAJAGOPAL — 6-Nov-2013

Japan's Eisai Pharma, a 741 billion yen ( Rs 46,439-crore) pharma major, is slated to launch in India its novel anti-cancer drug Eribulin, sold under the brand name of Halaven, as part of its strategy to expand its presence in the emerging markets.

Takeda drags DRL to US court for infringement

ENS Economic Bureau - HYDERABAD — 6-Nov-2013

Japanese pharma major Teijin Ltd and Takeda Pharmaceutical USA Inc together dragged city-based Dr Reddy’s Laboratories Ltd (DRL) to a US court allegedly for infringing their patent.

It’s strategies sans frontiers in pharma patent filings

Pallavi Ail — 6-Nov-2013

Despite seemingly strict criteria, pharmaceutical patents are not that hard to come by in India

Apple patents tech for tracking homes via iPhone

ANI — 06-Nov-2013

Apple has reportedly patented a technology that would allow users to track certain events in their home while they are commuting back home or away for a holiday.

Cadbury loses battle with ITC over Chocolate Eclairs

Sanjay Vijayakumar — 07-Nov-2013

After Kellogg's and Bata, it is now the turn of Cadbury to lose a trademark for non-use, 'eclairs' in this case, leaving experts intrigued as to why the chocolate maker couldn't come up with enough evidence of its use when asked in a court.

Reliance Telecom's domain name plea rejected

LUBNA KABLY — 8-Nov-2013

The company filed a complaint against the domain name holder with World Intellectual Property Organisation (WIPO), an international arbitration service provider for settlement of domain name disputes.

Rakesh Roshan to pursue Krrish 3 copyright violation case

Geety Sahgal — 9-Nov-2013

Rakesh Roshan is a relieved man that the Bombay HC did not entertain an appeal by Uday Singh Rajput.

Government rejects BDR Pharma's CL application for anti-cancer drug

PTI — 10-Nov-2013

The government has rejected a compulsory licensing application by BDR Pharmaceuticals to manufacture the generic version of patented anti-cancer drug 'Dasatinib', a decision that is seen as evidence that IP rules prevail in India.

Ignorance to blame for basmati setback

TNN — 11-Nov-2013

Indian inventors lack the knowledge of patenting and hence lose out to international competitors.

Jury selection starts in Samsung-Apple patent trial

DPA — 13-Nov-2013

Smartphone giants Apple and Samsung renewed their US court battle on Tuesday in a trial to determine damages for Samsung’s violation of Apple’s iPhone and iPad patents.

Apple wants $380 mn in patent trial with Samsung

PTI — 14-Nov-2013

Apple demanded today that Samsung Electronics pay it $380 million for copying vital iPhone and iPad features, as a billion-dollar patent fight between the world’s two biggest smartphone makers resumed in a Silicon Valley courtroom.

Emerging economies' trademark filings climb sharply: WIPO

AFP | Geneva — 14-Nov-2013

Emerging economies have almost tripled their trademark applications over the past three decades, underscoring the growing store they place in branding, the World Intellectual Property Organization said today.

Natco wins patent war against Teva

Fe Bureau : New Delhi/ Hyderabad — 15-Nov-2013

Hyderabad based-Natco Pharma has won a patent battle against Israeli drug giant Teva Pharmaceuticals, which could enable it to launch a generic version of the multiple sclerosis drug Copaxone in the US market in 2014.

WikiLeaks expose: Drug makers see red

Sushmi Dey | New Delhi — 16-Nov-2013

Approach govt to open negotiations on generics

Whose tribunal is it anyway?

Justice Prabha Sridevan — 18-Nov-2013

The independence of specialist tribunals must be ensured. But this is not happening, as the functioning of the Intellectual Property Appellate Board shows

'Superbugs may erase medical advances'

Charlie Cooper — 18-Nov-2013

Even Routine Operations Could Become Deadly 'In The Very Near Future', say Doctors.

‘It’s Wholly Reasonable for India to Think About Pricing’

Divya Rajagopal & Sagar Malviya — 18-Nov-2013

Glaxo CEO Andrew Witty says MNCs need to look at things from India’s perspective. It might hurt to go through price adjustments but there are alternative ways to have a good dialogue

Emerging economies' trademark filings rise

AAP — 18-Nov-2013

When Cadbury replaced its eclairs

Viveat Susan Pinto | Mumbai — 19-Nov-2013

Mondelez, the parent, recently, was asked to remove three of its Chocolate Eclairs label trademarks by the Intellectual Property Appellate Board following a case lodged by rival ITC.

Expiry of patent to make rheumatic drugs cheap

Shimona Kanwar — 20-Nov-2013

With the patent date of drugs used in the treatment of rheumatic diseases nearing its expiry, those suffering with the crippling disease would soon be able to afford the expensive treatment.

Samsung sued for patent infringement

AFP — 20-Nov-2013

A Taiwanese electronics company said that it has filed a lawsuit against South Korean tech giant Samsung for allegedly infringing on its optics technology patents.

IPAB revokes a patent of US-based Kibow Biotech

BS Reporter | Chennai — 20-Nov-2013

The revocation petition was filed by the Indian firm after it was challenged by Kibow Biotech in the Madras High Court.

US house panel passes bill targeting ‘patent trolls’

Reurtes — 21-Nov-2013

The bill requires companies filing infringement lawsuits to provide specific details on what patent is infringed, how it is used.

Microsoft sues Acacia over smartphone patents

Reuters — 21-Nov-2013

Microsoft filed a lawsuit against Acacia Research, charging that Acacia broke a contract to license various smartphone and mobile computing technologies to Microsoft.

US Jury awards Apple $290 million in Samsung patent case

AFP — 22-Nov-2013

A US federal jury Thursday ordered Samsung to pay $290 million in damages to Apple in a partial retrial of the blockbuster patent case involving the two smartphone giants.

India’s monopoly regime stops us from making many drugs here: Cipla’s Hamied

C.H. Unnikrishnan — 22-Nov-2013

Cipla’s market is not India alone and it has to go global, says Yusuf K. Hamied, who stepped down as MD in February.

Biocon ups generic war with nod for Roche's cancer drug clone

Soma Das — 22-Nov-2013

Two months after the Swiss innovator firm Roche threw in a surprise by announcing that it would no longer pursue a patent on breast cancer drug Herceptin in India, it will have to brace up for generic competition, probably much earlier than it anticipated.

Creative Commons: thinking beyond copyright

T. Ramachandran — 22-Nov-2013

Are there ways of going beyond copyright when it comes to promoting and sharing original work and content online? Yes, think of Creative Commons, which has been relaunched in India.

India, EU should address regulatory problems, tariff issues

PTI — 22-Nov-2013

Seeking deeper co-operation with India, European Union today said both sides need to work on eliminating tariff barriers and regulatory difficulties in their bilateral economic exchanges.

Now, a bid to trademark ‘stem cells’

Bindu D. Menon — 22-Nov-2013

After bima (insurance) and manjal (turmeric), a company now wants to be the brand owner of the word ‘stem cell’.

Samsung shares rise despite patent case setback

AFP — 22-Nov-2013

South Korean markets took in stride a US federal jury's order for Samsung to pay $290 million in damages to Apple, with Samsung shares going up 0.69% on Friday.

Gilead’s patent application on hepatitis C drug opposed

P. T. Jyothi Datta — 23-Nov-2013

US drug-maker Gilead Sciences’ patent application on hepatitis C drug sofosbuvir has been opposed at the Indian Patent Office by legal group I-MAK — Initiative for Medicines, Access & Knowledge.

Indian health activists move to prevent Gilead’s drug patent

Andrew Jack in London — 24-Nov-2013

Indian health activists are seeking to prevent Gilead from patenting its new treatment for Hepatitis C in the country in a fresh battle over affordable access to medicine.

European Patent Office to slash fee to euro 5,000 by 2015

BS Reporter | Hyderabad — 25-Nov-2013

Says lack of complete database on Indian patents slowing down patent filing by local inventors.

Suggestion of WTO complaint irks public health workers in India

P. T. Jyothi Datta — 25-Nov-2013

A US trade lawyer’s observation on the possibility of hauling India to the World Trade Organisation, “for violating international patent treatises”, has ruffled feathers back in India.

The NDTV Dialogues: Why is India's healthcare in critical condition?

Sonia Singh — 25-Nov-2013

India's health parameters are amongst the worst in the world right now and a child born in India today has less chances of survival than in Nepal or Bangladesh. On The NDTV Dialogues, Dr Srinath Reddy, Kiran Mazumdar Shaw, Dr Binayak Sen and Dr Ashok Seth join NDTV's Sonia Singh to look at why India's healthcare is in a critical condition.

Govt should not interfere with cross-fertilisation in Indian pharma sector

Habil Khorakiwala — 26-Nov-2013

The last 10 years in the Indian pharmaceutical industry have been characterised by many events that led to its stellar performance.

Sony seeks ‘SmartWig’ patent in US

Grace Huang — 26-Nov-2013

SmartWig hairpieces can be used to navigate, check blood pressure or control a slideshow and can communicate wirelessly with another device.

Biocon, Mylam get approval for biosimilar of cancer drug Herceptin

C.H. Unnikrishnan — 26-Nov-2013

Biocon says the biosimilar Trastuzumab will be sold in India under the brand name Canmab.

WTO deal teeters, some blame Indian electioneering

Reuters — 27-Nov-2013

India may hold the key to the credibility of the World Trade Organization and to a trillion-dollar trade deal that apparently was derailed this week, diplomats in Geneva said on Tuesday.

EU lays down data protection steps for US

27-Nov-2013

The EU on Wednesday laid down steps Washington must take to restore trust after a huge spying scandal, including giving EU citizens the right to US legal redress to protect personal data.

Government mulls stricter norms for patents in pharma space

Soma Das — 27-Nov-2013

In a move that could usher in more transparency in the pharma patent landscape, the Indian Patent Office is considering a proposal that seeks to make it mandatory for drug firms to disclose the WHO-assigned generic names of drugs, whenever known, while applying for their patent.

Industry to benefit from utility model for patents

BS Reporter | Chennai — 27-Nov-2013

After the elections, Centre may bring an amendment in the 2014 sessions of the Parliament, to accept the utility model in Indian Patent Act

Centre mulling new premises for Intellectual Property Appellate Board in Chennai

Aparna Ramalingam — 27-Nov-2013

The Union commerce ministry is in the process of setting up new premises for the Intellectual Property Appellate Board (IPAB) here.

Wockhardt’s 2nd plant faces US ban

Rupali Mukherjee — 28-Nov-2013

Drug major Wockhardt suffered a huge blow on Wednesday with the US Food and Drug Administration (FDA) banning products shipped from its key plant located at Chikalthana in Maharashtra.

KKR Set to Pick Up 35% Stake in Gland Pharma

Arun Kumar — 28-Nov-2013

At about . 1,300 crore, it will be one of the largest private equity deals in pharmaceutical sector

Wockhardt Revenues may Dip Up to $250 m on USFDA Ban

Divya Rajagopal — 28-Nov-2013

Wockhardt may suffer an annual revenue fall of up to $250 million and its American operations may grind to a halt after the US’s drug regulator banned the sale of medicines produced from the firm’s Chikalthana plant in the world’s biggest pharma market.

Interview Dr. Jeremy Desai - “The pharma industry is going through a major transition”

Sheetal Srivastava — 28-Nov-2013

Dr. Jeremy Desai, president and COO of Apotex Inc. discusses with Sheetal Srivastava the future of the pharmaceutical industry

India to investigate Ericsson in smartphone patent row

Reuters | Stockholm — 28-Nov-2013

Ericsson had sued Micromax in March 2013 for patent infringement.

IP tribunal upholds US company’s product patent

Our Bureau — 29-Nov-2013

The Intellectual Property Appellate Board has upheld its 2009 decision to grant US-based Kibow Biotech a patent for a probiotic dietary supplement that will augment kidney function, according to a statement by the company.

Facts about the WTO

AAP — 2-Dec-2013

The World Trade Organisation (WTO) meets for its ninth ministerial conference on the Indonesian island of Bali this week, fighting to salvage a deal on slashing barriers to global commerce.

14 items on GI tag list

A Subramani — 2-Dec-2013

Oranges of Nagpur, paintings of Kangra, Moradabad metal craft and Kolhapur jaggery are among 14 items waiting for Geographical Indications (GI) tag.

US biotech firm Kibow to enter India after favourable patent ruling

C.H. Unnikrishnan — 2-Dec-2013

Kibow has sought marketing approval for Renadyl, a biological supplement that helps kidney patients sustain themselves without dialysis, and has already set up a local entity.

Govt to dissolve panel on patented drug pricing

Sushmi Dey — 2-Dec-2013

Almost six years after forming a committee to derive a mechanism to negotiate and bring down prices of patented medicines in the country, the government has decided to dissolve the panel and dump the report the body submitted at the start of this year.

Pharmaceuticals: Compulsory licensing & reasonable efforts

Anurag K Agarwal — 02-Dec-2013

Globally harmonised patenting laws recognise the sovereignty of nations like India which retain the right to compulsory licensing.

Medical Device Cos Urge Govt not to Punish All for a Quality Lapse

Soma Das — 03-Dec-2013

Cos want input providers, component suppliers to also be held responsible for a faulty device

Pharma industry has a deep culture of corruption

Chirantan Chatterje — 3-Dec-2013

Circumventing 56 patents protecting a medicine to re-invent a novel process and procure a 57th one for Eli Lilly’s drug Cefaclor had been Ranbaxy’s biggest claim to fame in the last couple of decades. But in 2013, the situation flipped in what can be termed as its summer of dirty medicine.

J&J faulty implants: $2.5b payout in US, Indians left in lurch

Sumitra Deb Roy — 4-Dec-2013

Pharmaceutical giant Johnson & Johnson recently agreed to pay $2.5 billion (over Rs 15,000 crore) as compensation to around 8,000 US citizens who had sued the company after being fitted with its faulty hip implants

Indian pharma seeks women part-time sales force in Tier II cities to ensure diversity, stability in cos

Nandita Vijay, Bengaluru — 04-Dec-2013

Indian pharma companies are now seeking out to employ women part time sales work force in Tier II cities. The move comes in because the industry is seen grappling with an attrition rate of 18-20 per cent particularly in sales and marketing.

IPAB scraps 7 trademarks of TT Industries in favour of Korean firm Tageu Tec

Gireesh Babu | Chennai — 04-Dec-2013

South Korean firm says TT Industries has not sold or marketed a single product under the impugned marks despite obtaining registration.

India to showcase drugmaking facilities to global regulators

Raji Reddy Kesireddy — 4-Dec-2013

India is showcasing its best pharmaceutical manufacturing facilities to regulators from emerging economies to counter adverse publicity the country's drug industry has endured in recent times.

Govt may issue compulsory licences on diabetes drugs

C.H. Unnikrishnan — 5-Dec-2013

Health ministry panel may suggest compulsory licences for at least two patented drugs that are yet to be identified.

US House passes IT firms-backed patent bill

Reuters — 06-Dec-2013

The US House of Representatives has approved a bill aimed at reining in "patent trolls," companies that buy or license patents from others, then extract licensing fees or file infringement lawsuits viewed by many as frivolous.

US Supreme Court case could mean 'death' of software patents

Associated Press — 7-Dec-2013

The US Supreme Court decided Friday to hear an appeal of a lower court decision that a federal judge called the "death" of software patents.

WTO: 5 Gains for World Trade

9-Dec-2013

Even the diehard optimist did not believe the Bali Ministerial of the World Trade Organization (WTO) would achieve anything.The sceptics said its failure would be a nail in the coffin of multilateral attempts at equitable trade orders, after all in its 12 years the Doha Round had nothing to show. Unexpectedly, Bali did deliver a result.ET deciphers the gains from Bali.....

Patents law

Poonam Jain — 9-Dec-2013

Anirban Mazumdar, associate professor of law at West Bengal National University of Juridical Sciences, on career options in patents law.

Global patent growth hits 18-year high: World Intellectual Property Organization

AFP — 09-Dec-2013

Global patent filings grew at their fastest pace in almost two decades in 2012, with China the driving force, the UN's intellectual property agency said Monday.

Samsung may need to offer more to settle patent dispute: Almunia

Reuters — 09-Dec-2013

Samsung Electronics Co Ltd will likely need to do more to settle an investigation over whether its use of patent lawsuits against Apple Inc breached EU rules, the EU antitrust chief said on Monday.

India records growth in patent filings

Rupali Mukherjee — 09-Dec-2013

Global patent filings in 2012 increased at its strongest rate in nearly two decades as industrial-design registration notched its best-ever rate of growth, a report says.

European Union warns Nokia not to become 'patent troll

AP — 09-Dec-2013

Europe's top regulator has warned Nokia not to try to become a "patent troll'' after the Finnish company sold most of its cellphone-making business to Microsoft Corp. this year but retained its patent portfolio.

Drug retailing: SC upholds 15-day deadline for price-control rollout

BS Reporter — 10-Dec-2013

The Supreme Court ruled on Monday that manufacturers and importers of pharmaceutical products must implement the Drugs (Prices Control) Order within 15 days from the date of notification or receipt of the order.

No reprieve for drug cos in new DPCO prices

Jayati Ghose, Indu Bhan — 10-Dec-2013

Reducing the leeway for drug firms to sell older stocks of price-regulated medicines in the market at previously notified — rather than new — prices, the Supreme Court on Monday held that the firms are liable to replace these stocks within the grace period provided by the National Pharmaceuticals Pricing Authority (NPPA).

Sell drugs at govt rates, not higher prices mentioned on box, says SC

Utkarsh Anand — 10-Dec-2013

The Supreme Court on Monday ruled that drug manufacturers and retailers cannot sell medicines at higher prices mentioned on the label of the boxes if the government notifies a lower rate. They must implement the price fixed under the Drugs (Prices Control) Order (DPCO) within 15 days from the date of notification.

Global patents for Mahindra Two Wheelers

10-Dec-2013

Mahindra Two Wheelers Ltd — the scooter and motorcycle making arm of Mahindra and Mahindra Ltd — has obtained international patents for four of its indigenously developed technologies.

Baring India sees geographical diversification driven by patent expires, rise in R&D spend as 2 emerging trends

Nandita Vijay, Bengaluru, — 10-Dec-2013

Baring India, a leading private equity fund, signals that Indian pharmaceutical sector seems to suggest two clear emerging trends.

With most patents, China biggest intellectual property growth driver, says report

Vanita Srivastava — 10-Dec-2013

China– with the highest number of patents filed and received– was the biggest driver of the intellectual property growth in 2012, according to the World Intellectual Property Organisation.

No clarity on pricing, patents

P. T. Jyothi Datta — 10-Dec-2013

Interview with Pfizer India chief, Aijaz Tobaccowalla, on prospects and pitfalls of doing business in India.

Intellectual Property Appellate Board crippled due to poor infrastructure, PIL says

A Subramani — 10-Dec-2013

Despite being a premier body settling disputes over intellectual property rights and trademark rows, the Intellectual Property Appellate Board headquartered in Chennai has neither proper infrastructure nor finance to function efficiently, said a PIL in the Madras high court.

Apple granted patent for curved touchscreen

ANI — 11-Dec-2013

Apple has been reportedly granted patent for curved touchscreen designs for smartphones and other devices.

MSME Dept Bats for IPR

Express News Service - CUTTACK — 11-Dec-2013

The State MSME Department has pressed the entrepreneurs, manufacturers and producers to protect their innovations, designs and work processes through Intellectual Property Rights.

Former Google executive Michelle Lee to run US patent office

Reuters — 11-Dec-2013

Former Google Inc executive Michelle Lee has been named deputy director of the US Patent and Trademark Office and will run the agency until a new director is named, the agency said on Wednesday.

Samsung loses patent lawsuit in South Korea against Apple

IANS — 12-Dec-2013

The three technologies under the legal dispute included those related with multi-tasking service while writing text messages.

Cadila Healthcare gains after settling patent litigation with Warner Chilcott

Capital Market — 12-Dec-2013

Cadila Healthcare rose 2.63% to Rs 744.50 after the company said it has settled a patent litigation with US-based Warner Chilcott Company LLC.

Apple Inc scores legal victory over Samsung on sales of iPhone 4S, iPhone 5 in South Korea

Reuters — 12-Dec-2013

Apple Inc products such as the iPhone 5, iPhone 4S and iPad2 do not violate Samsung Electronics patents, said a Seoul judge.

HC Favours Colgate in HUL Ad Row

Our Bureau — 12-Dec-2013

The battle for supremacy in the oral care segment took another interesting turn on another turf when market leader Colgate Palmolive obtained a favourable court order against its arch rival Hindustan Unilever (HUL), India’s largest consumer goods company.

11 more items from Bengal identified for GI tag

Our Bureau — 12-Dec-2013

After Darjeeling tea, 11 more items from West Bengal are in line to get Geographical Indication tag.

Medicines Patent Pool, BMS sign agreement to increase access to key HIV medicine

Rupali Mukherjee — 12-Dec-2013

The Medicines Patent Pool, a UN-backed organisation, and pharma company Bristol-Myers Squibb have signed a licensing agreement to increase access to a key HIV medicine, atazanavir, in 110 developing countries, including India.

Cadila, Zydus Pharma in pact with Warner Chilcott to settle US patent issue

Our Bureau — 12-Dec-2013

Warner Chilcott had lodged a suit in the Delaware federal court in 2011 seeking to stop Cadila Healthcare and its US unit from launching a generic version of Asacol.

Seoul court rules in favour of Apple in patent row with Samsung

ANI | Washington — 13-Dec-2013

A Seoul court has reportedly ruled that Apple did not infringe on some of Samsung's patents, in a patent battle that has spread to multiple continents.

Nod for anti-depressant cheers Indian pharma

BS Reporter | Mumbai — 13-Dec-2013

Five companies get US regulator's approval for Cymbalta generic

MNCs lead in patenting of both product and processes in India after change in patent law: Origiin IP

Nandita Vijay, Bengaluru — 14-Dec-2013

Origiin IP Solutions LLP has observed that there is an impressive number of foreign multinational pharmaceutical companies which have taken a lead in patenting activities in India.

Presence of law to protect copyright 'not effectual': CJI

PTI — 15-Dec-2013

Observing that the revenue of conventional record labels has plunged in recent years due to copyright infringement, Chief Justice of India P Sathasivam on Sunday said in spite of the existence of a law, its implementation was not "effectual" as envisaged.

GSK to spend $1 billion to raise stake in Indian unit

Reuters — 16-Dec-2013

GlaxoSmithKline Plc said on Monday it plans to raise its stake in its Indian pharmaceutical unit to up to 75 per cent from 50.7 per cent through an open offer in a deal worth about 629 million pounds.

Indian pharma company wins patent war against US firm

Express News Service — 18-Dec-2013

Gujarat-based La Renon Healthcare Pvt Ltd has successfully got revoked the Indian patent held by a US firm for a proprietary probiotic formulation, named Renadyl.

Lack of awareness about GI spelling doom for many products

Press Trust of India | Kolkata — 18-Dec-2013

Lack of awareness about the importance of geographical indicators for goods is pushing many products, unique to India, out of business, according to the Trade Marks & GI Registry, the Intellectual Property office of India.

ZTE says India operations unaffected in Vringo patents row

Danish Khan — 18-Dec-2013

Chinese telecom gear maker ZTE said that the Delhi High Court has set aside the injunction sought against the company's products by Vringo Inc.

Patent war spills over to non-cancer drugs

Rupali Mukherjee — 19-Dec-2013

The turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly priced drugs for cancer and HIV, is now spilling over to chronic and lifestyle problems.

Hisar university issued patent to estimate multi residue in milk and milk products

Madhvi Sally — 20-Dec-2013

Chaudhary Charan Singh Haryana Agricultural University Hisar has been issued a patent on a technique for estimation of multi residue in milk and milk products, announced the Vice-Chancellor, Dr K.S. Khokhar.

Apple granted patent for flexible sapphire display

TOI Tech — 20-Dec-2013

Flexible and bendable screens are the new buzzwords in the technology industry, with all major manufacturers readying display panels for the next generation of gadgets.

Ramnad farmers seek GI tag for their ‘Madurai Malli’ plants

Walter Scott — 21-Dec-2013

Claiming that ‘Madurai Malli’ which was recently given the coveted Geographical Indication tag, had its origin in Ramanathapuram, farmers have urged the district administration to help them secure GI mark also for the plants raised in the district and which produced ‘Madurai Malli.’

He Has the Patent to Cure Many Ills

Shevlin Sebastian — 22-Dec-2013

This was Shet’s 79th patented invention in his 30-year career as an inventor.

New patenting norms may put India's software innovation into sleep mode

Surabhi Agarwal — 23-Dec-2013

Patenting of software applications could virtually become impossible in the country if the draft guidelines on computer-related innovation come into force. The rules, the first ever for software applications in the country, were recently issued by the patent office and mandate each new software to be "machine-specific" and packaged with "new hardware" to qualify for a licence. Technology experts argue the guidelines defeat the very objective of most software applications - to be hardware agnostic and interoperable.

Pharma firms might resume sales of analgin-based drugs

Sushmi Dey — 23-Dec-2013

Soon, drug makers might be able to resume the sale of analgin, the popular pain-relief drug. The Drugs Controller General of India is considering the recommendations of its advisory body to revoke the suspension of the sale of analgin-based medicines in the country

Japanese companies keen to establish telecom gear test labs in India

Kalyan Parbat — 24-Dec-2013

Japanese companies are keen to establish telecom gear test labs in India even as the government prepares to invite bids from private lab operators to pave the way for local testing from July 2014.

Chennai Patent Office revokes Pfizer's second patent on Detrol

Our Bureau, Mumbai — 24-Dec-2013

In yet another blow to the multinational drug companies in patent cases in India, the Chennai Patent Office has revoked Pfizer's patent on Detrol, a drug used to manage overactive bladder symptoms.

New patenting norms may put India's software innovation into sleep mode

Surabhi Agarwal | New Delhi — 24-Dec-2013

Technology experts argue the guidelines defeat the very objective of most software applications - to be hardware agnostic and interoperable

CMIA’s summit to provide platform to patent holders

Mohammed Akhef — 24-Dec-2013

The Chamber of Marathwada Industries and Agriculture will organise a first-of-its-kind innovation summit on January 7 for industries, education and service sectors to discuss ways of exploring more opportunities.

Govt may have to Reset Prices of Essential Drugs

Soma Das — 24-Dec-2013

Seven months into the new pharma pricing regime, the government may have to go back to the drawing board and reset prices of essential drugs, adding to the prevailing confusion in the domestic drug market.

Google files lawsuit against Apple, Microsoft backed Rockstar patent group

ANI — 27-Dec-2013

Google has reportedly filed a lawsuit against Apple and Microsoft backed consortium Rockstar, claiming that its patent campaign is unfairly targeting Google's Android partners and customers.

Traditional knowledge, culture can be patented

Rupali Mukherjee — 27-Dec-2013

Traditional Knowledge and Traditional Cultural Expression reflecting a community's cultural and social identity, handed down generations, may soon be recognized as a form of intellectual property.

2013: Few bitter pills, booster injections for pharma sector

Press Trust of India — 29-Dec-2013

Domestic firms coming under increased scrutiny of global regulators, resulting in Ranbaxy paying a record $500-million fine, and drugs becoming cheaper in India thanks to a new pricing policy marked a roller-coaster year 2013 for the pharma industry.

Sole right to make ‘Tirupati laddu’ will vest with TTD

R. Sivaraman — 30-Dec-2013

Madras High Court restrains Chennai sweet stall from making and selling ‘laddus’ under a near similar name.

The cancer divide

Gardiner Harris — 30-Dec-2013

Alka Kudesia needs an expensive drug to treat her breast cancer, but refuses to tell her children for fear they will take loans to buy the medicine and spend the rest of their lives in debt.

PIL wants additional statutory protection for GI-tagged handicrafts

Subra Mani — 30-Dec-2013

While GI-tagged liquor and spirits of foreign make enjoy additional protection in India, nearly 130 Indian handicraft products having GI status do not have such additional protection overseas, intellectual property rights (IPR) attorneys have informed the Madras high court.

Naidu has Patent for Graft: Botcha

Express News Service - HYDERABAD — 31-Dec-2013

Taking exception to TDP chief N Chandrababu Naidu alleging that AICC supremo Sonia Gandhi is encouraging corruption in the country, PCC president Botcha Satyanarayana said Naidu was the embodiment of corruption and had got ‘patent rights’ for graft.

Haleem makers vie for international geographical indication tag

Rohit PS — 31-Dec-2013

The savoury Haleem may soon be sold in Europe with the Hyderabadi tag proudly displayed on the packaging if makers manage to bag an international geographical indication tag for it.

Samsung, Apple working on patent deal: Report

TOI Tech — 31-Dec-2013

Arch rivals Apple and Samsung are reportedly back to the negotiating table.

Glenmark faces patent infringement suit in US

PTI — 1-Jan-2014

Glenmark Pharmaceuticals has been slapped with a patent infringement case by US-based Cephalon Inc over plans to sell generic version of leukaemia treatment drug Treanda in the American market.

Health ministry sought tough laws for drugs, clinical trials.

By PTI — 01-Jan-2014

As India inches towards being a polio-free country, the health sector made some rapid strides in strengthening regulations for drugs and clinical trials, and saw stronger food laws and re-establishment of an elected medical regulator during 2013.

Microsoft’s Nokia deal to face China limits on patent fees

Bloomberg — 2-Jan-2014

Chinese mobile phone makers asked regulators to make sure Microsoft's 5.44-billion euro bid to take over Nokia Oyj's handset business doesn't result in higher patent fees on wireless technology, said two government officials with knowledge of the matter.

Software patents: US Supreme Court needs to clear the air

Anurag K Agarwal — 6-Jan-2014

Granting a patent involves three important criteria – novelty or inventive step, non-obviousness and utility.

Student Gets Patent for her Innovation

Express News Service - KOCHI — 07-Jan-2014

An MTech student from Alappuzha has developed a sensor faucet with a sensor-controlled flow kit which ensures that water is provided manually through the water taps in case of electronic failure.

Madhya Pradesh’s basmati plea may delay India’s geographical indication battle

Sanjay Vijayakumar — 7-Jan-2014

India's battle to protect the distinctive identity of basmati rice name, fought in part through a filing for a geographical indication protection by state-run export registration agency Apeda, is facing a hurdle in Madhya Pradesh.

India sees sharp drop in patent applications

Mihika Basu — 8-Jan-2014

While patent filing at the Indian patent office has seen a rise of 23.97 per cent from 2007-08 to 2012-13, assessment shows that only a meagre 22 per cent of them have been filed by Indian applicants in 2012-13.

Nestle's cumin extract patent bid raises hackles

Sushmi Dey | New Delhi — 8-Jan-2014

Company claims new use for kala jeera extract, provoking alarmed campaigners here and abroad; says reaction not based on facts

Centre to SC: No advantage in contesting US patent of wheat variety

Utkarsh Anand — 8-Jan-2014

The Centre has told the Supreme Court that it was not "advantageous" to contest the United States' patent of a wheat variety, similar to Indian Nap Hal, since the patent granted to American multinational chemical and agricultural biotechnology corporation Monsanto had already expired in 2010.

Ghansal rice variety set to attain GI status

Nikhil Deshmukh — 9-Jan-2014

Following the footsteps of Kolhapur jaggery, the Ghansal variety of rice grown in the Ajara tehsil is set to attain geographical indication status to preserve its aroma and peculiarity.

Apple, Samsung agree to mediation in US patent fight

Reuters | San Francisco — 9-Jan-2014

The rivals are facing a March trial date in the United States

Pharma FDI: No Ban on Non-compete Clause

Our Bureau, New Delhi — 09-Jan-2014

The government has decided against a blanket ban on the incorporation of a ‘non-compete’ clause if an Indian pharma company is acquired by a foreign drug company. The ban was mooted by the Department of Industrial Policy and Promotion (DIPP) as a safeguard to ensure large scale acquisition of Indian pharma companies does not lead to shortage of critical drugs.

Glenmark's anti-diabetes drugs shake up Indian anti-diabetes market

DIVYA RAJAGOPAL — 9-Jan-2014

Mumbai-based Glenmark Pharmaceuticals has shaken up India's Rs 3,000-crore lucrative anti-diabetes market dominated by multinationals with its new drugs, Zitamed and Zita.

After Basmati rice, MP govt to seek patent for rare poultry breed

Shashikant Trivedi | Bhopal — 09-Jan-2014

Farmers Welfare and Agriculture Development department will file applications for patenting breed soon.

Solvay wins two rare earth mixed oxides patent cases against HySci in China

BS B2B Bureau | Brussels — 10-Jan-2014

Solvay has won two rare earth mixed oxides patent cases against China-based HySci (Tianjin) Specialty Materials Co Ltd. Solvay was awarded RMB 5.6 million (Euro 0.67 million) in damages and HySci was ordered to immediately stop the production and the sale of certain rare earth mixed oxides used in automotive catalysts.

Apple did not violate Google patents: US court

Reuters — 11-Jan-2014

The US Court of Appeals for the Federal Circuit upheld a decision by the International Trade Commission in April that Apple did not violate a Google patent to make the popular iPhone.

Pharma companies rope in third-party advisors to deal with compliance issues

Pallavi Ail | Mumbai — 11-Jan-2014

Inadequate resources, coupled with rising demand, has proved to be a stumbling block for Indian pharmaceutical companies

Why India needs to take intellectual property seriously

Rod Hunter — 11-Jan-2014

Without reform of IP law, Indian companies - and broader economic growth - will remain stunted.

Gujarat-based CMSCRI gets European patent for 'green plastic'

Avinash Nair | Ahmedabad — 13-Jan-2014

The institute developed biodegradable plastic by using a residue generated from Jatropha.

Allergan wins lawsuit against Lupin, two others over Lumigan

Susan Decker — 14-Jan-2014

The patent will prevent copies of Allergan’s Lumigan glaucoma treatment from entering the US until 2027.

India has an impeccable Copyright Act - now it needs teeth: Javed Akhtar

Arnab Banerjee — 15-Jan-2014

Poet and writer Javed Akhtar is also Vice President of the Brussels-based International Confederation of Societies of Authors and Composers (CISAC), addressing copyrights, intellectual property rights, etc.

No copyright over yoga, pranic healing techniques: HC

Aneesha Mathur — 15-Jan-2014

The court has held that the expression ‘pranic healing’ cannot be monopolised as trademark by the institute.

Swarovski drops 'Crystal' mark after Indian company challenge

Manish Raj — 17-Jan-2014

In a letter to the Intellectual Property Appellate Board, Austrian crystal jewellery and accessories maker Swarovski said it will not renew its trademark 'Crystal Glamour' for its clothing, footwear and headgear

Patent mapping system to find more innovation

Leslie D’Monte — 16-Jan-2014

Patent maps provide visual representation of where universities, companies and other organizations are protecting intellectual property produced by their research

Unbranded generics way to cheaper cure

Rupali Mukherjee | TNN — 18-Jan-2014

Rajasthan, TN implement Model that cuts prices of branded drugs by at least 30%.

Google set to face Intellectual Ventures in landmark patent trial

Reuters — 20-Jan-2014

Intellectual Ventures is set to square off this week against Google Inc's Motorola Mobility unit in the first trial that the multibillion-dollar patent-buying firm has undertaken since it was founded.

IBM leads in tech patent filings in 2013

ANI — 20-Jan-2014

IBM has retained its patent crown in 2013, while Google climbed to No. 11 in the rankings.

No More 'Tricky' Postures can Get a Yoga Copyright

Wilson George Thomas - COIMBATORE — 20-Jan-2014

Practitioners of yoga lose no time in waxing eloquent of its antiquity.

Biocon’s copy of Roche breast cancer drug still expensive for India

Naomi Kresge, Ketaki Gokhale — 21-Jan-2014

Biocon will sell its version of Herceptin, which it is calling Canmab, at a 25% lower price

Sherlock Holmes just escaped the bonds of copyright, new adventures beckon

21-Jan-2014

Its elementary a character in public domain cannot be appropriated as private intellectual property.

Merck to Bristol-Myers Face More Threats on India Drug Patents

Ketaki Gokhale — 21-Jan-2014

Pharmaceutical companies from Merck & Co. to Bristol-Myers Squibb Co. face fresh threats to protecting their patents in India as a government-appointed panel prepares to evaluate more drugs for local makers to copy.

IPAB refers opposition to anti-cancer drug to patent office

Gireesh Babu | Chennai — 22-Jan-2014

Board has set aside an earlier order of Assistant Controller of Patent stating that it was passed in 'flagrant violation of principles of natural justice'

HC Restrains Jubilant Co from Infringing Pidilite's Trademarks

PTI — 23-Jan-2014

Holding that it was a case of an infringement of copyright and passing off goods in someone else's name, the Bombay High Court has restrained M/s Jubilant Agri & Consumer Products Ltd from using the registered trademarks of M/s Pidilite Industries Ltd.

With a GI tag in the bag, Udupi farmers cash in on rare green brinjal

AJ Vinayak — 23-Jan-2014

‘Mattu Gulla’, a special variety of green brinjal grown in Karnataka’s Udupi district for over five centuries now, is now attracting special attention from growers.

Apple wins 'autocomplete' patent claim against Samsung

TOI Tech & Agencies — 23-Jan-2014

Apple has won a patent claim against Samsung, after a US Judge ruled that the South Korean electronics giant infringed on auto complete patent owned by the iPhone maker.

Mera-vala pink

B Desikan — 23-Jan-2014

Colours, sounds, smells, gestures and moves… you can trademark them all.

Qualcomm buys Palm patents from Hewlett-Packard

AP — 24-Jan-2014

Cellphone chip-maker Qualcomm said that it has acquired patents once owned by smartphone maker Palm from Hewlett-Packard for an undisclosed amount.

GI tag won, hopes soar for MP’s basmati

Milind Ghatwai | Bhopal — 24-Jan-2014

Basmati rice, in the cultivation of which Madhya Pradesh has already taken long strides, has finally got what it had been seeking for a long time: a geographical indication tag.

Google, Intellectual Ventures face off as patent trial begins

Reuters — 24-Jan-2014

Opening statements began in patent owner Intellectual Ventures' trial against Google's Motorola Mobility unit in a lawsuit that could be a bellwether on public opinion toward intellectual property.

Nokia says Indian mobile app downloads rise 15-fold globally

Press Trust of India | New Delhi — 24-Jan-2014

Mobile handset company Nokia has seen a 15-fold increase in downloads of applications developed by Indian companies globally on a yearly basis.

European office upholds 3G patent disputed by Nokia, HTC, Apple

PTI — 25-Jan-2014

The European Patent Office has upheld a narrowed version of a patent on 3G technology rejecting claims from Nokia, HTC, Apple, Ericsson and Vodafone.

Developed cancer drug for 'western patients' who could afford, not 'for Indians': Bayer's CEO

AFP — 25-Jan-2014

Global medical charity Medecins Sans Frontieres slammed on Friday a statement by Bayer's chief executive that the giant German firm only developed its cancer drug Nexavar for people who could afford the medicine, not "for Indians".

USFDA bans Ranbaxy’s 4th plant

Rupali Mukherjee — 25-Jan-2014

India’s largest drug maker Ranbaxy faced fresh regulatory trouble due to manufacturing violations at its fourth domestic facility, which may threaten new drug launches and jeopardize lucrative revenues from the US, the world’s biggest pharma market.

IPAB directs patent office to consider Schering Corporation's application afresh

Gireesh Babu | Chennai — 26-Jan-2014

The Intellectual Property Appellate Board has directed the patent office to consider the patent application of US-based Schering Corporation for a crystalline form of a compound for treatment of heart related disease afresh.

Google and Samsung Electronics, which are frequently involved in patent infringement lawsuits but not against each other, announced that they have reached a global patent cross-licensing agreement.

Reuters — 27-Jan-2014

Google and Samsung Electronics, which are frequently involved in patent infringement lawsuits but not against each other, announced that they have reached a global patent cross-licensing agreement.

Safeguarding your intellectual property rights

Sakina Babwani — 27-Jan-2014

Have you wondered what you would do if someone sells their products under your brand name or uses the content you have written without your permission?

Patented drugs face price caps

Sidhartha — 27-Jan-2014

After sitting on it for years, the government is finally initiating steps to regulate the price of patented medicines and medical devices, a move that may provide relief to patients suffering from life-threatening diseases.

Sanofi India stock likely to be re-rated on company's improving fundamentals

Narendra Nathan — 27-Jan-2014

Sanofi India is a subsidiary of Sanofi, one of the world's leading pharmaceutical companies.

MSF criticises Bayer CEO's comments on CL issued by Indian patent office on Nexavar

Ramesh Shankar — 28-Jan-2014

German drug major Bayer's CEO Marijn Dekkers' reported comments that “We did not develop this medicine for Indians,” have come in for severe criticism from the international medical humanitarian organization Médecins Sans Frontières.

GI battle: Madhya Pradesh govt puts basmati in a rice soup

Sandip Das — 28-Jan-2014

The state has asked for inclusion in basmati rice growing zone although being outside the Indo-Gangetic plain.

Google, Samsung sign patent agreement

Eric Pfanner | Washington — 28-Jan-2014

The deal covers existing patents as well as some that would be filed during the next 10 years.

Ericsson agrees to end patent dispute with Samsung

Reuters | Stockholm — 28-Jan-2014

Ericsson said on Monday it had signed a cross-licensing deal with Samsung Electronics Co, ending a long-running patent dispute and boosting fourth-quarter sales by 4.2 billion crowns.

US Record Company Sues Vietnam Site for Copyright

Chris Brummit | AP - HANOI — 28-Jan-2014

A record company that accuses a Vietnamese entertainment portal of making its songs available for free download has filed suit in an American court against the U.S- venture capital firm which invested in the website, seeking millions in damages for copyright violations.

Apple patents 'magnetic add-on camera lens' for iPhones

ANI | Washington — 29-Jan-2014

The external camera lens could be attached securely to the iPhone with magnets and aligned with its camera.

Venus Remedies bags US patent for painkiller injection

PTI — 29-Jan-2014

Venus Remedies Ltd, a research oriented global pharmaceutical company today said it has bagged a patent from US Patent Office for Achnil, a once-a-day painkiller injection developed by Venus Medicine Research Centre, the R&D wing of Venus Remedies.

Doha talks will be back on track: WTO

Times News Ntework — 29-Jan-2014

The Doha Round of talks on lowering world trade barriers would resume this year, following the successful trade talks in Bali recently:WTO

Basmati WARS

Summary — 30-Jan-2014

Madhya Pradesh joining the battle for geographical indications gives it a new twist

Protecting patents: India worst in world

Surabhi Agarwal | New Delhi — 30-Jan-2014

Ranking by arm of US Chamber of Commerce; study says all BRICS countries lack the required drive to enforce patents; Indian law & SC rulings rapped

IPAB sets aside Patent Office's order for Roche's anti-viral drug

Gireesh Babu | Chennai — 30-Jan-2014

The Intellectual Property Appellate Board has set aside an order of Indian Patent Office, which revoked the patent of Hoffmann-La Roche's antiviral drug Valganciclovir, branded as Valcyte, and remanded the matter back to the patent official for fresh consideration.

Twitter buying 900 IBM patents to end infringement dispute

Susan Decker — 31-Jan-2014

The agreement also resolves a dispute that prompted IBM to write to Twitter last year about possible infringement of at least three patents.

Apple gets 'sapphire window' and pressure-sensitive display patents granted

Robin Sinha — 31-Jan-2014

Apple, a tech firm best known for its innovations, after introducing a sapphire- based fingerprint sensor on its iPhone 5s, got one of its important patents granted by the USPTO on Thursday, detailing a cutting and processing method for sapphire material.

India's IP environment has deteriorated in last 2 years: Jasper MacSlarrow

Sudipto Dey — 02-Feb-2014

Interview with Executive Director of International IP, Global Intellectual Property Center, US Chamber of Commerce

Patent filing by IIT Bombay up by nearly 400%, students major contributors

Mihika Basu — 3-Feb-2014

In 2012-13, 94 patents were filed and Indian trademark and design and copyright registered, a rise of nearly 400 per cent from 2008-09, when 19 were filed.

Registering trademarks turns cheaper for firms

C.H. Unnikrishnan — 3-Feb-2014

New system works on a single registration fee to be paid in India, is likely to help firms save more money

Mylan launches biosimilar for cancer

TNN — 4-Feb-2014

Mylan Inc, a leading generic and specialty pharmaceutical company, said that its Indian subsidiary Mylan Pharmaceuticals has launched the world’s first trastuzumab biosimilar in India. The product, which will be marketed under the brand name Hertraz, is a biosimilar to Roche’s Herceptin

India slips in rankings as slowdown hits pharma

Rupali Mukherjee | TNN — 4-Feb-2014

India has slipped from the 8th rank as forecast in 2016 to the 11th position in 2017, figures culled from IMS Health said. The downgrade suggests that the market may not be growing at the pace projected earlier, and has lost value due to the currency fluctuation, impacting the country’s global ranking, experts say.

Cisco, Google sign patent-sharing agreement

Reuters — 05-Feb-2014

Google Inc entered into a patent cross-licensing agreement with Cisco Systems Inc, the internet search giant's second such deal in as many months.

Turning down knowledge

Business Standard Editorial Comment — 05-Feb-2014

Troublingly, India is an outlier on intellectual property.

Big pharma firms pushes for US action against India over patent worries

Reuters — 06-Feb-2014

Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.

Patents and Copyrights Are Not for Violation

The New Indian Express — 7-Feb-2014

India has for the second time in succession found itself at the bottom of the International Intellectual Property Index issued by the US apex trade body’s Global Intellectual Property Centre.

Roche sues Biocon, Mylan, DCGI over breast cancer drug

Soma Das — 7-Feb-2014

The Indian arm of Swiss pharma major Roche, which unexpectedly gave up its patent on it s $6 billion breast cancer drug Herceptin in India last year, has sued Bangalore based BioconBSE 2.29 % and US generic giant Mylan Inc in Delhi High Court for launching world's first biosimilar version of the original drug in India.

Cancer drug may lose patent shield

Rupali Mukherjee — 7-Feb-2014

The government is studying options to issue a compulsory licence on life-saving anti-cancer drug dasatinib, which could bring down its price by over 90%.

Apple gets patent for autocorrect review system: Report

ANI — 07-Feb-2014

Apple has reportedly patented an autocorrect review system in which autocorrect changes are highlighted to a user once they press the send button.

HTC, Nokia reach truce in patent dispute

AFP — 8-Feb-2014

Taiwan's smartphone maker HTC said it has signed a patent and technology collaboration agreement with Finnish phone giant Nokia to end all pending patent litigation between them.

Novartis sues Dr Reddy’s Laboratories over patent infringement on cancer drug

fe Bureau | Hyderabad — 8-Feb-2014

The patent and Novartis' new drug application, approved by the FDA in 2001.

Trade Groups Seek More US Pressure on India over Patent Protection

Bill Berkrot | Reuters - US Chamber of Commerce — 8-Feb-2014

The US Chamber of Commerce on Friday called on the government to ratchet up pressure on India over intellectual property rights, in a move that could help prevent Indian companies from producing cheap generic versions of medicines still under patent protection.

HTC, Nokia ink deal on patent lawsuits

AFP | Taipei — 09-Feb-2014

Under the deal, HTC will make payments to Nokia and the collaboration will involve HTC’s LTE patent portfolio.

IPA slams methodology used by US Chamber of Commerce to rank IP environment of India

Joseph Alexander — 10-Feb-2014

The Indian Pharmaceutical Alliance, representing large domestic drug-makers in India, has taken exception to the methodology that the Global Intellectual Property Centre of the US Chamber of Commerce adopted to rank India in the recent International Intellectual Property index.

India raises concerns over USFDA actions

10-Feb-2014

The government on Monday expressed clearly to the US its growing unease over its drug regulator USFDA’s "disproportionate penalties" on India’s generic pharmaceutical companies, many of these which have been rattled by a string of import bans without getting sufficient opportunity to clarify details.

Immense opportunities await Indian pharma manufacturing industry: Study

Peethaambaran Kunnathoor, Chennai — 10-Feb-2014

Immense opportunities are waiting for the Indian pharmaceutical industry, both at the domestic and at the global level, and the future will be extremely promising with many more milestones, according to a research study conducted by Dr G Selvaraju, former director of drugs control, Tamil Nadu for the Vinayaka Mission University, Salem, Tamil Nadu.

Intellectual property rights: US set to punish India

TNN — 10-Feb-2014

Tensions over the Khobragade episode are yet to fully dissipate, but the two sides are locking horns again over intellectual property rights.

India, US seek to better drug-making processes

fe Bureau — 11-Feb-2014

No surprise checks on drug firms as US FAA and its Indian counterpart agree to coordinate in drug making.

US business pressure again on Indian IPR

Nayanima Basu | New Delhi — 11-Feb-2014

Tells trade representative's office that New Delhi's already bad record got worse last year; wants action, even as bilateral investment treaty being negotiated.

India patent regime not about access to medicine: U.S body

Staff Reporter — 11-Feb-2014

Representative Michael Froman set to announce a trade enforcement action tied to India, the highly influential U.S Chamber of Commerce has lashed out at India’s recent pattern of pharma patent denials, pointing out that the country’s actions “are not about access to medicine.”

US challenges India's requirements for solar products in WTO

IANS | Washington — 11-Feb-2014

In another potential blow to India-US ties after the Khobragade affair, US Monday challenged India's domestic content requirements in Phase II of India's National Solar Mission.

India faces US trade action over patents

TIMES NEWS NETWORK — 11-Feb-2014

The US, which recently downgraded the DGCA’s safety ratings, is expected to announce traderelated measures in what is seen as a retaliatory move against India’s recent stand on the patent regime.

India faces trade action from US

Times News Ntework — 11-Feb-2014

Washington’s Retaliatory Move Aimed At Govt’s Stance On Patent Regime

COFFEE TIME JOKE? ‘Dumb Starbucks’: A parody cafe in LA

Adam Withnall — 11-Feb-2014

An independent coffee shop has opened up in LA using the same name, logo and store layout as any branch of the Starbucks chain — with one crucial exception — the prefix ‘dumb’. “Dumb Starbucks” has rocketed to social media fame by claiming to be completely legal under “parody law”, with its mysterious owners insisting it makes “fair use” of the chain’s famous brand.

India Raises Concerns over FDA Actions on Local Drug Companies

Our Bureau, New Delhi — 11-Feb-2014

India will issue an informal note to the US in which it will protest against the “disproportionate” action targeting Indian pharmaceutical companies, commerce and industry minister Anand Sharma said after his meeting with visiting US Food and Drug Administration (US FDA) chief Margaret Hamburg

Big Pharma's profiteering protests

Amit Gupta — 11-Feb-2014

The war against the Indian patent regime is little more than multinationals' chagrin at their inability to exercise monopolies

Nokia, HTC settle long-running patent battles, agree on collaboration

ANI — 11-Feb-2014

Nokia and HTC have reportedly settled their long-running patent infringement battles by agreeing on a 'patent and technology collaboration' that would settle all outstanding litigation.

CII feels International IP Index does not give true picture of India's IP ecosystem

ANI | New Delhi — 11-Feb-2014

Commenting on the Global Intellectual Property Centre's International IP Index 2014 which presents India as the weakest among 25 countries, the Confederation of Indian Industry on Tuesday said the index does not represent the true picture of India's IP ecosystem.

After Starbucks parody, trademark violations take center stage: Here's all you need to know about Trademark laws

Vishal Manve — 11-Feb-2014

When King, the makers of popular game, Candy Crush Saga trade-marked the word Candy, there were protests around the world.

Editorial: Patent problems

12-Feb-2014

While the agreement between the US FDA and its Indian counterpart to share information and perhaps coordinate action is good news as both regulators will now be on the same page, the need of the day is for the Indian regulators to be more stringent and conduct more surprise tests in the manner the FDA does.

‘Dumb Starbucks’ a TV stunt, shut down

12-Feb-2014

Long lines formed outside the shop over the weekend as word of mouth and social media attracted large crowds. On Monday Canadian comedian Nathan Fielder, known for a Comedy Central prank show, said it was his idea. In a “press meet” outside the shop, he said: “By adding the word ‘dumb’, we are legally allowed to use the Starbucks name and logo.

‘EU rules denying kids of cancer drugs’

Kounteya Sinha TNN — 12-Feb-2014

Children with cancer are being denied entry into potentially life-saving drug trials because of loopholes in European Union regulations. Of the 28 cancer drugs which have received authorization in Europe since 2007, 26 have the potential to work on children but 14 of them have been waived from being tested on under-18-year-olds.

US FDA Refuses to Sweeten Indian Drug Cos’ Bitter Pill

Soma Das , New Delhi — 12-Feb-2014

The head of the US drug regulatory body has turned down Ranbaxy Laboratories’ plea to allow drugmakers to continue exporting from banned manufacturing facilities while they take remedial measures to rectify the issues flagged.

Majority of Indian IT-BPM firms at an initial stage of IP development: Report

Rajesh Kurup — 12-Feb-2014

Majority of the Indian Information Technology-Business Process Management firms are at an initial stage of Intellectual Property rights development.

A duel on drugs

T S Vishwanath — 12-Feb-2014

The discussions between the SA govt and pharma giants on intellectual property policy should keep both the needy and the inventor in mind

Trade team in US to explain India’s position

P. T. Jyothi Datta — 12-Feb-2014

Indian drugmakers and IT representatives will be in Washington tomorrow, making submissions before the US International Trade Commission to explain India’s trade policies.

U.S. probing ‘discrimination’ in Indian trade policies

Narayan Lakshman — 13-Feb-2014

India’s policies for regulating foreign trade and investment, particularly in the context of intellectual property rights affecting the pharmaceutical industry, were in the crosshairs of the US Congress this week, as a lengthy investigation was launched into whether such policies were harming the US economy by discriminating against American firms.

MORE BACKING FROM BIG PHARMA

R SRIRAM & DIVYA RAJAGOPAL MUMBAI — 13-Feb-2014

The US Chamber of Commerce may think India is an inhospitable terrain for innovation, but surprisingly, Big Pharma doesn’t agree. Merck Serono, whose pharmaceutical roots go back to 1668, has not only become the latest global giant to support lower pricing for emerging markets and but has also opposed incremental innovation — a favourite bugbear of the Indian government and local industry.

India faces US sanction threat

Rupali Mukherjee — 13-Feb-2014

India is facing multiple threats on its trade and investment policies.

Time to call the US bluff on pharmaceuticals

Shishir Asthana | Mumbai — 13-Feb-2014

While Indian drug makers are expected to adhere to norms in the US, one of their key markets, why aren't US companies operating in India following the laws here?

Suven Life Sciences gets patent approval from New Zealand

14-Feb-2014

Suven Life Sciences has received patent rights from New Zealand for two products

Patent troll Intellectual Ventures lays off 5% employees

Reuters — 14-Feb-2014

Privately held patent owner Intellectual Ventures has cut about 5% of its global workforce and "consolidated positions" in a corporate restructuring.

Doctors association slams US for pressuring India on pharma patent laws

PTI — 15-Feb-2014

A Geneva-based non-profit doctors association has criticised the US and its pharma lobby for exerting pressure on India over its patent laws, saying such actions undermine the global trading system.

India has strong legal framework to protect intellectual property rights: Boeing

PTI — 15-Feb-2014

Even as a section of the US' corporate sector lobbies against India over protection of intellectual property rights, American aircraft major Boeing, On Saturday said the country has a strong legal framework to protect such rights.

Indian policy on clinical research restrictive: US pharma cos

Press Trust of India | Washington — 15-Feb-2014

American pharma companies and their advocacy groups today rued at the alleged restrictive India policies on clinical research, saying such policies are harming the companies.

Geographical indication tag to Patan patola to end feud over name

Rupam Singh Gupta — 15-Feb-2014

The geographical indication (GI) tag to Patan patola puts an end to the conflict between the Salvi brothers of Patan and the Rajkot weavers over the name patola.

Novartis puts pressure on India over patent abuse

Andrew Ward in London and Amy Kazmin in New Delhi — 16-Feb-2014

Novartis has urged US and European governments to “apply pressure” on India to respect intellectual property and warned New Delhi that its stance on patents is deterring investment.

IISc professor’ virtual liver product gets patent in US

Anshul Dhamija — 17-Feb-2014

Strand Life Sciences, founded by professors at the Indian Institute of Science, Bangalore, was awarded a patent in the US last week for its two-year-old virtual liver product, used by pharmaceuticals companies across the world to test new drug toxicity in the liver.

Success strategies for Indian pharma industry in an uncertain world

Manish Panchal, Charu Kapoor and Mansi Mahajan — 17-Feb-2014

The Indian pharmaceutical industry is going through a period of significant volatility and uncertainty, requiring companies to re-visit their traditional growth strategies to succeed

Research funding body a growth tonic for pharma cos

TEAM TOI — 18-Feb-2014

Research and development (R&D) in innovation and technology-driven sectors is expected to get a boost with the fi nance minister announcing the setting up of a ‘research funding organisation’ to fund projects selected through a competitive process.

Indian firms under pressure on drug patent regime, as global majors mount lobbying

Yashwant Raj and Himani Chandna Gurtoo — 19-Feb-2014

India is defending its patent regime more aggressively than ever before from attacks in the US that have come to define the state of ties between the two countries lately.

Separate Copyright Office for Authors, Performers: Raju

IANS - NEW DELHI — 19-Feb-2014

A separate copyright office and a permanent copyright board is being set up to provide better services to the authors, performers and creators of various works," Raju said.

A FAIR GAME: RPG Life loses domain name battle

Lubna Kably TNN — 19-Feb-2014

A complaint filed by RPG Life Sciences, a pharma company that is part of the diversified RPG Group, against the owner of the domain name ‘rpglife.com’ has been denied by an international arbitration panel. Interestingly, the owner has now offered to sell the domain name to RPG Life.

US FDA Plans to Deploy More Inspection Staff in India

Divya Rajagopal — 19-Feb-2014

The US Food and Drug regulator said on Tuesday that it will increase the number of its inspection staff in India. Currently, the FDA deploys 12 officials in India, which the regulatory body plans to increase by 19, said Margaret Hamburg, Commissioner, US Food and Drug Administration in the course of an interaction in Mumbai.

Intellectual property and economic development

Rod Hunter — 20-Feb-2014

In his recent State of the Union address, US President Barack Obama reiterated his ambition to complete the Trans-Pacific Partnership, a proposed trade agreement among the US and 11 Pacific countries.

‘Indian drug cos must meet US standards’

Times News Ntework — 19-Feb-2014

When US Food & Drug Administration commissioner Margaret Hamburg signed off her 9-day visit to India on Tuesday, she praised everything Indian with a steely demand for quality.

Patent error

Shamnad Basheer — 20-Feb-2014

In its criticism of India’s IP regime, the US takes its cue from flawed rankings.

GI Basmati: CM urges PM to step in for state's inclusion

TNN — 20-Feb-2014

Expressing 'shock and deep dismay' over apex agency monitoring India's agricultural exports deciding to oppose inclusion of Madhya Pradesh areas for Geographical Indication tag for basmati, chief minister Shivraj Singh Chouhan has written to Prime Minister Manmohan Singh to intervene in state's favour.

India should put more resources to keep pace with global practices: de Acedo

C.H. Unnikrishnan — 20-Feb-2014

Etienne Sanz de Acedo speaks about the critical issues that India should address in the transformation phase

Onerous licensing regime killing legal digital music

TNN — 20-Feb-2014

Last Friday, one of four major legal music streaming services — Dhingana — shut down, leaving only Gaana.com, Saavn, and Hungama as the remaining digital music outlets broadcasting music from India for consumption in India and abroad. This follows another recent shutdown of Flyte, a music download service offered by Flipkart, a company that has raised over $200 million to date.

Ranbaxy, Teva settle claims in US

Agencies — 20-Feb-2014

Ranbaxy Laboratories and Israel-based Teva Pharmaceuticals have agreed to settle allegations levelled by New York state that the two rival generic drug makers made an unlawful agreement to restrict competition.

Ranbaxy, Teva Settle US Case Over Competition

OUR BUREAU NEW DELHI — 20-Feb-2014

Ranbaxy Laboratories, the largest India-based drugmaker, and Israeli generic drug giant Teva Pharma have reached a settlement with the New York Attorney General, which will end a 2010 pact between the two companies that “restricted competition” in the US market.

India has to indicate its position on certain aspects of IPR: Kiran Mazumdar-Shaw

Vidya Krishnan — 20-Feb-2014

Biocon head addresses issue of US lobbies demanding trade sanctions against India if it does not take a tough stand on intellectual property rights.

APEDA rues delay in traditional basmati growers' protection by MP govt

Shashikant Trivedi | Bhopal — 20-Feb-2014

Agricultural and Processed Food Products Export Development Authority (APEDA) on Thursday said that intervention of Madhya Pradesh government will unnecessarily delay the process of protecting "traditional" basmati rice growers of India.

‘Illegal e-purchase of pharma drugs a growing concern’

Sanjiv Shivadekar TNN — 22-Feb-2014

There are growing concerns in the state food and drug administration (FDA) over Maharashtra’s gradual rise as a hub for drugs sold overseas through illegal internet pharmacies.

India hardens stance against US Says Disputes Should Go To WTO, Officials To Skip Trade Body Meet

Sidhartha TNN — 22-Feb-2014

The government is set to ask all its officials to stay away from any interaction with a delegation from the US International Trade Commission (USITC), a quasi-judicial agency, probing the impact of India’s trade and investment regime on the American economy in what is seen as the latest sore point in economic ties between the two countries.

Apple, Samsung fail to reach settlement in US patent infringement case

ANI | Washington — 23-Feb-2014

The mediator's settlement proposal to the parties was unsuccessful

India-US ties are under stress again, this time over trade and investment

Sachin Parashar — 23-Feb-2014

US pharmaceutical companies like Pfizer have demanded that India amend its patents law by doing away with section 3(d) altogether.

India set to take on US over probe into IPR laws

Nayanima Basu | New Delhi — 24-Feb-2014

To deny visa to trade officials planning to scrutinise country's trade & industrial practices

US-India trade war worsens

Sachin Parashar TNN — 24-Feb-2014

India-US ties are again under stress—this time over trade and investment. There are calls in the US for designating India a Priority Foreign Country (PFC), the worst downgrading of status by the US Trade Representative for inability to protect intellectual property rights.

57 farm products enjoy GI status in India

Press Trust of India | New Delhi — 24-Feb-2014

Government has granted Geographical Indicator status to around 57 agricultural products such as Darjeeling tea, Pokkali rice and Dharwad Pedha in the last ten years.

India ready to take on US over patents at World Trade Organization

TNN — 25-Feb-2014

The government is readying for a fresh battle with the US at the World Trade Organization in the wake of the continued pressure over its intellectual property rights regime.

US, India must stop trading petty insults over various issues

ET Bureau — 25-Feb-2014

This is more substantive than the childish tantrums over cancelled or postponed visits to India of senior US officials in the wake of India's tough stance and childish retaliations against US embassy personnel over the US decision to prosecute Indian diplomat Devyani Khobragade.

India, US trade spat intensifies

Sidhartha TNN — 25-Feb-2014

Amid the ongoing trade spat, the government has advised deputy US Trade Representative Wendy Cutler to defer her planned trip to India next month in the view of the “flux” as well as the fiscal year-end commitments of officials.

US industry wants India designated Priority Foreign Country

PTI — 25-Feb-2014

Ramping up their anti-India campaign, an influential section of American businesses, in particular those from the pharma and manufacturing sectors, here on Monday urged the Obama Administration to designate India as a Priority Foreign Country.

Chinese firm awaits ruling in Apple Siri patent infringement lawsuit

Agence France-Presse — 25-Feb-2014

A Chinese company suing Apple over similarities between its product and the "Siri" personal assistant believes its case has merit and is awaiting a court ruling, a lawyer said Tuesday.

Patent laws safe from US challenge: India

Amiti Sen — 25-Feb-2014

India has said its patent laws cannot be successfully challenged by the US either in a bilateral or multilateral forum as they strictly comply with the intellectual property agreement of the World Trade Organization.

Drug Regulator Seen Failing US Quality Test

Divya Rajagopal — 26-Feb-2014

US drug regulator Margaret Hamburg’s recent visit to India has done little to clear the air about the quality of drugs manufactured by Indian companies and one reason for this may be India’s drug controller. There is a growing perception in the US that the drug regulator is unwilling to monitor the quality of drugs manufactured by the local companies, said Roger Bate of Washington DC-based think tank, the American Enterprise Institute.

Ranbaxy Suspends Shipment of Drug Ingredients from Two Plants

Our Bureau, New Delhi — 26-Feb-2014

Gurgaon-based drugmaker Ranbaxy Laboratories on Tuesday said it has suspended all shipments of drug ingredients produced at two of its India-based plants located at Dewas and Toansa ‘voluntarily’ to review processes and controls. The Punjab-based Toansa facility and Madhya Pradesh-based Dewas plant are already facing a ban from the US drug regulator on quality concerns

Apple asks Chinese court to overturn patent ruling

AFP — 27-Feb-2014

US technology giant Apple on Thursday asked a Beijing court to strike down a patent ruling by state authorities, as it fights an intellectual property battle with a Chinese firm.

Apeda moves patent board over order on basmati rice

Gireesh Babu | Chennai — 27-Feb-2014

The move by IPAB came amidst protests from rice producers, processors and the state govt of MP, against the Apeda's application for registration of basmati as GI in class 30 under the Geographical Indications of Goods (Registration & Protection) Act,

Applications for trademark on the rise

Bindu D Menon — 28-Feb-2014

The International Trademark Association (INTA) has said that the number of applications for trademark from India is on the rise, with more companies seeking brand protection.

Now, Geographical Indication rights for 'Tirupati laddu'

IANS | Hyderabad — 28-Feb-2014

Tirumala Tirupati Devasthanam (TTD), which runs the affairs of the richest Hindu temple, is enforcing Geographical Indication (GI) rights for its famous 'Tirupati laddu'.

Apple wins dismissal of $2.2-bn German patent suit

Bloomberg | Berlin — 1-Mar-2014

The rulings are a blow to Munich-based patent holding company IPCom, which has sued mobile-device makers over technology it acquired from Robert Bosch GmbH in 2007

Govt cautious on cancer drug patent regimes

Sidhartha — 1-Mar-2014

Amid heightened scrutiny of the intellectual property regime, the government has decided to tread with caution on a compulsory licence for a cancer drug to ensure that its decision is in line with the legal provisions.

Tirupati laddu gets stern with imitators

Our Bureau — 02-Mar-2014

Makers of clones or identically named versions of the Tirupati laddu, beware.

Innovation Incubator

Deepshikha Punj — 3-Mar-2014

In 2012-13, 94 patents were filed, and Indian trademark and design and copyright registered by the Institute, a rise of nearly 400 per cent from 2008-09, in which 19 were filed. In 2013-14, already 89 patents have been filed.

Bid to get GI tag for Tirunelveli 'halwa', Tuticorin macaroons

TNN — 3-Mar-2014

After 'Kancheepuram Silk', 'Madurai Malli' and Coimbatore wet grinders, makers of 'Tirunelveli Halwa', famous for its taste and long shelf-life and Tuticorin macaroons, an Indianised dish of European macaroons, are trying to get Geographical Indication tag.

Sequoia Looks to Exit GVK Bio

Sneha Shah — 3-Mar-2014

Venture capital fund Sequoia Capital is looking to exit its seven-year-old investment in GVK Group’s GVK Biosciences, a biotech research and development outsourcing company. The fund has appointed investment bank Avendus to look for buyers for its 20% stake in the company, said three people with knowledge of the development

Novartis Chief Rules out Merger with Rival Roche

Reuters Zurich — 3-Mar-2014

Swiss pharma group Novartis will work more closely with rival Roche but rules out a merger, its chairman said in a newspaper interview on Sunday. Asked whether the two companies wanted to stay independent, Joerg Reinhardt, who took over as Novartis chairman in August, told Swiss newspaper SonntagsZeitung: “Absolutely.”

Natco wins Indian patent dispute case

Special Correspondent — 03-Mar-2014

Natco Pharmaceuticals, the Hyderabad-based drug manufacturer, has won a patent case against Teva Pharmaceuticals of Israel.

Google, Samsung said to express Microsoft-Nokia concern to China

Steven Yang — 03-Mar-2014

Google, Samsung express concern that Microsoft’s bid to take over Nokia may result in higher patent licensing fees.

AstraZeneca Jumps 20% on Delisting Plan

Our Bureau, Mumbai — 4-Mar-2014

British drug maker AstraZeneca’s India unit has revived its plan of delisting the company from the stock markets, an announcement about which sent the company’s shares soaring 20% to hit the upper circuit on the BSE on Monday.

Outside the patent monopolies

Ritu Kamal — 4-Mar-2014

India’s role in pharmaceutical patent wars has broadened access to healthcare.

Cadila R&D unit served closure notice over pollution

Paul John TNN — 4-Mar-2014

The Gujarat Pollution Control Board (GPCB) has issued closure notices to the research wing of pharma major Cadila Healthcare— Zydus Research Centre (ZRC)—at Changodar on the outskirts of Ahmedabad. The notice was issued on March 1 after the company was found allowing waste water from its laboratories to percolate through a dead borewell into an underground aquifer.

Is the Indian patent regime weak?

4-Mar-2014

India's Patent Act is no weak IPR regime given its ability to scupper ever-greening bids through an innovation filter.

Anand Sharma accuses US of protectionism, says India's patent laws WTO compliant

Reuters — 04-Mar-2014

Says has approached finance ministry to ease gold import curbs

Foundation stone laid for Intellectual Property Appellate Board building in Chennai

Manish Raj — 04-Mar-2014

Supreme Court judge Justice F M Ibrahim Kalifulla has laid the foundation stone for a new building of the Intellectual Property Appellate Board (IPAB) at Kelambakkam on the outskirts of Chennai.

India must call the US' bluff on patents

Arvind Panagariya — 04-Mar-2014

Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors.

Sanofi files cases against Glenmark on patent infringement

PTI — 05-Mar-2014

French drug-maker Sanofi filed patent infringement petition against Glenmark on cardiac drug Multaq, in the district court of Delaware, on three counts.

India’s IPR regime in line with global pacts: Sharma

Times News Ntework — 5-Mar-2014

The government on Tuesday said its laws on intellectual property were fully in line with global agreements and rejected arguments that New Delhi had not followed global practices.

PSU Insurers may Stay Out of GSK Open Offe

Dheeraj Tiwari & Soma Das, New Delhi — 5-Mar-2014

State-run financial institutions Life Insurance Corporation, General Insurance Corporation of India and Oriental Insurance are unlikely to take part in UK drug maker GlaxoSmithKline’s ongoing open offer to shareholders of its Indian subsidiary GlaxoSmithKline Pharmaceuticals.

Sharma Accuses US of Trade Protectionism

Our Bureau, New Delhi — 5-Mar-2014

Commerce and industry minister Anand Sharma on Tuesday accused the United States of protectionist trade policies while asserting that India’s trade and intellectual property rights are compliant with the respective multilateral regimes.

Patent attorneys demand fair deal for Indian applicants

A Subramani — 5-Apr-2014

Highlighting a major anomaly in the Indian Patents Act, 1970 which provides for fast-track award of patent to foreign entities, attorneys specializing in patents have demanded similar facility for individuals and companies from India as well.

Targeting India’s IP laws undermines WTO’s legitimacy’

PTI — 6-Mar-2014

A Geneva-based inter-governmental organisation of developing countries has slammed America and developed world countries for pressurising India over its IP (intellectual property) laws, which it alleged undermines the legitimacy of WTO.

Patent filing fees doubled for cos, up 60% for individuals

Rupali Mukherjee — 6-Mar-2014

Invention and innovation will now cost more.

Now, Indian industry raises its voice against US

Nayanima Basu | New Delhi — 06-Mar-2014

High chances that US in its Special 301 report will put India as 'Priority Foreign Country'

U.S. fears for patents on next-generation drugs in India

Douglas Busvine and Zeba Siddiqui — 06-Mar-2014

The United States on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on patent.

Patent office issues draft pharma norms

C.H. Unnikrishnan — 7-Mar-2014

The guidelines are aimed at minimizing the risk of patent litigations of the kind that Novartis AG fought for seven years over its cancer drug Glivec.

Sun Pharma Seeks to Enter Japan Via Buys, Deals

REUTERS — 07-Mar-2014

Sun Pharmaceutical Industries, India’s biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of low-cost drugs, a senior executive said.

Seed savers network formed to fight intellectual property rights by corporations

Jayashree Nandi — 07-Mar-2014

Farmers from 15 states are all set to form a national seed savers network that will be one of the largest repositories of seeds for crops and vegetables in India.

MNC buys Mangalore fisheries college's patent

Staff Correspondent — 8-Mar-2014

In a major boost for the research capabilities of the College of Fisheries in Mangalore city, its patent on a shrimp disease testing kit will be sold to a private multinational company for mass distribution.

A flimsy case against Indian pharma

Mike Palmedo — 09-Mar-2014

Much of the controversy surrounds flexibilities in Indian patent law designed to promote access to generic medicines.

U.S. pharma companies benefit from large Indian generic market

Ramnath Subbu — 9-Mar-2014

The tirade by the U.S. against India with regard to its ‘unfriendly’ business environment, particularly the Indian pharmaceutical sector, is largely misplaced according to the Indian Pharmaceutical Alliance.

Cipla may put patent for new HIV drug in open access pool

C.H. Unnirkishnan — 10-Mar-2014

Cipla says product under development, doesn’t have a time frame for completion as yet

GSK pays $1bn to up stake in Indian arm to 75% from 50.7%

Times News Ntework — 11-Mar-2014

GlaxoSmithKline Plc has increased its stake in its Indian pharma subsidiary, GlaxoSmithKline Pharmaceuticals, from 50.7% to 75%, following a recent open offer. The company announced that the subsidiary will remain publicly-listed. The offer of Rs 3,100 per share values the transaction at approximately Rs 6,400 crore ($1 billion).

Indian patent laws sound, unchallenged: Drug companies tell US International Trade Commission

Soma Das — 11-Mar-2014

The commission, a quasi-judicial body set up by the US Congress, is investigating whether Indian policies discriminate against American manufacturers and is due to submit its views later this year.

Clinical trials: SC asks govt to give details on deaths

Agencies — 11-Mar-2014

he Supreme Court on Monday directed the Centre to provide details on the number of deaths and severe adverse effects caused to people who were subjected to clinical trials.

Indian patent laws sound, unchallenged: Drug companies tell US International Trade Commission

Soma Das — 11-Mar-2014

The World Health Organization has strongly endorsed India's patent laws and no country, including the United States, has challenged these laws at the WTO claiming that these infringe trade-related intellectual property rights, Indian drugmakers have told the US International Trade Commission.

Sun Pharma recalls batch of drug in US

Times News Ntework — 11-Mar-2014

Following Ranbaxy’s drug recall in the US, another domestic company, Sun Pharma has recalled 2,528 bottles of its generic version of diabetes drug Glumetza.

How to strengthen India's case on intellectual property rights

ET Bureau — 12-Mar-2014

New Delhi is well within its rights to rebuff the US pharma lobby's attempt to label India a habitual intellectual property rights offender.

US and India could accomplish a lot together: Obama

Chidanand Rajghatta,TNN — 12-Mar-2014

India's new ambassador to the United States, Dr S Jaishankar, presented his credentials to President Obama at the White House on Monday in a formal ceremony at which the American President essayed an anodyne ''the U.S and India could accomplish a lot together,'' at a time New Delhi has largely fallen off Washington's radar, in part because of India's pre-occupation with the general elections.

Strand Lifesciences’ virtual liver gets US patent

Our Bureau — 12-Mar-2014

Strand Lifesciences has received a US patent for virtual liver, which would aid the pharmaceutical industry in understanding liver-related issues better.

The thorn in India-US business ties

Arvind Subramanian — 12-Mar-2014

As the Office of the US Trade Representative (USTR) turns its lens on India's intellectual property and patents regime, Business Standard brings you what Arvind Subramanian, columnist and economist,

Big Pharma still betting on "messed up" Indian drugs market

Ben Hirschler and Zeba Siddiqui — 12-Mar-2014

Global drugmakers have had a nauseous time in India's $14 billion market.

How to strengthen India's case on intellectual property rights

ET Bureau — 12-Mar-2014

New Delhi is well within its rights to rebuff the US pharma lobby's attempt to label India a habitual intellectual property rights offender.

Drug makers pump up injectables as US patent cliff looms

Pallavi Ail — 13-Mar-2014

Indian and foreign generic drug makers seem to focus increasingly on the relatively fast-growing injectables segment to ramp up their revenues.

US firms like Honeywell and Boeing, professors back India on patent regime

Dilasha Seth — 14-Mar-2014

Leading US companies such as Honeywell and Boeing, and professors of US universities have backed India before the US by shopping-chip"

FICCI lambasts US for pressurising India to increase IPR protection beyond TRIPS

Our Bureau, Mumbai — 14-Mar-2014

The Federation of Indian Chambers of Commerce and Industry has taken strong exception to the effort being made by the US to declare India as 'Priority Foreign Country' under the Special 301 provisions of the US Trade Act of 1974.

Google unmasks patent accuser

Bloomberg | Washington — 14-Mar-2014

Google Inc wanted to find out who was behind a company called Suffolk Technologies LLC that accused the world's largest search engine's owner of using its internet-search technology without permission.

India undermining intellectual property: Pfizer

PTI — 14-Mar-2014

Months after its patent for a cancer medication was revoked by India, American firm Pfizer has told US lawmakers that New Delhi is undermining intellectual property by misuse of its compulsory licence provisions.

On intellectual property, a new strategy

Meir Perez Pugatch — 17-Mar-2014

India could use IP rights to take its rightful place as a leader in global innovation.

Google, Viacom Settle YouTube Copyright Suit

PTI - NEW YORK — 18-Mar-2014

Google and Viacom announced a settlement today in a long-running lawsuit claiming the Internet giant's YouTube video-sharing site promoted copyright infringement.

US leads the world in use of compulsory licenses: KEI

PTI — 20-Mar-2014

While the US Government and strong American pharma sector have been up in arms against India for issuing compulsory licence in the sector, an eminent global non-governmental organisation has said that it is the United States which leads the world in use of compulsory licenses.

Merck HIV drug strategy in India seen shielding patent

Ketaki Gokhale — 20-Mar-2014

Merck is set to sell an HIV medication in India by mid-year in partnership with local company Cipla

Indian Data Comes in Handy for US Tirade against Sub-standard Drugs

Our Bureau, New Delhi — 20-Mar-2014

About 2.3% of drugs tested by the Drug Controller General of India (DCGI) since December 2012 were found to be sub-standard. As many as 1,123 samples were tested of which 26 failed to qualify, according to a surveillance report prepared by the central drug regulator early this month.

Quality Woes Point to a Generic Drugs Shake-out: Novartis CEO

Ben Hirschler & Caroline Copley, Basel, Switzerland. — 21-Mar-2014

Recent manufacturing problems in India suggest some makers of generic drugs will struggle to compete in the face of a rising quality bar, pointing to a likely shake-out in the low-cost sector, according to Novartis. Chief executive Joe Jimenez said the Swiss group’s Sandoz unit — a world leader in making cheap off-patent medicines — was well placed to thrive in an era of tougher standards.

Pharma firm gets FDA notice

Maitri Porecha — 21-Mar-2014

Drug authority issues notices to Wockhardt’s three plants in Aurangabad and seeks explanation on poor compliance with good manufacturing practices.

Apple's new patent hints at stylus for iPad

Techradar — 21-Mar-2014

Apple's latest patent is titled simply "Input Device Having Extendable Nib," but don't let that fool you; this may be the long-awaited iStylus.

Health organisations demand affordable access to oral HCV drugs; oppose patent on new hepatitis C drug

Our Bureau — 22-Mar-2014

With the availability of oral drugs promising to simplify and improve hepatitis C treatment in India, the Delhi Network of Positive People wants the ministry of health to start rolling out treatment with the same, for the millions of patients waiting.

IPAB to take up Wockhardt plea against Novartis

Gireesh Babu | Chennai — 22-Mar-2014

A patent infringement case between the two over a diabetes drug is pending with the Delhi HC.

Indian pharma sector still attractive for foreign investors

C.H. Unnikrishnan — 23-Mar-2014

Section 3(d) of India’s patent law that denies patent protection for modified forms of already known drugs, unless they are proved to result in higher therapeutic benefits, has irked many foreign drug makers.

Changes to India's patent law will impact prices of life-saving drugs

Rupali Mukherjee — 23-Mar-2014

India's trade and investment policies, particularly balancing right to health with intellectual property and public health safeguards, are being questioned in a US investigation.

India ready to discuss intellectual property rights norms at WTO if US wants: Anand Sharma

PTI — 23-Mar-2014

Rejecting US allegations related to intellectual property rights (IPR), India said that it is ready to discuss the matter at WTO as it has not breached any international agreement.

Friction over drug patents

24-Mar-2014

Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India’s economic relations with the U.S.

Delay in Microsoft deal may lead to more Nokia patent concessions

Reuters — 24-Mar-2014

Nokia does not expect to close the sale of its phone business to Microsoft until April as talks with Asian regulators drag on, it said on Monday, fuelling speculation it may have to make technology patent concessions to get the deal done.

IPAB to take up Wockhardt plea against Novartis

Gireesh Babu | Chennai — 25-Mar-2014

The Intellectual Property Appellate Board (IPAB) has decided to proceed with the hearing of a revocation petition by Wockhardt against the patent of a diabetes drug of Swiss pharma major Novartis, even as a dispute between the parties on an alleged infringement of patent of the same product is pending with the Delhi High Court.

Plea against Gilead's patent bid

TNN — 25-Mar-2014

A patient group and a UK-based intellectual property law firm have together filed a patent opposition before the Delhi Patent Office to prevent US-based pharma company Gilead from gaining protection on a life-saving hepatitis-C drug in India.

Indian generic drug firms court US off-patent market

Pallavi Ail — 25-Mar-2014

With $32 billion worth of drugs going off patent in the next two years.

Apple wins another legal bout against Samsung in patent row

ANI | Washington — 26-Mar-2014

Samsung said it will analyze the decision and possibly appeal it

Patent seal on device to check vehicle pollution

Abhijeet Patil — 26-Mar-2014

A motor mechanic from Tardel, a non-descript village around 30km from Kolhapur, has earned the patent for a device developed by him, which he claims can bring down fuel consumption in both two- and four-wheelers.

IPAB stays revocation of Pfizer's patent on drug Detrol

Gireesh Babu | Chennai — 26-Mar-2014

Justice K N Basha says that Ranbaxy had enough time to appear and argue the matter of stay petition

Apple wins patent ruling against Samsung in Japan

ANI — 26-Mar-2014

Apple has won another legal bout against Samsung in its ongoing patent row.

Patent opportunis

Feroz Ali Khader — 27-Mar-2014

India’s trailblazing balance of patent law and necessary access falls foul of an IP index released by US companies.

Cheaper Versions of Cancer Drug Dasatinib Will Have to Wait

Dilasha Seth & Soma Das, New Delhi — 27-Mar-2014

The department of industrial policy and promotion (DIPP) has shot down a health ministry proposal to consider a government-initiated compulsory licence (CL) for cancer drug Dasatinib on the ground that it is unaffordable. This comes at a time when the US is reviewing India’s intellectual property regime that, in the worst case, could lead to trade sanctions.

New-age zamindars

Bhupesh Bhandari | New Delhi — 27-Mar-2014

Thanks to the regime of product patents India inherited, home-grown companies like Cipla found their attempts to make medicines blocked by multinationals.

Cisco sued by Spherix for patent infringement

Reuters — 27-Mar-2014

Spherix Inc, which buys and licenses technology patents, said it filed a lawsuit against Cisco Inc alleging infringement of 11 patents Spherix acquired from Nortel Networks.

Corning joins growing US firms doing business in India

Yashwant Raj — 28-Mar-2014

They had heard harrowing stories about infrastructure, bad patent laws.

First Case: Ed Seizes Assets for Faking SAIL Trademark

PTI - NEW DELHI — 28-Mar-2014

In the first case of money laundering charges being slapped for violation of the Trade Marks Act in the country, the Enforcement Directorate has seized Rs 7 crore assets of two Chhattisgarh based firms for allegedly fake branding of public sector SAIL.

In trademark battle, TN co beats US clothing giant

Manish Raj — 29-Mar-2014

In another example of David trouncing Goliath, an Erode-based hosiery manufacturer has humbled a US clothing giant by staving off a trademark infringement suit.

Patent trolls target US businesses, consumers ultimately foot the bill

Heesun Wee — 31-Mar-2014

Patent asserting groups that bully businesses and entrepreneurs into paying licensing fees or settlements—as opposed to actually using the patents—are not new, especially in the technology space.

US Supreme Court to scrutinise eligibility of software for patent protection

Reuters — 31-Mar-2014

The U.S. Supreme Court will on Monday delve into the hotly contested question of when software is eligible for patent protection.

Intellectual property office mops up 282cr despite staff crunch

A Subramani — 31-Mar-2014

Despite battling severe staff crunch and requiring critical infrastructure, the intellectual property office has mopped up more than Rs 282 crore in revenue for 2012-13.

Copyright Suit Against Bieber, Usher Dismissed

AP - NORFOLK, VIRGINIA — 01-Apr-2014

A judge has dismissed a $10 million lawsuit that claimed Justin Bieber and Usher copied parts of a song written by two Virginia songwriters.

Apple and Samsung trade barbs as new patent trial opens

AFP — 2-Apr-2014

Lawyers for Apple and Samsung exchanged barbs as a major new patent trial opened Tuesday, and debated the role of a company not even part of the case. Google.

Natco Pharma, Teva Patent Row Now in US Court

ENS Economic Bureau - HYDERABAD — 2-Apr-2014

Natco Pharma Ltd’s plan to sell multiple sclerosis drug Copaxone is likely to be further delayed with the patent battle between Natco and the innovator company Teva Pharmaceutical Industries Ltd among others, entering a new phase.

Chipmaker Marvell fined $1.54 billion over patent violation

Reuters — 2-Apr-2014

A federal judge ordered Marvell Technology to pay nearly $1.54 billion to Carnegie Mellon University for selling billions of semi-conductors that infringed the school's two hard disk drive patents.

GI tags stopped as poll code is in force

R. Sivaraman — 2-Apr-2014

The tags help identify goods — originating from a definite territory — with special characteristics

Samsung puts 'blame' on Google in Apple patent trial

AP — 2-Apr-2014

Samsung fired back at Apple's accusations of patent theft, saying the South Korean tech giant didn't write any of the Android software on its smartphones and tablets, Google did.

Compulsory licence for another cancer drug?

Amiti Sen — 2-Apr-2014

DIPP wants to know why generic version of Bristol-Myers Squibb’s drug is needed

Novartis sues Biocon for patent infringement on Galvus

Archana Shukla, CNBC-TV18 — 03-Apr-2014

In yet another patent infringement battles in India, Swiss drug maker Novartis has taken Indian biotech firm Biocon to court on anti-diabetes drug.

PE ChrysCap invests $40m in Torrent Pharma

Rupali Mukherjee TNN — 3-Apr-2014

Private equity firm ChrysCapital has invested around $40 million in drug company Torrent Pharma, expanding its portfolio of healthcare companies and taking up the total exposure in the sector to nearly $300 million. ChrysCapital, which has over $2.5 billion assets under management in India, will hold the largest non-promoter stake — of around 3% — in the drug firm, sources close to the development told TOI.

Torn Records Led to Sun Plant’s Ban

Soma Das, New Delhi — 3-Apr-2014

Torn documents, partially destroyed raw data showing undesirable results and unclean toilets were among the reasons cited by the US drug regulator for the ban it imposed last month on a Gujarat based facility of Sun Pharma, the largest Indian drugmaker by market capitalisation.

Lupin Approaches Cabinet Secy to Push FII Cap Proposal

Deepshikha Sikarwar & Soma Das, New Delhi. — 3-Apr-2014

Lupin has approached the nation’s senior most bureaucrat, seeking his intervention to secure approval to increase foreign institutional investor (FII) holding in the pharmaceutical major to 49% from 33%, according to a person with knowledge of the matter.

IPAB defers hearing on trademark dispute between Diageo, Khoday

BS Reporter | Chennai — 03-Apr-2014

Dispute is on Khoday Brewing's registration of 'Black Label' for beer

Samsung: Patents Developed by Google Engineers

AP — 03-Apr-2014

Samsung fired back at Apple's accusations of patent theft Tuesday, saying the South Korean tech giant didn't write any of the Android software on its smartphones and tablets, Google did.

Novartis sues Biocon for patent breach

BS Reporter | Zurich — 4-Apr-2014

According to industry estimates, Galvus, one of the best-selling medicines of Novartis, clocks Rs 200 crore of sales annually

Biocon rejects Novartis patent accusations

AFP — 04-Apr-2014

Biocon has a reputation for respecting all valid intellectual property and intends to operate within the applicable laws, the firm said

Poll fever cure: Ragaflam, Namo tablets fly off pharmacy shelves

Rahul Anand TNN — 5-Apr-2014

As election fever grips the country, Namo and Ragaflam tablets, named after BJP’s Narendra Modi and Congress’s Rahul Gandhi, are flying off pharmacy shelves. Neither Modi nor Rahul may have all the answers to what ails the nation, but generic drugs named after them are certainly getting people’s votes.

Apple loses bid to show patent use in trial

Bloomberg | San Jose/ California — 5-Apr-2014

Apple Inc, accusing Samsung Electronics Co of misleading jurors at the start of a $2-billion trial over smartphone technology, lost its bid to show jurors how it uses three of five patents disputed in the case.

US Patents rejects Teva's plea on Copaxone; Natco shares up

ET Bureau. — 5-Apr-2014

The US Patent and Trademark Office has rejected the application of Israel's Teva Pharmaceutical seeking re-issue of patent for its blockbuster multiple sclerosis drug Copaxone.

Teva's patent plea rejected in US: Natco

TNN — 7-Apr-2014

Hyderabad-based Natco Pharma said on Friday in a BSE filing that the US Patent and Trademark Office has issued a final office action rejecting Israel-based Teva Pharma's application on its blockbuster drug Copaxone.

BlackBerry wins patent lawsuit against NXP in the US

Reuters — 08-Apr-2014

A federal jury in Florida on Monday ruled in favor of Blackberry Ltd in a lawsuit accusing the company of infringing three patents belonging to Dutch semiconductor company NXP BV.

Court relief on NTT Docomo’s patent plea for network tech

Sajan C Kumar | Chennai — 08-Apr-2014

In a major relief to Japan-based telecommunication major NTT Docomo

Popular Ghee Brand Loses Trademark

Express News Service - CHENNAI — 09-Apr-2014

The Intellectual Property Appellate Board cancelled the trademarks ‘Udhayam’ and ‘GRB’s Udhayam’ of a popular ghee brand in the southern States in an order passed by the board on Friday.

Rovi loses patent fight with Amazon

Reuters — 09-Apr-2014

Rovi has lost a patent fight with Amazon.com when a federal appeals court upheld a US district judge's ruling in favour of the world's largest online retailer.

Samsung should pay over $2 bln for patent infringement: Apple

ANI | Washington — 09-Apr-2014

The figure comes from evaluating the scale of infringement, time span and the head-to-head rivalry between Apple and Samsung

D-St questions Ranbaxy spike

Times News Ntework — 10-Apr-2014

The 33% rise in Ranbaxy’s stock in just six days prior to the announcement of its merger with Sun Pharma has come under public scrutiny, raising pressure on market regulator Sebi to dig deeper into the trading patterns in the counter for any possible violations of securities laws.

ONE-ON-ONE Israel Makov | CHAIRMAN, SUN PHARMA

Rupali Mukherjee TNN — 10-Apr-2014

Admitting there are “challenges” in every acquisition, and even in this one, Sun Pharma chairman Israel Makov expressed confidence in handling them, including the sticky FDA issue which has been plaguing Ranbaxy over the past six years. In an interview with TOI, he said the company will reconsider whether it wants to use the Ranbaxy brand in the US — its largest and most lucrative market, and where it has faced a huge distrust. On the manpower front, he said the plan is to keep everyone who is good. Excerpts…

SUN-RANBAXY DEAL: Pharma MNCs May Need New Prescription for Growth Here

Divya Rajagopal — 10-Apr-2014

Sun Pharmaceutical’s acquisition of Ranbaxy Laboratories, the largest consolidation move in the Indian market, may force multinational pharmaceutical companies to change their strategy considering that the combined entity will become the country’s largest drug maker and the fifth-largest generic company in the world. It will command a turnover of $4 billion globally, while in India it will have estimated sales of . 6,921 crore

Natco seeks to block Gilead's hepatitis C drug patent in India - source

Zeba Siddiqui — 10-Apr-2014

India's Natco Pharma Ltd (NATP.NS) has formally asked the Indian patent office to deny U.S. drugmaker Gilead Sciences Inc's (GILD.O) new hepatitis C drug Sovaldi a patent in India, a source with direct knowledge of the matter said.

SAIL encashes bank guarantees of re-rollers misusing its trademark

ENS Economic Bureau | New Delhi — 10-Apr-2014

Over more than a year, SAIL has been receiving tip-offs that spurious steel products bearing its trademark have flooded marketsmarkets across the country.

Sun Pharma Refutes Allegations of Insider Trading Ahead of Ranbaxy Acquisition

Our Bureau, Mumbai. — 10-Apr-2014

Sun Pharma on Wednesday refuted allegations of insider trading by Sudhir Valia, the executive director and brother-in-law of managing director Dilip Shanghvi, in the run-up to the Ranbaxy deal.

Natco seeks to block Gilead’s drug

REUTERS — 11-Apr-2014

Natco Pharma has formally asked the Indian patent office to deny US drug maker Gilead Sciences’ new Hepatitis C drug Sovaldi a patent in India, a source with direct knowledge of the matter said. If successful, the move could clear the way for the Indian company to launch a cheap generic version of the drug.

Experts highlight importance of intellectual property rights

TNN — 11-Apr-2014

Protecting intellectual property right is very important.

Natco moves to oppose Gilead hepatitis C drug patent

Ramnath Subbu — 12-Apr-2014

Under India’s patent laws, a third party can dispute the validity of a pending patent application.

Are intellectual property and patent laws hampering innovation, research and development?

Ruchi Kumar — 14-Apr-2014

With over 200,000 filings, 2013 saw the highest intellectual property applications, says UN report.

FICCI discusses IPR issue with US delegation

PTI — 14-Apr-2014

Industry body FICCI today raised the issue of US proposal to declare India as a ‘Priority Foreign Country for IPR violations with a visiting delegation of American companies.

Are intellectual property and patent laws hampering innovation, research and development?

Ruchi Kumar — 14-Apr-2014

With over 200,000 filings, 2013 saw the highest intellectual property applications, says UN report.

Indian patent and pharma laws should not be considered discriminatory: Public Citizen

PTI — 15-Apr-2014

Asserting that Indian patent and pharma laws falls within the bounds of what is allowed under the rules of the World Trade Organization, a top American non-profit consumer rights advocacy group has said Indian pharma laws should not be considered discriminatory.

Cadila, Depomed settle US patent dispute on neuro pain drug Gralise

C.H. Unnikrishnan — 15-Apr-2014

Cadila can now launch its generic version of Gralise in the US soon after the expiry of Depomed’s original patent.

Novartis Sues Dr Reddy's Labs Over Patent Infringement

ENS Economic Bureau - HYDERABAD — 15-Apr-2014

Novartis Pharmaceuticals Corporation moved the District Court of Delaware, US against city-based Dr Reddy’s Laboratories Ltd (DRL) for alleged infringement of its patents.

Indian laws should not be considered discriminatory: Group

Press Trust of India | Washington — 15-Apr-2014

NSE alleges software trademark violation; sues domain registrar

Khushboo Narayan | Malvika Joshi — 15-Apr-2014

The firm drags GoDaddy and a Hyderabad-based tech firm to court over alleged copyright and trademark infringement of its software.

Cadila, Depomed Inc settle patent dispute

BS Reporter | Ahmedabad — 15-Apr-2014

The settlement permits Cadila and Zydus to begin selling generic versions of Gralise

‘Patent laws for IT sector needs clarity’

Our Bureau — 16-Apr-2014

The need for clearer regulations with regard to patents for computer-related inventions was underlined by experts at the two-day executive programme on Strategic Intellectual Property Management for Electronics and IT Sector, which began here today.

Apple-backed patent group Rockstar loses bid to move Google case

Reuters — 18-Apr-2014

A US judge on Thursday rejected a request by patent consortium Rockstar to transfer patent litigation from Google's home turf in California to Texas, according to a court ruling.

Insecticides (India) gets patent for insecticide preparation process

PTI — 18-Apr-2014

Agrochemical firm Insecticides (India) Ltd has been granted a patent for the preparation process of a chemical compound to control pests.

Committee of secretaries to take up Indo-US IPR issues

fe Bureau | New Delh — 19-Apr-2014

A committee of secretaries, led by cabinet secretary Ajit Seth, will meet next week to discuss the issues related to India’s intellectual property rights and the concerns raised by the US on the same.

On Mobile settles patent infringement dispute with US firm

Agencies — 19-Apr-2014

Mobile VAS company OnMobile has settled a patent infringement case with US-based Synchronoss Technologies for $ 3 million or about Rs 18 crore.

Patent rights meet on US concerns

BS Reporter | New Delhi — 19-Apr-2014

Cabinet Secretary Ajit Seth will on Monday meet officials from various ministries to discuss concerns raised by the US on India’s management of intellectual property rights (IPRs), it is learnt.

India-US ties headed for rough weather over drug IP issue

Amiti Sen — 20-Apr-2014

Facing the threat of sanctions by the US for what it terms India’s lax intellectual property (IP) rules, the Commerce Ministry is studying the possible impact on trade with the US if Washington goes ahead with its action.

We need to open up defence 100 pc to FDI: Amitabh Kant, DIPP secretary

ET Bureau — 21-Apr-2014

Compulsory licensing has been over talked about.

Boost for Natco Pharma as Teva denied stay in Copaxone patent fight

Lawrence Hurley — 21-Apr-2014

US Supreme Court denies Teva’s request to stay ruling that favours developers of generic versions of Copaxone.

Glenmark loses patent case to Abbott; stock plunges

R. Yegya Narayanan — 22-Apr-2014

Shares of Glenmark Pharmaceuticals were down by Rs 17.45 on the BSE after the company said it has lost its appeal to invalidate Abbott Laboratories' Tarka (trandolapril/verapamil hydrochloride) patent in a US court.

Govt prepares to battle US pressure on patents

Nayanima Basu | New Delhi — 22-Apr-2014

Top officials meet amid apprehension of sanctions under US law; decide to take Washington to the World Trade Organization if such action taken.

Samsung files 'patent-infringement' suit against Apple

ANI — 22-Apr-2014

Samsung has filed a 'patent- infringement' case against Apple saying that the American multinational infringed the '239 patent in its iPhone through the use of FaceTime.

Glenmark Pharma drops after losing appeal to invalidate Abbott's TARKA patent

Capital Market — 22-Apr-2014

Key benchmark indices trimmed intraday gains in early afternoon trade.

India businesses unlikely to be affected immediately

HT Correspondent — 23-Apr-2014

While Novartis AG, GlaxoSmithKline and Eli Lilly are unclear about the long-term impact of deal on their India businesses, there is unlikely to be any direct or immediate impact.

Abbott wins patent battle against Glenmark

BS Reporter — 23-Apr-2014

US-based Abbott Labs has won a patent battle against Glenmark Pharmaceuticals related to generic launch of Abbott's version of anti-hypertension drug, Tarka ((trandolapril/verapamil hydrochloride).

Ericsson takes Intex to court over patent infringement

Staff Reporter — 24-Apr-2014

The Swedish-based company moved the Delhi High Court last week, saying that it was taking legal action after failing to negotiate a licence agreement with Intex for "products compliant with GSM, EDGE, and UMTS/WCDMA standards.

Pfizer complains about India’s intellectual property regime again

Soma Das — 24-Apr-2014

In a letter to Jaishankar, India's Ambassador to the US a copy of which was seen by ET, Pfizer's senior vice-president for global policy and international public affairs, Justin McCarthy, has said that "a series of regulatory initiatives and legal challenges have frayed relations between the Indian government and global pharmaceutical firms", and urged the government to "shift from using destructive IP policy as an access strategy"

United States’ 1999 assurance to WTO may help India’s IPR case

Dilasha Seth & Soma Das — 25-Apr-2014

An undertaking given by the United States to a WTO dispute settlement panel on unilateral trade action in 1999 may prove to be an important ammunition in New Delhi's hands if the Obama administration takes action against India on its intellectual property regime.

Not facing any significant IPR challenges in India: Abbott

Press Trust of India | Washington — 25-Apr-2014

They added that India was an investment priority and fundamentally important to the future of the company.

U.S. appeals court revives an Apple patent lawsuit against Google

Diane Bartz and Dan Levine — 25-Apr-2014

A U.S. appeals court on Friday revived patent claims Apple made against Google subsidiary Motorola Mobility that were dismissed by an Illinois court shortly before trial.

Nude patent heels must-have fashion!

IANS — 25-Apr-2014

Nude court shoes are storming up the fashion charts - thanks to the Duchess of Cambridge, who has made them a must-follow trend.

US envoy raises IPR, taxation issues with India

Nayanima Basu | New Delhi — 25-Apr-2014

US had been extremely critical of some of India's trade and industrial policies.

India: Robin Hood of the pharma world

Feroz Ali Khader — 25-Apr-2014

India’s pro-consumer patent regime is an exciting alternative to the dominant IP model pushed by the US

India's pharma export growth hits a 15-year low as US holds on to import curbs

25-Apr-2014

Hit hard by the continuing row over intellectual property rights related to generic equivalents of some patented medicines and regulatory concerns in the West over the quality of India-made drugs, pharmaceutical exports from the country registered the slowest growth in at least 15 years of 1.2 per cent to $14.84 billion last fiscal.

Innovation that includes

Shamnad Basheer — 26-Apr-2014

The pharmaceutical industry needs to shed its archaic blockbuster model.

U.S. envoy calls on India to engage in discussions regarding intellectual property rights

ANI | New Delhi — 26-Apr-2014

U.S. Ambassador to India, Nancy Powell, has asked India to engage in discussions related to Intellectual Property Rights (IPR).

Geological Indications tag for Nagpur orange, Kannauj perfume

A Subramani — 26-Apr-2014

Intellectual Property Right (IPR) Day is observed on April 26. But the celebrations seem to have reached India a day early.

Ballot Petty' and 'Netamaker' Slug It out over IP Rights

Nidheesh M K - KOCHI — 26-Apr-2014

It’s raining apps in Kerala as many companies in the state, both big and small, have developed applications in Android and other platforms; so do controversies.

American drug major Abbott backs India’s drug patent regime

Sidhartha — 26-Apr-2014

The government has received support from an unexpected quarter in its battle against the US on the intellectual property (IP) regime.

Step up patent awareness drive

Our Bureau — 27-Apr-2014

There is an urgent need to create IP awareness to augment domestic filing of IP applications, said Amitabh Kant, Secretary, Department of Industrial Policy and Promotion, Ministry of Commerce and Industry.

New Apple patent seeks to prevent drivers from texting

PTI — 27-Apr-2014

American tech giant Apple has filed a patent application for a system that aims to make texting at the wheel impossible by blocking drivers from sending messages on cell phones.

India strikes a balance on IPR regime

Sudipto Dey | New Delhi — 27-Apr-2014

As India awaits the outcome of Special 301 report brought out by the office of the US Trade Representative, an annual survey of countries with lax intellectual property rights regime, the administration is getting ready to set its own IPR house in order.

Apple patent lawsuit against Google revived by US appeals court

Reuters — 28-Apr-2014

A U.S. appeals court on Friday revived patent claims Apple made against Google subsidiary Motorola Mobility that were dismissed by an Illinois court shortly before trial.

Govt Urged to Encourage Patents

Express News Service - CHENNAI — 28-Apr-2014

Intellectual Property Rights (IPR) is the next milestone in services sector revolution that’s being engineered by the middle class, said P Vanangamudi, Vice-Chancellor, Tamil Nadu Dr Ambedkar Law University.

HC asks Centre to reply on appointments in patents panel IPAB

PTI — 28-Apr-2014

The Delhi High Court on Monday sought a response from the Centre on a plea seeking quashing of certain provisions that lay down criteria for appointment of Vice Chairman and the judicial member of the patents' panel.

Apple patents technology to prevent texting and driving

Agencies — 28-Apr-2014

American tech giant Apple has filed a patent application for a system that aims to make texting at the wheel impossible by blocking drivers from sending messages from cellphones.

Aurobindo Pharma in patent litigation cases in US

PTI — 28-Apr-2014

Three multinational drug makers take Aurobindo to court in separate cases

Apple, Samsung set for closing arguments in patent trial

AP — 28-Apr-2014

The high-stakes battle between the world's largest smartphone makers is scheduled to wrap up this week after a month-long trial that has pulled the curtain back on just how very cutthroat the competition is between Apple and Samsung.

Alibaba on Patent-Buying Spree May Avoid Tech IPO Pitfall

Susan Decker — 29-Apr-2014

Alibaba Group Holding Ltd. is beefing up its patent holdings in the U.S., a move that may help avoid the pitfalls that bedeviled Google Inc., Facebook Inc. and Twitter Inc. ahead of their initial public offerings.

There is a rush for patents

Madhumathi D. S. — 29-Apr-2014

Karnataka working on a new intellectual property policy

AstraZeneca rejects Pfizer’s 2nd $100bn offer

Reuters — 29-Apr-2014

US drugmaker Pfizer is working on its next move in a potential $100 billion battle for Britain’s AstraZeneca after having two bids rejected, as deal-making grips the healthcare industry. Pfizer said on Monday it made a 59-billion pounds ($99 billion) bid for AstraZeneca in January and had contacted its British rival again on April 26 seeking further discussions about a takeover.

Novartis files injunctions against 4 cos

Times News Ntework — 29-Apr-2014

Drug MNCs are aggressively guarding their home turf and taking measures to safeguard against competition. Novartis has filed injunctions in the Delhi high court against four generic companies including Glenmark Generics, Cadila Healthcare, Alembic Pharma and Bajaj Healthcare, preventing them from launching generic versions of its blockbuster anti-diabetic drug Galvus (Vildagliptin).

Europe warns Google, Samsung on phone patent abuse

AP — 29-Apr-2014

The European Commission moved on Tuesday to stem aggressive patent lawsuits by smartphone and tablet makers against rivals, ruling that Motorola Mobility had broken EU law by taking such action against Apple.

Pfizer isolated in campaign against Indian patent regime, say Indian pharma alliance

Soma Das — 30-Apr-2014

A grouping of top domestic drugmakers, Indian Pharma Alliance, has told the government that global pharma giant 'Pfizer Inc is getting isolated in its campaign' to push the US to 'downgrade India' to a 'priority foreign country' in a review of its intellectual property (IP) regime.

Respect for intellectual property rights leads to innovation, investment

Aesha Datta — 30-Apr-2014

Need to see how India can improve its IP system: US trade chamber official

India not in the worst IPR classification of US

PTI — 30-Apr-2014

The US on Wednesday kept India out of Priority Foreign Country list, a worst classification, and said it will hold discussions with the next government in New Delhi on enforcement and protection of intellectual property rights.

U.S. resists pressure to give India worst offender rating in IP review

Krista Hughes — 30-Apr-2014

The United States has resisted lobbying by U.S. drug and pharmaceutical companies to take tougher trade action against India for its intellectual property policies, deciding against risking ties with a likely new government in New Delhi.

No downgrade but India still on US priority watch list on intellectual property rights

Asit Ranjan Mishra — 30-Apr-2014

US trade representative says it will try to resolve ongoing concerns through bilateral engagement

Intellectual Property Right experts flay EU ban on Indian mangoes

A Subramani — 30-Apr-2014

While the European Union's ban on Indian mangoes, including the famed Alphonso varieties, set to take effect on May 1, intellectual property right (IPR) attorneys in the country are citing provisions of Free Trade Agreements (FTAs) between EU and India and saying the former should have resolved the issue under the WTO instead of imposing unilateral ban.

India defends IPR laws, won't take part in unilateral US probe

PTI — 01-May-2014

Stressing that its IPR regime complies with international laws, India on Thursday bluntly said it will not take part in any unilateral investigation by the US on its intellectual property rights.

Apple Inc. vs Samsung Electronics patent case: Jurors end day without verdict

Associated Press | San Jose — 01-May-2014

California jurors failed to decide a patent-infringement case involving the world's two biggest smartphone makers.

US-India business lobby for dialogue on IPR issues

IANS — 01-May-2014

As the US retained India on its Priority Watch List of ten countries with "growing concerns" about protection of Intellectual Property Rights (IPR), a US-India business advocacy group called for a dialogue on the issue.

India invites US to discuss IPR

Reuters — 1-May-2014

US wants access to the Indian market for its own firms.

India invites U.S. to discuss IP, market access after polls

Manoj Kumar, NEW DELHI — 01-May-2014

India said on Thursday it would hold trade talks on intellectual property rights with the United States after its general election, buying time to address friction over drug patents until a new government is formed.

India dodges bullet from Big Pharma in patent war

Chidanand Rajghatta — 01-May-2014

The Obama administration has resisted pressure from the American domestic business lobby, notably Big Pharma, and avoided escalating a simmering trade dispute with New Delhi.

India won't participate in unilateral US probe on IPR

PTI — 01-May-2014

India today made it clear it will not take part in any unilateral investigation by the US on its intellectual property rights (IPR).

Column: The US IPR hypocrisy

Biswajit Dhar — 02-May-2014

The USTR Special 301 report on IP violations singles out India for naming and shaming

Commerce secy raps US step on IPR issue

Nayanima Basu — 2-May-2014

The Union commerce secretary has rapped the US Trade Representative’s (USTR’s) decision to retain India on that country’s “Priority Watch” (PW) list for various perceived deficiencies in India’s intellectual property rights (IPR) rules.

Patent relief

Summary — 2-May-2014

India escapes being downgraded by the US for IP violations, with a compelling self-defence.

USTR report: Global drug makers, patient groups lock horns over Indian pharma IPR

C.H. Unnikrishnan — 2-May-2014

Report retains India on its ‘priority watch’ list of countries that are alleged violators of US patent laws.

US jury says Samsung, Apple both infringed patents

Reuters — 03-May-2014

A US jury on Friday ordered Samsung Electronics Co Ltd to pay $119.6 million to Apple Inc, a big loss for the iPhone maker in the latest round of their globe-spanning mobile patent litigation.

Patent trial: US jury orders smartphone maker Samsung to pay Apple $119.6 mn

Reuters — 3-May-2014

A US jury on Friday ordered Samsung Electronics Co Ltd to pay $119.6 million to Apple Inc, a big loss for the iPhone maker in the latest round of their globe-spanning mobile patent litigation.

Drug MNCs stall generics with RTI

Rupali Mukherjee — 03-May-2014

A huge spurt in infringement suits (stay orders) recently against domestic drug companies highlight that multinational firms are increasingly using the right to information (RTI) route to enforce intellectual property and block entry of affordable generics.

Amarin files patent case against DRL on lipid lowering drug

Press Trust of India | Hyderabad — 04-May-2014

Amarin alleges Abbreviated New Drug Application seeking to market generic version would infringe patent of Vascepa on 16 counts

Cipla for Making Essential Drugs Affordable for All

Press Trust of India — 4-May-2014

Amid American firms' allegations of patent norm violations against Indian pharmaceutical companies, domestic drug maker Cipla has said that "essential" medicines should be made available to people at affordable rates and not be sold under "monopoly".

Make essential drugs affordable for all: Cipla

PTI — 04-May-2014

Amid US firms' allegations of patent norm violations against Indian pharma companies, leading domestic drug maker Cipla has said that "essential" medicines be made available to people at affordable rates and should not be sold under "monopoly".

Amarin Pharma files patent infringement case against Dr Reddy's Laboratories on lipid lowering drug, Vascepa

PTI — 04-May-2014

Dublin-based Amarin Pharma has filed a patent infringement case against Dr Reddy's Laboratories alleging that the latter is attempting to come out with generic versions of its patented drug Vascepa.

India Shaken But Not Stirred by US Concerns About Patent Laws

Sunitha Natti — 04-May-2014

India had a few anxious moments on April 26, when countries and companies globally observed World Intellectual Property Day.

US expects its restraint on IPR to pay off after polls

Shastri Ramachandaran — 5-May-2014

The Obama administration wants American big business, especially Big Pharma, to pause before reviving the push to prise open the Indian market.

Govt mulls cancer drug patent waiver

Sidhartha — 5-May-2014

The health ministry has reopened the issue of waiving a global drug giant's patent rights for Dasatinib, a cancer drug, arguing the move is needed to deal with an "emergency".

Apple vs Samsung: Patents at dispute

AP — 05-May-2014

Apple and Samsung are suing each other in courts and trade offices around the world, each making claims that the other copied patented mobile device features.

S wants more transparency on inter-ministerial panel on compulsory license issue

Joseph Alexander, New Delhi — 05-May-2014

While keeping India in its `priority watch list’ as in the previous years, the US Trade Representative (USTR) 2014 “Special 301 Report’ has called for greater transparency about the ongoing inter-ministerial process that is considering over a dozen patented medicines as candidates for government- initiated compulsory licenses.

Government mulls cancer drug patent waiver for Dasatinib

Sidhartha — 05-May-2014

The health ministry has reopened the issue of waiving a global drug giant's patent rights for Dasatinib, a cancer drug, arguing the move is needed to deal with an "emergency".

Apple-Samsung jury leaves $120 million patent verdict intact

Joel Rosenblatt — 6-May-2014

The jury recalculated damages and arrived at the same grand total as three days ago

Intellectual Property Rights Attorneys Association petitions British envoy over mango ban

PTI — 6-May-2014

With the British Parliament scheduled to debate EU ban on mango imports from India on May 8, the city-based Intellectual Property Rights Attorneys Association (IPRAA) has written to the British high Commissioner in India seeking UK's intervention in the matter.

US faces pressure to take India to WTO

Sidhartha — 6-May-2014

The US government is coming under intense pressure from lawmakers to act against India at the World Trade Organization (WTO) for what they say are violations of patent rules.

India spending billions of dollars on IPR imports: ASSOCHAM

Capital Market — 6-May-2014

India is estimated to have spent a tidy sum of over USD five billion in the fiscal 2013-14 on imports of the intellectual property rights (IPRs) clearly negating concerns over India's IPR track record by the countries like the US which has been threatening trade sanctions against New Delhi by putting it under the Priority Watch List under an American trade law, an ASSOCHAM paper on IPR Imports has pointed out.

Bayer to buy Merck arm for $14bn

TNN — 07-May-2014

Germany’s Bayer has trumped rival bidders for Merck & Co’s consumer care business in a $14.2-billion deal, adding to a string of major cross-border deals in the healthcare industry. “This acquisition marks a major milestone on our path towards global leadership in the attractive non-prescription medicines business,” Bayer’s CEO Marijn Dekkers said in a statement on Tuesday.

PDKV becomes guardian of Nagpur orange

Shishir Arya — 07-May-2014

As the good old Nagpuri Santra gets a special status on the basis of its geographical origin, Akola-based Panjabrao Deshmukh Krishi Vidyapeeth (PDKV) has become the guardian of this household fruit.

After BMS's patent rights for Dasatinib, expensive drugs should be brought under price control

ET Bureau — 7-May-2014

The health ministry has reportedly sought a waiver of drugmaker Bristol-Myers Squibb's (BMS) patent rights for cancer drug Dasatinib, citing an emergency.

Cancer drug patent waiver move lifts hopes

Shimona Kanwar — 7-May-2014

For 60-year-old Gian Tomar, who hails from Sirmour district in Himachal Pradesh, financial crunch has been more painful than his wife's suffering with Chronic Myelogenous Leukemia (CML), a type of blood cancer.

India needs to modify Intellectual Property Rights regime to attract FDI: Report

PTI — 07-May-2014

India needs to modify its Intellectual Property Rights (IPR) regime and fast-track legal system to attract foreign investments, a report said today.

Patent institute remains non-starter after recruitment ban

Shishir Arya — 7-May-2014

There is jubilation over Nagpur Orange getting a geographical indication (GI) tag but a massive building of the very department dealing in such matters, which include patents and intellectual property rights, awaits to get a befitting status.

Don’t Buckle under US Pressure on IP Rights

The New Indian Express — 8-May-2014

Special 301 report 2014, the US Trade Representative (USTR) has identified India as a “priority watch country” for failure to protect intellectual property.

Pfizer, Roche end association with US-India Business Council

Soma Das — 9-May-2014

Tension over intellectual property rights (IPR) between the US and India has led to cracks in the US India Business Council (USIBC), a grouping of hundreds of companies present in both countries, to the extent that a section of Big Pharma has chosen to end its association with the organisation seemingly in a huff.

Govt looking at incentive scheme to retain patent examiners

Amiti Sen — 11-May-2014

With the Indian Patent Office finding it difficult to retain patent examiners on Government pay-scales, a move is underway to increase remuneration by introducing an incentive scheme.

UK to review EU ban on Indian mangoes; IPR attorneys welcome call

A Subramani — 11-May-2014

Intellectual Property Rights Attorneys Association here has welcomed the British parliament's decision to go into the controversial European Union ban on the import of mangoes from India, and go through India's inspection process to prevent pest and insecticide presence in export materials.

Defending India’s patent law

Prabha Sridevan — 12-May-2014

No one can attack India’s well-founded Intellectual Property regime as being weak merely because a drug that is claimed to be an invention fails the test of law

Column: Get prudent with the patents law

Pravin Anand — 13-May-2014

To start with, India should rethink its ‘ever-greening’ argument given to justify Section 3(d) rules

Copyright act violated, 2 held

Mohammed Akhef — 14-May-2014

The crime branch of the city police on Tuesday arrested two persons under the Copyright Act for allegedly downloading and distributing songs and movies from a mobile shop he runs.

US Court Refuses to Revive Samsung Patent Case Against Apple

Reuters — 14-May-2014

A US appeals court on Wednesday affirmed a decision by the International Trade Commission that Apple Inc was innocent of violating three patents owned by Samsung Electronics to make its iPhones and iPads.

Apple, Samsung, Google Stop Suing Each Other And Start Focusing On Patent Reform

Cameron Fuller — 20-May-2014

With Apple, Samsung and Google calling a truce on their interlocking patent lawsuits, the money they’ll save in legal costs and damages is now expected to go to innovation and patent reform. Good news for consumers, bad news for patent trolls.

Merck HIV Drug Strategy Seen Shielding Patent: Corporate India

Ketaki Gokhale — 20-May-2014

Merck & Co. (MRK) is set to sell an HIV medication in India by mid-year in partnership with local company Cipla Ltd. (CIPLA), a strategy that may help the U.S. drugmaker protect its patent as the Asian nation seeks cheaper generics.

USFDA warns Sun Pharma on import ban

Reuters — 21-May-2014

Generic drugmaker Sun Pharmaceutical Industries’ response to an import ban on one of its plants lacked “sufficient corrective actions”, the US Food and Drug Administration said in a warning letter published on Tuesday. The FDA banned imports from Sun Pharma’s Karkhadi plant in Gujarat in March, but the reason for the ban was not clear at that time.

Plea alleges patent process biased against Indians

TNN — 22-May-2014

Highlighting an anomaly in patent laws, a PIL filed in the Madras high court has said that while foreign applicants are eligible for express processing of their applications, similar facility is being denied to Indian individuals and companies, resulting in delay in awarding patent for Indian products

Patent Case Against Facebook Goes to Trial in the US

Associated Press — 12-Jun-2014

Facebook infringed on patents held by a Dutch computer programmer who tried to launch a similar site called "Surfbook" more than a decade ago, according to a lawsuit heard by a federal jury Wednesday. The civil trial was underway in U.S. District Court in Alexandria, where social media giant Facebook is being sued by a holding company called Rembrandt Social Media.

Electric Car Maker Tesla Handing Over the Keys to its Technology

Associated Press, San Francisco, California — 13-Jun-2014

Electric car maker Tesla Motors is handing over the keys to its technology in an unusual effort to encourage other automakers to expand beyond gasoline-burning vehicles.

Roche and Cipla are ordered to mediate in a new twist on Indian IP fights.

Eric Palmer — 13-Jun-2014

Roche and Cipla are writing a new chapter in the bitter battles that have been fought by Western drugmakers over their patents in India. They are in mediation over the patent for Roche's blockbuster cancer fighter Tarceva, in what may be the first case to take this route.

Electric car maker Tesla Motors is handing over the keys to its technology in an unusual effort to encourage other automakers to expand beyond gasoline-burning vehicles.

Ameya Naik — 13-Jun-2014

Tesla CEO Elon Musk revealed that the company will allow other automakers to use their patents and will not initiate patent lawsuits against anyone who, in good faith, wants to use their technology. The message to the world is loud and clear, that the company wants electric vehicles on the road and the only way they see it happening is getting through to the competition and sharing expertise.

Nirmala Sitharaman discusses intellectual property rights related issues with officials

PTI — 17-Jun-2014

Amidst the US targeting India's intellectual property rights regime, Commerce and Industry Minister Nirmala Sitharaman today discussed various IPR related issues with her officials

MNC drug companies like Roche, Merck Serono, Novartis see top deck reshuffle

Divya Rajagopal — 17-Jun-2014

Multinational drugmakers including Roche, Merck Serono, Novartis and Bristol Myers Squibs are witnessing top-level changes in their management in India, with their chief executives exiting the country at a time when the Rs 72,000-crore market appears to be as challenging as it is potentially lucrative.

Nissan and BMW Keen To Collaborate with Tesla

AFP — 17-Jun-2014

Electric car-makers Nissan and BMW are keen to collaborate with rival Tesla after the US company agreed to share its patents with competitors, the Financial Times reported today.

Microsoft's Android Patents Revealed for the First Time

NDTV Correspondent — 17-Jun-2014

Microsoft's smartphone platform might be a distant third compared to Google's Android and Apple's iOS, but Microsoft has been earning a significant amount of money from Android device manufacturers through its patents, and has even sued some of these companies

Mahindra to Review Tesla Patents for Applicability to its Electric Vehicles

Press Trust of India — 22-Jun-2014

Homegrown auto major Mahindra & Mahindra, which has been developing a range of electric vehicles, will review technology patents that American electric carmaker Tesla Motors has made free for applicability to its products.

Patent medicine

Tarun Khanna — 23-Jun-2014

In the patenting literature, economists and legal scholars have focused on improving the quality of prior art available to patent examiners and mitigating the filing and granting of patents where prior art exists in common knowledge.

US company denied patent on anti-cancer drug

Rupali Mukherjee | TNN — 24-Jun-2014

The Indian Patent Office has refused a patent on US firm Abraxis BioSciences' anti-cancer drug Abraxane, paving the way for domestic companies to launch affordable versions in the local market. The application was refused on the grounds of the US firm's claims lacking of inventive step, not being patentable and insufficiency, legal sources say.

Copyright shocker on Thyagaraja kritis

25-Jun-2014

A spate of copyright-violation notices issued to video channels on YouTube for uploading Carnatic music rendition of compositions of saint Thyagaraja, has raised the hackles of musicians and fans of the art form.

Unconventional Energy Boom Drives Oil and Gas Patents to Record

Reuters — 30-Jun-2014

A boom in the search for unconventional forms of energy such as shale gas or oil sands has led to a record high in new oil and gas patents filed across the world, research published by Thomson Reuters' legal business showed.

Google, Dropbox and other top tech companies band together to fight patent trolls

Martyn Williams — 10-Jul-2014

Google, Dropbox and a few other high-tech firms have come up with a new way to help defend themselves against patent trolls. Patent trolls, or “non-practicing entities,” are companies that buy up old patents and try to monetize them by accusing others of infringement. They usually request a one-off licensing fee to end a lawsuit, something many companies reluctantly pay because it’s cheaper than defending the claim.

Merck seeks to settle patent row with Glenmark

Rupali Mukherjee, TNN — 12-Jul-2014

In the long-winding patent battle on a widely-prescribed diabetes drug, Januvia (sitagliptin), multinational company Merck (MSD) has sought a settlement to end the dispute with generic company, Glenmark on the blockbuster drug. Last year, US-based Merck's subsidiary in India dragged Glenmark to court, seeking a stop on the sale of a more affordable version of its diabetes drug, Januvia, joining the list of MNCs engaged in turf wars with generic companies in the country.

India emerges world's top consumer of antibiotics

Kounteya.Sinha@timesgroup.com — 14-Jul-2014

India has emerged as the world’s largest antibiotics consumer, with a 62% rise in use over the past decade. ‘Global Trends in Antibiotic Consumption, 2000-2010’, a study by Princeton University scientists, has found that worldwide antibiotic use has risen 36% in the same period, with Brics countries — Brazil, Russia, India, China and South Africa — accounting for over three-quarters of the surge. Among 16 antibiotics groups studied, cephalosporins, broad-spectrum penicillins and fluoroquinolones accounted for over half the increase — consumption rising 55% from 2000.

Diabetes, cardiac drugs to become up to 35% cheaper

14-Jul-2014

Coping with the inflation demon will become a tad easier for the burdened consumer. In a move that has shaken the pharma industry , prices of widely-used expensive anti-diabetic and cardiac medicines will reduce over the next few weeks by as much as 35%, with the drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), deciding to bring them under price control.

QUALITY ISSUES - Glenmark joins pharma cos setting up US plants

15-Jul-2014

With quality issues continuing to dog domestic pharma industry , more companies are de-risking their growth strategy by setting up manufacturing facilities in the US, the world's most lucrative market. The latest to jump on the bandwagon is Mumbaibased Glenmark Pharma, which is planning to set up a greenfield facility to serve the US market, which has sales of generic drugs totalling $65 billion. Over the years, leading companies like Ranbaxy , Sun Pharma and Dr Reddy's have either invested in greenfield facilities or acquired existing plants to grow their share in the fast-growing generics business. India is the largest supplier of generic medicines to the US, around 20% in volume and 12% in value terms, according to IMS.

Pharma Cos Find New Price Controls Difficult to Swallow

Divya Rajagopal — 15-Jul-2014

The drug price regulator's move to control the prices of more commonly used diabetes and heart-disease medicines has made pharmaceutical companies furious, as they fear it would wipe out their margins just when they seemed to recover from the previous government's decision to slash the prices of more than 300 drugs.

Bombay HC upholds IPAB order on Nexavar’s generic copy

Khushboo Narayan, C.H Unnikrishnan — 15-Jul-2014

The Bombay high court on Tuesday dismissed a challenge by Bayer AG against a decision to allow drug maker Natco Pharma Ltd to manufacture and sell a generic copy of a patent-protected cancer drug made by the German company.

More drug price caps soon Regulator examines prices of vaccines & medicines used in treatment of cancer, asthma, TB & malaria

Sushmi Dey | New Delhi — 15-Jul-2014

The government is scrutinising prices of vaccines and drugs used to treat cancer, viral infections, asthma, tuberculosis and malaria after having slashed prices of expensive anti-diabetic and cardiovascular medicines.

Get wonder drugs that cure hepatitis at subsidized cost, patients and doctors in Mumbai urge health ministry

Times News Ntework — 28-Jul-2014

City patient groups, NGOs and doctors have jointly petitioned the Union health ministry to procure two wonder drugs, which promise 90% cure for hepatitis C patients, at a subsidized cost.

CCI to scan drug patent settlements

C.H. Unnikrishnan — 3-Aug-2014

The country’s competition regulator may examine details of patent settlements being negotiated between foreign branded medicine companies and local generic drug makers as these agreements may restrict the access of cheaper drugs to the sick.

FDA chief who cracked down on erring chemists shunted out

Prafulla Marpakwar — 6-Aug-2014

Bowing to the mounting pressure of chemists and a section of multinational firms, CM Prithviraj Chavan on Tuesday shunted out Food and Drug Administration (FDA) commissioner Mahesh Zagade on the ground that he has completed his tenure. While no new assignment has been given to Zagade, director of municipal administration Purushottam Bhapkar will replace him. Significantly , Bhapkar, an IAS officer of the 1997 batch, did not complete even one year as the director.

Apple, Samsung agree to end patent lawsuits outside US

06-Aug-2014

Apple and Samsung, two of the world’s top technology companies, agreed to end ongoing patent lawsuits against each other outside of the US, the companies said in a joint statement on Wednesday.

Samsung, Apple drop patent disputes pending in courts outside US

By Reuters — 06-Aug-2014

Samsung Electronics Co Ltd and Apple Inc said they had agreed to drop all patent litigation outside the United States, scaling down a protracted legal battle between the smartphone rivals. The iPhone and Galaxy handset makers issued nearly identical statements announcing the global ceasefire while vowing to pursue ongoing litigation in the United States, which analysts say involves much bigger amounts of potential damages

Delhi HC issues notice on a PIL filed by Prof. Shamnad Basheer, seeking overriding powers of RTI Act against other Statutes and for declaring S.144 of Patent Act ultravires

Apoorva Mandhani — 6-Aug-2014

Delhi High Court today issued notice in a Public Interest Litigation filed by Prof. Shamnad Basheer, founder of SpicyIP and leading academician in the country, with path-breaking research in the field of Intellectual Property Rights, praying inter alia to declare that the mechanism under the Right to Information Act, 2005 overrides all other mechanisms under any other statute or rule for discharge of information from public authorities to the extent of inconsistencies therein and to declare Section 144 of the Patents Act, 1970 is ultra vires the Constitution of India.

Samsung-Apple patent war: What was it good for? Nothing

Bloomberg — 13-Aug-2014

The decision by Apple to scale back its patent battle with Samsung may represent more of a reboot than a truce.

THE PATENT SETTLEMENTS

P A Francis — 15-Aug-2014

A new trend of collusion of multinational drug corporations with large Indian companies is emerging in the Indian pharmaceutical market to overcharge essential drugs which are under patent.

Research lab to help fight patent war

Shounak Ghosal — 13-Aug-2014

A laboratory, devoted to research and document qualities of certain indigenous plants and crops that are at the risk of being patented by multi-national companies, started rolling off EM Bypass on Tuesday.

India’s action in WTO

New Delhi Times — 17-Aug-2014

On January 1 1995 when World Trade Organization came into existence the entire economy of the world was affected in respect of international trade because WTO framed the new global trade rules for international trade.

Indian drug regulator plugs quality gaps after drawing flak from USFDA

Our Bureau — 17-Aug-2014

The Indian drug regulator, the Central Drugs Standard Control Organisation, is busy reforming itself and plugging all quality gaps by organising skills development programs for its officers and inspectors to make them more attuned to international standards.

BU Prof’s Patented Technique to Purify Water Could Bring Hope to Several Lives

Bharath Joshi — 18-Aug-2014

Millions of children can be saved from the ill-effects of fluoride and arsenic contamination in water with the use of a nanoparticle technology patented by a Bangalore University professor.

Cipla Favours Zero Monopoly in Healthcare

ENS Economic Bureau — 18-Aug-2014

Amid growing tension with the US over Intellectual Property Rights (IPR)-related issues, pharma major Cipla said free competition, zero monopoly in healthcare and adoption of a pragmatic IPR policy will aid growth of pharma sector.

Swedish retailer Ikea locks horns over brand name with Varanasi-based fabric maker Ekaya

Maulik Vyas — 18-Aug-2014

Swedish retailer Ikea has objected to a Varanasi-based fabric maker's brand name 'Ekaya' on the grounds that it can create confusion among its customers as it sounds pretty similar to its own and urged the Registrar of Trademarks to strike it down.

Govt set to revise patent norms for pharma

Sushmi Dey | New Delhi — 19-Aug-2014

Guidelines won't replace present structure, but will let examiners adopt standard procedure in evaluating complex applications

Rise in ex-parte orders upset generic drugmakers' future business plans

Soma Das — 19-Aug-2014

A growing number of cases in the pharma sector, where courts forbid Indian drugmakers from launching generic versions of patented drugs (ex-parte injunction, without even hearing defendants) or ask them to furnish undertakings proclaiming that they have no plans to launch such a drug, has rattled domestic drugmakers.

Apple’s curved touchscreen patents hints at smartwatch

Techradar — 20-Aug-2014

Moto 360 will bring the first circular screen to wearables, but it looks like Apple may be looking to one-up Motorola with a curved touchscreen.

Payyannur Pavithra Mothiram in a Geographical Indication tag ownership tussle

P Sudhakaran — 20-Aug-2014

Payyannur Pavithra Mothiram, a unique gold ornament with a mythical tradition has been caught up in a battle over the Geographical Indication registration awarded to it in 2004.

US Patent to VIT Alumnus for Travel Aid Gizmo that Doesn't Need Internet

V NarayanaMurthi — 20-Aug-2014

Imagine travelling in a long-distance train with no idea about the current location, no internet connectivity to identify the spot through GPRS and not knowing when to alight.

Microsoft-backed patent buyer to layoff 19% employees

Reuters — 20-Aug-2014

Patent buyer Intellectual Ventures announced its second round of staff cuts this year, saying it will reduce its global workforce by 19% as the firm increasingly turns to litigation to generate licensing revenue.

IPAB allows Pfizer to appeal against rejection of patent for Tofacitinib

Gireesh Babu | Chennai — 22-Aug-2014

Patent Office rejected Pfizer's application in June, 2011, and a review application in March 27, 3014

Monkey does not own selfie, rules US Copyright Office

Express News Service | New Delhi — 22-Aug-2014

The copyright regulator ruled that "the Office will not register works produced by nature, animals, or plants.

Researchers earn patent for wooden honey box

TNN — 23-Aug-2014

For the first time in India, two farmers, who are also researchers, have got design patent for their wooden honey box design. Efforts are on to get process patent for the same product, as it uses a simple method to extract honey without damaging the honeybee colony.

Raisoni students file 70 patents in three years

Vaibhav Ganjapure — 12-Jun-2015

Students of GH Raisoni College of Engineering (GHRCE) made the city proud by filing 70 patents of their research that included many public-utility ones.

Gwyneth Paltrow slapped with copyright infringement lawsuit

Press Trust of India | Los Angeles — 27-Aug-2014

Gwyneth Paltrow has been slapped with a copyright infringement lawsuit over her lifestyle website Goop.

REVISED NORMS FOR ISSUE OF PATENTS

P A Francis — 27-Aug-2014

The Section 3(d) of the amended Indian Patent Act of 2005 is a key safeguard against ever greening of a drug patent by the inventor companies by making some incremental changes to the original molecule.

Disney patents filing reveals plan for flying puppets

Reuters — 27-Aug-2014

Walt Disney has filed for three drone-related patents that it says could lead to an era of aerial movie screens and larger-than-life puppets flying through the sky.

Apple loses bid for Samsung US sales ban after patent win

Joel Rosenblatt — 28-Aug-2014

A US Judge denied Apple’s bid for what the company had pitched as a narrowly tailored ban on some older Samsung smartphone models

Sun-Ranbaxy deal may hit fair trade: CCI

Agencies — 05-Sep-2014

Launching the first-ever public scrutiny of an M&A deal in India, the fair trade watchdog on Thursday said it has prima facie found that the $4-billion merger of Ranbaxy Labs into rival Sun Pharma is likely to have an “appreciable adverse impact” on competition in the market.

Sun Shines on Pharma Chart, Wockhardt Dims

Kiran Somvanshi — 5-Sep-2014

Mumbai-based Sun Pharma has made it to the top of the domestic drug makers' leaderboard through overseas acquisitions and quadrupling of revenue in five years. Others like Aurobindo Pharma and Glenmark, too, have outperformed their peers during this period.

Gitam scholars patent millet biscuits

TNN — 5-Sep-2014

Researchers of Gitam University's food science and technology department have successfully registered a patent for millet rich biscuits.

India revamps intellectual property policy in face of western anger

Amy Kazmin in New Delhi — 8-Sep-2014

India is hiring 1,000 officials for its patent offices and has vowed to clear the backlog of all pending applications over the next 18 months as it seeks to defend itself against western allegations that it tramples on companies’ intellectual property rights.

Poly Medicure wins long patent battle against German pharma giant B Braun

Soma Das — 8-Sep-2014

Poly Medicure, an Indian medical devices firm with annual sales of just over Rs 320 crore, has won a five-year long patent battle with Rs 40,000 crore German medical devices and pharma giant B Braun as the European Patent Office (EPO) revoked two of the latter's patents covering features of intravenous (IV) safety catheters.

Novartis drags DRL to US court for patent violation

fe Bureau | The Financial Express — 09-Sep-2014

Switzerland-based Novartis AG and Novartis Pharmaceuticals Corporation (NPC) have sued Dr Reddy’s Laboratories in a the United States’ District Court for the District of Delaware for a patent infringement action on the drug Gleevec.

IPR policy on the cards to protect national interests, says Nirmala Sitharaman

ET Bureau — 09-Sep-2014

India has proposed a national intellectual property rights (IPR) policy to safeguard its interests and bring clarity to existing laws ahead of Prime Minister Narendra Modi's visit to the US this month.

Novartis files lawsuit against Zydus

Premal Balan & Sohini Das | Ahmedabad — 10-Sep-2014

Zydus is accused of infringing patents related to a drug used to treat Alzheimer's and Parkinson's diseases

McDonald's Files Trademark Petition for 'McBrunch'

BurgerBusiness — 11-Sep-2014

McDonald's is in need of a secret weapon that will help boost sales and bring back lost customers.

Fresh, detailed norms for drug patent filing examiners

Sajan C Kumar | Chennai — 12-Sep-2014

Fresh and detailed guidelines are being put in place for examiners of drug patent filings

India’s drug industry to touch $48 billion by 2018

C.H. Unnikrishnan — 12-Sep-2014

Industry may see growth on back of patent expiry of some blockbuster drugs in US and local demand

PM Modi's US Visit: India, US discuss WTO, visa, IPR related issues

PTI — 12-Sep-2014

Ahead of Prime Minister Narendra Modi's visit to the US, a senior American official today met Commerce and Industry Nirmala Sitharaman and discussed various issues including India's stand in the WTO on the food security issue.

Increasing patent expiration may brighten India's export prospects: CARE Ratings

Sanjay Pingle — 13-Sep-2014

CARE Ratings has pointed out that the drug patent expiry in the USA will create new opportunity for Indian pharmaceutical industry in the coming years and the pharma industry will gain a larger foothold in the world's generic market.

India uses ancient texts to foil US bid to patent lotus to treat obesity

Vanita Srivastava — 14-Sep-2014

The claim made by a US company on the usefulness of lotus and cowhage (a herb) for treatment of obesity and hunger at the European Patent Office (EPO) has been foiled by India, largely because of submission of prior art evidence from ancient Hindu texts that refutes the claim of novelty.

Government to hear out US pharma companies' patent fears

Sidhartha — 15-Sep-2014

After months of skirmishes, the government is finally going to sit down with American pharma giants this week to hear out their concerns, a move that comes weeks before Prime Minister Narendra Modi leaves for the US.

Weaker currency, patent expiration boost for healthcare firms

Sneha Padiyath — 15-Sep-2014

Stocks of Indian pharma companies seem to be in the pink of health as investor-interest in them rises on the back of a weakening currency, the expiry of generic-drug patents later this year and a slew of US FDA approvals.

Gilead to license Sovaldi to Indian generics drug firms Read more at: http://www.livemint.com/Industry/no7AnbJi4dRkjJY7dn4SOI/Indian-companies-to-sign-generic-licensing-deal-for-Hepatiti.html?utm_source=copy

C.H. Unnikrishnan — 15-Sep-2014

The licensing agreements will allow the generic drug companies to make and sell copies of the expensive pill for low- and middle-income countries at lower prices

Draft Guidelines could lead to unnecessary bias against pharma patent applications: USIBC

Ramesh Shankar — 15-Sep-2014

The US-India Business Council (USIBC) has stated that the Draft 'Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals' issued recently by the Indian Patent Controller could lead to an unnecessary bias against pharmaceutical patent applications.

A strong IPR regime benefits India

17-Sep-2014

India’s growing population, at 1.3 billion citizens now, represents the second-largest consumer MARKET in the world, and may soon be the largest. Its productive capacity is also growing

India sends substandard generic drugs to Africa, say researchers

Anna Edney — 18-Sep-2014

Generic drugs that some Indian companies send to African countries are lower quality than the same medicines the companies sell at home and outside Africa, according to tests of 1,470 samples, researchers said.

Fresh opposition on Gilead’s Hepatitis C drug

PT JYOTHI DATTA — 18-Sep-2014

The last word is far from heard on drugmaker Gilead’s Hepatitis C drug sofosbuvir in India.

Software patent guidelines in the offing, says official

BS Reporter | Chennai — 19-Sep-2014

Currently, software is not patentable under the existing Act and it needs to be registered under copyright

Cipla grants patent rights in Rifaximin Complexes family to Salix Pharma

Our Bureau, Mumbai — 19-Sep-2014

Cipla, a Rs.9,800 crore plus fifth largest Mumbai based pharma major, has signed an agreement with Salix Pharmaceuticals, Inc., a US-based speciality pharmaceutical company.

US raps India's IPR regime

Rupali Mukherjee | TNN — 23-Sep-2014

US has rapped India's weak intellectual property regime on the eve of Prime Minister Narendra Modi's visit to the country , saying US companies “seek to invest“ in India, but “need transparent governance, a fair regulatory environment, and strong legal mechanisms“ to protect their investments

BITTER PILL - Drug pricing: `Govt bowed to lobbies'

24-Sep-2014

In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely-prescribed anti-diabetes, cancer, tuberculosis, HIV and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing “with immediate effect“ a May 29 guideline that had allowed it to put price caps on crucial drugs, to comply with a government “direction''.

NPPA withdraws May drug price control guideline

C.H. Unnikrishnan — 24-Sep-2014

India’s drug price regulator scrapped a May guideline giving itself sweeping powers to set the price of non-essential medicines. The move is likely to find favour with drug companies that have protested and also legally challenged a July order by the National Pharmaceutical Pricing Authority (NPPA) capping the price of 108 non-essential drugs

NGOs call upon Modi not to commit flexibilities in Indian Patents Act during his US visit

Ramesh Shankar — 24-Sep-2014

Ahead of Prime Minister Narendra Modi’s scheduled visit to the United States next week, experts and NGOs in the pharma sector have called upon the Prime Minister not to make any legal or political commitment that compromises flexibilities in the Indian Patents Act for facilitating access to medicines and safeguarding public health, which is based on policies and principles approved by Indian Parliament and is fully consistent with international laws.

IPR: US expert hopes to see commitment from Modi

Press Trust of India | New York — 28-Sep-2014

Underscoring the need to strengthen India's IP policy for creating a conducive environment for foreign investors, a US expert has expressed hope to see a principled commitment by Prime Minister Narendra Modi to amend country's patent laws to boost economic growth and global competitiveness.

India’s draft rules on patenting drugs draw mixed response

29-Sep-2014

India’s latest draft rules on patenting drugs that say modifications of existing medicines can be patented only if they show increased therapeutic value has drawn sharp reaction from international pharma companies.

The right prescription in the IPR debate

29-Sep-2014

Chief on the list will be the US TRADE Representative’s (USTR’s) requirement that India wind back parts of its posture on patents.

The right prescription in the IPR debate

29-Sep-2014

Chief on the list will be the US TRADE Representative’s (USTR’s) requirement that India wind back parts of its posture on patents.

Modi must resist U.S. pressure on drug patents - MSF

NITA BHALLA — 30-Sep-2014

Prime Minister Narendra Modi must not give in to U.S. pressure to change intellectual property laws which allow India to produce generic medicines poor people can afford, the medical charity Doctors Without Borders (MSF) said.

Online push buoys patent filings

P. T. JYOTHI DATTA — 1-Oct-2014

The Government’s efforts to encourage people to file their patent applications online seem to be paying off.

Apple wins LTE patent case against WiLan

Reuters — 2-Oct-2014

Canadian patent licensing company WiLan Inc said a US judge had ruled in favor of APPLE Inc in a litigation case against it.

Real-time online app opens India’s patent process to public eye

C.H. Unnikrishnan — 2-Oct-2014

The public will be able to access digital updates at each stage of file movement on the patent office’s website from September

Has PM Modi bowed to US pressure on patent laws?

Rema Nagarajan — 03-Oct-2014

A paragraph buried in the US-India joint statement, which talks of establishing an annual high-level Intellectual Property (IP) working group as part of the Trade Policy Forum, has made health activists across the world apprehensive that the Modi government might be bending to US pressure to change its patent laws.

Country's IPR regime is fully compliant with global norms: Government

PTI — 04-Oct-2014

Amidst the US raising concern over the country's IPR laws, government today said its intellectual property rights regime is fully compliant with the global norms.

DIPP Statement on Bilateral Mechanism for Discussing IPR Issues with USA

3-Oct-2014

The US- India Joint Statement issued by the Prime Minister of India and the President of the United States of America after the bilateral summit had the following reference to IPR issues Agreeing on the need to foster innovation in a manner that promotes economic growth and job creation the leaders committed to establish an annual high level Intellectual Property (IP) Working Group with appropriate decision making and technical level meetings as a part of the TRADE policy forum.

India’s intellectual property regime fully compliant with WTO norms: Government

ET Bureau — 04-Oct-2014

India's intellectual property regime is fully compliant with WTO norms, the government said on Friday, two days after the two countries decided to set up a high-level working group on IPR during Prime Minister Narendra Modi's US visit to sort out the contentious issue.

India says US agrees to its stand on IPR

BS Reporter | New Delhi — 04-Oct-2014

Says bilateral forum, mentioned in Obama-Modi statement, already exists

India’s intellectual property regime fully compliant with WTO norms: Government

ET Bureau — 4-Oct-2014

Government says India’s intellectual property regime fully compliant with WTO norms

ET Bureau — 4-Oct-2014

Govt mulls IPR courts to fast-track cases

Arun S — 06-Oct-2014

The government is working on a new, comprehensive policy on intellectual property rights (IPR), which would pave the way for setting up special IPR courts comprising experts to fast-track adjudication on infringement cases concerning all forms of IPRs, official sources told FE.

DIPP Dismisses PM Modi’s Efforts To Resolve IPR Issues, Says India’s IPR Laws TRIPS Compliant

Purba Das — 06-Oct-2014

In what could be a dismissal of Prime Minister Modi's efforts to resolve the US concern regarding India's Intellectual Property Rights (IPR) laws, the Department of Industrial Policy and Promotion (DIPP) has pointed out that there's already a committee to discuss IPR issues between the US and India.

The patent discord

Feroz Ali — 06-Oct-2014

India is probably the only country that is consciously working towards a system of open prosecution of patents.

Sri Lanka seeks cinnamon trademark

AAP — 06-Oct-2014

Ten years after the Asian tsunami devastated Sarath Kumara's cinnamon plantation in Sri Lanka, forcing him to start over with nothing, the farmer faces a new threat from further afield.

Samsung initiates arbitration against Microsoft after patent royalty lawsuit

Nate Raymond — 7-Oct-2014

The arbitration was commenced under the terms of a business collaboration agreement

Apple granted patent for digital newspaper

Business Insider — 8-Oct-2014

APPLE has been granted a patent for a flexible display that can be used as a self-updating digital newspaper.

IPAB to take up TVS Motor’s patent appeal

Sajan C Kumar | Chennai — 10-Oct-2014

The Intellectual Property Appellate Board (IPAB) will hear TVS Motor Company’s appeal against...

Google-Rockstar patent lawsuit goes to California court

Reuters — 10-Oct-2014

Google Inc will fight patent holder Rockstar Consortium in a California court instead of a Texas court that lawyers consider more friendly toward plaintiffs.

PILs challenge NPPA decision on price cap

Apoorva | C.H. Unnikrishnan — 10-Oct-2014

Two public interest litigations (PILs) filed on Thursday in the Supreme Court and Delhi high court challenged a 22 September decision by the National Pharmaceutical Pricing Authority (NPPA) to withdraw internal guideline to set prices of non-essential drugs following directions from the department of pharmaceuticals.

Playing the frenemy card

Viveka Roychowdhury — 10-Oct-2014

The pricing pill looks set to choke pharmaceutical companies in India again. On October 9, barely a fortnight after the National Pharmaceutical Pricing Authority (NPPA) withdrew its now infamous ‘internal guidelines’, a Spicy IP blogpost reported that the All India Drug Action Network (AIDAN) had filed yet another PIL in the Delhi High Court. The AIDAN’s PIL alleges that the NPPA’s volte face was a result of 'browbeating' by the Secretary, Department of Pharmaceuticals (DoP). The PIL reportedly refers to internal memos where the DoP has sent an endorsed copy of its opinion on the guidelines and directed the NPPA to withdraw them. AIDAN alleges that this amounts to ‘sabotaging the efforts of the Union Government and the stand taken by the Union Government in their two affidavits' at 'huge financial benefits to the pharmaceutical industries.'

Bose and Beats Agree to Settle Headphone Patent Dispute

Reuters — 11-Oct-2014

A high-profile patent spat over noise cancelling headphones between Bose Corp and Beats Electronics ended on Friday with the two sides settling the case out of court.

Pfizer wins patent for Voriconazole in India

Gireesh Babu | Chennai — 12-Oct-2014

The patent application was opposed by pharma firms including Ranbaxy Labs and Natco Pharma

Patent considerations

Patrick Kilbride — 13-Oct-2014

Among other things, they committed to establishing an annual intellectual property (IP) working group as a core element of the bilateral trade policy forum.

GI tag for basmati rice: Pakistan is MP’s new enemy

Milind Ghatwai | Bhopal — 13-Oct-2014

Madhya Pradesh which early this year celebrated a Geographical Indication (GI) tag for its basmati rice now has a new enemy: Pakistan.

Pharma patent regime may get stricter, say experts

Soumonty Kanungo — 14-Oct-2014

In order to boost dollar inflows in pharma sector and establish stronger IPR regime, govt may affect patent amendments.

US to launch fresh review of India's patent regime

Sidhartha — 14-Oct-2014

Within days of Prime Minister Narendra Modi's return from the US, the US TRADE Representative (USTR) has launched a fresh offensive against India's intellectual property rights (IPR) regime, a move that may lead to the government going slow on a bilateral dialogue with Washington.

US launches review of India's patent regime

Press Trust Of India — 15-Oct-2014

The US on Tuesday launched a review of India's Intellectual Property Regime, in which the focus is to measure the engagement that New Delhi has pursued in terms of intellectual property.

Patent office invites final comments on 'Revised draft guidelines for examination of patent applications'

Ramesh Shankar, Mumbai — 16-Oct-2014

The Controller General of Patents, Designs and Trademarks (CGPDTM) has invited final comments and suggestions from the stakeholders and others on “Revised draft guidelines for examination of patent applications in the field of pharmaceuticals”.

India says will not cooperate with US on IPR regime review

Nayanima Basu | New Delhi — 16-Oct-2014

The Government of India has told American authorities that it will not cooperate with the out-of-cycle review (OCR) initiated by the Office of the US Trade Representative (USTR) as part of the latter’s annual ‘Special 301 Report’, on India's supposedly slack intellectual property rights (IPR) regime.

US complaints about India's IPR regime are bullying attempts

Bibek Debroy — 16-Oct-2014

If India agrees to higher standards of IPR protection than necessary, one needs to ask what India gets in return.

Medical charity accuses US of pushing India to ease patent rules

AFP — 18-Oct-2014

Medical charity Medecins Sans Frontieres (MSF) on Saturday accused the United States of ratcheting up pressure on India's new government to relax strict patent conditions which have made the country the "world's pharmacy"

Erode-based phone manufacturer claims it has challenged trademark of iPhone in IPAB

BS Reporter | Chennai — 19-Oct-2014

The company said that it has filed a rectification application to remove the trademark of iPhone from Indian Trademark Registry

DU to soon have policy on registration of patents

PTI — 19-Oct-2014

What research exactly is patentable? What are the legal issues involved? If the student pursues a research using university infrastructure, is the outcome students' intellectual property?

Trademark name issue being sorted out: Abhishek Bachchan

Arun Venugopal — 22-Oct-2014

Chennai FC, a football club in the city, had sent a legal notice to Chennayin FC, asking to desist from using its trademark name.

Intellectual Property Rights and India's competitiveness

Amit Kapoor — 22-Oct-2014

Intellectual Property Rights are important from the standpoint of maintaining present as well as ensuring future competitiveness.

Govt sets up 6-member IPR think tank

Dhananjay Mahapatra — 25-Oct-2014

Taking into account India's dismal performance in protecting intellectual property rights over drug and agricultural products, the Centre has formed a six-member 'think tank' to draft national IPR policy and suggest legal means to handle undue pressure exerted by other countries on this issue.

Centre mulls trademark for Brand Khadi

Reshmi R Dasgupta & Vijaya Rathore — 25-Oct-2014

Finally khadi seems to be on the way to getting its due, not only on the catwalk but also officially.

Modi’s chief economic adviser Arvind Subramanian had opposed India on IPR till recently

TNN — 25-Oct-2014

he man who has been appointed the chief economic adviser to the government of India Arvind Subramanian was until recently urging the US to initiate disputes against India before the World TRADE Organization.

Under US pressure, Indian government is getting its act together on IP matters

27-Oct-2014

The pressure from the US government on India seems to be working.

The IPR stand-off

Business Standard Editorial Comment — 28-Oct-2014

Behind India's confrontation with the US on intellectual property

Update on the grant of Patent to the Company

BSE — 29-Oct-2014

Omkar Speciality Chemicals Ltd has informed BSE that the Companys claim for process patent for an Advance Intermediate namely "BENZENESELENINIC ANHYDRIDE”, having special applications in pharmaceutical industry has been accepted by the Patents Office, Govt. of India, vide their Certificate No. 022/11999 Patent Registration No. 263298 dated October 17, 2014.

Patent office eases rule for pharma companies

C.H. Unnikrishnan — 29-Oct-2014

Office drops a proposed clause that would have enforced a more stringent examination of patent applications

Cipla asks government to revoke five patents held by Novartis

ET Bureau — 30-Oct-2014

It also urged the government to consider COPD as an epidemic worthy of being qualified as a "public health crisis" as it claims 50 lakh lives annually in India, which is more than the toll from HIV-AIDS, malaria, cancer and tuberculosis.

Johnson & Johnson may buy electrolyte drink ORS-L for Rs 700cr

Boby Kurian, TNN — 30-Oct-2014

The world's sixth largest consumer health and pharma giant Johnson & Johnson (J&J) has emerged as a front-runner to acquire electrolyte energy drink business of Jagdale Healthcare in a deal estimated at Rs 700 crore, people directly involved with the matter said.

Roche-Cipla patent row mediation fails

Rupali Mukherjee — 31-Oct-2014

Efforts to end the long and bitter patent tussle between domestic pharma company Cipla and multinational Roche over a lung cancer drug have come to a naught, with the Delhi high court-appointed mediator submitting its "failure" report in the case.

Commerce Ministry Looking Into Merit of Case in Cipla-Novartis Patent Row

Press Trust of India — 02-Nov-2014

The Commerce and Industry Ministry is looking into the merit of Cipla's demand for revocation of patents of Swiss drug major Novartis for respiratory drug Indacaterol citing the need for public health access.

Cipla-Novartis patent row: DIPP looking into merit of case

PTI — 02-Nov-2014

MNCs ,other organisations, like Pepsi, IPA back India's IP regime

PTI — 03-Nov-2014

Multinational organisations including PepsiCo and industry associations like IPA, have come in favour of India's intellectual property regime, which is being reviewed by the US administration.

Trademark war: ‘Khadi’ registered in Germany, Spain

Sidhartha — 4-Nov-2014

The government's efforts to promote 'khadi' are facing a trademark hurdle with the brand having been registered abroad, in countries such as Germany, as well as in India.

Indra Nooyi-headed Pepsi-Co backs India's much-disputed Intellectual Property Rights

Dilasha Seth & Soma Das — 4-Nov-2014

US pharmaceutical companies may be gunning for India's patent regime, but New Delhi has found a prominent MNC ally in this high-profile dispute. Indra Nooyi-headed Pepsi-Co has backed India's regime of intellectual property rights, it said in comments to the US Trade Representative.

Kaththi gets embroiled in plagiarism controversy once again

M Suganth — 4-Nov-2014

The controversies around AR Murugadoss's Kaththi just refuse to die down. Minjur Gopi, who had earlier filed a case in the Chennai City Civil Court stating that the story of the film was his, has now appealed again to the court after it had dismissed his petition earlier in September.

Origiin IP considers Indian Patent Office effort to simplify analysis of patent applications a positive move

Nandita Vijay, Bengaluru — 5-Nov-2014

Origiin IP Solutions views the move by the Indian Patent Office to simplify the method of analysing the patent applications of pharma companies a positive development.

LG, Google strike patent-sharing

AFP — 5-Nov-2014

The deal covers patents on a ‘broad range of products and technologies” that already exist and will be filed in the next 10 years.

US Federal Trade Commission settles first case in crackdown on 'patent trolls'

Reuters — 06-Nov-2014

The US Federal Trade Commission has for the first time taken action against a patent assertion entity (PAE) under its consumer protection authority, the agency said on Thursday.

NRIs filed 78% of the patent pleas in India

Sushmi Dey — 07-Nov-2014

India registered the third highest rate for patent filings by non-residents at 78% of the total applications, ahead of China at 18%, Japan at 16% and the US at 50%, the latest data from the Indian patent office showed.

Cautious Japan Inc Reaches Out Via Lawyers

Deepali Gupta — 10-Nov-2014

Business enquiries from Japan have nearly doubled since last year but actual work has increased only 5-10%, lawyers said. Most Japanese business houses are watching for regulatory changes to simplify norms for control and exit clauses.

Sun Pharma, Ranbaxy Laboratories hit new high

SI Reporter — 10-Nov-2014

Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories have hit their respective lifetime high and are up over 4% each on NSE after Sun Pharma’s US subsidiary, Taro Pharmaceutical Industries, reported a strong 49% year on year growth in net profit to $143.4 million for the quarter ended September 2014.

US lobbyists lose fire ahead of trade intellectual property review

AESHA DATTA/AMITI SEN — 10-Nov-2014

The US pharmaceutical lobby seems to have become less aggressive in its efforts to make India tighten its intellectual property norms to give more protection to their own industry. In a recent proposal sent to the US Trade Representative (USTR), which is carrying out an investigation into India’s intellectual property regime, the Global Intellectual Property Centre (GIPC), an arm of the US Chambers, has refrained from talking about any sanctions against the country. The same body, however, had asked for India to be listed as a priority country as late as April this year.

Sun Basks in Taro After-glow

11-Nov-2014

Sun Pharma's stock hit a new high of `932 on Monday on strong performance of Taro, the Israeli company it acquired in 2010. This also pushed its latest buyout Ranbaxy Labs to a record high of `697.50.Sun Pharma stock got listed in 1994, an issue that was oversubscribed 55 times.

India, US IPR dialogue to begin this month

Nayanima Basu | New Delhi — 12-Nov-2014

India says it will engage bilaterally through the TRADE Policy Forum but not cooperate in the review process

Conflict of interest: US patent lobby to meet Indian judiciary, patent officials

Rema Nagarajan — 13-Nov-2014

In a glaring instance of conflict of interest many pharmaceutical MNC representatives from the US will be meeting members of judicial tribunals and higher judiciary and officers who are dealing with intellectual property (IP) cases of these companies on a visit to India next week.

Why it is important for India to defend its IPR

DG SHAH — 14-Nov-2014

The Office of the United States Trade Representative (USTR) is currently engaged in the Out-of-Cycle Review (OCR) of India’s intellectual property rights (IPR) regime, tracking its “progress” since March 2014. This article addresses the OCR and why it is important for India to defend its IPR regime.

American envoy to focus on IPR protection during his visit

Satyanarayan Iyer — 14-Nov-2014

Emphasising that intellectual property rights (IPR) protection is in the “best interests of India,” the US Assistant Secretary of State for Economic and Business Affairs Charles Rivkin said that is will be one of the main focus areas of his visit.

A reality check on intellectual property concerns

Moushami Joshi, Srividhya Ragavan — 15-Nov-2014

Alarms were sounded when the Indian Supreme Court rightly refused to endorse ever-greening of patents and denied patent protection on Glivec, a drug owned by Novartis.”

Appeal to chief justices to cancel meetings with US patent lobby

Rema Nagarajan — 15-Nov-2014

The Campaign for Affordable Transtuzumab, a group of individuals and organisations fighting to increase access to medicines, has written to the chief justices of the Supreme Court and the Delhi Court and to the chairperson of the Intellectual Property Appellate Board (IPAB) expressing grave concern over the meetings scheduled by the US lobby group, Intellectual Property Owners Association (IPOA) with IPAB, a quasi-judicial body, the Delhi High Court and the offices of the Controller of Patents.

US stand on India's IPR regime not arm twisting: Diplomat Charles Rivkin

DIVYA RAJAGOPAL — 15-Nov-2014

The US will push India into giving adequate protection to intellectual property regime (IPR, a major bone of contention between the two countries.

Group writes to SC, HC CJs against US patent body

Rema Nagarajan — 16-Nov-2014

The Campaign for Affordable Transtuzumab, a group of individuals and organisations fighting to increase access to medicines, has written to the chief justices of the Supreme Court and Delhi high court and to the chairperson of the Intellectual Property Appellate Board (IPAB) expressing grave concern over the meetings scheduled by the US lobby group Intellectual Property Owners Association (IPOA) with IPAB, a quasi-judicial body, the Delhi HC and the offices of the Controller of Patents.

Life-saving drugs to show govt-fixed rates in bold red

Sushmi Dey | New Delhi — 17-Nov-2014

From January 2015, all life-saving drugs will come with a bold red strip on the pack highlighting the price as fixed by the government and specifying if the drug is under price control.

Government holding IP conference with MNCs, their lawyers, excluding civil society, academics

Rema Nagarajan — 17-Nov-2014

The government of India claims to seek balance of public and private interests in intellectual property rights.

Foreign drug makers urge government to review IPR think tank

Soma Das — 18-Nov-2014

Foreign drug makers are urging the government to review the membership of a think tank it has set up to formulate intellectual property rights (IPR) policy in the next few months, saying that it lacks representation from innovator firms and needs to be more balanced.

Campaign concerned over US-based IPOA's 'Innovation Dialog' being organised in India from Nov 16-22

Ramesh Shankar, Mumbai — 18-Nov-2014

The Campaign for Affordable Trastuzumab has expressed grave concern over the intent and purpose of the “Innovation Dialog” being organised in India from November 16-22, 2014 by the Intellectual Property Owners Association (IPOA), a US-based group consisting of large corporations and law firms.

India Divided on Whether to Break Bristol-Myers Drug Patent

Rajesh Roy — 18-Nov-2014

The Indian government is divided about whether to break a patent on a Bristol-Myers Squibb Co.cancer drug.

Govt’s engagement with MNCs on patent protection keeps domestic industry on edge

Sushmi Dey — 19-Nov-2014

The government's intention to engage with multinational companies and patent lawyers to discuss protection and enforcement of intellectual property rights in India has triggered concerns from the civil society, local firms and those advocating affordable medicines.

India-US trade meet on Nov 25; IPR, market access on agenda

Press Trust of India | New Delhi — 19-Nov-2014

Intellectual property rights, market access for agri products, visa matters and a boost to investments are some of the issues that will come up for discussions during the Trade Policy Forum (TPF) meeting between India and the US on November 25 here.

India-US trade meet on Nov 25; IPR, market access on agenda

Press Trust of India | New Delhi — 19-Nov-2014

MSU to host workshop on 'Patents: concept and practice'

Prashant Rupera — 19-Nov-2014

The Department of Chemistry of M S University's Faculty of Science in association with the Baroda chapter of the Indian Society for Analytical Scientists and Infinvent IP is going to organize one day workshop on 'Patents: concept and practice' on November 29.

Claims of plagiarism pile on Kollywood

Udhav Naig — 20-Nov-2014

The Tamil film industry has aggressively fought the issue of piracy, with some degree of success. But, the issue of plagiarism within its own ranks has not been taken seriously enough.

Patent row: Delhi High Court asks Micromax to pay royalty to Ericsson

y Soma Das & Anandita Singh Mankotia — 20-Nov-2014

The Delhi High Court has asked homegrown handset maker Micromax to pay a royalty that amounts up to 1% of the selling price of its devices to Ericsson for using the Swedish equipment maker's patents on technologies that are essential to manufacture the products.

Google, Rockstar Agree to Settle Patent Litigation

Reuters — 21-Nov-2014

Google Inc has agreed to settle litigation with patent consortium Rockstar, though terms of the deal were not disclosed in a court filing made public this week.

Ebola vaccine running into patent cover in Canada?

Sushmi Dey — 21-Nov-2014

A Canadian patent protection may be blocking an Ebola vaccine even as the world is struggling to stop the spread of the deadly virus.

Kerala biotech firm receives US patent for Alzheimer’s drug

Sangeetha G. — 23-Nov-2014

Turmeric extract formulation made by Kerala-based Arjuna Natural Extracts has received a US patent for the treatment of Alzheimers disease.

National IPR policy relook: Government moves slowly

Nayanima Basu | New Delhi — 24-Nov-2014

India-US talks begin today at a high level, with little progress on New Delhi's homework in the two months since a review was to begin

US industry patent lobby meeting with judges foiled

Dilasha Seth & Soma Das — 24-Nov-2014

Public health groups successfully prevented meetings that had been scheduled between a visiting delegation of a US industry patent grouping and judges of the Delhi High Court and the Intellectual Property Appellate Board last week after questioning the propriety of such discussions, people familiar with the matter told ET.

India’s patent problems

Dipti Jain — 24-Nov-2014

India’s IP administration, which was widely criticized for lack of transparency in the initial years, has made its file movements and examination process public in just the first step

IPR unique opportunity for 'Make in India' innovations: WIPO official

IANS | Kolkata — 24-Nov-2014

With Intellectual Property Rights (IPR) set to "play a major role" in Prime Minister Narendra Modi's "Make in India" campaign, Indian innovators and businesses need to opt for the Madrid System of trademark registrations to manage their portfolios internationally, an IP official said Monday.

US trade rep Froman urges India to create ‘world class’ IPR regime

Amiti Sen — 24-Nov-2014

Pitching for tighter intellectual property protection in India, US Trade Representative Michael Froman has said that the country needed to enforce a world-class IPR regime and deal with issues such as piracy, counterfeiting, trade secrets and compulsory licensing.

Indian industry not taking advantage of IPR

IANS | Kolkata — 24-Nov-2014

Due to lack of awareness on Intellectual Property Rights (IPR), the Indian industry is lagging behind in exploiting benefits of registering and protecting trademarks internationally, an official said here Monday.

Arjuna Natural Extracts bags turmeric patent from US

ET Bureau — 24-Nov-2014

Arjuna Natural Extracts, a leading domestic manufacturer and exporter of botanical extracts, has said it has been granted a US patent related to a turmeric extract used for treatment of Alzheimer's disease.

Indian company receives US patent for Alzheimer treating med

Saswati Mukherjee — 24-Nov-2014

BCM-95, the patented turmeric extract formulation from Arjuna Natural Extracts Ltd has received a US patent (US Patent No. 8859020) for a composition for the treatment of Alzheimers disease comprising curcuminoid mixture and added essential oil of turmeric.

US urges India to toughen patent laws to draw investors

AFP — 25-Nov-2014

A top US trade envoy urged India on Tuesday to strengthen its drug and other intellectual property laws, saying such a move is needed to draw vital investment to spur a sputtering economy.

India needs to look at IPR norms more closely: USTR Froman

Press Trust of India | New Delhi — 25-Nov-2014

Raising concerns that issues related to Intellectual Property Rights (IPR) were impeding their bilateral trade, the US today asked India to look more closely at its IPR norms and address this problem mutually.

Modi urged to stand up to US pressure to change patent law

Rema Nagarajan — 25-Nov-2014

US Trade Representative meeting high-ranking Indian officials during his India visit is worrying public health activists that he will pressurise the government to weaken India's patent law which is seen to be pro-public health, with in-built safeguards that prevent pharma companies from getting extensions on patents by tweaking existing molecules and claiming them to be innovation.

India, US Trade Policy Forum meets after four years

Nayanima Basu | New Delhi — 25-Nov-2014

Both sides have set a target of achieving $500 bn worth of trade in goods and services from the present $100 bn

U.S. raises protection to firms in India, IPR issues

Puja Mehra — 26-Nov-2014

Both countries to explore enhanced market access to farm products

India to US: Tech companies violating copyright law

Sidhartha,TNN — 26-Nov-2014

For years, the US has blamed lax policing in countries such as India for a boost to piracy.

Affordable healthcare is beyond compulsory licenses, US tells India

Nayanima Basu | New Delhi — 26-Nov-2014

The discussion took place under the much-awaited India-US Trade Policy Forum

Patent expiries valued at $170 bn set Indian pharma to accelerate its complex generic programmes

Nandita Vijay, Bengaluru — 28-Nov-2014

Indian pharmaceutical industry will now be able to make further inroads and garner a fair share of the global MARKET opportunity as blockbuster drugs valued at $170 billion are set to come off the patents.

Differences on intellectual property rights between India and US widen

Asit Ranjan Mishra — 28-Nov-2014

US disappointed at the stature of joint working group; India insists the group is important to resolve bilateral issues

Intel wants government to strengthen protection for trade secrets under IPR policy

Dilasha Seth — 28-Nov-2014

Intel, the world's largest manufacturer of computer chips, has called on the Indian government to strengthen protection for Trade secrets under the intellectual property rights policy, raising concerns that the current regime is not strong enough.

Government files for ‘Make in India’ trademark

Nishtha Grover | New Delhi — 28-Nov-2014

In order to prevent the misuse of the “Make In India” phrase and the symbol, the government has filed for the trademark of the much celebrated phrase.

If US had a patent law like ours, they would discover many more drugs: Anand Grover

Rema Nagarajan — 30-Nov-2014

India's intellectual property (IP) law has been hailed as one of the most progressive for safeguarding public interest, and several nations like Argentina, the Philippines and Brazil are looking to learn from it.

CSIR files patent for leather tanning tech breakthrough

PTI — 30-Nov-2014

The CSIR has filed a patent for its breakthrough in leather tanning technology that does not require water.

Panel to draft intellectual property policy riddled with conflict of interest

Rema Nagarajan — 1-Dec-2014

Increased focus on India's intellectual property and patent law has put the spotlight on the IP think tank set up by the Department of Industrial Policy and Promotion (DIPP).

IPAB asks UK-based bed maker and Indian firm to explore settlement

Gireesh Babu | Chennai — 02-Dec-2014

Hypnos claims to be the supplier of beds and upholstery for Royal Family and Royal Household in Britain.

India, Japan spar over higher intellectual property standards

Nayanima Basu — 2-Dec-2014

India and Japan locked horns over a higher standard in intellectual property rights, with a special focus on the pharmaceutical sector, at the negotiations for a Regional Comprehensive Economic Partnership.

Public interest groups urge DIPP's IPR Think Tank not to revisit India’s Patent Act

Ramesh Shankar, Mumbai — 3-Dec-2014

A large number of patient groups, public interest organisations including MSF, treatment providers and academia world-wide have urged the newly constituted IPR Think Tank not to revisit or challenge democratically-determined and legally-consistent intellectual property rules introduced under India’s Patent Act.

Govt moves to protect 'khadi' trademark

Sidhartha — 3-Dec-2014

Hit by trademark infringement in Europe, the Khadi and Village Industries Commission (KVIC) has moved to quickly register 'khadi' as a 'wordmark' to check against further violation.

Cipla, Meda sue Apotex in US over nasal spray patent

Our Bureau — 03-Dec-2014

Swedish drug-maker Meda Pharmaceuticals Inc and India’s Cipla have sued Canadian pharmaceutical company Apotex in the US Federal District Court in Delaware to enforce their patents covering nasal spray Dymista.

New Google Glass Patent Tips Successor Will Feature Slimmer Profile

Ketan Pratap — 03-Dec-2014

Reports have started to emerge about Google's next-generation Glass wearable. On Monday, a report suggested that the Google Glass successor will be powered by an Intel chip.

Brands cry foul over counterfeit products on e-commerce sites like Flipkart, Snapdeal, Amazon & others

ET Bureau — 3-Dec-2014

Consumer brands and channel partners are turning the heat on India's online retailers, accusing them of not only undercutting prices but also encouraging the sale of counterfeit goods by sellers of dubious origins on their sites.

Patent protection, a key issue for foreign hybrid seed companies

TOMOJIT BASU — 05-Dec-2014

With demand for hybrid seeds growing across the developing world for characteristics ranging from drought- and pest-resistance to higher yield, the protection of technology that goes into making is becoming a key issue for developers, usually large companies such as Monsanto, DuPont and Bayer.

Burger King in trademark soup

BS Reporter | New Delhi — 6-Dec-2014

Burger King has about 13,000 outlets across the world and has had a trademark registration in India since 1979, which has been renewed by the company

Keryx Biopharma receives US patent for Auryxia covering orally administrable forms

New York — 6-Dec-2014

Keryx Biopharmaceuticals, a company focused on bringing innovative therapies to market for patients with renal disease, announced that the US Patent and Trademark Office issued US Patent No. 8,901,349.

Cisco Systems sues rival Arista for patent infringement

Reuters — 6-Dec-2014

Network equipment maker Cisco Systems Inc filed two lawsuits against Arista Networks Inc, accusing the smaller rival of copying its networking technologies.

UN Office on Drugs and Crime scheduled to meet to firm up model law

Dilasha Seth & Soma Das — 8-Dec-2014

A United Nations agency is scheduled to hold two days of closed-door meetings in Vienna starting Monday to firm up a model law prescribing harsh penalties for 'falsified' drug-related crimes, reviving fears about seizures of Indian-made generics similar to those made by the European Union in 2008.

India assumes frontline position in battles over intellectual property rights

Amy Kazmin — 10-Dec-2014

As their cities grow more polluted, more people in India grapple with respiratory difficulties.

Will India, US Bridge Divide Over Intellectual Property Rights?

Patralekha Chatterjee — 10-Dec-2014

There is an uptick in India-United States relations.

Delhi HC stops sale of Xiaomi phones over patent case

PTI — 11-Dec-2014

The court restrained Xiaomi from making, assembling, importing or offering for sale its devices which are infringing the patents of Ericsson

Agriculture department starts Geographical Indication process for Lasalgaon onions

TNN — 12-Dec-2014

Onions from Lasalgaon will get the Geographical Indication (GI) tag soon as the agricultural department of the state has started the process to grant the special status to the commodity produced in the district.

Max Sound files patent suit against Google, YouTube in Germany

Reuters — 12-Dec-2014

Technology company Max Sound Corp said it filed a lawsuit against Google Inc and YouTube in Germany earlier this month, alleging infringement of a video-streaming patent.

Google, YouTube face patent suit in Germany

Reuters — 12-Dec-2014

Technology company Max Sound said it filed a lawsuit against Google and YouTube in Germany earlier this month, alleging infringement of a video-streaming patent.

Protecting patents will boost innovation in India

RANJANA SMETACEK — 12-Dec-2014

This is also essential to meet the healthcare challenges facing the country

US concludes OCR of India's intellectual property policies

Press Trust of India | Washington — 13-Dec-2014

Citing positive steps taken by the new Indian government in addressing America's concerns on intellectual property (IP) rights, the US has concluded its Out-of-Cycle Review of India's intellectual property policies.

SHOT IN ARM FOR DESI COS, PATIENTS

TNN — 13-Dec-2014

SC order to boost access to medicines

US closes out-of-cycle review of India's trade and patent policies

HT Correspondent, Washington, — 14-Dec-2014

The United States Trade Representative (USTR) has announced closure of the out-of-cycle review of India’s trade and intellectual property rights practices, noting the progress made in recent months.

Xiaomi's India ban exposes wider patent risks

Reuters — 14-Dec-2014

The court order that banned Chinese mobile maker Xiaomi from selling its phones in India has halted its breakneck expansion into the world's fastest growing major smartphone market and could be just the start of a string of patent challenges.

Apple Just Patented An Idea That Steve Jobs Would Have Hated

Sam Colt | Business Insider — 14-Dec-2014

Apple recently filed a patent for a stylus that Steve Jobs would've hated.

India-led BRICS opposes UN arm’s move on model drug law

Soma Das — 15-Dec-2014

India has spearheaded a move by BRICS countries to oppose a United Nations agency's move to float without consultations with member states a model law on fraudulent drugs that has raised fears of genuine generic drugs getting disrupted.

India-led BRICS opposes UN arm’s move on model drug law

Soma Das — 15-Dec-2014

Obama administration content with Modi govt taking 'baby steps' to improving country's weak IPR laws

Nayanima Basu | New Delhi — 15-Dec-2014

Obama administration content with Modi govt taking 'baby steps' to improving country's weak IPR laws

Government may not act on Cipla’s patent plea

Sidhartha — 15-Dec-2014

In a setback to Cipla, the homegrown generics medicine company, the government has so far found little merit in its plea for waiver and cancellation of patent rights for five drugs over which Novartis has exclusive rights.

A doc’s call against patent overdose

PT Jyothi Datta — 15-Dec-2014

Public health groups have a supportive voice in American surgeon-author Atul Gawande in their fight to break “secondary patents” that drug companies seek on existing medicines.

A doc’s call against patent overdose

PT Jyothi Datta — 15-Dec-2014

Public health groups have a supportive voice in American surgeon-author Atul Gawande in their fight to break “secondary patents” that drug companies seek on existing medicines.

TM Registry Ordered to Examine Plea

Express News Service — 18-Dec-2014

The Intellectual Property Appellate Board (IPAB) has directed the TRADE Marks Registry to consider the petition of a US based multi-national company, E I Du Pont De Nemours and Company, that has challenged the trademark ‘Nomex’, registered by a pharmaceutical firm in Mumbai.

215 products registered as geographical indication: Govt

Press Trust of India | New Delhi — 19-Dec-2014

As many as 215 products were registered as geographical indication (GI) till December 15, 2014, government said today.

Govt studying options as Novartis-Cipla patent dispute moves to court

Amiti Sen — 18-Dec-2014

Cipla has requested the Centre to revoke Novartis’ patent on respiratory drug Onbrez

Copyright Not for Making CDs: Piracy Cell

Siva Sekaran — 21-Dec-2014

Using the copyright acquired for a feature film, no one can reproduce it in the form of CDs/DVDs evading the particulars to be included as per Section 52 A of the Cinematograph Act, the Video Piracy Cell has said in a counter affidavit before Madras HC, last week.

Patented medicine and affordability

C. R. L. Narasimhan — 22-Dec-2014

India’s ongoing efforts at safeguarding its intellectual property rights (IPRs) have been facing challenges from different directions.

AstraZeneca files patent case against Aurobindo Pharma

fe Bureau | Hyderabad — 24-Dec-2014

AstraZeneca has filed a patent infringement case against Aurobindo Pharma and Aurobindo Pharma USA…

Claris Lifesciences confirms patent challenge for its generic version of PROPOFOL in USA

COMPANY NEWS — 24-Dec-2014

Claris Lifesciences has filed an Abbreviated New Drug Application (ANDA) for Propofol for Injection, 10 mg/ml with the US Food and Drug Administration (USFDA) with a Paragraph IV certification.

40 years ago... And now: Cipla: The crusader for affordable drugs takes the patent battle to MNCs

Dev Chatterjee — 24-Dec-2014

In 1935, when Khwaja Abdul Hamied set up Cipla in Central Mumbai to manufacture medicines in India, few could have predicted that in the next few decades the company would take on the world's mightiest multinationals on patents and produce low-cost drugs for the world's extreme poor.

Role of IPR immense in knowledge economy

SPECIAL CORRESPONDENT — 24-Dec-2014

When compared to China, India is way behind in filing Intellectual Property Rights applications, says GSIB director.

Patent issue won't affect our product launches: Xiaomi India head Manu Jain

Gulveen Aulakh — 24-Dec-2014

Xiaomi says it needs to be prepared to face obstacles such as the patent infringement allegation it is fighting in India as it grows at a break-neck pace, already becoming the largest smartphone maker at home in China and the No. 3 globally.

US ITC to Investigate Samsung's Patent Infringement Case Against Nvidia

Hitesh Arora — 25-Dec-2014

Samsung's infringement case against Nvidia over semiconductor-related patents will now be investigated by the US International Trade Commission.

Micromax vs OnePlus: Delhi High Court lifts ban on OnePlus One, but case far from over

Express News Service — 25-Dec-2014

The Delhi High Court on Wednesday granted relief to mobile company OnePlus by lifting the ban imposed on the sales of its mobile phones by a single judge bench on December 16.

Micromax vs OnePlus: Delhi High Court lifts ban on OnePlus One, but case far from over

Express News Service — 25-Dec-2014

The Delhi High Court on Wednesday granted relief to mobile company OnePlus by lifting the ban imposed on the sales of its mobile phones by a single judge bench on December 16.

IPR must be a subject in law colleges, IITs and IIMs: Draft national policy

hananjay Mahapatra — 26-Dec-2014

Intellectual property rights may soon become one of the key courses in the education system as the IPR Think Tank, in its draft national policy, has recommended that it be made a compulsory subject in all law colleges, National Institute of Fashion Technology, agriculture universities and management institutes.

Chugai Pharma wins first instance patent infringement lawsuit for Oxarol ointment

Tokyo — 26-Dec-2014

Chugai Pharmaceutical, one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products, announced that the Tokyo District Court (Civil affairs No. 29, Chief Judge Kazuhide Shimasue) has granted Chugai an overall victory for the first instance demanding the suspension of patent infringement of the manufacturing process patent owned by Chugai (Patent No. 3310301) related to Oxarol Ointment 25 µg/g, a treatment drug for keratosis including psoriasis vulgaris (Oxarol ointment) .

Foreign pharma cos won 77% of all patents in last 10 years

PTI — 28-Dec-2014

India issued 4,614 drug patents between January 2005 and December 2014, of which 3,575 were given to foreign drug makers

India-US panel: Access to medicines may be under threat

Dr Gopal Dabade — 29-Dec-2014

Medicines when used appropriately can save lives.

SIMI, IM trademark on pipe bomb

Rajiv Kalkod — 30-Dec-2014

The improvised explosive device that went off on Church Street on Sunday night fits the bill of a typical 'pipe bomb', the go-to detonator of the Indian Mujahideen and the Students' Islamic Movement of India.

Suven Life surges on securing three product patents

SI Reporter | Mumbai — 30-Dec-2014

The company secured three product patents one each in Eurasia, Japan and Mexico.

Microsoft sues Indian company for technical support scam

Yoshita Singh — 31-Dec-2014

Microsoft’s filed a civil lawsuit for unfair and deceptive business practices and trademark infringement against C-Cubed Solutions

Apple gets patent for 'stylus-designed smart pen'

ANI — 01-Jan-2015

Tech giant Apple has been granted a patent for a stylus design of a smart pen capable of detecting hand movements that enables translation into digital line drawings and text, adding into the list of their new innovations.

Patent Office revokes the patent of Roche's osteoporosis drug Bonviva

Gireesh Babu | Chennai — 2-Jan-2015

Decision comes in a post-grant opposition filed by Cipla, and following an order from IPAB.

Apple patent could lead to truly flexible iPhone

Lance Whitney — 06-Jan-2015

The device described in the patent would use flexible materials for the display, housing, circuit boards and batteries.

Patent Office sets aside earlier order granting patent to Abbott's Humira

Gireesh Babu | Chennai — 06-Jan-2015

It had earlier granted patent without considering pre-grant opposition of Glenmark Pharma

New IPR policy focuses on utility patents

C.H. Unnikrishnan — 7-Jan-2015

First draft stresses the need to create new law that can facilitate the patenting of innovative utilitarian inventions

Tamil Nadu leads in ensuring GI protection in India

C.H. Unnikrishnan — 7-Jan-2015

Uttar Pradesh and Maharashtra were joint second in geographical indication protection; Goa and Punjab claimed the least with two each

Indian government plans to establish dynamic and balanced IPR policy

India Correspondent — 07-Jan-2015

Even as US President Barack Obama is slated to be the chief guest at India's Republic Day Parade on January 26, action has revved up behind the scenes with the readying of the draft of the national Intellectual Property Rights policy, reports The Pharma Letter’s India correspondent.

Facebook Copyright Post Just a Hoax

IANS — 07-Jan-2015

If you have received a Facebook copyright post in your news feed warning about your private photographs and content, just ignore it.

GI mark for basmati delayed as MP cos, farmers oppose APEDA

Gireesh Babu & T E Narasimhan | Chennai — 07-Jan-2015

Apeda representatives said GI registration should be seen from a "national interest" perspective, as Pakistan also is claiming rights over Basmati

Glenmark Pharma wins patent suit against Abbott; stock gains

ECONOMICTIMES.COM — 8-Jan-2015

Shares of Glenmark Pharma moved higher in early trade after the company won patent suit against US pharma major Abbott Biotechnology.

Glenmark wins patent row but says has no plans to launch produc

E. Kumar Sharma — 09-Jan-2015

The excitement was arguably more in the media than in the company or the analysts tracking it.

10 northeast products to get GI tag

TNN — 10-Jan-2015

Ten horticulture products from the northeast are set to get the much-coveted geographical indication (GI) tag by March this year.

Delhi HC stops Cipla’s generic drug sales

Rupali Mukherjee — 10-Jan-2015

In a move which may be a dampener for patients suffering from lung and respiratory diseases, the Delhi high court has decided in favour of drug MNC Novartis, restraining generic firm Cipla from selling its affordable version of respiratory drug Onbrez in the domestic market.

IBM again tops lists of US patent recipients

IANS | New Delhi — 12-Jan-2015

IBM has received a record 7,534 patents in 2014 -- marking the 22nd consecutive year that the company topped the annual list of US patent recipients, a company statement said here Monday.

India, US agree to restart talks on bilateral investment treaty

Sachin Parashar — 12-Jan-2015

India and the US have reaffirmed commitment to the long-pending Bilateral Investment Treaty with PM Narendra Modi on Sunday conveying to visiting secretary of state John Kerry that New Delhi was prepared to hold early talks for the same.

Bristol-Myers Squibb, Natco Pharma settle patent dispute

Gireesh Babu | Chennai — 12-Jan-2015

The dispute was over the patent of Hepatitis B drug entecavir

Trademark registry to look at claim of biryani eatery in Chennai

Manish Raj — 12-Jan-2015

It was an order in decidedly poor taste. Rapping the assistant registrar of the trademark registry in the city for passing an order with "total non-application of mind", the Intellectual Property Appellate Board asked it to consider afresh a trademark application by a biriyani eatery in Dindigul.

India suffers from an unpredictable regulatory environment: John Castellani

Nayanima Basu & Digbijay Mishra | New Delhi — 13-Jan-2015

The IPR think-tank has the critical task of developing a national IPR Policy that will advance the new government’s goals of fostering a spirit of innovation, entrepreneurship and growth in research and development (R&D).

Cipla moves HC against bar on sale of generic drug

TNN — 14-Jan-2015

Cipla has filed an appeal in the Delhi high court against a recent order which restrained it from selling its generic version of Novartis drug Onbrez in the domestic market. The matter is expected to come up for a hearing on Wednesday.

Patent filing sees unprecedented surge worldwide: WIPO

Ragini Verma — 14-Jan-2015

In 2012, 2.35 million patent applications, 6.58 million trademark class applications and 1.22 million design applications were filed worldwide, says Gurry

Government taking steps to reduce patent backlog: Kant

Nayanima Basu | New Delhi — 15-Jan-2015

Human resources in the IP office has not kept pace with the increase in filings

It’s time to ratchet up India’s IP stance

Chirantan Chatterjee — 15-Jan-2015

NE implies that unlike an encrypted code in a software, ideas unless protected through intellectual property (IP) are difficult to exclude from being used by others. NR in ideas gives rise to increasing returns (IR).

Monaco can't trademark 'Monaco', EU court rules

AFP — 15-Jan-2015

Monaco cannot register its own name as a trademark because the principality is too well known on account of its royal family and Formula One race, an EU court ruled Thursday.

IPR won't be part of model law on fake drugs, says UN arm

Soma Das — 16-Jan-2015

The UN agency for drug control has assured India and the other BRICS nations that it will steer clear of intellectual property rights matters while drafting a model law to combat fraudulent drugs.

India’s refuses patent to Gilead for its drug Sovaldi

DIVYA RAJAGOPAL, — 16-Jan-2015

India's patent office has refused a patent to US drugmaker Gilead for its blockbuster drug Sovaldi on the grounds that the molecules and compounds of the drug were "known" elements.

Xiaomi bolsters its patent portfolio across globe as it fights patent battle in India

ANI — 16-Jan-2015

Beset with a patent battle in India over its smartphones, Xiaomi is now trying to bolster its patent portfolio in China and elsewhere.

Patents are scourge on software industry, says Vishal Sikka

PTI — 16-Jan-2015

Terming patents as a "scourge" on the software industry, Infosys CEO Vishal Sikka has said his company is "rethinking" its approach on the subject.

Patented medicine

Dr. Srinivasan Nagarajan, Sydney, Australia — 19-Jan-2015

As a professional adviser on IP matters in Australia, I agree with the main thrust of the article, “Patented medicine and affordability” (Dec.22, 2014).

Hindustan Aeronautics’ patent filings see 10-fold rise in 3 years

Huma Siddiqui — 19-Jan-2015

State-owned Hindustan Aeronautics (HAL) is enriching its patents repository fast.

Global Patents Reflect Advances in Connected and Self-Driving Cars

Reuters — 20-Jan-2015

Technology advances in telematics and driver assistance systems are gathering steam as the enablers of future connected and self-driving cars, according to an analysis of global patent applications released Monday.

GRANTING OF UNDESERVING PATENTS

P A Francis — 20-Jan-2015

There has been a steady increase in disputes between Indian drug companies and the multinationals over the grant of patents in the country ever since the Indian Patent Act was amended in 2005.

Natco slumps; US court rules for Teva in drug patent case

Reuters — 21-Jan-2015

The US Supreme Court on Tuesday ruled Teva Pharmaceutical Industries can still benefit from patent protection for top-selling multiple sclerosis drug Copaxone

Medical charity warns India over patent rules

AFP — 21-Jan-2015

Doctors without Borders on Wednesday warned the Indian government not to bow to US pressure to amend patent regulations that allow millions access to affordable medicines, ahead of a visit by President Barack Obama.

‘Obama visit will pressurize India to alter patent law to suit US interests’

Rema Nagarajan — 21-Jan-2015

US President Barack Obama's visit has set alarms bells ringing among those working to improve access to medicines.

Blow for Natco, Mylan as US Supreme Court remands patent case

fe Bureau — 22-Jan-2015

The US Supreme Court has sent back to a federal Circuit Court a patent case over the multiple sclerosis treatment drug, Copaxone.

Setback to Natco pharma; US Supreme Court sends Teva patent case to Federal Circuit

TNN — 22-Jan-2015

In a setback to homegrown pharma player Natco, the US Supreme Court has sent back the patent case related to Teva's multiple sclerosis drug Copaxone for a review by the Federal Circuit, which hears appeals in patent, trademark and trade-related matters.

HC seeks Centre reply on Gilead plea for patent of Hep C drug

Press Trust of India | New Delhi — 23-Jan-2015

Delhi High Court has sought the Government's response on US-based pharma firm Gilead Sciences Inc's plea challenging rejection of its patent application for its Hepatitis C drug, sofosbuvir, marketed under the brand name Sovaldi.

Govt may negotiate price of drugs before market entry

Sushmi Dey — 23-Jan-2015

The government may negotiate prices of patented medicines with their manufacturers before allowing pharmaceutical companies to launch them in India.

US 'threats' to Patent Act irks RSS outfit

Suvojit Bagchi — 23-Jan-2015

Only days before President Barack Obama’s visit, Swadeshi Jagran Manch (SJM), the powerful economic wing of the Rashtriya Swayamsevak Sangh, has objected to the United States’ “threats” to India’s domestic policies on Intellectual Property Right (IPR).

India's patent laws under threat?

TNN — 24-Jan-2015

Setting up of a bilateral mechanism on intellectual property (IP) rights through the US-India trade policy forum and the new draft national IP policy championing IP as the only way to promote innovation have raised apprehensions among health activists that India might concede ground on IP during President Obama's visit.

World backs India against ‘bully’ US

TNN — 25-Jan-2015

Apprehensive of the US exerting pressure on India to dilute the public health safeguards in its patent laws, organizations from across the world have signed a global petition supporting India's patent law and urging India to stand strong in the face of " US bullying".

India, US to enhance engagement on intellectual property rights issues

PTI — 26-Jan-2015

India and the US today agreed to enhance their engagement on intellectual property rights, a vexed issue between the two countries.

CEOs from India, US brainstorm Intellectual Property Right, piracy among other issues

PTI — 26-Jan-2015

Issues related with intellectual property rights, including piracy of films and software, figured prominently during the India-US CEO Forum in New Delhi attended by Prime Minister Narendra Modi and US President Barack Obama.

Modi pledges open business environment, Obama raises IPR issue at US-India Business Summit

IndiaToday.in/New Delhi — 26-Jan-2015

Prime Minister Narendra Modi on Monday said the state should be driven by policies which should be consistent so as to draw more investments, while revealing US investments in India jumped by 50 per cent in the first six months of his government.

Ready to Accept India-US Panel's IPR Suggestions: PM Modi

Reuters — 26-Jan-2015

Prime Minister Narendra Modi on Monday said the government is ready to accept suggestions made by a joint working group with the United States on intellectual property rights (IPR).

CEOs from India, US brainstorm Intellectual Property Right, piracy among other issues

PTI — 26-Jan-2015

ssues related with intellectual property rights, including piracy of films and software, figured prominently during the India-US CEO Forum in New Delhi attended by Prime Minister Narendra Modi and US President Barack Obama.

Promote Indian drugs, US health groups urge Obama

Sushmi Dey — 27-Jan-2015

Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing "high-quality, low-cost generic medicines essential for health care around the world".

Japan’s Sharp, Coimbatore’s Sharp Ind told to settle trademark row amicably

Our Bureau — 27-Jan-2015

Japan’s entertainment electronics and consumer durables major Sharp Corporation and the Coimbatore-based water pumps manufacturer Sharp Industries are expected to settle a trademark dispute between them amicably.

Pfizer earnings slip on loss of drug patent exclusivity

AFP — 27-Jan-2015

Pfizer reported Tuesday that revenues and profits fell again in the fourth quarter of 2014 as the drug maker continued to suffer from the loss of exclusive rights to various treatments.

Will Modi give up India's intellectual property stand just to please Obama?

G Pramod Kumar — 28-Jan-2015

Amidst the feel-good roadshow of Barrack Obama and Narendra Modi and the promise of $ 4 billion American investment, something critical to the survival of India and the rest of the developing world went under the radar - continuing pressure by America to dilute India’s intellectual property regime that saves the lives of millions of people in India and elsewhere.

Patent row no hurdle for Gilead Pharma’s Sovaldi launch

DIVYA RAJAGOPAL — 28-Jan-2015

US drug maker Gilead Pharma says that the recent decision by the patent office, which rejected patent for one of its molecules, does not impact its India plans.

Demand for geographical indication status: This time for Gulbarga toor

Harish Damodaran | Gulbarga — 28-Jan-2015

After Dehraduni basmati, Darjeeling tea and Malabar pepper, it is the turn of pulses millers and traders in this Northeast Karnataka district to seek geographical indication (GI) status for “Gulbarga toor”.

US having a good dialogue with India on intellectual property issues: Mike Froman

PTI — 28-Jan-2015

The United States is having a good dialogue with the new Indian Government on issues related to intellectual property (IP), a top Obama Administration trade official told lawmakers.

Did PM concede to the US on IP and patents?

Rema Nagarajan — 28-Jan-2015

Reports of Prime Minister Narendra Modi telling a conclave of Indian and US corporate chiefs that India was ready to accept suggestions made by a joint working group with the United States on intellectual property rights has led to howls of protest and accusations of Indian selling out and bending to US interests.

International health activists criticise President Obama’s attempts to undermine India's IPR

Ramesh Shankar, Mumbai — 29-Jan-2015

US President Barack Obama’s comments during the India-US CEO Forum in New Delhi on Monday January 26 with Indian Prime Minister Narendra Modi have drawn harsh criticism from international health activists.

Coffee Board to monetise ‘Coffees of India’ logos

Vishwanath Kulkarni — 29-Jan-2015

Exporters, traders, roasters and curers displaying the ‘Coffees of India’ and the other regional/speciality coffee trademarks on their packages will now have to seek the Coffee Board’s permission to do so and pay a fee for using each logo.

Patent dispute: Novartis objects to Wockhardt filing fresh documents

Sajan C Kumar | Chennai — 30-Jan-2015

Swiss pharma company Novartis has raised objections to Wockhardt filing additional documents in a revocation petition by the latter against the former’s patent for anti-diabetes drug Vildagliptin.

Delhi high court sets aside order on Gilead’s Sovaldi patent

Apoorva & Vidya Krishnan Mail Me | Vidya Krishnan — 31-Jan-2015

The Controller General of Patents, Designs and Trademarks had rejected a patent to the US drug maker for the hepatitis C drug

Patent application refused to Wockhardt for skin care drug

Gireesh Babu | Chennai — 01-Feb-2015

It was refused because the drug was found incapable of industrial application

Samsung patent showcases new dual-edged screen design

2-Feb-2015

With MWC 2015 closing in fast all eyes are on manufacturers to usher forth their new device lineups. Samsung's next flagship S device - the Galaxy S6 has long been in the rumor mill and is still expected to make its first appearance at the Barcelona venue this year.

HC asks patent office to review Gilead's case

Rupali Mukherjee — 3-Feb-2015

The Delhi high court has sent the decision of patent refusal for US firm Gilead's hepatitis C drug, Sovaldi, back to the patent office on procedural grounds.

India ranked second last in Intellectual Property Index

ET Bureau — 04-Feb-2015

India has improved its rank marginally on the intellectual property (IP) index released by the US Chamber of Commerce on Wednesday.

Global Intellectual Property Index: India's dismal run continues

BS Reporter | New Delhi — 5-Feb-2015

India continues its dismal run in Global Intellectual Property Index score, occupying the 29th position among 30 countries.

US has secured commitments from India on IPR, claims Michael Froman

Soma Das & Dilasha Seth — 5-Feb-2015

A remark tucked away in the top US trade official's testimony before American lawmakers, stating that the US has secured commitments from India on intellectual property rights, has alarmed Indian drugmakers and public health activists.

Indian drug cos worried about patent regime changes

PT Jyothi Datta — 08-Feb-2015

Seek clarification on US trade representative’s testimony that India has committed to address IP issues that concern America

India may finally usher in pharma data protection

Arun S — 9-Feb-2015

Patent linkage would ensure patent controllers and drug regulators coordinate so that a generic versions of a patented product are not approved by the latter during the term of a patent.

IBM Sues Priceline for Patent Infringement

MARIA ARMENTAL — 09-Feb-2015

International Business Machines Corp. is suing Priceline Group Inc., claiming the online travel giant built its business on IBM’s inventions and owes it billions of dollars in royalties.

Venus Remedies scrip surges over 13% on patent win

PTI — 09-Feb-2015

Shares of pharmaceutical firm Venus Remedies Ltd today surged over 13 per cent after the company secured Indian product patent for an antibiotic research product, Vancoplus.

New policies, other IP reforms could improve India's IP score: Meir Pugatch

Jyotindra Dubey — 10-Feb-2015

The US Chamber of Commerce's Global Intellectual Property Center released the third annual edition of its International IP Index 2015 two days ago.

IBM sues Priceline for patent infringement

Reuters — 10-Feb-2015

IBM filed a lawsuit against Priceline Group, accusing it of infringing four IBM patents in running its travel and dining websites.

Microsoft, Samsung settle dispute over patents

Reuters — 10-Feb-2015

Microsoft and Samsung Electronics Co Ltd have settled a contract dispute over patent royalties, though terms of the settlement are confidential, Microsoft said in a statement on Monday.

Ten-fold rise in patent applications, says Nasscom

OUR BUREAU — 10-Feb-2015

Frontline IT companies have seen a 10-fold increase in the number of patent applications made over the last five years, an indication of the growing push towards automation and higher margin offerings.

Delhi HC stays release of ‘Badmashiyaan’

PTI — 11-Feb-2015

The release has been stayed on Multi Screen Media’s plea alleging copyright infringement by the movie’s producers

Big Pharma groupings urges US to ask India to change its IPR policies

Soma Das — 12-Feb-2015

Big Pharma groupings have urged the US government to keep nudging India to change its policies on intellectual property rights, which they claim don't conform to global norms.

Suven gets patent for neurodegenerative drug in 4 countries

16-Feb-2015

Pharmaceutical firm Suven Life Sciences has been granted one patent each by Australia, Canada, Japan and New Zealand for its drug used in treatment of neurodegenerative diseases.

Samsung to pay $15.7 million for patent infringements

IndiaToday.in New Delhi — 16-Feb-2015

Samsung has been dragged to the court for patent issues yet again.

Apple patents VR headset for iPhone

AFP — 18-Feb-2015

Apple has been awarded a patent on a headset that could let iPhones be part of augmented or virtual reality displays.

Microsoft, ZTE do not infringe InterDigital patents: Court

Reuters — 19-Feb-2015

InterDigital, a patent licensing firm, lost an infringement fight on Wednesday as a US appeals court ruled that wireless phones made by Nokia, since purchased by Microsoft, and ZTE do not infringe on InterDigital patents.

Xiaomi to take legal action against websites selling its phones illegally

Gulveen Aulakh — 21-Feb-2015

Xiaomi will be taking legal action against websites selling its phones illegally and infringing on the company's trademark in India where the Chinese handset maker has an ongoing patent dispute with Ericsson.

Experts come ouExperts come out against draft National IPR policyt against draft National IPR policy

G. KRISHNAKUMAR — 22-Feb-2015

The draft prepared by the Centre’s IPR Think Tank has failed to address many pertinent questions regarding intellectual property

Verdict in trademark row delivered 6 years after order is reserved

A Subramani — 22-Feb-2015

Even by the snail pace of Indian judicial machinery, delivering a verdict six years after reserving the order is a big delay, indeed.

First Traditional Healer in State Set to Get Patent

Archana Ravi — 24-Feb-2015

Shahul Hamid is all set to become the first traditional healer with a patent, if everything goes as planned.

No proposal to change patent law

Press Trust of India — 25-Feb-2015

"There is no proposal to amend patent law... There is no proposal to anything to do with Indian Patent Act," Commerce and Industry Minister Nirmala Sitharaman said while replying to questions in the Rajya Sabha.

Qualifying norms for start-up patent subsidy scheme now relaxed

Anita Babu — 26-Feb-2015

Many technology start-ups and small and medium enterprises could benefit from a government initiative that provides financial assistance to file global patents, as the Centre has eased the qualifying norms.

Ericsson sues Apple for patent infringement

Reuters — 28-Feb-2015

Swedish mobile telecom gear maker Ericsson is suing Apple Inc for patent infringement after Apple refused Ericsson's offer to have a court determine fair licensing terms, Ericsson said on Friday.

The Legal Implications Of Medicinal Marijuana As A Geographical Indication For Jamaica

Marsha Cadogan — 2-Mar-2015

The EU-Cariforum Economic Partnership Agreement between Caricom countries and the European Union, facilitated interest in, and led to the subsequent enactment of geographical indication (GI) legislation in most Caricom countries, including Jamaica.

IP Department hopes to see GI certification for every province in three years

PETCHANET PRATRUANGKRAI — 3-Mar-2015

THE Intellectual Property Department plans to extend its "one geographical indication, one province" scheme to all provinces within three years to boost development of localised products and income for local people.

India-US ties still problematic

Nayanima Basu | New Delhi — 03-Mar-2015

While merchandise trade grew at a sluggish 0.47% in FY14, Washington remains concerned about India's IPR laws

Natco Pharma ties up with Gilead on hepatitis C drug

Bloomberg — 3-Mar-2015

Natco Pharma Ltd., the Indian drugmaker that had challenged Gilead Sciences Inc.'s patent claims on a blockbuster hepatitis C treatment in the Asian country, said it signed a licensing agreement with the US company for the drug.

IPAB sets aside order against Cima Labs' painkiller for cancer

BS Reporter | Chennai — 03-Mar-2015

The Assistant Controller shall consider the matter afresh

Indian firm challenges Apple over ‘iPhone’ brand

Anupam Saxena,TOI Tec — 03-Mar-2015

Apple is getting aggressive in India with the company reportedly setting a target to double iPhone sales and increasing focus on e-commerce.

Huawei Bumps Up Patent Portfolio as 5G Era Draws Near: CEO

Reuters — 04-Mar-2015

China's Huawei Technologies, the world's second-biggest maker of network gear, is beefing up its patent portfolio ahead of 5G, the next generation of mobile equipment, its chief executive said on Tuesday.

Huawei Bumps Up Patent Portfolio as 5G Era Draws Near: CEO

Reuters — 04-Mar-2015

Bengaluru based Stempeutics Research has been granted a US process patent for its stem-cell based drug Stempeucel by the United States Patent and Trademarks Office.

Peerzada Abrar, ET Bureau — 04-Mar-2015

Bengaluru based Stempeutics Research has been granted a US process patent for its stem-cell based drug Stempeucel by the United States Patent and Trademarks Office.

Apple's Claims of Phone Patent Harm by Samsung Make Judges Wary

Reuters — 5-Mar-2015

Apple Inc told a U.S. appeals court on Wednesday that rival Samsung Electronics Co Ltd should be barred from selling products that infringe on its smartphone patents, but the judges were sceptical.

Trademark Through this App

Express News Service — 5-Mar-2015

IndiaFilings.com a leading online portal launched India’s first mobile application for company registration, trademark registration and tax registration. The mobile app was released by K Rosaiah, Governor of Tamil Nadu.

Patent law firms look to tap demand from startups

Vishal Dutta, ET Bureau — 5-Mar-2015

Intellectual property rights (IPR) law firms have spotted a new business opportunity in the growing number of startups in the country that could be at risk from both competitors and impersonators.

Ilaiyaraaja irked with copyright infringement of his songs

IANS — 5-Mar-2015

Maestro Illayaraja, who has the rights to all the songs that he has composed in over 1,000 films, says it's illegal for television channels and radio stations to play them without paying him.

Patent law firms look to tap demand from startups

Vishal Dutta — 5-Mar-2015

Intellectual property rights (IPR) law firms have spotted a new business opportunity in the growing number of start-ups in the country that could be at risk from both competitors and impersonators.

India is not being victimised: Meir Pugatch

Sudipto Dey — 8-Mar-2015

Continuing its dismal run for the third year, India was ranked second from bottom among 30 countries in the third edition of the annual international IP index brought out by the US Chamber of Commerce's Global Intellectual Property Center (GIPC).

KAU bid to get GI tag for Marayoor sandal

K. Santhosh — 8-Mar-2015

The Department of Wood Science of Kerala Agricultural University (KAU) has taken the initiative for securing forest certification and registration of Geographical Indication for Marayoor sandal.

EU expected to reach out to India to restart FTA talks

Elizabeth Roche — 8-Mar-2015

Both sides may have lost an opportunity to give a push to talks, with Narendra Modi dropping plans to visit Brussels during a visit to Europe next month

Suven Life up 5%, gets product patent in Eurasia & Israel

Moneycontrol Bureau — 09-Mar-2015

Shares of Suven Life Sciences (Suven) climbed 5 percent intraday Monday on getting product patent each in Eurasia and Israel.

Will Indian generic pharma players live up to their billing?

Rajabahadur V Arcot — 09-Mar-2015

Compared with many other industries in the country, save for the software industry, the Indian pharmaceutical sector’s performance has been impressive and its future secure.

Faster patent approvals on anvil for firms making in India

Apoorva, Vidya Krishnan — 09-Mar-2015

Patent applicants could soon jump the queue and fast-track to production if the views of an official panel take the form of law

Patent controller issues draft guidelines for search & examination of patent applications

Ramesh Shankar, Mumbai — 09-Mar-2015

The Controller General of Patents, Designs and Trademarks (CGPDTM) of India has issued draft guidelines for search and examination of patent applications.

Patent for modified poultry feed

TNN — 09-Mar-2015

Panjab University (PU) has been granted a patent by Technology Information, Forecasting and Assessment Council (TIFAC) for an invention entitled 'A Modified Poultry Feed for Production of Eggs'.

Patent office refuses patent for tosylate salt form of Bayer's sorafenib

Gireesh Bbau | Chennai — 09-Mar-2015

Bayer's sorafenib drug Nexavar was the first to have a compulsory license in India

Suven Life secures One (1) Product Patent each in Eurasia and Israel

Capital — 09-Mar-2015

For NCEs developed as therapeutic agents for major depressive disorder

Govt working to wrest Khadi trademark from German firm

PTI — 09-Mar-2015

Government is working in tandem with the Khadi and Village Industries Commission (KVIC) to expedite the process of de-registering 'Khadi' trademark in the European Union by a German company, Parliament was informed today.

Former Google executive Lee confirmed to lead U.S. patent office

Andrew Chung — 10-Mar-2015

The U.S. Senate on Monday confirmed former Google Inc (GOOGL.O) executive Michelle Lee to head the U.S. Patent and Trademark Office, a position that has been vacant for more than two years.

German co’s patent for asthma drug revoked

Rupali Mukherjee — 10-Mar-2015

India's Patent Office has revoked a patent on asthma drug, Spiriva (tiotropium bromide monohydrate) held by German major Boehringer Ingelheim on an opposition filed by generic company, Cipla.

UT court stays sale, transfer of copyrights of 'Dolly ki Doli' movie

Ajay Sura,TNN — 11-Mar-2015

A Chandigarh court on Tuesday stayed the sale or transfer of the copyrights of movie 'Dolly ki Doli' after a petition was filed alleging that the producers of the film had violated the Copyright Act.

IP Appellate Board upholds Wockhardt’s petition for relief in diabetes drug patent row

OUR BUREAU — 11-Mar-2015

The Intellectual Property Appellate Board (IPAB) on Wednesday ordered that Wockhardt need not produce any additional documents for evidence in a patent case against Novartis AG relating to an anti-diabetes drug.

Hewlett-Packard patents invalidated in ServiceNow case

Reuters — 11-Mar-2015

A federal judge in California has invalidated four Hewlett-Packard Co patents for being too abstract, marking a setback in the company's patent infringement lawsuit against competitor ServiceNow Inc.

Certain provisions in Trademarks Act unconstitutional: Madras High Court

PTI — 12-Mar-2015

Madras High Court today declared as unconstitutional a sub-section of by

High court raises bar for intellectual property forums, sets new rules

A Subramani — 12-Mar-2015

Cutting to size the role of bureaucrats in appointment of members and chiefs of statutory boards that decide patent, trademark and other related disputes, the Madras high court on Tuesday quashed existing selection criteria and ordered the reconstitution of the search committee to choose members of such boards.

IPR/patent issues: US calls for stock taking, India says wait

AMITI SEN — 12-Mar-2015

Washington unhappy with India’s unwillingness to change IP laws

Suven Life shares zoom 20 per cent on getting patent for drug

PTI — 16-Mar-2015

Shares of Suven Life Sciences soared 20 per cent today as the company has been granted a patent each by the US and New Zealand for a drug used in the treatment of neuro-degenerative diseases.

Patent Office refuses Wockhardt's application related to osteoarthritis drug

BS Reporter | Chennai — 17-Mar-2015

The company claimed that its invention shows at least 25% reduction in soft stool effect as compared to other drugs

Apple did not infringe wireless patents: Jury

Reuters — 17-Mar-2015

A federal jury in Texas on March 16 said Apple Inc did not infringe five wireless technology patents owned by Canadian patent licensing firm Conversant Intellectual Property Management Inc.

IPAB impleads MP farmer body in basmati GI tag plea

Manish Raj — 18-Mar-2015

There is quite another facet distinctive of the aromatic, slender and long-grained Basmati rice,apart from its delectable presence in cuisines across the country. It continues to be mired in a legal wrangle.

USFDA plans to shift to an incentive based from a penalty based audits

Soma Das — 18-Mar-2015

In a marked departure from its approach to dealing with Indian pharmaceuticals companies, the US drug regulator would now incentivize those adopting a culture of quality in addition to its usual practice of pulling up those for manufacturing lapses, a top US Food and Drug Administration (FDA) official currently on a visit to India told ET.

HC to govt: Can Delhi get IP tribunal bench?

Rupali Mukherjee — 18-Mar-2015

Clearance and disposal of trademark and patent disputes may soon get a leg up. The Delhi high court has directed the government to look into the feasibility of setting up a permanent bench of the Intellectual Property Appellate Board (IPAB) tribunal in the capital. This would ensure the smooth functioning of the tribunal and help in the timely and effective disposal of trademark and patent cases, according to legal experts.

India, Pharmacy to the Developing World, Must Honor IP Rights

Dr. Kristina Lybecker — 18-Mar-2015

The United States and India are locked in a vitriolic debate over intellectual property rights in the pharmaceutical sector.

ndia's new patent laws bulldoze domestic industry, appease foreign firms

K Yatish Rajawat — 19-Mar-2015

Sometimes a small sentence answers a lot of questions. For instance, Nirmala Sitharaman in reply to a question in the Rajya Sabha yesterday said that the draft Indian Patent policy is almost ready.

Chennai accounts for 17,000 of the 45,000 patent pleas in India

Special Correspondent — 20-Mar-2015

Nearly 45,000 patent applications are filed in India in a year; of them, 17,000 are filed from Chennai, said R.Devan, Deputy Controller of Patents and Designs, Patents Office, Chennai here on Wednesday

India remains bit player, China marches ahead in patent filings

D. Ravi Kanth — 20-Mar-2015

India registered an increase of 5.6% in patent filings during 2013-14, while China notched up a rise of 18.7%

Patents are like nuclear weapons: Vivek Wadhwa

ET Bureau — 20-Mar-2015

Vivek Wadhwa, Indian-American tech entrepreneur and academician is an outspoken advocate of abolishing software patents in the US.

Government seeds stronger IP protection with agrochemicals

Arun S — 20-Mar-2015

While the move would benefit global chemical giants like Bayer, Syngenta, BASF, Dow, Monsanto and DuPont, it is also seen as a precursor to similar exclusivity for pharmaceutical majors.

India remains bit player, China marches ahead in patent filings

D. Ravi Kanth — 20-Mar-2015

India registered an increase of 5.6% in patent filings during 2013-14, while China notched up a rise of 18.7%

Curved displays seems to be the craze right now and even more so, after Samsung set the tone with the Galaxy Note edge.

Press Trust of India | New Delhi — 22-Mar-2015

India needs to check high patent royalty payments demanded by foreign firms and bring them in line with rates allowed by China and the US to ensure that its efforts to develop a robust local mobile manufacturing base are not derailed, says a report.

Exclusive: Leaked Oppo patent reveals bezelless screen tech

News — 22-Mar-2015

Curved displays seems to be the craze right now and even more so, after Samsung set the tone with the Galaxy Note edge.

Indian Court Sides with Merck in Patent Dispute

Michael Mezher — 23-Mar-2015

A prominent court in India has issued an interim injunction, overturning a previous ruling, in favor of US drug maker Merck in a patent dispute with Glenmark Pharmaceuticals over an active ingredient used in two of Merck's diabetes medicines, Januvia and Janumet.

Big Pharma drives innovation in pain therapy development, despite declining patent applications

EP News Bureau-Mumbai — 23-Mar-2015

Patent applications for pain treatments between 2008 and 2012 were dominated by Big Pharma, including Sanofi, Novartis and Merck & Co

Open Invention Network calls Indian companies to join

Evelyn Fok — 24-Mar-2015

Open Invention Network, a community promoting open source innovation and patent non-aggression in Linux, is reaching out to Indian companies to join its shared patent pool.

Don't dilute Patent Act

Ashwani Mahajan — 24-Mar-2015

Recent visit of US President Barak Obama to New Delhi has been boasted as a major breakthrough in Indian diplomacy.

Facebook’s patent application rejected

Our Bureau — 24-Mar-2015

The patent office has refused to entertain Facebook’s application for patent to the “method and apparatus for an application crawler” that is used to search the Web for files, including texts and videos.

SC stays HC order against Glenmark in patent case

Amit Choudhary — 26-Mar-2015

The Supreme Court on Wednesday stayed a Delhi high court order restraining Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met for allegedly infringing the patent rights of US drug major Merck Sharp and Dohme (MSD).

Motorola found guilty of patent infringement

Reuters — 26-Mar-2015

Patent holding company Intellectual Ventures's second crack at holding Motorola Mobility liable for using its technology without permission partially succeeded after a US jury in Delaware found Motorola infringed a patent on multimedia text messaging.

Pakistan Farmers Challenge GI tag for Basmati rice

Express News Service — 30-Mar-2015

The Intellectual Properties Appellate Board (IPAB), Chennai, has adjourned to July 8 the hearing on an application filed by a Pakistan-based farmers organisation challenging the grant of geographical indication (GI) tag for Basmati rice to certain Indian areas in the himalayan foothills spread between Punjab and Uttar Pradesh.

Nine north-eastern Indian products gets geographical indication registry

Bikash Singh — 30-Mar-2015

The organic and exotic agricultural produce of Northeast India got leg up with as many as nine products accorded geographical indication (GI) registry.

Rasabale and Mattu brinjal losing ground

Niranjan Kaggere, Bangalore Mirror Bureau — 30-Mar-2015

While diseases affect the banana variety, seawater flooding has nearly wiped out the brinjal crop

Corrosion of WTO’S mandate

D. Ravi Kanth — 31-Mar-2015

WTO has done well as custodian of the multilateral trading system, but there have been a few ‘corrosive’ developments, as well as positive ones

Boeing patents Star Wars-style force field technology

PTI — 30-Mar-2015

US aviation giant Boeing has been granted a patent for a Star Wars-style 'force field' technology that would protect vehicles from nearby explosions.

Nine north-eastern Indian products gets geographical indication registr

Bikash Singh — 30-Mar-2015

The organic and exotic agricultural produce of Northeast India got leg up with as many as nine products accorded geographical indication (GI) registry.

Compulsory licensing hit India’s image:Hetero Pharma

DIVYA RAJAGOPAL — 31-Mar-2015

In what is seen as a contrarian stand adopted by an Indian drug maker over intellectual property (IP), Hyderabadbased Hetero Pharma said that the country has lost nearly $10 billion worth of investment by not respecting IP norms.

Nendran Banana gets GI tag

R. Sivaraman — 1-Apr-2015

Bangalore Rose Onion has also received the status

Research activity up in India, but patents are hard to come by

Adarsh Jain — 2-Apr-2015

More research may be happening in academic institutions and industries now than ever before, but the quality of the research remains questionable.

Spurt in number of IPR applicants from state

Laxmi Ajai Prasanna — 2-Apr-2015

Kerala State Council for Science, Technology and Environment (KSCSTE) has constituted a new advisory committee on intellectual property rights (IPR) and has issued an order in this regard.

Procter & Gamble fails to secure patent for smart sanitary napkin in India

Sajan C Kumar | Chennai — 2-Apr-2015

Procter & Gamble (P&G), which manufactures ‘Whisper’, has failed to secure a patent in India for an invention regarding a sanitary napkin that claims to signal the wearer indications on its status.

HC Restrains Centre From Appointing Babus in Copyright Board

IANS — 3-Apr-2015

The Madras High Court has restrained the Centre from appointing any bureaucrat as chairman or member of the Copyright Board and directed that its earlier order on appointments in quasi-judicial boards be followed.

After a decade: why we need to protect Section 3(d) of the patent law

Anand Grover — 03-Apr-2015

For affordable medicines; to ensure only true innovations are rewarded with patent protection

India's GI List Gets Longer with 20 New Products

Express News Service — 5-Apr-2015

Wooden lacquer wear and toys from Prime Minister Narendra Modi’s Varanasi, Bengaluru rose onion, Naga tree tomato, Mizo chilli, Makrana marble from Rajasthan, Nendran banana from Kerala and Meerut scissors - the Geographical Indications (GI) Registry has just got longer.

IPL opening ceremony's music copyright issue settled

IANS — 06-Apr-2015

The row between an official body that works to protect the rights of artists and the organisers of the Indian Premier League's (IPL) opening ceremony over payment of fees for music usage at the programme was resolved ahead of the event on Tuesday.

ICT and ONGC Energy receives patent for process to generate hydrogen from water

BS B2B Bureau | Mumbai — 6-Apr-2015

The patent, granted by US Patent and Trademark Office, holds the potential to open up new vista for generation of hydrogen from water on commercial scale in a sustainable manner in the coming years

Pharma companies dominate 2014 list of Indian firms filing for global patents

Rupali Mukherjee — 04-Apr-2015

Led by companies such as Ranbaxy, Wockhardt and Hetero, the pharma sector dominates the list of top Indian filers under the Patent Cooperation Treaty (PCT) in 2014, seeking protection internationally for their inventions.

IndiaFilings Launches 30 Minute Online Trademark Filing Service

Chennai, Tamil Nadu — 8-Apr-2015

IndiaFilings.com a leading website that helps Entrepreneurs start and manage a business has launched 30 Minute Online Trademark Filing service.

India to soon finalise Doha round work programme

Press Releases — 09-Apr-2015

India will soon finalise its work programme which will be discussed as part of the long-pending agenda of Doha round of talks at the next WTO meet in Nairobi in December, a Commerce Ministry official said on Thursday.

Modi visit will energise India-EU FTA talks: João Cravinho

Nayanima Basu | New Delhi — 09-Apr-2015

Interview with Ambassador of the European Union to India

Court questions Google on patent values in Microsoft case

Reuters — 09-Apr-2015

A US appeals court appeared skeptical on Wednesday toward Google's bid to charge Microsoft a high royalty rate to use some of the internet search provider's Motorola Mobility patents.

Natco takes patent blitz honed in India to US pharma market

Bloomberg — 09-Apr-2015

Natco expects to be among the first to win regulatory approval for its Copaxone generic, with sales anticipated to start in the next six months

Better intellectual property values luring Indian startups abroad

Evelyn Fok & Varun Aggarwal — 10-Apr-2015

Prime Minister Narendra Modi says Make in India.

US Patent Office revokes elements of podcasting patent

Reuters — 11-Apr-2015

The US Patent Office revoked key elements of a Texas company's patent, which the firm deployed in high-profile legal actions to claim ownership over a method for distributing podcasts and video episodes on the internet.

India, EU to discuss FTA on April 13 in Hannover

Nayanima Basu | New Delhi — 11-Apr-2015

EU to push for higher car emission standards

Azamgarh black clay pottery in race to get GI tag

Binay Singh — 11-Apr-2015

The unique black clay pottery of Nizamabad in Azamgarh district may soon join the league of Geographical Indication (GI) tagged products.

Google’s patent to put an end to TV, film spoilers online

PTI — 12-Apr-2015

Search giant Google has been granted a patent for a system that would spot and hide spoilers about TV shows, books and movies from a user’s social media feeds until they are up to date.

Kerala's Ayurveda Patent Cell's work infructuous: CAG

PTI — 12-Apr-2015

The traditional Ayurvedic knowledge in Kerala remain unprotected as the literature digitised by the state's 'Patent Cell' has not been included in the database of the Centre's TKDL, a CAG report has said.

Industrialist wins patent battle against nephew

Sunil Baghel — 12-Apr-2015

Dr Keki Hormusji Gharda's nephew Darius Kavasmaneck had moved the high court saying his uncle shouldn't be allowed to create rights on patents owned by him as their company had spent Rs 180 crore between 2001 and 2010 on research and development.

Mylan settles Viagra patent litigation with Pfizer

Reuters — 14-Apr-2015

Drugmaker Mylan N.V said it settled a patent litigation with Pfizer Inc related to Viagra, paving the way for the launch of the drug's generic version in the United States once approved.

Fears over EU plan for strict drug patent regime

Sushmi Dey — 14-Apr-2015

As Prime Minister Narendra Modi and German Chancellor Markel are set to discuss the India-EU free trade agreement, public health groups and Indian pharmaceutical companies are concerned that the European Commission may push for stringent patent regime for cheaper medicines manufactured at home.

India examines WTO option over EU drug suspension order

EP News Bureau-Mumbai — 15-Apr-2015

The European Medicines Agency (EMA) had in January suspended a number of medicines approved for sale in the EU

Dr Reddy’s in a legal tangle over patent

Trushna Udgirkar — 15-Apr-2015

Sanofi Aventis has sued Dr. Reddy’s Laboratories which wanted to make a generic version of their patented product Jevtana

Apple wins voice recognition patent case in China

PTI — 22-Apr-2015

US tech giant Apple has won a case relating to patent on voice recognition technology in China over a Chinese government agency and a Shanghai technology company.

Stempeutics gets process patent on novel product in China

PT Jyothi Datta — 22-Apr-2015

Even as it awaits regulatory approvals in India on its novel product targeting a limb disorder, Stempeutics Research has crossed a milestone in China with this product.

Despite GI tag, Kora silk has no takers

TNN — 24-Apr-2015

The congested lanes of Thiruvallur Street, located near Alangombu and Sirumugai, 40km from Coimbatore, echo the rhythmic sounds of wooden panels as weavers operate the loom, creating colorful designs on Saris adorned by millions of Indians across the country

India must align patent laws with global standards to boost trade: PM Narendra Modi

ET Bureau — 24-Apr-2015

Batting for opening of sectors such as legal and finance to foreign players, Prime Minister Narendra Modi on Thursday asked the services industry to overcome its fears, asserting that India is globally competitive and suggesting that the country could become a hub for global arbitration with some changes in legislation.

Peps wins intellectual property case against UK brand

Press Trust of India | New Delhi — 24-Apr-2015

Spring mattress company Peps Industries today said it has won an intellectual property rights case against a UK brand for using Hypnos brand name in the Indian market.

USIBC concludes pharmaceutical & biologics mission to India

Our Bureau, Mumbai — 24-Apr-2015

The US-India Business Council (USIBC) concluded its pharmaceutical & biologics executive mission to Hyderabad and New Delhi recently.

IPAB dismisses UK firm's plea to remove trademark Hypnos of Indian firm

BS Reporter | Chennai — 24-Apr-2015

Appellate Board said UK-based Hypnos Ltd, which supplies beds to the British Royal Family, failed to prove international reputation spill over to India

Innovation needs protection

Richard R. Verma — 26-Apr-2015

India and the US share a mutual interest in encouraging innovation and safeguarding intellectual property rights

National IPR Policy still awaited

Nayanima Basu | New Delhi — 27-Apr-2015

November draft proposals had drawn flak; DIPP formulation ready but Cabinet nod yet to come; clashing concerns on pharma sector a key area

International seed day: farmers promote use of patent-free seeds

R. Krishna Kumar — 27-Apr-2015

The movement against monopoly of patented seeds is gaining traction in the State, with hundreds of activist-farmers forming a loose network to propagate the use of indigenous crops and promote the use of patent-free seeds.

Coimbatore college’s novel windmill blade design wins patent

Adarsh Jain — 30-Apr-2015

Students and staff of Park College of Engineering and Technology here in the city have been awarded patent by the Indian Patent Office for designing a low-speed windmill blade.

US names India, China as partners that fail to protect intellectual property rights, hurt economy

AFP — 1-May-2015

The United States on Thursday kept India and China on its Priority Watch List of trading partners that fail to protect intellectual property rights (IPR), hurting the economy.

Talks on India-European Free Trade Association pact stuck over IPR issues

PTI — 1-May-2015

The negotiations between the European Free Trade Association and India over a free trade pact are stuck due to intellectual property rights issues but the Swiss government is hopeful that talks could soon resume.

USTR’s praise of Modi’s remarks worries pharma companies

Sushmi Dey — 2-May-2015

The United States' appreciation of Prime Minister Narendra Modi's remarks on intellectual property rights (IPR) has stirred concerns among the public health groups as well as the domestic drug manufacturing industry.

India will not respond under pressure on IPR issues

AMITI SEN — 3-May-2015

The IPR policy to keep national interest in mind, says Nirmala Sitharaman

India fully aligned with international IPR, will safeguard its own interests, says Nirmala Sitharaman

Dilasha Seth & Soma Das, ET Bureau — 4-May-2015

India is fully aligned with international intellectual property rights standards and "there is no need for anyone to question us", Commerce and Industry Minister Nirmala Sitharaman said, rebuffing a US report released last week that questions India's IP policies

US Welcomes India's Intellectual Property Policy

PTI — 6-May-2015

The US pharma sector has welcomed India's recent moves on intellectual property, including bringing out a draft policy and sustained engagement, while regretting the consistent barriers posed by the country's pharma sector to US companies.

Software needs a stronger IPR regime

VIPIN AGARWAL — 6-May-2015

In the past few decades, India has emerged as a major hub for innovation in product research and development across sectors.

IPR Policy to be Guided by National Interest

The New Indian Express — 6-May-2015

Reacting to the US Trade Representative’s Special 301 report that placed India yet again on the ‘priority watch list’ of countries with an “unfavourable” Intellectual Property Rights (IPR) regime, Commerce and Industry Minister Nirmala Sitharaman has said India’s IPR policy will not be formulated under any country’s pressure but will be guided by its national interest.

Will Real IP Policy Stand up?

Shamnad Basheer — 6-May-2015

Government has been speaking in two tongues on intellectual property.

Chinese company ZTE among world's top patent holders

PTI — 7-May-2015

China's leading telecom equipment manufacturer, ZTE Corp, was ranked third globally in patent applications, the company said citing the World Intellectual Property Organization (WIPO).

US lambasts India on IPR, trade policies

Nayanima Basu | New Delhi — 7-May-2015

USITC initiates fresh round of investigations

Patent pressures

OPINION » EDITORIAL — 7-May-2015

In its 2015 Special 301 Report on Intellectual Property Rights, the office of the United States Trade Representative (USTR) has retained India in its “Priority Watch List”, noting however that bilateral engagement between the two countries on IPR concerns had increased over the past year.

Ericsson takes patent fight against Apple to Europe

Reuters — 8-May-2015

Swedish mobile telecom equipment maker Ericsson has filed lawsuits in Germany, Britain and the Netherlands against Apple over technology licence payments.

India Rejects US Report on Intellectual Property as Unilateral

IANS — 9-May-2015

India has rejected the US' annual report on intellectual property rights (IPR) and patents, describing it as a "unilateral" action "inconsistent" with global trading rules, against the backdrop of its earlier announcement on bringing a national IPR policy by early 2015, parliament was told on Friday.

Protection against piracy: 'Bombay Velvet' producers move HC

Meeta Pillai — 10-May-2015

Producers of upcoming Bollywood crime drama "Bombay Velvet" have moved the Delhi High Court seeking a restraint on local cable operators and websites from showing or providing online access to pirated versions of the Ranbir Kapoor, Anushka Sharma starrer movie.

Patent office rejects J&J arm’s plea for HIV drug intermediate

Sajan C Kumar | Chennai — 12-May-2015

In a setback to US consumer health behemoth Johnson & Johnson, India’s patent office has rejected an application...

India should not give way on IPR

Ravi Kanth — 12-May-2015

The Indian industrial and economic policy elite must not succumb to pressures from Washington and Brussels

Suven Life Sciences gets patents for neurological drug

Press Trust of India | New Delhi — 13-May-2015

With these new patents, Suven has a total of 16 granted patents from Europe and 17 from Hong Kong

Tata Group to double patent base in three years to 4,000

Megha Mandavia & Devina Sengupta — 14-May-2015

Tata Group plans to double its patent base to more than 4000 in the next three years as it pushes through innovation in the century old conglomerate, its first chief technology officer (CTO) Gopichand Katragadda said.

SC bars Glenmark from selling copies of Merck diabetes drugs

Shreeja Sen — 15-May-2015

The court has, however, allowed Glenmark to continue to sell existing inventory

Patent Office rejects Novartis' patent claim on diabetes drug

BS B2B Bureau | Mumbai — 16-May-2015

The company was refused a patent for a modified release formulation of its diabetes drug, Vildagliptin, which it markets under the brand name of Galvus

Defending India’s IPR

C.R.L. NARASIMHAN — 17-May-2015

India’s IPR regime, never in the background, has come under sharp focus recently for a variety of reasons.

Wyeth denied patent for cancer drug

Sajan C Kumar | Chennai — 19-May-2015

The patent office order came in response to a pre-grant opposition filed by Fresenius Kabi Oncology, which alleged that the ‘invention’ was publicly known in India before the priority date of Wyeth’s claim

Mixed decision for Samsung appeal in Apple patent case

PTI — 19-May-2015

A US appeals court on Monday upheld most elements of the blockbuster patent case in which Samsung was found to have violated Apple iPhone patents, but invalidated some of the damages

Strong IPR regime can only entice companies to invest in India: Swiss minister

BS B2B Bureau | New Delhi — 19-May-2015

Johann Schneider Ammann, Swiss economic affairs minister, urges Indian government to remove the difficulties faced by pharma companies in testing and marketing facilities

Novo Nordisk, Baxter clash over haemophilia drug patent

Reuters — 20-May-2015

Novo Nordisk on Wednesday rejected claims by Baxter International that its drug used substances developed by the US rival, following the launch this week of a US investigation into possible patent infringement.

Godzilla creator sues US studio, alleges copyright violation

Associated Press | Yuri Kageyama — 20-May-2015

Japanese movie studio Toho Co. said on Wednesday, it is suing Voltage Pictures and a director in a lawsuit complaining that promotions of an upcoming film infringe on its copyright to Godzilla.

Draft policy on patents stresses enforcement, independence

Arun S | New Delhi — 21-May-2015

National IPR policy is aimed at boosting PM Narendra Modi’s pet ‘Make in India’ and ‘Digital India’ initiatives.

Tech startups plan to secure key intellectual property rights

Biswarup Gooptu, ET Bureau — 21-May-2015

Technology startups mindful of the need to protect key intellectual property in the fiercely competitive Indian startup industry where employees are often poached by rivals will have to ensure they lock the stable doors before the horses bolt.

Columns Letters India’s IPR environment is maturing

Ajay Batra — 22-May-2015

Legal systems are in place, landmark judgments have been pronounced, and next-gen policies are being evolved

Suven Life Sciences gets patents for neurodegenerative drug

PTI — 22-May-2015

Neurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's.

Chennai patent office rejects Merck arm’s plea for female contraceptive

Sajan C Kumar | Chennai — 23-May-2015

NV Organon has failed to secure a patent in India for its invention on a female contraceptive kit

Google to patent 'creepy' internet toys for homes

PTI — 24-May-2015

Google has filed a patent for internet-connected creepy-looking teddy bears and bunny rabbits which could keep a watchful eye on children, eavesdrop on anything we say and control smart home appliances

Smartphone ‘cold war’ seen in Asian moves on patent licensing

Susan Decker | Ian King | Jungah Lee — 26-May-2015

Asian regulators were spurred by the smartphone wars, in which tech giants battled over billions of dollars on four continents for more than four years

Pfizer gets IPAB breather on Zeldox patent

Sajan C Kumar | Chennai — 26-May-2015

In a reprieve to US-based pharma major Pfizer Inc, the Intellectual Property Appellate Board (IPAB) has set aside an order..

Smartphone 'Cold War' seen in Asian moves on patent licensingm the tech giant is fighting.

Susan Decker, Ian King & Jungah Lee — 26-May-2015

New antitrust policies and the clampdown on patents might weaken the ability of Apple, Microsoft and Qualcomm to compete in China and other countries

Basmati rice to get IPR protection as exporters support Centre’s view

Sandip Das | Chennai — 26-May-2015

Chennai-based Intellectual Property Appellate Board is slated to hear the claims of all the parties for three consecutive days from July 8 for granting GI certification to Basmati rice

US Supreme Court Rules Against Cisco in Patent Infringement Fight

Reuters — 27-May-2015

The U.S. Supreme Court on Tuesday ruled against Cisco Systems Inc over a patent infringement claim the tech giant is fighting.

We are not under pressure from the US on IPR: Nirmala Sitharaman

Asit Ranjan Mishra — 2-Jun-2015

The trade balance with China is definitely adverse and it is growing, and this cannot be sustained, says commerce minister Sitharaman

India’s average import tariffs up marginally in 4 years: WTO review

OUR BUREAU — 02-Jun-2015

Trade policy review report does not fault India on its patent regime

India’s import regime still complex: WTO

ENS Economic Bureau — 3-Jun-2015

India continues to have a very complex import regime, notwithstanding the steps taken by it to streamline customs procedures, a World Trade Organization (WTO) report has said. The country has, however, taken a slew of steps to modernise its intellectual property rights regime, the report said.

US co Abraxis denied patent on cancer drug

Rupali Mukherjee — 3-Jun-2015

The Indian Patent Office has refused a patent on US firm Abraxis BioSciences' anti-cancer drug Abraxane, paving the way for generic companies to launch affordable versions in the domestic market.

Relief for Natco Pharma as Chennai patent office rejects US firm’s application for cancer drug

Sajan C Kumar — 06-Jun-2015

The Chennai patent office has rejected an application by US-based Abraxis BioScience related to a new composition for Paclitaxel, an anti-cancer drug marketed under the trade name Abraxane, citing lack of novelty and inventive step.

Intellectual property vital to make in India

Ifftikhar Gilani — 6-Jun-2015

US ambassador to India Richard Verma has liked the success of "Make in India" to not only permitting...

Seeds of doubt: Monsanto never had Bt cotton patent

Shishir Arya & Snehlata Shrivastav — 8-Jun-2015

Fourteen years after US multinational Monsanto brought the genetically modified (GM) Bt Cotton (Bollgard) to India, there is no clarity on the discovery having ever been patented in the country.

With FTA talks set to start, EU seeks to tap Indian middle class

D. Ravi Kanth — 8-Jun-2015

EU director general for trade Jean-Luc Demarty wants more access for the bloc’s automobiles and wines

Cipla's Stempeutics gets process patent for Stempeucel from Japan

PTI — 08-Jun-2015

Drug major CiplaBSE -2.49 % today said its JV firm Stempeutics Research has received process patent from the Japan Patent Office for novel stem cell drug Stempeucel aimed at treatment of critical limb ischemia (CLI).

Opto Circuits subsidiary wins patent case against US firm

BS Reporter | Bengaluru — 9-Jun-2015

To get Rs 147 crore towards loss of royalty from Zoll LifeCor

Decoding Myths & Facts about Patents

Anant Kataria — 12-Jun-2015

A patent is a legal property granted by the government that confers a right for a limited period to anyone who makes an invention of a product or process that meets the conditions of novelty, non-obviousness and industrial use.

India to resist Japan and South Korea

Dilasha Seth — 12-Jun-2015

India will resist a push by Japan and South Korea for stringent patent legislation at the eighth round of negotiations for Regional Comprehensive Economic Partnership (RCEP), according to a senior official.

India’s patent law may face legal hurdle at WTO

D. Ravi Kanth — 12-Jun-2015

Potential challenge from US, Switzerland over provision which defines inventions could hurt Indian drug makers

Eureka Forbes denied patent for Aquasure after Hindustan Unilever’s opposition

Sajan C Kumar | Chennai — 13-Jun-2015

The patent office has rejected an application by Eureka Forbes for a patent for its flagship iron removal water purifier, Aquasure, on grounds of lack of inventive step and insufficient disclosure.

'Biased? India has a balanced pharma patent regime'

Soumonty Kanungo — 15-Jun-2015

India has a balanced pharmaceutical patent regime in place because it needs to hold the rights and interest of a wide section of consumers who are in need of free medicines, according to Frederick Abbott, professor of international law at the Florida State University.

Doctors Without Borders urges PM Modi not to change patent rules

BS B2B Bureau | New Delhi — 15-Jun-2015

MSF has launched global campaign, Hands Off!, urging India to take strong stand against the pressure from MNCs to change India's patent laws that would severely restrict production of generics.

Generic Mistake

The Financial Express — 16-Jun-2015

The push for generics in prescriptions will harm pharma companies and ultimately patients

Nokia, LG join hands; inks smartphone patent license

PTI — 16-Jun-2015

LG Electronics will soon embed technologies developed by Nokia in its smartphones as the Korean firm has agreed to take a royalty-bearing smartphone patent license from the Finnish telecom gear maker.

IPFACE, Gopakumar Nair Associates & others to organise seminar on recent developments in patent law on June 20 in Pune

OUR BUREAU — 16-Jun-2015

The Intellectual Property Facilitation Center (IPFACE), Venture Center & IP Group, NCL Innovations, Gnanlex Hermeneutics and Gopakumar Nair Associates to organise a one day seminar on current themes in pharma patenting with an aim to overview and insights on recent developments in patent law and practice of relevance to the pharma industry and research

India’s patent regime should not change – Cipla CEO

Zeba Siddiqui — 17-Jun-2015

Cipla Ltd, founded in 1935 by scientist Khwaja Abdul Hamied, is among India’s oldest pharmaceutical companies.

Cipla, BMS settles patent dispute

BS Reporter | Chennai — 17-Jun-2015

Parties seek confidentiality of the terms of settlement

The Reason the Statue of Liberty Has Its Own Patent

Kelsey Campbell-Dollaghan-, Gawker Media — 18-Jun-2015

Liberty Enlightening the World. That's the title of patent #USD11023 granted to one Auguste Bartholdi on February 18, 1879. You might know it better as the Statue of Liberty.

Snapdeal faces Heat for Misusing Nalli's Trademark, Photos

Express News Service — 18-Jun-2015

Iconic saree retailer Nalli Chinnasami Chetty has initiated legal action against leading e-commerce giant Snapdeal.com for ‘dishonestly’ using their trademark and brand on the site.

Call to Patent State's Knowledge

Express News Service — 20-Jun-2015

Kerala High Court Judge Justice V Chitambaresh on Friday said that though the State had a huge knowledge-base, processes, products and brands - ranging from Ayurveda to traditional knowledge - many of them were yet to be patented.

US court rejects Teva’s Copaxone patent plea

TNN — 20-Jun-2015

In a major booster for city-based Natco Pharma, the US Court of Appeals for the Federal Circuit has again struck down Israeli pharma giant Teva Pharmaceutical Industries Ltd's Copaxone patent, paving the way for Natco Pharma to manufacture the copycat version of the drug subject to the United States Food And Drug Administration (USFDA) nod.

A Short History Lesson on Patent Policy

Robert Taylor — 21-Jun-2015

To avert serious and lasting damage to our innovation ecosystem and our most promising young companies, it may be helpful to consider some history that appears to have been forgotten.

Bengaluru-based IT firms lead patent hunt

Madhumathi D. S. — 22-Jun-2015

Karnataka has surged ahead in the number of patents filed in 2013-14 with Bengaluru-based Samsung R&D Institute (84); Infosys (83); Wipro Ltd (59); Samsung India Software Operations Pvt. Ltd. (66) top filers from among infotech companies.

Recent developments in intellectual property laws in India- Part 2

Diljeet Titus & Rai S Mittal — 23-Jun-2015

Besides to the most recent developments, in order to bring progressive changes towards a free market society, rapid liberalization of international trade practices and demonstrating its commitments to the WTO under the Trade Related Intellectual Property Rights Agreement (TRIPS), the Government of India undertook a series of steps, to conform India IP legislation to acceptable international standards.

India, Japan to sign pact on increasing IP cooperation

PTI — 25-Jun-2015

The Memorandum of Cooperation will be signed between the Department of Industrial Policy and Promotion and the Japan Patent Office

Govt research body’s claim for constipation drug patent rejected

Sajan C Kumar | Chennai — 25-Jun-2015

The country’s patent office has refused to entertain a claim by the Central Council for Research in Unani Medicine (CCRUM), for a patent on a process for the preparation of a herbal drug composition to treat constipation.

TAKE Solutions secures patent for clinical data standardization process

Sindhu Hariharan — 25-Jun-2015

TAKE Solutions -- a Chennai-based global business technology solutions provider -- has been awarded a patent by the United States Patent and Trademark Office ( USPTO) for its clinical data standardization process.

Is weak IP law enforcement in India a deterrent to Indian industry and innovators?

Anant Kataria — 29-Jun-2015

IP laws or the intellectual property system plays a pivotal role in framing industrial, trade and financial policies, for scientific and technological development of any country.

EU, India aim to resume stalled FTA talks in August

Asit Ranjan Mishra — 30-Jun-2015

Commerce secretary says this is the best time to conclude the deal to give a boost to textile and leather exports

Suven Life Sciences gets patents from Israel, South Africa and Japan for neurological drug

PTI — 30-Jun-2015

Drug firm Suven Life Sciences today said it has been granted a patent each by Israel, Japan and South Africa for a drug used to treat neuro-degenerative diseases.

Coke Studio 'Rangabati...' Tunes on Copyright Notice

Express News Service — 6-Jul-2015

Telecast of remix version of Sambalpuri folk song ‘Rangabati, rangabati...’ on Coke Studio programme of MTV on Sunday even after legal notices were issued to the Coca Cola company, singers and music composer of the remix, has left the copyright owners of the original song shocked.

Delhi High Court upholds BMS’ patent for cancer drug Dasatinib

DIVYA RAJAGOPAL — 6-Jul-2015

The Delhi High Court has upheld the patent of US-based Bristol Myers Squibs (BMS) for Dasatinib, dashing the hopes of a local company to sell a generic version of the cancer drug and providing some relief to multinational drugmakers who are up in arms against India's patent laws.

Indian company seeks compulsory nod for MNC’s drug

Rupali Mukherjee — 6-Jul-2015

A little-known Hyderabad-based pharma company has filed an application with the Patent Office to manufacture saxagliptin, a diabetes drug patented and marketed in the country by MNC AstraZeneca.

Patent to CSIR's iodising agent

Gireesh Babu | Chennai — 06-Jul-2015

he Intellectual Property Appellate Board (IPAB) has directed the Patent Office to grant a patent to the national R&D organisation Council of Scientific & Industrial Research (CSIR) for a novel iodising agent finding its use in iodised salt.

Youth bags patent for music instrument

Shounak Ghosal — 7-Jul-2015

A young pakhawaj player from the city outskirts has bagged a patent for creating a percussion-melody instrument where sound or note is produced by leather and metal string fitted in tension.

Abbott Biotech allowed to appeal against cancellation of patent for Humira drug

Sajan C Kumar — 07-Jul-2015

The Intellectual Property Appellate Board (IPAB) on Tuesday allowed US pharma major Abbott Biotechnology to file an appeal against the order that cancelled the patent for its Humira drug, touted to be a blockbuster medicine for treating severe forms of arthritis. The patent was cancelled on a review petition by Glenmark Pharmaceutical.

AstraZeneca not importing enough of diabetes drug: Lee Pharma

Gireesh Babu | Chennai — 8-Jul-2015

The move was a sign of the evolution of compulsory licensing in India, say experts

GI dispute : Patiala growers join legal tussle at IPAB

BS Reporter | Chennai — 08-Jul-2015

The association says the GI should be allowed based on the geographical area where basmati grows naturally

Lee Pharma files compulsory license application for diabetes management drug Saxagliptin

Ramesh Shankar, Mumbai — 09-Jul-2015

The Hyderabad-based pharmaceutical company, Lee Pharma Limited, has filed a compulsory license (CL) application for the patent covering AstraZeneca’s diabetes management drug Saxagliptin.

Wipro aims to increase rate of patent filing

PTI — 12-Jul-2015

Country's third largest software services firm Wipro aims to significantly increase its rate of patent filing over the next three years.

Compulsory license application may prove to be test for Modi govt

Reghu Balakrishnan — 14-Jul-2015

The reason for the industry’s keen anticipation of the decision is because the govt had assured protection of IP rights to multinational pharmaceutical firms operating in India

Delhi HC stays order restraining Lupin from using disputed trademark

Priyanka Mittal — 14-Jul-2015

The court stayed an earlier order restraining Lupin from using the trademark LUCYNTA for its medicines

The curious case of Indian innovation

Avirup Bose — 15-Jul-2015

The govt should join India Inc in patronising research and training in codified frugal-engineering practices and brand it as a globally-relevant business methodology

CSIR cites ancient texts to foil MNC’s patent plea

Vishwa Mohan — 17-Jul-2015

India has cited ancient texts in foiling an attempt by US-based consumer goods giant Colgate-Palmolive to patent a mouthwash formula containing herb extracts.

India’s pharmaceutical patent law may face new hurdle

D. Ravi Kanth — 17-Jul-2015

The norm calls for applying non-violation complaints to the World Trade Organization’s trade-related intellectual property rights agreement

IPR is a means, not an end

Eben Moglen and Mishi Choudhary — 19-Jul-2015

The Indian government is preparing the National Intellectual Property Rights (IPR) Policy as a presumed base for the unleashing of Indian creativity that will drive...

IPR policy draft under inter-ministerial consultation, final version to be moved to the Cabinet soon

ET Bureau — 21-Jul-2015

The much-awaited National Intellectual Property Rights (IPR) policy will be moved to the Cabinet soon after incorporating inputs from various departments, commerce and industry minister Nirmala Sitharaman said on Monday.

India's IPR Policy to fully protect patents: Nirmala Sitharaman

BS B2B Bureau — 21-Jul-2015

The final draft of the National IPR Policy has been circulated for inter-ministerial consultation and is likely to be put up to the Union Cabinet for approval soon

India must keep patent laws for manufacture of cheap generic drugs

Leena Menghaney — 22-Jul-2015

Recently, trade ministers from 10 Asean countries, India, China, Japan, Australia, New Zealand and South Korea gathered to negotiate a deal on the Regional Comprehensive Economic Partnership (RCEP) trade agreement.

DIPP lays down norms on use of 'Make in India' logo

PTI — 22-Jul-2015

The Department of Industrial Policy and Promotion (DIPP) has come up with detailed guidelines for the use of 'Make in India' logo by various ministries, departments, states, private authorities and electronic media, among others.

Google patents new way to archive, search your ‘real-life experiences

Tech Desk — 23-Jul-2015

Google patent could make your real-life experiences searchable via a device like say the Google Glass.

India IPR Policy Update: Final Draft Circulated

WILLIAM NEW — 23-Jul-2015

The final draft of India’s national intellectual property policy has been circulated for inter-ministerial consultation and will be sent to the Cabinet for approval after receiving comments, the Ministry of Commerce and Industry said this week.

India rejects Swiss drug maker Roche Patent claims on Valcyte again

ET Now — 24-Jul-2015

Indian authorities have for the second time rejected Swiss drug maker Roche's patent claims on valganciclovir, or Valcyte, used to treat an eye infection affecting acquired immune deficiency syndrome (AIDS) patients.

Amul trademark to get global shield

Sidhartha — 24-Jul-2015

Amul is joining the league of global brands such as Coca-Cola, Kodak, Wimbledon and Viagra to get a "well-known" trademark, ensuring unparalleled protection not just in India but across the world.

Nutech gets patent to treat incurable diseases in Malaysia

Press Trust of India | Mumbai — 24-Jul-2015

A technology developed by Nutech Mediworld, the first facility in the world to provide human embryonic stem cell therapy, has been granted the 66th patent in Malaysia for the treatment of various medical conditions.

India granted patent to treat incurable disease in Malaysia

IBNS — 24-Jul-2015

Indian medical innovation has come to the forefront with the Human Embryonic Stem Cell technology developed by Dr Geeta Shroff at Nutech Mediworld being granted the 66th patent in Malaysia for the treatment of various medical conditions.

Colgate fails to secure patent for flexible dome toothbrush

Sajan C Kumar | Chennai | — 25-Jul-2015

Rejecting the application, the patent office based in New Delhi said Colgate-Palmolive’s claims lack novelty and inventive step

Google to curb patent trolls by offering them for free

IndiaToday.in New Delhi — 26-Jul-2015

Patent trolls can prove to be a grave block in the evolution of technology.

US court rejects Glenmark's patent plea for Finacea

Press Trust of India | New York — 28-Jul-2015

Drug firm Glenmark's generic skin care drug that was under patent litigation infinges patent of Bayer, a US court has ruled.

Govt to finalise national IPR policy in 3-4 months: Official

Press Trust of India | Mumbai — 29-Jul-2015

The Centre is likely to finalise the policy on intellectual property rights (IPR) in the next 3-4 months and will come out with clarification on FDI in the e-commerce space, a senior government official said today.

India, US on a collision course over e-commerce, IP norms

D. Ravi Kanth — 30-Jul-2015

The US wants rule of no customs duty on e-tail to continue; India not in favour of preparing any recommendations

High Court rejects AstraZeneca’s diabetes drug plea

ET Bureau — 30-Jul-2015

The Delhi High Court has dismissed AstraZeneca's plea to block Hyderabad based Lee Pharma from making copies of its anti-diabetes drug Onglyza and left it for the patent office to decide whether to grant a compulsory licence for the medicine.

Samsung can halt Smartflash patent infringement trial, says US appeals court

Reuters — 30-Jul-2015

Samsung Electronics Co Ltd, which faced a trial on patent infringement in a lawsuit brought by patent holder Smartflash LLC, can halt the proceedings while the Smartflash patents are scrutinized for their validity by the US Patent and Trademark Office, a US appeals court ruled on Thursday.

Google gets Indian patent

Sajan C Kumar | Chennai — 31-Jul-2015

Google has secured an Indian patent for an invention regarding a method and system for transferring annotations associated with video files.

Samsung can halt Smartflash patent infringement trial

Reuters — 31-Jul-2015

Samsung Electronics Co Ltd, which faced a trial on patent infringement in a lawsuit brought by patent holder Smartflash LLC, can halt the proceedings while the Smartflash patents are scrutinized for their validity by the U.S. Patent and Trademark Office, a U.S. appeals court ruled on Thursday.

2.26 lakh patent applications pending due to manpower shortage: Govt

PTI — 31-Jul-2015

Nirmala Sitharaman said a number of patent applications are lying pending with the govt for due to shortage of professionals

Patent Office refuses Eli Lilly's application for anti-cancer drug

BS Reporter | Chennai — 31-Jul-2015

The Patent Office has refused to grant patent for a crystalline form of Eli Lilly's cancer drug Pemetrexed, in favour of the pre-grant opposition filed by three pharma firms - Fresenius Kabi Oncology Ltd, Cipla Ltd and Glenmark Pharmaceuticals Ltd.

Future sustainability is key to strong brand value

RAMNATH SUBBU, LALATENDU MISHRA — 02-Aug-2015

The business of brands is highly competitive and today traditional global brands that straddled the space for years are confronting the emerging digital media, which is asking a lot of questions. The U.K.-based Brand Finance is a leading player in the global measurement and valuation of brands, and in a chat with The Hindu, Brand Finance CEO, David Haigh spoke about the impact of the economy on brands, the changing paradigm and tips on what Indian brands must do to break into the big league. Edited excerpts:

India foils UK dermaceutical company's bid to patent ayurvedic mix for hair loss

PTI — 02-Aug-2015

India has once again successfully foiled an attempt by a major European major dermaceutical company to take patent on a medicinal composition containing turmeric, pine bark and green tea for treating hair loss.

Mudhi to be promoted globally

Minati Singha — 3-Aug-2015

The humble 'mudhi', a popular snack of Odias, will soon satiate global taste buds.

Geographical indication identifies product's place of origin

TNN — 3-Aug-2015

Geographical indication (GI) of goods is a sign used for products that originate either from a particular country or a specific location in a country.

Startups, SMEs tardy in protecting patents

LUBNA KABLY — 03-Aug-2015

A startup recently found to its dismay that the patent created by its employee was not owned by it. The founders were unaware that under the Indian Patent Act, 1970, the inventor of the patent is the 'first owner'.

German drug maker Merck KGaA finds Indian market promising for its pharma, consumer health business

ET Bureau — 4-Aug-2015

Merck KGaA, the family-controlled $12.5-billion German drug maker, has identified India as one of its key markets under aglobal expansion strategy, amplified with forecasts that the economy could be equal or even outpace China over time.

No local plant registered with PPVFR authority

TNN — 4-Aug-2015

The Protection of Plant Varieties and Famers' Rights Act 2001 (PPVFR Act) is considered landmark legislation for protection of intellectual property rights of plants and seeds conserved by local farmers while keeping within WTO agreements.

India Foils UK Firm's Bid to Patent Use of Turmeric, Pine Bark and Tea

ANI — 04-Aug-2015

India has foiled British firm Pangaea Laboratories Limited's bid to patent the use of turmeric, pine bark and tea for treating hair loss.

Get States into the IPR policy loop

AJAY BATRA — 05-Aug-2015

Beyond the Centre, there is a lack of awareness on how to create an ecosystem that spurs inventiveness

India files 34.4 patents as regards to per million people:Government

PTI — 05-Aug-2015

India registers 34.4 patents in regards to per million people as compared to other developed countries, the government today said.

Need to strike 'careful balance' in Intellectual Property Rights related cases: CCI

PTI — 7-Aug-2015

As it probes cases related to intellectual property rights (IPR), CCI chairman Ashok Chawla on Friday said its intervention in such matters would be "cautious and balanced" to ensure that incentive for innovation is not undermined.

India's first e-flora database developed

IANS | Kolkata — 08-Aug-2015

The Botanical Survey of India (BSI) has developed the first open-access online database of India's floral diversity to document over 18,000 flowering plant species in an effort at boosting digitisation and conservation of endangered ones.

India to unveil new IPR policy in two months

Elizabeth Roche — 08-Aug-2015

Indian firms have done well in following intellectual property rights laws despite complaints from some quarters, says Amitabh Kant

India's Intellectual Property Spend Up by 57 Percentage in 4 Years

Express News Service — 08-Aug-2015

A 6.9 billion dollars was the cost Indian companies had to dish out as intellectual property (IP) royalty in the year 2013. This steep figure accounted for almost 18 per cent of the nations’ Foreign Direct Investment (FDI) that year, said former Supreme Court judge, Justice AR Lakshmanan.

Explaining the intellectual

K. SUBRAMANIAN — 8-Aug-2015

This book expands the boundaries of intellectual property rights to include not just economy but also arts, culture and heritage

Over 1500 yogic asanas shortlisted to thwart patenting by fgn MNCs, individuals

PTI — 09-Aug-2015

In a move that will help thwart attempts by foreign MNCs and individuals to get patents and trademark on ancient yoga techniques, the government has shortlisted over 1500 asanas and videographed over 250, classifying them as "traditional knowledge" of the country.

T-Series has filed a criminal complaint against Mahesh Bhupathi's Blue Whale Motion Pictures on multiple counts

IANS — 10-Aug-2015

T-Series has filed a criminal complaint against Mahesh Bhupathi's Blue Whale Motion Pictures on multiple counts.

Celebrating traditional treasures of GI handloom products

Abhijit Das — 11-Aug-2015

The Geographical Indication tag can be used effectively as a marketing tool for enhancing sales and raising incomes of weavers

Comic characters to give you lessons in IPR

Timsy Jaipuria — 11-Aug-2015

Imagine reading the adventures of your favourite comic characters, flying over houses, brandishing swords or triumphing over evil, and, learning about intellectual property rights (IPR).

Joynagarer Moya wins G I tag

Jhilmil Mukherjee Pandey — 11-Aug-2015

Here's a first from the world of Bengali sweets.

Two Gurgaon schools accused of misusing ‘DPS’ name, get notices

Sandali Tiwari Gurgaon — 12-Aug-2015

The education department has sent notices to two schools running under the popular chain, the Delhi Public School (DPS), in Gurgaon.

BMW checking whether Google’s Alphabet violates its trademark

Reuters, Frankfurt — 12-Aug-2015

BMW on Tuesday said it was looking into whether Google infringed any trademark rights after it set up a new company called Alphabet

Bengaluru Court stops Pearson's Indian arm from infringing on New Rubric Solutions' IP rights

Evelyn Fok — 12-Aug-2015

The Bengaluru City Court has restrained global educational corporation Pearson's Indian subsidiary from infringing on the intellectual property (IP) of Bengaluru-based education startup New Rubric Solutions.

Interim injunction on Audi: In battle for ‘TT’ trademark, garment firm wins round 1 against German auto giant

Aneesha Mathur — 12-Aug-2015

The Delhi High Court, in an order on July 21, has issued an ex-parte interim injunction restraining Audi from using the name ‘TT’ as a brand name.

India, US to hold key commercial dialogue next month

PTI — 12-Aug-2015

India and the US will hold first-ever high-level strategic and commercial dialogue next month in Washington focusing on areas such as ease of doing business and smart cities with an aim to boost investment and raise bilateral trade five-fold to US $ 500 billion annually.

Copycats beware! Amul now has trademark protection

VIRENDRA PANDIT — 12-Aug-2015

No one will be able to use the name, logos or fonts of the dairy product brand

In the forefront of fight against bio-piracy

TNN — 13-Aug-2015

It has been proven beyond doubt, with literature and other records as evidence, that India has always been a treasure trove of medicinal knowledge.

Protecting IPR regime will bring new medicines

13-Aug-2015

Protecting intellectual property will help bring new solutions for rare diseases and new medicines, to save and improve lives.

U.S. patent for MIT engineer’s device

SPECIAL CORRESPONDENT — 17-Aug-2015

aghunath Manohar, deputy engineer in the advanced material testing laboratory of Mechanical Engineering, Manipal Institute of Technology (MIT), Manipal University received a U.S. patent for his invention, Marking Gauge.

Camson’s patent filing may attract attention

17-Aug-2015

Camson Bio Technologies has filed for patent for its discovery of Natural Fertilizer, a product derived from microbial extracts.

India rejects Lee Pharma’s compulsory licence plea

Ruchika Chitravanshi — 18-Aug-2015

India has decided against giving the compulsory licence for Anglo-Swedish drugmaker AstraZeneca's key antidiabetes compound Saxagliptin sought by Hyderabad based Lee Pharma.

Eli Lilly fails to get Indian patent for drug to treat alcohol addiction

Sajan C Kumar — 21-Aug-2015

The Indian patent office has refused to entertain an application by US-based pharma major Eli Lilly and company for a patent on an invention regarding a drug compound of kappa opioid receptor, used for the treatment of disorders associated with alcohol dependency.

Bt cotton: Govt admits Monsanto never had patent in India

Shishir Arya — 26-Aug-2015

Nagpur: Thirteen years after US multinational Monsanto launched Bt cotton seeds in the country, the government has woken up to the fact that the first version of the genetically modified crop was not patented in India. Monsanto ended up earning huge royalties on the Bt seeds even without a patent, changing the economics of cotton farming in India.

Invention spree: 24% jump in patents at IIT-Bombay in five years

Apoorva Puranik — 01-Sep-2015

Students at Indian Institute of Technology, Bombay (IIT-B), are on an invention spree, with patents for inventions like solar-powered fluid heaters, speech decoding systems and a user-friendly map of Mumbai’s rail system jumping by more than 24% this year.

HC notice to govt over MNCs' patent disclosure

Rupali Mukherjee — 2-Sep-2015

MUMBAI: In a development that could have major ramifications on intellectual property cases in pharmaceutical and technology sectors, the Delhi high court issued a notice to the government on Tuesday in a PIL (public interest litigation) filed by IP expert Shamnad Basheer.

Pfizer’s patent application for arthritis drug rejected

Sajan C Kumar — 4-Sep-2015

In a setback to US drug major Pfizer, the country’s patent office has rejected for the second time, the patent application for its rheumatoid arthritis treatment drug Tofacitinib in India.

Recent guidelines from Indian Patent Office will stifle innovation: Software product lobbies

Vishal Dutta & Krithika Krishnamurthy — 7-Sep-2015

The Indian Patent Office's recent guidelines, declaring that software and business methods are patentable in India, has set off alarm bells across the software product industry.

Pfizer’s patent claim for Xeljanz dismissed

Vikas Dhoot — 7-Sep-2015

The Indian Patent Office has denied American drugmaker PfizerBSE -0.82 % patents for certain isomers and stereoisomers of tofacitinib, a product it markets globally as Xeljanz for the treatment of rheumatoid arthritis, in the latest example of a foreign company finding it difficult to patent incremental innovations in the country.

Free Software activists against changes to patent norms

OUR BUREAU — 07-Sep-2015

he Free Software Movement of India (FSMI) has alleged that the new Guidelines for Examination of Computer Related Inventions are illogical.

Pfizer's arthritis drug application gets rejected by Indian patent office again

PTI — 8-Sep-2015

The Intellectual Property Appellate Board (IPAB) in October last year set aside an order by the patent office which rejected Pfizer's patent for a new formula of the drug and directed it to re-consider the application.

Patent for Ayurveda Anti-rabies Medicine

Express Features — 10-Sep-2015

A traditional ayurveda practitioner from Kozhikode got patent for his herbal composition which has proved effective against Rhabdovirus.

More steps required to make India investment friendly: CII

Press Trust of India | Washington — 10-Sep-2015

More steps needs to be taken to make India an investment friendly destination as there is a long way to go, a top leader of an association of Indian businesses has said here in the US.

Suven Life gets patents for neurodegenerative drug

PTI — 10-Sep-2015

Biopharma firm Suven Life SciencesBSE 2.35 % today said it has been granted one patent each in 5 nations, including China and Israel, for a drug used in the treatment of neurodegenerative diseases.

CFTRI to file patent for bottled sugar cane juice

V. RAGHAVENDRA — 11-Sep-2015

The Central Food Technological Research Institute (CFTRI), Mysore, is in advanced stages of filing patent for bottled sugarcane juice, for which it has developed preservation and packaging technologies.

Patent Controller to hear Lee Pharma’s plea on compulsory licence for diabetes drug

AMITI SEN — 11-Sep-2015

CL application was prima facie rejected by the Patent Office in August

IPA, Natco withdraw opposition to Gilead's drug

Gireesh Babu | Chennai — 14-Sep-2015

We wanted to tell the big pharma that IPA is not unreasonable and we are not blindly following an idea, said IPA

Revised patent norms for software could impact tech start-ups

Sadhana Chathurvedula — 15-Sep-2015

Revised guidelines say software that demonstrates a technical application or improves hardware may also be patented, widening the scope of patents

Spicy insight: Curcumin database to preclude false patent claims

IANS — 15-Sep-2015

Indian scientists have created the world's first comprehensive open database on curcumin - the star therapeutic component of the golden Indian spice turmeric and a hot favourite with researchers across the globe -- to foster innovation and generate public awareness.

IPR policy contains commitment to legal rights of patent: US

Press Trust of India | Washington — 15-Sep-2015

Under the current administration, political attitudes toward IP seem to have improved, it said

Hope that IPR policy of India contains commitment to legal rights of patent: US

PTI — 15-Sep-2015

The US business community has hoped that the much-anticipated intellectual property rights (IPR) policy of India contains a principled commitment to the legal rights of patent, copyright, and trademark holders.

Revival of FTA talks on agenda for Merkel visit

Huma Siddiqui | New Delh — 16-Sep-2015

With German Chancellor Angela Merkel set to visit India early October, the two countries are working to take up several issues...

Onbrez case: Delhi High Court reserves decision on Novartis-Cipla patent dispute

Vikas Dandekar — 16-Sep-2015

A division bench of the Delhi High Court has reserved its decision on a high-profile patent case that pitted Swiss drug maker Novartis against Cipla over its respiratory drug brand Onbrez.

Trademark for Pokkali rice

SPECIAL CORRESPONDENT — 16-Sep-2015

The Indian Council of Agricultural Research-Krishi Vigyan Kendra attached to the Central Marine Fisheries Research Institute here has registered a trademark Jaiva Pokkali at the Chennai trademark registry to be leased free to groups of pokkali farmers, who wish to use the trademark on their produce.

Patent Office refuses application for AcelRX's Nanotab Sufentanil

Gireesh Babu | Chennai — 17-Sep-2015

Application failed to pass the test of Section 3(d)

Verdict corner: Aligning India’s patent law with global standards

Indu Bhan — 18-Sep-2015

The country is emerging as a jurisdiction where customised patent prosecution strategies must be followed

Dr Reddy's, BioMarin settle Kuvan patent suit

Agencies — 22-Sep-2015

The Californiabased BioMarin Pharmaceutical has entered into a settlement agreement with Dr Reddy's Laboratories to resolve patent litigation in the US regarding Kuvan, the former's 100mg oral tablets.

US industry waiting to hear PM Narendra Modi's stand on Intellectual Property Rights

Dipanjan Roy Chaudhury — 22-Sep-2015

The US industry will wait to hear the Narendra Modi government's stand on protection of Intellectual Property Rights when PM meets business leaders in New York and Silicon Valley this week.

US judge rules copyright for ‘Happy Birthday’ song invalid

Reuters — 23-Sep-2015

In order to make his ruling, US District Judge George H. King had to delve into the song's long and complicated history.

Can India & America take Gilead-IPA model further?

Ashok Malik — 24-Sep-2015

As Prime Minister Narendra Modi begins his second trip to the United States, the bilateral relationship between New Delhi and Washington, DC looks remarkably different from the summer of 2014.

Patent office rejects Google invention on improving online ads with audio

Sajan C Kumar | Chennai — 25-Sep-2015

Google has also informed the patent office about its new-found disinterest in the subject matter, just barely a month after it appeared for a hearing to push the application.

Modi in US: PM meets media magnates; promises protection to Intellectual Property Rights

PTI — 25-Sep-2015

Presenting India as a technology-driven society, Prime Minister Narendra Modi today pledged protection to Intellectual Property Rights (IPR) as he met top executives of major media and communication companies.

Patent Office refuses application for Genentech's cancer drug

BS Reporter | Chennai — 25-Sep-2015

While Glenmark and others filed pre-grant opposition, all parties told patent office they do not want to pursue the case

Alstom allowed to appeal against rejection of its patent application

Manish Raj — 28-Sep-2015

Showing a little leniency towards appeals that are delayed but have valid reasons, the Intellectual Property Appellate Tribunal (IPAB) has said the term "sufficient cause" should be analyzed "liberally" when appeals are filed with a little delay in judicial forums.

G20 should consider a new, more fair intellectual property rights regime

SA Aiyar in Swaminomics — 30-Sep-2015

Cynics say that G20 meetings are a complete waste of time.

West Bengal Submits Application for Rosogolla Geographical Indication Tag

All India | Indo-Asian News Service — 30-Sep-2015

West Bengal has submitted the application for a (Geographical Indication) GI tag for the rosogolla to stake claim on the sugary delicacy and beat Odisha, a minister said.

Facebook ‘copyright’ declaration again? It’s a hoax and let Jon Oliver explain that

Tech Desk — 1-Oct-2015

On Facebook, one popular scam that keeps resurfacing every year is a 'legal'-sounding message which aims to 'protect' users content. Sadly it remains a giant fraud

Google, Microsoft resolve global patent feud over smartphones, Xbox

Susan Decker, Dina Bass — 1-Oct-2015

Google, Microsoft to drop about 20 lawsuits in US and Germany

Why Bengal, Odisha’s claim to rasgulla is not ‘rational’

Zia Haq, Hindustan Times, New Delhi — 2-Oct-2015

Both states have staked claim to India’s most iconic snack -- a syrupy, spongy ball -- and are now reportedly preparing to acquire a Geographical Indication (GI) for it, which is essentially about putting a legal stamp of origin on the rasgulla.

Has the US diluted pressure on India’s IP regime?

DG SHAH — 2-Oct-2015

India should keep its patent dialogue alive with America, while protecting its interests

Microsoft and Google call truce in patent wars

PTI, San Francisco — 2-Oct-2015

After years of tussle over devices, applications and services, technology titans Microsoft and Google have announced their agreement over ending all patent infringement litigation against each other.

PM Narendra Modi wants delays in patent grants to be history

2-Oct-2015

Prime Minister Narendra Modi has slammed the delays in approving patent and trademark applications and asked for a reduction in paperwork for speedier clearances - a major gripe for global investors who often raise concerns about the enforcement of intellectual property rights in India.

PM Narendra Modi wants delays in patent grants to be history

ET Bureau — 2-Oct-2015

Cipher, Ranbaxy settle patent litigation with Actavis

05-Oct-2015

Cipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical Research, has entered into a patent litigation settlement with Actavis over generic version of Absorica, a drug used to treat acne.

Cipher, Ranbaxy settle patent litigation with Actavis

05-Oct-2015

Congress dismisses RSS claim against Rahul as 'patent lie'

PTI — 06-Oct-2015

Congress today dismissed as a "patent lie" a report in the RSS mouthpiece, which claimed that party vice-president Rahul Gandhi drew daily parliamentary allowance despite being absent from the House during his 56-day sabbatical earlier this year.

Modi's Valley hug sparks swadeshi talk

Sujit John & Shilpa Phadnis — 6-Oct-2015

This includes the issue of net neutrality , on which the government is seen to be waffling, and the guidelines issued by the Indian Patent Office declaring that software is patentable in India.

Patent blitz likely to pay off for Arrow Coated products; shares jumped 3000% in 2 years

Jwalit Vyas, ET Bureau — 6-Oct-2015

ET Intelligence Group: The shares of Arrow Coated Products have spiralled 3000 per cent — from Rs 15 to Rs 490 — in the past two years with the company beginning to 'monetise' its patents.

STALEMATE ON PRICING PATENTED DRUGS

P A Francis — 06-Oct-2015

The policy of price control in pharmaceutical industry continues to remain partial and unfair to patients in India as large number of expensive patented drugs still remain outside the purview of Drug Price Control Order. Indian Patent Act was amended in 2005 almost after 35 years of its notification allowing product patent to new drugs and pharmaceuticals.

International politics and IPR

Dr R Saha — 07-Oct-2015

The recent WTO’s Trade Policy Review (TPR) in respect of India has put to rest any misgivings about the robustness of India’s IPR regime particularly related to laws and the judicial system.

Apple Inc gets India patent for compact antenna in mobile phones

Sajan C Kumar | Chennai — 8-Oct-2015

The patent filing mentioned Zhang Zhijun, a Chinese citizen, and Caballero Ruben, a Canadian citizen, as the inventors.

Glenmark loses anti-diabetes drugs' patent battle to Merck

Press Trust of India | New Delhi — 8-Oct-2015

However while granting the injunction, the high court did not say anything about sale of existing stock

Indian drug makers engineer hepatitis C cocktails impossible in West

Ketaki Gokhale, Caroline Chen — 9-Oct-2015

Generic drug makers are working on a one-pill cocktail of the ingredients in Daklinza and Sovaldi that could compete with blockbuster Gilead drugs

Suven Life gets patent for neuro-degenerative drug

PTI — 13-Oct-2015

Drug firm Suven LifeBSE 0.83 % Sciences has been granted patent by Australia, China, Europe, South Korea and the US for a drug used in the treatment of neuro-degenerative diseases.

Samsung patent case: Nvidia to seek review of US judge’s determination

ALKA KSHIRSAGAR — 13-Oct-2015

In the next step in the patent infringement lawsuit against Samsung, Nvidia will seek a review by the six commissioners of the US International Trade Commission (ITC) on what the judge determined, and confirm the judgment of the US Patents Office.

Dr.Reddy’s and Helsinn settles patent litigation for anti-nausea Aloxi injection

Viswanath Pilla — 13-Oct-2015

The settlement will allow Dr. Reddy’s to market the generic version of Aloxi in the US on 30 September 2018 or earlier under certain circumstances

Apple loses patent lawsuit to University of Wisconsin, faces $862 mn in damages

Reuters — 14-Oct-2015

Apple Inc could be facing up to $862 million in damages after a US jury on Tuesday found the iPhone maker used technology owned by the University of Wisconsin-Madison's licensing arm without permission in chips found in many of its most popular devices.

India opposes proposed European Trademark rules

Asit Ranjan Mishra — 14-Oct-2015

India fears provision will be used to seize low-cost generic drugs headed for African and Latin American nations

Apple may face $400 million in damages over university patent case

Reuters, New York — 15-Oct-2015

The disputed patent relates to technology found in several of Apple’s phone models, including it’s latest releases.

US varsity cites two Indians' work in $862 million patent case against Apple

Chidanand Rajghatta — 15-Oct-2015

Gurindar Sohi and T N Vijaykumar are not names that will leap out of your latest iPhones as you gush over the performance of Apple's much-coveted devices.

Karnataka Pips TN to Post on Patents

Jonathan Ananda — 15-Oct-2015

Patents. Those innocuous bits of rubber stamped paper that make the difference between making yourself a million dollar invention or making an invention that earns someone else a million dollars

Leaked draft only an input to national IPR policy: Amitabh Kant

Asit Ranjan Mishra — 15-Oct-2015

Industry secretary says that the final policy will be in place in next 30 to 45 days

Shell companies' patents to come under domestic tax net on adoption of BEPS

Sachin Dave — 23-Oct-2015

Technologies that are developed in India but their patents registered in tax havens may come under the domestic tax net from the next financial year, when the country is expected to adopt a new world standard aimed at preventing abuse of double taxation avoidance agreements.

Colgate-Palmolive gets patent right for a powered toothbrush

BS Reporter | Chennai — 26-Oct-2015

There is a need in the art for a powered toothbrush with increased effectiveness, says the company in claims

Column: Drug licensing must recognise patents

Uttam Gupta | October — 30-Oct-2015

Once patent-linkage gets embedded in our law, cheap drugs won’t get market entry

Govt proposes patent rule changes to boost ease of doing business

FE Bureau | New Delhi — 30-Oct-2015

The government on Thursday proposed amendments to the rules under the Patents Act to streamline the application process, as part of its efforts to improve the ease of doing business in India.

Investigators get tips on combating counterfeiting, piracy

PTI — 02-Nov-2015

An interactive session was organised here for police and other investigating officers on combating counterfeiting and piracy.

Draft patent rules propose quick clearance, greater clarity

OUR BUREAU — 02-Nov-2015

Under ‘expedited examination’ provision, the examiner must complete report within 2 months

Plea on IBL's IPR to be heard on December 10

03-Nov-2015

BAI has recently announced that they will conduct the 2nd edition of IBL in January 2016 on their own.

Notice to Centre Over Appointment of Patents Registrar

Express News Service — 4-Nov-2015

he High Court on Tuesday issued notice to the Union government on public interest litigation (PIL) seeking directions to remove IAS officer Rajiv Aggarwal as Registrar and Controller of General Patents, Designs and Trademarks.

ESDS Software gets US patent for its cloud tech

RAJESH KURUP — 04-Nov-2015

ESDS Software Solution has been awarded a patent for its cloud computing technology by the US patent office, making it first Indian company to be recognised in this space.

Apeda says can’t include MP for Basmati GI tag

Sajan C Kumar | Chennai — 5-Nov-2015

The Basmati Growers Association from Pakistan also challenged the Apeda move in the IPAB claiming that Basmati is a name for a slender, aromatic and long grain variety of rice grown in the specific geographical area at the foothills of the Himalayas in Pakistan.

Strengthening IP policies will fuel India's growth, development

IANS — 5-Nov-2015

India's modest improvement in the World Bank's "Doing Business Index" this year, along with the Bank's projection that the economy will continue to experience merely moderate growth, were not the boosts that Indian officials hoped for.

Column: DCGI doesn’t infringe Indian patent laws

Anand Grover — 5-Nov-2015

It is neither authorised by the law to assess patent issues nor does it have the institutional competence for this

Pressure over patent laws

Ashima Sahni, — 6-Nov-2015

There is no doubt that India — often called the pharmacy of the world — has played an important role in improving the lives of people from the poor African countries by providing affordable drugs.

India catching up with China in patented products

T.V. SIVANANDAN — 6-Nov-2015

Executive council member of the Visvesvaraya Technological University, V.D. Mytri, an expert on Intellectual Property Rights (IPR), has said that India was catching up with China in getting patents for various products and innovations and in another decade would surpass it.

Merck & Co to expand in India, favourable IPR ruling encourages co to invest more

Vikas Dandekar, — 6-Nov-2015

Merck & Co. wants to expand its presence in India, building on what the $42-billion US pharmaceutical giant calls a "responsible pricing strategy" and heartened by a recent intellectual property rights ruling in its favour.

Tata Global Beverages fails to get patent for herbal tea

Sajan C Kumar | Chennai — 7-Nov-2015

The patent office has refused to grant a patent to Tata Global Beverages (formerly known as Tata Tea) for its 'invention' regarding a process for preparation of flavoured herbal tea.

Patent registration: Centre plans cutting approval time to 15 months from 5-6 yrs

As many as 2,26,339 patent applications were pending as on July 31, 2015, due to shortage of professionals, according to the government data.

Shruti Srivastava

23-Nov-2015

Google’s latest patent allows for device to draw blood without needles

Google has filed a patent that could allow for blood to be drawn without needles, and the patent is available online

Tech Desk

7-Dec-2015

TVS Motor backs out of patent row

The invention was novel as well as simple-a self-locating ignition lock assembly which comprises a lock body with a key slot for the ignition key, with a plate made of a fluorescent substance that absorbs light energy during the day and render itself fluorescent at night

Sajan C Kumar | Chennai

Only 8 patents granted to Panjab University inventors since 2007

According to the data from the Centre for Industry Institute Partnership Programme (CIIPP) at PU, only eight patents have been granted to inventors from the varsity since 2007.

Meghna Malik | Chandigarh

13-Jan-2016

Duplicate GI products hampering niche market: Textile Min

According to the statement, this is hampering the niche market of these handloom products affecting their goodwill adversely and shrinking their market value due to encroachment on their registered geographical indications.

PTI

13-Jan-2016

TVS Motor backs out of patent row

Sajan C Kumar | Chennai

12-Jan-2016

Lower tax on patent income to boost R&D

Rupali Mukherjee — 2-Mar-2016

The Budget has introduced a special 'royalty tax' which lowers the effective rate of tax on income earned from patents. The objective is to encourage indigenous research and development, and to make India an innovation hub. The benefit will be available across knowledge-based sectors of the economy, including pharmaceuticals.

Money laundering: Trade patents, a new tool for bringing back black money

Sachin Dave — 2-Mar-2016

People who own patents in India are suddenly in demand - in many cases not because of the value of their inventions that may be worthless, but as a conduit to launder money .

Johnson & Johnson receives patent for multifocal contact lens designs

BS Reporter — 28-Mar-2016

Johnson & Johnson Vision Care Inc has received patent in India for multifocal contact lens designs, for contact lens for the aged especially patients with presbyopia.

HC upholds CCI jurisdiction over patent matters

Deepak Patel — 31-Mar-2016

In a huge win for the Competition Commission of India (CCI), the Delhi High Court on Wednesday upheld its jurisdiction to investigate patent-related competition matters. The regulator would now be able to freely investigate and pass orders in the cases filed by Micromax and Intex against Ericsson, alleging abuse of dominance in the market of technology patents.

GlaxoSmithKline promises reduced drug patents to help world's poor

By Reuters — 31-Mar-2016

GlaxoSmithKline is to adopt a graduated approach to patenting its medicines, depending on the wealth of different countries, in order to make drugs more affordable in the developing world.

Start-ups should understand Intellectual Property

8-May-2016

There is a need to develop product-based technologies, for which patents can be obtained, according to Ramesh Loganathan, President of HYSEA and Vice-President of Progress Software Dev Pvt Ltd. He was speaking at a seminar organised on Intellectual Property Rights (IPR) management, organised by the Confederation of India Industry (CII) in association with the Department of Electronics & IT (DeitY), Government of India.

Shaping Standard Essential Patents policy

The government must ensure that standard essential technologies are accessible on FRAND terms.

Vaibhav Choukse

8-Aug-2016

Indian Pharma Exporters & The World of P-MEC-Collector’s Edition

8-Nov-2016

Indian Pharma Exporters & The World of P-MEC-Collector’s Edition: Key highlights

India defends IP rights despite threats from US pharma lobby groups

A week after the US Chamber of Commerce released its Global Intellectual Property Report that named India among worst countries in terms of IP rights, the commerce ministry has stood its ground by asking those discontented with the country’s IP regime to take up the issue at multilateral trade channels.

Divya Rajagopal

16-Feb-2017

Indra Nooyi-led PepsiCo gets Indian patent for wonder beverage preservative system

Many food and beverage products include chemical preservatives to extend the shelf life of the product by inhibiting the growth of spoilage microorganisms such as mold, yeast and bacteria.

Sajan C Kumar | Chennai

17-Mar-2017

India’s proposed Intellectual Property Exchange could help determine quality of patents

Several firms in telecommunication, especially SMEs and startups, that have struggled to pay desired royalties to use essential patents can build new and expand existing IP portfolios, which can facilitate cross-licensing deals with other patent holders

Ashish Bharadwaj and Punkhuri Chawla

31-Jul-2017

Patent Battle Over Breast Cancer Drug: Roche Withdraws Its SLP Against Delhi High Court’s Approval To Biosimilars.

Swiss Pharma major, Roche has withdrawn its Special Leave Petition filed in the Supreme Court against the Delhi High Court’s March 3 decision, rejecting its challenge to the grant of approval to drug companies, Biocon and Mylan, to use product data f...

Live Law News Network

13-Aug-2017

How pharma firms stretch their patents

(New Delhi edition) — 17-Sep-2017

Medicines are a big business, and a highly profitable one at that, but the key to maintaining super profits is to keep your patents alive for as long as possible. Leading pharma companies do it in a number of fair and unfair ways, an article in Statnews points out.

No Relief For Toyota From Supreme Court In The Prius Matter.

Adheesh Nargolkar, Shailendra Bhandare and Sourav Dan — 14-Dec-2017

the Supreme Court of India (Supreme Court) has affirmed the order of the Division Bench of the Delhi High Court (Division Bench) permitting the use of the mark PRIUS by Prius Auto.

Kamat Hotels (India) wins the trade mark case against ROHL

P Krishna Kumar — 15-Dec-2017

In a major legal victory for Kamat Hotels (India) Ltd., and a loss of face for the Royal Orchid Hotels Limited (ROHL) in a long drawn legal battle, the Supreme Court today while disposing of a Special Leave Petition (SLP) filed by ROHL has upheld the Madras High Court order of February 11, 2015 restraining them from using the trade mark/logo which is same or similar to that of ‘Orchid’, a brand promoted by Kamat Hotels.